Clustering O 0 3.1509339351032395e-06
of O 0 8.558005220038467e-07
missense O 0 1.1097483820776688e-06
mutations O 0 1.696928286776256e-08
in O 0 1.1298563196149303e-09
the O 0 2.271898296157815e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 2.9580067462120496e-07
in O 0 1.607976751749618e-09
a O 0 1.3984099433983488e-09
sporadic B-Disease 0 2.9862255246371205e-07
T I-Disease 0 0.00012177041207905859
- I-Disease 0 9.835504897637293e-06
cell I-Disease 0 5.915771907893941e-07
leukaemia I-Disease 0 1.9545408576959744e-05
. O 0 1.1074271100142141e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.534413164947182e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.0527583249597683e-09
is O 0 1.3832830714211042e-10
a O 0 1.8218077046938674e-10
recessive B-Disease 0 3.5306904067056166e-08
multi I-Disease 0 1.1406851285755693e-07
- I-Disease 0 0.008911498822271824
system I-Disease 0 3.1792465051694307e-06
disorder I-Disease 0 0.00023120490368455648
caused O 0 2.2744330863133655e-09
by O 0 3.918419755333247e-11
mutations O 0 4.487431537469888e-10
in O 0 1.4174079965290076e-10
the O 0 1.1017929679724148e-08
ATM O 0 5.4346901379176416e-06
gene O 0 2.4777093710071085e-09
at O 0 1.526045245725527e-08
11q22 O 0 7.258070127136307e-06
- O 0 1.9994661215605447e-06
q23 O 0 6.580648459930671e-06
( O 0 1.2818660577451624e-09
ref O 0 8.286671970836323e-08
. O 0 4.219364302393558e-10
3 O 0 1.7484151015878524e-08
) O 0 3.4948699489945056e-09
. O 0 3.750880850361682e-08

The O 0 5.896665911109267e-08
risk O 0 2.4687813038326567e-07
of O 0 6.349238645952937e-08
cancer B-Disease 0 2.849902784873848e-06
, O 0 8.250469751835965e-10
especially O 0 3.922813185397445e-09
lymphoid B-Disease 0 2.4495315642525384e-07
neoplasias I-Disease 0 0.00013207824667915702
, O 0 2.0238952735951443e-09
is O 0 2.1614705858485905e-10
substantially O 0 2.7757709464282243e-09
elevated O 0 1.878755426787393e-07
in O 0 9.715590554293385e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.4349548216330277e-08
and O 0 1.732205073823323e-10
has O 0 7.893443537687617e-11
long O 0 2.2013205147608517e-10
been O 0 3.018998939730011e-11
associated O 0 2.483845351619607e-10
with O 0 4.57407312026703e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 9.24067478536017e-07

By O 0 9.418348767553653e-09
analysing O 0 1.0481224990144256e-06
tumour B-Disease 1 1.0
DNA O 0 6.410726882677409e-08
from O 0 2.986276226302209e-10
patients O 0 7.680194674675178e-11
with O 0 8.830913431068232e-12
sporadic B-Disease 0 3.437947384554718e-07
T I-Disease 0 0.00017274374840781093
- I-Disease 0 3.123025089735165e-05
cell I-Disease 0 1.3158039564586943e-06
prolymphocytic I-Disease 1 0.9999630451202393
leukaemia I-Disease 0 0.00016343539755325764
( O 0 1.946992123080804e-09
T B-Disease 0 2.2013916805008193e-06
- I-Disease 0 4.4040044144821877e-07
PLL I-Disease 0 9.13366147869965e-06
) O 0 1.5080461879257712e-10
, O 0 1.0491256474676192e-10
a O 0 3.988540608901303e-10
rare O 0 1.0511617354325153e-08
clonal B-Disease 0 2.190009666946935e-07
malignancy I-Disease 0 1.5958711685470917e-07
with O 0 5.1420371433019696e-11
similarities O 0 5.610653608378868e-10
to O 0 1.3392696673886206e-10
a O 0 5.973523897750965e-10
mature B-Disease 0 3.1345759765599723e-08
T I-Disease 0 1.3746409877057886e-07
- I-Disease 0 1.3634141282636847e-07
cell I-Disease 0 1.7022188103510416e-08
leukaemia I-Disease 0 1.495961754471864e-07
seen O 0 1.4625693989245292e-09
in O 0 1.6260026658443394e-10
A B-Disease 1 1.0
- I-Disease 0 0.0013836363796144724
T I-Disease 1 1.0
, O 0 4.289015531622198e-10
we O 0 2.933222068013386e-11
demonstrate O 0 5.7291622834743094e-11
a O 0 1.416293905071031e-11
high O 0 1.0368026437390654e-09
frequency O 0 6.015312692397856e-10
of O 0 8.084724889556583e-09
ATM O 0 1.197262008645339e-05
mutations O 0 8.368121484636504e-08
in O 0 3.627499012281987e-08
T B-Disease 1 0.8491236567497253
- I-Disease 0 0.0003033433749806136
PLL I-Disease 0 0.0007646070444025099
. O 0 2.3124914605432423e-07

In O 0 9.262643096974443e-09
marked O 0 1.1845294523027405e-08
contrast O 0 9.07894537327536e-10
to O 0 3.058878428330303e-10
the O 0 4.179988355446085e-09
ATM O 0 1.0970277799060568e-05
mutation O 0 6.5035989926798266e-09
pattern O 0 3.5639906581508285e-09
in O 0 5.542410974612721e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 6.114924677724787e-10
the O 0 4.182171831068615e-10
most O 0 6.405254798780291e-11
frequent O 0 1.6998875917995093e-10
nucleotide O 0 7.348667230289152e-10
changes O 0 1.6384180123729664e-10
in O 0 3.357597533337753e-11
this O 0 2.3769827772746055e-10
leukaemia B-Disease 0 2.706981945266307e-07
were O 0 1.1799068388995693e-08
missense O 0 3.3516855637572007e-06
mutations O 0 3.4371149126855016e-07
. O 0 8.591912603606033e-08

These O 0 1.4699254258232486e-08
clustered O 0 1.3307155377617619e-08
in O 0 1.5285606114190387e-10
the O 0 8.058610445615955e-10
region O 0 1.0214300516508956e-08
corresponding O 0 1.9196020328848817e-09
to O 0 7.550017833146683e-10
the O 0 9.289288449565447e-09
kinase O 0 6.479395153746736e-08
domain O 0 5.517816425992805e-09
, O 0 2.156751027770909e-10
which O 0 6.017271403369051e-11
is O 0 1.0584638027166804e-10
highly O 0 2.677734922684749e-09
conserved O 0 1.020863305001285e-08
in O 0 7.350222652746652e-10
ATM O 0 7.035550311229599e-07
- O 0 3.843435436579057e-08
related O 0 1.0879559475540646e-08
proteins O 0 4.2046605780443613e-11
in O 0 4.329236968914074e-11
mouse O 0 7.677595448285501e-09
, O 0 3.6661690350214826e-10
yeast O 0 2.4657489383628217e-09
and O 0 1.2219666389867712e-09
Drosophila O 0 1.0906491354489845e-07
. O 0 2.1687203144438172e-08

The O 0 4.982976520295779e-07
resulting O 0 2.685432036741986e-07
amino O 0 1.5350718030049393e-08
- O 0 1.637510571583789e-08
acid O 0 1.1121979781592017e-08
substitutions O 0 9.706575099244219e-09
are O 0 5.161631191907823e-11
predicted O 0 2.2703459112705104e-09
to O 0 1.100104007889513e-09
interfere O 0 1.1590114645798621e-08
with O 0 1.4081015242695116e-09
ATP O 0 3.891759843099862e-05
binding O 0 7.076740615730159e-08
or O 0 1.078673927956686e-09
substrate O 0 5.1118288268980905e-08
recognition O 0 1.0142841233573563e-07
. O 0 9.38263511329751e-08

Two O 0 1.1887850348557549e-07
of O 0 3.977400524490804e-07
seventeen O 0 2.090254838549299e-06
mutated O 0 6.246011707844445e-07
T B-Disease 0 2.091598844344844e-06
- I-Disease 0 4.3702860352823336e-07
PLL I-Disease 0 3.6914407246513292e-06
samples O 0 1.4434966555398887e-09
had O 0 3.243711965694729e-10
a O 0 2.0516566223705013e-10
previously O 0 3.330188347305807e-09
reported O 0 6.463704238512946e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 4.771787871504785e-07
. O 0 8.836052955984997e-08

In O 0 3.074555943172186e-09
contrast O 0 2.9031463899542587e-09
, O 0 4.80539386060741e-10
no O 0 8.52577286547529e-10
mutations O 0 2.6068233682785547e-10
were O 0 1.058383103380578e-10
detected O 0 1.370238145170788e-09
in O 0 3.067150977642541e-10
the O 0 1.5784021201170617e-08
p53 O 0 6.40399306917061e-08
gene O 0 9.621521357416896e-10
, O 0 2.709426849545338e-10
suggesting O 0 4.065501268968319e-10
that O 0 3.42627627658576e-11
this O 0 4.780054130293365e-10
tumour B-Disease 1 1.0
suppressor O 0 0.0007674269727431238
is O 0 3.939924830831387e-09
not O 0 1.1360815066474572e-10
frequently O 0 2.587439984491624e-10
altered O 0 1.4331268394229824e-09
in O 0 1.857374948288637e-10
this O 0 1.6461120244670724e-09
leukaemia B-Disease 0 2.911049250542419e-06
. O 0 3.0083239721534483e-07

Occasional O 0 4.8069076001411304e-05
missense O 0 3.5683638088812586e-06
mutations O 0 1.14420277697036e-08
in O 0 6.363199411829612e-10
ATM O 0 1.4026160215507844e-06
were O 0 7.1551559122085e-10
also O 0 9.189622673932973e-11
found O 0 3.863022748906708e-11
in O 0 1.0878303813299794e-10
tumour B-Disease 1 1.0
DNA O 0 1.682708195005489e-08
from O 0 2.910806318201509e-11
patients O 0 9.447624974012747e-12
with O 0 1.3541973532121832e-12
B B-Disease 0 5.074274440630688e-07
- I-Disease 0 7.366959664523165e-08
cell I-Disease 0 7.030526916196322e-08
non I-Disease 1 0.9936989545822144
- I-Disease 1 0.9999092817306519
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.6582278609275818
( O 0 1.3979692403687238e-10
B B-Disease 0 1.6509054034941073e-07
- I-Disease 0 1.3134021870087054e-08
NHL I-Disease 0 0.02300979010760784
) O 0 4.632578348706673e-11
and O 0 5.6636577372426444e-11
a O 0 1.7726202450329964e-10
B B-Disease 0 4.984155452802952e-07
- I-Disease 0 5.605642172668013e-07
NHL I-Disease 1 0.9999051094055176
cell O 0 1.4752879451407352e-07
line O 0 7.444804168699193e-07
. O 0 9.412766388550153e-08

The O 0 7.509134647420979e-09
evidence O 0 1.0068778033556214e-09
of O 0 2.433176327087949e-09
a O 0 1.6456087881255854e-10
significant O 0 8.128540618379532e-10
proportion O 0 1.0328491395483752e-09
of O 0 3.458557440438881e-09
loss O 0 2.333946547139476e-08
- O 0 2.843642121774792e-08
of O 0 2.3484412636776142e-08
- O 0 3.4365964296512175e-08
function O 0 3.2216507239724024e-10
mutations O 0 6.547740127871293e-11
and O 0 5.123299701148554e-11
a O 0 9.369174880369258e-11
complete O 0 5.822584081549564e-10
absence O 0 2.3476518506981847e-09
of O 0 8.263321138457513e-10
the O 0 2.8366292648129843e-10
normal O 0 1.8838015869437896e-10
copy O 0 9.340630491294633e-10
of O 0 3.1079154805269127e-09
ATM O 0 1.4221313904272392e-07
in O 0 1.4289172622916624e-10
the O 0 1.2125450643551972e-09
majority O 0 1.8117241040727095e-10
of O 0 1.1530712384910657e-08
mutated O 0 1.341127813248022e-06
tumours B-Disease 1 1.0
establishes O 0 3.326413207105361e-07
somatic O 0 1.801563875858392e-08
inactivation O 0 5.0772555937328434e-08
of O 0 1.0695387908654652e-09
this O 0 5.642489080137647e-12
gene O 0 2.91378345063098e-11
in O 0 1.4336120832125765e-11
the O 0 1.0243306203250313e-09
pathogenesis O 0 6.584657796793181e-08
of O 0 5.380056578019321e-08
sporadic B-Disease 0 4.592930417857133e-05
T I-Disease 1 0.9928382039070129
- I-Disease 0 1.690534918452613e-05
PLL I-Disease 0 1.7762995412340388e-05
and O 0 6.524791817952291e-10
suggests O 0 1.476324618110425e-10
that O 0 1.3268813131572799e-11
ATM O 0 3.4457727338121913e-07
acts O 0 3.600256537339419e-09
as O 0 2.3192125997439916e-09
a O 0 3.4230872358875786e-08
tumour B-Disease 1 1.0
suppressor O 0 0.001022245967760682
. O 0 8.256906767201144e-07

As O 0 5.0088278413795706e-08
constitutional O 0 8.571436183046899e-08
DNA O 0 7.2819208440932925e-09
was O 0 2.8337848734238946e-10
not O 0 6.647577020096884e-12
available O 0 4.7732460345395467e-11
, O 0 3.466216202951955e-10
a O 0 6.606998059766056e-09
putative O 0 9.765622053237166e-06
hereditary O 1 0.9999926090240479
predisposition O 1 0.9982835054397583
to O 0 1.2834076414947049e-06
T B-Disease 1 1.0
- I-Disease 0 0.016009101644158363
PLL I-Disease 0 0.0005689339595846832
will O 0 1.7139429875356882e-09
require O 0 4.4990955405666e-10
further O 0 6.870436441985817e-10
investigation O 0 5.78352365998569e-10
. O 0 7.467168550157055e-10
. O 0 2.8873541779717016e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 3.8340829632943496e-05
kinase O 0 1.5348557269589946e-07
is O 0 1.699242413444324e-10
involved O 0 9.727094997524777e-12
in O 0 1.6985697787533227e-12
the O 0 3.018641933638655e-11
modulation O 0 1.684184458561333e-09
of O 0 5.267728919733372e-09
the O 0 1.738893651292983e-08
Ca2 O 0 1.4515808288706467e-07
+ O 0 5.815397940978073e-08
homeostasis O 0 3.6288349747337634e-07
in O 0 8.993034761317631e-09
skeletal O 0 3.810739144682884e-05
muscle O 0 4.087154138687765e-06
cells O 0 1.6434618999028316e-08
. O 0 1.641816993469547e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9795503616333008
DM B-Disease 1 1.0
) O 0 3.803687587122795e-09
, O 0 1.2037189300873052e-10
the O 0 2.1492771451470105e-10
most O 0 2.561723055904963e-10
prevalent O 0 1.1667706445450676e-07
muscular B-Disease 1 0.999994158744812
disorder I-Disease 0 0.0009663283708505332
in O 0 1.881252237323494e-10
adults O 0 1.7585440048595302e-10
, O 0 1.6598311267101984e-11
is O 0 2.4937080178588644e-11
caused O 0 4.324683389178574e-10
by O 0 1.4778965551354162e-10
( O 0 2.010168476118679e-09
CTG O 0 3.734428173629567e-05
) O 0 5.51009404770042e-10
n O 0 6.276219544076866e-10
- O 0 1.0150327689473215e-08
repeat O 0 1.1071078276359003e-08
expansion O 0 4.617560112052388e-09
in O 0 1.3425074940620618e-10
a O 0 4.0577463611413123e-10
gene O 0 1.9219384417290541e-10
encoding O 0 1.3282449584650635e-09
a O 0 4.384268503798694e-09
protein O 0 3.4055886999340146e-08
kinase O 0 3.806462700595148e-07
( O 0 2.5738868814073612e-08
DM B-Disease 1 1.0
protein O 0 4.166792422211074e-08
kinase O 0 8.026247222403526e-09
; O 0 4.886393373260134e-11
DMPK O 0 1.3990228580951225e-05
) O 0 2.7247549702624774e-11
and O 0 3.994278865993017e-11
involves O 0 6.570170796305064e-11
changes O 0 8.469575735192691e-11
in O 0 7.569666421458621e-11
cytoarchitecture O 0 1.0466941375852912e-06
and O 0 2.4240151219601103e-08
ion O 0 1.1576896213227883e-05
homeostasis O 0 4.141865792917088e-05
. O 0 7.58671774292452e-07

To O 0 1.9551951169205495e-08
obtain O 0 6.274833985742134e-09
clues O 0 8.101921800118816e-09
to O 0 2.3955892825000547e-10
the O 0 9.459282246382372e-10
normal O 0 8.791261607576928e-10
biological O 0 9.60109991510194e-10
role O 0 1.0623760759997936e-09
of O 0 2.8144070185476266e-08
DMPK O 1 1.0
in O 0 2.250707709094968e-08
cellular O 0 3.901347866985816e-08
ion O 0 5.454340339383634e-07
homeostasis O 0 1.423200615136011e-07
, O 0 8.315433341898881e-10
we O 0 1.567791035883559e-10
have O 0 1.2346351371816944e-11
compared O 0 1.8014487124240475e-10
the O 0 1.390073167684136e-09
resting O 0 3.9101203697100573e-07
[ O 0 7.109559607698657e-09
Ca2 O 0 1.7953817321725296e-09
+ O 0 3.6612635145871764e-10
] O 0 5.757416765561629e-10
i O 0 1.7451982914362674e-10
, O 0 2.5537795836361177e-11
the O 0 8.733363338064848e-11
amplitude O 0 1.2195496834621622e-09
and O 0 6.806511465562437e-10
shape O 0 2.1775447223149058e-08
of O 0 3.438720597159772e-08
depolarization O 0 6.386964201965384e-08
- O 0 2.8759777137565834e-07
induced O 0 1.602315933268983e-07
Ca2 O 0 1.1704071045670617e-09
+ O 0 1.186644810191595e-10
transients O 0 4.4846421021205174e-10
, O 0 7.994029049829265e-12
and O 0 2.6386070411943408e-11
the O 0 2.8276947450223133e-10
content O 0 1.6793632040545958e-09
of O 0 7.922880129740406e-09
ATP O 0 1.717919803922996e-05
- O 0 7.508205612793972e-07
driven O 0 5.488084298121976e-08
ion O 0 4.43733867427909e-08
pumps O 0 1.3494789286028208e-08
in O 0 4.5141118620861675e-10
cultured O 0 9.424673486080337e-09
skeletal O 0 1.0032479025312568e-07
muscle O 0 2.0878786699540797e-08
cells O 0 1.2310333308285237e-10
of O 0 1.076622568874086e-09
wild O 0 7.230255949508546e-09
- O 0 7.2061632216957605e-09
type O 0 6.737026492231735e-09
and O 0 1.9380370641641775e-09
DMPK O 1 0.9999926090240479
[ O 0 1.2616514943886159e-08
- O 0 7.126424605985449e-08
/ O 0 1.3537679421915527e-07
- O 0 7.178919645411952e-07
] O 0 7.17005335104659e-08
knockout O 0 4.5911347115179524e-05
mice O 0 8.027228659557295e-07
. O 0 6.691821852200519e-08

In O 0 2.2074743810662767e-07
vitro O 0 7.29403097921022e-07
- O 0 1.8298790109838592e-06
differentiated O 0 3.243689434384578e-06
DMPK O 1 0.9999868869781494
[ O 0 3.646367474630097e-08
- O 0 1.2474076527269062e-07
/ O 0 1.0564846064653466e-07
- O 0 3.9111907312872063e-07
] O 0 2.0273036582807435e-08
myotubes O 0 6.963650776015129e-07
exhibit O 0 1.0079389767270186e-08
a O 0 2.861927084207849e-10
higher O 0 2.7994953022414393e-09
resting O 0 7.38912362407973e-08
[ O 0 4.150902288557745e-09
Ca2 O 0 2.333366611040333e-09
+ O 0 5.696541571786895e-10
] O 0 9.91715820575223e-10
i O 0 8.247197369470882e-10
than O 0 2.837982349124246e-10
do O 0 7.523294209832443e-10
wild O 0 2.7482572662052007e-08
- O 0 1.744361455280341e-08
type O 0 1.2946413718850636e-08
myotubes O 0 2.791941255964048e-07
because O 0 3.597954711942464e-10
of O 0 1.4807471915290193e-09
an O 0 6.9900425725411e-11
altered O 0 2.5521071922440797e-09
open O 0 1.8718935290706895e-09
probability O 0 1.6023089799421797e-10
of O 0 1.4932663994216e-09
voltage O 0 8.884368440931212e-08
- O 0 9.825474478475371e-08
dependent O 0 3.994701458509553e-09
l O 0 4.763907601734729e-10
- O 0 5.4107309743756105e-09
type O 0 3.601636988648238e-09
Ca2 O 0 1.7512011840636887e-09
+ O 0 3.449174834635471e-10
and O 0 4.4845821500771876e-10
Na O 0 2.3747707018628716e-06
+ O 0 9.438418047125197e-09
channels O 0 8.863242584311593e-09
. O 0 1.2390532155848177e-08

The O 0 3.451776137808338e-06
mutant O 0 2.8941640266566537e-06
myotubes O 0 3.4347990549576934e-06
exhibit O 0 2.309845825720913e-08
smaller O 0 1.1206132022323345e-08
and O 0 1.2688181616482552e-09
slower O 0 1.0518155235672566e-08
Ca2 O 0 2.930506948217726e-09
+ O 0 4.478196979906812e-10
responses O 0 9.944826212526792e-11
upon O 0 3.411130544694885e-10
triggering O 0 6.3970326813489464e-09
by O 0 8.523688005412922e-11
acetylcholine O 0 6.900122428987743e-08
or O 0 2.4625248506993103e-09
high O 0 9.804058720419562e-08
external O 0 1.2605744359461823e-07
K O 0 8.200271963687555e-07
+ O 0 3.140704052384535e-08
. O 0 1.9516702920441276e-08

In O 0 7.62031859835588e-09
addition O 0 3.819609073474339e-09
, O 0 4.1225034497216484e-10
we O 0 5.479290285381744e-11
observed O 0 7.464330542550357e-11
that O 0 5.703101619430884e-12
these O 0 2.347480820841241e-10
Ca2 O 0 8.51597725670672e-09
+ O 0 4.2067020977754055e-09
transients O 0 1.9138923335049185e-08
partially O 0 1.1840821656505796e-08
result O 0 5.83182876989774e-11
from O 0 2.4789737970709602e-11
an O 0 2.1527470778215374e-11
influx O 0 1.098171220625943e-09
of O 0 1.934347793053348e-09
extracellular O 0 1.0185567056453237e-08
Ca2 O 0 3.914367496804516e-09
+ O 0 2.567299428601899e-10
through O 0 2.885026766097365e-11
the O 0 2.355724504354839e-10
l O 0 2.1760238055890113e-09
- O 0 4.9487173470197376e-08
type O 0 3.491433986368975e-08
Ca2 O 0 1.3039620050392386e-08
+ O 0 4.4137014043599265e-09
channel O 0 1.0923849380617412e-08
. O 0 1.7428813947617527e-08

Neither O 0 2.2857332737657998e-07
the O 0 1.0754162893533703e-08
content O 0 4.711849577176963e-09
nor O 0 3.972371320770662e-09
the O 0 1.2559222550834193e-09
activity O 0 1.3106787877248394e-09
of O 0 1.8590105455018602e-08
Na O 0 2.1298041247064248e-05
+ O 0 4.772178741063726e-08
/ O 0 1.242615610408393e-07
K O 0 3.322203099287435e-07
+ O 0 1.1714551995112288e-08
ATPase O 0 1.4257817326779332e-07
and O 0 4.878985215839293e-09
sarcoplasmic O 0 1.7018248854583362e-06
reticulum O 0 1.1707720659615006e-07
Ca2 O 0 2.190934544898937e-08
+ O 0 3.5560596689521162e-09
- O 0 9.102253173409736e-09
ATPase O 0 1.295735785333818e-08
are O 0 1.2037320792912531e-11
affected O 0 9.55735490748566e-11
by O 0 1.701256358010994e-10
DMPK O 1 1.0
absence O 0 1.3376571814660565e-06
. O 0 2.0483319929098798e-07

In O 0 3.722933783478766e-08
conclusion O 0 9.837378911470296e-09
, O 0 9.235348041869429e-10
our O 0 2.590931358348314e-10
data O 0 1.2919611214190496e-10
suggest O 0 5.786456036549481e-11
that O 0 4.0637545412058884e-11
DMPK O 0 0.03353694826364517
is O 0 5.105489919721151e-10
involved O 0 6.229655680201063e-11
in O 0 7.961135917167184e-11
modulating O 0 3.271339110710869e-08
the O 0 2.758664852109405e-09
initial O 0 3.0959881325287597e-09
events O 0 9.578053905556771e-10
of O 0 6.087789383713016e-09
excitation O 0 1.1313991876704677e-07
- O 0 6.369597826960671e-07
contraction O 0 3.926872693682526e-08
coupling O 0 7.357407572072816e-09
in O 0 5.138736103305064e-10
skeletal O 0 8.154836450557923e-07
muscle O 0 1.0751541879017168e-07
. O 0 2.8938917928655883e-09
. O 0 2.737537485586472e-08

Constitutional O 0 0.0002962204744108021
RB1 O 1 0.9999986886978149
- O 0 5.4695472499588504e-05
gene O 0 8.550518515448857e-08
mutations O 0 1.1198589611183252e-08
in O 0 2.0841524339676454e-10
patients O 0 5.524806723222753e-10
with O 0 5.117911094920657e-10
isolated O 0 9.851377171798958e-07
unilateral B-Disease 0 0.05381351709365845
retinoblastoma I-Disease 1 1.0
. O 0 2.7415774184191832e-06

In O 0 8.74454020305393e-09
most O 0 3.5938896303377987e-09
patients O 0 5.813506342988717e-10
with O 0 3.0880953350020945e-10
isolated O 0 2.597438992779644e-07
unilateral B-Disease 0 0.0005109519697725773
retinoblastoma I-Disease 1 1.0
, O 0 4.7470322783738084e-08
tumor B-Disease 1 0.9999402761459351
development O 0 6.625801685089527e-09
is O 0 1.243033453945941e-10
initiated O 0 3.7534103602965274e-10
by O 0 1.087661731513645e-11
somatic O 0 1.479637634638209e-09
inactivation O 0 6.18755393588799e-08
of O 0 3.7318970136368534e-09
both O 0 6.159900367563864e-10
alleles O 0 4.2275971612326657e-10
of O 0 4.3986081443847524e-09
the O 0 3.262714898255581e-08
RB1 O 0 0.0006732113542966545
gene O 0 1.4359108035932877e-07
. O 0 1.1022936519111681e-07

However O 0 1.1276587663644477e-08
, O 0 3.8781594602355085e-10
some O 0 4.837218472997229e-11
of O 0 4.206347214985584e-10
these O 0 4.127964081668267e-10
patients O 0 2.9335925355589154e-10
can O 0 1.897997176092403e-10
transmit O 0 4.925833962943216e-08
retinoblastoma B-Disease 0 2.7640392090688692e-06
predisposition O 0 2.2576011815544916e-06
to O 0 9.390616284576936e-09
their O 0 1.9509558413233208e-08
offspring O 0 1.1151509937690207e-07
. O 0 1.4131443570875035e-08

To O 0 5.170799788345448e-09
determine O 0 1.347572387011553e-09
the O 0 3.7625993987155937e-10
frequency O 0 1.4000058889962474e-09
and O 0 4.944042952814698e-10
nature O 0 1.4256274383228629e-08
of O 0 2.452710390343782e-08
constitutional O 0 4.844076102017425e-06
RB1 O 1 0.9997480511665344
- O 0 1.3601301134258392e-06
gene O 0 1.2408269967068009e-08
mutations O 0 8.692221387107679e-10
in O 0 3.069028017832487e-11
patients O 0 1.4680298643376943e-10
with O 0 2.8122134829167145e-11
isolated O 0 3.599969744527698e-08
unilateral B-Disease 0 3.3339319998049177e-06
retinoblastoma I-Disease 0 0.00015997733862604946
, O 0 1.0761995739017038e-09
we O 0 4.6443626722236786e-11
analyzed O 0 1.4446721596783618e-10
DNA O 0 8.649320704101626e-10
from O 0 6.445452505055016e-11
peripheral O 0 9.527388442620577e-07
blood O 0 2.6305897460332517e-09
and O 0 7.322837891621248e-10
from O 0 1.3187180236684526e-09
tumor B-Disease 1 0.9983022212982178
tissue O 0 7.078751309563813e-07
. O 0 4.678047105244332e-08

The O 0 4.2532324329158655e-08
analysis O 0 3.9603578194657985e-09
of O 0 1.456432698887511e-07
tumors B-Disease 1 1.0
from O 0 8.558608044495486e-09
54 O 0 3.307237506078309e-08
( O 0 6.284302245251894e-11
71 O 0 4.919981755335812e-09
% O 0 5.249399179230174e-11
) O 0 1.677447243608743e-11
of O 0 8.96417495788171e-10
76 O 0 2.151124967042506e-08
informative O 0 2.1421162621493295e-09
patients O 0 1.4045870022627582e-10
showed O 0 9.238074194506396e-11
loss O 0 2.6644528805519485e-09
of O 0 2.667525578203822e-08
constitutional O 0 4.853296559303999e-06
heterozygosity O 0 8.005944255273789e-05
( O 0 9.316774018941487e-09
LOH O 1 1.0
) O 0 1.4529775604898987e-08
at O 0 5.7375480366772535e-08
intragenic O 0 1.7991547792917117e-05
loci O 0 1.4069956932871719e-06
. O 0 1.1026426705029735e-07

Three O 0 5.697307869922952e-08
of O 0 5.10654665220045e-08
13 O 0 8.342415469542175e-08
uninformative O 0 2.63528163486626e-05
patients O 0 4.172327905394013e-08
had O 0 1.8009764346516022e-08
constitutional O 0 2.3921732008602703e-06
deletions O 0 2.1784810542158084e-06
. O 0 5.31532919012534e-07

For O 0 9.978966630797004e-08
39 O 0 2.6725427915152977e-07
randomly O 0 1.1008875588913725e-08
selected O 0 6.480075143144859e-08
tumors B-Disease 1 1.0
, O 0 2.8782489280843038e-08
SSCP O 1 1.0
, O 0 5.591280327621462e-08
hetero O 0 9.248220749213942e-07
- O 0 2.295046286349134e-08
duplex O 0 8.273071117059771e-09
analysis O 0 8.354505282026636e-11
, O 0 1.8093334122615268e-11
sequencing O 0 1.6996831719851002e-10
, O 0 2.9395170325630104e-11
and O 0 2.398798937264246e-10
Southern O 0 2.5000362668947673e-08
blot O 0 5.880962703486148e-07
analysis O 0 1.1507104991093087e-10
were O 0 1.4389101021805573e-11
used O 0 2.996350736972353e-11
to O 0 1.4870042697179287e-10
identify O 0 7.882965391559082e-09
mutations O 0 6.70354936005424e-08
. O 0 7.781624589142666e-08

Mutations O 0 1.3762176820364402e-07
were O 0 1.0902528879697115e-09
detected O 0 1.6011855175079859e-09
in O 0 1.449206449288809e-10
21 O 0 8.84672335388359e-09
( O 0 5.095000810140249e-11
91 O 0 2.6932189811645912e-09
% O 0 3.446779320293025e-11
) O 0 4.9826739956237986e-11
of O 0 6.087464310411406e-09
23 O 0 3.6277181152399862e-06
tumors B-Disease 1 1.0
with O 0 1.620237298993743e-06
LOH O 1 1.0
. O 0 8.018560038181022e-06

In O 0 2.985368041663605e-08
6 O 0 7.498159959595796e-08
( O 0 2.7208510444687306e-10
38 O 0 3.521454683408365e-09
% O 0 4.084619448230242e-11
) O 0 2.4771917156440892e-11
of O 0 2.045683178408808e-09
16 O 0 2.859597998394747e-07
tumors B-Disease 1 1.0
without O 0 2.8715865241224492e-08
LOH O 1 1.0
, O 0 5.905982813914079e-09
one O 0 4.4344405925045294e-10
mutation O 0 1.343683359023018e-10
was O 0 1.2505577129395817e-10
detected O 0 1.7613434322161226e-10
, O 0 1.9540438711551644e-11
and O 0 4.355973567959914e-11
in O 0 7.115358302556274e-11
9 O 0 5.945337111512572e-09
( O 0 4.096455119562137e-11
56 O 0 1.0351072221581603e-09
% O 0 2.5835970515752926e-11
) O 0 1.92409421728712e-11
of O 0 1.870733568054561e-09
the O 0 1.9230000702918915e-08
tumors B-Disease 1 1.0
without O 0 1.5162017064085376e-07
LOH O 1 1.0
, O 0 7.400926538281283e-09
both O 0 2.0993060623197835e-09
mutations O 0 4.26752411186726e-09
were O 0 3.4634800583077663e-10
found O 0 6.808588692841511e-10
. O 0 1.2284497863390698e-08

Thus O 0 7.825890691037785e-08
, O 0 6.540952779410247e-10
a O 0 1.1409674594009545e-10
total O 0 8.729366535176197e-11
of O 0 4.698968436578355e-10
45 O 0 3.6525116264840563e-09
mutations O 0 3.6827862981425596e-10
were O 0 5.1646246307379684e-11
identified O 0 2.0790189014796567e-10
in O 0 1.2171189611720479e-09
tumors B-Disease 1 1.0
of O 0 0.003229049500077963
36 O 0 1.3627346788780414e-06
patients O 0 6.2350586915727035e-09
. O 0 8.812922835943482e-09

Thirty O 0 4.086800515779032e-07
- O 0 6.862649826189227e-08
nine O 0 2.563660173038329e-09
of O 0 8.282398100689647e-10
the O 0 5.111023826387395e-10
mutations O 0 7.749534902679045e-10
- O 0 4.475193549069445e-09
including O 0 6.398761520642893e-10
34 O 0 8.789505123729668e-09
small O 0 1.2509853153375161e-09
mutations O 0 2.9427157932637726e-10
, O 0 3.7091919813381224e-11
2 O 0 8.547151875148984e-10
large O 0 8.902357739870581e-10
structural O 0 5.894236920767071e-08
alterations O 0 1.0512422932151821e-07
, O 0 8.214167124265259e-10
and O 0 1.0393587102086599e-09
hypermethylation O 0 4.874146725342143e-06
in O 0 3.87312715233179e-09
3 O 0 2.077724502669298e-06
tumors O 1 1.0
- O 0 1.3382960162289237e-07
were O 0 5.213808274007192e-10
not O 0 3.7952991444045736e-11
detected O 0 4.1223385816024916e-10
in O 0 4.3882796701977256e-11
the O 0 1.4403394033024597e-09
corresponding O 0 4.981120849123499e-09
peripheral O 0 1.0757219115475891e-06
blood O 0 1.579769381976348e-08
DNA O 0 1.0651445592202435e-07
. O 0 1.9413862517581038e-08

In O 0 1.4628269262573212e-08
6 O 0 3.2128298244060716e-08
( O 0 8.76771225066797e-11
17 O 0 2.8779714722482197e-10
% O 0 7.856445528864331e-12
) O 0 4.193829745285926e-12
of O 0 1.3419083899623985e-10
the O 0 6.189319057270382e-10
36 O 0 4.476644832607235e-09
patients O 0 1.8509420385282027e-10
, O 0 7.385773936885442e-11
a O 0 4.5559855887944423e-10
mutation O 0 1.0581534537479342e-09
was O 0 1.5699551658698851e-09
detected O 0 2.9779603782920105e-10
in O 0 5.0822668989924935e-11
constitutional O 0 1.0955733209527807e-08
DNA O 0 8.14576794905264e-10
, O 0 1.1049754861103267e-11
and O 0 1.4067874469503305e-11
1 O 0 7.117018085978088e-10
of O 0 3.840720241843343e-10
these O 0 1.456525039467138e-10
mutations O 0 4.117929885971705e-10
is O 0 2.571954108021579e-11
known O 0 8.800617873339078e-11
to O 0 6.774478200632927e-11
be O 0 6.080797670948712e-11
associated O 0 1.4347616150711673e-10
with O 0 1.1845467939863852e-09
reduced O 0 4.562995741252962e-07
expressivity O 0 2.9523678676923737e-05
. O 0 2.701991093090328e-07

The O 0 3.908520440631946e-08
presence O 0 3.2502536218004252e-09
of O 0 1.0621294066481823e-08
a O 0 2.174078250760658e-09
constitutional O 0 6.655340456518388e-08
mutation O 0 6.149616371686761e-10
was O 0 3.328840258998156e-10
not O 0 5.99387857055933e-12
associated O 0 1.4320788478683344e-11
with O 0 1.8925772407585306e-11
an O 0 5.1177426879656096e-11
early O 0 1.5848056200695737e-09
age O 0 6.276833275364879e-09
at O 0 6.340159952600288e-09
treatment O 0 5.5398487575075706e-08
. O 0 7.756344189147057e-08

In O 0 1.3592980074861316e-08
1 O 0 1.1590969961616793e-07
patient O 0 2.5106542622665984e-08
, O 0 2.4194686254475073e-09
somatic O 0 2.711361446472438e-07
mosaicism O 0 1.1184521099494305e-05
was O 0 2.3471697474519715e-08
demonstrated O 0 9.142057666444714e-10
by O 0 1.4061463798897833e-11
molecular O 0 1.258460974318254e-10
analysis O 0 6.931807124826994e-12
of O 0 1.2520899594914425e-10
DNA O 0 7.427537473958523e-10
and O 0 1.5051093704698815e-10
RNA O 0 1.5014522958267662e-08
from O 0 1.6716327211341309e-09
peripheral O 0 0.00015029945643618703
blood O 0 5.6166555850722943e-08
. O 0 3.53021896160044e-08

In O 0 1.3745605542681005e-08
2 O 0 1.0090049329392059e-07
patients O 0 1.897455081945054e-09
without O 0 3.307467910662609e-10
a O 0 5.581248241348646e-10
detectable O 0 5.190100864638225e-07
mutation O 0 3.4074971733133452e-09
in O 0 3.573927265243526e-10
peripheral O 0 0.0011146542383357882
blood O 0 3.979942064802344e-08
, O 0 1.1296753532619164e-09
mosaicism O 0 9.294659548686468e-07
was O 0 2.3023802864230447e-09
suggested O 0 1.4105845658196614e-10
because O 0 4.1930962174641095e-11
1 O 0 8.693000763670966e-10
of O 0 6.41596942241307e-10
the O 0 7.624559872354553e-10
patients O 0 6.862617696334894e-10
showed O 0 5.131049807260979e-09
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 1.2464916210319643e-08
the O 0 3.5761111849552663e-09
other O 0 1.0391520977037771e-10
later O 0 9.60897805768468e-10
developed O 0 8.767487180705302e-09
bilateral B-Disease 0 3.489697974146111e-06
retinoblastoma I-Disease 0 0.2756642699241638
. O 0 4.444958392468834e-07

In O 0 2.5131839720415883e-08
conclusion O 0 7.452829464682509e-09
, O 0 8.689337027689703e-10
our O 0 4.661617758472403e-10
results O 0 3.991795435864809e-11
emphasize O 0 8.938922935186611e-10
that O 0 1.7781595640364856e-11
the O 0 4.2078396322864364e-10
manifestation O 0 1.2400509952215089e-08
and O 0 5.287384974295151e-10
transmissibility O 0 1.5532400254869572e-07
of O 0 1.3945831156547683e-08
retinoblastoma B-Disease 0 3.7971368271882966e-08
depend O 0 5.128131808085357e-10
on O 0 6.592719703490957e-10
the O 0 3.919572999500076e-10
nature O 0 9.569744996440477e-10
of O 0 7.334789442481338e-10
the O 0 2.021941641894287e-10
first O 0 5.2094221297815935e-11
mutation O 0 1.6490390650214515e-11
, O 0 4.778025631396732e-12
its O 0 9.548603227549357e-12
time O 0 5.432076229799909e-12
in O 0 3.78137365170117e-12
development O 0 1.4028942070531958e-11
, O 0 1.0739326962438955e-11
and O 0 2.8710287619526653e-11
the O 0 7.906900134635464e-11
number O 0 2.0895049579472413e-11
and O 0 3.061625952760494e-11
types O 0 2.761075812429681e-09
of O 0 1.6940170377566233e-09
cells O 0 2.316813754732472e-11
that O 0 3.433529719223949e-12
are O 0 7.620190069224098e-12
affected O 0 3.5081051952268183e-10
. O 0 5.201203912008623e-10
. O 0 2.986073965871583e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999728202819824
the I-Disease 0 3.1576300898450427e-06
fifth I-Disease 0 4.9997030515669394e-08
component I-Disease 0 2.308427582420336e-08
of I-Disease 0 1.3977387247621209e-08
complement I-Disease 0 7.234781218556918e-09
in O 0 1.7366456050993406e-09
man O 0 8.530466288902971e-08
. O 0 1.1104645381010414e-07

I O 0 0.0014089717296883464
. O 0 8.272163540823385e-06

Clinical O 0 8.092416464933194e-06
, O 0 6.404968111439757e-09
immunochemical O 0 1.962243231901084e-06
, O 0 2.7512139233465405e-09
and O 0 4.324380409315154e-09
family O 0 7.96670374114683e-09
studies O 0 2.2902973739746812e-08
. O 0 5.563239113826057e-08

The O 0 1.4290378658188274e-07
first O 0 1.4998665420762336e-08
recognized O 0 1.4151477500945475e-07
human O 0 9.366896591700424e-09
kindred O 0 1.730811845845892e-06
with O 0 2.2758868123418097e-09
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999998807907104
the I-Disease 0 0.013373185880482197
fifth I-Disease 0 4.1527658822815283e-07
component I-Disease 0 1.7802312868298031e-07
of I-Disease 0 6.419157472237202e-08
complement I-Disease 0 9.354545227324707e-08
( O 0 1.1578309422333177e-09
C5 O 1 0.9999527931213379
) O 0 1.4748730015057276e-09
is O 0 6.459189849650215e-10
described O 0 6.752747694349637e-09
. O 0 7.703694393512706e-08

The O 0 6.508080900857749e-07
proband O 0 2.7581840186030604e-05
, O 0 9.676407231040685e-09
a O 0 1.643589597755124e-09
20 O 0 2.8865376755504712e-09
- O 0 2.3811770333281856e-09
year O 0 7.511905680823716e-11
- O 0 3.881891252888181e-09
old O 0 4.918902618555876e-09
black O 0 9.828371450026907e-10
female O 0 2.458984404984932e-10
with O 0 1.262963067460987e-09
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 2.429667631531629e-07
age O 0 5.6927564884290405e-08
11 O 0 1.593456255832848e-09
, O 0 1.5767394334620377e-10
lacked O 0 4.9768495102853194e-08
serum O 0 8.166559695155229e-08
hemolytic O 0 7.1148369897855446e-06
complement O 0 7.761846276821416e-09
activity O 0 1.7715396927187044e-09
, O 0 1.6773840649797478e-10
even O 0 5.409345749107786e-10
during O 0 8.114634297839984e-09
remission O 0 7.547446330136154e-07
. O 0 5.292930538303153e-08

C5 O 1 0.9989283680915833
was O 0 4.7236846967280144e-07
undetectable O 0 5.468856443258119e-07
in O 0 2.8262550633151307e-10
her O 0 5.642322720156301e-10
serum O 0 2.4947416354947904e-10
by O 0 2.0245801563012478e-11
both O 0 1.4104347689780639e-09
immunodiffusion O 0 4.701547368313186e-05
and O 0 2.0524149135781045e-07
hemolytic O 0 0.0005245485808700323
assays O 0 2.036956630036002e-06
. O 0 4.689424031312228e-07

Other O 0 2.5272572923284997e-09
complement O 0 1.0581373555140772e-09
components O 0 1.3832072154329467e-09
were O 0 4.664862246483992e-11
normal O 0 3.823091287991076e-10
during O 0 3.3666666676701595e-10
remission O 0 2.106406427060392e-08
of O 0 1.3758352679360542e-08
lupus O 1 0.9999994039535522
, O 0 3.040411922228259e-09
but O 0 1.7375102467909187e-09
C1 O 0 0.0002564833266660571
, O 0 5.12509323868926e-09
C4 O 1 0.9986101388931274
, O 0 6.9451311368595725e-09
C2 O 0 5.974326086288784e-06
, O 0 1.050555864523517e-09
and O 0 5.496482824440818e-09
C3 O 1 0.9999998807907104
levels O 0 3.2963527019092e-07
fell O 0 8.860048978931445e-07
during O 0 2.654025976767116e-08
exacerbations O 0 9.785257134353742e-05
. O 0 2.484992762674665e-07

A O 0 1.35847994897631e-06
younger O 0 6.219416093244945e-09
half O 0 1.4592953512249096e-09
- O 0 3.1746846929081585e-08
sister O 0 1.3120150299528177e-08
, O 0 6.91237955763313e-10
who O 0 1.1116545461931082e-09
had O 0 2.0723409654976876e-09
no O 0 4.589199242843733e-09
underlying O 0 0.00012612013961188495
disease O 0 0.0005362354568205774
, O 0 6.184174283774269e-10
was O 0 1.268013249955402e-08
also O 0 1.317745024209671e-09
found O 0 9.388033683777053e-10
to O 0 2.514132235731381e-09
lack O 0 2.692047473829007e-07
immunochemically O 0 0.07970026880502701
detectable O 1 0.9981399774551392
C5 O 1 0.9999278783798218
. O 0 7.379405246865645e-07

By O 0 6.492928861234759e-08
hemolytic O 0 7.741468834865373e-06
assay O 0 4.1700285891010935e-08
, O 0 2.9278921509501288e-09
she O 0 5.967852323429668e-10
exhibited O 0 2.0834221015064713e-09
1 O 0 6.760734749811093e-10
- O 0 7.086756736995881e-10
2 O 0 7.751072006456639e-10
% O 0 2.6617175477583466e-11
of O 0 2.045658781257842e-10
the O 0 5.470541242225124e-10
normal O 0 3.645850732425515e-09
serum O 0 3.4534157755672368e-09
C5 O 0 2.4447851956210798e-06
level O 0 1.7644512517733801e-09
and O 0 1.5387580099002207e-10
normal O 0 2.6763499749726805e-10
concentrations O 0 2.763803907956941e-10
of O 0 2.493728279429064e-10
other O 0 4.1814676721152466e-11
complement O 0 2.409470845066153e-09
components O 0 2.9094506359683692e-08
. O 0 1.8503792276192144e-08

C5 O 0 8.332209108630195e-05
levels O 0 3.378789514840719e-08
of O 0 4.464519420821489e-09
other O 0 9.116248034235497e-11
family O 0 3.975808918199597e-11
members O 0 4.932311069988371e-12
were O 0 4.5149533417498944e-11
either O 0 2.729635684151077e-10
normal O 0 6.221144710494286e-10
or O 0 4.284859619896331e-11
approximately O 0 4.311536197509902e-11
half O 0 1.487262257793276e-10
- O 0 4.17049594858554e-09
normal O 0 7.962871473310429e-10
, O 0 2.5726804367409706e-11
consistent O 0 6.680746511555924e-10
with O 0 2.3206626897920302e-10
autosomal O 0 1.9244022553266404e-07
codominant O 0 1.5926569858493167e-06
inheritance O 0 4.548913778990027e-08
of O 0 1.5547140463922915e-08
the O 0 6.375569405747683e-09
gene O 0 9.05733301692635e-08
determining O 0 5.887994484510273e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.5086136500030989e-06

Normal O 0 9.052693712874316e-06
hemolytic O 0 2.0104656869079918e-05
titers O 0 3.914432454621419e-06
were O 0 1.9194226208441023e-09
restored O 0 1.2754915346135931e-08
to O 0 9.366321052084459e-10
both O 0 7.124545842174257e-09
homozygous O 0 0.00015416245150845498
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 2.896588036094272e-08
C5D B-Disease 1 1.0
) O 0 2.505190277446445e-09
sera O 0 3.429306048019498e-07
by O 0 2.2773737756720536e-11
addition O 0 1.0081191437194548e-09
of O 0 4.730967617661008e-09
highly O 0 9.296292802218886e-08
purified O 0 1.4684968618894345e-07
human O 0 1.5612306114576313e-08
C5 O 0 0.0024196531157940626
. O 0 6.971624344487282e-08

In O 0 6.406998664942876e-08
specific O 0 3.0712701004631526e-07
C5 O 0 6.165578088257462e-05
titrations O 0 5.967846732346516e-07
, O 0 5.533147828806761e-10
however O 0 1.9173909682201895e-10
, O 0 1.1811079891899112e-10
it O 0 5.045274961701374e-11
was O 0 1.3804450915699817e-09
noted O 0 8.384424821095138e-10
that O 0 1.075209626194562e-11
when O 0 1.7188037104709508e-10
limited O 0 2.726222303461867e-10
amounts O 0 7.797186785118981e-10
of O 0 4.448267532097816e-09
C5 O 0 7.088667643984081e-06
were O 0 8.44056824433892e-10
assayed O 0 8.000234252847349e-09
in O 0 4.378113496739111e-11
the O 0 3.189685182647395e-10
presence O 0 1.994752418799095e-10
of O 0 1.2422708417503259e-09
low O 0 1.3435053070054437e-08
dilutions O 0 1.9822654451218114e-07
of O 0 3.84695582056338e-08
either O 0 3.5024257272198156e-08
C5D B-Disease 1 1.0
serum O 0 9.807631329294964e-08
, O 0 1.1219557505270927e-09
curving O 0 1.505200515339311e-07
rather O 0 2.503822982280468e-10
than O 0 2.9702101889128585e-11
linear O 0 3.942208226526134e-10
dose O 0 2.9785640620616505e-09
- O 0 1.0761709301476685e-09
response O 0 7.415274644317904e-11
plots O 0 1.6377221800922825e-09
were O 0 2.080720734598529e-10
consistently O 0 9.048207738615588e-10
obtained O 0 7.805605467536836e-11
, O 0 5.896341748190537e-11
suggesting O 0 3.026333905697953e-10
some O 0 1.2316675457313409e-10
inhibitory O 0 1.9526466132901987e-07
effect O 0 5.209003575146198e-07
. O 0 1.4238766254948132e-07

Further O 0 2.2486165107693523e-07
studies O 0 3.578813467797204e-09
suggested O 0 1.0058681665370273e-09
that O 0 3.468033152320693e-11
low O 0 1.3864250192341387e-08
dilutions O 0 9.451686082684319e-07
of O 0 2.3373104340862483e-07
C5D B-Disease 1 1.0
serum O 0 6.38143617948117e-08
contain O 0 6.988743805891318e-09
a O 0 1.7519219408512754e-10
factor O 0 4.0277586821346745e-10
( O 0 4.334985495568766e-12
or O 0 1.0234157271638011e-11
factors O 0 3.4150800243271107e-11
) O 0 4.642031117135792e-12
interfering O 0 1.6438708727584128e-10
at O 0 4.2285008827747106e-10
some O 0 2.149826566766322e-10
step O 0 2.3680422067684503e-09
in O 0 1.77740752671518e-10
the O 0 6.620205716956207e-09
hemolytic O 0 1.1624561011558399e-06
assay O 0 2.772010709861661e-08
of O 0 7.808028357203511e-08
C5 O 1 0.9707938432693481
, O 0 5.451168405556928e-10
rather O 0 9.3246757537635e-11
than O 0 4.622040250534809e-11
a O 0 5.868911467921123e-10
true O 0 7.476805841122314e-09
C5 O 0 1.7244165064767003e-05
inhibitor O 0 1.124557655884928e-07
or O 0 6.918358330665342e-09
inactivator O 0 4.357395027909661e-06
. O 0 1.526530724049735e-07

Of O 0 4.532857474259799e-06
clinical O 0 2.2461333628598368e-06
interest O 0 1.249042824724711e-08
are O 0 4.0101259118907606e-11
( O 0 1.2704685393993831e-11
a O 0 1.836656000897552e-11
) O 0 8.417168004259956e-12
the O 0 3.819860400211539e-11
documentation O 0 1.0285560847478337e-08
of O 0 6.040992417410962e-08
membranous O 1 0.9999417066574097
glomerulonephritis B-Disease 1 1.0
, O 0 1.6628160892651067e-07
vasculitis B-Disease 1 1.0
, O 0 9.608835505048319e-09
and O 0 6.255740458982473e-08
arthritis B-Disease 1 1.0
in O 0 1.1104507313675072e-09
an O 0 2.1069267164275374e-10
individual O 0 1.9934591477532848e-10
lacking O 0 2.8030375798238083e-09
C5 O 0 0.00020589662017300725
( O 0 2.8197544993391332e-11
and O 0 8.071589230329579e-11
its O 0 2.1470893118991086e-10
biologic O 0 7.923333100734453e-09
functions O 0 2.0636534148188446e-11
) O 0 2.2831571702686126e-12
, O 0 3.5805898176977102e-12
and O 0 1.992853798649108e-11
( O 0 2.456376942128191e-11
b O 0 1.7130213914029468e-09
) O 0 9.865534777997453e-11
a O 0 4.32288566054595e-10
remarkable O 0 2.4334270154469095e-09
propensity O 0 2.4111866281373295e-08
to O 0 3.871367393326608e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 0.9999996423721313
in O 0 4.4184982062045464e-11
the O 0 4.1673292594524014e-10
proband O 0 2.0920747090258374e-07
, O 0 2.735154880362245e-10
even O 0 2.058759690504175e-10
during O 0 6.972017962958432e-10
periods O 0 3.3068447979900384e-09
of O 0 7.787971934014593e-10
low O 0 6.0840052995558835e-09
- O 0 1.0934564365072674e-08
dose O 0 1.4704469641912965e-08
or O 0 1.2226421264305287e-10
alternate O 0 5.672471381501509e-10
- O 0 1.2833933915601392e-08
day O 0 6.8760375171450505e-09
corticosteroid O 0 2.3171915017883293e-05
therapy O 0 2.0264153022253595e-07
. O 0 1.0899291247312703e-08

Other O 0 4.2439378233893876e-08
observations O 0 1.4182099050685792e-08
indicate O 0 3.5965758149458793e-10
that O 0 2.2631018586904972e-11
the O 0 2.395837084279151e-09
C5D B-Disease 1 1.0
state O 0 2.2498321428088275e-08
is O 0 9.520716437450005e-10
compatible O 0 5.2498649871779435e-09
with O 0 1.1819734080376065e-10
normal O 0 1.4740350051667406e-09
coagulation O 0 5.336689756774149e-09
function O 0 1.3367278117737413e-10
and O 0 4.154850422044554e-11
the O 0 3.131907511111365e-10
capacity O 0 1.0393428340194077e-09
to O 0 1.7406913688233772e-09
mount O 0 1.1786485629272647e-05
a O 0 4.63574963305291e-07
neutrophilic O 0 0.13496077060699463
leukocytosis O 0 0.000104276739875786
during O 0 1.7581842826075444e-07
pyogenic B-Disease 0 0.0002141756849596277
infection I-Disease 0 4.323104292325297e-07
. O 0 2.8564042242607e-09
. O 0 3.796615288820249e-08

Susceptibility O 0 0.0003654486790765077
to O 0 9.196454584525782e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.007356390357017517
twins O 0 5.222960908213281e-07
: O 0 1.8905243689970597e-11
the O 0 5.385376866673397e-11
role O 0 2.6096891314608683e-10
of O 0 1.4263937808678406e-09
genes O 0 1.3150552868879117e-10
, O 0 9.585943844259148e-11
HLA O 0 2.0991794258407026e-07
, O 0 4.889249005657348e-10
and O 0 1.1327219162637903e-09
the O 0 1.1376265263152163e-08
environment O 0 6.497042193132074e-08
. O 0 5.6970687722923685e-08

OBJECTIVE O 0 8.013667866180185e-06
To O 0 1.194404464222032e-09
determine O 0 7.341620089640344e-10
the O 0 3.4204927779057925e-10
relative O 0 1.5986313384175332e-09
effects O 0 1.2465859811072733e-07
of O 0 1.49571270924298e-08
genetic O 0 3.777039569996532e-09
and O 0 1.1407434025167973e-10
environmental O 0 2.7421362958079953e-08
factors O 0 8.198327572372932e-10
in O 0 4.0487838776082086e-11
susceptibility O 0 3.298324315892387e-07
to O 0 5.9351314973810076e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.003522978164255619
AS B-Disease 1 1.0
) O 0 9.749659746205452e-09
. O 0 2.3307434204866695e-08

METHODS O 0 1.620980583538767e-06
Twins O 0 4.549703547240824e-08
with O 0 5.925870211198614e-11
AS B-Disease 1 0.9999985694885254
were O 0 9.357030428258639e-11
identified O 0 2.3397818404991e-11
from O 0 9.61245145980616e-12
the O 0 1.9876691959019865e-10
Royal O 0 4.59721789525247e-08
National O 0 2.2381532289728057e-06
Hospital O 0 5.319304182194173e-05
for O 0 2.4658911357278157e-08
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999942779541016
database O 0 1.8822166225618275e-07
. O 0 4.899597527696642e-08

Clinical O 0 1.04754894891812e-06
and O 0 4.451153223783422e-09
radiographic O 0 1.8770805354506592e-06
examinations O 0 3.4970589979366196e-08
were O 0 1.3546842814182725e-10
performed O 0 7.355790421215147e-10
to O 0 6.880070818615636e-11
establish O 0 7.6358241951624e-10
diagnoses O 0 1.730119265630492e-07
, O 0 7.093139409164451e-10
and O 0 1.0007094708441855e-08
disease O 0 3.954578278353438e-05
severity O 0 0.0019873620476573706
was O 0 7.765918574875741e-09
assessed O 0 3.37192673782738e-08
using O 0 1.1731891846888942e-10
a O 0 1.4389713032247897e-10
combination O 0 6.464748736334514e-10
of O 0 2.6553006460261486e-09
validated O 0 4.1193011668383406e-08
scoring O 0 5.158292992746283e-08
systems O 0 2.3724972209038242e-07
. O 0 5.6192700270685236e-08

HLA O 0 0.0001372339465888217
typing O 0 3.1703766012469714e-07
for O 0 8.807007567668279e-09
HLA O 0 7.089532573445467e-06
- O 0 1.0837351283043972e-06
B27 O 0 2.9319621717149857e-06
, O 0 1.372691849077512e-09
HLA O 0 2.1323711507648113e-07
- O 0 2.7386814593910458e-08
B60 O 0 2.4603858150840097e-07
, O 0 1.004517927172266e-10
and O 0 2.988863323505342e-10
HLA O 0 8.837079121803981e-07
- O 0 5.343507041288831e-07
DR1 O 1 0.9998937845230103
was O 0 3.465294184934464e-08
performed O 0 4.078924753514457e-09
by O 0 1.8007823010535162e-10
polymerase O 0 5.264193525533756e-09
chain O 0 3.999878650517985e-09
reaction O 0 4.424654739820788e-11
with O 0 8.852972174788754e-12
sequence O 0 4.964062494394739e-11
- O 0 2.8585447897633287e-10
specific O 0 7.740520030496967e-11
primers O 0 2.096037343690682e-09
, O 0 8.018374852980514e-11
and O 0 4.1836553665852705e-10
zygosity O 0 7.542639650637284e-07
was O 0 1.232284407848283e-08
assessed O 0 1.900535409049553e-07
using O 0 5.310715422979229e-09
microsatellite O 0 5.734740398111171e-07
markers O 0 1.1546667337825056e-06
. O 0 8.438402687716007e-08

Genetic O 0 6.003965040690673e-07
and O 0 2.6749731318886916e-09
environmental O 0 4.1281101204049264e-08
variance O 0 5.3885882422832765e-09
components O 0 1.3000152065956172e-09
were O 0 3.2908974156864446e-11
assessed O 0 7.411860902806211e-09
with O 0 1.1810764866115875e-10
the O 0 2.168975665739481e-09
program O 0 6.206342106906959e-10
Mx O 0 2.6933287244901294e-06
, O 0 7.898941223327682e-11
using O 0 9.332002184891941e-12
data O 0 7.121003006010929e-12
from O 0 2.3593015562040076e-12
this O 0 2.119301912781313e-12
and O 0 4.243510057233557e-11
previous O 0 1.1615686190680208e-10
studies O 0 1.0324173460585229e-10
of O 0 6.343640057693278e-10
twins O 0 1.3123048203667054e-09
with O 0 1.3932949238792958e-10
AS B-Disease 1 1.0
. O 0 2.114132939823321e-07

RESULTS O 0 5.425956146609678e-07
Six O 0 1.3043500501908056e-08
of O 0 1.4541531534462138e-08
8 O 0 8.339647195043653e-08
monozygotic O 0 4.496543510867923e-07
( O 0 4.894289418189146e-09
MZ O 1 0.9999990463256836
) O 0 3.866292619392198e-09
twin O 0 2.8705576937682054e-07
pairs O 0 4.3147302397628096e-10
were O 0 1.0386250193228364e-10
disease O 0 9.983645909983352e-09
concordant O 0 1.039470660657571e-07
, O 0 4.8851728218224366e-11
compared O 0 2.0429437655455907e-11
with O 0 1.486178367871016e-11
4 O 0 3.5328644454324376e-09
of O 0 3.2123503856951174e-09
15 O 0 7.212571428993897e-09
B27 O 0 4.463772995677573e-07
- O 0 8.958233621569889e-08
positive O 0 3.1615221551817285e-09
dizygotic O 0 2.924562636508199e-07
( O 0 1.3779171137429103e-09
DZ O 0 0.0004563263210002333
) O 0 2.2386417164454997e-09
twin O 0 7.039557203825098e-08
pairs O 0 8.666937306722744e-11
( O 0 5.550265975984292e-12
27 O 0 3.1799415878275283e-10
% O 0 3.9611976893061396e-12
) O 0 1.7830320553358092e-12
and O 0 3.076811722069195e-11
4 O 0 3.598251918646156e-09
of O 0 1.4551964078179935e-08
32 O 0 4.131482000957476e-07
DZ O 1 0.9999240636825562
twin O 0 1.3816490991302999e-06
pairs O 0 4.6286943722329e-10
overall O 0 6.035182353869573e-10
( O 0 1.972038504716167e-11
12 O 0 3.320723140909365e-10
. O 0 2.419189328028981e-11
5 O 0 1.2703097462818391e-09
% O 0 2.658618603046392e-10
) O 0 9.020603153331308e-10
. O 0 3.483690846906029e-08

Nonsignificant O 0 4.94075684400741e-05
increases O 0 2.5612665766061582e-08
in O 0 1.289969103757116e-10
similarity O 0 4.417000654122205e-10
with O 0 2.6925638801911234e-11
regard O 0 3.831013284383289e-09
to O 0 2.506030105653423e-10
age O 0 3.6833991412521527e-09
at O 0 8.834123432777119e-10
disease O 0 6.748604164386052e-08
onset O 0 1.9873491297062174e-08
and O 0 4.4181636127405e-10
all O 0 1.3273832033533495e-10
of O 0 6.278590425345953e-10
the O 0 5.321541540759256e-10
disease O 0 3.1230329433640236e-09
severity O 0 1.047658937380902e-08
scores O 0 4.123872077155255e-10
assessed O 0 3.578745078058887e-09
were O 0 3.262112802104866e-11
noted O 0 3.0757629776445583e-10
in O 0 2.751569250225572e-10
disease O 0 3.685580054479942e-07
- O 0 5.230869646766223e-06
concordant O 0 0.00019679903925862163
MZ O 1 0.9999990463256836
twins O 0 5.349502529838901e-08
compared O 0 3.5975775136698473e-10
with O 0 1.2154209860781862e-09
concordant O 0 0.00018224857922177762
DZ O 1 1.0
twins O 0 3.709569682541769e-06
. O 0 6.31633625403083e-08

HLA O 0 7.698105036979541e-05
- O 0 2.0237282569723902e-06
B27 O 0 2.1147491224837722e-06
and O 0 1.4909468104562507e-09
B60 O 0 1.2178749386748677e-07
were O 0 2.9048161445666132e-11
associated O 0 2.244299884823775e-11
with O 0 1.6394862897839424e-11
the O 0 1.041446373584165e-09
disease O 0 2.4445929724947746e-08
in O 0 1.2465140031281408e-10
probands O 0 4.036912287119776e-05
, O 0 1.5295814614901815e-10
and O 0 7.879469299254538e-11
the O 0 4.69486505227934e-10
rate O 0 1.2359322454358335e-09
of O 0 3.572702356180457e-09
disease O 0 3.0132338224575506e-07
concordance O 0 2.1026973939797244e-08
was O 0 1.3847012425571847e-09
significantly O 0 2.5964819183599275e-10
increased O 0 5.071085218411042e-10
among O 0 1.0275202910747794e-09
DZ O 0 0.00011491803161334246
twin O 0 5.315704143527e-08
pairs O 0 1.3247267866001167e-11
in O 0 5.014151854138005e-12
which O 0 9.46629406806121e-12
the O 0 1.459247445101397e-10
co O 0 1.6845314032565284e-09
- O 0 2.9168907289545132e-08
twin O 0 1.067558699219262e-07
was O 0 1.5837389177875139e-09
positive O 0 1.0161455704649214e-10
for O 0 7.004644086983092e-11
both O 0 1.0045355658405697e-09
B27 O 0 4.129506578465225e-06
and O 0 7.028797455177482e-08
DR1 O 1 0.9988388419151306
. O 0 1.4599220321542816e-06

Additive O 0 1.0303094768460141e-06
genetic O 0 2.544924093683676e-08
effects O 0 2.1333672606260734e-08
were O 0 1.0143311190979887e-10
estimated O 0 5.6262643849391836e-11
to O 0 8.776279009081733e-11
contribute O 0 6.425742160587333e-10
97 O 0 9.474238282791703e-09
% O 0 3.1825916901873086e-11
of O 0 3.231299949835176e-10
the O 0 7.124786316481391e-10
population O 0 5.412026035656048e-11
variance O 0 1.0798560268199253e-08
. O 0 2.069624116529667e-08

CONCLUSION O 0 9.949050081559108e-07
Susceptibility O 0 4.2758409790621954e-07
to O 0 3.3067377724904645e-09
AS B-Disease 1 1.0
is O 0 4.467712033662252e-10
largely O 0 3.5887706695270083e-10
genetically O 0 1.5392392915813957e-10
determined O 0 1.5860718294291587e-10
, O 0 2.8538961124868756e-11
and O 0 1.2588187436879394e-10
the O 0 3.975219042828826e-10
environmental O 0 2.050935563602252e-07
trigger O 0 2.939611043473178e-08
for O 0 1.8299710358160581e-10
the O 0 5.706538352967527e-09
disease O 0 5.689532258656982e-07
is O 0 3.4973639539970236e-09
probably O 0 1.3061076664655502e-08
ubiquitous O 0 9.219180014952144e-07
. O 0 2.4447615487588337e-07

HLA O 0 0.0003674544277600944
- O 0 4.391260063130176e-06
B27 O 0 1.740943389449967e-06
accounts O 0 3.7188704893331703e-10
for O 0 2.6727264498815906e-11
a O 0 6.380489886437246e-11
minority O 0 4.77421123468158e-11
of O 0 4.116288698785553e-10
the O 0 1.1010234945985076e-09
overall O 0 3.7232514848994924e-09
genetic O 0 7.448367256301935e-09
susceptibility O 0 3.6107110190641833e-08
to O 0 9.753714280691383e-09
AS B-Disease 1 1.0
. O 0 1.0721742000896484e-06

Cell O 0 5.170189979253337e-06
cycle O 0 1.9198635925476992e-07
- O 0 7.902131926584843e-08
dependent O 0 1.2575096519640283e-08
colocalization O 0 4.576300796088617e-07
of O 0 5.236526945395781e-08
BARD1 O 1 0.9999986886978149
and O 0 3.9092807213592096e-08
BRCA1 O 0 3.299670225942464e-08
proteins O 0 1.204508992547204e-10
in O 0 8.277229596176383e-11
discrete O 0 1.600997023842865e-08
nuclear O 0 1.804597786758677e-07
domains O 0 3.5741976489589433e-07
. O 0 1.289210871391333e-07

Germ O 0 1.0901642781391274e-05
- O 0 9.515856618236285e-07
line O 0 2.1585029230664077e-07
mutations O 0 4.624214344772781e-09
of O 0 8.56670911986157e-09
the O 0 2.0001644784883865e-08
BRCA1 O 0 2.3464494347535947e-07
gene O 0 2.2267008237264463e-09
predispose O 0 7.3694725877260225e-09
women O 0 2.0314023900513956e-12
to O 0 1.6451238158202153e-12
early O 0 2.814296851116893e-10
- O 0 1.1261723784627975e-06
onset O 0 0.45183706283569336
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 5.877635878004384e-11
compromising O 0 2.1438260944250942e-08
the O 0 9.182671845131551e-10
genes O 0 1.1024167134721097e-09
presumptive O 0 1.1249138509583645e-07
function O 0 4.103489548157313e-09
as O 0 1.2541508942476298e-09
a O 0 5.8365858812692295e-09
tumor B-Disease 0 5.17265398229938e-05
suppressor O 0 8.44960450194776e-05
. O 0 5.687026032319409e-07

Although O 0 1.0525203464339938e-07
the O 0 2.2853924974697293e-08
biochemical O 0 1.2055484432949015e-07
properties O 0 1.1792705834068329e-07
of O 0 1.1863273385870343e-07
BRCA1 O 0 1.0471219979990565e-07
polypeptides O 0 1.2465550813800519e-09
are O 0 9.72234619200929e-12
not O 0 4.906002687432576e-12
understood O 0 3.933030290337314e-10
, O 0 4.512439727433204e-11
their O 0 7.68117583427319e-11
expression O 0 3.5816385968168163e-10
pattern O 0 7.153873049503545e-10
and O 0 3.3750119365905107e-10
subcellular O 0 5.129506774892434e-08
localization O 0 1.1683334300016668e-08
suggest O 0 1.4980874318837323e-09
a O 0 5.39817301969947e-10
role O 0 2.3786712599616067e-09
in O 0 1.0228410340928917e-09
cell O 0 2.5028130679061178e-08
- O 0 9.0043812406293e-07
cycle O 0 1.278631742707148e-07
regulation O 0 2.698826051528158e-07
. O 0 6.248501449590549e-08

When O 0 9.977804893424036e-08
resting O 0 2.1740022475569276e-06
cells O 0 1.661467297076058e-09
are O 0 8.116669142355093e-11
induced O 0 8.08342992542066e-09
to O 0 5.300933997309798e-11
proliferate O 0 1.4554232263819245e-09
, O 0 1.202860588911392e-10
the O 0 5.880407827341116e-10
steady O 0 5.517237777752371e-09
- O 0 2.0850083881640558e-09
state O 0 2.841968882449919e-10
levels O 0 4.701729561240597e-10
of O 0 8.74885663915137e-10
BRCA1 O 0 7.587044881240956e-10
increase O 0 1.5395145228080942e-11
in O 0 1.6071350847357557e-11
late O 0 1.7932837437228955e-09
G1 O 0 3.2792550541671517e-07
and O 0 6.118074935557161e-10
reach O 0 5.507246880753769e-10
a O 0 2.2535404098356082e-10
maximum O 0 4.9062154339196695e-09
during O 0 3.769554446364509e-09
S O 0 3.2390096293966053e-06
phase O 0 2.7112423595099244e-07
. O 0 1.07227890566719e-07

Moreover O 0 2.2127608190203318e-07
, O 0 4.957387389481482e-09
in O 0 1.3372462026595144e-09
S O 0 4.533504807113786e-07
phase O 0 2.5206441378600175e-08
cells O 0 2.214915612031021e-10
, O 0 6.19791939993064e-10
BRCA1 O 0 1.2481473632419693e-08
polypeptides O 0 2.66915800573031e-09
are O 0 5.267793840024737e-11
hyperphosphorylated O 0 2.448966540669062e-07
and O 0 3.8033540761261975e-09
accumulate O 0 1.2224386125581077e-07
into O 0 6.2278795454062674e-09
discrete O 0 4.816722309897159e-08
subnuclear O 0 6.064271019567968e-06
foci O 0 1.5334702538893907e-06
termed O 0 4.949883418703394e-07
" O 0 2.8026335030517657e-07
BRCA1 O 0 3.42843372891366e-06
nuclear O 0 7.821172971489432e-07
dots O 0 2.0923689589835703e-06
. O 0 2.629215032357024e-07

" O 0 6.7854998633265495e-06
BRCA1 O 0 1.975474333448801e-06
associates O 0 3.160673855973073e-08
in O 0 3.028668205118379e-09
vivo O 0 1.8332293905132246e-07
with O 0 8.068853918352659e-10
a O 0 5.6013007565525186e-09
structurally O 0 1.7704772403703828e-07
related O 0 2.640703939960076e-07
protein O 0 3.770391572288645e-07
termed O 0 7.283312015715637e-07
BARD1 O 1 1.0
. O 0 1.1270909681115882e-06

Here O 0 4.825915667083791e-09
we O 0 3.472231113743618e-10
show O 0 2.1786973614101868e-10
that O 0 8.58216622767749e-12
the O 0 2.3371382606995894e-10
steady O 0 4.1656305072024225e-09
- O 0 2.068293536439114e-09
state O 0 1.9076183688238046e-10
levels O 0 4.5769504852799514e-10
of O 0 1.317875808481972e-09
BARD1 O 0 0.03303186222910881
, O 0 1.2297003693095832e-10
unlike O 0 1.1948572686826253e-10
those O 0 5.206163972149014e-11
of O 0 2.0631831798567646e-09
BRCA1 O 0 2.051216618781382e-08
, O 0 2.5141402848483096e-10
remain O 0 4.874882719718698e-09
relatively O 0 9.682347146267034e-10
constant O 0 9.43233491312867e-09
during O 0 1.118962256185796e-08
cell O 0 1.100084077165775e-07
cycle O 0 2.6969428290612996e-07
progression O 0 1.2485324418776145e-07
. O 0 3.4208486709985664e-08

However O 0 2.85044706060944e-07
, O 0 3.504323586867031e-08
immunostaining O 0 6.470431344496319e-06
revealed O 0 3.391664549212692e-08
that O 0 2.837085233409198e-09
BARD1 O 1 0.9999996423721313
resides O 0 1.5512918025706313e-06
within O 0 6.358776261095045e-08
BRCA1 O 0 1.8050488392873376e-07
nuclear O 0 5.9113954620215736e-08
dots O 0 1.873751820369307e-08
during O 0 2.9182136707106565e-09
S O 0 1.9897011327429937e-07
phase O 0 1.009324090972541e-08
of O 0 7.3537038680626665e-09
the O 0 2.6706092892681e-09
cell O 0 7.578208616187965e-10
cycle O 0 4.860740143719511e-10
, O 0 9.642860294978295e-12
but O 0 1.044799750188341e-11
not O 0 1.4409425042050117e-11
during O 0 6.386531858915134e-10
the O 0 1.615752687200711e-08
G1 O 0 1.2449643691070378e-05
phase O 0 9.106387324209209e-07
. O 0 1.9365641890090046e-07

Nevertheless O 0 3.5017160371353384e-06
, O 0 7.129714418852018e-08
BARD1 O 0 0.00014648574870079756
polypeptides O 0 9.858265315187964e-09
are O 0 1.736703489352287e-11
found O 0 2.70188450605946e-12
exclusively O 0 3.22343159109284e-11
in O 0 9.38385220222715e-12
the O 0 2.038422070027579e-10
nuclear O 0 1.5044040457823371e-09
fractions O 0 2.471133853099161e-10
of O 0 9.613451146250895e-10
both O 0 1.1775209696196498e-09
G1 O 0 8.956711212704249e-07
- O 0 9.249406218714284e-08
and O 0 7.134472568282035e-09
S O 0 8.247345135714568e-07
- O 0 4.9036923854828274e-08
phase O 0 1.0223017454791261e-07
cells O 0 3.797641756619896e-09
. O 0 9.027285585716527e-09

Therefore O 0 8.257435979430738e-08
, O 0 3.050606212084972e-09
progression O 0 2.093573137074145e-08
to O 0 8.347628144278474e-10
S O 0 2.740670481671259e-07
phase O 0 1.9116523475304348e-08
is O 0 1.1040090369673905e-10
accompanied O 0 2.860873760113236e-10
by O 0 1.5005510722865267e-11
the O 0 5.166046479487818e-10
aggregation O 0 7.2732726508206724e-09
of O 0 2.451699998573531e-08
nuclear O 0 1.0110255743711605e-06
BARD1 O 1 0.9988871216773987
polypeptides O 0 1.4038617734968284e-07
into O 0 2.445367286441069e-08
BRCA1 O 0 3.998561624030117e-07
nuclear O 0 2.876795122119802e-07
dots O 0 6.213525693965494e-07
. O 0 1.439964449900799e-07

This O 0 3.162151074320718e-08
cell O 0 5.540324465869162e-08
cycle O 0 1.6940825631195366e-08
- O 0 1.653107162269407e-08
dependent O 0 4.884907589541854e-09
colocalization O 0 2.5375186396559e-07
of O 0 3.121247971193952e-08
BARD1 O 1 1.0
and O 0 1.623574696907326e-08
BRCA1 O 0 9.592706362582248e-08
indicates O 0 3.730884212682639e-10
a O 0 5.932711960587866e-11
role O 0 4.188062674437276e-10
for O 0 3.471542497912594e-10
BARD1 O 1 0.9999994039535522
in O 0 3.4385632119438014e-08
BRCA1 O 0 1.8173719581682235e-05
- O 0 5.026197413826594e-06
mediated O 0 1.6062386976045673e-06
tumor B-Disease 1 0.9989829659461975
suppression O 0 0.0001718116836855188
. O 0 1.3576389790159737e-07

Ethnic O 0 5.512391112461046e-07
differences O 0 1.938604157203372e-07
in O 0 8.881196222887411e-09
the O 0 3.10215511944989e-07
HFE O 0 0.05223902314901352
codon O 0 1.1746493328246288e-05
282 O 0 1.6678776546541485e-06
( O 0 1.4442443330153765e-07
Cys O 1 1.0
/ O 0 0.00011985338642261922
Tyr O 0 0.0024011379573494196
) O 0 1.8039880700371214e-08
polymorphism O 0 8.34020426054849e-08
. O 0 5.3141633316045045e-08

Recent O 0 1.3362957851370538e-08
studies O 0 6.707636113212345e-10
have O 0 9.92485000433918e-12
shown O 0 1.9879384249854581e-10
that O 0 3.4049050245954504e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 4.751149390358478e-06
HH B-Disease 1 1.0
) O 0 1.0841522124493963e-09
is O 0 1.0322853682964706e-10
likely O 0 5.510270018049823e-11
to O 0 2.737695313503874e-11
be O 0 3.560202826990988e-11
caused O 0 4.811795406567398e-10
by O 0 1.7967373422411725e-10
homozygosity O 0 1.6747694644436706e-06
for O 0 3.379999835573244e-09
a O 0 1.1458101134564913e-08
Cys282Tyr O 0 2.0114859580644406e-05
mutation O 0 5.661578761362307e-09
in O 0 5.044912265717016e-10
the O 0 3.045933283374325e-08
HFE O 0 0.00013686581223737448
gene O 0 1.6947611314321875e-08
located O 0 1.2099251023300894e-07
4 O 0 4.46625108452281e-07
. O 0 1.0723320542638248e-07

5 O 0 2.3399976271321066e-05
Mb O 0 0.0001255995302926749
telomeric O 0 5.818008503410965e-05
to O 0 1.96961735809964e-07
HLA O 0 0.0015688774874433875
- O 0 6.287409632932395e-05
A O 0 4.303074547351571e-06
. O 0 1.252754486813501e-07

Population O 0 2.615939465044903e-09
studies O 0 4.5697454154058903e-10
of O 0 2.729713677318557e-10
this O 0 7.922686812156243e-12
polymorphism O 0 1.91424834317111e-10
are O 0 1.1329497236201025e-11
facilitated O 0 2.644572755228225e-11
by O 0 3.424314434438691e-12
the O 0 2.2798522791855902e-10
fact O 0 2.5033261574769483e-10
that O 0 4.143691639812985e-11
the O 0 6.530933571724518e-09
Cys282Tyr O 0 0.0001315347763011232
mutation O 0 1.630797470397738e-07
creates O 0 1.858575018331976e-07
a O 0 2.4324442904344323e-08
Rsal O 0 3.148317409795709e-05
restriction O 0 2.41443871118463e-07
site O 0 2.73844449338867e-07
. O 0 1.575737655912235e-07

We O 0 5.988839291148906e-08
have O 0 1.0344144429907942e-09
studied O 0 5.174285888642771e-08
the O 0 2.3662014569936218e-08
codon O 0 5.220391585680773e-07
282 O 0 2.894741442105442e-07
( O 0 5.763949317838524e-08
Cys O 1 1.0
/ O 0 1.863069883256685e-05
Tyr O 0 0.00010915671737166122
) O 0 8.253838168492678e-10
polymorphism O 0 2.9472546625441964e-10
in O 0 2.4914688367960736e-11
different O 0 2.2342884486992176e-11
ethnic O 0 3.7267591790346444e-10
groups O 0 6.930449270026173e-11
. O 0 3.7063596636244256e-09

In O 0 1.3089008099598232e-08
agreement O 0 2.0150215718217623e-08
with O 0 5.128562019507399e-10
previous O 0 1.1773440888873665e-08
observations O 0 1.8162237935825942e-08
the O 0 1.304185826001003e-08
Tyr O 0 6.928919174242765e-05
allele O 0 1.5059831159902615e-09
appeared O 0 8.179661947771422e-10
to O 0 1.388196502194461e-10
be O 0 1.2064611809581294e-10
rare O 0 1.0137727324277535e-09
or O 0 9.68441549176191e-10
absent O 0 9.352936203299578e-09
in O 0 4.128609953912843e-10
Asiatic O 0 2.686623190584214e-07
( O 0 8.964084335927325e-11
Indian O 0 2.1337964728473935e-10
, O 0 1.2156151085740419e-10
Chinese O 0 1.3661957121158252e-09
) O 0 3.3633032470170576e-10
populations O 0 2.4760509198529235e-09
. O 0 1.2855492670382773e-08

The O 0 1.1589478532414432e-07
highest O 0 8.440125043307489e-08
allele O 0 4.2156481083743813e-10
frequency O 0 1.06968778279537e-09
( O 0 4.404547560010741e-11
7 O 0 1.1310530290131737e-09
. O 0 2.4037946980137725e-11
5 O 0 5.379138245942272e-10
% O 0 3.2419476825307214e-11
) O 0 2.2145681122243133e-11
was O 0 1.2844996177818757e-09
found O 0 2.1177726239329786e-10
in O 0 9.287653979228594e-10
Swedes O 0 3.370967533555813e-06
. O 0 2.424954459456785e-07

Saamis O 0 0.00010503420344321057
( O 0 5.348612663880203e-09
2 O 0 1.879095279377907e-08
% O 0 2.230087225996158e-10
) O 0 5.489656645929486e-11
and O 0 4.708136658315709e-10
Mordvinians O 0 7.947096491989214e-07
( O 0 5.825847443352572e-11
1 O 0 6.735790258893815e-10
. O 0 2.5983435888998763e-11
8 O 0 7.715583727474495e-10
% O 0 4.138841699918849e-11
) O 0 3.8703686089380795e-11
had O 0 1.08151626543318e-10
significantly O 0 2.8196589507700764e-10
lower O 0 1.229185087048279e-09
frequencies O 0 2.0726138583171405e-09
of O 0 8.08188893586248e-09
the O 0 7.174786276209488e-08
Tyr O 0 0.0003412876685615629
allele O 0 5.864732202098821e-07
. O 0 2.2501201613067678e-07

Comparisons O 0 2.3598290965765045e-07
with O 0 2.2650818998215527e-09
allele O 0 2.2057389248431036e-09
frequencies O 0 1.2763670120818915e-09
based O 0 3.415160376718518e-10
on O 0 1.1101521923961855e-09
prevalence O 0 6.634780724823486e-09
estimates O 0 9.176613358086172e-10
of O 0 1.3948704413735413e-08
HH B-Disease 1 1.0
showed O 0 1.0078085921350066e-07
some O 0 1.561768825375509e-09
disagreements O 0 1.376707245981379e-07
with O 0 4.919031848515942e-10
the O 0 6.538561247992902e-09
RFLP O 0 6.117876409916789e-07
data O 0 7.43439698691617e-10
, O 0 2.438806379068126e-10
particularly O 0 1.2297574070174733e-09
in O 0 4.635782868689375e-09
Finns O 0 1.4605550859414507e-05
. O 0 2.823957743203209e-07

The O 0 9.455463327867619e-07
newly O 0 2.6420568701723823e-06
described O 0 1.7202164315222035e-07
HFE O 1 0.9911364316940308
marker O 0 7.1125982685771305e-06
provides O 0 3.135554926814166e-09
a O 0 7.399351964476608e-11
new O 0 2.3332575455059512e-11
approach O 0 2.2568729871053073e-11
to O 0 7.87058872936397e-12
the O 0 3.153064268013317e-11
screening O 0 1.0704347408463377e-09
of O 0 6.69649224960267e-09
HH B-Disease 1 1.0
as O 0 2.6073370129608975e-09
well O 0 1.7076347280653437e-10
as O 0 3.3094662427179955e-11
studies O 0 5.4239307489822863e-11
of O 0 2.6482233073110706e-10
the O 0 3.3359592865878085e-10
relationship O 0 8.021556335835456e-11
between O 0 1.626902224050042e-10
the O 0 1.008873606878069e-08
HFE O 0 0.0008754981099627912
Tyr O 0 6.055598714738153e-05
allele O 0 1.2520004588623124e-08
and O 0 1.822990536304303e-09
different O 0 1.3977254020858254e-08
disorders O 1 0.9999237060546875
including O 0 1.7082477370422566e-06
cancer B-Disease 1 1.0

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
associated O 0 8.617909941222024e-08
with O 0 5.15231146636097e-09
a O 0 2.9338529827782622e-08
missense O 0 1.1264730801485712e-06
mutation O 0 2.8296126330928928e-08
encoding O 0 1.5134476782918682e-08
Gly23 O 0 4.424227881827392e-05
- O 0 9.540659448248334e-06
- O 0 3.348219479448744e-06
> O 0 1.5343421466695872e-07
Val O 0 1.3351133247851976e-06
in O 0 3.0235776105058676e-09
neurophysin O 0 3.272413232480176e-05
II O 1 1.0
. O 0 1.6194665022339905e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 5.156541647011181e-07
ADNDI B-Disease 1 1.0
) O 0 7.992791317690262e-09
is O 0 4.647076612407375e-10
an O 0 7.249862377101124e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 3.656037733890116e-05
by O 0 9.46040024096817e-10
progressive O 1 0.998728334903717
degeneration O 1 1.0
of O 0 0.10007370263338089
the O 0 1.5349304760547966e-07
magnocellular O 0 3.728238880285062e-06
neurons O 0 2.014160926933073e-08
of O 0 1.234054707310861e-07
the O 0 1.533085622895669e-07
hypothalamus O 0 2.9370303309406154e-06
leading O 0 3.5638155537753846e-08
to O 0 8.528098782711879e-10
decreased O 0 9.23519483109203e-09
ability O 0 2.1357346446926329e-10
to O 0 5.066493335981193e-10
produce O 0 2.3872127385970998e-08
the O 0 4.6494751160253145e-08
hormone O 0 8.297662930090155e-07
arginine O 0 1.1326012554491172e-06
vasopressin O 0 1.568270363350166e-06
( O 0 1.808280636339532e-08
AVP O 0 0.0003050125960726291
) O 0 1.27798278626301e-08
. O 0 5.2848296405727524e-08

Affected O 0 2.4279927401948953e-07
individuals O 0 1.7010745589907117e-10
are O 0 1.2867100614155635e-11
not O 0 1.2770231920533615e-11
symptomatic O 0 2.210687632953068e-09
at O 0 2.884180949624948e-10
birth O 0 1.4648420254559369e-09
, O 0 1.2552989203662435e-10
but O 0 2.4138346876867445e-10
usually O 0 1.459276610660254e-08
develop O 0 7.025848276498436e-07
diabetes B-Disease 1 0.9395694732666016
insipidus I-Disease 0 1.1805655958596617e-05
at O 0 7.813462765682289e-09
1 O 0 4.262628650053557e-08
- O 0 2.3022110440251708e-07
6 O 0 2.1201213940003072e-07
yr O 0 4.110536792722996e-06
of O 0 4.28405719787861e-08
age O 0 5.887675058602326e-08
. O 0 2.2094747365031253e-08

The O 0 1.20120589031103e-07
genetic O 0 2.4217877481191863e-08
locus O 0 7.768099408167473e-08
of O 0 1.810931316015285e-08
the O 0 1.614766809154844e-08
disease O 0 4.752413587993942e-06
is O 0 1.695287243919097e-09
the O 0 2.0676003131825382e-08
AVP O 1 0.5039538145065308
- O 0 5.4079550864116754e-06
neurophysin O 1 0.5665772557258606
II O 1 1.0
( O 0 1.1898689145084518e-08
NPII O 1 1.0
) O 0 5.068387376461203e-10
gene O 0 3.944359006080589e-10
, O 0 1.0699484354059763e-10
and O 0 1.2135422666759155e-09
mutations O 0 6.803996477344754e-09
that O 0 1.0810378286985056e-10
cause O 0 1.1776113417738543e-08
ADNDI B-Disease 1 0.9999997615814209
have O 0 5.040908315767645e-11
been O 0 1.3653710974337319e-11
found O 0 4.223869518038548e-12
in O 0 6.4266916441346744e-12
both O 0 5.46021908243155e-11
the O 0 4.852625523632526e-10
signal O 0 1.5519043827794121e-09
peptide O 0 3.947258520042851e-09
of O 0 2.8983842881302735e-08
the O 0 7.144088698396445e-08
prepro O 0 0.011401165276765823
- O 0 0.19128134846687317
AVP O 1 0.9999687671661377
- O 0 2.6126579541596584e-05
NPII O 1 0.9999850988388062
precursor O 0 9.86022499205319e-08
and O 0 4.901931305312246e-09
within O 0 1.2238122515384475e-08
NPII O 0 0.12986703217029572
itself O 0 2.0301943237654996e-08
. O 0 2.668858911647476e-08

An O 0 2.0254059762692123e-08
affected O 0 4.51718271676782e-08
girl O 0 2.4631461315038905e-08
who O 0 3.128892422932239e-10
presented O 0 5.415002335418251e-10
at O 0 2.769291462811907e-10
9 O 0 7.807723356734186e-10
months O 0 4.196744340934089e-11
of O 0 3.486798627605481e-10
age O 0 3.927827507688164e-10
and O 0 3.755800531690667e-11
her O 0 9.48784523169266e-11
similarly O 0 6.487609754968204e-11
affected O 0 1.579430475295851e-10
younger O 0 4.670535624917704e-10
brother O 0 2.2911874619779837e-09
and O 0 1.918013525781248e-09
father O 0 4.477174631034586e-09
were O 0 6.269423868943136e-10
all O 0 2.1293812546563373e-10
found O 0 1.479847841490134e-11
to O 0 8.71299837834627e-11
have O 0 7.039090837990258e-11
a O 0 1.5809532571964269e-09
novel O 0 3.1761993568579783e-07
missense O 0 1.35957770908135e-06
mutation O 0 3.6350623844327856e-08
( O 0 6.641195926526677e-10
G1758 O 0 1.836468300098204e-06
- O 0 2.096326738865173e-07
- O 0 2.4909647322601813e-07
> O 0 2.642468999169978e-08
T O 0 3.4117260128141425e-08
) O 0 6.477952896322137e-11
encoding O 0 5.09140896109983e-10
the O 0 1.1330308913315434e-09
amino O 0 1.8546817415199257e-09
acid O 0 1.10554787546846e-09
substitution O 0 2.9063043083255025e-09
Gly23 O 0 6.911186119396007e-06
- O 0 4.9798063628259115e-06
- O 0 7.81925700721331e-06
> O 0 1.0374122894063476e-06
Val O 0 2.3134622097131796e-05
within O 0 1.3619884953186556e-07
NPII O 1 0.999942421913147
. O 0 4.349388689206535e-07

The O 0 1.0298103916284163e-06
mutation O 0 2.4736456794016703e-07
was O 0 3.407953741429992e-08
confirmed O 0 6.755568549010604e-09
by O 0 6.953000952769628e-10
restriction O 0 1.5274596876224678e-07
endonuclease O 0 2.908163651227369e-06
analysis O 0 8.670669870980419e-08
. O 0 1.42402598157787e-07

A O 0 2.919927101174835e-05
T1 O 0 5.54815778741613e-05
- O 0 5.181297524359252e-07
weighted O 0 3.055878892155306e-07
magnetic O 0 9.390795696617715e-09
resonance O 0 4.553269317142394e-09
imaging O 0 3.809076787320009e-08
of O 0 4.038432521724644e-08
the O 0 1.4231150657906255e-07
fathers O 0 9.917145007420913e-07
pituitary O 1 0.9739755392074585
gland O 0 0.00020186498295515776
demonstrates O 0 4.25285122673813e-08
an O 0 1.7373875671466976e-09
attenuated O 0 9.400345334142912e-06
posterior O 0 3.333292852403247e-06
pituitary O 1 0.9999992847442627
bright O 0 6.098924859543331e-05
spot O 0 9.179856533592101e-06
. O 0 4.3850650399690494e-07

This O 0 8.062334799774362e-09
mutation O 0 4.930098551625406e-09
may O 0 1.2132615745397146e-10
be O 0 5.4240962416018945e-11
valuable O 0 5.018557791558464e-10
for O 0 7.77164096965599e-12
developing O 0 8.275177765248998e-11
models O 0 3.963922801109021e-10
of O 0 5.459318774825306e-09
dominantly B-Disease 1 0.8553667068481445
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 1.5850021295449324e-09
as O 0 6.32739624584211e-11
the O 0 5.558192794907768e-11
early O 0 1.2054880704770454e-10
age O 0 1.1499935448355814e-09
of O 0 1.2126329940187475e-09
onset O 0 2.62841786025092e-06
of O 0 1.2080209899067995e-06
symptoms O 1 0.9999979734420776
suggests O 0 2.9655697342256815e-10
that O 0 3.357531483741405e-12
this O 0 5.3777169349567e-12
mutation O 0 1.6344135767010215e-10
may O 0 2.4177593954677334e-11
be O 0 4.064320408003752e-11
particularly O 0 4.0454981031778914e-10
deleterious O 0 2.6524452323428704e-07
to O 0 7.037380012064887e-09
the O 0 9.892965380231544e-08
magnocellular O 0 1.6903899449971505e-05
neuron O 0 7.565836881440191e-07
. O 0 1.757633683041604e-08
. O 0 1.6914066236495273e-07

Frequent O 0 2.918643986049574e-06
inactivation O 0 6.919978477526456e-05
of O 0 2.184370532631874e-05
PTEN O 1 1.0
/ O 0 0.00017850958101917058
MMAC1 O 1 1.0
in O 0 9.682688073553436e-08
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1468813454484916e-06

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 6.41085280221887e-05
the O 0 4.544031639852619e-08
most O 0 4.889593729906494e-10
common O 0 9.103602871540772e-10
male B-Disease 0 2.4216326166559554e-10
cancer I-Disease 0 1.6076601161429949e-10
in O 0 6.961937970562104e-12
the O 0 2.9060201467423497e-10
Western O 0 3.5698757283597615e-09
world O 0 1.873130817120483e-11
, O 0 6.176812099994988e-12
yet O 0 4.11114501816523e-12
many O 0 3.790464470077026e-12
of O 0 7.471837037975604e-11
the O 0 2.7620858378263335e-10
major O 0 7.897382303667655e-09
genetic O 0 3.987340679856288e-09
events O 0 8.481829821826992e-11
involved O 0 1.070801260161236e-11
in O 0 1.0088798720053749e-11
the O 0 3.055985742239642e-10
progression O 0 3.3396023724208135e-09
of O 0 1.5075752868298764e-09
this O 0 2.826147094125986e-10
often O 0 1.2231425650099936e-08
fatal O 0 3.023763383680489e-06
cancer B-Disease 0 1.35770403630886e-06
remain O 0 1.4063416209353363e-08
to O 0 1.2923191405889156e-09
be O 0 3.023623573739087e-09
elucidated O 0 2.5830252070591087e-06
. O 0 1.1782116615677296e-07

Numerous O 0 4.212118255964015e-06
cytogenetic O 0 5.592394882114604e-05
and O 0 7.220474884661598e-08
allelotype O 0 7.783844012010377e-06
studies O 0 5.227921651140832e-09
have O 0 5.5981122515369464e-11
reported O 0 2.0811653789198914e-10
frequent O 0 3.884068622284076e-09
loss O 0 2.8638249105483737e-08
of O 0 9.227697006508606e-08
heterozygosity O 0 2.5613317120587453e-05
on O 0 6.007710453559412e-07
chromosomal O 0 0.0023903308901935816
arm O 0 5.759691248385934e-06
10q O 0 1.4338939763547387e-05
in O 0 1.721318554359641e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.969736538550933e-07

Deletion O 0 1.5262819943018258e-05
mapping O 0 6.17048883100324e-08
studies O 0 1.0203026867827703e-08
have O 0 2.2365963248116572e-10
unambiguously O 0 8.159553743780634e-08
identified O 0 5.765120048017991e-10
a O 0 4.222004967857629e-10
region O 0 6.316092537872464e-09
of O 0 2.9708493443081352e-08
chromosome O 0 3.938378867474057e-08
10q23 O 0 1.3715676061565318e-07
to O 0 2.1606874622825956e-10
be O 0 8.005965335122767e-11
the O 0 3.314983565427809e-10
minimal O 0 4.179958779104709e-08
area O 0 1.279019699040873e-07
of O 0 2.701344499200786e-07
loss O 0 1.6472848074045032e-05
. O 0 8.355790441783029e-07

A O 0 4.050963980262168e-06
new O 0 1.6034822181154595e-07
tumor B-Disease 0 8.156349213095382e-05
suppressor O 0 2.6729436285677366e-05
gene O 0 1.3404508081293898e-07
, O 0 3.176235452428955e-08
PTEN O 1 0.999962568283081
/ O 0 2.061767918348778e-05
MMAC1 O 1 1.0
, O 0 1.317316034032956e-08
was O 0 8.483039692919192e-08
isolated O 0 1.7249503159177948e-08
recently O 0 5.6607984966206e-10
at O 0 7.878631635982458e-10
this O 0 2.7947921754645222e-11
region O 0 3.719248242717299e-09
of O 0 1.5040548362321715e-08
chromosome O 0 1.9153459263065997e-08
10q23 O 0 1.5833811062293535e-07
and O 0 3.110404989126181e-10
found O 0 6.128022395079924e-11
to O 0 2.842802555858004e-11
be O 0 8.734391682141407e-12
inactivated O 0 6.531618801375316e-09
by O 0 2.165050951019598e-11
mutation O 0 2.914174179746709e-10
in O 0 2.6048999068883916e-10
three O 0 7.753326514148284e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 3.088160156039521e-06
lines O 0 9.969719627633822e-08
. O 0 3.374268331413077e-08

We O 0 7.481331465442054e-08
screened O 0 1.2315816775299027e-06
80 O 0 5.102309842186514e-06
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 5.091955301850248e-09
microsatellite O 0 7.632337428731262e-08
analysis O 0 1.6092767396447272e-10
and O 0 8.441916610202327e-11
found O 0 1.8787349453930346e-10
chromosome O 0 2.886020311620996e-09
10q23 O 0 7.868397489119161e-08
to O 0 3.8357417242451675e-10
be O 0 2.347042005190758e-10
deleted O 0 5.397125413253434e-09
in O 0 5.106327027881719e-10
23 O 0 4.1658232419194974e-08
cases O 0 2.268350396406049e-09
. O 0 1.6861394058764745e-08

We O 0 6.353987913598758e-08
then O 0 2.3314359332005097e-09
proceeded O 0 2.035299484504094e-09
with O 0 5.792691847028575e-12
sequence O 0 6.8350737396360994e-12
analysis O 0 8.952068253353929e-12
of O 0 9.245059162665825e-10
the O 0 1.4536484904681402e-08
entire O 0 3.1631211641069967e-06
PTEN O 1 0.9999922513961792
/ O 0 1.5454470485565253e-05
MMAC1 O 1 0.9999997615814209
coding O 0 1.3649011521010834e-07
region O 0 3.4593902853430336e-08
and O 0 1.4378855883734332e-09
tested O 0 3.7336622682460074e-09
for O 0 3.876665377600119e-10
homozygous O 0 2.6061401925403516e-08
deletion O 0 3.852357988165522e-09
with O 0 2.5500610303930138e-11
new O 0 3.9339603796761935e-10
intragenic O 0 1.670850053869799e-07
markers O 0 6.988503553628789e-09
in O 0 3.5024139838357726e-11
these O 0 5.691238452731895e-11
23 O 0 5.02839825333723e-10
cases O 0 4.767558917095904e-11
with O 0 1.0845053327601661e-10
10q23 O 0 1.4553411347151268e-05
loss O 0 1.3436075505524059e-06
of O 0 2.5871916022879304e-06
heterozygosity O 0 0.0023386445827782154
. O 0 1.0064386515296064e-06

The O 0 6.400889152047284e-09
identification O 0 1.2527594517308671e-09
of O 0 7.795644130226265e-09
the O 0 7.57932472339462e-09
second O 0 2.242506091931773e-08
mutational O 0 4.7160688154690433e-07
event O 0 2.012547017926636e-09
in O 0 2.9815638846741876e-10
10 O 0 2.710451640908218e-09
( O 0 7.653112865657619e-11
43 O 0 9.167066217230513e-09
% O 0 2.006969479495524e-09
) O 0 7.356288023174784e-08
tumors B-Disease 1 1.0
establishes O 0 0.00040726413135416806
PTEN O 1 1.0
/ O 0 8.99626229511341e-06
MMAC1 O 1 1.0
as O 0 1.621178746802343e-09
a O 0 1.3994873315770207e-10
main O 0 3.2454094966993807e-09
inactivation O 0 1.3183358760215924e-07
target O 0 4.563581068595113e-09
of O 0 7.209544961028769e-09
10q O 0 5.980168680252973e-06
loss O 0 3.639121075593721e-07
in O 0 8.700618892021339e-09
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.0897751085158234e-08
. O 0 2.8371896831913546e-08

Risk O 0 7.844398169254418e-06
reversals O 0 1.5348295789863187e-07
in O 0 7.244346789114786e-10
predictive O 0 5.008761050362409e-08
testing O 0 4.5009600491141555e-09
for O 0 4.331256686640472e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.74252414556031e-07

The O 0 5.2979704179279e-08
first O 0 1.0830898400371325e-09
predictive O 0 4.346218496209531e-09
testing O 0 1.6893770826698074e-09
for O 0 1.896608425866475e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.5719898716071157e-09
HD B-Disease 0 0.3418634235858917
) O 0 1.0712593312423024e-10
was O 0 2.196907933349479e-10
based O 0 4.60598781337751e-11
on O 0 2.726175674094833e-10
analysis O 0 1.3785420027723205e-10
of O 0 8.295900078003626e-10
linked O 0 1.59238151553609e-08
polymorphic O 0 2.47174920531279e-08
DNA O 0 6.58400178821239e-09
markers O 0 1.829099538497303e-09
to O 0 1.8647678887151464e-11
estimate O 0 6.0631936971145e-11
the O 0 2.019629186111871e-10
likelihood O 0 4.612058734920765e-09
of O 0 1.1809357935987919e-08
inheriting O 0 1.1741310146362594e-07
the O 0 8.46754932837257e-09
mutation O 0 5.246601819663965e-09
for O 0 2.543214749906042e-09
HD B-Disease 0 0.005504907574504614
. O 0 3.261601762005739e-07

Limits O 0 6.84489691593626e-07
to O 0 2.0233317243878446e-09
accuracy O 0 1.1527787613374585e-08
included O 0 8.322541544814044e-10
recombination O 0 5.197046612503975e-11
between O 0 3.9399129792005994e-11
the O 0 2.19633811138209e-10
DNA O 0 1.0687903895245654e-09
markers O 0 7.1526486955519886e-09
and O 0 4.3266798477326063e-10
the O 0 2.2738255722742906e-09
mutation O 0 1.3420319300294636e-09
, O 0 1.0214699919242065e-10
pedigree O 0 2.65932498244581e-09
structure O 0 2.189592285262165e-09
, O 0 1.1358886747858676e-10
and O 0 1.1281395956297402e-10
whether O 0 4.117487947818965e-11
DNA O 0 1.2722684017418828e-10
samples O 0 5.754040473260336e-12
were O 0 1.4155019387521173e-12
available O 0 4.786681901541856e-12
from O 0 6.19279974523046e-11
family O 0 4.725950741857332e-10
members O 0 4.2061867877585257e-10
. O 0 3.020143779508544e-08

With O 0 4.7482342502291885e-09
direct O 0 3.4287117589570926e-09
tests O 0 1.987847386697439e-10
for O 0 9.039613502181965e-11
the O 0 2.569054302625773e-09
HD B-Disease 0 0.06010826304554939
mutation O 0 4.8418016262985475e-09
, O 0 1.4741298459686192e-10
we O 0 6.726003781709622e-11
have O 0 5.287823998112451e-12
assessed O 0 5.0327568779096055e-09
the O 0 1.720903003432639e-10
accuracy O 0 2.640190732705605e-09
of O 0 1.6718686435268637e-09
results O 0 1.6635846866730475e-10
obtained O 0 1.0226201829777182e-10
by O 0 4.3152877104990495e-11
linkage O 0 6.2490119745461925e-09
approaches O 0 3.95051991119999e-09
when O 0 1.4589411623244786e-10
requested O 0 4.140265352781114e-10
to O 0 2.805143339834615e-10
do O 0 3.332505660313956e-10
so O 0 1.0852849001430354e-11
by O 0 8.731793066374394e-12
the O 0 5.904177702298341e-10
test O 0 1.033428564944927e-09
individuals O 0 1.271407285008408e-10
. O 0 1.327341436763163e-08

For O 0 1.6443303607616144e-08
six O 0 7.917860811446076e-10
such O 0 8.184230376739876e-11
individuals O 0 4.569426868133997e-12
, O 0 1.24596669787147e-11
there O 0 1.3657409404788101e-11
was O 0 1.0101286473940263e-09
significant O 0 5.295381466652316e-09
disparity O 0 2.428272338761417e-08
between O 0 4.836676614772273e-10
the O 0 1.4051269481285544e-08
tests O 0 1.7010957975571728e-08
. O 0 3.8624097697947946e-08

Three O 0 5.555488158393018e-08
went O 0 8.177934773812012e-09
from O 0 2.2429871848750338e-10
a O 0 5.027621652331504e-10
decreased O 0 5.8083005072262495e-09
risk O 0 1.5295764654865707e-09
to O 0 5.411788378539839e-11
an O 0 1.3134026852212877e-11
increased O 0 4.549080556692786e-11
risk O 0 8.518734606610678e-10
, O 0 2.2310179745299585e-11
while O 0 6.875165020625573e-11
in O 0 4.844420004035399e-11
another O 0 1.7823505171765675e-10
three O 0 2.0864433791789594e-10
the O 0 1.057031906448458e-09
risk O 0 2.8206947888520517e-08
was O 0 2.4375530927045475e-08
decreased O 0 4.3318206621734134e-07
. O 0 1.3437633583635034e-07

Knowledge O 0 6.774241967377748e-08
of O 0 1.825169526625814e-08
the O 0 2.0766102171165812e-09
potential O 0 2.303931045943841e-09
reasons O 0 5.510304434963587e-10
for O 0 1.7006453537082855e-11
these O 0 1.2906427662717768e-11
changes O 0 3.028832740170628e-11
in O 0 1.3425170697356492e-11
results O 0 4.7424727339651085e-11
and O 0 6.38550531895099e-11
impact O 0 7.829171089213105e-09
of O 0 1.623400525119223e-09
these O 0 1.6266850366708496e-10
risk O 0 5.069566988424867e-10
reversals O 0 7.861414297316571e-10
on O 0 4.1002015671587344e-10
both O 0 2.671402821174951e-10
patients O 0 1.265322985277706e-10
and O 0 8.145795149516744e-11
the O 0 6.350443504388181e-10
counseling O 0 1.5843877598786804e-10
team O 0 1.3870841975016646e-11
can O 0 1.871815636517171e-12
assist O 0 7.20142973031912e-11
in O 0 2.335296712951962e-11
the O 0 5.077327447366997e-10
development O 0 1.410520034106355e-10
of O 0 4.020068444798852e-10
strategies O 0 2.528625364650594e-10
for O 0 4.364154437136447e-12
the O 0 1.67326430489112e-11
prevention O 0 2.4626548023043426e-10
and O 0 1.3155689211619137e-11
, O 0 8.949097539401318e-12
where O 0 2.754697685236618e-11
necessary O 0 2.0969119496339061e-10
, O 0 4.0253449878902003e-11
management O 0 9.015167501402743e-10
of O 0 5.093567789771214e-09
a O 0 4.722997548611829e-09
risk O 0 2.3739948673551226e-08
reversal O 0 3.424176053812289e-09
in O 0 1.947756261833078e-10
any O 0 2.053446968020012e-09
predictive O 0 6.112129469215688e-09
testing O 0 5.578991713051096e-10
program O 0 9.197566319674166e-11
. O 0 1.883715267103625e-10
. O 0 9.184988769561642e-09

A O 0 3.812002432823647e-06
novel O 0 9.402266414326732e-07
common O 0 4.041830337087049e-08
missense O 0 5.165953211871965e-07
mutation O 0 1.715072173169574e-08
G301C O 0 2.7743200803342916e-07
in O 0 3.288621597263841e-10
the O 0 3.1760880592202057e-09
N O 0 5.219117227284187e-08
- O 0 6.210480307800026e-08
acetylgalactosamine O 0 2.776077508315211e-06
- O 0 5.560597173825954e-07
6 O 0 3.1472470141125086e-07
- O 0 8.314852379953663e-07
sulfate O 0 7.886575303928112e-07
sulfatase O 0 9.832391697273124e-06
gene O 0 1.3342480897904352e-08
in O 0 4.638179174065726e-09
mucopolysaccharidosis B-Disease 0 0.014238445088267326
IVA I-Disease 1 1.0
. O 0 6.464861598942662e-06

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 0 0.002155415015295148
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 8.170766108150929e-08
is O 0 1.2286085482315912e-09
an O 0 2.427261724946561e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.689225541667838e-07
by O 0 2.0279167234349416e-10
a O 0 8.490967928764803e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 7.585366224027723e-10
N O 0 6.019507026167048e-08
- O 0 4.211344872828704e-08
acetylgalactosamine O 0 9.33871888264548e-06
- O 0 8.64845219439303e-07
6 O 0 5.862562488800904e-07
- O 0 2.6535965389484772e-06
sulfate O 0 2.5451145120314322e-06
sulfatase O 0 4.609489405993372e-05
( O 0 1.9823283015085735e-09
GALNS O 1 0.9959775805473328
) O 0 1.0545595507949201e-08
. O 0 3.919270241681261e-08

In O 0 1.5220251725622802e-08
previous O 0 8.529534412105022e-09
studies O 0 8.307126098117124e-10
, O 0 8.387620459293643e-11
we O 0 2.2978813296603562e-11
have O 0 3.283810723342384e-12
found O 0 2.5773265466266793e-11
two O 0 2.0066268091589734e-11
common O 0 1.420024653420171e-10
mutations O 0 1.386333825514896e-10
in O 0 4.5634628020874146e-11
Caucasians O 0 8.16375234080624e-09
and O 0 3.4740793575238627e-10
Japanese O 0 2.732878634503777e-08
, O 0 1.2398799764667956e-09
respectively O 0 2.1990901544199914e-08
. O 0 7.621063247142956e-08

To O 0 5.504752920160172e-08
characterize O 0 7.199378728728334e-07
the O 0 1.0206047562633103e-07
mutational O 0 2.9655386697413633e-06
spectrum O 0 4.283885601807924e-08
in O 0 1.4421640270878555e-10
various O 0 2.2162215118637363e-10
ethnic O 0 2.1467698452237727e-10
groups O 0 4.1510384539422684e-12
, O 0 1.6893174359378094e-11
mutations O 0 8.027786074782384e-11
in O 0 5.108039338730386e-11
the O 0 5.761330079678828e-09
GALNS O 1 0.9999998807907104
gene O 0 1.8385540867527084e-09
in O 0 2.408463151137852e-10
Colombian O 0 1.7049195548679563e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 7.180316856647551e-07
were O 0 1.4232733047681023e-10
investigated O 0 1.5342689341224514e-09
, O 0 4.772708617206689e-11
and O 0 1.7800029505909976e-10
genetic O 0 2.0160699776283764e-09
backgrounds O 0 6.009655967309513e-11
were O 0 2.9065343881695682e-11
extensively O 0 2.6714996881338493e-10
analyzed O 0 3.9720735034443067e-10
to O 0 5.1018658048240795e-11
identify O 0 2.035399487843037e-10
racial O 0 5.153242832456328e-10
origin O 0 2.1065076766246804e-11
, O 0 7.088236247954072e-12
based O 0 3.0296820607844666e-11
on O 0 5.644733569454274e-10
mitochondrial O 0 2.234785023702557e-09
DNA O 0 1.1577123260053668e-08
( O 0 2.499967177715945e-10
mtDNA O 0 1.20111887103036e-09
) O 0 9.819208779404676e-10
lineages O 0 4.285795718317331e-09
. O 0 1.185994324970352e-08

Three O 0 3.6709732853523747e-07
novel O 0 1.9918061298085377e-06
missense O 0 7.795438250468578e-07
mutations O 0 2.1152073870212007e-08
never O 0 6.463334312201141e-09
identified O 0 6.046889655664245e-10
previously O 0 7.284708947175034e-10
in O 0 4.048320706440123e-11
other O 0 4.5757699712600797e-11
populations O 0 2.942938948091722e-11
and O 0 3.079153945706459e-11
found O 0 1.92114588126735e-11
in O 0 4.0312767013439554e-11
16 O 0 1.0813930861885979e-09
out O 0 2.535812115844749e-10
of O 0 1.5000317654667583e-09
19 O 0 1.855744358181255e-08
Colombian O 0 5.991855687170755e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 1.9369829260540428e-06
alleles O 0 9.943806889012308e-10
account O 0 1.0356735608008094e-10
for O 0 2.603563753478255e-10
84 O 0 3.2908531011344166e-07
. O 0 7.419926362217666e-08

2 O 0 1.1346332229322798e-07
% O 0 1.2424699047386412e-09
of O 0 1.9456631861203277e-09
the O 0 1.8625055941967616e-09
alleles O 0 3.5886682514529866e-10
in O 0 1.3011780541916096e-10
this O 0 2.781822272535095e-10
study O 0 5.187257290373282e-09
. O 0 2.677281685237176e-08

The O 0 9.041658017849841e-07
G301C O 0 1.5968202205840498e-05
and O 0 5.011981585312242e-08
S162F O 0 5.606953436654294e-06
mutations O 0 1.2073830824022025e-08
account O 0 2.6653883544724977e-09
for O 0 6.782863604115619e-09
68 O 0 1.2891744063381338e-06
. O 0 2.514788661756029e-07

4 O 0 4.880309347754519e-07
% O 0 4.759568295042982e-09
and O 0 3.03501757059621e-09
10 O 0 3.528582936951352e-08
. O 0 7.395849621616435e-08

5 O 0 4.947339604655099e-08
% O 0 9.060435179897297e-10
of O 0 2.4710924417803426e-09
mutations O 0 7.873644514155842e-10
, O 0 1.630331702973109e-10
respectively O 0 4.943693232561941e-10
, O 0 1.846671565663982e-10
whereas O 0 3.1471655836945445e-10
the O 0 1.7116333905775605e-09
remaining O 0 9.896984920487739e-08
F69V O 1 0.999995231628418
is O 0 7.136674029517565e-10
limited O 0 6.103366145815414e-10
to O 0 2.1786807080648174e-10
a O 0 1.3578203006403555e-09
single O 0 5.71897107448649e-09
allele O 0 2.9565926595864767e-08
. O 0 8.769715265088962e-08

The O 0 8.349562818921186e-08
skewed O 0 2.2648151798421168e-08
prevalence O 0 3.5813414456242754e-08
of O 0 1.4059714281700053e-08
G301C O 0 6.355587629514048e-07
in O 0 3.287015937214477e-10
only O 0 3.3352592909707823e-10
Colombian O 0 4.4892164652310385e-08
patients O 0 1.3682924793201323e-09
and O 0 2.6306484768312544e-10
haplotype O 0 1.6984883499659986e-09
analysis O 0 3.5398552145071704e-11
by O 0 3.2651627929203286e-11
restriction O 0 3.003391535472133e-09
fragment O 0 4.2167278557769805e-09
length O 0 1.9754511360048355e-09
polymorphisms O 0 6.750606185157437e-10
in O 0 3.6355507493368577e-10
the O 0 1.0126252725228824e-08
GALNS O 1 0.9999823570251465
gene O 0 7.645738264727697e-09
suggest O 0 1.179546238461171e-09
that O 0 9.581593851670789e-11
G301C O 0 2.2313281533570262e-07
originated O 0 1.498621227113972e-10
from O 0 1.7914471295288337e-10
a O 0 1.1652394604766414e-09
common O 0 5.247792866924783e-09
ancestor O 0 6.094763449482343e-08
. O 0 8.160829167991324e-08

Investigation O 0 1.4410427695565886e-07
of O 0 9.248524435179206e-08
the O 0 5.039951567198386e-09
genetic O 0 2.664696907572761e-09
background O 0 1.8699476689310046e-10
by O 0 4.44139655608744e-11
means O 0 2.716703972893697e-09
of O 0 8.162662545885269e-09
mtDNA O 0 1.1979933711714352e-09
lineages O 0 4.2548891493465746e-11
indicate O 0 3.713276214289962e-11
that O 0 5.532044874273501e-12
all O 0 4.087939708963262e-11
our O 0 5.88544282753567e-11
patients O 0 6.57513193197401e-12
are O 0 7.447470916875643e-13
probably O 0 4.715755563822199e-11
of O 0 1.7074986979892515e-09
native O 0 5.928060531346091e-08
American O 0 3.7792185025864455e-07
descent O 0 1.8402411114948336e-06

Low O 0 1.7910154781475285e-07
frequency O 0 1.3524293684952227e-08
of O 0 6.448708234074729e-08
BRCA1 O 0 7.632000347257417e-07
germline O 0 1.1040821590313499e-07
mutations O 0 8.0253398371255e-10
in O 0 1.4323391084314352e-10
45 O 0 2.152208367078856e-08
German O 1 0.9999997615814209
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.866729407306593e-10
. O 0 1.6155021764774347e-09

In O 0 1.4284609939352322e-08
this O 0 1.314904712890197e-10
study O 0 1.3726832170934955e-10
we O 0 3.721167471382181e-11
investigated O 0 4.828915045607118e-10
45 O 0 3.188141972643166e-09
German O 1 0.9487168788909912
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.177505993381182e-11
for O 0 1.0028141511631006e-10
germline O 0 1.049074693781904e-08
mutations O 0 4.894502025898362e-10
in O 0 1.4848387797083973e-10
the O 0 1.3182158475899541e-08
BRCA1 O 0 6.612017955376359e-07
gene O 0 2.9340096574514973e-08
. O 0 4.4331429194244265e-08

We O 0 2.4926942288061582e-08
identified O 0 6.376566830113006e-09
four O 0 2.8285591646692865e-09
germline O 0 3.67506416409924e-08
mutations O 0 1.1163119317814107e-09
in O 0 2.0743726181216005e-10
three O 0 8.88012496869095e-10
breast B-Disease 0 7.794620273671171e-07
cancer I-Disease 0 9.656421440240592e-09
families O 0 5.352928929107381e-13
and O 0 6.9188361637162465e-12
in O 0 5.15070451567734e-11
one O 0 6.320216527910816e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.195345211701948e-10
. O 0 1.238611210124807e-12
among O 0 6.565604180122642e-13
these O 0 1.4693028694764965e-12
were O 0 2.229316384272373e-11
one O 0 2.4204782622661014e-10
frameshift O 0 1.167327141615715e-07
mutation O 0 1.2803998972188424e-09
, O 0 4.763962002662936e-10
one O 0 1.670956817356739e-09
nonsense O 0 5.440537620415853e-08
mutation O 0 1.6845409511745402e-09
, O 0 3.785779467690986e-10
one O 0 6.718019474050152e-10
novel O 0 3.7065735369878894e-08
splice O 0 1.0237886272079777e-07
site O 0 6.181736456056797e-09
mutation O 0 2.2670874066932356e-09
, O 0 3.6302083561423615e-10
and O 0 4.054027336053423e-09
one O 0 3.3341049032742376e-08
missense O 0 3.7671670725103468e-06
mutation O 0 6.761939062016609e-07
. O 0 1.7944861951946223e-07

The O 0 3.033896064152941e-06
missense O 0 2.259151642647339e-06
mutation O 0 2.764386586306955e-08
was O 0 6.693070098151566e-09
also O 0 6.684021669478568e-10
found O 0 2.185589903502816e-10
in O 0 5.304719441490136e-10
2 O 0 3.3975314295275894e-07
. O 0 1.302001635394845e-07

8 O 0 6.926058659928458e-08
% O 0 7.586986594532164e-10
of O 0 1.506652469451808e-09
the O 0 1.1848722003549028e-09
general O 0 1.2009905292487133e-09
population O 0 9.278371126963947e-11
, O 0 6.939562813279565e-11
suggesting O 0 1.9846840837445257e-10
that O 0 8.126733661018015e-12
it O 0 8.313588706343467e-11
is O 0 2.213061678357775e-10
not O 0 2.733918647024325e-10
disease O 0 3.066300280352152e-08
associated O 0 3.7902481153651024e-08
. O 0 4.562356252790778e-07

The O 0 5.456833207517775e-08
average O 0 5.4425588480455644e-09
age O 0 3.3724847359195564e-09
of O 0 4.348424287314856e-09
disease O 0 2.2199769489361643e-07
onset O 0 5.787391899048089e-08
in O 0 2.8441599075890167e-10
those O 0 4.4576764501869093e-10
families O 0 2.3247195835018886e-11
harbouring O 0 6.198669666446222e-08
causative O 0 2.387732536135445e-07
mutations O 0 1.0970307329216666e-08
was O 0 1.3065710291471078e-08
between O 0 1.381077918694018e-08
32 O 0 1.2563382369989995e-06
. O 0 1.9403059070555173e-07

3 O 0 1.3630412922793766e-06
and O 0 8.27040835815751e-08
37 O 0 1.2534792404039763e-06
. O 0 1.809712983913414e-07

4 O 0 2.2227986562484148e-07
years O 0 4.1451344579002125e-09
, O 0 2.287863093419773e-10
whereas O 0 3.469510234666018e-10
the O 0 8.965884701339633e-10
family O 0 4.379002938037502e-09
harbouring O 0 9.324409688815649e-07
the O 0 8.959020192378375e-08
missense O 0 6.823063927186013e-07
mutation O 0 1.3019092470756277e-08
had O 0 6.888320469577991e-10
an O 0 2.8716641911619156e-11
average O 0 1.3163500844903808e-10
age O 0 9.823591939905896e-10
of O 0 3.777392620918363e-09
onset O 0 8.874763466337754e-07
of O 0 7.06017044649343e-06
51 O 0 8.251370672951452e-06
. O 0 9.217863095045686e-08

2 O 0 6.4767659750941675e-06
years O 0 2.758706614258699e-07
. O 0 3.51536357356963e-07

These O 0 3.0529712091720285e-08
findings O 0 1.848861064246421e-09
show O 0 6.761146642553229e-10
that O 0 1.2947315441991236e-10
BRCA1 O 0 4.7125617186338786e-08
is O 0 4.0056483130435083e-10
implicated O 0 9.807472611811363e-10
in O 0 6.313219391707037e-11
a O 0 2.369730800477754e-10
small O 0 4.20336376816266e-10
fraction O 0 2.1682931006239414e-09
of O 0 3.065835585402965e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.6917475193233287e-11
suggesting O 0 1.3871371065676819e-11
the O 0 3.638094686619908e-11
involvement O 0 2.0782299492427825e-10
of O 0 2.032932933104803e-09
another O 0 2.025374090663945e-09
susceptibility O 0 2.3291219974908017e-07
gene O 0 2.7455538287313175e-08
( O 0 1.1910541886095416e-08
s O 0 9.278177799387777e-07
) O 0 2.4772671736172924e-07

Paternal O 0 0.0018776049837470055
transmission O 1 0.9939122200012207
of O 1 0.9999997615814209
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0001513527677161619

We O 0 3.373110146753788e-08
report O 0 1.5509870054941644e-09
a O 0 3.963075978496988e-10
rare O 0 9.131392308958652e-10
case O 0 1.832640594834345e-09
of O 0 3.069881415740383e-08
paternally O 1 0.9999998807907104
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.525427594780922e-05
DM B-Disease 1 1.0
) O 0 3.087486177832943e-08
. O 0 5.2187388632773946e-08

The O 0 3.974640208070923e-07
proband O 0 1.5936011550365947e-05
is O 0 3.980744622822385e-09
a O 0 6.554928266844229e-10
23 O 0 1.8468521156833617e-09
year O 0 5.82953754713067e-11
old O 0 2.206131277660006e-08
, O 0 3.2408133954220375e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 3.1108623943509883e-07
who O 0 3.756135669163996e-08
suffers O 1 0.9999998807907104
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 5.0605802243808284e-05

He O 0 1.2833351092922385e-07
presented O 0 2.599844606265833e-08
with O 0 6.6948060428728695e-09
respiratory O 1 0.9997946619987488
and O 0 9.696361047417668e-09
feeding O 0 4.305367156121065e-07
difficulties O 0 1.0129019045734822e-07
at O 0 2.9051308914063156e-08
birth O 0 2.0262373823243252e-07
. O 0 7.619915010081968e-08

His O 0 3.85878365705139e-06
two O 0 4.339196948421886e-07
sibs O 1 0.7829946875572205
suffer O 0 8.912795692594955e-07
from O 0 1.0554610518909158e-08
childhood O 0 0.0006126316729933023
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 1.6336208545908448e-06

Their O 0 7.562054982201971e-09
late O 0 8.960520325729249e-09
father O 0 1.5403157860305328e-08
had O 0 1.054506704178948e-09
the O 0 4.33201446936593e-10
adult O 0 1.3108787388915744e-09
type O 0 2.729585224514608e-09
of O 0 6.560925669418793e-08
DM B-Disease 1 1.0
, O 0 3.8482821373975185e-09
with O 0 6.508086847212269e-10
onset O 0 9.575373951520305e-07
around O 0 7.37741867595787e-09
30 O 0 2.034369117609458e-08
years O 0 1.9678358942343266e-09
. O 0 3.304520035385394e-08

Only O 0 1.494794510392694e-08
six O 0 3.2286018303295805e-10
other O 0 1.0691012311547787e-11
cases O 0 2.1581738132714356e-11
of O 0 1.939622490398918e-10
paternal O 0 7.19132287940738e-07
transmission O 0 0.29366669058799744
of O 1 1.0
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 2.441625497340283e-07
been O 0 2.4584043689657165e-09
reported O 0 2.032339851965048e-09
recently O 0 4.173410061980576e-08
. O 0 9.833817671278666e-08

We O 0 2.7198161944852473e-08
review O 0 1.0268860428652715e-08
the O 0 1.5609707970654085e-09
sex O 0 2.6766355798457653e-10
related O 0 4.707131351366911e-10
effects O 0 2.130471976613535e-08
on O 0 9.494933728149135e-09
transmission O 0 1.6344920368283056e-06
of O 0 2.3305681679630652e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 9.003848390420899e-06

Decreased O 0 2.11143401429581e-06
fertility O 0 4.93987180050226e-08
of O 0 1.6485249831887927e-09
males O 0 1.2528734993910717e-10
with O 0 2.0134048941966576e-11
adult O 0 2.023181977506283e-08
onset O 0 8.310832413371827e-07
DM B-Disease 1 1.0
and O 0 1.6821786630316637e-08
contraction O 0 2.0041742487819647e-08
of O 0 1.9432080389236717e-09
the O 0 1.1045383496721684e-09
repeat O 0 4.701193656586611e-09
upon O 0 8.103648307944411e-10
male O 0 7.122137324344635e-10
transmission O 0 1.8736248663664412e-10
contribute O 0 3.509287999081678e-11
to O 0 3.3144317151956315e-11
the O 0 9.468162920356349e-10
almost O 0 3.853017349619847e-10
absent O 0 1.0963754348836119e-09
occurrence O 0 8.729371669957686e-10
of O 0 1.388340331587301e-09
paternal O 0 1.1014572010026313e-07
transmission O 0 1.814851088965952e-06
of O 0 1.9179662558599375e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 2.5812178137130104e-06

Also O 0 1.855018894048044e-08
the O 0 4.133623221491689e-09
fathers O 0 8.10807421203208e-09
of O 0 3.902187017956749e-09
the O 0 4.399170361324423e-09
reported O 0 7.110413591249198e-09
congenitally O 0 7.036832272433458e-08
affected O 0 2.6384487927799682e-09
children O 0 3.743258480959355e-10
showed O 0 3.7198708002783576e-10
, O 0 5.2640173470175355e-11
on O 0 1.3328714798532815e-09
average O 0 1.5719597845631483e-09
, O 0 8.56693271877873e-10
shorter O 0 1.8299316195680149e-07
CTG O 0 0.000125736856716685
repeat O 0 4.9230539644895543e-08
lengths O 0 2.37953479143016e-08
and O 0 1.7254263573462936e-09
hence O 0 8.693866959674779e-09
less O 0 2.6802335906239705e-09
severe O 0 2.0520430155102076e-07
clinical O 0 2.1395943861080013e-07
symptoms O 0 1.7795226625594296e-08
than O 0 3.1404700888415515e-12
the O 0 1.883459360696449e-11
mothers O 0 2.988679095872193e-11
of O 0 6.895639614867832e-11
children O 0 2.0111186327387287e-10
with O 0 7.98080179720273e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 5.5773439271433745e-06

We O 0 2.7595188356599465e-08
conclude O 0 2.3372863644510744e-09
that O 0 2.4539138082646517e-11
paternal O 0 8.02269966015956e-08
transmission O 0 2.3052809865475865e-06
of O 1 0.868897557258606
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 3.8869242757755273e-07
rare O 0 2.380168950821826e-09
and O 0 1.5607198866618432e-10
preferentially O 0 1.413796080207419e-09
occurs O 0 1.320413136468579e-11
with O 0 7.849824089356527e-12
onset O 0 3.760293409982296e-08
of O 0 1.3998803183312702e-07
DM B-Disease 1 1.0
past O 0 4.0686391145072776e-08
30 O 0 1.3961367617554288e-09
years O 0 3.274593096680434e-11
in O 0 1.1072264632927542e-11
the O 0 4.0636094489343577e-10
father O 0 5.206367781340759e-09
. O 0 3.014053895356028e-09
. O 0 8.263407380582066e-08

The O 0 3.244865183660295e-06
RB1 O 0 0.004614217206835747
gene O 0 6.814700981294664e-08
mutation O 0 5.326175056552529e-09
in O 0 2.8636251703240134e-10
a O 0 4.3583301412297715e-09
child O 0 1.066408898964255e-07
with O 0 1.4924789581982623e-07
ectopic B-Disease 1 0.9992901086807251
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 1.936765102072968e-06

The O 0 4.355932105681859e-06
RB1 O 1 0.9926450252532959
gene O 0 1.735066206265401e-07
mutation O 0 7.025189763254502e-09
was O 0 5.242280387562914e-09
investigated O 0 7.0806795982036874e-09
in O 0 6.937237451154488e-10
a O 0 1.629406831682445e-08
child O 0 6.731191888320609e-07
with O 0 2.0001840539407567e-07
ectopic B-Disease 0 0.0025369904469698668
intracranial I-Disease 1 0.8396255970001221
retinoblastoma I-Disease 0 3.121422878393787e-06
using O 0 3.2652142101241566e-10
DNA O 0 6.42559505603657e-10
obtained O 0 1.1338728567178435e-11
from O 0 8.575506624253215e-12
both O 0 9.688141955344065e-11
the O 0 2.034034496389836e-09
pineal B-Disease 0 1.9477123714750633e-05
and I-Disease 0 6.299732291381588e-08
retinal I-Disease 1 0.9985499978065491
tumours I-Disease 1 1.0
of O 0 0.0013914189767092466
the O 0 7.339973535636091e-07
patient O 0 2.903636016071687e-07
. O 0 2.9057238393193074e-08

A O 0 1.2157493983977474e-05
nonsense O 0 1.941021764650941e-06
mutation O 0 1.1430183910476899e-08
in O 0 1.1434037050506163e-09
exon O 0 2.6852757173401187e-07
17 O 0 7.065276719231406e-08
( O 0 5.432485572498535e-10
codon O 0 1.5204960845949245e-08
556 O 0 4.108235529542981e-09
) O 0 5.3181094944454443e-11
of O 0 1.4901536671274584e-09
the O 0 9.9101100659027e-09
RB1 O 0 0.0018225947860628366
gene O 0 1.7356189818684697e-09
was O 0 1.4370246104178364e-09
found O 0 3.5702465289721985e-11
to O 0 2.4066849207970975e-11
be O 0 3.599510967067232e-11
present O 0 1.7365552051895605e-10
homozygously O 0 1.6169772720786568e-07
in O 0 2.538551036046499e-10
both O 0 1.2350602762722929e-09
the O 0 1.111281910937123e-08
retinal B-Disease 0 9.091028232433018e-07
and I-Disease 0 5.835286742694734e-08
the I-Disease 0 1.2171218486400903e-06
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 2.8301067231950583e-06

The O 0 6.75827749319069e-08
same O 0 1.4851682106353792e-09
mutation O 0 1.4666536873875202e-09
was O 0 1.5962761112930934e-09
present O 0 7.806919555264358e-10
heterozygously O 0 2.5653790203250537e-07
in O 0 1.2288986495079257e-10
the O 0 5.009281878187721e-10
DNA O 0 6.575527344843124e-10
from O 0 2.7137908240049136e-11
the O 0 4.2077916151406214e-10
constitutional O 0 3.157919792329267e-08
cells O 0 7.884189828777366e-11
of O 0 8.562554554281121e-10
the O 0 7.092706977296359e-10
patient O 0 1.0345645451437235e-09
, O 0 4.31147062496251e-11
proving O 0 1.9822865571228476e-09
it O 0 3.792628711085655e-11
to O 0 1.1494995927341378e-10
be O 0 3.1640903785934427e-10
of O 0 1.6244140255139428e-08
germline O 0 2.4705477130737563e-07
origin O 0 6.1716636245989775e-09
. O 0 3.0017549335070726e-08

The O 0 1.4967837103085913e-07
initial O 0 3.436085194152838e-08
mutation O 0 5.249744639002074e-09
was O 0 2.23487894857044e-09
shown O 0 1.6306488104245176e-10
to O 0 2.384643593700275e-10
have O 0 3.285246727435798e-11
occurred O 0 2.866073212093312e-10
in O 0 2.0234579289901689e-10
the O 0 1.3350526018029996e-08
paternally O 0 2.8080000902264146e-06
derived O 0 1.5174400402884203e-07
RB1 O 0 0.00031835385016165674
allele O 0 3.4879201393778203e-07
. O 0 1.507138307488276e-07

The O 0 1.1934514532185858e-07
mutation O 0 7.131180090880207e-09
is O 0 1.2348995437339028e-10
in O 0 1.5980352457978242e-11
an O 0 1.978058168650154e-11
area O 0 5.18521936498928e-09
of O 0 7.231083731795707e-09
the O 0 6.408487518427819e-09
gene O 0 2.959930078816342e-10
that O 0 7.68529476169455e-11
encodes O 0 2.6759772175921626e-10
the O 0 2.928482734088078e-10
protein O 0 3.944675142086851e-10
- O 0 1.4039127638199034e-09
binding O 0 3.773295453868286e-09
region O 0 6.230184812494599e-09
known O 0 5.909743250320787e-10
as O 0 1.2184935005432607e-10
the O 0 6.447939404630176e-10
pocket O 1 0.9999330043792725
region O 0 6.038539481778571e-07
and O 0 1.5917224871486724e-08
has O 0 9.518464905156065e-10
been O 0 2.64141319927802e-10
detected O 0 3.055426189835231e-10
in O 0 1.5950935017272627e-11
other O 0 4.037647993726523e-11
cases O 0 1.0173441256089433e-10
of O 0 2.102523932734357e-09
retinoblastoma B-Disease 0 1.3757560282101622e-06
. O 0 7.490365661055876e-09
. O 0 8.642535220815262e-08

Low O 0 2.309253943622025e-07
levels O 0 5.009303638559004e-09
of O 0 4.580515966523535e-09
beta O 0 2.0511527054623002e-07
hexosaminidase O 0 5.6834969655028544e-06
A O 0 4.966892319657745e-08
in O 0 1.819821376924935e-10
healthy O 0 4.577205725553313e-09
individuals O 0 2.3107312504405675e-12
with O 0 2.543124912046668e-11
apparent O 0 3.79613744883045e-08
deficiency O 0 1.849931140895933e-05
of O 0 1.5637510841770563e-06
this O 0 4.350880100645327e-09
enzyme O 0 7.850738370507315e-08
. O 0 2.0607378914405672e-08

Appreciable O 0 5.805549517390318e-05
beta O 0 8.608850293967407e-06
hexosaminidase O 0 5.7521556300343946e-05
A O 0 2.457056552884751e-06
( O 0 7.895695652848644e-09
hex O 0 2.2067380996304564e-05
A O 0 2.086581361027129e-07
) O 0 1.7862505918841975e-10
activity O 0 2.7195332097385005e-10
has O 0 4.3618931383493376e-11
been O 0 5.1529551459150724e-11
detected O 0 6.780777606074651e-10
in O 0 1.1169034447311432e-10
cultured O 0 1.68297784597371e-08
skin O 0 1.8302943090020563e-06
fibroblasts O 0 6.943635000311588e-09
and O 0 5.2082974377754e-08
melanoma B-Disease 1 1.0
tissue O 0 2.4058845156105235e-06
from O 0 8.184141142564272e-10
healthy O 0 3.643306545342284e-09
individuals O 0 1.5857012968314987e-12
previously O 0 3.9167606658008225e-11
reported O 0 2.584839113584092e-11
as O 0 1.4162622463675945e-10
having O 0 4.579912893376559e-09
deficiency B-Disease 0 1.2787036212102976e-05
of I-Disease 0 1.1287300367257558e-05
hex I-Disease 1 0.9999749660491943
A I-Disease 0 3.591466111174668e-07
activity O 0 8.30354618397422e-10
indistinguishable O 0 2.228135731474623e-10
from O 0 1.981606935833047e-12
that O 0 5.469761471012247e-13
of O 0 2.6007236295089164e-11
patients O 0 2.975574300845274e-11
with O 0 1.8588669492558552e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.0507824771698324e-08
TSD B-Disease 1 0.9999995231628418
) O 0 8.15646838958628e-09
. O 0 2.302702029055581e-08

Identification O 0 5.3769689145610755e-08
and O 0 9.836215397740489e-09
quantitation O 0 6.636366833845386e-06
of O 0 2.190315626648953e-06
hex O 0 0.12415152788162231
A O 0 1.7211564227181952e-06
, O 0 1.930794413240733e-09
amounting O 0 1.9085046432110175e-08
to O 0 2.1670525374162253e-09
3 O 0 2.5963271355067263e-07
. O 0 1.3577749768955982e-07

5 O 0 5.152859898771567e-07
% O 0 2.649787411712623e-08
- O 0 2.5827051786109223e-07
6 O 0 4.403218554216437e-07
. O 0 8.669280759932008e-08

9 O 0 1.598959045168158e-07
% O 0 2.130023935009717e-09
of O 0 9.294534031312196e-09
total O 0 2.3441037999560876e-09
beta O 0 4.275526777064442e-08
hexosaminidase O 0 5.998670644657977e-07
activity O 0 6.330392876563451e-10
, O 0 1.2874423749309472e-10
has O 0 9.540634948734805e-11
been O 0 8.41389805050774e-11
obtained O 0 5.078952536319292e-11
by O 0 1.3283658895080208e-10
cellulose O 0 1.2139062164351344e-06
acetate O 0 1.1835332998089143e-06
gel O 0 8.897194447854417e-07
electrophoresis O 0 1.1464353910639602e-08
, O 0 1.0596117316907794e-09
DEAE O 0 0.0001115313425543718
- O 0 4.5323375275074795e-08
cellulose O 0 2.760559425496467e-07
ion O 0 3.0282484431154444e-07
- O 0 1.9438451204223384e-07
exchange O 0 5.865523622361479e-09
chromatography O 0 3.2502057933925244e-08
, O 0 3.005991844329259e-10
radial O 0 1.0099869030000264e-07
immunodiffusion O 0 9.686268640507478e-07
, O 0 1.8490585729225018e-09
and O 0 9.62189439235317e-09
radioimmunoassay O 0 3.20580875268206e-05
. O 0 3.336083693739056e-07

Previous O 0 3.171518528688466e-06
family O 0 9.696361047417668e-09
studies O 0 6.286703380098402e-10
suggested O 0 1.2673712079802613e-10
that O 0 6.475836793889966e-12
these O 0 3.601942355491161e-11
individuals O 0 3.308366601506574e-12
may O 0 1.596024701289167e-11
be O 0 2.9021413744390046e-11
compound O 0 6.14023998313229e-10
heterozygotes O 0 4.9198223273094754e-09
for O 0 1.8073409435714893e-10
the O 0 3.821343685928014e-09
common O 0 1.4588897201406326e-08
mutant O 0 6.058220378690748e-07
TSD B-Disease 0 0.00013360970478970557
gene O 0 2.7411466430038445e-09
and O 0 9.300666348188713e-10
a O 0 2.050801084507725e-09
rare O 0 9.054428318222563e-09
( O 0 2.695444090150545e-09
allelic O 0 1.9353046809555963e-06
) O 0 1.0353900847803743e-08
mutant O 0 6.83835878589889e-07
gene O 0 4.874318193515137e-08
. O 0 3.427510364417685e-08

Thus O 0 3.088364053382975e-07
, O 0 8.517358374149353e-09
the O 0 1.680578520790732e-08
postulated O 0 5.619805278911372e-07
rate O 0 3.174557861029825e-08
mutant O 0 6.333103641509297e-08
gene O 0 6.458549250965007e-10
appears O 0 2.3272940519181162e-10
to O 0 2.1098451111201122e-11
code O 0 5.1074158791131197e-11
for O 0 1.708493936602995e-11
the O 0 2.7804378244233874e-10
expression O 0 2.2966642476696109e-10
of O 0 5.587255103023381e-10
low O 0 9.43618516657807e-09
amounts O 0 4.501028882941682e-09
of O 0 1.97030445292512e-08
hex O 0 2.5613611796870828e-05
A O 0 1.8597129383124411e-06
. O 0 9.741056317125185e-08

Heterozygotes O 0 9.097949259739835e-06
for O 0 6.620192838369121e-09
the O 0 1.4064006848002464e-08
rare O 0 3.158016070869962e-08
mutant O 0 9.591718708179542e-08
may O 0 1.3476744720186673e-10
be O 0 3.067131965073244e-11
indistinguishable O 0 1.1418737067003804e-09
from O 0 3.628891284690461e-11
heterozygotes O 0 6.760918491721668e-09
for O 0 2.354502703916239e-10
the O 0 6.8618355442140455e-09
common O 0 7.071559338100997e-08
TSD B-Disease 0 0.0029256646521389484
mutant O 0 6.5393892327847425e-06
. O 0 1.7187014123010158e-07

However O 0 2.5622339805408956e-08
, O 0 2.6143336384620852e-09
direct O 0 3.7026288701724752e-09
visualization O 0 7.039232752248381e-09
and O 0 2.5328261710200195e-09
quantitation O 0 3.3416001770092407e-06
of O 0 1.0028956012320123e-06
hex O 0 0.0013306904584169388
A O 0 6.552809139748206e-08
by O 0 2.99171937223619e-11
the O 0 2.432933854379371e-10
methods O 0 7.501685939104163e-10
described O 0 1.837427709983075e-10
may O 0 1.8818981095680698e-10
prevent O 0 6.019941434232123e-09
false O 0 1.642104230370478e-09
- O 0 5.4152535788887235e-09
positive O 0 5.246599266151009e-10
prenatal O 0 3.4881970645272986e-09
diagnosis O 0 2.1560695451228185e-09
of O 0 3.763017897284726e-09
TSD B-Disease 1 0.9999265670776367
in O 0 3.4607416932175283e-09
fetuses O 0 2.491714923280597e-08
having O 0 1.346672495738943e-10
the O 0 3.238407875194582e-10
incomplete O 0 3.5497794925731796e-08
hex B-Disease 0 5.601799057330936e-05
A I-Disease 0 9.694437039797776e-07
deficiency I-Disease 0 1.2401405911077745e-06
of O 0 7.058111606284001e-08
the O 0 5.458975049776882e-09
type O 0 6.299393007225262e-09
described O 0 1.7719171963026525e-10
in O 0 8.069557522194515e-11
the O 0 9.213659168949562e-09
four O 0 1.0413991446966975e-08
healthy O 0 1.1506715225095832e-07
individuals O 0 3.7165537314365338e-09

The O 0 9.190262062475085e-06
tumor B-Disease 1 0.9982231259346008
suppressor O 0 0.0022280155681073666
gene O 0 1.3900893236495904e-06
Smad4 O 0 0.030699148774147034
/ O 0 2.2918893591850065e-06
Dpc4 O 0 6.931021925993264e-05
is O 0 3.7622549520222037e-10
required O 0 1.1628321916479223e-10
for O 0 4.3887733724989886e-11
gastrulation O 0 7.331548257383247e-09
and O 0 1.1222227314089395e-10
later O 0 3.231226120004038e-10
for O 0 1.4170134510216315e-10
anterior O 0 6.716577871657137e-08
development O 0 6.0579057326037855e-09
of O 0 6.698999044374432e-08
the O 0 5.988427886904901e-08
mouse O 0 1.1358603160260827e-06
embryo O 0 2.5282767524004157e-07
. O 0 4.380592599773081e-08

Mutations O 0 3.9920158201312006e-07
in O 0 8.542820673085316e-09
the O 0 1.4352644939208403e-07
SMAD4 O 1 1.0
/ O 0 0.4800213575363159
DPC4 O 1 1.0
tumor B-Disease 1 0.9979332685470581
suppressor O 0 4.395441919768928e-06
gene O 0 1.4268755066382255e-09
, O 0 1.5830314836762227e-10
a O 0 3.38242295283564e-10
key O 0 2.225428374913463e-08
signal O 0 7.736305818184519e-09
transducer O 0 6.059918433720668e-08
in O 0 1.3890448791187282e-09
most O 0 4.508323492302679e-09
TGFbeta O 0 1.9824137780233286e-05
- O 0 1.1230186913735452e-07
related O 0 1.635534729871324e-08
pathways O 0 5.79280845514063e-10
, O 0 8.221713240774697e-12
are O 0 4.017938867902082e-13
involved O 0 2.8752250146729663e-12
in O 0 4.5167771432763626e-12
50 O 0 7.443420879660323e-10
% O 0 2.700449863723975e-10
of O 0 4.063985414859417e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.2419174001697684e-06

Homozygous O 0 0.0002053316420642659
Smad4 O 0 0.0007393702981062233
mutant O 0 9.826589121075813e-06
mice O 0 2.128514893229294e-07
die O 0 2.111966068696347e-08
before O 0 5.870826047527089e-10
day O 0 1.834690066537803e-09
7 O 0 7.619507869094377e-08
. O 0 5.214520015783819e-08

5 O 0 3.5395141821936704e-06
of O 0 1.2983404076294391e-06
embryogenesis O 0 3.6159328828944126e-06
. O 0 1.4307739775176742e-06

Mutant O 0 3.254410557929077e-06
embryos O 0 1.2212659328270092e-08
have O 0 5.573373706990736e-11
reduced O 0 5.111482348496565e-10
size O 0 9.850366078367756e-10
, O 0 4.050887403295178e-10
fail O 0 9.828357683261402e-09
to O 0 2.557272171799241e-09
gastrulate O 0 1.4089093383518048e-05
or O 0 1.0194701971499853e-08
express O 0 2.4726625191817675e-09
a O 0 5.979725048455009e-10
mesodermal O 0 1.1924866782919707e-07
marker O 0 2.6485071202841937e-07
, O 0 5.414775294809715e-10
and O 0 8.531906292574831e-10
show O 0 7.966433912542925e-08
abnormal O 0 3.048912731173914e-07
visceral O 0 4.371205250208732e-06
endoderm O 0 1.1163325325469486e-05
development O 0 1.37104976261071e-07
. O 0 1.356956857989644e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 2.0283679987187497e-05
the O 0 1.35850939386728e-07
Smad4 O 0 0.0003146787639707327
- O 0 1.284125119127566e-06
deficient O 0 1.746542892533398e-07
embryos O 0 1.6797028212778287e-09
results O 0 1.3128192109801429e-11
from O 0 3.091262705881559e-12
reduced O 0 4.701998235212557e-10
cell O 0 1.5048856605304195e-10
proliferation O 0 1.0368604641541879e-08
rather O 0 3.5760822081343235e-10
than O 0 9.83956388589391e-11
increased O 0 4.094857786185457e-09
apoptosis O 0 2.888699270897632e-07
. O 0 1.3639876783599902e-07

Aggregation O 0 3.3184205676661804e-06
of O 0 1.8499308680475224e-06
mutant O 0 7.208507668110542e-06
Smad4 O 0 0.0008518369868397713
ES O 0 0.0001780664169928059
cells O 0 5.107954059724307e-10
with O 0 1.1320624992983142e-10
wild O 0 1.275586924975869e-07
- O 0 1.4199807196746406e-07
type O 0 1.0904162195402023e-07
tetraploid O 0 2.022040916926926e-07
morulae O 0 3.08825701722526e-06
rescues O 0 5.225462018643157e-07
the O 0 4.1194734734517624e-08
gastrulation B-Disease 0 1.4679994819744024e-05
defect I-Disease 0 5.15880310558714e-06
. O 0 4.13672609056448e-07

These O 0 4.5150461147613896e-08
results O 0 1.5408616604872805e-09
indicate O 0 2.9989477567937683e-10
that O 0 3.869719128468674e-11
Smad4 O 0 1.5894067928456934e-06
is O 0 1.2167564178433565e-10
initially O 0 1.0383635618005371e-10
required O 0 2.0247734044964716e-11
for O 0 1.6461793733713037e-11
the O 0 3.2411145989286183e-10
differentiation O 0 2.4578966639765554e-10
of O 0 4.8452286627309604e-09
the O 0 7.537775736921049e-09
visceral O 0 1.4098174005994224e-07
endoderm O 0 8.685169206046339e-08
and O 0 1.2827221507194508e-09
that O 0 9.073054807462455e-11
the O 0 4.754179272481451e-09
gastrulation B-Disease 0 2.7932676971431647e-07
defect I-Disease 0 2.605543691913681e-08
in O 0 2.2558196977051637e-10
the O 0 5.308750772314852e-09
epiblast O 0 6.710264415232814e-07
is O 0 5.247229317717483e-10
secondary O 0 1.8903181242535538e-08
and O 0 8.686917296607533e-10
non O 0 7.695630301896017e-07
- O 0 2.9174639166740235e-06
cell O 0 7.851289751670265e-07
autonomous O 0 4.1613999201217666e-05
. O 0 2.1488126833446586e-07

Rescued O 0 3.6214476040186128e-06
embryos O 0 8.500855841475641e-08
show O 0 3.540306536820026e-08
severe O 0 3.8054713513702154e-06
anterior O 0 2.2139385691843927e-05
truncations O 0 8.119781705318019e-05
, O 0 7.107715749299359e-09
indicating O 0 2.4064945591817377e-09
a O 0 4.643638806811623e-10
second O 0 8.44293523982742e-10
important O 0 2.269787247044519e-09
role O 0 3.4753671052101254e-09
for O 0 1.1296796831317124e-09
Smad4 O 0 7.156518404372036e-05
in O 0 1.6856249729357842e-08
anterior O 0 1.0874417057493702e-05
patterning O 0 1.8791312186294817e-06
during O 0 2.114078654358309e-07
embryogenesis O 0 8.017374284463585e-07
. O 0 2.572091375441232e-07

Prevalence O 0 7.557179287687177e-06
of O 0 7.879103236518858e-07
p16 O 0 2.1217183530097827e-06
and O 0 9.395529332323349e-08
CDK4 O 1 1.0
germline O 0 5.072656222182559e-06
mutations O 0 4.395842267967964e-08
in O 0 1.4297305561683515e-09
48 O 0 1.7331726098746003e-07
melanoma B-Disease 0 0.23017443716526031
- O 0 4.769685801875312e-06
prone O 0 1.8657225382412435e-06
families O 0 1.0844578013369244e-10
in O 0 2.9533658851832456e-10
France O 0 1.2228537116243388e-07
. O 0 1.0237886272079777e-07

The O 0 4.496433120948495e-06
French O 0 0.0002541343856137246
Familial B-Disease 1 0.9999908208847046
Melanoma I-Disease 1 1.0
Study O 0 6.736772206750175e-07
Group O 0 3.3370760377238184e-08
. O 0 2.8261121443051707e-08

Germline O 0 7.826016371836886e-06
mutations O 0 5.947007153395134e-08
in O 0 1.165855301188401e-09
the O 0 9.058573446907303e-09
p16 O 0 7.501635934659134e-08
and O 0 4.222635130446406e-09
CDK4 O 1 0.9999998807907104
genes O 0 1.7950906316954729e-09
have O 0 2.4278612106853892e-11
been O 0 3.0856209948249e-11
reported O 0 6.736223384651296e-11
in O 0 6.375903277566763e-11
a O 0 5.920055001773505e-10
subset O 0 9.53955314741961e-09
of O 0 1.9263223904886217e-08
melanoma B-Disease 1 0.7962120175361633
pedigrees O 0 4.444724766017316e-08
, O 0 1.3912819507577723e-10
but O 0 1.6463174573599915e-11
their O 0 2.8671872168151147e-11
prevalence O 0 2.165309043178354e-09
is O 0 2.49538289337492e-11
not O 0 1.7099217874960715e-11
well O 0 4.669707398541334e-10
known O 0 1.5446877554836647e-08
. O 0 1.3173516322240175e-07

We O 0 1.3905246731837906e-08
searched O 0 1.1841950531277234e-08
for O 0 5.248820822423284e-10
such O 0 3.1541498302090076e-09
germline O 0 1.608478328307683e-07
mutations O 0 2.3494393097678312e-09
in O 0 3.695529160463451e-10
48 O 0 6.956243936429019e-08
French O 0 2.045167093456257e-06
melanoma B-Disease 1 0.9999997615814209
- O 0 7.604061011079466e-06
prone O 0 3.464105589046085e-07
families O 0 1.2894026991949747e-11
selected O 0 2.7953573483729954e-11
according O 0 1.1786988485945615e-12
to O 0 8.601569977118029e-12
two O 0 1.2474694888187088e-11
major O 0 8.359801739743489e-10
criteria O 0 4.72406069818021e-09
families O 0 8.812299848171001e-13
with O 0 2.0674185020191915e-12
at O 0 1.1514179609761754e-09
least O 0 1.4351940469392588e-10
three O 0 1.4140812132357183e-10
affected O 0 1.1020908630143822e-09
members O 0 1.6641424349650435e-11
( O 0 4.2463275951032387e-11
n O 0 2.1938929839482313e-10
= O 0 7.684297642640558e-11
20 O 0 1.597335180791859e-10
) O 0 3.835065078006128e-12
or O 0 4.137560953576536e-12
families O 0 1.2950431742611568e-13
with O 0 6.523139233632902e-13
two O 0 4.333960707675333e-12
affected O 0 5.7447442636249235e-11
members O 0 9.28774635325369e-13
, O 0 1.0077279288811525e-11
one O 0 1.792932989574947e-11
of O 0 1.7794563045292477e-10
them O 0 1.6055264756564824e-11
affected O 0 2.7606096228427468e-11
before O 0 1.680149769311967e-11
the O 0 1.6240313260862393e-10
age O 0 6.737074786933306e-10
of O 0 1.0152549911879305e-09
50 O 0 1.9872268275378246e-09
( O 0 2.659789055670103e-11
n O 0 1.6887480303040547e-10
= O 0 1.177697800391897e-10
28 O 0 6.162485521876704e-10
) O 0 1.3247014596373674e-11
, O 0 1.5208882764294884e-11
and O 0 3.578270665882677e-11
one O 0 9.917965754224767e-11
additional O 0 2.482648087109851e-09
minor O 0 3.1476673711949843e-07
criterion O 0 2.904419307014905e-05
. O 0 1.6647487655063742e-07

Sixteen O 0 1.9688224710989743e-05
different O 0 5.5359826944823e-08
p16 O 0 5.976366992399562e-07
germline O 0 4.735339942385508e-08
mutations O 0 3.946639126617413e-10
were O 0 4.9519201239522914e-11
found O 0 9.57855583044731e-12
in O 0 6.635087011069851e-12
21 O 0 2.9909047460918714e-10
families O 0 5.865444848568435e-13
, O 0 1.1703389993233948e-11
while O 0 1.8740108076453765e-10
one O 0 1.959259643413702e-09
germline O 0 3.89668493028239e-08
mutation O 0 3.4454614716850074e-09
, O 0 7.164073223542289e-10
Arg24His O 0 3.298786759842187e-05
, O 0 3.512660162741099e-09
was O 0 1.4179990515117424e-08
detected O 0 1.580293940151023e-08
in O 0 1.3268700582713677e-09
the O 0 1.1095202268052162e-07
CDK4 O 1 0.9999982118606567
gene O 0 6.211913614606601e-07
. O 0 3.1359817853626737e-07

The O 0 1.707334291722873e-07
frequency O 0 4.176786916332276e-08
of O 0 1.1861565951676312e-07
p16 O 0 6.133469128144498e-07
gene O 0 7.782690047974938e-09
mutation O 0 5.435906169637406e-10
in O 0 8.233330683893314e-11
our O 0 2.254099268350629e-10
sample O 0 9.898500769045526e-11
( O 0 6.024021125677903e-12
44 O 0 4.014735210944309e-10
% O 0 1.1127480013806146e-11
) O 0 1.0752177793948992e-11
is O 0 1.372056895182494e-11
among O 0 8.584523716881343e-12
the O 0 5.007425724068426e-11
highest O 0 5.994593155200789e-10
rates O 0 1.900554574829627e-10
yet O 0 5.0831776288173813e-11
reported O 0 3.9813787683362634e-11
and O 0 2.130620263551819e-10
the O 0 4.33579439018672e-09
CDK4 O 1 0.9999988079071045
mutation O 0 8.1514919259007e-09
is O 0 1.652137870955528e-10
the O 0 1.1020804269179507e-09
second O 0 1.0732483346487243e-08
mutation O 0 2.1647186265738583e-09
detected O 0 1.9561638975318374e-09
in O 0 3.1380126275237785e-10
this O 0 9.31557941896699e-10
gene O 0 8.106682436448409e-09
worldwide O 0 6.373867655895538e-09
. O 0 9.623475705211604e-08

In O 0 1.6696418470019125e-08
summary O 0 2.405536569938249e-08
, O 0 7.579292193859999e-10
our O 0 9.581780924250438e-10
results O 0 2.0245813359132114e-10
show O 0 9.196553518719952e-10
frequent O 0 3.782028024090778e-09
involvement O 0 2.486510330967917e-09
of O 0 1.0372441572314983e-08
the O 0 2.4760336003737393e-08
p16 O 0 3.447653114108107e-07
gene O 0 7.820545100400977e-09
in O 0 1.845130381816773e-09
familial B-Disease 0 8.511663509125356e-06
melanoma I-Disease 0 0.42667287588119507
and O 0 6.872179492134478e-10
confirm O 0 1.4243677071146266e-10
the O 0 3.0811764251126306e-10
role O 0 9.03241370586727e-10
of O 0 9.27692944685532e-09
the O 0 4.338104275802834e-08
CDK4 O 1 1.0
gene O 0 2.8370974902713897e-08
as O 0 3.147214933107989e-09
a O 0 1.784396452819692e-08
melanoma B-Disease 1 0.5556391477584839
- O 0 1.277467526961118e-05
predisposing O 0 6.69383371132426e-06
gene O 0 5.500069288899567e-09
. O 0 1.0647819292941563e-09
. O 0 1.5103102768421195e-08

Progression O 0 1.6971094737527892e-05
of O 0 2.0489778762566857e-06
somatic O 0 1.4989596820669249e-05
CTG O 0 0.00045954412780702114
repeat O 0 1.0538441586049885e-07
length O 0 3.1713784931497457e-09
heterogeneity O 0 1.5792934959790728e-08
in O 0 1.1277888345428977e-10
the O 0 7.431023019144334e-10
blood O 0 1.0600785804726343e-09
cells O 0 4.814329490621105e-10
of O 0 4.533669084594294e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.8265994867761037e-06
. O 0 1.7890961601096933e-08

The O 0 5.3490534668299006e-08
genetic O 0 3.1167566305612127e-08
basis O 0 7.591014927754713e-09
of O 0 2.9853335945517756e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.070058326353319e-05
DM B-Disease 1 1.0
) O 0 3.9806363760774843e-10
is O 0 2.6438715799992352e-11
the O 0 1.3192608117051918e-10
expansion O 0 6.699916177410614e-09
of O 0 6.4403224975251305e-09
an O 0 1.34233157922381e-09
unstable O 0 2.0856862192886183e-07
CTG O 0 4.592921686707996e-05
repeat O 0 1.7023941367710904e-08
in O 0 1.31847602280466e-10
the O 0 2.114572961176009e-09
34 O 0 1.1351209749932423e-08
UTR O 0 1.1670031199173536e-05
of O 0 4.293357847018342e-08
the O 0 1.2093933321466466e-07
DM B-Disease 1 1.0
protein O 0 6.01811279921094e-07
kinase O 0 6.194001400672278e-08
gene O 0 1.7529255824655365e-09
on O 0 5.536930469673962e-09
chromosome O 0 6.171794808551567e-08
19 O 0 9.303299464136217e-08
. O 0 3.073701648759197e-08

One O 0 1.1733895632914937e-08
of O 0 4.37142588793904e-09
the O 0 4.971711931034406e-10
principal O 0 1.0100250413813683e-08
features O 0 1.293539830804491e-09
of O 0 1.8179429517317658e-08
the O 0 6.414054496417521e-07
DM B-Disease 1 1.0
mutation O 0 5.258967306076556e-08
is O 0 8.411987773015994e-11
an O 0 1.8339604140882315e-11
extraordinarily O 0 3.6195628716484407e-09
high O 0 2.0197312267100642e-08
level O 0 2.2222216955469776e-08
of O 0 2.5927170099748764e-07
somatic O 0 2.936643795692362e-06
mosaicism O 0 6.135462172096595e-06
, O 0 2.683096245181815e-10
due O 0 1.8107854105053889e-09
to O 0 2.6112523254795406e-10
an O 0 6.34547622779813e-11
extremely O 0 4.646722173706763e-10
high O 0 6.3072800315921995e-09
degree O 0 5.691895843540351e-09
of O 0 1.2599416621128512e-08
somatic O 0 7.772887045121024e-08
instability O 0 1.793797821392218e-08
both O 0 3.836693185377271e-10
within O 0 2.09804826289961e-10
and O 0 1.0429844488069051e-10
between O 0 2.9692881486909073e-10
different O 0 1.2790525305561573e-09
tissues O 0 4.8742251124167524e-08
. O 0 2.635653650884251e-08

This O 0 9.47763894032505e-08
instability O 0 4.668438293720101e-07
appears O 0 5.012380732694055e-09
to O 0 1.8928779377258564e-10
be O 0 6.143516945167349e-11
biased O 0 1.1641664299233412e-09
towards O 0 8.262974193762318e-10
further O 0 2.933503162605433e-10
expansion O 0 1.318449016629586e-09
and O 0 2.2168682167755804e-10
continuous O 0 7.144382307977537e-10
throughout O 0 2.6679795525619276e-11
the O 0 2.8008131924828206e-10
life O 0 2.0348406293280163e-10
of O 0 2.439364543693756e-10
an O 0 1.160943476768983e-11
individual O 0 6.481521049039873e-12
, O 0 4.348027580342029e-12
features O 0 1.0703810754408849e-10
that O 0 2.9741088064527688e-12
could O 0 1.631083636211006e-11
be O 0 6.652435113191357e-12
associated O 0 2.7500463711804812e-11
with O 0 4.0318613031553596e-11
the O 0 3.183772578907451e-09
progressive O 0 1.072525947165559e-06
nature O 0 2.7271511271464988e-08
of O 0 2.4131741938049345e-08
the O 0 4.4079492056425806e-08
disease O 0 1.415766064383206e-06
. O 0 7.298303472680345e-08

Although O 0 4.827962385434148e-08
increasing O 0 7.151803149696434e-09
measured O 0 1.3950087307534886e-08
allele O 0 1.3106488117031745e-09
size O 0 2.3092192602547357e-09
between O 0 2.4544031251849674e-09
patients O 0 6.607590474771996e-09
clearly O 0 1.8077209729128185e-09
correlates O 0 2.6892765792041473e-09
with O 0 1.7793570436519524e-11
an O 0 8.260602271659145e-12
increased O 0 1.0585567145060537e-10
severity O 0 6.754978443268556e-08
of O 0 2.151879918699251e-08
symptoms O 0 2.601700771265314e-06
and O 0 1.010106859267168e-10
an O 0 1.1808326885742737e-11
earlier O 0 8.632670966957079e-11
age O 0 2.5302959727468988e-09
of O 0 3.537969028855059e-09
onset O 0 4.3397594851057875e-08
, O 0 8.086412789376496e-11
this O 0 3.3906098415026342e-12
correlation O 0 5.904985528326634e-11
is O 0 1.3437620807743578e-11
not O 0 2.5471623508327434e-12
precise O 0 3.7891387250077457e-10
and O 0 1.7519687089961877e-10
measured O 0 4.936798081445204e-09
allele O 0 6.571690969181532e-10
length O 0 1.1115357523294733e-09
cannot O 0 2.44452513786797e-10
be O 0 1.5836316633044412e-11
used O 0 2.4836924183979647e-11
as O 0 2.3694947046126735e-11
an O 0 4.5266780775155e-12
accurate O 0 1.5310708256777161e-09
predictor O 0 6.329216262201953e-08
of O 0 1.368916890953642e-08
age O 0 1.3199819903775278e-08
of O 0 3.56124054690099e-08
onset O 0 2.5906779228535015e-06
. O 0 1.3157345790659747e-07

In O 0 7.028821524812656e-09
order O 0 1.750934064403964e-09
to O 0 1.6875598141119497e-10
further O 0 8.303704390755229e-10
characterize O 0 1.1976810654346082e-08
the O 0 6.025409060583797e-09
dynamics O 0 1.0483829271379363e-07
of O 0 1.5137211448745802e-06
DM B-Disease 1 1.0
CTG O 1 0.9999996423721313
repeat O 0 4.153106658577599e-07
somatic O 0 6.417504749833824e-08
instability O 0 5.346072917689071e-09
, O 0 8.600983120166106e-11
we O 0 2.3520151104516884e-11
have O 0 2.1392059131042362e-12
studied O 0 1.2820177142103262e-09
repeat O 0 4.3370743108006593e-10
length O 0 8.772713805393906e-11
changes O 0 3.543705953679144e-11
over O 0 1.1133812621855199e-10
time O 0 1.3198095394351128e-10
in O 0 7.377724542401154e-10
111 O 0 1.8129447880710359e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.0417274154406186e-07
with O 0 1.0681458495476193e-10
varying O 0 9.747497253798088e-10
clinical O 0 4.522585861366224e-09
severity O 0 6.108553662897975e-08
and O 0 1.6554191351048075e-09
CTG O 0 9.599616532796063e-06
repeat O 0 1.6184475981617652e-09
size O 0 2.0552011481544952e-10
over O 0 1.8005454072156368e-10
time O 0 8.629048864339239e-11
intervals O 0 3.865501529976001e-10
of O 0 6.047419787158503e-10
1 O 0 5.318053997172001e-09
- O 0 3.3556496248365875e-08
7 O 0 1.7439521826645432e-08
years O 0 4.904699757446451e-09
. O 0 2.7252792023091388e-08

We O 0 2.7228372445620153e-08
have O 0 1.0083552048900657e-10
found O 0 8.57641180296298e-11
a O 0 9.052519150953842e-11
direct O 0 7.660682088683757e-10
progression O 0 3.7172838140975273e-09
of O 0 1.6628622923064995e-09
the O 0 1.001568272762654e-09
size O 0 3.3199649696058486e-09
heterogeneity O 0 1.7082781411659198e-08
over O 0 3.5588552105281224e-09
time O 0 4.334973213726556e-10
related O 0 2.390446507405386e-09
to O 0 3.077241517157603e-10
initial O 0 6.870426894067805e-09
CTG O 0 3.0077383144089254e-06
repeat O 0 1.499127932902411e-09
size O 0 2.8151717068602977e-10
and O 0 1.5431313171720973e-10
the O 0 2.031265156077211e-10
time O 0 6.610469810430786e-11
interval O 0 5.031267069632861e-10
and O 0 2.3641058555234906e-10
always O 0 2.492796247199891e-10
biased O 0 1.8637458243375704e-09
towards O 0 1.845260499955259e-09
further O 0 6.199104785054033e-09
expansion O 0 2.930190987626702e-07
. O 0 1.2874956212272082e-07

Attempts O 0 3.5321730251780536e-07
to O 0 3.037090801072395e-09
mathematically O 0 2.9353293129474878e-09
model O 0 4.849072809953725e-10
the O 0 5.410645820269622e-10
dynamics O 0 5.52043788459855e-09
have O 0 1.7449854061712955e-10
proved O 0 6.081267489577158e-09
only O 0 2.7633714760888495e-10
partially O 0 2.3471338650438156e-08
successful O 0 1.2087673084693051e-09
suggesting O 0 1.1435601077192104e-10
that O 0 7.398120310808665e-12
individual O 0 1.2795783529973015e-11
specific O 0 1.313265607372216e-10
genetic O 0 6.393198748178008e-10
and O 0 2.796483877798295e-10
/ O 0 2.820463329555878e-08
or O 0 3.6356548327454163e-10
environmental O 0 3.0944072193506145e-08
factors O 0 2.18226259285359e-09
also O 0 6.972998567444932e-11
play O 0 2.6012916265472086e-09
a O 0 5.741745412457533e-10
role O 0 4.61491822534299e-09
in O 0 4.673915476871571e-09
somatic O 0 5.989616056467639e-07
mosaicism O 0 3.361785502420389e-06
. O 0 8.202726498041102e-09
. O 0 4.496912353602056e-08

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 1.7897143322898046e-07
Palestinian O 0 1.8954219171973818e-07
Arabs O 0 7.454254102867708e-08
. O 0 6.815299258278174e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 4.297972554923035e-05
AGU B-Disease 1 1.0
) O 0 1.7690622300392533e-08
is O 0 9.625560348780482e-10
a O 0 1.3159993095257505e-09
rare O 0 4.1065459299716167e-07
disorder B-Disease 1 1.0
of I-Disease 1 0.999971866607666
glycoprotein I-Disease 0 0.0001904765231302008
metabolism I-Disease 0 2.658518098996865e-07
caused O 0 7.605605034655127e-10
by O 0 2.4024516750986713e-11
the O 0 5.5779945107303774e-09
deficiency B-Disease 0 9.382433199789375e-05
of I-Disease 0 3.1112203942029737e-06
the I-Disease 0 1.2678144685196457e-06
lysosomal I-Disease 0 0.00016137091733980924
enzyme I-Disease 0 2.3342185784258618e-07
aspartylglucosaminidase I-Disease 0 9.084961675398517e-06
( O 0 3.026173756026651e-09
AGA O 0 5.532106661121361e-05
) O 0 1.9972214104768682e-08
. O 0 5.631211763557076e-08

AGU B-Disease 1 1.0
is O 0 9.470390409660467e-07
inherited O 0 3.865214966936037e-05
as O 0 1.840769137118059e-08
an O 0 1.119933745741264e-08
autosomal O 0 0.0012135785073041916
recessive O 0 1.8057382476399653e-05
trait O 0 1.50815054666964e-07
and O 0 5.278186221424619e-10
occurs O 0 2.195239649782632e-11
with O 0 2.034760597860452e-12
a O 0 2.5886777096917335e-11
high O 0 1.9124610783904927e-09
frequency O 0 5.522035606553288e-10
in O 0 2.5632970745981254e-10
Finland O 0 2.480751959410554e-07
because O 0 3.4198683884767433e-09
of O 0 3.969994821773071e-08
a O 0 1.3293227851818301e-08
founder O 0 2.013385653754085e-07
effect O 0 2.649681789534952e-07
. O 0 9.984525206618855e-08

While O 0 3.2069031874470966e-08
very O 0 1.019419104686392e-09
few O 0 1.6146119996562902e-09
patients O 0 6.074192815397339e-10
with O 0 1.1548425549179342e-09
AGU B-Disease 1 1.0
have O 0 2.578961710852923e-09
been O 0 1.6502701982723522e-10
reported O 0 4.4585755226700385e-11
from O 0 7.372374932756998e-11
non O 0 5.444357853434667e-08
- O 0 1.7029071486263092e-08
Finnish O 0 7.282520186890906e-07
origin O 0 7.953699504570366e-11
, O 0 2.3239127636132118e-11
we O 0 1.2246820224603994e-10
diagnosed O 0 8.159521769357525e-08
the O 0 3.3735332305440124e-09
disorder O 0 1.2859602065873332e-05
in O 0 3.973354145703212e-10
8 O 0 1.6211268771826326e-08
patients O 0 8.840726761771833e-11
originating O 0 3.2411731718667847e-12
from O 0 7.306535584894469e-12
3 O 0 7.587334094338871e-10
unrelated O 0 4.815991494488969e-10
families O 0 5.176078749641322e-13
, O 0 2.133216563462992e-12
all O 0 9.74994217306513e-12
Palestinian O 0 5.584056481100497e-11
Arabs O 0 1.6117026116480027e-11
from O 0 6.7285664887006824e-12
the O 0 1.9513148041827577e-10
region O 0 6.325062251733016e-09
of O 0 8.806961204754771e-08
Jerusalem O 0 7.616471975779859e-06
. O 0 3.7056270230095834e-07

The O 0 6.104186809352541e-07
clinical O 0 3.234508994864882e-06
diagnosis O 0 2.7795089408755302e-05
of O 0 0.012588361278176308
AGU B-Disease 1 1.0
is O 0 6.42486330804104e-09
often O 0 9.400177164442525e-11
difficult O 0 1.1149197537418942e-10
, O 0 1.1646250804020486e-11
in O 0 4.879349962266799e-12
particular O 0 2.144419884719806e-11
early O 0 6.507897692964448e-11
in O 0 2.7479908973337963e-11
the O 0 3.867817177649613e-10
course O 0 5.700410699027714e-10
of O 0 7.387750411425031e-10
the O 0 4.2643727438118617e-10
disease O 0 6.3455676269086325e-09
, O 0 2.8834039322855887e-11
and O 0 6.968451510269702e-11
most O 0 6.237906718942199e-11
of O 0 2.699831747055015e-10
the O 0 3.1164262837002354e-10
patients O 0 6.771700561403193e-11
are O 0 3.729059162155268e-12
diagnosed O 0 4.5560033523628363e-10
after O 0 6.497764132307182e-11
the O 0 5.09614961341498e-10
age O 0 9.998923911069824e-10
of O 0 1.9846511101206943e-09
5 O 0 2.02412770988758e-08
years O 0 5.903279642893722e-09
. O 0 5.4279336580975723e-08

However O 0 2.863376913353477e-08
, O 0 1.1487768514228947e-09
since O 0 1.0429765384678547e-10
these O 0 1.9901920389475691e-10
patients O 0 1.0977099090814235e-10
excrete O 0 5.336445507708731e-09
early O 0 9.608752682410682e-11
large O 0 8.07552025250402e-10
amounts O 0 2.697372769588924e-09
of O 0 9.159515812484642e-09
aspartylglucosamine O 0 1.5575178622384556e-06
in O 0 6.053166856645475e-10
urine O 0 3.7165537314365338e-09
, O 0 6.0384038047534e-11
biochemical O 0 6.647064010323334e-10
screening O 0 1.7365594517926297e-09
is O 0 7.215260333648388e-11
easy O 0 1.4470685760770152e-10
by O 0 3.2817082384895e-11
urine O 0 4.98091168310566e-09
chromatography O 0 1.239756954873883e-07
. O 0 5.163881322545194e-09
. O 0 5.1358309605120667e-08

Detection O 0 1.026800759973412e-06
of O 0 1.3385819386257936e-07
heterozygous O 0 2.1362989599538196e-08
carriers O 0 6.517602568756331e-10
of O 0 5.240880618373467e-09
the O 0 3.1887034879218845e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.456320468193553e-08
ATM O 0 1.6507527107023634e-05
) O 0 5.185256113371395e-10
gene O 0 3.091619737993767e-10
by O 0 7.389014400338567e-11
G2 O 0 5.491913725563791e-06
phase O 0 2.823235334403762e-08
chromosomal O 0 1.6274711356345506e-07
radiosensitivity O 0 2.5398478555871407e-06
of O 0 2.808077965710254e-07
peripheral O 1 0.8974452018737793
blood O 0 4.136339271099132e-07
lymphocytes O 0 2.1726312127157144e-07
. O 0 1.6660312240901476e-08

In O 0 4.149450433033053e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 6.034394459675241e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.9628896558442364e-10
patients O 0 7.705976134975145e-11
, O 0 2.313113763030561e-11
mutations O 0 8.429607012416795e-11
in O 0 3.307680518371825e-11
a O 0 1.675839467196738e-10
single O 0 2.0237320152993732e-10
gene O 0 5.526542418143876e-11
, O 0 1.0585162607545939e-10
ATM O 0 4.4452764313973603e-07
, O 0 7.32986310536532e-11
result O 0 5.2827960755896797e-11
in O 0 5.0222517117282095e-11
an O 0 3.369432377553494e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.7589474321511034e-09
embraces O 0 1.4812450821466427e-08
a O 0 4.244708404210762e-11
variety O 0 4.912908413423622e-10
of O 0 5.523889679004412e-10
clinical O 0 4.0683580948552844e-09
features O 0 1.449472541992236e-09
and O 0 7.281347746967981e-10
manifests O 0 5.266834524064734e-09
extreme O 0 3.948864346625669e-08
radiosensitivity O 0 9.358647048429702e-07
and O 0 3.0792628447073866e-09
a O 0 2.3656225867085823e-09
strong O 0 1.504100843874312e-08
pre O 0 2.2233082290767925e-06
- O 0 1.5724666582173086e-06
disposition O 0 4.6863087845849805e-06
to O 0 2.7593610951726077e-08
malignancy B-Disease 0 6.758540985174477e-05
. O 0 1.2822047779081913e-07

Heterozygotes O 0 2.708804913709173e-06
for O 0 7.426945725086398e-09
the O 0 1.7538761554192206e-08
ATM O 0 8.338739121427352e-07
gene O 0 8.173969834324168e-10
have O 0 5.851907153298086e-11
no O 0 2.704356738547631e-10
clinical O 0 1.7646329952825113e-09
expression O 0 6.954323228391956e-11
of O 0 3.356921851604966e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.2555873835372608e-10
may O 0 9.158493408101265e-11
be O 0 1.24962776237858e-10
cancer B-Disease 0 9.642857179414932e-09
prone O 0 1.3478763882801559e-08
with O 0 2.2540135036219766e-10
a O 0 8.549548291547637e-10
moderate O 0 4.128840380701604e-09
increase O 0 3.4215172362017654e-10
in O 0 2.4864427183857174e-10
in O 0 2.3473205601476366e-09
vitro O 0 2.5354577815051016e-07
radiosensitivity O 0 1.645312840992119e-05
. O 0 1.6439078365237947e-07

We O 0 9.487985153100453e-08
performed O 0 2.5814787818490004e-07
a O 0 2.588207692610922e-08
blind O 0 2.615233256619831e-07
chromosomal O 0 1.3559504452587134e-07
analysis O 0 1.2502195945174321e-09
on O 0 8.477180735155798e-09
G2 O 0 1.5721997215223382e-06
- O 0 1.2585367414885695e-08
phase O 0 4.4903272211627154e-09
lymphocytes O 0 1.4301305972796996e-10
from O 0 4.545732540384151e-11
7 O 0 2.886879180152846e-09
unrelated O 0 3.251408742244166e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.2992776571584272e-09
, O 0 3.4233234302849525e-11
13 O 0 1.1965273216674177e-09
obligate O 0 3.251631852663195e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
heterozygotes O 0 5.1064297679204174e-08
( O 0 9.104427281525496e-12
parents O 0 3.0928315464251455e-12
of O 0 1.469477491078397e-11
the O 0 1.4559436989358687e-11
patients O 0 3.2283399044319427e-12
) O 0 1.3737610224731633e-12
, O 0 8.547338184450304e-12
and O 0 1.259599369252129e-10
14 O 0 2.305021062909418e-09
normal O 0 1.4242759194260657e-09
controls O 0 9.35985955408114e-09
following O 0 6.147634623587805e-10
X O 0 5.311336082058915e-08
- O 0 1.4308742635193994e-08
irradiation O 0 7.512428901179646e-09
with O 0 5.080018003478237e-11
1 O 0 3.850286312001572e-09
Gy O 0 1.2064505199305131e-06
in O 0 2.4238541729282304e-11
order O 0 2.496649241512383e-11
to O 0 1.0997694074865727e-11
evaluate O 0 1.5849476175944233e-09
this O 0 3.907426118776591e-11
cytogenetic O 0 7.5793138876179e-08
method O 0 4.360531380420696e-10
as O 0 5.851639311993395e-11
a O 0 4.608597878319465e-11
tool O 0 8.205820467566127e-10
for O 0 3.7729316199053287e-11
detection O 0 1.1218879159002881e-08
of O 0 6.70344704190029e-08
ATM O 0 0.00023855146719142795
carriers O 0 1.1424717172303644e-07
. O 0 7.239768251565692e-08

Both O 0 4.072110186825739e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 9.891962690744549e-06
and O 0 5.871288344394543e-09
heterozygotes O 0 5.4939491178629396e-08
showed O 0 3.1061123118014677e-10
significantly O 0 1.1504580621490845e-10
increased O 0 1.1918437070601584e-10
levels O 0 5.400613845019109e-10
of O 0 7.932916545883018e-10
radiation O 0 5.451555352919968e-06
- O 0 1.8608110394779942e-06
induced O 0 4.2944161577906925e-06
chromatid O 0 3.0632336347480305e-06
damage O 0 5.468783683681977e-07
relative O 0 7.805043278352741e-10
to O 0 5.1253720018129556e-11
that O 0 2.2422801462806952e-11
of O 0 7.493567544258894e-09
normal O 0 4.854231860917935e-08
controls O 0 9.360413741887896e-07
. O 0 1.908803710648499e-07

These O 0 1.0571957531624321e-08
results O 0 9.369214293286632e-10
show O 0 1.0563990793244216e-09
that O 0 9.419884317019012e-11
the O 0 8.319688937774572e-09
G2 O 0 6.0140078858239576e-05
- O 0 3.2091604680317687e-06
phase O 0 1.105757178265776e-06
chromosomal O 0 1.107705543290649e-06
radiosensitivity O 0 4.358403202786576e-07
assay O 0 3.448374030767809e-09
can O 0 2.472518717544503e-11
be O 0 2.0018129948812247e-12
used O 0 4.382288368992571e-12
for O 0 6.026089783423005e-12
the O 0 4.151048255129908e-11
detection O 0 6.782151729112229e-09
of O 0 9.245455601103458e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.621163755771704e-05
. O 0 1.354097207695304e-07

In O 0 5.5645447361030165e-08
combination O 0 2.664078380121282e-08
with O 0 2.6477689485382427e-10
molecular O 0 7.2370167636393035e-09
genetic O 0 5.7447691048651e-10
analyses O 0 2.5830365624202045e-10
, O 0 1.1090146162517911e-11
this O 0 9.554575013115407e-13
test O 0 7.492312326107253e-12
may O 0 2.364310787081325e-12
be O 0 2.1156227811292005e-12
of O 0 2.0866811750730463e-11
value O 0 4.394410529906523e-11
in O 0 3.3882113694566618e-12
studies O 0 1.6055395901659608e-10
of O 0 8.381418892255965e-10
familial B-Disease 0 5.326787544390754e-08
and I-Disease 0 4.831524513804197e-09
sporadic I-Disease 0 4.6455127744593483e-07
cancers I-Disease 0 2.391677980995155e-06
aimed O 0 3.950987093048752e-09
at O 0 1.6180022599510124e-10
determination O 0 4.307560141914024e-10
of O 0 4.420591115383843e-10
the O 0 2.9829858028129763e-10
potential O 0 9.484285579119955e-10
involvement O 0 8.953426333668801e-10
of O 0 4.186852464727053e-08
ATM O 1 0.9999251365661621
mutations O 0 2.3701943518972257e-08
in O 0 1.1538868749383369e-09
tumor B-Disease 1 1.0
risk O 0 4.6120078422973165e-08
or O 0 8.62253324296347e-11
development O 0 8.535515350072131e-11
. O 0 3.5511232843177254e-10
. O 0 1.4711567075664789e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 2.071605775810781e-09
identification O 0 9.3943386403339e-10
and O 0 8.886253538564759e-11
detection O 0 3.786592017718249e-08
of O 0 7.745005348169798e-08
founder O 0 9.080650897885789e-08
- O 0 1.5481644766168756e-07
effect O 0 4.751235493927197e-08
mutations O 0 2.4294560807547327e-10
in O 0 2.687643337051515e-11
the O 0 1.0506240322172289e-09
ATM O 0 3.81786378511606e-07
gene O 0 5.818210357944054e-10
in O 0 1.6865558949419324e-10
ethnic O 0 5.653874257660618e-09
populations O 0 3.296026784838091e-09
. O 0 8.72937544471597e-09

To O 0 1.6430513838372462e-08
facilitate O 0 2.9535927037471765e-09
the O 0 6.459313084405949e-10
evaluation O 0 6.8608021486227244e-09
of O 0 2.2607322236467553e-08
ATM O 0 0.0010277227265760303
heterozygotes O 0 2.9385861921582546e-07
for O 0 9.367892017664303e-10
susceptibility O 0 5.638649014372277e-08
to O 0 2.2183063719261042e-10
other O 0 5.502500677323496e-10
diseases O 0 1.1683549928420689e-05
, O 0 1.2511827685024457e-10
such O 0 1.0844604103610322e-09
as O 0 4.7836135053103135e-09
breast B-Disease 1 0.5006138682365417
cancer I-Disease 0 2.8144293651166663e-07
, O 0 8.875260248952799e-11
we O 0 5.659478788389016e-11
have O 0 1.0705847666714341e-11
attempted O 0 5.925951951368802e-10
to O 0 2.9661734873842605e-11
define O 0 1.5853521273534454e-10
the O 0 7.815318531223525e-11
most O 0 5.333122485295938e-11
common O 0 9.102278653028151e-11
mutations O 0 7.606471702503725e-11
and O 0 3.859399952399478e-11
their O 0 3.262504849610437e-11
frequencies O 0 1.1656440257468148e-09
in O 0 5.945019587727529e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.4304572459877818e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.2282910506230564e-10
homozygotes O 0 6.409651120975468e-08
from O 0 9.416434992859379e-11
10 O 0 5.229066069034616e-10
ethnic O 0 1.0276967055133923e-09
populations O 0 8.299619325136121e-10
. O 0 5.429525717914885e-09

Both O 0 1.297247251841327e-07
genomic O 0 1.635578996683762e-07
mutations O 0 4.219849358833017e-09
and O 0 2.6154792220900447e-10
their O 0 1.88324481009694e-10
effects O 0 2.0150832114040895e-08
on O 0 4.343268411588497e-09
cDNA O 0 1.1785887821247343e-08
were O 0 1.1334718719169246e-09
characterized O 0 3.7664374730184136e-08
. O 0 6.14319759506543e-08

Protein O 0 7.759420554975804e-07
- O 0 1.2354620082533074e-07
truncation O 0 8.965892561718647e-08
testing O 0 4.405677600516356e-09
of O 0 4.754532767492492e-09
the O 0 7.759034303944645e-09
entire O 0 1.5365532135547255e-07
ATM O 0 1.7338682027912e-06
cDNA O 0 4.078148663211323e-08
detected O 0 1.5895624372319617e-08
92 O 0 6.33714023479115e-08
( O 0 2.1885893097817188e-10
66 O 0 1.6155677684537295e-08
% O 0 2.6352889315184314e-10
) O 0 3.1003238865068283e-10
truncating O 0 2.4506675799784716e-07
mutations O 0 3.615960864067347e-09
in O 0 4.5651193936180334e-10
140 O 0 2.4544229759726477e-08
mutant O 0 9.011839807726574e-08
alleles O 0 1.1904993657552154e-09
screened O 0 1.2897126566713268e-07
. O 0 4.203015180337388e-08

The O 0 3.598377702473954e-07
haplotyping O 0 4.5567634515464306e-05
of O 0 5.698741460946621e-07
patients O 0 1.0916518355941207e-08
with O 0 4.4540218735455994e-10
identical O 0 1.1236057417818301e-07
mutations O 0 3.5409393195351413e-09
indicates O 0 3.633963130411644e-10
that O 0 6.436947763005518e-12
almost O 0 9.483154712885966e-12
all O 0 6.5528589499042056e-12
of O 0 3.745034837798755e-11
these O 0 1.4235874631896017e-11
represent O 0 5.420143067008665e-12
common O 0 1.4573385900829017e-11
ancestry O 0 7.15181906751905e-12
and O 0 1.718278297424547e-11
that O 0 1.1268572013001243e-11
very O 0 2.330741155631699e-10
few O 0 8.145228491684975e-09
spontaneously O 0 6.488373571755801e-08
recurring O 0 1.3826554095430765e-05
ATM O 0 0.00038186501478776336
mutations O 0 7.17206376066315e-07
exist O 0 6.219465831236448e-08
. O 0 1.1514882203300658e-07

Assays O 0 1.1307288332318421e-06
requiring O 0 6.69728663638125e-08
minimal O 0 7.077550634448926e-08
amounts O 0 7.436471438637682e-09
of O 0 3.1009048662156147e-09
genomic O 0 9.720595439688395e-10
DNA O 0 5.013601755976538e-10
were O 0 1.4681327334398198e-11
designed O 0 5.575194195195365e-10
to O 0 1.4135499715184352e-10
allow O 0 1.8096381337873169e-10
rapid O 0 3.909970680560093e-10
screening O 0 3.4294098116838256e-10
for O 0 4.440701625862964e-11
common O 0 6.949871789174722e-10
ethnic O 0 5.915114176247016e-09
mutations O 0 2.5777682211014508e-08
. O 0 1.8687801528471937e-08

These O 0 2.3939753646118334e-07
rapid O 0 2.616468179894582e-07
assays O 0 1.1720288028982395e-07
detected O 0 2.7012148962057836e-08
mutations O 0 7.816813307748305e-10
in O 0 1.0679136741575945e-10
76 O 0 2.127175058319608e-08
% O 0 5.894452287380503e-11
of O 0 3.2665598004300023e-10
Costa O 0 9.718082338849854e-08
Rican O 0 3.223910596261703e-07
patients O 0 3.0185395849535723e-10
( O 0 1.5112119455124029e-12
3 O 0 9.878282913877712e-11
) O 0 4.028838027081427e-12
, O 0 9.013542516533857e-12
50 O 0 1.2320856834779903e-10
% O 0 3.161603270851465e-11
of O 0 2.8868557544470264e-10
Norwegian O 0 8.159829256726425e-09
patients O 0 1.1090067059127406e-10
( O 0 3.1238145750678292e-12
1 O 0 2.685953681691444e-10
) O 0 7.201837650544496e-12
, O 0 5.199493179758319e-12
25 O 0 8.432501918953506e-11
% O 0 7.496199841416917e-12
of O 0 7.632179610528311e-11
Polish O 0 1.8064885409785347e-07
patients O 0 2.3979940255713927e-10
( O 0 3.102166310289811e-12
4 O 0 2.456139180928574e-10
) O 0 6.914060903667751e-12
, O 0 1.1292174660615384e-11
and O 0 3.6496597410895504e-11
14 O 0 3.840851803271761e-10
% O 0 1.5488629476201332e-11
of O 0 1.0345600071071104e-10
Italian O 0 3.260773695501484e-08
patients O 0 1.3914835950146198e-10
( O 0 2.673999910385305e-12
1 O 0 4.2731415628161074e-10
) O 0 2.2781165842644668e-11
, O 0 2.6005003705975582e-11
as O 0 2.6221762608469312e-11
well O 0 4.348245721819133e-11
as O 0 3.8029732141176e-11
in O 0 5.0811230223324344e-11
patients O 0 4.2310741021900355e-10
of O 0 3.734111242437166e-09
Amish O 0 5.8600697627753107e-08
/ O 0 3.6345351617228516e-08
Mennonite O 0 1.6467973651401735e-08
and O 0 4.5436110429619703e-10
Irish O 0 4.8323382628723266e-08
English O 0 1.0071279810119904e-08
backgrounds O 0 6.586890588522465e-09
. O 0 1.4208660914505344e-08

Additional O 0 3.1554517931908777e-07
mutations O 0 4.292143529482928e-09
were O 0 2.1897041124763206e-10
observed O 0 3.445663476764338e-10
in O 0 8.693510494817147e-11
Japanese O 0 2.1661611171452932e-08
, O 0 6.07266403829243e-10
Utah O 0 7.380264577250273e-08
Mormon O 0 1.4029704065166015e-09
, O 0 2.3373731769527062e-11
and O 0 9.648900428649299e-11
African O 0 2.5200358466648254e-10
American O 0 6.257575790868941e-09
patients O 0 4.804315167916684e-09
. O 0 2.0538513112455803e-08

These O 0 6.335010294122867e-09
assays O 0 5.055799334741096e-09
should O 0 6.19240977939306e-11
facilitate O 0 4.307599069108825e-11
screening O 0 5.916487855195385e-10
for O 0 3.8262426560464746e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 4.619509041958736e-08
in O 0 1.0484734608295909e-10
the O 0 4.870372993792671e-10
populations O 0 1.2582138109173968e-10
studied O 0 2.0043262605184964e-09
. O 0 7.629738507652917e-10
. O 0 2.129147702589762e-08

The O 0 5.009505457564956e-06
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 1.0
tumor I-Disease 1 1.0
suppressor O 0 4.5654887799173594e-05
gene O 0 6.477131719861973e-09
is O 0 1.2765172252571233e-10
required O 0 1.8826450121078864e-10
for O 0 1.59092572449282e-10
cell O 0 3.382153890285622e-09
cycle O 0 1.1764844209949388e-08
exit O 0 7.881161501188672e-09
upon O 0 2.532884124661905e-09
serum O 0 2.6958311138969293e-08
withdrawal O 0 9.955734014965856e-08
. O 0 1.1954129774949251e-07

The O 0 5.689988569201887e-08
inactivation O 0 2.2543204067915212e-06
of O 0 1.5821584042896575e-07
the O 0 1.1561493806766521e-07
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 3.952486054004112e-07
VHL I-Disease 1 1.0
) I-Disease 0 4.40793250788829e-08
tumor I-Disease 0 0.023711837828159332
suppressor O 0 7.174906204454601e-05
gene O 0 3.740692733344986e-08
predisposes O 0 1.0812001960402995e-07
affected O 0 6.592493217993933e-10
individuals O 0 2.518784009489239e-12
to O 0 8.583263440276045e-12
the O 0 8.173470233963087e-10
human O 0 1.3956415614302387e-06
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 5.453789087006555e-10
is O 0 4.4422941020139106e-11
associated O 0 1.599865934176492e-10
with O 0 3.9039865784573635e-10
sporadic B-Disease 0 0.0004039499326609075
renal I-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
( O 0 4.931182502332376e-07
RCC B-Disease 1 1.0
) O 0 3.5381393814759576e-08
and O 0 9.171093040549749e-08
brain B-Disease 0 0.3703468143939972
hemangioblastomas I-Disease 0 0.0011785529786720872
. O 0 2.1976021002956259e-07

VHL O 1 0.9999359846115112
- O 0 2.371288246649783e-05
negative O 0 4.5782999791299517e-07
786 O 0 4.8853848966246e-07
- O 0 1.1960219126194715e-07
0 O 0 7.071667340596832e-08
RCC B-Disease 0 0.00012191437417641282
cells O 0 1.586968445543846e-09
are O 0 9.7444996516316e-11
tumorigenic O 0 1.390977672599547e-06
in O 0 1.9193091560509856e-09
nude O 0 1.4402984334083158e-06
mice O 0 2.3922481773297477e-09
which O 0 4.0555392377683575e-11
is O 0 2.137596002982356e-11
suppressed O 0 1.8420746039637947e-09
by O 0 1.6345841347131795e-11
the O 0 9.737239903273576e-10
reintroduction O 0 5.279359243104409e-07
of O 0 3.5654684893415833e-07
VHL B-Disease 1 0.9113935828208923
. O 0 1.271337850994314e-06

Remarkably O 0 5.723507570110087e-07
, O 0 1.2166038176886218e-09
this O 0 1.810987297623523e-11
occurs O 0 4.1703324821229515e-11
without O 0 8.350634073117646e-11
affecting O 0 6.02609628863604e-10
the O 0 2.019814177023349e-10
growth O 0 3.4593605757748946e-10
rate O 0 2.774308560660188e-10
and O 0 1.8189259820555748e-10
cell O 0 1.1027153634657338e-09
cycle O 0 3.8928477108512993e-10
profile O 0 2.1239295044939155e-10
of O 0 5.715347639601021e-10
these O 0 1.673147037584144e-10
cells O 0 3.312434354585392e-11
in O 0 1.3809131615971637e-10
culture O 0 4.691465882444845e-09
. O 0 2.709284885327179e-08

The O 0 2.7117414447275223e-07
786 O 0 2.5366935574311356e-07
- O 0 2.8068912527601242e-08
0 O 0 4.811724796383032e-09
cell O 0 8.246474059170339e-10
line O 0 1.6946966496789173e-08
, O 0 1.9610679746762116e-10
like O 0 2.947198596281453e-10
many O 0 4.773093587040478e-10
cancer B-Disease 0 5.898890265143564e-09
cells O 0 2.482470305709139e-11
, O 0 3.8101896637776633e-11
fails O 0 4.817194976247663e-10
to O 0 1.0057467358937089e-10
exit O 0 1.3605430559948672e-08
the O 0 5.598822294672345e-09
cell O 0 1.2397482151982331e-08
cycle O 0 9.739046902268456e-09
upon O 0 3.2644316139140983e-09
serum O 0 1.790577819349437e-08
withdrawal O 0 7.889978093089667e-08
. O 0 5.967288529973303e-08

Here O 0 6.2225362640333515e-09
, O 0 5.200073149858042e-10
it O 0 5.0274461677046745e-11
is O 0 6.746248958772183e-12
shown O 0 3.2874829161005925e-12
that O 0 3.7846132477925565e-12
reintroduction O 0 2.8955385644735543e-08
of O 0 2.2727328907734545e-09
the O 0 4.455179336559922e-09
wild O 0 1.431996992096174e-07
- O 0 5.127824351802701e-07
type O 0 8.364576729036344e-07
VHL B-Disease 0 0.18713712692260742
gene O 0 1.0776894043829088e-08
restores O 0 9.566993419696246e-09
the O 0 9.362748354391215e-10
ability O 0 3.6111225121260304e-09
of O 0 2.736216764276378e-08
VHL O 1 1.0
- O 0 3.98444572056178e-05
negative O 0 1.8286822296431637e-06
RCC B-Disease 1 0.9998836517333984
cancer I-Disease 0 1.2348411360108003e-07
cells O 0 3.259798680987913e-11
to O 0 2.6452387155706525e-11
exit O 0 1.2781745661882837e-09
the O 0 5.140157188776584e-10
cell O 0 2.0166661673926e-09
cycle O 0 4.006674547696321e-09
and O 0 2.3737583010330354e-09
enter O 0 6.832401311385183e-08
G0 O 0 9.557727025821805e-05
/ O 0 2.1561604626185726e-06
quiescence O 0 1.0848352758330293e-06
in O 0 5.3060480453837044e-09
low O 0 3.412533828850428e-07
serum O 0 9.672794476500712e-08
. O 0 3.269804693672995e-08

Both O 0 1.368369680676551e-06
VHL O 1 0.9999997615814209
- O 0 8.337359759025276e-06
positive O 0 7.894506381944666e-09
and O 0 2.558160128174336e-09
VHL O 0 0.002833906328305602
- O 0 3.0721898269803205e-07
negative O 0 7.986165684314983e-08
RCC B-Disease 0 2.9803795769112185e-05
cells O 0 1.3827798905907684e-09
exit O 0 6.437767652300863e-09
the O 0 2.9978513005346485e-09
cell O 0 6.605461067010765e-09
cycle O 0 3.828726669041771e-09
by O 0 1.1346219103147703e-10
contact O 0 6.974348654154028e-09
inhibition O 0 2.7762868626268755e-07
. O 0 1.7841080079961102e-07

The O 0 2.565442628110759e-06
cyclin O 0 1.0624885362631176e-05
- O 0 4.514712145464728e-06
dependent O 0 2.9597759976240923e-07
kinase O 0 2.0324964111750887e-07
inhibitor O 0 1.1243690067885836e-07
, O 0 1.9577688359362355e-09
p27 O 0 4.1357714053447125e-07
, O 0 5.23240839545025e-10
accumulates O 0 3.793790614992076e-09
upon O 0 2.1469254152250983e-10
serum O 0 3.417662541860267e-10
withdrawal O 0 3.9535483220554113e-10
, O 0 4.584007479158103e-11
only O 0 8.973779185017516e-12
in O 0 9.550570403971115e-12
the O 0 3.814380200584111e-10
presence O 0 5.815236625572595e-10
of O 0 1.0246399284596919e-08
VHL B-Disease 1 0.9165197014808655
, O 0 7.648010003080685e-10
as O 0 1.950540839956716e-10
a O 0 4.761288932564334e-11
result O 0 6.635760690931747e-11
of O 0 5.941502290163214e-10
the O 0 4.810887244133255e-10
stabilization O 0 3.1778593978515346e-08
of O 0 3.981642748840386e-08
the O 0 4.4833633694452146e-08
protein O 0 1.68442525705359e-07
. O 0 3.534193737664282e-08

We O 0 2.274117427703004e-08
propose O 0 1.104102764770687e-08
that O 0 7.272599189533935e-11
the O 0 2.579807922842292e-09
loss O 0 8.07237015010287e-08
of O 0 2.3138370863762248e-07
wild O 0 1.9739056824619183e-06
- O 0 4.186683781881584e-06
type O 0 2.048231635853881e-06
VHL B-Disease 0 0.052114810794591904
gene O 0 8.751043223398369e-10
results O 0 3.346153562566734e-11
in O 0 2.6450570900227177e-11
a O 0 2.5549257154366956e-10
specific O 0 2.337237292593386e-09
cellular O 0 1.830269624747416e-08
defect O 0 4.312357049229831e-08
in O 0 4.3754944112350813e-10
serum O 0 1.5672245723408196e-08
- O 0 1.5466194724922389e-07
dependent O 0 5.318216533822806e-09
growth O 0 6.750645042963299e-10
control O 0 2.4589434932664744e-09
, O 0 9.84187314978513e-11
which O 0 7.102896742994247e-11
may O 0 6.355969639493253e-10
initiate O 0 1.7452641998261242e-07
tumor B-Disease 0 7.17406437615864e-05
formation O 0 9.73052465269575e-07
. O 0 3.188910397966538e-07

This O 0 6.752850723046322e-09
is O 0 9.074686557752898e-10
corrected O 0 9.145759705120327e-09
by O 0 4.9109480371178904e-11
the O 0 2.150754463414728e-09
reintroduction O 0 1.0536029293461979e-07
of O 0 3.6629575816959914e-08
wild O 0 3.1019717994240636e-07
- O 0 1.59402452482027e-06
type O 0 5.5259674809349235e-06
VHL B-Disease 1 1.0
, O 0 7.849851435537403e-09
implicating O 0 7.3000546763069e-06
VHL B-Disease 1 0.999996542930603
as O 0 4.816260723572441e-09
the O 0 3.025711903248407e-09
first O 0 2.1300645691724185e-09
tumor B-Disease 0 1.040595066115202e-06
suppressor O 0 3.164763882068655e-07
involved O 0 6.91797230611968e-10
in O 0 6.418059139701171e-11
the O 0 9.534708578229356e-10
regulation O 0 1.6074224618023436e-08
of O 0 3.41385479885048e-08
cell O 0 5.602390107384281e-09
cycle O 0 2.2117252473918825e-09
exit O 0 1.2697575213493906e-09
, O 0 2.1181270279391207e-11
which O 0 2.0303732653492723e-11
is O 0 3.601365386463051e-11
consistent O 0 8.872675372195715e-10
with O 0 2.308155576391524e-11
its O 0 8.455892652747821e-10
gatekeeper O 0 4.528068942022401e-08
function O 0 5.853584839066173e-10
in O 0 1.4047450702658892e-10
the O 0 1.4929481650938214e-08
kidney O 0 6.863893304398516e-06
. O 0 1.085108536358348e-08
. O 0 1.2332606047493755e-07

Piebaldism B-Disease 1 1.0
with O 0 0.008942745625972748
deafness B-Disease 1 1.0
: O 0 1.257960757783394e-08
molecular O 0 2.9124860301266153e-09
evidence O 0 1.985528269576875e-10
for O 0 1.0271043737741792e-10
an O 0 3.9354838832217354e-10
expanded O 0 1.9169285678799497e-06
syndrome O 1 0.9585602283477783
. O 0 2.0004607392820617e-07

In O 0 5.085762477818889e-09
a O 0 7.193635132018983e-10
South O 0 5.20251619562373e-09
African O 0 3.95191213087287e-10
girl O 0 3.848876772849508e-09
of O 0 1.0039092890323786e-09
Xhosa O 0 7.839874882620279e-08
stock O 0 5.3502651198300555e-09
with O 0 7.359590020739049e-11
severe O 0 2.076593318633968e-06
piebaldism B-Disease 1 0.9999985694885254
and O 0 5.405560659710318e-05
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 3.5146772461303044e-06
identified O 0 8.95539464806916e-09
a O 0 7.276571567516044e-10
novel O 0 1.270291072330565e-08
missense O 0 1.4066581677241174e-08
substitution O 0 2.9004287860345812e-09
at O 0 1.6842421901586135e-09
a O 0 4.683586851683685e-10
highly O 0 3.4158131878569975e-09
conserved O 0 1.6719395645736768e-08
residue O 0 6.423762499707664e-08
in O 0 4.990437507679246e-10
the O 0 2.789011688264509e-09
intracellular O 0 4.97789098830026e-09
kinase O 0 3.359664901836368e-08
domain O 0 6.577198785606697e-09
of O 0 6.050769663090705e-09
the O 0 2.3278200700360685e-08
KIT O 0 0.000391302106436342
proto O 0 0.00013281352585181594
- O 0 0.00020867545390501618
oncogene O 0 1.300444910157239e-05
, O 0 2.5971534256541418e-08
R796G O 0 1.609860009921249e-05
. O 0 1.5635630745691742e-07

Though O 0 2.982807245643926e-07
auditory B-Disease 0 2.9186828669480747e-06
anomalies I-Disease 0 2.1755472516815644e-06
have O 0 6.369998972743929e-10
been O 0 5.634944733046154e-10
observed O 0 1.001048799409432e-09
in O 0 1.726176007688096e-10
mice O 0 3.7917793349606654e-09
with O 0 1.6587242690491166e-10
dominant O 0 1.0360701452327703e-07
white O 0 6.30600505147072e-09
spotting O 0 1.248780563400942e-06
( O 0 1.1909490060801886e-09
W O 0 1.0483751793799456e-05
) O 0 1.369753893643022e-10
due O 0 1.4829319994191792e-09
to O 0 3.530834791209969e-10
KIT O 1 0.9999997615814209
mutations O 0 6.871163122923463e-07
, O 0 1.4629412348199367e-08
deafness B-Disease 1 1.0
is O 0 4.486466309572279e-09
not O 0 1.3723035208190737e-10
typical O 0 2.749052763206805e-09
in O 0 3.763130640432877e-10
human O 0 5.804380087681693e-09
piebaldism B-Disease 0 4.333673587098019e-06
. O 0 1.1907036423508544e-07

Thus O 0 6.672932784113073e-08
, O 0 9.666809575037405e-10
the O 0 1.3188212744097427e-09
occurrence O 0 7.156062764579474e-08
of O 0 4.256058218743419e-06
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 1.4551957292496809e-06
this O 0 9.685380497614915e-09
patient O 0 1.3175472268756039e-08
extends O 0 1.1818883649539202e-09
considerably O 0 6.119822010264286e-11
the O 0 1.1111197378843585e-10
phenotypic O 0 1.1030423507918385e-07
range O 0 3.6949270310060456e-08
of O 0 1.155682660680668e-08
piebaldism B-Disease 0 3.5246151242063206e-07
due O 0 4.556796717736233e-09
to O 0 1.0262002358985e-09
KIT O 0 3.849551285384223e-05
gene O 0 1.7639878890918226e-08
mutation O 0 2.630925921565108e-09
in O 0 1.8219155351051342e-10
humans O 0 6.055245194147574e-10
and O 0 4.557098309820873e-10
tightens O 0 1.116755896646282e-07
the O 0 1.0298668584596271e-09
clinical O 0 5.414044768059512e-09
similarity O 0 4.860313818078055e-10
between O 0 1.6446266570824264e-10
piebaldism B-Disease 0 1.0662380134363048e-07
and O 0 1.2272424743109411e-10
the O 0 9.022801256142188e-11
various O 0 2.524606357301451e-10
forms O 0 3.0513571669388284e-09
of O 0 1.657331978321963e-07
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999159574508667
. O 0 3.2546956241219505e-09
. O 0 2.8575609434255966e-08

Cycloheximide O 0 6.62597012706101e-05
facilitates O 0 7.076754116042139e-08
the O 0 5.033265804144094e-09
identification O 0 9.241079901300964e-09
of O 0 4.773171013994215e-08
aberrant O 0 7.049742833942219e-08
transcripts O 0 1.6083241405340232e-08
resulting O 0 3.2536171090669086e-08
from O 0 1.4460981301311904e-09
a O 0 3.4525464709389553e-09
novel O 0 8.183149446949756e-08
splice O 0 2.2617982153860794e-07
- O 0 3.168611328874249e-08
site O 0 1.9080388824477268e-08
mutation O 0 2.408335975090381e-09
in O 0 2.4952795385502213e-10
COL17A1 O 1 0.9949091076850891
in O 0 1.4069578835318453e-09
a O 0 5.634990696279374e-09
patient O 0 1.2379996583433694e-08
with O 0 6.79038381079522e-09
generalized O 0 6.841360300313681e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999939203262329
. O 0 4.907341008220101e-06

Patients O 0 1.8359691011937684e-06
with O 0 3.50875133392492e-08
generalized O 0 0.0003447974449954927
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999988079071045
often O 0 1.3915673946485185e-08
show O 0 4.467492598081435e-09
decreased O 0 1.0945456985211877e-08
expression O 0 1.1468918037493836e-09
of O 0 3.3959222101032083e-09
type O 0 6.75270484862267e-07
XVII O 1 1.0
collagen O 1 0.9999864101409912
, O 0 9.817322066396628e-09
a O 0 8.418047592329003e-09
transmembrane O 0 2.6772152494913826e-08
hemidesmosomal O 0 1.6367382613680093e-06
protein O 0 6.762543414140509e-09
encoded O 0 1.7325751944241574e-10
by O 0 2.6550359133459267e-10
COL17A1 O 1 0.993760883808136
. O 0 3.33761136062094e-07

This O 0 7.394732381982294e-09
report O 0 2.0172126191653206e-09
documents O 0 1.2396961679428387e-08
a O 0 6.295597376748674e-09
novel O 0 1.0135627803720126e-07
splice O 0 3.0488402558148664e-07
- O 0 5.717414452988123e-08
site O 0 1.5575217560126475e-08
mutation O 0 3.432114148438359e-09
in O 0 2.2499328788949668e-10
COL17A1 O 1 0.999996542930603
in O 0 1.9413779472898796e-09
a O 0 4.282854071391284e-09
patient O 0 1.0458421684234054e-08
with O 0 5.790845136743883e-09
generalized O 0 0.0001894968590931967
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9998944997787476
, O 0 9.981475201925605e-09
and O 0 3.7188507828744832e-09
applies O 0 7.989117811746382e-09
a O 0 5.5104594498534e-11
new O 0 4.0488459807086485e-11
methodology O 0 1.3987268288051524e-10
to O 0 5.326535046368264e-11
define O 0 1.5585193136047337e-09
and O 0 5.803956204530891e-10
characterize O 0 2.5486595944812507e-08
the O 0 1.4224361244430384e-08
resulting O 0 9.474892692651338e-08
mRNA O 0 1.4850775187369436e-07
splice O 0 6.939803824934643e-07
variants O 0 1.7645943728439306e-07
. O 0 1.2230158574766392e-07

Mutational O 0 5.7742054195841774e-05
analysis O 0 3.989213936961278e-08
of O 0 2.378269385872045e-07
COL17A1 O 1 1.0
identified O 0 1.1268303978795302e-07
a O 0 2.5796618174922514e-08
maternally O 0 1.491808689024765e-06
inherited O 0 7.93933304521488e-06
G O 0 4.089641606697114e-06
- O 0 9.485668783781875e-08
to O 0 5.836507721568296e-09
- O 0 2.5417816686967853e-06
T O 0 1.7276985317948856e-06
transversion O 0 1.282803168578539e-06
at O 0 1.563440932272897e-09
the O 0 5.881843900823469e-10
- O 0 5.316025841750616e-09
1 O 0 5.18981035924071e-09
position O 0 3.5023841604697736e-09
of O 0 1.690512618779394e-08
exon O 0 1.1991700148428208e-06
32 O 0 1.0634448699420318e-06
. O 0 1.348370659570719e-07

This O 0 1.2697630502600532e-08
acceptor O 0 1.0222754864841477e-09
splice O 0 1.2908212454476597e-07
- O 0 6.983096767498864e-08
site O 0 1.6221044063513546e-08
mutation O 0 1.7430102916549117e-09
led O 0 9.119626720455187e-10
to O 0 1.6956130943768244e-10
the O 0 1.3623548955621345e-09
formation O 0 5.670873548524469e-09
of O 0 4.0079221719224734e-08
aberrant O 0 9.6858983056336e-09
transcripts O 0 2.815801591893319e-09
present O 0 1.738985622168343e-09
at O 0 1.4988541963134594e-08
extremely O 0 2.496719808675607e-08
low O 0 2.4483640004291374e-07
levels O 0 1.2890043876723212e-07
. O 0 5.666486657673886e-08

Based O 0 5.030235428193919e-08
on O 0 2.374212293432265e-08
our O 0 3.241994228631029e-09
recent O 0 8.862003353371506e-10
finding O 0 9.394661715234065e-10
that O 0 1.472763994092574e-10
cycloheximide O 0 5.184745987207862e-06
stabilized O 0 2.520851921872236e-06
mutant O 0 1.967427579074865e-06
COL17A1 O 0 0.0001267254410777241
transcripts O 0 3.7788865370202984e-08
in O 0 2.409176635964627e-09
keratinocytes O 0 6.953033704348854e-08
homozygous O 0 2.4828244349350825e-08
for O 0 5.802041069813413e-10
a O 0 3.0968030362288346e-09
frameshift O 0 8.405953622059315e-08
mutation O 0 6.123445084327273e-10
, O 0 4.7053153040543805e-11
the O 0 3.0189714617101515e-10
effects O 0 1.839978125417474e-07
of O 0 2.895604822583664e-08
the O 0 1.1981859948662077e-08
splice O 0 1.691561521965923e-07
- O 0 2.3332253462626795e-08
site O 0 6.508103389535336e-09
mutation O 0 8.407453067071913e-10
on O 0 4.5959511196791425e-10
splicing O 0 5.151309157014339e-09
of O 0 1.3010826194204128e-08
COL17A1 O 0 0.0002733279252424836
transcripts O 0 1.9766204673032917e-08
were O 0 6.870253255186753e-10
determined O 0 4.993845892364845e-10
using O 0 1.156250234446432e-10
reverse O 0 8.506589876944304e-10
transcriptase O 0 8.662182082730396e-10
polymerase O 0 3.6474348541482016e-10
chain O 0 7.106735755435523e-10
reaction O 0 4.9589332640209705e-11
of O 0 7.741704499686364e-10
total O 0 2.8502583626632827e-10
RNA O 0 1.7915128269763159e-09
from O 0 1.6440653005656003e-10
keratinocytes O 0 1.9841970289036226e-09
incubated O 0 2.0031643011009237e-09
for O 0 1.1266256677577857e-10
2 O 0 4.279263166040437e-08
. O 0 4.09981453231012e-08

5 O 0 9.499483866193259e-08
h O 0 4.151812671437938e-09
in O 0 1.1691436707650382e-10
the O 0 8.329322231936942e-10
presence O 0 1.425673024080254e-09
or O 0 1.323657183860405e-09
absence O 0 1.7883694525266947e-08
of O 0 4.087197424951228e-08
10 O 0 5.022297600021375e-08
microg O 0 9.605807463231031e-06
cycloheximide O 0 9.556886652717367e-06
per O 0 4.1925265037434656e-08
ml O 0 2.4571502308390336e-06
. O 0 1.087923280351788e-07

Using O 0 7.472044316614301e-09
this O 0 3.0827637664820884e-10
approach O 0 1.0328476740539827e-08
, O 0 2.203531135336334e-09
an O 0 3.245186563916036e-09
abnormally O 0 4.5797935399605194e-07
spliced O 0 3.3868943205561663e-07
transcript O 0 2.3758794043260423e-08
was O 0 2.1539248606927686e-08
identified O 0 2.673044008361103e-10
that O 0 1.987528197577859e-11
contains O 0 1.0154369567416666e-09
an O 0 8.621678371234509e-11
extra O 0 4.3769157187512064e-09
264 O 0 1.484191214373709e-09
bases O 0 4.204841363986134e-09
upstream O 0 1.3346936000857568e-08
from O 0 7.660097556261292e-10
exon O 0 6.803817598211026e-08
32 O 0 1.6854158957357868e-08
, O 0 1.1980705316716467e-10
resulting O 0 9.402011391657084e-10
in O 0 2.9437827175904374e-10
a O 0 1.1566529956041904e-08
premature O 0 1.4712892948409717e-07
termination O 0 1.6632142774142267e-07
codon O 0 2.513601771170215e-07
27 O 0 7.224400633276673e-08
bp O 0 4.833877653709351e-08
downstream O 0 1.0438616016017477e-07
from O 0 2.228230489009775e-09
the O 0 4.0853734617485316e-08
cryptic O 0 1.5744684560559108e-06
splice O 0 1.987392579394509e-06
site O 0 6.831241421423329e-07
. O 0 3.3446087854827056e-07

Three O 0 8.332650480724624e-08
other O 0 1.870947619053709e-09
splice O 0 3.1816920653682246e-08
variants O 0 2.2368533691974335e-09
, O 0 1.878770888863457e-10
including O 0 6.816628511652212e-11
one O 0 4.6915683143966547e-11
derived O 0 3.737634507450238e-11
from O 0 1.4361190188438844e-11
the O 0 3.642554036176193e-10
skipping O 0 1.1142107680939262e-08
of O 0 1.609852517958643e-08
exon O 0 1.2810778571292758e-07
32 O 0 3.838695405988801e-08
, O 0 2.435570911618612e-10
were O 0 2.5210553089571874e-10
also O 0 1.3339828131009313e-09
identified O 0 6.144484032688524e-09
. O 0 3.780688828669554e-08

These O 0 1.5862489988194284e-08
results O 0 1.2781259384198052e-09
indicate O 0 2.2968657531485803e-10
the O 0 7.240478772096992e-10
usefulness O 0 2.0051874827231586e-08
of O 0 1.1814427658407567e-08
cycloheximide O 0 1.5727815707577975e-06
treatment O 0 6.991703660474968e-09
in O 0 6.84935441697121e-11
evaluating O 0 7.209105312711017e-09
the O 0 1.2730992926535123e-09
abnormal O 0 4.46928855035722e-10
processing O 0 6.088669013415426e-10
of O 0 2.1268087291304028e-09
mRNA O 0 3.9834331388988176e-09
due O 0 2.4389423813886424e-09
to O 0 4.0304795612122746e-10
splice O 0 4.987302659742454e-08
- O 0 1.820184358791721e-08
site O 0 4.1586520893588386e-09
mutations O 0 2.1833067298526743e-10
, O 0 2.7520770384814597e-11
because O 0 1.4779587276247952e-10
( O 0 1.5796834673675875e-10
i O 0 3.6265561664805546e-09
) O 0 1.6439782868360453e-09
aberrant O 0 1.6973297434219603e-08
splicing O 0 6.222014459211778e-09
often O 0 2.664034826072026e-10
generates O 0 1.5124254071352539e-09
a O 0 9.9081398641232e-10
premature O 0 1.2966283158277747e-08
termination O 0 9.873130757398485e-09
codon O 0 5.908529221443359e-09
, O 0 1.6094886534645525e-10
( O 0 5.225344115733499e-11
ii O 0 1.0298344932380132e-07
) O 0 4.758495264489682e-10
transcripts O 0 3.8292018444963105e-09
with O 0 1.2038366969946424e-09
premature O 0 8.82417907632771e-08
termination O 0 3.700138861972846e-08
codons O 0 3.807732795735319e-08
can O 0 7.676387303590104e-11
occur O 0 1.4393108233035079e-11
at O 0 3.8107439426227074e-10
low O 0 2.8727642487069716e-08
or O 0 1.8327943607232555e-09
undetectable O 0 4.825900035143604e-08
levels O 0 3.400496551009269e-10
due O 0 7.368105570115802e-10
to O 0 6.512780870160384e-10
nonsense O 0 2.1776942915607833e-08
- O 0 1.1835628477285809e-08
mediated O 0 2.3297246354303525e-09
mRNA O 0 2.9100194476328056e-10
decay O 0 1.3590588654466274e-09
, O 0 7.885539443641676e-12
and O 0 2.4161226838681493e-11
( O 0 6.84658510441416e-11
iii O 0 8.149954169311968e-07
) O 0 3.047045948889604e-10
the O 0 2.6151400489560217e-10
levels O 0 2.1717190545889054e-10
of O 0 2.6062069169441315e-10
these O 0 3.6365268435423204e-11
transcripts O 0 2.1674484429468066e-10
can O 0 1.1490299163530171e-11
be O 0 2.865404961915896e-11
increased O 0 1.5724149760032446e-10
by O 0 4.254291086080997e-10
cycloheximide O 0 1.8482876839698292e-05
. O 0 2.3744075861031888e-07

A O 0 7.522764917666791e-06
deletion O 0 4.7678119585725653e-07
mutation O 0 1.1989678583290697e-08
in O 0 6.366671079227615e-10
COL17A1 O 1 0.9995676875114441
in O 0 1.806025440309611e-09
five O 0 2.2929449450259654e-09
Austrian O 0 1.8441255633661058e-07
families O 0 2.991429604026763e-10
with O 0 3.5305807166707837e-09
generalized O 0 3.5754590498982e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9998552799224854
represents O 0 1.397335438468872e-07
propagation O 0 5.7819192988972645e-08
of O 0 4.87794586945256e-08
an O 0 2.740226490161035e-09
ancestral O 0 5.000065925742092e-07
allele O 0 2.662199563019385e-07
. O 0 1.8718841943154985e-07

Patients O 0 2.6972177238349104e-06
with O 0 4.640288153723304e-08
generalized O 0 0.0011575327953323722
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 3.482355381834168e-08
a O 0 3.0101585668518283e-09
usually O 0 7.226337306320829e-10
nonlethal O 0 2.4906489670684095e-07
form O 0 1.6713648243182888e-09
of O 0 1.3777817287063954e-07
junctional B-Disease 1 0.9514327049255371
epidermolysis I-Disease 1 0.9998520612716675
bullosa I-Disease 1 0.9922730326652527
, O 0 1.6058413265795934e-08
have O 0 8.517467842139581e-10
generalized O 0 6.485961279167896e-08
blistering B-Disease 0 6.116219992691185e-07
, O 0 1.0273718764608475e-08
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.0905904446190107e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 1.2223803480537754e-07
and O 0 5.192289336264366e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 3.821637619694229e-07

Skin B-Disease 1 1.0
fragility I-Disease 0 7.219521648949012e-06
in O 0 9.411806889403351e-10
most O 0 2.0092627561751897e-10
cases O 0 6.20510795523721e-11
is O 0 6.56959122519174e-12
due O 0 4.748920146013802e-10
to O 0 3.0001606754481713e-10
mutations O 0 3.738863108004864e-10
in O 0 1.3848432123264587e-10
the O 0 5.191988616815024e-09
gene O 0 4.1399985661882965e-09
encoding O 0 2.8802752183310076e-08
type O 0 1.2305049494898412e-05
XVII O 1 1.0
collagen O 1 1.0
( O 0 2.9671795687136182e-08
COL17A1 O 1 1.0
) O 0 8.801214868014995e-09
. O 0 2.999534487457822e-08

Recently O 0 2.9070440632494865e-07
, O 0 4.531565789278602e-09
we O 0 3.7224401339130964e-10
reported O 0 4.0786971022832574e-10
five O 0 1.969964330550411e-10
Austrian O 0 6.924076956238423e-08
families O 0 1.359721918392509e-10
with O 0 2.3409270077934252e-09
generalized O 0 2.194256376242265e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 4.197543717054941e-07
share O 0 1.3438307355784218e-08
the O 0 1.1912404396241527e-08
same O 0 1.3482235772244167e-08
COL17A1 O 1 1.0
mutation O 0 1.5980489251887775e-06
. O 0 1.1467496108252817e-07

Affected O 0 4.7878696562975165e-08
individuals O 0 5.983304129930644e-11
in O 0 2.1545216999374617e-11
three O 0 2.8133401858143614e-11
families O 0 8.893146093667814e-13
are O 0 3.4437151481131467e-12
homozygous O 0 4.099771355736692e-10
for O 0 4.7772077960139825e-11
4003delTC O 0 2.3027592277458098e-08
, O 0 5.0581962229845345e-11
whereas O 0 4.783371268524128e-11
those O 0 2.9478263580129394e-11
in O 0 2.2920769449097378e-11
two O 0 9.848896004305274e-11
others O 0 2.2339187444320174e-10
are O 0 6.06903624578159e-11
compound O 0 1.531755167150095e-08
heterozygotes O 0 6.68768677769549e-07
. O 0 8.961242059513097e-08

To O 0 1.0330427180349488e-08
determine O 0 4.2346770534607e-09
if O 0 7.04769242965142e-10
the O 0 7.751752573170734e-10
occurrence O 0 1.1013474576770932e-08
of O 0 2.8090548553905137e-08
4003delTC O 0 3.722749397638836e-07
in O 0 5.503550948304792e-10
these O 0 7.410556057685369e-10
unrelated O 0 4.696210531562883e-09
families O 0 6.002183992881438e-12
signifies O 0 7.406963237199804e-11
propagation O 0 4.5003911708363376e-10
of O 0 2.683220756694027e-09
an O 0 6.320149958938259e-10
ancestral O 0 1.3662307196682377e-07
allele O 0 4.850335599826394e-08
or O 0 1.5418207155448727e-08
a O 0 1.6492492704855977e-08
mutational O 0 9.441862857784145e-06
hot O 0 3.524228986861999e-06
spot O 0 1.7048904510374996e-07
, O 0 4.909433415356546e-10
haplotypes O 0 5.092729571387622e-10
were O 0 3.5413949550644475e-11
determined O 0 1.4264664449648023e-10
for O 0 7.801110452065885e-11
polymorphisms O 0 1.4345873378118768e-09
both O 0 6.19950368818678e-10
within O 0 2.399033416367047e-09
and O 0 8.855671751462069e-09
flanking O 0 6.642039807047695e-05
COL17A1 O 1 1.0
. O 0 2.1667910914402455e-06

Five O 0 9.07643993741658e-07
intragenic O 0 3.045787707378622e-06
polymorphisms O 0 2.22747509326382e-08
were O 0 7.991567962939428e-10
chosen O 0 3.381984414740913e-10
based O 0 1.2389196613060705e-10
on O 0 3.807389958865315e-09
their O 0 5.405397907054521e-09
informativeness O 0 2.0419032807694748e-05
. O 0 5.531675810743764e-07

One O 0 9.348976703904555e-09
of O 0 2.4822173205762965e-09
these O 0 1.3929707387561052e-10
, O 0 3.748271831804928e-11
not O 0 1.888009193429241e-11
previously O 0 1.115730841050322e-09
reported O 0 3.4159289286073147e-10
, O 0 5.683843395942745e-10
was O 0 3.2389056769943636e-08
2988 O 0 1.7789727280614898e-05
A O 0 4.881836730419309e-07
or O 0 1.3400880405356475e-09
C O 0 3.487194533136062e-08
that O 0 1.0684841206254347e-10
introduces O 0 4.850481349905067e-09
a O 0 7.883137198572143e-11
new O 0 1.442783115201962e-10
restriction O 0 9.867742178926164e-10
site O 0 1.874348010133531e-09
for O 0 6.342672498327317e-10
Eco0109 O 0 6.1653163356822915e-06
I O 0 8.042714398470707e-06
. O 0 3.3765164175747486e-07

All O 0 5.367480326867735e-08
the O 0 7.146185421191831e-09
4003delTC O 0 3.9888382730168814e-07
alleles O 0 4.175556012064874e-10
showed O 0 2.822833911064748e-10
the O 0 1.6914268596845972e-10
same O 0 1.1327580540232418e-10
haplotype O 0 1.868622145906329e-09
for O 0 1.1242472924832825e-10
these O 0 6.123515028377824e-10
five O 0 1.5132045616539358e-09
polymorphic O 0 5.162544880477071e-07
markers O 0 1.9916158180421917e-06
. O 0 9.076304507971145e-08

Fourteen O 0 1.0657572602212895e-05
microsatellite O 0 6.165078048070427e-07
polymorphisms O 0 8.04270605669899e-09
were O 0 2.2223167750468065e-10
selected O 0 3.1689706414539387e-10
based O 0 2.463151731191271e-11
on O 0 3.2299199426155667e-10
their O 0 1.2673712079802613e-10
high O 0 2.473173310590937e-08
heterozygosity O 0 2.871494189093937e-07
and O 0 1.0898849600593508e-09
their O 0 1.2561475193351157e-09
location O 0 8.217634572815768e-09
within O 0 7.638172760948692e-09
10q23 O 0 4.666382665163837e-06
- O 0 2.0883580873487517e-06
q25 O 0 2.3729260647087358e-05
near O 0 4.661774710257305e-06
COL17A1 O 1 0.9998437166213989
. O 0 1.2595761518241488e-06

Three O 0 5.53545476122963e-08
families O 0 4.944382125948721e-10
shared O 0 4.898548233711608e-09
microsatellite O 0 1.2299848606289743e-07
polymorphisms O 0 1.0834622976574337e-08
covering O 0 1.7243621641682694e-07
at O 0 5.133281799629685e-09
most O 0 4.88953766364375e-10
19 O 0 1.4020609118148286e-09
cM O 0 2.0276479162362193e-08
, O 0 1.5677850684348016e-10
whereas O 0 9.242004384013569e-11
the O 0 3.834424999737962e-10
others O 0 2.614302385683942e-10
shared O 0 1.703243379669317e-10
smaller O 0 2.4264192877154755e-09
regions O 0 9.361216690706442e-09
consistent O 0 2.372793961313846e-09
with O 0 2.805463153454646e-11
cross O 0 4.312174173293215e-09
- O 0 1.7852237021998008e-08
over O 0 1.7959947973267276e-09
events O 0 2.963839451641803e-10
during O 0 8.241343718573546e-11
passage O 0 1.2914659619500668e-10
of O 0 8.80612596732e-11
this O 0 1.2954816906718403e-11
mutation O 0 2.7544994063433137e-10
through O 0 1.0082340518025035e-10
several O 0 1.5230929850673647e-09
generations O 0 1.91477607103252e-08
. O 0 3.196826625639915e-08

These O 0 4.884518389758341e-08
results O 0 2.3633768275743705e-09
indicate O 0 5.592160068346175e-10
that O 0 1.0703484626395365e-10
4003delTC O 0 2.826258764798695e-07
occurs O 0 1.0757598978283767e-10
on O 0 8.726607769737882e-10
a O 0 9.550781276956855e-10
single O 0 1.830753881826297e-09
ancestral O 0 2.4842647050604683e-08
allele O 0 5.659246848921384e-09
. O 0 6.088648696334076e-09
. O 0 1.457041207686416e-07

The O 0 2.18402465179679e-06
haptoglobin O 0 3.833673326880671e-05
- O 0 1.5944822280289372e-06
gene O 0 3.499140532881029e-08
deletion O 0 3.658042047050003e-08
responsible O 0 7.998647966189765e-09
for O 0 4.929111341311909e-09
anhaptoglobinemia B-Disease 0 0.0004033584555145353
. O 0 4.155800752414507e-07

We O 0 2.8983288657968842e-08
have O 0 9.41339992066581e-11
found O 0 1.2068453181246497e-10
an O 0 5.4878459415652614e-11
allelic O 0 1.879812714378204e-07
deletion O 0 3.5860715286162304e-08
of O 0 1.1153935020047356e-07
the O 0 1.9517230498422578e-07
haptoglobin O 0 7.575290055683581e-06
( O 0 1.5927785756986168e-09
Hp O 0 2.385032615848104e-08
) O 0 1.9789499206002148e-10
gene O 0 1.3178122482138122e-10
from O 0 6.24476373389804e-11
an O 0 8.56326953790898e-11
individual O 0 7.896741593960144e-11
with O 0 3.819505267621537e-10
anhaptoglobinemia B-Disease 0 5.052546475781128e-05
. O 0 3.7330701729842986e-07

The O 0 1.8401498209641431e-06
Hp O 0 7.105996360223799e-07
gene O 0 4.238660977762265e-09
cluster O 0 1.907798541367356e-08
consists O 0 1.131678861732155e-09
of O 0 8.328480682884276e-10
coding O 0 7.2642749593399e-09
regions O 0 4.8265810903558304e-08
of O 0 1.1775235861932742e-06
the O 0 1.0895845292679951e-07
alpha O 0 2.7761695164940647e-08
chain O 0 1.1279206457714963e-09
and O 0 2.002353421959313e-10
beta O 0 1.6490636411958803e-08
chain O 0 1.769391966277567e-09
of O 0 2.3775645896506603e-09
the O 0 5.349316545277816e-09
haptoglobin O 0 2.1799930038923776e-07
gene O 0 3.252552671639819e-10
( O 0 3.67533919964913e-11
Hp O 0 2.245449604032501e-09
) O 0 2.011604598173289e-11
and O 0 9.455129734714518e-11
of O 0 1.7620366277171229e-09
the O 0 2.468289794776979e-09
alpha O 0 4.258197794371199e-09
chain O 0 5.054196505760444e-10
and O 0 1.305583141597566e-10
beta O 0 1.2128464454974619e-08
chain O 0 2.681010746741208e-09
of O 0 1.4989792740394137e-09
the O 0 2.621273864633622e-09
haptoglobin O 0 3.538720534379536e-07
- O 0 4.861653835064317e-08
related O 0 3.783985746963481e-08
gene O 0 1.69547809125703e-09
( O 0 1.0436709829697577e-10
Hpr O 0 1.0868530608831861e-07
) O 0 7.973232490909865e-11
, O 0 7.947966590426958e-11
in O 0 5.8066666058786964e-11
tandem O 0 2.15955964222303e-09
from O 0 2.202555221542113e-10
the O 0 1.6436365601890657e-09
5 O 0 3.749550359088971e-08
side O 0 1.9983612276064378e-07
. O 0 1.330180481318166e-07

Southern O 0 1.816420626710169e-05
blot O 0 5.934941509622149e-05
and O 0 6.571894584084248e-09
PCR O 0 1.1009862355138011e-08
analyses O 0 1.1169444258385397e-09
have O 0 4.9867974333261955e-12
indicated O 0 1.3821614859577114e-11
that O 0 1.8129044272729988e-12
the O 0 5.936028751873934e-11
individual O 0 5.4196365277536795e-12
with O 0 1.3720542930972801e-11
anhaptoglobinemia B-Disease 0 9.790395552045084e-07
was O 0 2.991940561969386e-08
homozygous O 0 1.2278641214891195e-08
for O 0 3.9143205343705745e-10
the O 0 2.4696882316987967e-09
gene O 0 3.0781338589136453e-10
deletion O 0 8.297419418212826e-10
and O 0 1.0916257481285996e-10
that O 0 2.0970869138436932e-11
the O 0 9.144290324947235e-10
gene O 0 1.853428938103363e-10
deletion O 0 1.3188815595199799e-09
was O 0 1.0017096041536888e-09
included O 0 1.6830724314242929e-10
at O 0 7.292966786032196e-10
least O 0 2.169647794758589e-11
from O 0 4.838787009964207e-11
the O 0 1.1047531778274333e-09
promoter O 0 8.763960295254947e-07
region O 0 4.0568767190052313e-07
of O 0 1.072781628863595e-06
Hp O 0 3.975261506639072e-07
to O 0 2.1874230426988106e-08
Hpr O 0 1.8580376490717754e-06
alpha O 0 9.161280623004586e-09
but O 0 1.3370694829095697e-10
not O 0 5.6597809772185315e-11
to O 0 8.468643009074128e-10
Hpr O 0 4.0737672861723695e-06
beta O 0 8.085158356152533e-07
( O 0 5.197150709790321e-09
Hpdel O 0 2.2272864953265525e-05
) O 0 1.5398663677501645e-08
. O 0 6.348875558614964e-08

In O 0 2.9624958042262506e-09
addition O 0 1.568997376466541e-09
, O 0 1.0223061980285664e-10
we O 0 4.178438151036801e-11
found O 0 2.60427755749415e-11
seven O 0 3.8229870658046394e-11
individuals O 0 1.5153452494545694e-12
with O 0 5.261405026935062e-12
hypohaptoglobinemia B-Disease 0 1.0260484373247891e-07
in O 0 1.205984756502687e-10
three O 0 8.718867294810195e-11
families O 0 4.877058500975251e-13
, O 0 2.727312082770328e-12
and O 0 1.9874218590287818e-11
the O 0 1.496978513371161e-10
genotypes O 0 2.8558160281022538e-09
of O 0 1.561412332762302e-08
six O 0 1.0383680582037869e-09
of O 0 5.545152781394336e-09
the O 0 4.690571042686997e-09
seven O 0 4.739563741473773e-10
individuals O 0 9.712078363754983e-12
were O 0 4.970694342243398e-11
found O 0 1.3920517516474717e-10
to O 0 1.5364536309903087e-09
be O 0 1.7156217779756844e-08
Hp2 O 1 0.9998142123222351
/ O 0 0.00020455275080166757
Hpdel O 1 0.9990105628967285
. O 0 2.0884635887341574e-06

The O 0 4.4572982460522326e-07
phenotypes O 0 1.0592529520181415e-07
and O 0 2.7773969790700903e-09
genotypes O 0 5.413001602505574e-09
in O 0 3.3116006464828374e-11
one O 0 2.9548571922610734e-11
of O 0 1.0783277742953956e-10
these O 0 1.0141004355701533e-11
three O 0 5.8604154515307094e-12
families O 0 2.298878318610087e-13
showed O 0 1.9150033989112636e-11
the O 0 5.608588593553065e-10
father O 0 3.035538709283969e-09
to O 0 1.0163495600679084e-09
be O 0 2.118097031100774e-09
hypohaptoglobinemic B-Disease 0 9.042158126248978e-06
( O 0 2.373206076100587e-09
Hp2 O 0 0.00015777259250171483
) O 0 2.106196328455212e-09
and O 0 7.308120775206817e-09
Hp2 O 0 5.497187885339372e-05
/ O 0 1.1390838494662603e-07
Hpdel O 0 1.712518496788107e-05
, O 0 7.878782071202295e-10
the O 0 2.2361239526702548e-09
mother O 0 1.2337982857602015e-09
to O 0 3.2309180331147047e-10
be O 0 3.7949898779032765e-10
Hp2 O 0 1.7082608110285946e-06
- O 0 7.564063508880281e-08
1 O 0 3.5664605491092516e-08
and O 0 3.210598453762259e-09
Hp1 O 0 7.5173720688326284e-06
/ O 0 4.147857168845803e-08
Hp2 O 0 3.0485832667181967e-06
, O 0 2.0211629592203906e-10
one O 0 4.303878781142245e-11
of O 0 1.8656939881900314e-10
the O 0 1.2583002695354395e-10
two O 0 2.0267051925593194e-11
children O 0 1.4871255268888994e-11
to O 0 2.577778962509214e-11
be O 0 3.741773557663919e-10
hypohaptoglobinemic B-Disease 0 1.459184318264306e-06
( O 0 1.0400924566056347e-09
Hp2 O 0 9.430151840206236e-05
) O 0 1.2100268564907424e-09
and O 0 3.454904806687864e-09
Hp2 O 0 8.450547466054559e-05
/ O 0 1.2110703551115876e-07
Hpdel O 0 2.3654993128729984e-05
, O 0 3.7137384834018405e-10
and O 0 9.4850044485284e-11
the O 0 1.3902685946920457e-10
other O 0 6.348502973319015e-11
child O 0 1.4998308150993012e-10
to O 0 4.823297317102515e-11
be O 0 3.885711474804765e-10
Hp1 O 0 3.340459807077423e-05
and O 0 2.9720393257548494e-08
Hp1 O 1 0.9987990856170654
/ O 0 3.0930675620766124e-06
Hpdel O 0 0.00371118588373065
, O 0 2.5272379744478712e-09
showing O 0 7.2948491691704476e-09
an O 0 5.957105364551296e-10
anomalous O 0 1.6564219151860016e-07
inheritance O 0 3.1368611530524504e-07
of O 0 5.980004402772465e-07
Hp O 0 2.105061440715872e-07
phenotypes O 0 1.6757580212356515e-08
in O 0 6.660017676241026e-11
the O 0 1.9314942978354566e-09
child O 0 4.672604969613303e-09
with O 0 1.3834657863753819e-09
Hp1 O 0 0.0008314505103044212
. O 0 4.190104334611533e-07

The O 0 1.746177645145508e-06
Hp2 O 0 0.002269183751195669
/ O 0 8.127166438498534e-06
Hpdel O 0 0.0007309849024750292
individuals O 0 2.011299793380772e-09
had O 0 2.203060622818498e-09
an O 0 2.5631796685132713e-10
extremely O 0 4.196092362462878e-09
low O 0 6.718641287761784e-08
level O 0 6.947055197770169e-08
of O 0 3.454788668477704e-07
Hp O 0 1.0063446325148107e-06
( O 0 3.060146136490971e-09
mean O 0 3.361088118936095e-08
+ O 0 3.2255629278665765e-09
/ O 0 2.0099241382354194e-08
- O 0 3.878666916534712e-07
SD O 0 0.00013300894352141768
= O 0 8.951091423625712e-09
0 O 0 2.625301753766962e-09
. O 0 4.548666165948845e-10
049 O 0 7.574435585411265e-07
+ O 0 1.4049010843564247e-09
/ O 0 4.2097525465578656e-09
- O 0 1.4179124541158217e-08
0 O 0 4.665142494530983e-09
. O 0 8.091879388771872e-10
043 O 0 1.5521383147643064e-06
mg O 0 2.6403537844998937e-07
/ O 0 2.0635148700876016e-08
ml O 0 1.2256717418779317e-08
; O 0 2.8789196721001886e-11
n O 0 2.961752718078081e-11
= O 0 2.714432671691025e-11
6 O 0 9.305842901818906e-11
) O 0 3.2948273016170093e-12
, O 0 5.345340489681938e-12
compared O 0 1.0123668396644359e-11
with O 0 6.264994165811055e-12
the O 0 2.7736951624390827e-10
level O 0 7.238463162195785e-10
( O 0 2.0527086974642117e-11
1 O 0 1.777205049791064e-09
. O 0 1.7048977507538865e-10
64 O 0 1.2706449226129735e-08
+ O 0 2.8408633778731485e-10
/ O 0 1.1096420449163702e-09
- O 0 1.28538752974805e-08
1 O 0 1.1461118276656634e-08
. O 0 1.0060657862354105e-09
07 O 0 1.2014971844109823e-06
mg O 0 2.832189238688443e-07
/ O 0 3.363550504786872e-08
ml O 0 3.3937741505951635e-08
) O 0 2.537668859770026e-11
obtained O 0 5.887137999316394e-11
from O 0 5.888272508469683e-11
52 O 0 7.491481213151019e-09
healthy O 0 2.8010760377839006e-09
volunteers O 0 5.984779893886127e-10
having O 0 1.4208544341087759e-09
phenotype O 0 9.080664220562085e-09
Hp2 O 0 2.1931814444542397e-06
, O 0 8.43815350926036e-10
whereas O 0 6.566791554973861e-10
the O 0 5.918158185735933e-10
serum O 0 1.1637379948581383e-09
Hp O 0 3.250452129677228e-09
level O 0 1.4408587656333793e-09
of O 0 4.229575356617943e-09
an O 0 2.625515638232656e-10
individual O 0 3.7520000994994973e-10
with O 0 7.935972989869811e-10
Hp1 O 0 0.00022721140703652054
/ O 0 1.4027591532794759e-06
Hpdel O 0 8.145995525410399e-05
was O 0 1.7640559235587716e-07
0 O 0 1.8839872950593417e-07
. O 0 5.40599884857329e-08

50 O 0 1.6989611140161287e-06
mg O 0 1.7616563354749815e-06
/ O 0 1.5889415294623177e-07
ml O 0 9.414292634346566e-08
, O 0 7.050687117482468e-11
which O 0 3.901995046518003e-12
was O 0 1.6957488191415848e-10
approximately O 0 2.1668604410773895e-11
half O 0 2.9721711203301027e-11
the O 0 8.469171891567484e-11
level O 0 1.4389884839260958e-09
of O 0 7.439138638432041e-09
Hp O 0 2.0937408251597844e-08
in O 0 6.133638041916356e-10
control O 0 2.3698176221387257e-07
sera O 0 1.817403062887024e-05
from O 0 3.887003163782765e-09
the O 0 1.4772274070651292e-08
Hp1 O 0 4.318557330407202e-06
phenotype O 0 1.08750308758232e-09
( O 0 1.3749413066421745e-11
1 O 0 8.533859174875147e-10
. O 0 8.55657558695988e-11
26 O 0 2.682790878338892e-09
+ O 0 1.3917118846240584e-10
/ O 0 8.754382219144929e-10
- O 0 6.6275456234166086e-09
0 O 0 1.8416108638064088e-09
. O 0 2.4328086767333446e-10
33 O 0 1.7986970135552838e-08
mg O 0 5.729848595592557e-08
/ O 0 1.1462430116182531e-08
ml O 0 1.718516884352539e-08
; O 0 3.291713429609544e-11
n O 0 5.859669693908387e-11
= O 0 5.570163774670789e-11
9 O 0 2.640430929456983e-10
) O 0 3.435464066003924e-11
, O 0 1.1632580315668051e-10
showing O 0 8.159716791134031e-10
a O 0 9.345691998063899e-10
gene O 0 1.2732109810897896e-09
- O 0 3.8495908682989466e-08
dosage O 0 3.106095505245321e-07
effect O 0 4.54613804379278e-08
. O 0 1.6356157317432007e-08

The O 0 3.032704398719943e-08
other O 0 1.3582891478236547e-09
allele O 0 1.5267257458262407e-09
( O 0 1.3997676628907385e-10
Hp2 O 0 2.0581121589202667e-06
) O 0 3.999068021176555e-10
of O 0 7.574758598138942e-09
individuals O 0 3.77645970051077e-11
with O 0 3.149207006281074e-10
Hp2 O 1 0.9999923706054688
/ O 0 1.3138102303855703e-06
Hpdel O 0 0.06061733886599541
was O 0 6.167709454274473e-09
found O 0 2.1950302686590817e-11
to O 0 1.664463011863404e-11
have O 0 3.564528880395379e-12
, O 0 8.681774049668078e-12
in O 0 1.1504004346352126e-11
all O 0 2.0469702322056804e-10
exons O 0 6.116048112403405e-09
, O 0 2.924921416180837e-10
no O 0 6.702725041662916e-10
mutation O 0 2.2624467577170293e-10
, O 0 3.596985556630905e-11
by O 0 5.484915299724946e-11
DNA O 0 9.229347952555145e-09
sequencing O 0 1.2222563405828168e-08
. O 0 2.7023590476460413e-08

On O 0 4.7079620202339356e-08
the O 0 1.4302160566970201e-09
basis O 0 2.95506757952424e-10
of O 0 3.0322447330810576e-10
the O 0 3.8715225469942993e-10
present O 0 5.924660761991163e-11
study O 0 6.610999941925044e-11
, O 0 2.4763698036611714e-11
the O 0 8.09473044149911e-11
mechanism O 0 1.0631098223967683e-09
of O 0 2.1005317485389696e-09
anhaptoglobinemia B-Disease 0 9.156477744909353e-07
and O 0 1.5029012478962045e-09
the O 0 3.095456557744569e-09
mechanism O 0 1.593545206901581e-08
of O 0 1.8901090470535564e-08
anomalous O 0 5.750156901740411e-07
inheritance O 0 5.564103275901289e-07
of O 0 6.912477488185687e-07
Hp O 0 3.822993619451154e-07
phenotypes O 0 2.943852983605666e-08
were O 0 1.1198690863523098e-09
well O 0 3.11289904963985e-09
explained O 0 1.0619475432349645e-07
. O 0 6.293775101084975e-08

However O 0 2.0342099560366478e-08
, O 0 1.9096981773714106e-09
the O 0 2.0341663908851615e-09
mechanism O 0 1.926667714258201e-08
of O 0 5.349359710749013e-08
hypohaptoglobinemia B-Disease 0 0.00014855251356493682
remains O 0 6.870868674013764e-06
unknown O 0 2.2144631657283753e-06

ATM O 0 0.010700646787881851
mutations O 0 5.007424306313624e-07
and O 0 4.64265177413381e-08
phenotypes O 0 2.2375088519765995e-06
in O 0 5.4208157962420955e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 3.6708713846422825e-10
in O 0 1.688415553202649e-11
the O 0 1.6823277493305255e-10
British O 0 3.800647019325254e-10
Isles O 0 3.168308992940183e-08
: O 0 6.113196060475445e-11
expression O 0 1.801469390327881e-10
of O 0 7.162857529330324e-10
mutant O 0 9.66596669371711e-09
ATM O 0 3.8106609423493865e-08
and O 0 5.926423934932146e-11
the O 0 1.3901757522916114e-10
risk O 0 1.8306841598203505e-09
of O 0 1.7107358862844535e-09
leukemia B-Disease 1 0.9999984502792358
, O 0 2.7505645761038977e-08
lymphoma B-Disease 1 1.0
, O 0 1.8266258905441646e-07
and O 0 3.033636346572166e-07
breast B-Disease 1 1.0
cancer I-Disease 1 0.7134715914726257
. O 0 7.651095046412593e-08

We O 0 8.194657397098126e-09
report O 0 3.73169578571364e-10
the O 0 6.318185419296185e-10
spectrum O 0 1.105645441867864e-08
of O 0 3.394486469687763e-08
59 O 0 2.904084794863593e-07
ATM O 0 7.733130587439518e-06
mutations O 0 1.2559036477455265e-08
observed O 0 6.806177399454327e-09
in O 0 1.402880211998081e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.694099805466976e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.1443224973438646e-10
patients O 0 4.503574943526267e-11
in O 0 7.948842105365284e-12
the O 0 1.2573747598665364e-09
British O 0 2.1455194954000945e-08
Isles O 0 2.2020740289008245e-06
. O 0 1.4284533733643912e-07

Of O 0 5.515971497516148e-05
51 O 0 1.985997732845135e-05
ATM O 0 0.00013036205200478435
mutations O 0 1.5539431075239918e-08
identified O 0 3.7624056647977966e-10
in O 0 3.266894740838744e-11
families O 0 3.5205961410045283e-12
native O 0 5.700299260391617e-11
to O 0 3.610857446378901e-11
the O 0 4.2212480733105906e-10
British O 0 1.049172304590229e-09
Isles O 0 4.077775628275049e-08
, O 0 3.938555315219361e-10
11 O 0 1.6966038574039999e-09
were O 0 3.8335185026383556e-10
founder O 0 7.192596296334841e-09
mutations O 0 6.922486472937806e-10
, O 0 5.14354774050485e-11
and O 0 8.539586399125554e-11
2 O 0 3.305255846797195e-09
of O 0 1.7624635084700913e-09
these O 0 4.563108502164681e-10
11 O 0 1.6371568545281434e-09
conferred O 0 2.4546570998040806e-08
a O 0 1.574090080502799e-09
milder O 0 1.63204830982977e-07
clinical O 0 2.0749721940660493e-08
phenotype O 0 3.1576152803580726e-10
with O 0 5.967618326579993e-12
respect O 0 2.1401262706444157e-10
to O 0 5.381621814848359e-10
both O 0 2.7105565791885056e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 0.00010856492008315399
cellular O 0 5.456145686366654e-07
features O 0 2.926124977875588e-07
. O 0 7.97588981527042e-08

We O 0 3.0964841801761622e-09
report O 0 2.1514265369226848e-10
, O 0 5.3640741154437066e-11
in O 0 2.639805214699198e-11
two O 0 1.0727151111833422e-10
A B-Disease 1 0.9999997615814209
- I-Disease 0 0.0005482489941641688
T I-Disease 1 1.0
families O 0 5.1415861151982156e-11
, O 0 7.112550132193363e-11
an O 0 2.153076605893034e-10
ATM O 0 6.188284714880865e-06
mutation O 0 1.1678120692693028e-08
( O 0 3.6153455229559484e-10
7271T O 0 1.9359346481451212e-07
- O 0 5.2600508837485904e-08
- O 0 7.635540555384068e-08
> O 0 4.9671076141066806e-09
G O 0 2.3194171916429696e-08
) O 0 7.385966838135971e-12
that O 0 1.6024173090864458e-12
may O 0 7.608195323749456e-12
be O 0 2.523212541682973e-12
associated O 0 1.166819592335333e-11
with O 0 1.2834060203470443e-11
an O 0 1.801922153155111e-11
increased O 0 4.0417724722630055e-10
risk O 0 1.1745225236836632e-08
of O 0 4.1668563710572926e-08
breast B-Disease 1 0.9999198913574219
cancer I-Disease 0 3.8242919231379346e-07
in O 0 1.8543659663361467e-10
both O 0 9.054043070833018e-10
homozygotes O 0 1.6036076999625948e-07
and O 0 8.793944461515935e-10
heterozygotes O 0 2.5138168879834666e-08
( O 0 3.471567130985953e-11
relative O 0 3.833094397442949e-10
risk O 0 2.4262053477386303e-10
12 O 0 8.469624307450019e-11
. O 0 1.1252806846051566e-11
7 O 0 8.724477251753626e-10
; O 0 1.314904712890197e-10
P O 0 5.556738358336588e-08
= O 0 2.860726378006717e-10
. O 0 4.97367216856226e-11
0025 O 0 2.3776699720201577e-08
) O 0 3.3072641847375905e-11
, O 0 1.950990063948055e-11
although O 0 1.7540108254721076e-11
there O 0 2.581912288135424e-11
is O 0 5.5802022724815714e-11
a O 0 1.5376959427992887e-10
less O 0 2.610954785708941e-09
severe O 0 0.002997774165123701
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.077131939197784e-09
in O 0 5.151881091874921e-12
terms O 0 7.06012054374483e-11
of O 0 7.048213401805725e-11
the O 0 1.7565258969565178e-10
degree O 0 1.1112988751449393e-08
of O 0 1.1224683049704254e-07
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 6.918888630025322e-06

This O 0 6.746660830003748e-08
mutation O 0 2.5321803320821346e-08
( O 0 1.9198034273415487e-09
7271T O 0 1.4327580402095919e-06
- O 0 1.457861174003483e-07
- O 0 1.5763900762522098e-07
> O 0 1.55349848540709e-08
G O 0 5.533660285550468e-08
) O 0 3.88394628958455e-11
also O 0 2.7858618190101936e-11
allows O 0 3.697346248610067e-11
expression O 0 1.7793469822557917e-11
of O 0 1.5672946274136734e-10
full O 0 1.40571262963185e-10
- O 0 2.4089330530330244e-09
length O 0 1.918979641857277e-09
ATM O 0 2.204621694090747e-07
protein O 0 8.171724963368376e-10
at O 0 4.2494088803302077e-10
a O 0 4.368270675736419e-11
level O 0 9.63343502191627e-11
comparable O 0 1.4160299321996916e-10
with O 0 1.0146827822410387e-11
that O 0 1.9564605144295477e-11
in O 0 2.7465357765876774e-10
unaffected O 0 2.3694764195170137e-07
individuals O 0 1.0011214079952424e-09
. O 0 2.241813135128723e-08

In O 0 2.8211342151251984e-09
addition O 0 1.0905232272762078e-09
, O 0 1.4593336261636836e-10
we O 0 3.2890148937703145e-11
have O 0 6.633656731563908e-12
studied O 0 4.3327603727050246e-09
18 O 0 1.0727592147929954e-08
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.8524153828620911
T I-Disease 1 1.0
patients O 0 7.38666516841846e-10
, O 0 3.110971116132566e-12
in O 0 1.4815528361425412e-12
15 O 0 1.0322105670201864e-10
families O 0 1.3195716221103826e-12
, O 0 1.4315353590033109e-11
who O 0 1.298213203604348e-10
developed O 0 1.8759511277721685e-08
leukemia B-Disease 1 1.0
, O 0 4.905769515062275e-07
lymphoma B-Disease 1 1.0
, O 0 9.184711302623327e-08
preleukemic O 1 0.5242992043495178
T O 0 6.09403559792554e-06
- O 0 3.983291492204444e-07
cell O 0 3.999476305693861e-08
proliferation O 1 0.9964020252227783
, O 0 8.125409234338576e-10
or O 0 1.3860654846098441e-08
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 1.2396110804502314e-08
mostly O 0 3.640234502721995e-10
in O 0 2.1924623228031237e-10
childhood O 0 3.197687306055741e-07
. O 0 6.408807706748121e-08

A O 0 2.731170297920471e-06
wide O 0 6.13757663359138e-07
variety O 0 6.473700153719619e-08
of O 0 1.4279302718023246e-07
ATM O 0 2.169694380427245e-05
mutation O 0 5.229577215715153e-09
types O 0 7.789521028200852e-09
, O 0 1.8295556736269702e-10
including O 0 1.1242349273743457e-09
missense O 0 5.303288475033696e-08
mutations O 0 4.758876070987128e-10
and O 0 5.0856607120008945e-11
in O 0 7.765155185524009e-11
- O 0 9.135542988758516e-09
frame O 0 2.9263849121718977e-09
deletions O 0 5.536930469673962e-09
, O 0 6.703360089233001e-11
were O 0 7.125326717538627e-11
seen O 0 3.723292230084496e-10
in O 0 3.999966330381355e-11
these O 0 9.331744266205533e-10
patients O 0 6.799582008554239e-10
. O 0 7.108989397153209e-09

We O 0 8.927714567619205e-09
also O 0 2.700295265167796e-10
show O 0 7.65860361240378e-11
that O 0 2.135520709919958e-12
25 O 0 2.5947594073372215e-10
% O 0 1.88488617075544e-11
of O 0 3.5006991749853e-10
all O 0 1.3912879737176809e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.427331029039806e-09
carried O 0 8.339604007367996e-11
in O 0 2.4280973065504696e-11
- O 0 2.10377653075966e-08
frame O 0 2.006599331139114e-08
deletions O 0 7.134693191801489e-08
or O 0 3.295775208300711e-09
missense O 0 1.0710521358703318e-08
mutations O 0 1.8200919937871873e-10
, O 0 6.774797736697202e-12
many O 0 1.9904329920383823e-12
of O 0 2.24809129645287e-11
which O 0 1.8932442419350437e-12
were O 0 4.946046176790286e-12
also O 0 3.5611719736289293e-12
associated O 0 1.526817561270377e-11
with O 0 6.24028745344063e-11
expression O 0 2.5050086449596165e-09
of O 0 5.5430827927693826e-08
mutant O 0 2.3799670998414513e-06
ATM O 0 2.6843468731385656e-05
protein O 0 2.8590392275873455e-07
. O 0 4.127370090145632e-08

The O 0 8.941221381064679e-07
DMPK O 1 1.0
gene O 0 1.158510158916215e-07
of O 0 6.169889275042806e-07
severely O 1 1.0
affected O 1 0.9999998807907104
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.009122533723711967
is O 0 2.9886824126634792e-09
hypermethylated O 0 1.0989134580086102e-06
proximal O 0 4.703456397692207e-07
to O 0 3.1503979425195894e-09
the O 0 1.8877960528129734e-08
largely O 0 1.0850634168946272e-07
expanded O 0 5.601665975518699e-07
CTG O 0 0.0008924335124902427
repeat O 0 2.0926045181113295e-06
. O 0 2.0650273313549405e-07

Using O 0 3.3134252674926756e-08
methylation O 0 1.765919250829029e-07
- O 0 3.1095305530470796e-07
sensitive O 0 2.9551898705904023e-07
restriction O 0 9.386247334930431e-09
enzymes O 0 6.894314563687942e-10
, O 0 2.3404081450628667e-10
we O 0 1.2582473951638917e-10
characterized O 0 1.0002166872524754e-09
the O 0 6.805460084358117e-10
methylation O 0 3.753462429756382e-09
pattern O 0 1.1057124105207095e-09
on O 0 2.9522789768421376e-10
the O 0 2.785570940577742e-10
5 O 0 1.1198264537881641e-09
side O 0 4.972160017047145e-09
of O 0 4.815544407676953e-09
the O 0 1.198629462351164e-08
CTG O 0 4.890495984000154e-05
repeat O 0 1.1768321428462514e-08
in O 0 1.3771991880240364e-10
the O 0 2.9563318459935317e-09
DMPK O 1 0.7734673619270325
gene O 0 1.0004647110761766e-09
of O 0 1.366060264906821e-09
normal O 0 5.243457890102832e-10
individuals O 0 1.8839721449559477e-12
and O 0 1.0927230474633287e-11
of O 0 7.284556291509148e-10
patients O 0 2.6278301756832434e-10
affected O 0 6.157315768362537e-10
with O 0 4.1954204554883745e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 4.592553004556521e-09
showing O 0 2.8533875262581887e-09
expansions O 0 5.447473938602343e-08
of O 0 8.43846326148423e-09
the O 0 7.817592795333894e-09
repetitive O 0 6.076099339225038e-07
sequence O 0 4.416210952484789e-09
. O 0 1.0237959813252928e-08

The O 0 9.462147545491462e-07
gene O 0 3.284525007529737e-08
segment O 0 2.41024888936181e-08
analyzed O 0 5.557138305078979e-09
corresponds O 0 2.6365973848641033e-09
to O 0 1.0312821707714193e-09
the O 0 1.577781993944427e-08
genomic O 0 2.281207969190291e-07
SacI O 0 1.0231068699795287e-05
- O 0 2.350552676944062e-07
HindIII O 0 2.2928077214601217e-06
fragment O 0 3.2145951678330675e-08
carrying O 0 3.6578868822800814e-09
exons O 0 2.105177365763211e-08
11 O 0 4.53207604778072e-09
- O 0 8.629670844584325e-08
15 O 0 6.473923264138648e-08
. O 0 3.9335141366336757e-08

There O 0 9.640782394626513e-08
is O 0 1.0744116707428475e-08
constitutive O 0 1.7051603151685413e-07
methylation O 0 6.739625746376987e-08
in O 0 5.151485904519859e-09
intron O 0 1.2646313507502782e-06
12 O 0 3.222022471049968e-08
at O 0 1.9581125609846595e-09
restriction O 0 3.0900062508720794e-09
sites O 0 2.128415665936245e-09
of O 0 4.754859173061732e-09
SacII O 0 7.632403139723465e-06
and O 0 1.9420749453047392e-08
HhaI O 0 2.9604992960230447e-05
, O 0 2.605378135456249e-09
localized O 0 9.40415318950727e-08
1 O 0 1.7123134909979854e-08
, O 0 2.373204688321806e-10
159 O 0 1.3914471796994121e-09
- O 0 5.251146628637571e-09
1 O 0 1.241783476046976e-08
, O 0 7.344841401746294e-10
232 O 0 5.688422621830114e-09
bp O 0 3.45122974643175e-09
upstream O 0 1.2608528443536215e-08
of O 0 5.839380978756026e-09
the O 0 1.821510942079385e-08
CTG O 0 5.1922888815170154e-05
repeat O 0 1.4090803190924817e-08
, O 0 1.0388707255559737e-10
whereas O 0 2.6688854251610827e-11
most O 0 1.542365540840862e-11
, O 0 5.8162736779610036e-12
if O 0 5.533669876489622e-12
not O 0 3.2546532743177314e-12
all O 0 1.660055946872685e-11
, O 0 1.7137092092611717e-11
of O 0 1.7575180200068985e-10
the O 0 2.0196136429895262e-10
other O 0 5.2300705433161454e-11
sites O 0 4.4844367108609617e-10
of O 0 3.50474960164604e-09
SacII O 0 6.445297913160175e-06
, O 0 1.828757700828021e-09
HhaI O 0 8.223129952966701e-06
, O 0 8.120513705911492e-10
and O 0 1.0478342638009508e-09
HpaII O 0 7.903018968136166e-07
in O 0 9.725133892635185e-11
this O 0 2.7389174261926996e-11
region O 0 2.219145533999267e-09
are O 0 3.952716626232089e-11
unmethylated O 0 2.450933145325962e-08
, O 0 1.0555928353639388e-10
in O 0 2.5484760135530138e-11
normal O 0 4.291830502101135e-10
individuals O 0 1.0815544423600776e-12
and O 0 2.1230819186035532e-11
most O 0 1.0993903704070718e-10
of O 0 1.73897241051435e-09
the O 0 1.6468035823891114e-08
patients O 0 6.21726892191532e-09
. O 0 1.866528620553254e-08

In O 0 3.757767874645879e-09
a O 0 2.958676914577296e-10
number O 0 9.097279873859776e-11
of O 0 1.1557790280392055e-09
young O 0 5.795084412341112e-10
and O 0 3.308174290062027e-10
severely O 0 3.9453945532841317e-07
affected O 0 5.958733506616909e-09
patients O 0 2.3210434962894766e-10
, O 0 1.1156083869201527e-11
however O 0 3.911199489281536e-11
, O 0 1.0310810538705084e-10
complete O 0 1.6364379296085474e-10
methylation O 0 4.8269837016334805e-09
of O 0 1.1939108368608231e-08
these O 0 5.146043036141634e-10
restriction O 0 1.9240007365084466e-09
sites O 0 2.823609401847449e-10
was O 0 3.9016639918898477e-10
found O 0 3.2225954543774193e-11
in O 0 1.1327105226e-10
the O 0 8.848276777939645e-09
mutated O 0 1.0543306672161634e-07
allele O 0 4.049578095077777e-08
. O 0 1.1110576991768539e-07

In O 0 6.62567511966472e-09
most O 0 3.254501113048036e-10
of O 0 6.059704960037493e-10
these O 0 5.7927170005189765e-11
patients O 0 4.5054134034661075e-11
, O 0 7.469681991001398e-12
the O 0 8.27827181804075e-11
onset O 0 1.5795405872154333e-08
of O 0 2.685229105736653e-08
the O 0 2.2247137110298354e-07
disease O 1 0.9999992847442627
was O 0 0.0005251832189969718
congenital O 1 1.0
. O 0 2.6197089937340934e-06

Preliminary O 0 2.6775990136229666e-06
in O 0 1.0400101757568336e-07
vivo O 0 2.9539319257310126e-06
footprinting O 0 3.8447592487500515e-06
data O 0 3.3147764533225654e-09
gave O 0 2.601370896471167e-09
evidence O 0 7.589852635270233e-10
for O 0 1.8199983187194846e-10
protein O 0 7.613210617485322e-10
- O 0 4.791393060088467e-09
DNA O 0 6.034656330200505e-09
contact O 0 2.4888957561586267e-10
in O 0 1.0472903100300357e-10
normal O 0 1.1071727978873014e-09
genes O 0 6.457511608770616e-11
at O 0 3.324487352074357e-10
an O 0 2.402361365394512e-10
Sp1 O 0 6.113185918366071e-06
consensus O 0 1.2912209967907984e-08
binding O 0 8.09444511418178e-09
site O 0 6.8837144873157285e-09
upstream O 0 1.2318119857468446e-08
of O 0 4.376247808579592e-09
the O 0 9.475539464176563e-09
CTG O 0 1.4711290532432031e-05
repeat O 0 4.175462642308503e-09
and O 0 1.096425103486176e-10
for O 0 4.733255454247853e-11
a O 0 3.164185580217804e-11
significant O 0 7.327570494819469e-11
reduction O 0 1.7798441609429005e-09
of O 0 7.098173715469613e-10
this O 0 1.2287198168647873e-11
interaction O 0 7.069418661576066e-11
in O 0 6.653326500849488e-11
cells O 0 5.4195873483431356e-11
with O 0 1.1598152299674425e-10
a O 0 6.976703659233863e-09
hypermethylated O 0 1.0581706192169804e-05
DMPK O 0 0.23419584333896637
gene O 0 1.87900930370688e-08
. O 0 4.781032014733455e-09
. O 0 7.18152293188723e-08

The O 0 8.974821867013816e-06
hemochromatosis B-Disease 1 1.0
gene O 0 3.7916073836186115e-08
product O 0 5.4902797863576325e-09
complexes O 0 4.5562897899031896e-10
with O 0 7.124457274132467e-11
the O 0 3.2773830316301655e-09
transferrin O 0 1.230692276976697e-07
receptor O 0 4.083197779891634e-09
and O 0 9.640442888425582e-10
lowers O 0 9.37079533969154e-08
its O 0 3.2659491777664584e-10
affinity O 0 1.8525453393536395e-10
for O 0 1.25209953516503e-10
ligand O 0 2.1097115165957803e-08
binding O 0 1.3510337737443479e-07
. O 0 6.4069375582676e-08

We O 0 9.799216371675357e-08
recently O 0 1.7825493969780837e-08
reported O 0 3.808217741152475e-09
the O 0 1.896850898575053e-09
positional O 0 9.763991926092785e-08
cloning O 0 2.4518296282138863e-09
of O 0 1.782052172494275e-09
a O 0 2.7341900965538457e-10
candidate O 0 3.2777704994657597e-09
gene O 0 6.187598877716027e-09
for O 0 4.1425757046908984e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 1.0
HFE O 1 1.0
. O 0 7.872508263062628e-07

The O 0 8.593551825697432e-08
gene O 0 2.3386498293476166e-10
product O 0 4.1731512689935357e-10
, O 0 7.506348320696077e-11
a O 0 9.184629445879722e-11
member O 0 1.2336683063995935e-10
of O 0 2.4190347502894838e-09
the O 0 7.634226584229964e-09
major O 0 1.6705617156276276e-07
histocompatibility O 0 2.284008132846793e-06
complex O 0 3.346784183122509e-08
class O 0 2.629690354361003e-10
I O 0 5.023195637221534e-09
- O 0 4.196524461264062e-09
like O 0 2.357135875374894e-10
family O 0 1.332466637027352e-10
, O 0 4.883635509878026e-11
was O 0 3.6936831371292556e-10
found O 0 3.333832862550956e-11
to O 0 1.5337561776185282e-10
have O 0 1.2719093833712947e-10
a O 0 2.8263855700316753e-09
mutation O 0 2.3255834591395796e-08
, O 0 6.708023025936427e-09
Cys O 1 0.9995146989822388
- O 0 6.698654942738358e-06
282 O 0 4.6911236495361663e-07
- O 0 2.7403277726989472e-06
- O 0 2.4925479920057114e-06
> O 0 1.5437576905696915e-07
Tyr O 0 4.965090556652285e-05
( O 0 5.251934998007357e-10
C282Y O 0 2.1084609613808425e-07
) O 0 4.8487557718912555e-11
, O 0 2.823877069679792e-11
in O 0 2.3923278288928707e-11
85 O 0 8.167895693134142e-09
% O 0 3.3975530722152314e-10
of O 0 6.777625571885437e-09
patient O 0 2.951927058347792e-08
chromosomes O 0 5.768180599829975e-09
. O 0 1.511849312407776e-08

This O 0 1.773088698087122e-08
mutation O 0 5.551777704226879e-09
eliminates O 0 6.385197792724284e-08
the O 0 2.1447164044730016e-09
ability O 0 3.353453292831432e-09
of O 0 3.2748477707400525e-08
HFE O 0 0.3253973126411438
to O 0 1.1604670113740667e-08
associate O 0 1.1040270031514865e-08
with O 0 7.994997996974007e-10
beta2 O 0 7.850762631278485e-05
- O 0 1.9482249626889825e-05
microglobulin O 0 0.00040524103678762913
( O 0 2.371481899743344e-09
beta2m O 0 2.861408802345977e-06
) O 0 6.137640951031642e-10
and O 0 1.0881048284616668e-09
prevents O 0 1.2400130700029877e-08
cell O 0 3.904569556567594e-09
- O 0 6.930577711727892e-08
surface O 0 2.414936091099662e-07
expression O 0 4.281696419639047e-08
. O 0 1.9218743929627635e-08

A O 0 7.75621083448641e-06
second O 0 4.829813349260803e-08
mutation O 0 1.2369509860832295e-09
that O 0 3.843239268497278e-11
has O 0 1.5801172870144597e-10
no O 0 1.376369296313129e-10
effect O 0 1.0401797201353702e-09
on O 0 3.299083450869489e-09
beta2m O 0 1.3773023965768516e-06
association O 0 3.7645736528091334e-10
, O 0 3.497068745694776e-10
H63D O 1 0.9999264478683472
, O 0 4.722436330872881e-10
was O 0 9.70316493820178e-10
found O 0 2.4122962308248397e-11
in O 0 2.776504200163732e-11
eight O 0 1.976128566338886e-10
out O 0 8.541541085538285e-11
of O 0 1.0860852217575712e-09
nine O 0 3.2777704994657597e-09
patients O 0 1.0755362572778537e-10
heterozygous O 0 2.730411452489534e-10
for O 0 2.3646740121563425e-10
the O 0 3.412591809137666e-08
C282Y O 0 2.7848122044815682e-05
mutant O 0 2.13573434848513e-06
. O 0 1.0570167319201573e-07

In O 0 3.750735722007903e-09
this O 0 2.967605328141332e-11
report O 0 6.334762575610497e-11
, O 0 1.187650255918271e-10
we O 0 1.0204651706979817e-10
demonstrate O 0 6.392686380252144e-10
in O 0 5.567882821466696e-10
cultured O 0 8.131879170036882e-09
293 O 0 4.514176765724187e-08
cells O 0 4.824937671621399e-10
overexpressing O 0 1.6543316405659425e-07
wild O 0 2.6512230633102263e-08
- O 0 2.8152017605975743e-08
type O 0 1.161135632088417e-08
or O 0 5.770444122532581e-10
mutant O 0 2.007958421756939e-08
HFE O 0 5.078175604467106e-07
proteins O 0 1.413360574409328e-11
that O 0 1.0338882527882731e-12
both O 0 1.0455813298504424e-11
the O 0 3.251963420769499e-10
wild O 0 1.0910960135390724e-08
- O 0 1.501521040836451e-08
type O 0 1.5099155703524048e-08
and O 0 5.795839363997857e-09
H63D O 1 0.99982750415802
HFE O 0 2.2401272872230038e-05
proteins O 0 2.0087723151540615e-10
form O 0 5.598902244607906e-11
stable O 0 2.909503193926355e-10
complexes O 0 2.775037664937141e-11
with O 0 9.687841674710373e-12
the O 0 1.607716071383436e-09
transferrin O 0 3.5717067703444627e-07
receptor O 0 5.8497064969742496e-08
( O 0 3.986138974454434e-09
TfR O 0 1.8506809738028096e-06
) O 0 2.4824253763711113e-09
. O 0 1.994328258092537e-08

The O 0 1.7153948874693015e-06
C282Y O 0 3.807005487033166e-05
mutation O 0 9.015072777174282e-08
nearly O 0 2.5251902791012526e-09
completely O 0 2.7041415773254585e-09
prevents O 0 1.0368758074363882e-09
the O 0 5.06678310419062e-10
association O 0 1.2112061353874992e-10
of O 0 6.802517660275953e-09
the O 0 3.127230741029052e-08
mutant O 0 1.1383187938918127e-06
HFE O 0 6.272849714150652e-05
protein O 0 9.19077169925231e-09
with O 0 3.640373280600073e-10
the O 0 4.861801983224723e-08
TfR O 0 1.912713014462497e-05
. O 0 7.577810379189032e-08

Studies O 0 5.518124979175809e-08
on O 0 1.4064006848002464e-08
cell O 0 3.0440847620383238e-09
- O 0 2.61397588019463e-08
associated O 0 5.4686877248855126e-09
transferrin O 0 3.7463837543327827e-07
at O 0 2.460727799302731e-08
37 O 0 3.1314982607000275e-08
degrees O 0 1.7416121878000013e-08
C O 0 2.3102863622170844e-08
suggest O 0 2.695232093063993e-10
that O 0 1.0363335883889491e-10
the O 0 9.488126728740554e-09
overexpressed O 0 5.45540387975052e-06
wild O 0 1.1518137625898817e-06
- O 0 9.053962344296451e-07
type O 0 2.4158228484338906e-07
HFE O 0 3.66763852071017e-05
protein O 0 2.3379373992327146e-09
decreases O 0 4.866092528921229e-10
the O 0 8.176663512937665e-11
affinity O 0 2.1548185458186708e-10
of O 0 3.77657105588014e-09
the O 0 1.6809599046041512e-08
TfR O 0 8.148384722517221e-07
for O 0 2.9602928997007893e-09
transferrin O 0 2.4834507712512277e-06
. O 0 1.5788845075803692e-07

The O 0 1.669463745201938e-05
overexpressed O 0 0.00042123725870624185
H63D O 1 0.9999420642852783
protein O 0 3.230268319498464e-08
does O 0 2.7637142574477025e-10
not O 0 1.3410710909822487e-11
have O 0 2.1512067301110438e-12
this O 0 6.91920208194946e-13
effect O 0 3.230042899815544e-10
, O 0 4.034661146845586e-11
providing O 0 5.638167016597251e-11
the O 0 7.911817728745163e-11
first O 0 5.984479578557966e-11
direct O 0 6.324283458036817e-11
evidence O 0 5.8128165475457294e-11
for O 0 2.8102830826326475e-11
a O 0 2.1446334985686377e-10
functional O 0 1.016026462963282e-08
consequence O 0 3.903064982324622e-09
of O 0 4.020936916759865e-09
the O 0 2.6110360096254226e-08
H63D O 1 0.9999972581863403
mutation O 0 2.474126858942327e-07
. O 0 6.936079444130883e-08

Addition O 0 5.434879426502448e-07
of O 0 5.42604936981661e-07
soluble O 0 6.430139819713077e-06
wild O 0 2.8415058750397293e-06
- O 0 4.843882379645947e-06
type O 0 4.31975131505169e-05
HFE O 1 1.0
/ O 0 0.005357548128813505
beta2m O 0 0.0006394597585313022
heterodimers O 0 4.625716883310815e-06
to O 0 3.3906280005879808e-09
cultured O 0 2.5511774914832586e-09
cells O 0 1.637115443209325e-10
also O 0 3.8348182268554964e-11
decreased O 0 5.694716920245924e-10
the O 0 1.1088797935432382e-10
apparent O 0 5.906655720089304e-10
affinity O 0 2.2479339223391293e-10
of O 0 5.545385040051087e-09
the O 0 8.501014114870031e-09
TfR O 0 5.9278573161236636e-08
for O 0 3.850033139518594e-11
its O 0 8.147410524017573e-11
ligand O 0 3.9114025907061034e-10
under O 0 7.731817408540564e-10
steady O 0 1.9980435084221426e-09
- O 0 1.2736310894823077e-09
state O 0 3.21816240322903e-10
conditions O 0 1.5775736272871654e-09
, O 0 3.574232229630603e-11
both O 0 2.3536663937284708e-11
in O 0 8.134988516150798e-11
293 O 0 1.6873451524901384e-09
cells O 0 1.3731591384791297e-11
and O 0 1.119881340438944e-10
in O 0 1.0246433701510682e-09
HeLa O 0 2.739935780482483e-06
cells O 0 7.130037893432473e-09
. O 0 1.920152392642649e-08

Furthermore O 0 9.929753019832788e-08
, O 0 2.3832216200503353e-09
at O 0 1.457189813258708e-09
4 O 0 3.314371666007787e-09
degrees O 0 5.905847810794285e-09
C O 0 7.438230475997898e-09
, O 0 9.52180140290082e-11
the O 0 6.488701798090801e-10
added O 0 5.590051088688597e-09
soluble O 0 6.28326830565129e-08
complex O 0 4.049856272558827e-08
of O 0 1.292129354624194e-07
HFE O 1 0.9997023940086365
/ O 0 2.051363480859436e-06
beta2m O 0 3.4154486456827726e-06
inhibited O 0 2.0879026507714116e-08
binding O 0 1.5791279395216407e-08
of O 0 1.7794038242868737e-08
transferrin O 0 2.6262904384566355e-07
to O 0 7.010224845060975e-09
HeLa O 0 9.821547791943885e-06
cell O 0 1.1459886906095562e-07
TfR O 0 1.9797791139808396e-07
in O 0 2.854986802525161e-10
a O 0 9.890994689953914e-10
concentration O 0 4.217630689140606e-08
- O 0 6.19506508314771e-08
dependent O 0 1.921141468130827e-08
manner O 0 2.031561585624786e-08
. O 0 2.252167696781271e-08

Scatchard O 0 2.9904351322329603e-05
plots O 0 3.000295691890642e-07
of O 0 8.332730772053765e-08
these O 0 9.614257168166773e-10
data O 0 4.306705547740819e-10
indicate O 0 2.7059152141184484e-10
that O 0 5.786554915787612e-11
the O 0 4.4662740172896065e-09
added O 0 2.577596092123713e-08
heterodimer O 0 1.0456430032945718e-07
substantially O 0 4.2589696214179185e-09
reduced O 0 2.8266067264581807e-09
the O 0 8.787505723084621e-10
affinity O 0 3.879086385438768e-09
of O 0 4.489969995802312e-08
TfR O 0 1.6075626945166732e-06
for O 0 7.169886462321529e-09
transferrin O 0 3.0587700621254044e-06
. O 0 1.907646378640493e-07

These O 0 3.283134475395855e-08
results O 0 1.9501662507082074e-09
establish O 0 6.559534249106491e-09
a O 0 7.824002556944265e-10
molecular O 0 3.225747446933269e-09
link O 0 2.032944479424259e-09
between O 0 1.5147061382947413e-09
HFE O 0 0.00014895349158905447
and O 0 7.202673124595549e-09
a O 0 1.3314053193269615e-09
key O 0 2.0834550085169212e-08
protein O 0 2.91613677649849e-10
involved O 0 7.981874883267182e-11
in O 0 1.1115797171612485e-10
iron O 0 4.913550810670131e-07
transport O 0 1.1603866756360048e-09
, O 0 1.2653882108804027e-10
the O 0 1.3793185482668946e-09
TfR O 0 5.824833948508967e-08
, O 0 6.811702590869828e-11
and O 0 9.063334804881862e-11
raise O 0 7.304967741816881e-10
the O 0 3.9087177938768036e-10
possibility O 0 6.794448337288372e-10
that O 0 1.557210263514186e-11
alterations O 0 7.535835067074004e-09
in O 0 1.4094765632410855e-10
this O 0 5.6262109554561235e-11
regulatory O 0 5.539433800549887e-09
mechanism O 0 1.4615264554151963e-09
may O 0 1.0467890443344174e-10
play O 0 3.251270586090982e-09
a O 0 3.407358839524477e-10
role O 0 9.610242601709729e-10
in O 0 1.503462493390728e-10
the O 0 2.559155554138215e-09
pathogenesis O 0 3.7710133256041445e-06
of O 0 0.008728984743356705
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 2.2070837530918652e-06
. O 0 1.52423666577306e-07

Genomic O 0 1.398074118696968e-06
organization O 0 8.144995788939013e-09
of O 0 5.450966256148604e-08
the O 0 1.602424504199007e-07
UBE3A O 1 1.0
/ O 0 8.109088958008215e-05
E6 O 1 0.9999784231185913
- O 0 1.2990983577765292e-06
AP O 0 4.626069767255103e-06
gene O 0 6.961324849896755e-09
and O 0 1.9816137619699248e-09
related O 0 6.666711982461493e-08
pseudogenes O 0 1.4340813550006715e-06
. O 0 4.64873011196687e-08

The O 0 6.7884320742450655e-06
UBE3A O 0 0.0013851289404556155
gene O 0 5.671968850151643e-08
encodes O 0 1.0495710078828324e-08
the O 0 1.0660262006467747e-08
E6 O 0 2.291799864906352e-05
- O 0 4.5626430278389307e-07
AP O 0 1.2693872122326866e-06
ubiquitin O 0 4.1379163207011516e-08
- O 0 3.376792534481865e-08
protein O 0 1.6168432148688794e-09
ligase O 0 5.014453297036425e-10
and O 0 1.3428455569730602e-10
has O 0 9.996879019036342e-11
recently O 0 1.9087867397793445e-10
been O 0 3.285604080471849e-11
shown O 0 1.0441304071351354e-11
to O 0 1.3717612983021876e-11
be O 0 6.265762908519434e-11
mutated O 0 2.5167434358763785e-08
in O 0 1.230954804753992e-08
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.967865384562174e-07
who O 0 4.715433599145058e-10
lack O 0 1.2219276257496858e-08
15q11 O 0 2.8000631573377177e-06
- O 0 9.346017577627208e-07
q13 O 0 8.609006727056112e-06
deletions O 0 4.2137955347243405e-07
or O 0 1.4184155183727398e-08
chromosome O 0 2.932701193003595e-07
15 O 0 9.478723939082556e-08
paternal O 0 5.09471556142671e-06
uniparental B-Disease 1 0.9982330799102783
disomy I-Disease 0 0.019772969186306
. O 0 2.3671777853451204e-06

Previous O 0 1.0864362593565602e-05
UBE3A O 0 0.0019565869588404894
cDNA O 0 1.5283457344139606e-07
analysis O 0 1.2691085959914972e-09
has O 0 1.243132957684523e-10
shown O 0 4.623592134156418e-11
a O 0 9.724576699454701e-11
coding O 0 7.668126578153078e-09
region O 0 8.383885585772077e-09
of O 0 2.5672433068280043e-08
approximately O 0 4.334694381213922e-09
2 O 0 3.999804576437782e-08
. O 0 1.9271823248345754e-08

6 O 0 5.597048584604636e-06
kb O 0 1.2482907550293021e-05
and O 0 1.4539700998739136e-08
a O 0 4.0501246800772606e-09
3 O 0 1.859499931811115e-08
- O 0 2.445293034725182e-07
untranslated O 0 0.0002272892015753314
region O 0 1.647725014208845e-07
( O 0 2.509647822890315e-09
UTR O 0 0.00041028199484571815
) O 0 5.642290523688587e-10
of O 0 1.5121663921036088e-08
< O 0 4.097266170788316e-08
50 O 0 4.599022496165617e-09
bp O 0 2.976201507465248e-09
, O 0 6.083166748105384e-10
whereas O 0 5.920710033358034e-10
Northern O 0 1.1499327712272134e-08
analysis O 0 2.3851576269606767e-10
has O 0 1.0876458067521355e-10
indicated O 0 4.471904097025359e-11
mRNA O 0 2.3192467391019989e-10
sizes O 0 2.1995828769494352e-10
of O 0 6.63270161016527e-10
5 O 0 1.1078323147728497e-08
- O 0 1.7754247494394804e-07
8 O 0 2.1559395690928795e-07
kb O 0 1.6598056390648708e-05
. O 0 1.8716627891990356e-07

We O 0 9.51313694486089e-08
have O 0 3.4659652925483897e-10
analyzed O 0 1.5829899613351017e-09
additional O 0 1.5758564453349777e-09
cDNA O 0 2.256957065682741e-09
clones O 0 2.4880140170324694e-09
and O 0 6.08860808992695e-11
provide O 0 1.1846202838117215e-11
evidence O 0 2.099151928669496e-11
for O 0 2.990652170353769e-11
an O 0 4.980108686547524e-11
additional O 0 2.636225238106249e-09
0 O 0 2.947735389113859e-08
. O 0 5.4100318891414645e-08

5 O 0 1.0657616940079606e-06
kb O 0 5.1365445870033e-06
of O 0 3.201626554982795e-07
5 O 0 1.690177953150851e-07
- O 0 8.816555805424287e-07
UTR O 0 0.00011944039579248056
and O 0 3.788945157623402e-09
> O 0 1.1395637322664243e-08
2 O 0 1.532170124107779e-08
kb O 0 5.584826112681185e-07
of O 0 4.188162705531795e-08
3 O 0 5.016438535676571e-07
- O 0 6.038785613782238e-06
UTR O 0 0.00537237711250782
. O 0 1.2813245575671317e-07

We O 0 4.291720401283783e-08
have O 0 1.8633503073850477e-10
established O 0 1.365575652556572e-09
the O 0 7.250995914809266e-10
genomic O 0 3.746846388708036e-09
organization O 0 1.2260563397870072e-10
of O 0 2.9488531616550517e-09
UBE3A O 0 0.0003834612143691629
and O 0 3.2959386331299356e-09
the O 0 7.990717421080262e-09
sequence O 0 2.7739555097383573e-09
of O 0 1.9917738569574794e-08
intron O 0 6.9753482421219815e-06
- O 0 4.765509584103711e-05
exon O 0 1.2193687325634528e-05
borders O 0 9.277248409489403e-07
. O 0 2.608570071060967e-07

We O 0 1.2174440655599028e-07
have O 0 1.5866535862940623e-09
also O 0 1.834284169e-09
mapped O 0 5.951239856472057e-08
two O 0 1.6399069879824424e-09
highly O 0 9.960592350921615e-09
homologous O 0 1.182830944301827e-09
processed O 0 8.509775106801953e-09
pseudogenes O 0 2.175908875301502e-08
, O 0 6.030557164748984e-10
UBE3AP1 O 0 0.08796326816082001
and O 0 1.0738053113357182e-08
UBE3AP2 O 1 0.9999557733535767
, O 0 5.352324139451525e-10
to O 0 7.58996476779572e-11
chromosomes O 0 3.940121666434759e-12
2 O 0 7.950635289022401e-11
and O 0 2.2208283823044184e-11
21 O 0 8.783785920840614e-10
, O 0 2.682685670829521e-11
respectively O 0 1.4876254395002064e-10
, O 0 6.348115783039177e-11
and O 0 2.3804674897931477e-10
determined O 0 1.6333204788665512e-09
their O 0 3.5352418215062187e-10
genomic O 0 2.344494021144783e-08
organization O 0 8.758792024998741e-10
. O 0 2.0962941604807384e-08

These O 0 1.790536785506447e-08
results O 0 6.822056253241726e-10
will O 0 4.841251705078875e-11
form O 0 7.994363851460129e-12
the O 0 2.3965111145551887e-11
basis O 0 1.2581987535176253e-11
for O 0 2.1302890007568465e-12
studies O 0 7.095463105954991e-11
of O 0 5.818387438516481e-10
mutation O 0 8.366628501121909e-10
and O 0 1.0128836658296336e-09
imprinting O 0 6.920379860275716e-07
of O 0 1.0283304163749563e-06
UBE3A O 1 0.9999978542327881
. O 0 1.1138090485474095e-06

Mutation O 0 5.476181740959873e-06
spectrum O 0 1.0066527238450362e-06
and O 0 1.5974677580743446e-08
genotype O 0 1.1594607229881149e-07
- O 0 1.4966467176691367e-07
phenotype O 0 1.5851057355575904e-08
analyses O 0 6.975453104018925e-09
in O 0 6.586887146831089e-10
Cowden B-Disease 1 0.9998682737350464
disease I-Disease 0 6.820813723606989e-06
and O 0 6.300114208102059e-09
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.95134902575478e-09
two O 0 1.039993779983206e-08
hamartoma B-Disease 1 0.9998559951782227
syndromes I-Disease 0 6.542020855704322e-05
with O 0 5.8014940407247195e-08
germline O 0 0.00045176129788160324
PTEN O 1 1.0
mutation O 0 3.56045688931772e-06
. O 0 1.2548686356694816e-07

The O 0 4.3069998355349526e-05
tumour B-Disease 1 1.0
suppressor O 1 0.9999111890792847
gene O 0 9.84824146144092e-06
PTEN O 0 0.0009685404947958887
, O 0 3.309369001058826e-09
which O 0 1.5577844569847343e-10
maps O 0 8.525728567576607e-09
to O 0 9.15780429266988e-09
10q23 O 0 2.8182937967358157e-05
. O 0 2.487313963683846e-07

3 O 0 5.346228704183886e-07
and O 0 1.0211787859759625e-08
encodes O 0 1.2869427301609448e-08
a O 0 2.292918743762584e-09
403 O 0 4.846578249839695e-09
amino O 0 4.968007782935047e-09
acid O 0 2.8657920481123256e-08
dual O 0 8.15317449109898e-08
specificity O 0 3.8422118109338044e-07
phosphatase O 0 0.0005959472618997097
( O 0 4.423707977707636e-08
protein O 0 3.737383735824551e-07
tyrosine O 0 4.350583537870989e-07
phosphatase O 0 8.050733981690428e-07
; O 0 2.677636445902465e-10
PTPase O 0 3.6551207927004725e-07
) O 0 7.528615925123106e-11
, O 0 5.2839146252869895e-11
was O 0 1.2585168462919682e-09
shown O 0 7.581341110451945e-11
recently O 0 2.196568621437578e-10
to O 0 1.6874278363498973e-10
play O 0 6.077475411814248e-09
a O 0 1.0303581321480237e-09
broad O 0 1.7911856886598798e-08
role O 0 7.843161675680221e-09
in O 0 3.289193806210733e-09
human O 0 5.4232668134091e-08
malignancy B-Disease 0 3.680525333038531e-05
. O 0 1.0510618864145727e-07

Somatic O 0 0.0004155016504228115
PTEN O 0 0.0002843183756340295
deletions O 0 3.473073206805566e-07
and O 0 1.3032360079989758e-08
mutations O 0 2.6682773768271772e-09
were O 0 1.4463621966775975e-10
observed O 0 2.2708165903218003e-10
in O 0 6.733988366924848e-11
sporadic B-Disease 0 2.362126224397798e-06
breast I-Disease 1 1.0
, I-Disease 0 9.783808962993135e-08
brain I-Disease 1 1.0
, I-Disease 0 1.8441919991118993e-08
prostate I-Disease 1 1.0
and I-Disease 0 0.002206594916060567
kidney I-Disease 1 1.0
cancer I-Disease 0 0.0005902652628719807
cell O 0 2.5731639041737253e-09
lines O 0 4.002761455623727e-10
and O 0 3.836354844910517e-11
in O 0 1.5528503830020135e-11
several O 0 2.263387671730399e-10
primary O 0 1.9845654719574668e-07
tumours B-Disease 1 1.0
such O 0 1.6192295504424692e-08
as O 0 1.4456458075073897e-07
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.01560287643224001
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999996423721313
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 7.49360106055974e-06

In O 0 1.3452002178837574e-08
addition O 0 2.2143433753285535e-08
, O 0 9.95749704912896e-09
PTEN O 0 0.00042710817069746554
was O 0 2.3100044543866716e-08
identified O 0 3.876162446569964e-10
as O 0 1.4364265332744708e-10
the O 0 6.095222659929789e-10
susceptibility O 0 4.20562926706225e-08
gene O 0 1.3772942786260955e-09
for O 0 2.1700885532993652e-09
two O 0 2.0699565084214555e-07
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.7397353557768724e-09
CD B-Disease 1 0.9999994039535522
; O 0 1.0460895261132919e-08
MIM O 0 0.10519473999738693
158350 O 0 6.621482953050872e-07
) O 0 2.4875526638545864e-10
and O 0 7.732275375538222e-10
Bannayan B-Disease 0 7.439344335580245e-05
- I-Disease 0 1.3227642739366274e-05
Zonana I-Disease 0 0.018692228943109512
( I-Disease 0 2.6866532110148e-08
BZS I-Disease 0 0.0069371494464576244
) I-Disease 0 1.0954306350896559e-09
or I-Disease 0 3.470205234279433e-10
Ruvalcaba I-Disease 0 1.9953363334934693e-06
- I-Disease 0 1.0712690823311277e-07
Riley I-Disease 0 3.2129944429470925e-06
- I-Disease 1 0.9976141452789307
Smith I-Disease 1 0.9998772144317627
syndrome I-Disease 1 1.0
( O 0 3.012170068927844e-08
MIM O 1 0.9999992847442627
153480 O 0 4.022858774987981e-05
) O 0 1.568902341375633e-08
. O 0 7.778151456250271e-08

Constitutive O 0 1.210886011904222e-06
DNA O 0 2.9328905526426752e-08
from O 0 7.493219933429884e-10
37 O 0 5.275964110040832e-09
CD B-Disease 0 1.366433139082801e-06
families O 0 5.573479525122771e-11
and O 0 3.418770821994599e-10
seven O 0 2.356184136687034e-09
BZS B-Disease 0 5.580950892181136e-05
families O 0 1.0229361108171631e-10
was O 0 1.6138976821622464e-09
screened O 0 1.5235055172979628e-07
for O 0 6.884597070211385e-08
germline O 0 0.00010910708806477487
PTEN O 1 0.9999697208404541
mutations O 0 1.9361057184141828e-06
. O 0 2.3304595231365965e-07

PTEN O 0 0.0004872134595643729
mutations O 0 2.1930752325260983e-08
were O 0 1.0658304239186123e-09
identified O 0 8.441546073267858e-11
in O 0 4.9628315346161855e-11
30 O 0 3.3989551173618793e-09
of O 0 6.24605700494385e-09
37 O 0 2.6862124968829448e-08
( O 0 6.924886358783411e-11
81 O 0 7.416045999519838e-09
% O 0 1.764086099420581e-11
) O 0 9.170777852396395e-12
CD B-Disease 0 6.75551859785628e-07
families O 0 3.3160123952269416e-11
, O 0 5.932395547025848e-11
including O 0 3.988829544443462e-10
missense O 0 1.0734616751051362e-07
and O 0 5.787245349608838e-09
nonsense O 0 2.0021077773435536e-07
point O 0 1.2533867277397803e-07
mutations O 0 4.994229918509063e-09
, O 0 4.750089210858732e-10
deletions O 0 3.833332229419284e-08
, O 0 3.4271947502162448e-09
insertions O 0 2.1571035802026017e-07
, O 0 4.29083435449229e-09
a O 0 1.0879559475540646e-08
deletion O 0 7.249674354170565e-07
/ O 0 4.298216822462564e-07
insertion O 0 8.636982329335297e-08
and O 0 8.94218388225454e-09
splice O 0 2.0380427940835943e-06
site O 0 3.215699848624354e-07
mutations O 0 1.711412949134683e-07
. O 0 5.46351905938991e-08

These O 0 3.082026012179995e-08
mutations O 0 9.697650460438467e-10
were O 0 1.0374252151779118e-10
scattered O 0 6.840845667710482e-10
over O 0 4.864394442805065e-10
the O 0 1.1931112764429486e-09
entire O 0 5.445736306342042e-09
length O 0 1.9864272449154896e-09
of O 0 1.1358746832001998e-08
PTEN O 0 7.082964202709263e-06
, O 0 6.678181618813284e-11
with O 0 4.4520129770242445e-12
the O 0 1.3925349762189398e-10
exception O 0 1.7430626386705228e-10
of O 0 1.5220411042626836e-10
the O 0 1.1251954923352514e-10
first O 0 2.2360714668767656e-10
, O 0 2.405882992828623e-10
fourth O 0 5.932095703542473e-09
and O 0 1.952421557760431e-09
last O 0 3.662189129727267e-08
exons O 0 2.2061917661631014e-06
. O 0 4.0084120200845064e-07

A O 0 2.3475837224395946e-05
hot O 0 1.1151717444590759e-05
spot O 0 5.125683060214214e-07
for O 0 8.84829365332962e-09
PTEN O 0 9.386084275320172e-05
mutation O 0 5.980161699170594e-09
in O 0 2.992182890348971e-10
CD B-Disease 1 0.8657553195953369
was O 0 2.787939124004879e-08
identified O 0 5.449359297138301e-10
in O 0 1.6723716855793214e-10
exon O 0 2.397977993950917e-08
5 O 0 4.149833365829636e-09
that O 0 5.422823995404613e-11
contains O 0 1.7847530120462807e-09
the O 0 1.1607409478031627e-09
PTPase O 0 8.651471716802916e-07
core O 0 9.57839105808489e-08
motif O 0 3.0836708742043584e-09
, O 0 3.018123598264033e-11
with O 0 1.6726642640407796e-11
13 O 0 1.127989479599023e-09
of O 0 1.7968171395210675e-09
30 O 0 6.5630132439764566e-09
( O 0 7.102640003919802e-11
43 O 0 2.9874285267794676e-09
% O 0 7.379451216760202e-11
) O 0 2.652429109684107e-10
CD B-Disease 0 3.79324919776991e-05
mutations O 0 7.650581501650322e-09
identified O 0 2.6505225791950693e-10
in O 0 1.247931757930587e-10
this O 0 7.398608392605865e-10
exon O 0 1.400002133777889e-06
. O 0 2.9136165835552674e-07

Seven O 0 5.312348960728741e-08
of O 0 1.337014765567801e-08
30 O 0 5.800396163380128e-09
( O 0 3.3453750186707154e-11
23 O 0 7.599210705144799e-10
% O 0 1.49600158649843e-11
) O 0 7.153783641855593e-12
were O 0 3.36577918313985e-11
within O 0 3.920400809542812e-11
the O 0 1.4681025839458073e-10
core O 0 8.283334906877826e-09
motif O 0 3.4590175168602855e-10
, O 0 1.104252713574061e-11
the O 0 6.831636645276973e-11
majority O 0 7.399334617241848e-12
( O 0 8.36920636959615e-12
five O 0 3.5225190819776486e-11
of O 0 2.847003743866594e-10
seven O 0 4.844059875441786e-11
) O 0 8.492509646906843e-12
of O 0 3.227727529697688e-10
which O 0 1.2247730607484186e-10
were O 0 1.7179720979143553e-09
missense O 0 1.3564471146310098e-07
mutations O 0 5.112517964533936e-09
, O 0 2.346603467096031e-10
possibly O 0 8.248267069355109e-10
pointing O 0 3.867273612456756e-09
to O 0 8.100460580084956e-11
the O 0 7.949638169968409e-10
functional O 0 1.0184867171858514e-08
significance O 0 1.302006147341217e-08
of O 0 4.8234678473590975e-09
this O 0 5.70920255515972e-10
region O 0 8.772509119125971e-08
. O 0 1.2798335546904127e-07

Germline O 0 0.0003811614296864718
PTEN O 0 0.0007019084878265858
mutations O 0 1.4995919173088623e-08
were O 0 3.8800754276202554e-10
identified O 0 5.307307718305232e-11
in O 0 2.7515470804595488e-11
four O 0 1.6706054595250208e-10
of O 0 6.028881394115615e-09
seven O 0 1.6746165565351134e-09
( O 0 9.026519115495901e-11
57 O 0 1.0584204623853566e-08
% O 0 4.499756123266252e-10
) O 0 1.3076474347784028e-09
BZS B-Disease 0 0.0006719527300447226
families O 0 8.027238873609122e-10
studied O 0 1.029732317192611e-07
. O 0 1.0875352529637894e-07

Interestingly O 0 1.5021518606772588e-07
, O 0 2.1294959129392055e-09
none O 0 1.261174498168316e-09
of O 0 1.1771145169703345e-09
these O 0 3.1200900196814985e-10
mutations O 0 1.26980348458261e-09
was O 0 1.7990804401790683e-09
observed O 0 2.587781766649755e-09
in O 0 6.927241558152275e-10
the O 0 3.33965495258326e-08
PTPase O 0 0.00025965043460018933
core O 0 6.894159741932526e-05
motif O 0 2.312073320354102e-06
. O 0 1.7584994793651276e-07

It O 0 7.226919507274943e-09
is O 0 2.516899189064503e-10
also O 0 5.885633647118027e-11
worthy O 0 1.035180741126851e-08
of O 0 1.8367979359723563e-09
note O 0 2.5652191482095077e-10
that O 0 2.267828980162534e-11
a O 0 3.4006131244268545e-10
single O 0 6.209918135269277e-10
nonsense O 0 2.7726873241817884e-08
point O 0 1.8793461009636303e-08
mutation O 0 2.866576143123467e-10
, O 0 1.1610857414412479e-10
R233X O 0 2.0675989276242035e-07
, O 0 4.416217391778332e-10
was O 0 2.2419062162271075e-09
observed O 0 9.611250684216088e-10
in O 0 1.40335784659662e-10
the O 0 1.8490374786850339e-09
germline O 0 1.754233425188545e-09
DNA O 0 1.3495708994781808e-09
from O 0 2.9267057527482265e-11
two O 0 1.722590126096435e-11
unrelated O 0 9.087226526816039e-10
CD B-Disease 0 2.3546815555164358e-06
families O 0 2.1501618194252892e-11
and O 0 5.225676003028923e-10
one O 0 7.235636978464299e-09
BZS B-Disease 1 0.7768918871879578
family O 0 1.2071740229657735e-07
. O 0 3.172399942741322e-07

Genotype O 0 1.032792511068692e-06
- O 0 2.6296388000446314e-07
phenotype O 0 3.0753888324852596e-09
studies O 0 1.0688550738935376e-10
were O 0 1.2567836528420973e-11
not O 0 2.234555639482605e-12
performed O 0 7.878597774180207e-11
on O 0 1.4836357142833378e-10
this O 0 1.1813778254265994e-11
small O 0 7.645938882028247e-10
group O 0 2.1437542019331346e-10
of O 0 2.356999040387109e-08
BZS B-Disease 1 0.5945296287536621
families O 0 3.4492817491127425e-09
. O 0 3.559915739970165e-08

However O 0 1.015745851873362e-07
, O 0 1.1969502722308789e-08
genotype O 0 5.046033635380809e-08
- O 0 7.937282475722895e-08
phenotype O 0 6.199128321782155e-09
analysis O 0 1.2755584088974814e-10
inthe O 0 9.562068470359009e-09
group O 0 3.217215382989025e-11
of O 0 5.933054048057329e-10
CD B-Disease 0 0.049771055579185486
families O 0 5.338883155014962e-11
revealed O 0 1.236780539093374e-10
two O 0 1.8238721297136884e-11
possible O 0 1.2765270784864668e-10
associations O 0 5.2023524377275976e-11
worthy O 0 2.98123126185601e-08
of O 0 1.2546778727084984e-08
follow O 0 1.2326692999664601e-09
- O 0 1.5590256197128838e-08
up O 0 7.661912881928856e-09
in O 0 3.7408243169778643e-10
independent O 0 4.334801850802705e-09
analyses O 0 5.818548842739801e-08
. O 0 4.091986838261619e-08

The O 0 1.0067480360476111e-07
first O 0 7.256976797265224e-09
was O 0 1.913914360329727e-08
an O 0 2.938935206309168e-10
association O 0 3.4233516021942023e-10
noted O 0 9.115209698151716e-10
in O 0 8.653375932476948e-11
the O 0 1.0230186697768318e-09
group O 0 4.0773495690871187e-11
of O 0 9.729442806971633e-10
CD B-Disease 1 0.9999997615814209
families O 0 4.6398673791969713e-10
with O 0 5.640754086044808e-09
breast B-Disease 1 1.0
disease I-Disease 1 0.9998993873596191
. O 0 3.0082551916166267e-07

A O 0 4.608534709404921e-07
correlation O 0 6.8721042190134085e-09
was O 0 3.380296487165424e-09
observed O 0 3.0130523076543625e-10
between O 0 5.557599172534289e-11
the O 0 5.557940774281178e-10
presence O 0 1.2196474941106317e-09
/ O 0 1.2065110865933093e-07
absence O 0 8.097166670495426e-08
of O 0 8.2789938460337e-08
a O 0 1.8222127806666322e-08
PTEN O 0 3.86435967811849e-05
mutation O 0 8.346832114369818e-10
and O 0 3.394474631934763e-11
the O 0 1.4552281601964978e-10
type O 0 6.1571427956153e-09
of O 0 7.338490348729465e-08
breast O 1 0.9999966621398926
involvement O 0 1.8684846736505278e-07
( O 0 2.8510482863453035e-09
unaffected O 0 8.631676564618829e-07
versus O 0 4.241123860992957e-06
benign O 0 0.00766174029558897
versus O 0 4.4245909521123394e-05
malignant O 1 0.9990179538726807
) O 0 7.934858103908482e-09
. O 0 2.6101247385668103e-08

Specifically O 0 1.569210539287269e-08
and O 0 5.25601395739983e-10
more O 0 1.3380306411459042e-11
directly O 0 6.659547219234341e-11
, O 0 6.152053172447935e-11
an O 0 6.346323466743797e-11
association O 0 1.3148294952802786e-10
was O 0 2.78709744172545e-09
also O 0 2.8954691422278245e-10
observed O 0 1.7748498504222e-10
between O 0 3.142580987103294e-11
the O 0 3.566579809266557e-10
presence O 0 1.2766347978754311e-09
of O 0 1.8618884212173725e-08
a O 0 5.401340175126279e-08
PTEN O 1 1.0
mutation O 0 1.978710088224034e-06
and O 0 8.742623549551354e-07
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999996423721313
. O 0 1.2240904823102028e-07

Secondly O 0 2.935157965566759e-07
, O 0 3.524525338249873e-09
there O 0 3.0134661432867915e-10
appeared O 0 7.210559371806369e-10
to O 0 1.6967389993016724e-10
be O 0 2.3159754669599408e-10
an O 0 3.9104849913762507e-10
interdependent O 0 5.563801863672779e-08
association O 0 1.7407776331523905e-09
between O 0 5.723685525538258e-09
mutations O 0 1.1628909390992703e-08
upstream O 0 5.419220627800314e-09
and O 0 2.4619692395866366e-10
within O 0 9.505003450982485e-10
the O 0 2.911497265500884e-09
PTPase O 0 8.725286897970363e-05
core O 0 1.0071473298012279e-05
motif O 0 5.193031427097594e-08
, O 0 2.57580429208204e-10
the O 0 4.688833765698064e-10
core O 0 4.949907150830768e-08
motif O 0 1.6181080919608348e-09
containing O 0 1.7989766620818415e-10
the O 0 1.0536597983001883e-10
majority O 0 6.058881868442612e-11
of O 0 1.908278202122915e-09
missense O 0 1.776704294798037e-08
mutations O 0 2.9288849123787486e-10
, O 0 1.4322947342049197e-11
and O 0 2.559006652413931e-11
the O 0 1.4140030812903603e-10
involvement O 0 1.4614924548350672e-10
of O 0 5.628201904528396e-09
all O 0 9.219315311170817e-10
major O 0 1.5048962609398586e-07
organ O 1 0.9999977350234985
systems O 1 0.9999974966049194
( O 0 9.807322731703039e-10
central O 0 0.049756333231925964
nervous O 0 2.364181682423805e-06
system O 0 7.681614079046994e-06
, O 0 9.03701913301802e-09
thyroid O 1 1.0
, O 0 1.5575490408537007e-07
breast O 1 1.0
, O 0 2.4778760376875653e-08
skin O 1 0.9999892711639404
and O 0 6.25599057002546e-07
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 1.1316016568230225e-08
. O 0 4.4570178658887016e-08

However O 0 1.584298736645451e-08
, O 0 1.0706512343361396e-09
these O 0 9.952341034624723e-11
observations O 0 6.646277972421899e-10
would O 0 3.9249423156029195e-11
need O 0 5.907103278746106e-11
to O 0 4.599702216334656e-11
be O 0 3.0013151686159034e-11
confirmed O 0 3.721273983403606e-11
by O 0 1.513780420459021e-11
studying O 0 6.617020820165465e-10
a O 0 5.973019301386273e-11
larger O 0 4.50119830297524e-10
number O 0 1.9728746414315879e-10
of O 0 1.5106955686405854e-09
CD B-Disease 0 8.126210741465911e-05
families O 0 2.079705962998446e-09
. O 0 2.1321875820490277e-08

Molecular O 0 0.008889812976121902
defects O 1 0.9999033212661743
leading O 0 2.1677738004655112e-07
to O 0 1.380676795115221e-09
human O 0 2.29941798934874e-09
complement B-Disease 0 2.322694626855082e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.387537083123561e-10
an O 0 7.536877372205097e-11
African O 0 8.692747216487717e-11
- O 0 5.404718006474241e-09
American O 0 2.8707032306840574e-09
family O 0 2.148556887959785e-09
. O 0 1.48789363052515e-08

Complement B-Disease 0 8.433440962107852e-05
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 5.202119623959334e-09
C6D B-Disease 1 1.0
) O 0 1.3110713625863468e-09
was O 0 1.858727038950292e-08
diagnosed O 0 1.2440219165910094e-07
in O 0 4.668736508506299e-10
a O 0 9.98775395721907e-10
16 O 0 1.4195542519246374e-09
- O 0 1.1973400049214433e-09
year O 0 4.675738268788976e-11
- O 0 4.665178021667771e-09
old O 0 7.87536080792961e-09
African O 0 9.696017599925e-11
- O 0 7.914418009846713e-10
American O 0 1.6207760134001603e-10
male O 0 1.9003082440960384e-10
with O 0 8.698734788037399e-11
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.0588751564455379e-07

The O 0 2.9392074551992664e-08
patients O 0 1.2825753792355954e-09
father O 0 5.914919110061589e-10
and O 0 1.1305288927232482e-09
two O 0 8.693846198504218e-10
brothers O 0 1.9774500259472916e-08
also O 0 1.2245331415527971e-09
had O 0 6.3361462743216634e-09
C6D B-Disease 1 1.0
, O 0 6.455224133006254e-10
but O 0 8.870690987317076e-11
gave O 0 2.157715117689918e-09
no O 0 1.1427714330380923e-09
history O 0 1.113216185899546e-09
of O 0 6.875709779308181e-09
meningitis B-Disease 1 1.0
or O 0 1.777205049791064e-09
other O 0 2.4818289645622826e-09
neisserial B-Disease 0 0.00012031808000756428
infection I-Disease 0 4.035902293253457e-06
. O 0 5.123229485093361e-08

By O 0 1.1252803133743328e-08
using O 0 1.1619021300646182e-08
exon O 0 1.8143754232369247e-07
- O 0 1.3078604865768284e-07
specific O 0 9.469576234266697e-09
polymerase O 0 4.2601717709089826e-09
chain O 0 2.7019400050676268e-09
reaction O 0 7.382168487612972e-11
( O 0 1.8188834119414743e-11
PCR O 0 4.427098687642683e-09
) O 0 7.794328377164206e-11
/ O 0 1.397319482343562e-09
single O 0 7.224074116685131e-11
- O 0 9.676844880956992e-10
strand O 0 1.7296959697876702e-10
conformation O 0 4.176445994596989e-11
polymorphism O 0 3.541232931891791e-11
as O 0 1.5640148898210526e-11
a O 0 9.679272140739048e-12
screening O 0 2.9698038472858457e-10
step O 0 3.6385405799421733e-10
and O 0 6.213990433323602e-11
nucleotide O 0 1.0817638451676714e-10
sequencing O 0 9.065858480594713e-11
of O 0 7.101207399884402e-10
target O 0 3.4728819819918044e-09
exons O 0 7.3373960240985525e-09
, O 0 2.808146770671982e-10
we O 0 5.554599835644325e-11
determined O 0 2.435924240096199e-10
that O 0 1.5598263999883066e-11
the O 0 1.5683450094172713e-09
proband O 0 2.0777897589141503e-06
was O 0 3.06317851084259e-08
a O 0 2.6814299669553066e-09
compound O 0 6.452248513255654e-09
heterozygote O 0 3.399838277573508e-08
for O 0 7.669746504568309e-10
two O 0 9.503049902548355e-09
C6 O 1 0.9635825753211975
gene O 0 5.802666578347271e-07
mutations O 0 3.4182468766630336e-07
. O 0 1.1610231354097778e-07

The O 0 2.153987139763558e-07
first O 0 1.509618918760225e-08
, O 0 1.9608932255721356e-09
1195delC O 0 2.2786683473441371e-07
located O 0 7.076818686613251e-09
in O 0 7.932855483616663e-10
exon O 0 6.128966134610891e-08
7 O 0 1.6588904472314425e-08
, O 0 3.6909503231541407e-10
is O 0 9.022766561672668e-11
a O 0 1.0520913307221491e-10
novel O 0 9.333612771555977e-10
mutation O 0 2.171258312033686e-11
, O 0 5.48196340752205e-12
while O 0 2.099752489936879e-11
the O 0 3.418490768236637e-10
second O 0 1.2870893240091164e-09
, O 0 3.781449320339192e-10
1936delG O 0 7.01933942082178e-08
in O 0 9.268789069594163e-10
exon O 0 5.975990546858156e-08
12 O 0 1.6226087140580603e-08
, O 0 2.537215160192119e-10
has O 0 6.015573456030765e-11
been O 0 3.248242300135651e-11
described O 0 6.764355048316517e-11
before O 0 6.217950460074562e-11
to O 0 2.656768416375854e-10
cause O 0 1.4200072229186844e-08
C6D B-Disease 1 1.0
in O 0 1.582639796993135e-09
an O 0 5.749131726240364e-10
unrelated O 0 1.6200173647007432e-08
African O 0 1.1212198947063712e-09
- O 0 2.3600085441444207e-08
American O 0 3.6643670320302135e-09
individual O 0 1.3853775904237864e-09
. O 0 4.1776848647145925e-09

Both O 0 2.3486479960865836e-07
mutations O 0 5.28899448681841e-08
result O 0 5.397846170041021e-09
in O 0 2.2866470938964767e-09
premature O 0 8.673317353213861e-08
termination O 0 8.075311797028917e-08
codons O 0 1.7856366696378245e-07
and O 0 2.600454784840167e-08
C6 O 0 0.0023305434733629227
null O 0 4.76629384138505e-06
alleles O 0 3.077490973169006e-08
. O 0 4.775830575454165e-08

Allele O 0 1.359783539101045e-07
- O 0 3.147984983797869e-08
specific O 0 2.1456820764598206e-09
PCR O 0 4.719017621113153e-09
indicated O 0 2.759600326029954e-10
that O 0 1.7737254373595412e-11
the O 0 1.2560660289651082e-09
probands O 0 4.321350388636347e-06
two O 0 2.2407604660656943e-09
brothers O 0 4.522683028085339e-08
also O 0 3.6249243606789605e-09
inherited O 0 1.9043903876081458e-06
the O 0 6.366361304799284e-08
1195delC O 0 4.073162642725947e-07
mutation O 0 7.573310312203319e-10
from O 0 4.0893902847338737e-11
their O 0 2.810981447609606e-10
heterozygous O 0 1.4657755009750417e-09
mother O 0 3.6505251599372457e-10
and O 0 1.8684323532802694e-10
the O 0 2.143628607953474e-09
1936delG O 0 1.0947340456368693e-07
mutation O 0 8.980414745174414e-10
from O 0 8.110695448593219e-11
their O 0 6.569874089201733e-10
homozygous O 0 2.8170171972874414e-08
father O 0 1.8558079517561055e-08
. O 0 5.787355927822091e-09
. O 0 5.834863614495589e-08

PAX6 O 1 0.9972259402275085
mutations O 0 7.666676538065076e-06
reviewed O 0 3.3653716400294797e-06
. O 0 1.3038048791713663e-06

Mutations O 0 4.4875986304759863e-07
in O 0 5.589155360752329e-09
PAX6 O 0 0.0002807300188578665
are O 0 2.978255975172317e-10
responsible O 0 8.085445646344169e-10
for O 0 1.2551935879567822e-10
human O 0 8.372902926545578e-10
aniridia B-Disease 1 1.0
and O 0 1.7900040560903108e-08
have O 0 1.3780872276658584e-10
also O 0 8.10757086466829e-11
been O 0 3.825058672579651e-11
found O 0 1.3318154738761745e-11
in O 0 8.480110710862299e-12
patients O 0 3.097036169186218e-11
with O 0 1.132403198988996e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.031451901667424e-08
with O 0 1.5759702364448458e-05
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 7.515584456996294e-07
with O 0 1.6729292440231802e-07
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.999996542930603
keratitis I-Disease 1 0.9709459543228149
, O 0 3.493269007392996e-10
and O 0 6.43479325379559e-10
with O 0 1.2317579844989268e-08
isolated B-Disease 1 0.999202311038971
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 5.421460809884593e-05

No O 0 5.03466083046078e-07
locus O 0 1.733046985918918e-07
other O 0 1.6026520111012132e-09
than O 0 2.9249883071180705e-10
chromosome O 0 1.0270152728253379e-08
11p13 O 0 2.206680989047527e-07
has O 0 1.0234928460306492e-09
been O 0 3.422189476243176e-10
implicated O 0 3.46047079879952e-09
in O 0 6.406406516390462e-10
aniridia B-Disease 1 1.0
, O 0 2.416881139666316e-09
and O 0 5.375274447771972e-09
PAX6 O 1 0.9995915293693542
is O 0 1.4748730015057276e-09
clearly O 0 8.751778191040671e-10
the O 0 7.636494214757761e-10
major O 0 1.041951502855909e-08
, O 0 3.5011266108497807e-10
if O 0 1.0144917544918641e-10
not O 0 5.150773557671684e-11
only O 0 1.3986120594999818e-10
, O 0 7.703496729405401e-10
gene O 0 1.4324935904141967e-08
responsible O 0 9.397214029149836e-08
. O 0 2.5555482352501713e-07

Twenty O 0 9.134002425525978e-07
- O 0 9.892436736436139e-08
eight O 0 3.556792416148369e-09
percent O 0 2.042642055499755e-09
of O 0 2.488284689405873e-09
identified O 0 8.22364043528978e-09
PAX6 O 1 0.8531981110572815
mutations O 0 7.935039292306101e-09
are O 0 5.735602270906526e-11
C O 0 6.280165365524226e-08
- O 0 1.9737738057301613e-06
T O 0 1.9189149043086218e-06
changes O 0 4.64142724254657e-09
at O 0 4.2945678124794995e-09
CpG O 0 2.1916622472417657e-07
dinucleotides O 0 2.5887911192512547e-07
, O 0 2.961692002756422e-10
20 O 0 8.920272853707445e-10
% O 0 2.74195961075252e-11
are O 0 8.044162124604126e-13
splicing O 0 1.8727353001679603e-10
errors O 0 5.558919546899688e-09
, O 0 4.102726491872488e-11
and O 0 5.285507101437936e-11
more O 0 1.048755006449742e-11
than O 0 8.836608528239864e-12
30 O 0 4.4068185212076116e-10
% O 0 5.272799558087016e-11
are O 0 1.5701932809530916e-11
deletion O 0 2.2827698842320387e-08
or O 0 1.5169843159412721e-09
insertion O 0 2.0867121364176455e-08
events O 0 1.3786986663433254e-08
. O 0 5.078456410956278e-08

There O 0 4.7883993659070256e-08
is O 0 6.4884821959765304e-09
a O 0 2.4303377088585876e-09
noticeably O 0 1.0587116605620395e-07
elevated O 0 2.790873736557842e-07
level O 0 7.429751480714231e-09
of O 0 1.1095536933680705e-08
mutation O 0 8.327813993957989e-10
in O 0 1.1580556652512897e-10
the O 0 1.1602848681846467e-09
paired O 0 2.4673671994435153e-09
domain O 0 2.0525765809242813e-10
compared O 0 1.1134486561925616e-11
with O 0 7.967846868406347e-12
the O 0 6.77780331859168e-10
rest O 0 4.0903462839025906e-09
of O 0 7.005813706939534e-09
the O 0 2.6457572133153917e-08
gene O 0 5.2325830779409443e-08
. O 0 1.256616997125093e-07

Increased O 0 3.2152703965948604e-07
mutation O 0 8.680412832973161e-09
in O 0 3.839738527133818e-10
the O 0 4.944101572590398e-09
homeodomain O 0 5.288550823934202e-07
is O 0 7.549253999705741e-10
accounted O 0 5.426769034144741e-10
for O 0 1.4797687380996294e-11
by O 0 9.885859492131388e-11
the O 0 3.416922922383492e-08
hypermutable O 0 4.402763079269789e-05
CpG O 0 3.271992318332195e-05
dinucleotide O 0 8.854864063323475e-06
in O 0 6.140608377336321e-08
codon O 0 1.20792765301303e-06
240 O 0 1.539315093168625e-07
. O 0 5.439790484729201e-08

Very O 0 3.073654752938637e-08
nearly O 0 3.146776839102472e-09
all O 0 4.887766302807961e-10
mutations O 0 1.8248135225107376e-09
appear O 0 3.440120965869653e-10
to O 0 2.330923509763494e-10
cause O 0 5.777804457096636e-09
loss O 0 2.0510993792299814e-08
of O 0 1.889964984513881e-08
function O 0 3.1405572586962194e-10
of O 0 1.9138004514474005e-09
the O 0 1.3314358504601387e-09
mutant O 0 4.818429211184139e-09
allele O 0 1.964256535202935e-11
, O 0 1.5026991803668288e-11
and O 0 3.1408133038812736e-11
more O 0 2.9793095074337472e-12
than O 0 9.278862400652343e-12
80 O 0 4.507005602061298e-10
% O 0 3.210031893075005e-11
of O 0 3.9989003774998366e-10
exonic O 0 8.005302447600116e-07
substitutions O 0 1.9340092194397585e-08
result O 0 1.9310595344990134e-09
in O 0 2.2689041756507322e-09
nonsense O 0 7.665299790460267e-07
codons O 0 1.06564596080716e-06
. O 0 7.097286669477398e-08

In O 0 4.3056751053427433e-08
a O 0 4.373727602313693e-09
gene O 0 4.099568184923186e-10
with O 0 1.1875460337318344e-10
such O 0 3.1034255165707236e-09
extraordinarily O 0 5.259669677570855e-08
high O 0 7.98039465621514e-08
sequence O 0 2.3374724378300016e-10
conservation O 0 5.202774211454653e-09
throughout O 0 1.1780391939719692e-10
evolution O 0 1.5368573080820624e-10
, O 0 1.303338340030713e-11
there O 0 2.522227392220966e-11
are O 0 6.633204402417547e-11
presumed O 0 6.466641622182578e-08
undiscovered O 0 1.3095484973746352e-05
missense O 0 3.343154446611152e-07
mutations O 0 2.7564976967653365e-09
, O 0 1.584717218561238e-10
these O 0 1.2618692202259751e-10
are O 0 9.532936072476073e-12
hypothesized O 0 3.3159638923585533e-10
to O 0 7.16960588120763e-11
exist O 0 1.1392757570671819e-10
in O 0 8.239834509149446e-11
as O 0 9.723376548365081e-10
- O 0 7.080359409883386e-08
yet O 0 3.858814601187532e-09
unidentified O 0 2.1398836480557293e-08
phenotypes O 0 6.636960137029746e-08
. O 0 3.570658657636727e-09
. O 0 5.289044935352649e-08

Genetic O 0 2.970996320073027e-06
heterogeneity O 0 1.1072810366385966e-06
and O 0 2.654434894111546e-09
penetrance O 0 5.5919738173315636e-08
analysis O 0 1.860647746987354e-10
of O 0 3.4239016066806016e-09
the O 0 1.618880673959211e-08
BRCA1 O 0 8.159457820511307e-07
and O 0 8.841701060191554e-08
BRCA2 O 0 1.0110166840604506e-05
genes O 0 2.9365387899105144e-09
in O 0 8.958704889039382e-10
breast B-Disease 1 0.9999866485595703
cancer I-Disease 0 5.085627890366595e-06
families O 0 4.28245938710603e-10
. O 0 7.456270267880427e-09

The O 0 9.700942609924823e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 3.399663546588272e-05
Consortium O 0 2.752969407993078e-07
. O 0 4.2232496610949966e-08

The O 0 1.3586137548315946e-08
contribution O 0 2.6058419422270163e-08
of O 0 8.964079967199723e-08
BRCA1 O 0 5.396067308538477e-07
and O 0 5.6741654930192453e-08
BRCA2 O 0 0.01158581767231226
to O 0 9.419627389206653e-08
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 1.1639522057294016e-07
assessed O 0 4.6014463350729784e-08
by O 0 1.1352323942004361e-10
linkage O 0 4.70001015884236e-09
and O 0 3.310952068069639e-10
mutation O 0 7.297917131721121e-11
analysis O 0 2.2752106188655974e-12
in O 0 4.2251506113255566e-12
237 O 0 1.0285668844423057e-10
families O 0 3.175924150403131e-13
, O 0 1.0465824170843852e-12
each O 0 7.555378848597694e-13
with O 0 1.7153695998362029e-12
at O 0 2.283568750760523e-10
least O 0 3.0336084338999925e-11
four O 0 2.1915455561405395e-11
cases O 0 1.6833678895267212e-10
of O 0 9.38162969532641e-09
breast B-Disease 1 0.9999973773956299
cancer I-Disease 0 5.435672392195556e-07
, O 0 5.987642326399367e-11
collected O 0 1.3484459382429037e-10
by O 0 4.3136914179564556e-11
the O 0 5.820458071070789e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 9.812548569243518e-07
Consortium O 0 3.772966294945945e-08
. O 0 1.2144806937897101e-08

Families O 0 1.0242643400104612e-09
were O 0 6.115178502463792e-11
included O 0 9.867510974981286e-11
without O 0 8.764769465763322e-11
regard O 0 3.608738585736404e-10
to O 0 3.884390725739095e-11
the O 0 4.341568493604342e-10
occurrence O 0 3.5971421397107406e-08
of O 0 0.22487521171569824
ovarian B-Disease 1 1.0
or I-Disease 0 2.046599320237874e-06
other I-Disease 0 4.291163975267409e-07
cancers I-Disease 1 1.0
. O 0 1.2173663321846107e-07

Overall O 0 1.453636559745064e-05
, O 0 6.320397005765699e-08
disease O 0 7.744702998024877e-06
was O 0 5.382263523756592e-08
linked O 0 3.616597510358588e-08
to O 0 4.552991317297028e-09
BRCA1 O 0 1.03281418972756e-08
in O 0 6.976590832818985e-11
an O 0 3.3212408517835357e-11
estimated O 0 1.9127482930869633e-10
52 O 0 3.5542133125510134e-10
% O 0 6.499050429764619e-12
of O 0 7.795071532701314e-11
families O 0 7.434871295008971e-12
, O 0 4.7485553683612736e-11
to O 0 8.455214861591287e-10
BRCA2 O 0 3.234343637359416e-08
in O 0 6.09812686458433e-11
32 O 0 8.998607414767434e-10
% O 0 5.273179462528255e-12
of O 0 4.877324238927727e-11
families O 0 9.912509181531082e-13
, O 0 7.311483883609693e-12
and O 0 6.322523060653396e-11
to O 0 3.042156526689155e-10
neither O 0 1.9589716515611144e-09
gene O 0 1.4480847077003034e-10
in O 0 1.4755588417791898e-10
16 O 0 7.104381083422595e-09
% O 0 1.4319129215678572e-10
( O 0 2.658399368693498e-11
95 O 0 1.4767709721752453e-08
% O 0 7.529495915647999e-10
confidence O 0 2.2718835701596163e-09
interval O 0 2.6001224284755153e-08
[ O 0 4.6245517637544253e-08
CI O 1 0.6287854909896851
] O 0 2.708973489973232e-09
6 O 0 1.3389050979029093e-09
% O 0 2.7081751771684814e-11
- O 0 5.42911882117636e-10
28 O 0 1.4394770930792333e-09
% O 0 3.0254146410335636e-11
) O 0 2.6572638187061237e-11
, O 0 8.28771981598031e-11
suggesting O 0 9.404378387145584e-10
other O 0 1.5494613370137245e-09
predisposition O 0 1.249702677341702e-06
genes O 0 6.757388604228254e-08
. O 0 6.189560508573777e-08

The O 0 8.25428685402585e-08
majority O 0 1.1871933436324866e-09
( O 0 1.0177477610673336e-10
81 O 0 6.048738399044851e-09
% O 0 2.7585883230485386e-11
) O 0 1.1488809036064307e-11
of O 0 1.937819016362141e-09
the O 0 2.6953665610562894e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.49351275475263e-12
were O 0 1.030101026179564e-12
due O 0 4.93005636315047e-11
to O 0 5.5044295510509045e-11
BRCA1 O 0 1.456022968859827e-09
, O 0 1.2285510282705747e-11
with O 0 8.414150452773494e-12
most O 0 1.1300691632465387e-10
others O 0 9.690951513485757e-11
( O 0 1.4862350933286805e-11
14 O 0 6.302658950296802e-10
% O 0 5.132787250783366e-11
) O 0 6.27104687622726e-11
due O 0 1.593891596485264e-08
to O 0 1.0960292939898864e-07
BRCA2 O 0 2.917995152529329e-05
. O 0 2.101206462157279e-07

Conversely O 0 3.235731682593723e-08
, O 0 3.5369820960973186e-10
the O 0 2.0008683598859989e-10
majority O 0 3.148304533739932e-11
of O 0 1.5407373987752493e-10
families O 0 1.6980387365292393e-12
with O 0 1.2935336829444921e-11
male B-Disease 0 1.8329482376344686e-09
and I-Disease 0 7.749327846084952e-10
female I-Disease 0 1.5545776221870256e-08
breast I-Disease 0 0.00023123821301851422
cancer I-Disease 0 1.5265393358276924e-06
were O 0 5.145532333550307e-10
due O 0 7.237517252178804e-08
to O 0 4.094766126172544e-08
BRCA2 O 0 3.744751666090451e-06
( O 0 2.536441057188199e-10
76 O 0 1.2316679942614428e-07
% O 0 8.314545163479181e-10
) O 0 1.1375955732972898e-09
. O 0 2.985368041663605e-08

The O 0 2.4051107061495713e-07
largest O 0 7.502236343270852e-08
proportion O 0 4.429472344469332e-09
( O 0 4.392583866086319e-11
67 O 0 2.3141044636076913e-09
% O 0 2.3860028536271116e-11
) O 0 1.0019264931604432e-11
of O 0 4.759003191523448e-10
families O 0 4.589700147716869e-12
due O 0 1.935564625243913e-10
to O 0 6.761788351461462e-11
other O 0 6.574771282963354e-11
genes O 0 4.6952299687097465e-11
was O 0 1.9594192934846433e-10
found O 0 1.2028599470637058e-11
in O 0 1.0006469611245628e-11
families O 0 1.6932973035885257e-12
with O 0 6.494713187393808e-12
four O 0 9.275823165122432e-11
or O 0 3.9219637953946673e-11
five O 0 2.923458697345893e-11
cases O 0 8.79996353564394e-11
of O 0 1.0995046650918994e-08
female O 0 5.915929435218459e-08
breast B-Disease 1 0.9717105627059937
cancer I-Disease 0 1.0865108379221056e-05
only O 0 1.7918101447023105e-09
. O 0 1.584730924264477e-08

These O 0 1.677110539333171e-08
estimates O 0 2.6219739712729506e-09
were O 0 1.7855590617177342e-10
not O 0 1.666721621829126e-11
substantially O 0 3.870045950371548e-10
affected O 0 1.710304398105933e-10
either O 0 6.66267249704866e-11
by O 0 2.179610658625819e-11
changing O 0 1.5546537390775939e-09
the O 0 1.343307354240153e-09
assumed O 0 1.309949748673489e-08
penetrance O 0 5.2181615473045895e-08
model O 0 6.961626830559453e-10
for O 0 8.210032098610043e-10
BRCA1 O 0 1.2055123121967881e-08
or O 0 5.837392375029893e-11
by O 0 1.4327208690267934e-11
including O 0 1.6646964917654827e-09
or O 0 2.1032828811939908e-08
excluding O 0 1.7186863487950177e-06
BRCA1 O 0 4.744755699448433e-07
mutation O 0 5.635936162207145e-09
data O 0 2.2196280369257693e-09
. O 0 2.2401293264806554e-08

Among O 0 9.617086682567333e-09
those O 0 5.758328258664847e-10
families O 0 3.8742151847737105e-12
with O 0 2.970193188622794e-11
disease O 0 1.7068703073164215e-07
due O 0 7.052997119672e-08
to O 0 8.69729976926692e-09
BRCA1 O 0 2.5078305654346877e-08
that O 0 1.7988385087042147e-11
were O 0 4.6577228185462616e-11
tested O 0 5.3640741154437066e-11
by O 0 3.3265267710552715e-12
one O 0 2.2364115767614656e-11
of O 0 1.463344584395898e-10
the O 0 7.336058843732118e-11
standard O 0 1.2639046753637473e-10
screening O 0 1.4071879772536988e-10
methods O 0 1.3056679348810718e-10
, O 0 8.321839051195212e-11
mutations O 0 2.01105715413874e-10
were O 0 6.568216109892333e-11
detected O 0 3.7590344725835223e-10
in O 0 3.569320186636027e-11
the O 0 1.5724276325457254e-09
coding O 0 9.824964841698147e-09
sequence O 0 8.149839691995453e-10
or O 0 7.697529419425919e-11
splice O 0 2.1387034365716318e-09
sites O 0 1.5771424444199766e-10
in O 0 2.165323476077674e-11
an O 0 3.5785912427810374e-11
estimated O 0 5.271927894234807e-10
63 O 0 1.40585081354061e-08
% O 0 4.5332060327751833e-10
( O 0 2.0168883230198276e-10
95 O 0 8.690754071949414e-08
% O 0 5.299139793635277e-09
CI O 1 0.9963440299034119
51 O 0 4.510140527713702e-08
% O 0 2.2635948671023698e-10
- O 0 1.0268507821820094e-08
77 O 0 1.9657099059600114e-08
% O 0 3.7381001072311903e-10
) O 0 4.895239213986713e-10
. O 0 1.8864067641288784e-08

The O 0 5.7335437730898775e-08
estimated O 0 1.4487069321944546e-09
sensitivity O 0 4.535162911878388e-09
was O 0 3.6016918336656545e-09
identical O 0 1.0015720475209378e-09
for O 0 1.0203327766022952e-10
direct O 0 5.285550330746958e-10
sequencing O 0 1.7707145472112273e-10
and O 0 2.730656256666464e-10
other O 0 9.047759208513639e-10
techniques O 0 2.467392157257109e-08
. O 0 3.25702558257035e-08

The O 0 5.501561304299685e-07
penetrance O 0 1.2516989045252558e-05
of O 0 6.144221060822019e-06
BRCA2 O 0 6.298954303929349e-06
was O 0 4.0729695172103675e-09
estimated O 0 1.5931909957966894e-10
by O 0 2.5007287907108378e-11
maximizing O 0 1.0650003190448842e-07
the O 0 5.749376086328084e-09
LOD O 1 1.0
score O 0 1.3135505128047953e-07
in O 0 3.483755728339588e-09
BRCA2 O 0 3.5868382042281155e-07
- O 0 6.882493241988641e-09
mutation O 0 1.624025219859604e-10
families O 0 1.8676145699392244e-12
, O 0 2.338397704637618e-12
over O 0 4.4275590138642684e-11
all O 0 3.152885175161657e-10
possible O 0 1.2803998972188424e-09
penetrance O 0 9.792963737709215e-07
functions O 0 5.324471530343544e-08
. O 0 8.028195708220665e-08

The O 0 5.094133470606721e-08
estimated O 0 2.8321545109122326e-09
cumulative O 0 5.449032514093233e-08
risk O 0 2.2769951257828325e-08
of O 0 8.791856487277983e-08
breast B-Disease 1 0.999997615814209
cancer I-Disease 0 4.74488706458942e-06
reached O 0 5.076323361663526e-09
28 O 0 1.0687644547147102e-08
% O 0 1.6098201938152812e-10
( O 0 3.806688644858447e-11
95 O 0 2.3958568462489893e-08
% O 0 1.1476030126189585e-09
CI O 0 0.0003073692205362022
9 O 0 2.6449080703372374e-09
% O 0 1.986864665848298e-11
- O 0 4.096105676865136e-10
44 O 0 1.7859917711415818e-10
% O 0 2.4506477576402563e-12
) O 0 4.834363703624944e-13
by O 0 1.9205440189573597e-12
age O 0 3.19592741160335e-10
50 O 0 2.6567584243686326e-10
years O 0 4.580319110103481e-11
and O 0 3.156435113282896e-10
84 O 0 3.221924416152433e-08
% O 0 3.637749823592884e-10
( O 0 1.4639195411447758e-10
95 O 0 1.1586207193658993e-07
% O 0 6.498118043651857e-09
CI O 1 0.8189149498939514
43 O 0 2.466992121696876e-08
% O 0 9.158930558417211e-11
- O 0 1.943274652305149e-09
95 O 0 3.3255802556197978e-09
% O 0 2.1807543618135306e-11
) O 0 2.2268463115149295e-12
by O 0 1.2536281908392954e-11
age O 0 2.5726927255220744e-09
70 O 0 5.1523705302258804e-09
years O 0 3.154631222912485e-09
. O 0 4.417123022903979e-08

The O 0 1.2684046168942587e-06
corresponding O 0 0.3527824580669403
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 5.716059968108311e-05
were O 0 1.6316640261138105e-09
0 O 0 1.490660395120358e-08
. O 0 6.535681329467025e-09

4 O 0 1.376640625494474e-06
% O 0 1.9192588851524306e-08
( O 0 1.4217138577521382e-09
95 O 0 2.2595949644710345e-07
% O 0 8.183177691023502e-09
CI O 0 0.0002121995494235307
0 O 0 3.3798708276577827e-09
% O 0 1.931624825368683e-11
- O 0 1.3084426597753662e-10
1 O 0 1.8247428568152202e-10
% O 0 2.9089287402472852e-12
) O 0 2.7060864942092533e-13
by O 0 7.409908732609882e-13
age O 0 1.8449781979956725e-10
50 O 0 1.5568370204110948e-10
years O 0 3.252817806775887e-11
and O 0 2.2900110974166665e-10
27 O 0 1.0126948168931449e-08
% O 0 2.7540003610937447e-10
( O 0 1.053991408039856e-10
95 O 0 3.8867234763984015e-08
% O 0 2.263138565439249e-09
CI O 0 8.681763574713841e-05
0 O 0 2.279801236682033e-09
% O 0 3.9509982091567863e-11
- O 0 1.27284671691541e-09
47 O 0 9.768379438668262e-10
% O 0 1.190716102106304e-11
) O 0 3.0072101493000547e-12
by O 0 8.873428034017472e-12
age O 0 2.835624623998001e-09
70 O 0 6.4990350878701975e-09
years O 0 3.0939630857318434e-09
. O 0 5.322156582110438e-08

The O 0 2.1693453788884653e-07
lifetime O 0 5.191877789911814e-07
risk O 0 2.179046077799285e-06
of O 0 1.8575647118268535e-06
breast B-Disease 1 1.0
cancer I-Disease 0 9.668195707490668e-05
appears O 0 6.734556801113456e-10
similar O 0 2.0987036761233036e-11
to O 0 2.3814016730794307e-11
the O 0 5.116993495590805e-10
risk O 0 2.6239650452453134e-09
in O 0 1.0181457760216617e-10
BRCA1 O 0 2.418296674022713e-09
carriers O 0 4.705082157219209e-11
, O 0 5.2017548254901236e-12
but O 0 4.157789564029901e-12
there O 0 6.759334845313214e-12
was O 0 1.4348984500589523e-10
some O 0 3.024081679514623e-11
suggestion O 0 2.7410524960913563e-09
of O 0 4.7019645954549105e-09
a O 0 1.5367114247766267e-09
lower O 0 4.49348291908791e-08
risk O 0 3.2011957529221036e-08
in O 0 2.5888875487822816e-09
BRCA2 O 0 2.0698716696188058e-07
carriers O 0 3.6197128627790676e-10
< O 0 2.6613902193162176e-09
50 O 0 5.98842198051841e-10
years O 0 1.412897715491468e-10
of O 0 4.54800952454093e-09
age O 0 3.350002941715502e-08
. O 0 3.130931247596891e-08

Eye B-Disease 1 1.0
movement I-Disease 0 1.3122950122124166e-06
abnormalities I-Disease 0 8.072514901868999e-06
correlate O 0 3.2949348138799905e-08
with O 0 6.934485208276442e-10
genotype O 0 4.3839026631076194e-08
in O 0 6.016543263598351e-09
autosomal O 1 0.9999856948852539
dominant O 1 1.0
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 8.206797019738588e-07

We O 0 5.433060934478817e-08
compared O 0 2.903657403408033e-08
horizontal O 0 3.007268105648109e-07
eye O 0 3.690675657708198e-05
movements O 0 5.682569792497816e-08
( O 0 2.681348254540694e-09
visually O 0 2.1415210937902884e-08
guided O 0 1.8907081766883493e-07
saccades O 0 3.8472131791422726e-07
, O 0 7.560119197336235e-10
antisaccades O 0 2.0745612516748224e-07
, O 0 3.711288498742249e-10
and O 0 6.809549590869324e-10
smooth O 0 6.6127721076725265e-09
pursuit O 0 4.456581770284629e-09
) O 0 4.9464449897174134e-11
in O 0 8.801624706844535e-11
control O 0 1.5873023784251927e-08
subjects O 0 5.967038418930315e-08
( O 0 1.8649182198515746e-10
n O 0 8.84224915509435e-10
= O 0 6.152666709446919e-10
14 O 0 5.396495472709262e-10
) O 0 2.871466953102697e-11
and O 0 4.617634399850523e-11
patients O 0 2.283328214003344e-11
with O 0 1.3440048770088642e-12
three O 0 4.3532993182493485e-11
forms O 0 1.788815540137989e-09
of O 0 9.915331844467801e-08
autosomal O 1 0.9992675185203552
dominant O 1 0.9999382495880127
cerebellar B-Disease 1 0.9999996423721313
ataxias I-Disease 1 0.6671371459960938
type I-Disease 0 3.9972332160687074e-05
I I-Disease 0 3.156506136292592e-05
spinocerebellar B-Disease 1 0.9999980926513672
ataxias I-Disease 0 4.690343121183105e-05
1 I-Disease 0 8.794388861588232e-08
and I-Disease 0 9.78874648005501e-10
2 I-Disease 0 1.5231432115569987e-08
( O 0 3.699168193982416e-10
SCA1 B-Disease 0 0.00033230349072255194
, O 0 1.0987619702973461e-09
n O 0 4.693164190605614e-10
= O 0 2.7736579699677577e-10
11 O 0 1.698947510453408e-10
; O 0 4.1044875831453e-11
SCA2 B-Disease 0 1.497702396591194e-05
, O 0 5.228257826672689e-10
n O 0 1.6706405703281746e-10
= O 0 1.3817563759843665e-10
10 O 0 1.6386648982180674e-10
) O 0 9.247453497396307e-11
and O 0 1.4620618049576706e-09
SCA3 B-Disease 1 1.0
/ O 0 2.518535211493145e-07
Machado B-Disease 0 6.836116313024831e-07
- I-Disease 0 1.0939179162505752e-07
Joseph I-Disease 0 3.0476064694084926e-06
disease I-Disease 0 6.631837459281087e-05
( O 0 1.7855839029579101e-09
MJD B-Disease 1 1.0
) O 0 1.4873935416659378e-09
( O 0 1.965190649100279e-10
n O 0 1.2136510685323287e-09
= O 0 1.4970078510145868e-09
16 O 0 6.050907774834968e-09
) O 0 1.4323234820423636e-09
. O 0 2.8649120409340867e-08

In O 0 2.2164397250890033e-07
SCA1 B-Disease 1 0.9889358878135681
, O 0 3.164479878137172e-08
saccade O 0 6.214189056663599e-07
amplitude O 0 3.349261845642104e-08
was O 0 4.782099161104725e-09
significantly O 0 7.277265456906434e-10
increased O 0 9.803694522858564e-10
, O 0 5.063903740776254e-10
resulting O 0 6.3766640856499635e-09
in O 0 3.443129115154875e-09
hypermetria B-Disease 0 5.816110933665186e-05
. O 0 7.416812763949565e-07

The O 0 1.957266249519307e-06
smooth O 0 2.181091986130923e-06
pursuit O 0 6.51441439458722e-07
gain O 0 1.3029854528667784e-07
was O 0 2.1397515581611515e-07
decreased O 0 1.0727018207035144e-06
. O 0 2.574258246568206e-07

In O 0 4.26284032073454e-07
SCA2 B-Disease 1 0.9999788999557495
, O 0 1.1074271100142141e-07
saccade O 0 2.5435567749809707e-06
velocity O 0 1.2428135676145757e-07
was O 0 8.114900396094527e-08
markedly O 0 9.346750573513418e-08
decreased O 0 3.951690530357155e-07
. O 0 1.2825154271922656e-07

The O 0 3.960450456474973e-08
percentage O 0 1.987826792060332e-08
of O 0 1.4826952110524871e-08
errors O 0 9.404454317518685e-07
in O 0 4.051353030831706e-09
antisaccades O 1 0.9999756813049316
was O 0 8.449483601680186e-08
greatly O 0 7.1270735979567235e-09
increased O 0 1.1763020557609138e-09
and O 0 6.269890162613478e-10
was O 0 1.3168781620720438e-09
significantly O 0 1.2547436700760528e-10
correlated O 0 6.876165192792882e-10
with O 0 3.868103060078454e-11
age O 0 7.391530942868485e-09
at O 0 1.3702622148059618e-08
disease O 0 1.2690967423623079e-06
onset O 0 5.3034682423458435e-06
. O 0 2.6450339873917983e-07

In O 0 8.350689917335785e-09
addition O 0 6.310203914949852e-09
, O 0 7.009031133264898e-10
a O 0 2.2765889173825826e-10
correlation O 0 5.719273388216095e-10
between O 0 4.6281825594185477e-10
smooth O 0 1.1452945258838554e-08
pursuit O 0 4.0783332266869365e-09
gain O 0 4.487568372457673e-10
and O 0 7.251074740644015e-11
the O 0 4.3977668728878427e-10
number O 0 7.852797301310943e-10
of O 0 1.830873763708496e-08
trinucleotide O 0 2.9586913115053903e-06
repeats O 0 1.2292466600172247e-08
was O 0 1.804862392873474e-08
found O 0 2.1833589158859468e-08
. O 0 9.426042879567831e-08

In O 0 1.95014166592955e-07
SCA3 B-Disease 1 1.0
, O 0 1.908396143335267e-07
gaze B-Disease 0 1.1614872164500412e-05
- I-Disease 0 7.790082236169837e-06
evoked I-Disease 0 4.978938932254096e-07
nystagmus I-Disease 0 1.7767232520782272e-06
was O 0 2.5081305921048624e-09
often O 0 6.699040627777819e-11
present O 0 1.3922747676975433e-10
as O 0 3.2420172102476386e-10
was O 0 1.1534363686394045e-08
saccade O 0 5.368913207348669e-07
hypometria O 0 5.441198027256178e-06
and O 0 1.0574865427770419e-07
smooth O 0 1.470297661398945e-06
pursuit O 0 6.741682341271371e-07
gain O 0 6.64772841219019e-08
was O 0 1.1049375103766579e-07
markedly O 0 2.0280081969303865e-07
decreased O 0 4.3519116843526717e-07
. O 0 9.449481552792349e-08

Three O 0 5.526086965801369e-08
major O 0 5.945725689571191e-08
criteria O 0 1.8602047191507154e-07
, O 0 1.8889800834642756e-09
saccade O 0 9.191406036279659e-08
amplitude O 0 2.454750713809517e-08
, O 0 7.603704887948481e-10
saccade O 0 2.360629736131159e-08
velocity O 0 2.0490531493777553e-09
, O 0 8.064941076080245e-11
and O 0 2.661307563212034e-10
presence O 0 1.7553880571341551e-09
of O 0 1.2672009219727443e-08
gaze B-Disease 0 9.474145372223575e-06
- I-Disease 0 7.809673661540728e-06
evoked I-Disease 0 3.3239905405935133e-07
nystagmus I-Disease 0 6.275764121710381e-07
, O 0 1.513252717577629e-10
permitted O 0 2.0926527177778098e-10
the O 0 1.4558723671065366e-10
correct O 0 3.45961148617846e-10
assignment O 0 1.9094495429250458e-10
of O 0 4.4300951795861465e-10
90 O 0 1.6766458221795233e-09
% O 0 3.7684223797018745e-11
of O 0 7.850056715774656e-10
the O 0 2.016189437625826e-09
SCA1 B-Disease 1 0.9983727931976318
, O 0 5.886613418937259e-10
90 O 0 1.2467404886251643e-09
% O 0 1.3782390159700064e-11
of O 0 1.846872377253561e-10
the O 0 8.779899585142914e-10
SCA2 B-Disease 1 0.9998718500137329
, O 0 2.918841002230721e-10
and O 0 2.4546359389532313e-10
93 O 0 3.5613609838947013e-09
% O 0 1.9691817620959284e-11
of O 0 2.06096389954169e-10
the O 0 6.25489993133499e-10
patients O 0 2.2558241385972622e-10
with O 0 7.182923700277399e-11
SCA3 B-Disease 1 1.0
to O 0 7.038212235244146e-09
their O 0 1.8489315634084846e-09
genetically O 0 4.134979914027781e-09
confirmed O 0 4.0268195028447806e-11
patient O 0 1.3481270266790801e-10
group O 0 9.537205010110017e-13
and O 0 1.3814024577007977e-11
, O 0 2.2109680405946186e-11
therefore O 0 5.679917300382975e-11
, O 0 5.798133154155671e-11
may O 0 2.0080904994390636e-10
help O 0 1.132551163962603e-09
orient O 0 8.497871704093996e-07
diagnoses O 0 8.472221679767244e-08
of O 0 1.0893019464219833e-07
SCA1 B-Disease 1 1.0
, O 0 6.792379103615076e-09
SCA2 B-Disease 1 1.0
, O 0 2.1106119074687513e-09
and O 0 1.0266765215760643e-08
SCA3 B-Disease 1 1.0
at O 0 1.6593968865663555e-08
early O 0 1.7416610376130848e-09
clinical O 0 1.960497897357527e-08
stages O 0 3.065000697688447e-09
of O 0 2.3637733992387666e-09
the O 0 7.860158746098023e-09
diseases O 0 3.2586791576250107e-07
. O 0 2.387780639878656e-09
. O 0 3.891990729698591e-08

Genetic O 0 3.0938295481064415e-07
basis O 0 4.10652001292533e-09
and O 0 1.424775297742542e-10
molecular O 0 6.9873045127621936e-09
mechanism O 0 2.9190724504246646e-08
for O 0 2.3921816705296806e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 9.327050065621734e-06

Ventricular B-Disease 1 1.0
fibrillation I-Disease 0 0.17569205164909363
causes O 0 1.2867248244674556e-07
more O 0 1.0822963358858573e-10
than O 0 3.7827820736913154e-11
300 O 0 4.3841824615142855e-10
, O 0 1.4983839169424584e-10
000 O 0 9.481142981826451e-09
sudden O 0 3.3165472590468426e-09
deaths O 0 2.8444258060034144e-10
each O 0 1.2554658701535715e-11
year O 0 5.292750612784225e-11
in O 0 1.8328843998105526e-10
the O 0 2.1203696576321818e-08
USA O 0 1.929468226080644e-06
alone O 0 3.635242507016301e-08
. O 0 4.829914601600649e-08

In O 0 1.132322768881977e-08
approximately O 0 1.1104847041920607e-09
5 O 0 7.339925889304766e-10
- O 0 1.7461515566807861e-09
12 O 0 5.209723208388084e-10
% O 0 1.1972384021674554e-11
of O 0 2.4761998007605257e-11
these O 0 1.4773653220917504e-12
cases O 0 2.642816521181146e-12
, O 0 1.026940685266986e-12
there O 0 3.3607220738945953e-12
are O 0 3.898543380481678e-12
no O 0 6.361426940770798e-10
demonstrable O 0 0.0001309326326008886
cardiac O 1 0.9974755644798279
or O 0 6.140163577583735e-08
non O 1 0.9999998807907104
- O 1 0.9999898672103882
cardiac O 1 0.9127689003944397
causes O 0 1.4205130405287036e-09
to O 0 2.4542787940839972e-11
account O 0 1.556016773762714e-11
for O 0 8.158167717764453e-12
the O 0 3.337906895328757e-10
episode O 0 7.654343270324659e-10
, O 0 1.9990172711592535e-11
which O 0 7.030634321253393e-12
is O 0 1.6188904383707126e-11
therefore O 0 6.988123274487279e-11
classified O 0 3.4477030119717256e-09
as O 0 9.355026264756816e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.9868019762725453e-07
IVF B-Disease 1 1.0
) O 0 1.028285456783351e-08
. O 0 4.02326350013027e-08

A O 0 1.5850957879592897e-06
distinct O 0 2.284730094004317e-08
group O 0 5.772217148702907e-10
of O 0 2.1186636445236218e-08
IVF B-Disease 1 1.0
patients O 0 4.5956380922973494e-09
has O 0 2.8601192594845948e-11
been O 0 2.003101157166398e-11
found O 0 1.0423416470228819e-11
to O 0 1.7138662017357476e-11
present O 0 1.5154506816106306e-10
with O 0 1.9748964963373083e-10
a O 0 9.151536417562056e-09
characteristic O 0 2.751577994786203e-06
electrocardiographic O 0 4.603910565492697e-05
pattern O 0 1.4346476291393628e-06
. O 0 1.22621926834654e-07

Because O 0 2.8684278063906277e-08
of O 0 2.2611722272358747e-08
the O 0 1.043506392406357e-09
small O 0 5.409944159318059e-10
size O 0 9.786805810207966e-10
of O 0 3.339704068849869e-09
most O 0 2.292226686240184e-10
pedigrees O 0 1.1338610050870557e-09
and O 0 1.113544742525896e-10
the O 0 3.2053590337532967e-10
high O 0 7.661912881928856e-09
incidence O 0 9.827817137875172e-08
of O 0 4.277084642012596e-08
sudden B-Disease 0 4.8764754012609046e-08
death I-Disease 0 2.326444104028269e-08
, O 0 3.64033164723665e-10
however O 0 2.0700645364524206e-10
, O 0 1.9199744571984922e-10
molecular O 0 2.1008763617658133e-09
genetic O 0 2.667451814986066e-10
studies O 0 1.0041347614508922e-10
of O 0 1.2574562502365438e-09
IVF B-Disease 1 1.0
have O 0 2.128478643337317e-11
not O 0 1.183953889788425e-11
yet O 0 1.0235821912285559e-10
been O 0 2.3045453045877906e-10
done O 0 3.918079638509653e-09
. O 0 4.1309771603437184e-08

Because O 0 6.592274985450786e-06
IVF B-Disease 1 1.0
causes O 0 0.10667623579502106
cardiac O 1 0.9999997615814209
rhythm O 1 0.9996647834777832
disturbance O 1 0.9047126770019531
, O 0 2.1579125153436962e-09
we O 0 5.700454552837186e-10
investigated O 0 5.345858422600713e-09
whether O 0 2.384931363508258e-09
malfunction O 0 3.568778993212618e-06
of O 0 2.2377292907549418e-08
ion O 0 3.43503074873297e-07
channels O 0 6.132296004324189e-09
could O 0 2.0280375157000208e-09
cause O 0 5.697272431604006e-09
the O 0 1.5725475366323849e-09
disorder O 0 1.0590020416145762e-08
by O 0 4.2399906502454954e-11
studying O 0 3.4572249507647257e-09
mutations O 0 2.497241025078978e-10
in O 0 8.172999083067012e-11
the O 0 5.7698086308732854e-09
cardiac O 0 4.826976578442554e-07
sodium O 0 3.970085771243248e-08
channel O 0 4.4695827483565154e-08
gene O 0 1.813790646565394e-07
SCN5A O 1 0.9999998807907104
. O 0 1.3716005469177617e-06

We O 0 3.813212856584869e-08
have O 0 3.970399842234684e-10
now O 0 8.809254992137028e-10
identified O 0 2.0389285815269886e-09
a O 0 4.044928836322015e-09
missense O 0 5.71972066154558e-07
mutation O 0 2.6478675252405992e-08
, O 0 1.7388032125253972e-09
a O 0 1.054186959947856e-09
splice O 0 4.0375848442408824e-08
- O 0 1.7387211670438774e-08
donor O 0 4.676168896544652e-10
mutation O 0 1.1613808803545567e-09
, O 0 1.0894374985470634e-10
and O 0 6.660338391917264e-10
a O 0 3.7141441033838873e-09
frameshift O 0 1.4187217800554208e-07
mutation O 0 6.416213671478488e-10
in O 0 2.6216712828430744e-11
the O 0 2.2960773560232184e-10
coding O 0 6.3364602453930274e-09
region O 0 2.2198110016802275e-08
of O 0 7.646179511766604e-08
SCN5A O 1 1.0
in O 0 5.3750794926088474e-09
three O 0 1.2901377743901321e-08
IVF B-Disease 0 0.46241989731788635
families O 0 4.3859724185857374e-10
. O 0 5.106378431207759e-09

We O 0 6.4603269400720365e-09
show O 0 3.833606210257301e-10
that O 0 1.444046011239708e-11
sodium O 0 2.1826572493832685e-10
channels O 0 4.0480736818171437e-11
with O 0 4.194503772092517e-11
the O 0 1.800121474104799e-08
missense O 0 5.739560720030568e-07
mutation O 0 1.7206062352670415e-08
recover O 0 8.09231526233134e-09
from O 0 2.1419763185370755e-10
inactivation O 0 7.292792361113243e-07
more O 0 2.404262379462896e-11
rapidly O 0 4.699897762638905e-11
than O 0 3.093421569247412e-12
normal O 0 3.402375950423142e-11
and O 0 7.473173121996801e-12
that O 0 1.6235287420007793e-11
the O 0 3.19694093420253e-09
frameshift O 0 5.372857003749232e-07
mutation O 0 7.0286607645186905e-09
causes O 0 1.6053994800202531e-09
the O 0 1.257269288679197e-09
sodium O 0 1.8245629451740797e-09
channel O 0 3.6059655261766466e-10
to O 0 2.3524290848619955e-10
be O 0 6.112907402489043e-10
non O 0 1.425445930181013e-07
- O 0 3.6889241528115235e-07
functional O 0 6.243581651688146e-07
. O 0 3.8830336279715993e-08

Our O 0 1.3887095917652914e-07
results O 0 2.1011927753278314e-09
indicate O 0 1.2465384280346825e-09
that O 0 2.030068335656665e-10
mutations O 0 4.5859707142881234e-09
in O 0 1.5453235358009465e-09
cardiac O 0 1.2571326806209981e-06
ion O 0 2.6042675926873926e-07
- O 0 9.212922122969758e-07
channel O 0 6.865775947773045e-09
genes O 0 1.0865903316004122e-10
contribute O 0 6.1245869487081e-11
to O 0 1.3210882041092553e-11
the O 0 1.9696785868994482e-10
risk O 0 1.7203460878079113e-09
of O 0 1.997746190696148e-09
developing O 0 1.4363567224506824e-08
IVF B-Disease 1 0.9999904632568359
. O 0 1.6742555120075053e-09
. O 0 1.4686306393230097e-08

Molecular O 0 6.856997174509161e-07
heterogeneity O 0 4.018807828742865e-07
in O 0 7.970807125445845e-09
mucopolysaccharidosis B-Disease 0 0.00012116118159610778
IVA I-Disease 1 1.0
in O 0 4.342390003131413e-09
Australia O 0 3.9880918012435984e-10
and O 0 1.115723832767479e-10
Northern O 0 1.3300050838438437e-08
Ireland O 0 1.0303939923517191e-08
: O 0 2.1464013899574752e-10
nine O 0 1.5337159320338856e-09
novel O 0 4.52120563210201e-09
mutations O 0 7.851449490559048e-10
including O 0 2.3852442243565974e-10
T312S O 0 1.0509631920285756e-06
, O 0 4.433391986857771e-10
a O 0 1.76698974896361e-10
common O 0 5.197018926317298e-10
allele O 0 9.208453999320909e-10
that O 0 1.680685868254983e-10
confers O 0 2.762360793440166e-07
a O 0 4.62248799237841e-08
mild O 0 1.0017552085628267e-05
phenotype O 0 6.642164294135e-07
. O 0 7.958900738458397e-08

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 0 0.0010236103553324938
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 7.144524971636201e-08
is O 0 1.318692932628096e-09
an O 0 2.501666429566285e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 4.4387695652403636e-07
by O 0 1.6477130770908843e-10
a O 0 1.2870361665306973e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.510378599967055e-09
N O 0 5.507399691850878e-08
- O 0 3.7713689948759566e-08
acetylgalactosamine O 0 3.847517746180529e-06
- O 0 4.946504645886307e-07
6 O 0 4.354365046310704e-07
- O 0 2.4369408038182883e-06
sulfate O 0 2.664742169145029e-06
sulfatase O 0 1.9030514522455633e-05
( O 0 2.0933645927811995e-09
GALNS O 1 0.9889615178108215
) O 0 6.840535693442007e-09
. O 0 3.749221377802314e-08

Previous O 0 5.826934312835874e-08
studies O 0 2.165581713953202e-09
of O 0 1.9668113804272025e-09
patients O 0 1.570071295198261e-10
from O 0 1.7236221130922935e-11
a O 0 5.978399025829972e-11
British O 0 1.6735492158748144e-10
- O 0 1.2347359579223394e-08
Irish O 0 1.5654856966307307e-08
population O 0 2.3404693114126296e-11
showed O 0 1.742769296930735e-11
that O 0 3.1143017852064414e-12
the O 0 5.72781044816395e-10
I113F O 0 6.176524038892239e-07
mutation O 0 2.1628490110003895e-09
is O 0 4.586193924627224e-11
the O 0 8.574382870385477e-11
most O 0 9.155245311864846e-11
common O 0 2.8722244027612476e-10
single O 0 4.786074869755907e-10
mutation O 0 2.010870359114847e-09
among O 0 2.2518487075018356e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.0006661773659288883
and O 0 8.305355514437451e-09
produces O 0 1.378725471568032e-07
a O 0 4.552123122891771e-09
severe O 0 2.2910808183951303e-06
clinical O 0 2.6400671231385786e-06
phenotype O 0 6.541732489040442e-08
. O 0 1.2586759190469365e-08

We O 0 3.760365174798608e-08
studied O 0 1.5189415591976285e-07
mutations O 0 1.936555360515513e-09
in O 0 2.7163968296939345e-10
the O 0 5.593026486394592e-09
GALNS O 1 0.9859744906425476
gene O 0 1.6009900072333494e-09
from O 0 2.3270188553858873e-10
23 O 0 6.040944633411982e-09
additional O 0 9.146178925334425e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.3760300987541996e-07
( O 0 1.7178883315871474e-11
15 O 0 9.751211643704849e-11
from O 0 2.0945354825552265e-12
Australia O 0 2.708328786932279e-12
, O 0 3.677328840739902e-12
8 O 0 4.440142697959004e-11
from O 0 6.026330909986166e-12
Northern O 0 1.38213118727748e-09
Ireland O 0 1.1657373955031858e-09
) O 0 7.26378263093963e-11
, O 0 2.392879991375274e-11
with O 0 8.702896042711572e-12
various O 0 8.116023408888395e-10
clinical O 0 9.614357310283594e-08
phenotypes O 0 5.5088914763246066e-08
( O 0 2.283385980295094e-10
severe O 0 5.38360563950846e-06
, O 0 2.3693691453274823e-10
16 O 0 4.792853336432756e-10
cases O 0 2.4654360150644372e-11
; O 0 4.22944795505642e-12
intermediate O 0 5.241920231213726e-09
, O 0 2.115058995999508e-11
4 O 0 5.163868777025016e-10
cases O 0 1.114668843338329e-10
; O 0 1.0329195831992877e-10
mild O 0 7.55064348822998e-08
, O 0 4.048570090287029e-10
3 O 0 7.021331516199325e-09
cases O 0 1.0328806698822746e-09
) O 0 1.1731314808471893e-09
. O 0 2.4470281800859084e-08

We O 0 1.2437817886734592e-08
found O 0 3.527724778962238e-10
two O 0 9.289456009975439e-11
common O 0 1.7120374562473728e-10
mutations O 0 1.188774356730704e-10
that O 0 9.898986144674105e-12
together O 0 3.3911935759523004e-11
accounted O 0 8.590609890113399e-10
for O 0 3.330591705208441e-11
32 O 0 1.4299595951783317e-09
% O 0 4.02325742165921e-11
of O 0 6.78075096072206e-10
the O 0 5.1841713144540336e-09
44 O 0 1.8369670229390067e-08
unrelated O 0 1.5598763170032726e-08
alleles O 0 2.368194529367429e-10
in O 0 9.579017440364268e-11
these O 0 3.61358232225939e-09
patients O 0 4.39411307340265e-09
. O 0 1.3213573346604335e-08

One O 0 1.0455632803996195e-07
is O 0 2.625527129040961e-09
the O 0 6.021112497478498e-09
T312S O 0 3.4731403957266593e-06
mutation O 0 1.482126865681721e-08
, O 0 9.021514646434525e-10
a O 0 1.376690206278397e-09
novel O 0 4.3326629395323835e-08
mutation O 0 2.0356916152763915e-09
found O 0 9.275682305576183e-11
exclusively O 0 1.3739097637355258e-09
in O 0 5.187462681632837e-10
milder O 0 3.017264816662646e-06
patients O 0 7.313158079114146e-08
. O 0 4.635236905414786e-08

The O 0 4.467537095820262e-08
other O 0 8.487433533765909e-10
is O 0 1.8626075681815735e-10
the O 0 7.099582588487863e-10
previously O 0 1.394237347795979e-08
described O 0 2.4414510413350854e-09
I113F O 0 6.85036923186999e-07
that O 0 6.985954592586552e-10
produces O 0 9.728486105586853e-08
a O 0 1.9385000271654462e-08
severe O 0 6.820416729169665e-06
phenotype O 0 4.7214871301548555e-07
. O 0 1.4081055610404292e-07

The O 0 4.949312142343842e-07
I113F O 0 8.559020898246672e-06
and O 0 3.056431907566548e-08
T312S O 0 3.305943437226233e-06
mutations O 0 2.6861752822071594e-09
accounted O 0 3.1377329623438754e-09
for O 0 1.1228244028993473e-10
8 O 0 1.860311460433195e-09
( O 0 1.891389996011572e-11
18 O 0 4.411410126081705e-10
% O 0 1.1844123772031256e-11
) O 0 3.1320716419730443e-12
and O 0 6.54910153885524e-11
6 O 0 2.6935889074763963e-09
( O 0 1.4682224186435278e-11
14 O 0 3.406026849450683e-10
% O 0 1.257306325025409e-11
) O 0 1.3421227670895597e-11
of O 0 9.184773497317167e-10
44 O 0 4.064185432639533e-09
unrelated O 0 4.880939652451843e-09
alleles O 0 1.4865872421943038e-10
, O 0 4.1989087207205955e-10
respectively O 0 1.2547161531983875e-08
. O 0 6.661996110324253e-08

The O 0 3.281435283497558e-07
relatively O 0 2.9888092001328914e-08
high O 0 2.1845256981123384e-07
residual O 0 5.254237476037815e-05
GALNS O 1 0.9998970031738281
activity O 0 2.478528315918993e-08
seen O 0 3.007128768217626e-09
when O 0 3.4693251049766616e-10
the O 0 2.933549181349804e-09
T312S O 0 2.186227447964484e-06
mutant O 0 1.737448940275499e-07
cDNA O 0 3.7060786439724325e-08
is O 0 8.818466512572343e-10
overexpressed O 0 1.553460577952137e-07
in O 0 1.119010772931972e-09
mutant O 0 9.746594997750435e-08
cells O 0 1.0318503690376346e-10
provides O 0 8.475389660922428e-12
an O 0 1.7042099068748096e-12
explanation O 0 1.4275762863502628e-11
for O 0 2.9382669908262216e-11
the O 0 1.7457586487523713e-09
mild O 0 1.033687226481561e-06
phenotype O 0 8.419766217571123e-09
in O 0 1.4102134737736804e-10
patients O 0 1.8186414874055146e-10
with O 0 1.2318031143709884e-11
this O 0 3.2772312641426993e-10
mutation O 0 5.96349991610623e-08
. O 0 4.731493419285471e-08

The O 0 1.2358008838475598e-08
distribution O 0 5.415869974711995e-10
and O 0 6.510194466846642e-11
relative O 0 1.5329343350245495e-10
frequencies O 0 2.6401589248159496e-10
of O 0 1.5563389466066724e-09
the O 0 8.801147366455098e-09
I113F O 0 8.246810239143088e-07
and O 0 1.0310939657642848e-08
T312S O 0 2.5710073714435566e-06
mutations O 0 9.884545404403866e-10
in O 0 9.15269596224455e-11
Australia O 0 9.897896391386496e-11
corresponded O 0 1.559464085643114e-10
to O 0 3.460348674266811e-11
those O 0 2.0320004359697386e-11
observed O 0 2.5223909766447505e-11
in O 0 1.3605176013564702e-11
Northern O 0 6.899843363328273e-09
Ireland O 0 9.35648225564023e-10
and O 0 2.1148906237389298e-10
are O 0 4.972418310433824e-12
unique O 0 5.809687366603589e-12
to O 0 2.928725621395567e-12
these O 0 2.1604060554403226e-11
two O 0 1.6199408134354165e-11
populations O 0 7.721394357229627e-11
, O 0 3.2822466966564434e-11
suggesting O 0 5.864422142343173e-11
that O 0 9.527209750281873e-12
both O 0 2.0320868598933117e-10
mutations O 0 3.000979187373076e-10
were O 0 9.818398871708212e-11
probably O 0 5.333102362503617e-11
introduced O 0 1.1664708088332532e-10
to O 0 6.236479388466165e-11
Australia O 0 2.5592311256317224e-11
by O 0 9.364417227764044e-12
Irish O 0 1.6168009153716412e-08
migrants O 0 1.295853008231873e-10
during O 0 8.27344165399424e-11
the O 0 1.2562983986441623e-09
19th O 0 4.5003613280414356e-08
century O 0 9.53944763182335e-08
. O 0 2.5394118097210594e-07

Haplotype O 0 5.979564775770996e-06
analysis O 0 1.332823806876604e-08
using O 0 9.702817216350468e-09
6 O 0 1.6286463733194978e-07
RFLPs O 0 1.8395568986306898e-05
provides O 0 1.4407242066027948e-09
additional O 0 3.899580935939895e-10
data O 0 1.0573883435505138e-10
that O 0 3.3555741518753734e-11
the O 0 7.658084832939949e-09
I113F O 0 4.242822797095869e-06
mutation O 0 4.3408996397431565e-09
originated O 0 1.668204741012147e-10
from O 0 1.7507628680135667e-10
a O 0 9.628424724184015e-10
common O 0 3.809539794730199e-09
ancestor O 0 2.3690599704195847e-08
. O 0 7.755042474855145e-08

The O 0 4.8610974801022167e-08
other O 0 2.047549019223993e-09
9 O 0 2.1066153266247056e-08
novel O 0 1.9982653753913837e-08
mutations O 0 8.922706462577423e-10
identified O 0 3.685982075118943e-11
in O 0 1.2475242193443759e-11
these O 0 1.0808852424215587e-10
23 O 0 1.2703534890690094e-09
patients O 0 3.252761948679961e-11
were O 0 1.0697683190674656e-11
each O 0 8.561893381775487e-12
limited O 0 9.722907895470811e-11
to O 0 3.111104707187451e-10
a O 0 1.3859325909137965e-09
single O 0 5.8455098539411665e-09
family O 0 1.5441633749446737e-08
. O 0 1.2247689085143065e-07

These O 0 2.0168362979688936e-08
data O 0 1.0130073446745769e-09
provide O 0 2.4353002253674205e-11
further O 0 1.0755342449986216e-10
evidence O 0 1.343926914199045e-10
for O 0 9.653760429939595e-11
extensive O 0 3.8338878738386484e-08
allelic O 0 4.2843515757340356e-07
heterogeneity O 0 5.4283894712625624e-08
in O 0 1.0536145289563592e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 1.4211126497798432e-08
British O 0 4.959864963183236e-09
- O 0 6.134018093462146e-08
Irish O 0 2.000210308494843e-08
patients O 0 6.482636649707274e-11
and O 0 2.021561737453048e-12
provide O 0 5.596718292803782e-13
evidence O 0 3.3831680946311282e-12
for O 0 1.799712614179716e-12
their O 0 2.932628792584602e-11
transmission O 0 2.274883059705246e-10
to O 0 4.519934079794119e-11
Australia O 0 3.1907303188472014e-11
by O 0 9.067686705666045e-12
British O 0 7.059101081452468e-10
- O 0 3.282339378074539e-08
Irish O 0 4.719469970382306e-08
migrants O 0 2.1258504678822732e-10
. O 0 1.4403167547527573e-10
. O 0 6.947516340005677e-09

Identification O 0 2.1269605099405453e-07
of O 0 3.34053140704782e-07
constitutional O 0 9.894700633594766e-05
WT1 O 1 1.0
mutations O 0 1.8487321540305857e-07
, O 0 4.281528465099882e-10
in O 0 7.684898550852637e-11
patients O 0 6.227021120963627e-10
with O 0 2.341913052372746e-10
isolated O 0 2.1515415937756188e-05
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.9104557935634148e-09
and O 0 1.5794122953938228e-10
analysis O 0 2.701902868107453e-10
of O 0 3.1558888835547805e-09
genotype O 0 9.371439091410139e-08
/ O 0 5.40966063056203e-08
phenotype O 0 3.770467937869171e-09
correlations O 0 1.504903535121116e-09
by O 0 1.5125392258119597e-11
use O 0 5.894276178253222e-10
of O 0 5.925819390739662e-09
a O 0 6.682865372198421e-09
computerized O 0 1.457445819141867e-06
mutation O 0 9.366291919832292e-08
database O 0 4.494288674550262e-08
. O 0 4.6419433630262574e-08

Constitutional O 0 9.100943316298071e-06
mutations O 0 1.5226240179799788e-07
of O 0 1.5420920362885226e-07
the O 0 1.0586772702936287e-07
WT1 O 0 0.0004661663551814854
gene O 0 5.576781703098277e-09
, O 0 4.879280868230751e-10
encoding O 0 3.770719736451156e-09
a O 0 2.866074710894395e-09
zinc O 0 7.894566920185753e-07
- O 0 1.607762101230037e-07
finger O 0 1.1112734910057043e-06
transcription O 0 2.82480897340065e-07
factor O 0 3.012377192135318e-08
involved O 0 4.375444173643217e-10
in O 0 2.1693344343098886e-10
renal O 1 1.0
and O 0 5.202231534440216e-08
gonadal O 1 0.9998863935470581
development O 0 1.903581292594936e-09
, O 0 4.339504450223686e-11
are O 0 1.0650688230667837e-12
found O 0 3.5290067309373674e-12
in O 0 2.045102585543357e-12
most O 0 3.622280253523513e-11
patients O 0 8.37952450483126e-12
with O 0 1.6233058300341163e-11
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.1792761756577193e-09
DDS B-Disease 1 1.0
) O 0 7.224160158969539e-10
, O 0 3.28360089119073e-10
or O 0 1.0214709966760438e-08
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.6443618022776718e-08
DMS B-Disease 1 0.9998830556869507
) O 0 4.373773218602217e-11
associated O 0 1.2253782710747174e-10
with O 0 2.4174379165131654e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 3.8015500081201026e-08
/ O 0 4.414189788803924e-06
or O 0 5.208993059113709e-08
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 1.9554226682316767e-08
WT B-Disease 1 1.0
) O 0 3.42769812533561e-09
. O 0 1.62730113828502e-08

Most O 0 3.453550050380727e-07
mutations O 0 2.0497994057677715e-07
in O 0 6.8633019267849704e-09
DDS B-Disease 1 1.0
patients O 0 3.2768289770501724e-07
lie O 0 2.6309924905376647e-08
in O 0 6.92078339081803e-10
exon O 0 1.0465349475907715e-07
8 O 0 3.245349233793604e-08
or O 0 7.722356087924709e-10
exon O 0 1.4162420569618916e-08
9 O 0 7.7807902343352e-09
, O 0 5.314745310514013e-10
encoding O 0 1.3824271505313845e-08
zinc O 0 6.354714514600346e-07
finger O 0 1.4249690138967708e-06
2 O 0 2.781396233331179e-07
or O 0 3.736569276213686e-09
zinc O 0 1.8542164070822764e-07
finger O 0 6.279937281306047e-08
3 O 0 4.996802527301725e-09
, O 0 4.074224291272799e-11
respectively O 0 1.0497921976160285e-10
, O 0 7.600685358877257e-11
with O 0 1.531388349462759e-10
a O 0 2.1390174076429957e-09
hot O 0 2.888208996409958e-07
spot O 0 1.7916083550062467e-07
( O 0 5.263658398035886e-10
R394W O 0 4.7190829377541377e-07
) O 0 3.289267469508417e-10
in O 0 1.0931597849150876e-09
exon O 0 1.2515143907876336e-06
9 O 0 6.713926268275827e-07
. O 0 1.334660879592775e-07

We O 0 2.6519918705503187e-08
analyzed O 0 6.432931964894806e-09
a O 0 2.2661611476237908e-10
series O 0 1.770930624367395e-10
of O 0 7.525705059130416e-10
24 O 0 1.7428440912681253e-09
patients O 0 3.233666112656408e-11
, O 0 1.8194662790294025e-11
10 O 0 7.080271369197533e-10
with O 0 1.4174709184189282e-09
isolated B-Disease 0 3.041944410142605e-06
DMS I-Disease 1 1.0
( O 0 9.021811742115915e-09
IDMS B-Disease 1 1.0
) O 0 5.218474541379692e-10
, O 0 1.2585738007331315e-10
10 O 0 2.6372801165130966e-10
with O 0 9.771058268048805e-11
DDS B-Disease 1 1.0
, O 0 7.499167953284314e-10
and O 0 4.154614707818638e-10
4 O 0 7.606755225708639e-09
with O 0 6.811471942036462e-10
urogenital B-Disease 1 0.9999995231628418
abnormalities I-Disease 1 1.0
and O 0 1.2219607015140355e-07
/ O 0 2.741246862569824e-05
or O 0 1.3681344057658862e-07
WT B-Disease 1 1.0
. O 0 1.3651576580286928e-07

We O 0 1.7846389255282702e-07
report O 0 5.5488587946683765e-08
WT1 O 0 0.0022954207379370928
heterozygous O 0 1.2829472950670606e-07
mutations O 0 9.83339631943636e-10
in O 0 7.910384153264616e-11
16 O 0 1.7977084265652366e-09
patients O 0 2.446613744933046e-11
, O 0 6.553059310465681e-12
4 O 0 7.762108733544437e-10
of O 0 1.6841072980611216e-09
whom O 0 1.4387551150463196e-09
presented O 0 1.3330628156893454e-08
with O 0 1.5682770637681642e-08
IDMS B-Disease 1 1.0
. O 0 3.0852604595565936e-06

One O 0 8.423961617154418e-08
male O 0 7.1689565395161026e-09
and O 0 2.4882737537090804e-10
two O 0 3.7905770189361476e-10
female O 0 6.2308975756764085e-09
IDMS B-Disease 1 1.0
patients O 0 3.633440215367045e-08
with O 0 1.1237210273407072e-08
WT1 O 1 1.0
mutations O 1 0.6476698517799377
underwent O 0 0.0002823477843776345
normal O 0 2.3431182398780948e-06
puberty O 0 1.3273107697386877e-06
. O 0 2.4506059403961444e-08

Two O 0 1.3021059430684545e-07
mutations O 0 3.5446173995978825e-08
associated O 0 1.1397327526196932e-09
with O 0 1.3553881350603092e-09
IDMS B-Disease 1 1.0
are O 0 2.1432514096808575e-10
different O 0 2.4773903414820886e-11
from O 0 2.1310215744807515e-11
those O 0 4.606673376095216e-11
described O 0 3.8915856648280567e-10
in O 0 1.9482588875519014e-09
DDS B-Disease 1 1.0
patients O 0 6.844994686616701e-07
. O 0 5.72812197674466e-08

No O 0 5.854315986653091e-06
WT1 O 1 0.660257875919342
mutations O 0 4.689589161444019e-08
were O 0 7.043902683356862e-10
detected O 0 1.5066784486705842e-09
in O 0 7.945238217343942e-11
the O 0 2.1154806795209424e-09
six O 0 1.0508645065243627e-09
other O 0 2.3312713981482602e-09
IDMS B-Disease 1 1.0
patients O 0 1.5409035825086903e-08
, O 0 2.0698118219364403e-10
suggesting O 0 7.483465513935528e-10
genetic O 0 4.516869989146244e-09
heterogeneity O 0 3.434132622714969e-08
of O 0 2.299085899437614e-08
this O 0 1.929686188617552e-09
disease O 0 7.202139045148215e-07
. O 0 5.287632731665326e-08

We O 0 2.355031227807558e-07
analyzed O 0 2.606255122827861e-07
genotype O 0 2.2513866326789866e-07
/ O 0 1.7864439882941952e-07
phenotype O 0 5.634367195028744e-09
correlations O 0 1.0862862831473308e-09
, O 0 4.056545030439729e-11
on O 0 1.506577224086314e-10
the O 0 5.14250794725335e-11
basis O 0 7.258492418227291e-11
of O 0 1.729395793237387e-10
the O 0 7.019667624952319e-10
constitution O 0 7.167589188838974e-09
of O 0 2.0560893432275407e-08
a O 0 1.890080270072758e-08
WT1 O 0 0.0006781726260669529
mutation O 0 1.8453494732284526e-08
database O 0 2.685827116266637e-09
of O 0 2.086994754790794e-08
84 O 0 1.394378870145374e-07
germ O 0 2.762215842722071e-07
- O 0 8.258348316303454e-07
line O 0 1.072777536137437e-06
mutations O 0 2.1120174498179267e-09
, O 0 2.33890736639486e-11
to O 0 1.5995782823297056e-11
compare O 0 4.7777293232798e-10
the O 0 8.15997755476694e-11
distribution O 0 1.419198925045606e-10
and O 0 5.47640648107528e-11
type O 0 3.525076452959297e-09
of O 0 3.67000474454926e-09
mutations O 0 2.783828723096349e-10
, O 0 1.014657628750637e-11
according O 0 6.215860291758357e-12
to O 0 4.734267144979043e-11
the O 0 8.63791260741209e-10
different O 0 3.8883083419705144e-09
symptoms O 0 6.479926355495991e-07
. O 0 4.6249219565197563e-08

This O 0 2.8401390128607318e-09
demonstrated O 0 1.564308904633549e-09
( O 0 5.3215390427574505e-11
1 O 0 1.921792724957072e-09
) O 0 7.09473244042691e-11
the O 0 3.3312030911503143e-10
association O 0 2.4359460629175267e-11
between O 0 1.1714294811948633e-10
mutations O 0 1.8207865770669684e-10
in O 0 8.086567526710553e-11
exons O 0 4.599356007162214e-09
8 O 0 2.0318242643924123e-09
and O 0 2.417170352764231e-10
9 O 0 7.607858343305907e-09
and O 0 1.4637863143818208e-09
DMS B-Disease 0 4.097424971405417e-05
; O 0 1.2201215038309954e-10
( O 0 1.8610406618546627e-11
2 O 0 7.779835664578627e-10
) O 0 4.839257466970892e-11
among O 0 4.831179206687963e-11
patients O 0 7.906176408001286e-11
with O 0 6.519165762775003e-11
DMS B-Disease 1 0.9996747970581055
, O 0 3.563431494324476e-10
a O 0 7.651069361402918e-11
higher O 0 1.5248392826183732e-10
frequency O 0 1.508411590078751e-10
of O 0 1.9274422058401797e-09
exon O 0 7.858408679339846e-08
8 O 0 4.6746219339866e-08
mutations O 0 2.3235338098004377e-09
among O 0 2.9005267632165044e-10
46 O 0 1.259189730262733e-08
, O 0 1.2874674659713037e-09
XY O 0 2.787658195302356e-05
patients O 0 3.466917308792006e-10
with O 0 3.2078041611871555e-11
female O 0 2.886547667557693e-10
phenotype O 0 1.1317171505487167e-10
than O 0 1.215690915989942e-11
among O 0 6.039808930768942e-11
46 O 0 5.080972975690656e-09
, O 0 7.427621850908395e-10
XY O 0 0.0002889057213906199
patients O 0 4.740376979839311e-10
with O 0 6.066802615833922e-11
sexual O 0 3.813152904541539e-09
ambiguity O 0 1.3830074863108166e-08
or O 0 2.6255256302398777e-10
male O 0 2.586813263594223e-10
phenotype O 0 3.6940898257009636e-11
; O 0 4.767210931566623e-12
and O 0 7.326676071395255e-11
( O 0 2.867799747674482e-11
3 O 0 1.1484964090868743e-09
) O 0 6.112473027730658e-11
statistically O 0 7.888491942997788e-11
significant O 0 1.069107857798457e-10
evidence O 0 8.307724647105275e-11
that O 0 1.6167366057029398e-11
mutations O 0 1.0976262260209424e-10
in O 0 1.759335732653966e-10
exons O 0 1.927189607897617e-08
8 O 0 9.67976632182399e-09
and O 0 8.078863134031167e-10
9 O 0 1.225075685340471e-08
preferentially O 0 8.050917266189117e-09
affect O 0 3.2630618207463158e-09
amino O 0 4.6386550156540807e-10
acids O 0 2.6987235363096218e-11
with O 0 2.494629719809738e-12
different O 0 1.1947063130457458e-11
functions O 0 6.8800748431741e-10
. O 0 4.437765988019038e-10
. O 0 2.9013541791300668e-08

The O 0 4.927017471345607e-06
185delAG O 0 9.585364750819281e-05
BRCA1 O 0 1.2245311609149212e-06
mutation O 0 2.026564471790948e-09
originated O 0 5.6018932548251854e-11
before O 0 1.1568431108888166e-11
the O 0 1.5731459537815518e-11
dispersion O 0 1.8640053944807278e-09
of O 0 4.661778185699461e-10
Jews O 0 1.946909300443167e-10
in O 0 1.2411682792645706e-11
the O 0 6.142767544625727e-11
diaspora O 0 2.210466358565366e-11
and O 0 5.232325683834915e-11
is O 0 5.512225398351944e-11
not O 0 7.733760853945171e-11
limited O 0 2.1338137923265776e-09
to O 0 1.0503259595395775e-08
Ashkenazim O 0 1.888517726911232e-05
. O 0 6.30858210115548e-07

The O 0 1.3037700909990235e-06
185delAG O 0 9.487236638960894e-06
mutation O 0 7.543791724629045e-08
in O 0 3.379496904543089e-09
BRCA1 O 0 1.5515344387040386e-07
is O 0 1.982289193902531e-10
detected O 0 9.541472473229007e-11
in O 0 8.764949703532476e-12
Ashkenazi O 0 6.786418649262771e-10
Jews O 0 4.670339670553858e-10
both O 0 4.0898659459109865e-11
in O 0 1.2251352710102026e-10
familial B-Disease 1 0.9998559951782227
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 6.08168237992146e-10
in O 0 2.4040927235069454e-11
the O 0 2.241605789876644e-10
general O 0 5.178229511848542e-10
population O 0 2.2294024959457204e-10
. O 0 6.63562804703588e-09

All O 0 1.8001786372678907e-07
tested O 0 5.2881876655419546e-08
Ashkenazi O 0 4.413888987642167e-08
mutation O 0 5.4503601631950005e-09
carriers O 0 2.9040309046379775e-10
share O 0 1.1550600059750948e-10
the O 0 4.2029790758846275e-10
same O 0 9.177033577500993e-10
allelic O 0 4.1923027538359747e-07
pattern O 0 1.067829114020924e-08
at O 0 1.696675866469377e-08
the O 0 1.1005563038679611e-07
BRCA1 O 0 2.8408421712811105e-06
locus O 0 3.5144896628480637e-06
. O 0 2.9544514745794004e-07

Our O 0 4.0202570517067215e-07
previous O 0 1.1673934707800981e-08
study O 0 6.921826445349666e-10
showed O 0 2.44445075292532e-10
that O 0 1.169946084456086e-11
this O 0 4.907212136640027e-11
Ashkenazi O 0 1.9351752200691408e-08
mutation O 0 2.1151578266653814e-09
also O 0 1.3334225390515542e-10
occurs O 0 1.3964815415157261e-11
in O 0 7.357873858804265e-12
Iraqi O 0 4.767997663357448e-10
Jews O 0 3.678693183406523e-10
with O 0 7.312966204819915e-11
a O 0 1.4982475260438832e-09
similar O 0 1.2796877335574663e-08
allelic O 0 6.245181793929078e-06
pattern O 0 8.029265359255078e-07
. O 0 1.6582680473220535e-07

We O 0 1.3739004600665794e-07
extended O 0 2.2832054469290597e-08
our O 0 5.543986936196177e-10
analysis O 0 4.201470074627345e-11
to O 0 5.875046282799445e-11
other O 0 6.879877778587229e-10
non O 0 6.540272323718455e-08
- O 0 4.697341893233897e-08
Ashkenazi O 0 1.2958000006335624e-08
subsets O 0 4.2650500908791855e-09
354 O 0 8.995964528857314e-10
of O 0 3.399316106378336e-10
Moroccan O 0 6.376761341186921e-09
origin O 0 3.0310476351047555e-10
, O 0 1.598688542658877e-10
200 O 0 6.412702591163111e-10
Yemenites O 0 1.5783862750140543e-07
and O 0 6.254613493794636e-10
150 O 0 2.969941181873992e-09
Iranian O 0 6.317923517684676e-09
Jews O 0 1.2082884914832448e-08
. O 0 4.0434958492596706e-08

Heteroduplex O 0 8.832692401483655e-05
analysis O 0 2.0095676234177517e-08
complemented O 0 3.127314229800504e-08
by O 0 1.4462711583895782e-10
direct O 0 1.1913261488416538e-09
DNA O 0 3.0633291459025713e-09
sequencing O 0 2.9373790066955507e-09
of O 0 6.1200151613149956e-09
abnormally O 0 3.37733196964507e-09
migrating O 0 1.4512838153457608e-10
bands O 0 8.52894910252644e-09
were O 0 4.638018025193702e-10
employed O 0 6.183104250823135e-09
. O 0 2.7013282277721373e-08

Four O 0 3.746361798562248e-08
of O 0 3.5221344063529614e-08
Moroccan O 0 6.303133659457671e-08
origin O 0 2.147842875777073e-10
( O 0 5.295787246228922e-12
1 O 0 9.658916721999589e-11
. O 0 2.295777283556344e-12
1 O 0 4.851299570396428e-11
% O 0 1.921115610342694e-12
) O 0 1.1095852969073006e-12
and O 0 1.7973294727524625e-11
none O 0 6.752456926939487e-11
of O 0 4.809795339788536e-10
the O 0 1.1810230571285274e-09
Yemenites O 0 1.3941368592895742e-07
or O 0 3.770955214754679e-10
Iranians O 0 2.609340521431136e-10
was O 0 1.1160777857455173e-09
a O 0 3.959796934793758e-10
carrier O 0 3.022966321708509e-09
of O 0 2.1778063796773495e-08
the O 0 1.223838381747555e-07
185delAG O 0 2.311909520358313e-05
mutation O 0 7.548080134256452e-07
. O 0 1.6683088688296266e-07

BRCA1 O 0 2.3563805370940827e-05
allelic O 0 1.6863200471561868e-06
patterns O 0 2.5907944678493777e-09
were O 0 7.567890758508611e-11
determined O 0 3.562913158949854e-11
for O 0 1.0188503686558992e-11
four O 0 1.782859623822297e-11
of O 0 4.891186414224258e-11
these O 0 9.436531417383875e-12
individuals O 0 4.518299796807401e-13
and O 0 3.781156811266673e-12
for O 0 2.635649511140148e-11
12 O 0 9.254763067012561e-10
additional O 0 6.122499174310292e-10
non O 0 3.36821130986209e-08
- O 0 4.75712056413613e-08
Ashkenazi O 0 2.256071596207221e-08
185delAG O 0 2.0976767700631171e-07
mutation O 0 2.9806668244702905e-09
carriers O 0 2.779737828806361e-10
who O 0 8.791211092429307e-10
had O 0 3.120034364201274e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.5195416242240753e-07

Six O 0 2.8987335554120364e-07
non O 0 3.9784853811397625e-07
- O 0 8.556163777484471e-08
Ashkenazi O 0 1.92001312626644e-08
individuals O 0 5.771256042508277e-11
shared O 0 3.317962848914391e-10
the O 0 3.427506889419618e-10
common O 0 8.500524173449264e-10
Ashkenazi O 0 4.146431198392975e-09
haplotype O 0 1.3452925884394062e-08
, O 0 1.506465729939066e-09
four O 0 1.5910356365722578e-09
had O 0 5.163891092507811e-09
a O 0 6.582165368307358e-10
closely O 0 2.5087895649811287e-10
related O 0 2.8411357710922402e-09
pattern O 0 2.3483863742512767e-09
, O 0 5.93907492629775e-11
and O 0 2.4000712528504664e-10
the O 0 3.6760299249039008e-09
rest O 0 1.5207511694370623e-08
( O 0 3.1807728673172164e-10
n O 0 1.6011519887726422e-09
= O 0 6.901524352009858e-10
6 O 0 2.384694886004013e-09
) O 0 1.17751128292376e-10
displayed O 0 1.434675578337874e-08
a O 0 4.9507349331179284e-09
distinct O 0 5.7637954853362316e-08
BRCA1 O 0 1.1609914736254723e-06
allelic O 0 4.074210210092133e-06
pattern O 0 3.6692969729301694e-07
. O 0 8.307085863634711e-08

We O 0 2.9257611444677423e-08
conclude O 0 5.430002225637054e-09
that O 0 6.505874311502069e-11
the O 0 7.49159578816716e-09
185delAG O 0 1.0643911082297564e-05
BRCA1 O 0 9.8419593541621e-07
mutation O 0 7.392616740986568e-09
occurs O 0 1.0159750818417024e-10
in O 0 2.192034748160765e-11
some O 0 1.7278922737062885e-10
non O 0 4.916991613868049e-08
- O 0 6.835399091187355e-08
Ashkenazi O 0 9.781435217348644e-09
populations O 0 4.4740650073649135e-10
at O 0 5.731533997410665e-11
rates O 0 7.228291576399926e-11
comparable O 0 8.69997893171437e-11
with O 0 1.0392308541495865e-11
that O 0 5.250340093243544e-11
of O 0 2.745454175112627e-08
Ashkenazim O 0 1.1371359505574219e-05
. O 0 1.8165361836963712e-07

The O 0 4.7290033222679995e-08
majority O 0 1.595983900593012e-09
of O 0 2.0674031375733648e-08
Jewish O 0 8.980011756420936e-08
185delAG O 0 4.461193725546764e-07
mutation O 0 2.3273305505000508e-09
carriers O 0 5.101440381238831e-10
have O 0 6.31972529863134e-11
a O 0 3.233291412385597e-10
common O 0 4.2486875129199575e-10
allelic O 0 5.74043781398359e-08
pattern O 0 2.747406746550496e-09
, O 0 1.5049773927078292e-10
supporting O 0 3.3653200226524405e-09
the O 0 1.3781885854768916e-08
founder O 0 4.541371723121301e-08
effect O 0 2.63823878299263e-08
notion O 0 2.079321159698111e-09
, O 0 6.843125371913672e-11
but O 0 2.628330192377959e-11
dating O 0 7.579548794156565e-11
the O 0 2.312056379683014e-10
mutations O 0 9.845552845222372e-11
origin O 0 1.8958831032866996e-11
to O 0 2.3062237883286762e-11
an O 0 1.597456195101543e-11
earlier O 0 1.5340428927146377e-10
date O 0 5.27362997715386e-09
than O 0 6.049657996776148e-10
currently O 0 5.037635641969018e-09
estimated O 0 1.2517712200121878e-08
. O 0 1.2433659435373556e-07

However O 0 2.7405102187572083e-08
, O 0 9.920335664048707e-10
the O 0 1.118788728327047e-09
different O 0 2.3080952427090295e-10
allelic O 0 1.5625181504219654e-07
pattern O 0 6.2800307176758e-09
at O 0 2.6516668860665504e-09
the O 0 2.414214783641455e-08
BRCA1 O 0 6.085122095100814e-08
locus O 0 1.0403192085561841e-08
even O 0 2.9507643550807927e-10
in O 0 5.5121830710991304e-11
some O 0 1.289988810215803e-10
Jewish O 0 2.58810750608518e-09
mutation O 0 3.4881819654941637e-10
carriers O 0 6.92113658051774e-11
, O 0 9.080568241781606e-11
might O 0 1.8302119542124018e-10
suggest O 0 1.1791946585848478e-10
that O 0 3.481666344118395e-11
the O 0 3.043248986145386e-09
mutation O 0 3.140355087083435e-09
arose O 0 9.027522063220772e-10
independently O 0 7.00224322969234e-10
. O 0 2.003714527631928e-09
. O 0 8.684026653327237e-08

Crystal O 0 2.875310656236252e-06
structure O 0 7.990141881464297e-08
of O 0 3.672184902825393e-07
the O 0 3.752287227598572e-07
hemochromatosis B-Disease 1 1.0
protein O 0 8.213827982217481e-07
HFE O 0 0.0001873354776762426
and O 0 2.1405970329624324e-09
characterization O 0 1.371203417477318e-08
of O 0 2.619156269645373e-08
its O 0 3.1806104416887138e-09
interaction O 0 1.8998851381013537e-09
with O 0 4.2381656517598287e-10
transferrin O 0 1.285725602429011e-06
receptor O 0 1.7653653117122303e-07
. O 0 3.2365218061158885e-08

HFE O 1 0.9999997615814209
is O 0 2.858133996141987e-07
an O 0 1.2665919868481978e-08
MHC O 0 7.956053195812274e-06
- O 0 2.00193980504082e-07
related O 0 3.946627913364864e-08
protein O 0 5.185771256854821e-10
that O 0 5.3446067016516e-12
is O 0 2.1209650355458187e-11
mutated O 0 8.027407072397352e-10
in O 0 2.266332781164504e-11
the O 0 2.6549664688957364e-09
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.00011115888628410175

HFE O 0 0.0025247770827263594
binds O 0 2.626580908327014e-07
to O 0 4.3631729340631864e-08
transferrin O 0 1.2156671118646045e-06
receptor O 0 2.7018023374125733e-08
( O 0 1.1418781475924789e-09
TfR O 0 9.63758353123012e-08
) O 0 3.40528473474766e-11
and O 0 1.0378705533886645e-10
reduces O 0 2.5458160024527388e-09
its O 0 1.8454004990786643e-10
affinity O 0 1.9800447392803733e-10
for O 0 2.93160135056425e-10
iron O 0 1.67086597002708e-07
- O 0 4.4322717940303846e-08
loaded O 0 9.528423383642348e-09
transferrin O 0 4.017006816070534e-08
, O 0 1.2498285739681592e-09
implicating O 0 1.7097537465815549e-06
HFE O 1 0.999980092048645
in O 0 3.950017628540081e-07
iron O 1 0.9995144605636597
metabolism O 0 2.6800393243320286e-05
. O 0 1.9386486371786305e-07

The O 0 2.3369900645775488e-06
2 O 0 3.904745881300187e-06
. O 0 3.963590984312759e-07

6 O 0 5.917824182688491e-06
A O 0 8.64848516357597e-07
crystal O 0 4.3883912326236896e-07
structure O 0 4.3122501125480994e-08
of O 0 1.639451880919296e-07
HFE O 1 0.6049983501434326
reveals O 0 5.823297843932096e-09
the O 0 6.632145388429933e-10
locations O 0 1.948961436681884e-09
of O 0 6.675657004961977e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 6.917410360074427e-07
and O 0 1.2781265823491594e-08
a O 0 5.26409316137233e-09
patch O 0 9.983620111597702e-05
of O 0 0.00016789155779406428
histidines O 0 0.21751627326011658
that O 0 2.1564096341908368e-10
could O 0 4.0177688953590973e-10
be O 0 6.358755882951428e-11
involved O 0 1.0314075982176263e-10
in O 0 3.6317321372436595e-10
pH O 0 1.902690200950019e-05
- O 0 1.4596379287468153e-06
dependent O 0 9.70581908177337e-08
interactions O 0 2.4004858545367824e-08
. O 0 1.7746181413258455e-08

We O 0 3.209430587958195e-08
also O 0 1.5033428946154004e-09
demonstrate O 0 1.3092495976252394e-09
that O 0 1.9564463937804533e-10
soluble O 0 1.1491454188217176e-06
TfR O 0 1.3971143744129222e-06
and O 0 8.59795790120188e-09
HFE O 0 3.5190889320801944e-05
bind O 0 4.797813257795269e-09
tightly O 0 1.195857191049754e-08
at O 0 1.2683754047060347e-09
the O 0 7.987970840339642e-10
basic O 0 5.66168711912951e-09
pH O 0 7.670850976637666e-08
of O 0 1.5025207744656655e-08
the O 0 4.5681787241846905e-09
cell O 0 4.0871153683674777e-10
surface O 0 1.0630023528079846e-09
, O 0 4.0581853849586125e-11
but O 0 2.1371028210981358e-11
not O 0 2.2754459774732005e-11
at O 0 2.9713448368440254e-10
the O 0 1.7535709551097511e-09
acidic O 0 1.7091439303840161e-06
pH O 0 4.6745249164814595e-06
of O 0 4.2827335278161627e-07
intracellular O 0 4.199469287868851e-07
vesicles O 0 3.7439017432916444e-06
. O 0 4.3111398895234743e-07

TfR O 0 0.0027262435760349035
HFE O 0 0.0011587925255298615
stoichiometry O 0 3.027872480743099e-06
( O 0 5.528888902261997e-09
2 O 0 2.6308720535439534e-08
1 O 0 1.5425825949932914e-08
) O 0 3.32483013343321e-10
differs O 0 8.949345708941792e-10
from O 0 1.7454622192047964e-09
TfR O 0 5.666983042829088e-07
transferrin O 0 2.900823048435086e-08
stoichiometry O 0 8.157043929202246e-09
( O 0 4.05580985463061e-11
2 O 0 1.0049208132301146e-09
2 O 0 1.1655861831272318e-09
) O 0 4.197345249146167e-11
, O 0 4.640962267266069e-11
implying O 0 1.911632380169337e-10
a O 0 1.9738183310025192e-11
different O 0 2.0124787253328336e-12
mode O 0 1.9437185194703943e-10
of O 0 4.011135867898474e-11
binding O 0 8.70702232536047e-10
for O 0 2.730500270331504e-10
HFE O 0 7.843638741178438e-05
and O 0 7.833518722577537e-09
transferrin O 0 7.156145187536822e-08
to O 0 2.0788810672911495e-09
TfR O 0 1.9031072895359102e-07
, O 0 1.1091843415966807e-10
consistent O 0 5.896794719184584e-10
with O 0 4.159989019925092e-11
our O 0 3.8103661892385787e-10
demonstration O 0 2.095729589868256e-09
that O 0 2.0477433637644538e-10
HFE O 0 2.880179999920074e-05
, O 0 3.3254405895633e-09
transferrin O 0 6.275555364254615e-08
, O 0 1.100309732215976e-09
and O 0 4.6358890060105296e-09
TfR O 0 1.0764011904029758e-06
form O 0 6.502502980509917e-10
a O 0 1.503942193004093e-09
ternary O 0 1.6694612270384823e-07
complex O 0 5.961782676422445e-07
. O 0 2.0438888270746247e-07

Identification O 0 8.992472544377961e-08
of O 0 7.35685006247877e-08
three O 0 1.516585079741617e-09
novel O 0 4.578035284197313e-09
mutations O 0 1.3706059898144218e-10
and O 0 7.208245111911538e-11
a O 0 4.804273298630868e-11
high O 0 1.884356004566712e-09
frequency O 0 7.228418974492001e-10
of O 0 4.062999270360024e-09
the O 0 1.181690656437695e-08
Arg778Leu O 0 0.00011959310359088704
mutation O 0 6.17375883749105e-09
in O 0 1.1097811558613557e-10
Korean O 0 4.019321053760905e-08
patients O 0 6.820412984387403e-11
with O 0 3.906994172631073e-11
Wilson B-Disease 0 2.940104423032608e-06
disease I-Disease 0 1.5113180324988207e-06
. O 0 7.299863113985339e-08

Four O 0 2.727073820096848e-07
mutations O 0 1.4510501245013074e-08
- O 0 4.710934931040356e-08
- O 0 7.281201419573335e-08
R778L O 0 5.629052566291648e-07
, O 0 3.4914438007405124e-10
A874V O 0 1.4468498932274088e-07
, O 0 4.849535217843481e-10
L1083F O 0 1.341569912938212e-07
, O 0 2.1644575021184664e-10
and O 0 2.336839610705965e-10
2304delC O 0 5.205616204762009e-08
- O 0 7.428731407799205e-09
- O 0 1.329462229193723e-08
in O 0 3.3256800091585603e-10
the O 0 2.3178681196611706e-09
copper O 0 2.2907910235403506e-08
- O 0 1.1082042838950201e-08
transporting O 0 3.986793117860543e-09
enzyme O 0 6.28714691419674e-10
, O 0 1.1516941567091266e-10
P O 0 1.0303453024107512e-07
- O 0 1.0429322117033735e-07
type O 0 1.1202504168750238e-07
ATPase O 0 1.1316431169916541e-07
( O 0 1.575017338772966e-10
ATP7B O 1 0.999998927116394
) O 0 6.8421990295775e-11
, O 0 2.4639505713519583e-11
were O 0 1.2646177507957823e-11
identified O 0 1.5832390953818276e-11
in O 0 9.481002788414017e-12
Korean O 0 1.0536366445990097e-08
Patients O 0 2.2991231141133994e-10
with O 0 8.72530520057424e-11
Wilson B-Disease 0 9.621926437830552e-06
disease I-Disease 0 1.5760002497700043e-05
. O 0 1.8265595258526446e-07

Arg778Leu O 0 0.00022606052516493946
, O 0 2.1198317767812114e-08
the O 0 9.093022335093792e-09
most O 0 1.9907699932986134e-09
frequently O 0 8.614352009495008e-10
reported O 0 1.1067631255912147e-09
mutation O 0 4.728250013741331e-10
of O 0 1.0913597803252628e-09
this O 0 1.483120050382869e-11
enzyme O 0 2.954592473458639e-11
, O 0 9.125151155531253e-12
was O 0 1.496381907273303e-10
found O 0 2.0672933850884867e-11
in O 0 3.3248539338393e-11
six O 0 3.8605060814767e-10
of O 0 2.0748325280095514e-09
eight O 0 1.5261376606900967e-09
unrelated O 0 4.430672273514347e-09
patients O 0 4.973748496395203e-11
studied O 0 8.05939426307134e-10
, O 0 4.495876240739882e-11
an O 0 2.0693924004944186e-11
allele O 0 5.442586936688087e-10
frequency O 0 2.694904521760577e-09
of O 0 9.220905639040211e-08
37 O 0 1.19871947390493e-06
. O 0 2.0218402596583473e-07

5 O 0 1.525273489733081e-07
% O 0 1.983621711332262e-09
, O 0 1.1797031407301262e-10
which O 0 4.4581758423811735e-11
is O 0 3.679421003988104e-11
considerably O 0 1.0376745990248182e-10
higher O 0 1.1091971091614639e-10
than O 0 7.706353784275866e-12
those O 0 1.771879171164059e-11
in O 0 3.861211003708398e-11
other O 0 6.548604991607476e-10
Asian O 0 8.541680251994421e-09
populations O 0 9.425177083244307e-09
. O 0 2.6922856832811703e-08

The O 0 2.8463341550377663e-07
novel O 0 1.052030640380508e-07
single O 0 1.4646743817792185e-09
nucleotide O 0 8.170700560583555e-09
deletion O 0 6.192439450103393e-09
, O 0 2.89969159794623e-10
2304delC O 0 1.1291248824818467e-07
, O 0 3.8442235505975475e-10
was O 0 1.9169750231640137e-09
found O 0 1.0827319596451446e-10
in O 0 3.2441266339944264e-10
one O 0 1.056091392115377e-08
patient O 0 8.348925462087209e-08
. O 0 4.617756133029616e-08

Since O 0 9.143548851398009e-08
a O 0 1.2539219440554916e-08
mutation O 0 3.242198287622955e-09
at O 0 8.455767641635248e-09
cDNA O 0 5.5093327233635137e-08
nucleotide O 0 9.211518658958084e-08
2302 O 0 6.3772899920877535e-06
( O 0 1.1619193385214999e-09
2302insC O 0 2.0672224820827978e-07
) O 0 4.3005657368588857e-10
had O 0 4.908028983230395e-10
been O 0 1.0874901673618709e-10
previously O 0 8.920153504732298e-10
described O 0 5.6187148683717325e-11
, O 0 1.6513934317230472e-11
this O 0 5.992186347808515e-12
region O 0 1.2463101661808196e-09
of O 0 9.551405000252089e-09
the O 0 3.132388570747935e-08
ATP7B O 1 1.0
gene O 0 9.772185727285887e-09
may O 0 5.412524317627287e-10
be O 0 3.13449516342601e-10
susceptible O 0 1.4777212697936193e-07
to O 0 4.6404800002619595e-09
gene O 0 3.3352438322253875e-07
rearrangements O 1 0.9999094009399414
causing O 1 0.9976867437362671
Wilson B-Disease 0 0.3908117711544037
disease I-Disease 0 0.037466663867235184
. O 0 2.8775110649803537e-07

Disruption O 0 5.732155386795057e-06
of O 0 4.901635293208528e-07
splicing O 0 1.055447356179684e-07
regulated O 0 2.5017296678697676e-08
by O 0 3.223925293394103e-10
a O 0 3.2278399952900827e-09
CUG O 0 0.0002040552208200097
- O 0 1.7149945108485554e-07
binding O 0 1.2659029380301945e-07
protein O 0 4.786956608882065e-08
in O 0 1.527961757119556e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 9.62236663326621e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999442100524902
DM B-Disease 1 1.0
) O 0 5.464415409051071e-08
is O 0 9.765697139840768e-10
caused O 0 1.2785599246001311e-09
by O 0 1.4990213237364713e-10
a O 0 4.913051743216101e-09
CTG O 0 6.929725350346416e-05
expansion O 0 4.197687530904659e-08
in O 0 1.2357902201554083e-10
the O 0 3.977797813359274e-10
3 O 0 3.2008764527802214e-09
untranslated O 0 1.247951900040789e-06
region O 0 1.8624746189743746e-08
of O 0 4.917666984738389e-08
the O 0 4.295184510283434e-07
DM B-Disease 1 1.0
gene O 0 6.58191993352375e-07
. O 0 7.120146960915008e-08

One O 0 6.986000755659916e-08
model O 0 3.9277715302432625e-08
of O 0 4.056447266975738e-07
DM B-Disease 1 1.0
pathogenesis O 0 3.604785888455808e-05
suggests O 0 8.529823514180634e-10
that O 0 6.531309781204753e-12
RNAs O 0 3.768878986676327e-09
from O 0 2.439476121107731e-10
the O 0 1.291971640782208e-09
expanded O 0 4.537698217177422e-09
allele O 0 1.4113443747021392e-09
create O 0 2.4938628939707996e-09
a O 0 5.448070883318223e-10
gain O 0 8.139292573261514e-10
- O 0 5.5268647436435e-09
of O 0 3.4975775609069615e-09
- O 0 1.6914993850036808e-08
function O 0 1.3538216381281387e-10
mutation O 0 3.53348773851625e-11
by O 0 1.9456378782395367e-12
the O 0 5.762203908465935e-11
inappropriate O 0 3.668043646598562e-10
binding O 0 1.0677675410519782e-09
of O 0 2.324003656184459e-09
proteins O 0 1.3134258958213962e-10
to O 0 4.898639271999627e-10
the O 0 3.427458139526607e-08
CUG O 1 0.9999998807907104
repeats O 0 2.8049171874044987e-07
. O 0 1.3627472128519003e-07

Data O 0 1.5709295198007567e-08
presented O 0 5.617177389893868e-09
here O 0 1.8516410627000823e-10
indicate O 0 2.530487763774403e-10
that O 0 2.0359497074351474e-11
the O 0 2.4017943189846847e-09
conserved O 0 3.086600486312818e-07
heterogeneous O 0 2.185867771231642e-07
nuclear O 0 9.457736496187863e-07
ribonucleoprotein O 0 1.6515366496605566e-06
, O 0 7.121719658442771e-09
CUG O 0 9.399034752277657e-05
- O 0 4.905900041762834e-08
binding O 0 1.437924712632821e-08
protein O 0 9.239382592340917e-10
( O 0 5.077460674129952e-11
CUG O 1 0.9999935626983643
- O 0 2.047222693590811e-07
BP O 0 1.671417493298577e-07
) O 0 1.5706523581737741e-10
, O 0 1.8674384261174737e-10
may O 0 2.7574431626931073e-10
mediate O 0 5.074851650022083e-09
the O 0 4.372910478167569e-09
trans O 0 2.2166886992636137e-08
- O 0 2.9428647962959076e-08
dominant O 0 3.212878851854839e-08
effect O 0 7.560050363508708e-09
of O 0 3.925672675819669e-09
the O 0 2.984660518734472e-09
RNA O 0 1.9509749904500495e-07
. O 0 4.522932783856959e-08

CUG O 1 1.0
- O 0 0.00013928950647823513
BP O 0 4.521390565059846e-06
was O 0 1.0376794534749934e-08
found O 0 5.454639517843418e-11
to O 0 3.380125346286178e-11
bind O 0 5.1024889174966503e-11
to O 0 2.0122579991177503e-10
the O 0 2.4862364611522025e-08
human O 0 1.903553794591062e-07
cardiac O 1 0.9996811151504517
troponin O 1 0.9975180625915527
T O 1 0.8600274324417114
( O 0 1.3349449323740714e-09
cTNT O 0 5.380568950386078e-07
) O 0 1.55588708583565e-10
pre O 0 7.042297056614188e-08
- O 0 4.3593878729097923e-08
messenger O 0 2.4552833099988902e-09
RNA O 0 3.549242677536313e-09
and O 0 2.0160730029861185e-10
regulate O 0 5.74959502230854e-09
its O 0 7.241100496990782e-10
alternative O 0 2.8646427452372336e-09
splicing O 0 2.6558288013234232e-08
. O 0 1.832603047091652e-08

Splicing O 0 4.4596370685212605e-07
of O 0 2.6025941224361304e-07
cTNT O 0 3.585284866858274e-05
was O 0 2.532366920604545e-07
disrupted O 0 7.287703169822635e-07
in O 0 1.1937724764266022e-07
DM B-Disease 1 1.0
striated O 1 0.9999591112136841
muscle O 0 9.066025086212903e-06
and O 0 7.257004330796235e-09
in O 0 8.661538153376114e-10
normal O 0 4.9264330392873035e-09
cells O 0 1.2358797318867687e-10
expressing O 0 2.2596004234376466e-10
transcripts O 0 4.587650703768986e-09
that O 0 9.657576960364622e-10
contain O 0 6.424865546250658e-07
CUG O 1 0.9573540687561035
repeats O 0 1.9400950179715437e-07
. O 0 1.3423148459423828e-07

Altered O 0 1.5451466879312648e-06
expression O 0 7.350313779852513e-08
of O 0 6.244367511953897e-08
genes O 0 7.4258128535120704e-09
regulated O 0 7.238041632717795e-08
posttranscriptionally O 0 1.1082232731496333e-06
by O 0 1.6714987172150586e-09
CUG O 1 1.0
- O 0 5.153240999788977e-05
BP O 0 3.6780697882932145e-06
therefore O 0 3.0176718901486765e-09
may O 0 3.642415258298115e-10
contribute O 0 2.281027811079639e-09
to O 0 9.69804325734458e-09
DM B-Disease 1 1.0
pathogenesis O 0 1.8807892047334462e-05
. O 0 1.0584689569270722e-08
. O 0 6.987680478687253e-08

Identification O 0 2.664328064838628e-07
of O 0 1.63741134429074e-07
a O 0 1.1927022924851371e-08
novel O 0 2.6701783895077824e-07
nonsense O 0 1.6091350119040726e-07
mutation O 0 2.9013582647507974e-09
and O 0 1.0671811212503712e-09
a O 0 8.587251465463908e-10
missense O 0 7.51230011530879e-09
substitution O 0 1.2760018597290923e-09
in O 0 1.126105805826505e-10
the O 0 2.577240643120149e-09
vasopressin O 0 3.653412505855158e-08
- O 0 8.793969641374133e-08
neurophysin O 0 3.19716741614684e-06
II O 1 0.9999997615814209
gene O 0 1.5918553142313385e-09
in O 0 4.621370300328387e-11
two O 0 1.2890270795207215e-10
Spanish O 0 3.2320311760258846e-08
kindreds O 0 2.809012357829488e-06
with O 0 1.1981243552838805e-08
familial B-Disease 1 0.9995980858802795
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 1.341198071713734e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 3.1186289106699405e-06
FNDI B-Disease 1 1.0
) O 0 1.252996550960006e-08
is O 0 6.294153531705149e-10
an O 0 1.6985854944806533e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 2.981510149879796e-08
by O 0 2.9742025509094105e-10
deficiency O 0 0.00026643442106433213
in O 0 4.527842101254009e-09
the O 0 2.570531933088205e-06
antidiuretic O 0 0.01043724361807108
hormone O 0 4.8542315198574215e-06
arginine O 0 9.83040195023932e-07
vasopressin O 0 6.918439794389997e-07
( O 0 3.384141189499701e-09
AVP O 0 4.748091669171117e-06
) O 0 7.5771777741096e-11
encoded O 0 2.75498131252494e-11
by O 0 3.1696218566468204e-11
the O 0 1.0030867692023548e-08
AVP O 0 0.0004440109187271446
- O 0 4.321201686252607e-06
neurophysin O 1 0.667291522026062
II O 1 1.0
( O 0 3.4457991660019616e-07
AVP O 1 0.9999856948852539
- O 0 6.0396378103177994e-06
NPII O 1 0.9999923706054688
) O 0 2.5574087292312697e-09
gene O 0 3.382618407599125e-09
on O 0 2.218938988107766e-08
chromosome O 0 1.8838939297438628e-07
20p13 O 0 8.01709211373236e-06
. O 0 1.7904827132042556e-07

In O 0 1.0650730075667525e-08
this O 0 1.0318444015888772e-10
study O 0 8.741479762264248e-11
, O 0 4.103219500284361e-11
we O 0 2.1193959781617977e-11
analyzed O 0 1.9091653258307417e-10
two O 0 2.1762376622991297e-11
families O 0 2.466337680959163e-12
with O 0 6.038081146186869e-11
FNDI B-Disease 1 1.0
using O 0 5.4399951210371e-09
direct O 0 2.9536884049718992e-09
automated O 0 9.726144334365472e-09
fluorescent O 0 1.5745472481398792e-08
, O 0 6.529796703347301e-10
solid O 0 8.217556413114835e-09
phase O 0 3.8347196529286975e-09
, O 0 5.5955500649629286e-11
single O 0 1.054735535022111e-10
- O 0 1.0172747089143286e-09
stranded O 0 2.645360874797831e-10
DNA O 0 4.776169390541263e-11
sequencing O 0 1.1299958191379744e-10
of O 0 9.660359179264333e-10
PCR O 0 1.8171425608670688e-07
- O 0 2.657227923918981e-06
amplified O 0 5.05542539031012e-06
AVP O 0 0.0009015232208184898
- O 0 2.9543659820774337e-06
NPII O 0 0.002019021427258849
DNA O 0 3.5017853861063486e-07
. O 0 2.409508681466832e-08

In O 0 6.283409348384339e-09
one O 0 8.659257755283534e-10
of O 0 9.33336408159846e-10
the O 0 3.3928063136734465e-10
families O 0 3.055102611865257e-12
, O 0 1.574109592672457e-11
affected O 0 1.3165259160619058e-10
individuals O 0 7.290289899541946e-12
presented O 0 1.868134091864704e-09
a O 0 1.0628786739630414e-09
novel O 0 1.6365769184290002e-08
nonsense O 0 1.6275929937137334e-08
mutation O 0 1.0796984140082344e-10
in O 0 2.6416034290543955e-11
exon O 0 5.370201616727854e-09
3 O 0 1.936448112971334e-09
of O 0 1.0098569758199005e-09
the O 0 2.607838112123062e-10
gene O 0 2.9007633101096886e-11
, O 0 3.067617687646518e-11
consisting O 0 2.7973736174691233e-11
in O 0 2.1558492838136267e-11
a O 0 6.841002209156954e-10
G O 0 9.170497605737182e-08
to O 0 2.8824884701350584e-09
T O 0 4.1207320577996143e-07
transition O 0 8.138659524092873e-09
at O 0 3.0840709985824333e-09
nucleotide O 0 5.7508673378947606e-09
2101 O 0 1.799366629029464e-07
, O 0 1.4882101107005496e-10
which O 0 1.3042435187404777e-11
produces O 0 5.738198249893856e-10
a O 0 1.3137264887053135e-10
stop O 0 1.3522842845503646e-09
signal O 0 1.463454135652853e-09
in O 0 8.194950273932022e-10
codon O 0 1.4125170366696693e-07
82 O 0 3.098914476140635e-07
( O 0 6.016107167994278e-09
Glu O 1 0.9970546960830688
) O 0 7.433620829999654e-09
of O 0 1.1846834979678533e-07
NPII O 1 0.9999992847442627
. O 0 3.9847355992606026e-07

The O 0 1.2949225265401765e-06
premature O 0 5.69611188439012e-07
termination O 0 1.686136954504036e-07
eliminates O 0 1.6408974090609263e-07
part O 0 1.0438929720635315e-08
of O 0 3.808698778584585e-08
the O 0 6.607729030605469e-09
C O 0 5.861679497343175e-08
- O 0 3.533432035851547e-08
terminal O 0 1.1251151121882685e-08
domain O 0 1.8504416887665798e-09
of O 0 6.982880940142877e-09
NPII O 1 1.0
, O 0 1.119232817536897e-09
including O 0 3.2133290472913245e-10
a O 0 2.969996470980618e-10
cysteine O 0 3.996414588147701e-10
residue O 0 5.1320285798794885e-09
in O 0 8.787769817386604e-11
position O 0 2.038765156697764e-09
85 O 0 4.965488020758357e-09
, O 0 7.536589408108085e-11
which O 0 1.0275114092905824e-11
could O 0 9.647022763958901e-11
be O 0 4.6320836055713244e-11
involved O 0 4.2576008690842215e-11
in O 0 2.0372743422814032e-11
the O 0 9.079810792123055e-10
correct O 0 3.719716534789086e-09
folding O 0 7.778878341468953e-08
of O 0 8.021032016358731e-08
the O 0 2.430645622553129e-07
prohormone O 0 0.0005062786513008177
. O 0 3.8442459526777384e-07

In O 0 6.238960459370446e-09
the O 0 8.746575019813463e-09
second O 0 5.8633875532621005e-09
family O 0 7.433404447532155e-10
, O 0 8.805357554209081e-10
a O 0 9.583462912132745e-10
G279A O 0 8.390816219616681e-08
substitution O 0 3.5960132094281505e-10
at O 0 2.2625160078781903e-10
position O 0 3.6906269706982187e-10
- O 0 9.62166901707917e-10
1 O 0 1.248820602484102e-09
of O 0 1.1481481321240494e-09
the O 0 6.434449639769468e-10
signal O 0 5.833967198221046e-10
peptide O 0 8.342805335459502e-10
was O 0 8.726008249304584e-10
observed O 0 2.0207310824638114e-10
in O 0 1.0244474712983731e-10
all O 0 8.143282714812017e-10
affected O 0 3.513102253549505e-09
individuals O 0 3.671193349319424e-10
. O 0 2.206434146501124e-08

This O 0 7.913489241673233e-08
missense O 0 7.651028113286884e-07
mutation O 0 1.2160545459494188e-08
, O 0 7.123536760467175e-10
which O 0 7.572847904313562e-10
replaces O 0 1.027865778269188e-06
Ala O 0 9.431683793081902e-06
with O 0 6.617932868380194e-09
Thr O 1 0.9182107448577881
, O 0 6.35798569348367e-09
is O 0 4.383831353482748e-10
frequent O 0 2.1520678572528595e-09
among O 0 9.51316581065953e-10
FNDI B-Disease 1 1.0
patients O 0 1.2675416272145412e-08
and O 0 6.441068234330771e-10
is O 0 2.87530471654307e-10
thought O 0 3.30765054235016e-10
to O 0 5.2490286422957055e-11
reduce O 0 6.425610710181218e-09
the O 0 8.552500374570116e-10
efficiency O 0 1.2360318990545238e-08
of O 0 3.6787233259616414e-09
cleavage O 0 1.1953458223246116e-09
by O 0 1.3451474656367424e-10
signal O 0 1.9006943574595425e-08
peptidases O 0 3.731415176844166e-07
. O 0 6.80465905844585e-09
. O 0 8.377207905141404e-08

Genetic O 0 1.1713132153090555e-06
heterogeneity O 0 8.589116760049365e-07
of O 0 3.247244251269876e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.9540531959758596e-10
due O 0 6.210016056940049e-09
to O 0 1.8426932202331159e-09
TWIST O 0 1.151176547864452e-05
and O 0 4.954894450293068e-08
FGFR O 1 1.0
mutations O 0 5.717053568332631e-07
. O 0 9.060668304528008e-08

Thirty O 0 5.056345798948314e-06
- O 0 9.069102588910027e-07
two O 0 7.146589986462004e-10
unrelated O 0 1.836728813486843e-08
patients O 0 7.238417504273897e-11
with O 0 1.7695714685239672e-12
features O 0 8.303387977193211e-10
of O 0 1.5055473312486356e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.2172150226928977e-10
a O 0 2.708946122975675e-10
common O 0 1.8740198726163726e-08
autosomal B-Disease 0 0.28833991289138794
dominant I-Disease 1 0.8540547490119934
condition I-Disease 0 1.7587791489859228e-06
of O 0 0.00010647586896084249
craniosynostosis B-Disease 1 1.0
and O 0 1.4020493836142123e-05
limb B-Disease 1 1.0
anomalies I-Disease 0 0.0941842645406723
, O 0 2.9796989875485735e-10
were O 0 6.207546976444434e-11
screened O 0 5.398330227279757e-09
for O 0 3.6074929155027746e-10
mutations O 0 1.0914014136886863e-09
in O 0 1.406742500265068e-10
TWIST O 0 1.6379062799387611e-06
, O 0 9.888051488715632e-10
FGFR2 O 1 0.9999780654907227
, O 0 5.410400572003482e-09
and O 0 2.991832204202183e-08
FGFR3 O 1 0.9999966621398926
. O 0 7.065464728839288e-07

Nine O 0 1.7788175910027348e-07
novel O 0 4.979679246730484e-08
and O 0 2.6566127075966506e-09
three O 0 2.0754460372529593e-09
recurrent O 0 2.640187858560239e-06
TWIST O 0 1.981223249458708e-06
mutations O 0 3.46433909337307e-10
were O 0 1.5503940145600303e-11
found O 0 6.204441908158609e-12
in O 0 2.2782862402204174e-11
12 O 0 2.8781483862871937e-09
families O 0 3.667943726526346e-11
. O 0 5.7002615960755065e-09

Seven O 0 3.9373276194965e-08
families O 0 6.486743087119606e-11
were O 0 3.377972554452491e-11
found O 0 1.800455270983825e-11
to O 0 5.605078207127079e-11
have O 0 4.057620212050139e-11
the O 0 3.6949250326046013e-09
FGFR3 O 1 1.0
P250R O 0 2.2399106001103064e-06
mutation O 0 1.2089609313647998e-09
, O 0 6.426057602704205e-11
and O 0 2.0267373890270335e-10
one O 0 1.514881414754754e-10
individual O 0 2.7232743837757312e-11
was O 0 3.1841174141788997e-10
found O 0 6.158486914875638e-11
to O 0 1.956401707303712e-10
have O 0 2.0423761293297815e-10
an O 0 9.010285295651954e-10
FGFR2 O 1 0.9998086094856262
VV269 O 0 1.09482352854684e-05
- O 0 2.391570887994021e-06
270 O 0 3.826064585155109e-07
deletion O 0 6.367551463881682e-07
. O 0 6.463632473696634e-08

To O 0 1.0595354815734481e-08
date O 0 1.6668195712554734e-08
, O 0 3.3028974000259836e-10
our O 0 7.837590992876287e-11
detection O 0 7.640049148882611e-10
rate O 0 1.7796940310343956e-10
for O 0 5.7941536985017805e-11
TWIST O 0 7.359459459621576e-07
or O 0 3.521978486631383e-09
FGFR O 1 0.9959877133369446
mutations O 0 5.081884246749269e-09
is O 0 8.14188091946555e-11
68 O 0 1.7015882036730545e-09
% O 0 3.5171414392021205e-11
in O 0 2.2546657249544744e-11
our O 0 8.874114221235629e-10
Saethre B-Disease 1 0.9998769760131836
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.8658514733260745e-09
, O 0 1.2248519039304018e-11
including O 0 2.7521348047732097e-11
our O 0 4.27118590495823e-10
five O 0 1.7506592009386424e-10
patients O 0 3.906800577491154e-11
elsewhere O 0 4.41721763333458e-11
reported O 0 1.3067491533291786e-10
with O 0 1.0052582100072982e-09
TWIST O 0 0.00023341852647718042
mutations O 0 2.3357374345778226e-07
. O 0 5.66428219883619e-08

More O 0 6.652292938724713e-09
than O 0 4.768352934725328e-10
35 O 0 3.077777366300438e-09
different O 0 8.471837814605365e-11
TWIST O 0 1.7852246969596308e-07
mutations O 0 3.497775957761462e-10
are O 0 7.009879655905937e-12
now O 0 3.779168991635551e-11
known O 0 7.39542940775273e-11
in O 0 6.801291474456406e-11
the O 0 2.6049558066176814e-09
literature O 0 1.3853122204920965e-08
. O 0 2.058223991241448e-08

The O 0 5.795930846375086e-08
most O 0 6.196335666786013e-10
common O 0 2.2190595194704343e-10
phenotypic O 0 1.3191515435551082e-08
features O 0 4.711802059631509e-10
, O 0 2.0943888984215064e-11
present O 0 1.0250606786998961e-11
in O 0 5.9708063146479695e-12
more O 0 3.363107535514498e-12
than O 0 6.14857774069999e-12
a O 0 2.88551092741951e-11
third O 0 3.318279262476409e-10
of O 0 1.1126238819159084e-09
our O 0 6.443710565129379e-10
patients O 0 3.7517339929182825e-11
with O 0 2.623481987207299e-11
TWIST O 0 1.6842773220560048e-06
mutations O 0 2.407017918315546e-09
, O 0 1.8801976642279783e-10
are O 0 6.552237918899806e-11
coronal B-Disease 0 3.72062004316831e-07
synostosis I-Disease 0 7.736331326668733e-07
, O 0 1.9253663108287355e-09
brachycephaly B-Disease 0 3.162946313750581e-06
, O 0 6.9260956969685594e-09
low B-Disease 0 1.5257712220773101e-05
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 9.250788366443885e-07
facial B-Disease 1 1.0
asymmetry I-Disease 0 5.4686079238308594e-05
, O 0 1.1368586072535436e-08
ptosis B-Disease 1 0.9999138116836548
, O 0 1.1673934707800981e-08
hypertelorism B-Disease 0 1.5533969417447224e-05
, O 0 6.356942972018942e-09
broad B-Disease 0 5.425063591246726e-06
great I-Disease 0 2.117349322361406e-05
toes I-Disease 0 0.00048385345144197345
, O 0 1.1979620850866013e-08
and O 0 3.524419511791166e-08
clinodactyly B-Disease 0 0.0004945355467498302
. O 0 8.749630637794326e-07

Significant O 0 1.188873102364596e-05
intra O 0 5.568054984905757e-05
- O 0 2.2439837721321965e-06
and O 0 1.5427032096226867e-08
interfamilial O 0 6.6118691393057816e-06
phenotypic O 0 1.6384092305088416e-06
variability O 0 8.292617081906428e-08
is O 0 6.589171569482133e-11
present O 0 2.930291773117766e-11
for O 0 5.7597863978298136e-11
either O 0 3.1657219068392806e-09
TWIST O 0 9.074121408048086e-06
mutations O 0 3.520441893556381e-08
or O 0 1.2486403022649029e-08
FGFR O 1 1.0
mutations O 0 1.0580166645013378e-06
. O 0 7.611983221522678e-08

The O 0 1.8130332080090739e-07
overlap O 0 2.0392640465161094e-08
in O 0 2.0413673529340315e-10
clinical O 0 2.2989095072034615e-09
features O 0 2.1132777472399056e-10
and O 0 5.183711446199446e-11
the O 0 1.0574346953617919e-10
presence O 0 1.2281370365130329e-10
, O 0 2.7463668492155868e-11
in O 0 1.0572103088801743e-11
the O 0 1.1475017464013249e-10
same O 0 2.453632956533891e-11
genes O 0 1.3553892383444399e-11
, O 0 2.1605462210971815e-11
of O 0 4.319918311956883e-10
mutations O 0 5.559146892819555e-11
for O 0 1.0410005323036042e-11
more O 0 5.669274945330205e-12
than O 0 1.4068384478205243e-11
one O 0 1.317309594739413e-10
craniosynostotic B-Disease 0 1.0559003982280046e-07
condition I-Disease 0 2.993771452963756e-09
- O 0 2.2113045616833915e-08
such O 0 1.3969624346188425e-09
as O 0 8.137351348302957e-10
Saethre B-Disease 0 1.8485271766621736e-06
- I-Disease 0 5.5740198234843774e-08
Chotzen I-Disease 0 7.899712727521546e-06
, I-Disease 0 8.720933974970535e-10
Crouzon I-Disease 0 7.319465657928959e-05
, I-Disease 0 3.4839153784105292e-09
and I-Disease 0 2.262371445738154e-08
Pfeiffer I-Disease 0 0.003648357233032584
syndromes I-Disease 0 1.225672690452484e-06
- O 0 1.3879650317960568e-08
support O 0 4.09496520026309e-10
the O 0 8.290221287232669e-10
hypothesis O 0 2.5385607504979646e-10
that O 0 2.9758224964065993e-12
TWIST O 0 3.0838840814340074e-08
and O 0 7.346266650554156e-11
FGFRs O 0 3.520594020756107e-07
are O 0 1.5252573509760836e-11
components O 0 4.2424927459983053e-10
of O 0 1.4492735900262232e-09
the O 0 1.053573894793658e-09
same O 0 2.2505336483291671e-10
molecular O 0 1.2337088017844167e-09
pathway O 0 6.166080146474684e-11
involved O 0 2.031139145763916e-12
in O 0 1.694302033741768e-12
the O 0 1.9153367780688768e-10
modulation O 0 4.6530768571528824e-08
of O 0 5.830074201185198e-07
craniofacial O 1 1.0
and O 0 0.00017985385784413666
limb O 1 0.9999998807907104
development O 0 1.954195738562703e-08
in O 0 1.0575521569577973e-09
humans O 0 1.6374192002288623e-09
. O 0 4.227677929957707e-10
. O 0 8.688379793397871e-09

Mutation O 0 9.094482322780095e-08
analysis O 0 2.830674805665012e-09
of O 0 3.8894452103477306e-08
UBE3A O 1 1.0
in O 0 2.5021983674378134e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.128391068050405e-05
. O 0 4.30944631091279e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 7.124330636543164e-07
AS B-Disease 1 1.0
) O 0 4.393367447619312e-09
is O 0 5.058208296659927e-10
caused O 0 3.3636131657743817e-09
by O 0 2.1947300921087987e-10
chromosome O 0 8.927719363782671e-08
15q11 O 0 1.4628263897975557e-06
- O 0 6.699139021293377e-07
q13 O 0 3.4635413612704724e-06
deletions O 0 4.309520207357309e-08
of O 0 8.265910622640149e-09
maternal O 0 9.501817110901811e-09
origin O 0 1.1575941594177408e-10
, O 0 3.558023667360466e-11
by O 0 2.5917470947156573e-10
paternal O 0 6.789202871004818e-06
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999966621398926
( O 0 1.3504360651950265e-07
UPD B-Disease 1 1.0
) O 0 1.9331083400686566e-09
15 O 0 4.49164661020518e-09
, O 0 3.974656020977463e-11
by O 0 6.374516886564763e-11
imprinting O 0 2.3060945295583224e-06
defects O 0 3.203155074515962e-06
, O 0 2.037784663233566e-10
and O 0 1.206076905013731e-10
by O 0 1.0728788690794744e-10
mutations O 0 3.445086882436499e-09
in O 0 7.206131802384164e-10
the O 0 9.920780286165609e-08
UBE3A O 1 0.999943733215332
gene O 0 3.477424854736455e-07
. O 0 2.0246999099526874e-07

UBE3A O 1 0.9713243842124939
encodes O 0 2.8949700663361e-06
a O 0 5.522473145447293e-08
ubiquitin O 0 2.9311271987353393e-07
- O 0 2.287412428358948e-07
protein O 0 2.4846247725918147e-08
ligase O 0 8.851264610143517e-09
and O 0 1.8025118064812773e-09
shows O 0 2.8121320383434067e-08
brain O 0 4.4106704422119947e-07
- O 0 2.2976486491188552e-07
specific O 0 3.511884472118254e-08
imprinting O 0 4.187766080576694e-06
. O 0 6.580690126156696e-08

Here O 0 3.9696164577662785e-08
we O 0 6.448237943601498e-09
describe O 0 2.8729449041975386e-08
UBE3A O 0 0.001858435571193695
coding O 0 1.388148461956007e-06
- O 0 0.0006949231028556824
region O 0 3.0277453788585262e-06
mutations O 0 3.668872849971194e-08
detected O 0 1.4591199359870188e-09
by O 0 3.6398162261974676e-11
SSCP O 0 7.853769602661487e-06
analysis O 0 2.9194577311209e-11
in O 0 2.7195733512397346e-11
13 O 0 2.857483138996031e-09
AS B-Disease 1 0.9999998807907104
individuals O 0 1.1955730849777524e-10
or O 0 2.8389243733606406e-10
families O 0 3.733103409730987e-11
. O 0 8.158740349983873e-09

Two O 0 4.9268297885873835e-08
identical O 0 4.951663257202199e-08
de O 0 6.6833281380240805e-06
novo O 0 7.149403700168477e-06
5 O 0 1.7976172728140227e-07
- O 0 1.289437108198399e-07
bp O 0 3.238596590904308e-08
duplications O 0 7.88014204999854e-08
in O 0 9.177680837524349e-10
exon O 0 1.8064885409785347e-07
16 O 0 1.5994769952953902e-08
were O 0 7.168405868895888e-10
found O 0 6.17196627139549e-10
. O 0 1.416804007448036e-08

Among O 0 1.1611599681771168e-08
the O 0 1.3848149293949064e-09
other O 0 2.9308297455621357e-10
11 O 0 6.169588728788256e-10
unique O 0 2.395305898073019e-10
mutations O 0 7.643601723783533e-11
, O 0 6.694952925379027e-11
8 O 0 2.157406475689072e-09
were O 0 5.153802939972252e-10
small O 0 7.701854265462771e-09
deletions O 0 8.706930998414464e-08
or O 0 4.354815175133808e-09
insertions O 0 5.3286470347302384e-08
predicted O 0 1.8810460744589363e-08
to O 0 3.122889946638452e-09
cause O 0 8.145993746211388e-08
frameshifts O 0 3.966259555454599e-06
, O 0 1.819038031314335e-09
1 O 0 2.3904979329358866e-08
was O 0 1.918724379379455e-08
a O 0 1.5636346661906941e-09
mutation O 0 1.192594800691893e-09
to O 0 3.232569767419591e-10
a O 0 1.1496624763296381e-09
stop O 0 4.5285761807178915e-09
codon O 0 1.555478301717983e-09
, O 0 9.061226075024464e-11
1 O 0 4.968576217123655e-09
was O 0 1.1658224607913326e-08
a O 0 3.0787694615952432e-09
missense O 0 2.040820490378792e-08
mutation O 0 6.813499209279428e-10
, O 0 4.605021572401391e-11
and O 0 9.728361866079283e-11
1 O 0 3.5957683497400694e-09
was O 0 2.9880895535683294e-09
predicted O 0 4.1240078019200155e-09
to O 0 7.14525438816338e-10
cause O 0 3.6808709413804763e-09
insertion O 0 4.9012958136529505e-09
of O 0 1.3554973143925508e-08
an O 0 1.3958331157581938e-09
isoleucine O 0 2.7073740511696087e-06
in O 0 2.192371617582012e-09
the O 0 2.183008973588585e-08
hect O 0 1.6191668237297563e-06
domain O 0 1.4094028166766748e-08
of O 0 2.0827080504659534e-08
the O 0 2.482559402494644e-08
UBE3A O 0 9.350297477794811e-05
protein O 0 4.157296285001166e-09
, O 0 8.363003345390752e-11
which O 0 1.562059336046584e-11
functions O 0 1.793440118635914e-10
in O 0 1.3640234775014193e-10
E2 O 0 9.443442650081124e-07
binding O 0 6.91637902505704e-09
and O 0 3.6191074581637395e-09
ubiquitin O 0 4.13941307897403e-07
transfer O 0 8.784319334154134e-07
. O 0 3.7169954225646507e-07

Eight O 0 1.2523209136361402e-07
of O 0 6.6799468179112864e-09
the O 0 6.379409778212164e-10
cases O 0 1.1452540304990322e-10
were O 0 6.426682797044947e-11
familial O 0 8.377491589328656e-09
, O 0 1.466988613918474e-10
and O 0 5.31194810360347e-10
five O 0 1.3695352629738977e-09
were O 0 8.327956102505141e-10
sporadic O 0 2.1912246666033752e-06
. O 0 3.003593747052946e-07

In O 0 2.8309461441722306e-08
two O 0 3.4153506689449387e-09
familial O 0 6.205235081324645e-08
cases O 0 1.309369501711899e-09
and O 0 5.807267444701836e-10
one O 0 4.829025512798069e-10
sporadic O 0 2.4832981893041506e-08
case O 0 3.828390937599124e-09
, O 0 1.4168842765727163e-09
mosaicism O 0 1.1487958317957236e-06
for O 0 2.5051150487342966e-08
UBE3A O 1 1.0
mutations O 0 2.0177983728331128e-08
was O 0 1.8683372626782102e-09
detected O 0 3.118121039147326e-10
in O 0 9.425881949964854e-12
the O 0 1.5677791009860442e-10
mother O 0 2.0552873292167817e-10
of O 0 5.099436428679383e-10
three O 0 1.2237433288930788e-10
AS B-Disease 1 1.0
sons O 0 4.136115450137368e-09
, O 0 1.9809955759120257e-11
in O 0 1.3635857200322565e-11
the O 0 4.1547260076768566e-10
maternal O 0 4.113041907061188e-09
grandfather O 0 5.804047908952725e-09
of O 0 6.386513717870912e-08
two O 0 1.490764955924817e-09
AS B-Disease 1 1.0
first O 0 1.4152232719055746e-09
cousins O 0 1.5370046346774302e-09
, O 0 5.322635387994268e-11
and O 0 8.275240909183523e-11
in O 0 6.886163167463266e-11
the O 0 1.6007092318304217e-09
mother O 0 1.7823241771353082e-09
of O 0 4.9481108099769244e-09
an O 0 1.6356211940404819e-09
AS B-Disease 1 1.0
daughter O 0 7.6189348874322604e-06
. O 0 1.0899394737862167e-06

The O 0 3.0040805398812154e-08
frequencies O 0 3.4341831600670503e-09
with O 0 1.0469067973639667e-10
which O 0 1.3663774278693808e-10
we O 0 2.137022225845442e-10
detected O 0 1.044764941227072e-09
mutations O 0 2.2684011613538502e-10
were O 0 1.3153111932950878e-10
5 O 0 1.0539035200096691e-09
( O 0 1.605266267135086e-11
14 O 0 3.306080409437584e-10
% O 0 1.0388048060638866e-11
) O 0 7.621324578377386e-12
of O 0 5.375794254192101e-10
35 O 0 1.434412144618591e-09
in O 0 5.0699899140083104e-11
sporadic O 0 6.140758568307092e-09
cases O 0 2.3788968017690593e-10
and O 0 1.3369981510802376e-10
8 O 0 1.8385224453965066e-09
( O 0 1.5749953424792906e-11
80 O 0 4.432038902546509e-10
% O 0 9.17250910642542e-12
) O 0 9.61004973515367e-12
of O 0 3.6724889795891613e-10
10 O 0 7.397352175253502e-10
in O 0 1.785937231435497e-10
familial O 0 4.211537429910095e-08
cases O 0 2.1540964567634546e-09
. O 0 1.0413748752213792e-09
. O 0 2.1464854782493603e-08

The O 0 4.22750563302543e-05
hemochromatosis B-Disease 1 1.0
845 O 0 6.487122300313786e-05
G O 0 4.29261444878648e-06
- O 0 2.8637654736485274e-07
- O 0 2.1062622579393064e-07
> O 0 1.638588464913937e-08
A O 0 2.1278809825275857e-08
and O 0 2.1421558971113086e-10
187 O 0 1.328665621969094e-09
C O 0 2.2323151327441337e-08
- O 0 1.2459619824767287e-07
- O 0 1.27537430216762e-06
> O 0 2.7198584007237514e-07
G O 0 6.553617367899278e-06
mutations O 0 2.679625410451081e-09
: O 0 1.2161153160883398e-11
prevalence O 0 9.207540840883155e-10
in O 0 3.629908873481469e-11
non O 0 8.43907912440045e-08
- O 0 2.0565410352446634e-07
Caucasian O 0 2.2346588934851752e-07
populations O 0 6.064264201910419e-09
. O 0 5.3122350962553355e-09

Hemochromatosis B-Disease 0 0.001294800778850913
, O 0 1.7318697587143106e-08
the O 0 4.893722689303104e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 0 2.1447110611916287e-06
, O 0 1.401776889009554e-10
leads O 0 6.170647881553748e-10
, O 0 6.42402381290097e-11
if O 0 8.222788006051474e-10
untreated O 0 0.002036700025200844
, O 0 1.8607611285137438e-10
to O 0 1.640927060897468e-09
progressive O 1 0.9999967813491821
iron B-Disease 1 1.0
overload I-Disease 1 0.6853017210960388
and O 0 2.542915922276734e-07
premature B-Disease 0 2.1372341052483534e-06
death I-Disease 0 7.550829081992561e-07
. O 0 1.4030614181592682e-07

The O 0 1.2351724762993399e-05
hemochromatosis B-Disease 1 1.0
gene O 0 3.547417861682334e-07
, O 0 3.9025756848332094e-08
HFE O 1 1.0
, O 0 1.159909324144337e-08
recently O 0 3.950806348740343e-09
has O 0 1.5133248820742295e-10
been O 0 2.298652761190123e-11
identified O 0 3.346498078649063e-11
, O 0 2.601199811103072e-11
and O 0 7.987205341564163e-11
characterization O 0 8.969481157805603e-09
of O 0 6.512364336686005e-08
this O 0 5.776104594623632e-10
gene O 0 7.362261356114175e-10
has O 0 9.439055786986117e-11
shown O 0 1.8003831064872244e-11
that O 0 2.155572812259643e-12
it O 0 1.060002779995628e-11
contains O 0 1.470728816510558e-10
two O 0 1.7419383643857422e-11
mutations O 0 1.0816524759205137e-10
that O 0 1.557819498398949e-11
result O 0 2.506852503358914e-10
in O 0 3.15043269250026e-10
amino O 0 2.3800192927581065e-09
acid O 0 2.8874851398796864e-09
substitutions O 0 4.66094451923027e-09
- O 0 1.444304409403685e-08
cDNA O 0 1.2113228642363083e-08
nucleotides O 0 1.5687010579412686e-09
845 O 0 2.3090265699465817e-08
G O 0 1.5254574492473694e-08
- O 0 1.2854120434724337e-08
- O 0 3.7838916000509926e-08
> O 0 1.0162880315078837e-08
A O 0 1.7487520764802866e-08
( O 0 5.4740878496772893e-11
C282Y O 0 5.7828568600371e-08
) O 0 1.612720547383706e-11
and O 0 5.600482924639216e-11
187 O 0 9.216414298407472e-10
C O 0 9.43920941409715e-09
- O 0 6.436493293904277e-08
- O 0 3.745548156075529e-07
> O 0 1.1677257560904764e-07
G O 0 2.458929429849377e-06
( O 0 1.9020280905834852e-09
H63D O 1 0.9998359680175781
) O 0 7.821096659199611e-09
. O 0 2.625939110600939e-08

Although O 0 4.012904810224427e-06
hemochromatosis B-Disease 1 1.0
is O 0 2.0472961992368255e-08
common O 0 1.412596595251614e-09
in O 0 2.2515513065091142e-10
Caucasians O 0 4.026664726097806e-07
, O 0 3.3669957932858097e-09
affecting O 0 1.0454616017341323e-07
> O 0 2.8069338853242698e-08
= O 0 1.2666661053373218e-09
1 O 0 1.7432896237679074e-09
/ O 0 2.3077926236680923e-09
300 O 0 3.3191149828581956e-10
individuals O 0 4.636766231386202e-12
of O 0 1.266907134755968e-10
northern O 0 1.7769102855780261e-09
European O 0 4.832637068297174e-10
origin O 0 2.6290721336086342e-11
, O 0 6.022171476771643e-12
it O 0 8.643689063114746e-12
has O 0 1.2073098597242815e-11
not O 0 4.258686719244009e-12
been O 0 3.647363314152052e-11
recognized O 0 9.790259714037575e-10
in O 0 1.9454171606980708e-10
other O 0 2.492650086338699e-09
populations O 0 3.39533934301528e-09
. O 0 1.6737136121491858e-08

The O 0 1.3208325810865063e-07
present O 0 6.028352039777474e-09
study O 0 2.840495061384729e-10
used O 0 1.0109087178467036e-10
PCR O 0 7.867073215095388e-09
and O 0 3.6321548546602855e-10
restriction O 0 4.954041177285262e-09
- O 0 6.534048413442406e-09
enzyme O 0 2.342936122889938e-10
digestion O 0 4.994722413442787e-10
to O 0 2.0089015520530218e-11
analyze O 0 2.331550230660895e-10
the O 0 7.793882206286185e-11
frequency O 0 2.4964696976326195e-10
of O 0 3.8465137741638955e-09
the O 0 1.0302721342725363e-08
845 O 0 1.7351440817492403e-07
G O 0 7.626123021964304e-08
- O 0 3.129092362996744e-08
- O 0 5.98124714201731e-08
> O 0 6.453885426083161e-09
A O 0 7.408129665265051e-09
and O 0 7.731253831577689e-11
187 O 0 4.761672722786159e-10
C O 0 3.8601029039853074e-09
- O 0 1.4205110865361803e-08
- O 0 1.0098712976969182e-07
> O 0 5.98767400106226e-08
G O 0 1.7556486682224204e-06
mutations O 0 5.418890225428186e-09
in O 0 4.949420873145982e-10
HLA O 0 1.4317745353764622e-06
- O 0 5.4925660464277826e-08
typed O 0 3.4729414899459243e-09
samples O 0 4.0812086349317767e-11
from O 0 9.009933424342087e-12
non O 0 3.1412836776212316e-09
- O 0 3.5759204486396357e-09
Caucasian O 0 7.0888424019699414e-09
populations O 0 3.666097286858516e-11
, O 0 1.0329268690378868e-11
comprising O 0 1.6065924632324702e-11
Australian O 0 1.9265959660952348e-10
Aboriginal O 0 9.21400622466706e-10
, O 0 3.88605050916091e-11
Chinese O 0 3.694000105802786e-10
, O 0 5.7823405785750737e-11
and O 0 9.453365867884145e-10
Pacific O 0 5.302984718014159e-08
Islanders O 0 3.3870085189846577e-06
. O 0 2.095169406857167e-07

Results O 0 2.7190640849994452e-08
showed O 0 2.0355168661723155e-09
that O 0 7.917750483033004e-11
the O 0 3.7150227338855757e-09
845 O 0 2.690150893158716e-07
G O 0 4.4602410298466566e-07
- O 0 4.024929864954174e-07
- O 0 1.050341893460427e-06
> O 0 5.908126610165709e-08
A O 0 6.54310525760593e-08
mutation O 0 5.619092413589044e-10
was O 0 2.7891913778610444e-10
present O 0 6.677201153104662e-11
in O 0 1.878167933677677e-11
these O 0 7.111722322150626e-11
populations O 0 1.3124093478644738e-10
( O 0 8.422403399710454e-12
allele O 0 1.1645495331946698e-11
frequency O 0 5.5693144540569506e-11
0 O 0 7.124918710577077e-11
. O 0 1.0127319122199552e-11
32 O 0 3.1446334425311306e-10
% O 0 6.920314148117779e-12
) O 0 4.080490719621244e-12
, O 0 8.724601770204732e-12
and O 0 6.763387766506312e-11
, O 0 3.995269046153105e-11
furthermore O 0 1.1924462806067737e-10
, O 0 3.079617810763935e-11
it O 0 2.5813410436947848e-11
was O 0 3.217605515359878e-09
always O 0 1.973846641689647e-09
seen O 0 1.2925064352131699e-09
in O 0 1.309456293396849e-10
conjunction O 0 5.554679827213249e-09
with O 0 1.7800683149715724e-09
HLA O 0 9.45241299632471e-06
haplotypes O 0 1.2440592556117736e-08
common O 0 8.641174997769951e-10
in O 0 1.2995385323399944e-10
Caucasians O 0 2.1410350825590285e-08
, O 0 2.0947374390622997e-10
suggesting O 0 4.522091867631417e-10
that O 0 7.174694865996756e-11
845 O 0 1.6607464203843847e-07
G O 0 4.53465077043802e-07
- O 0 6.995073817961384e-07
- O 0 3.0156077173160156e-06
> O 0 7.243178856697341e-08
A O 0 9.328246619588754e-08
may O 0 1.4818454796561298e-10
have O 0 8.337595371055162e-12
been O 0 9.470230155628201e-12
introduced O 0 2.934497783657619e-11
into O 0 2.1568897709545176e-11
these O 0 4.178946251542914e-12
populations O 0 1.2378419469993851e-11
by O 0 2.278320934689937e-11
Caucasian O 0 2.418146323179826e-07
admixture O 0 2.5389661573171907e-07
. O 0 1.4723055130616558e-07

187 O 0 5.644275802296761e-07
C O 0 2.807839791785227e-07
- O 0 1.009671066753981e-07
- O 0 9.452797655740142e-08
> O 0 1.6472560204761066e-08
G O 0 9.408727663640093e-08
was O 0 1.300454188779554e-09
present O 0 1.308816943712543e-10
at O 0 2.7122395995782256e-10
an O 0 4.1157605101815875e-11
allele O 0 2.551497624292409e-10
frequency O 0 1.2672534133173485e-09
of O 0 2.252575903582965e-08
2 O 0 9.301309660258994e-07
. O 0 2.963718941373372e-07

68 O 0 1.2493022722992464e-06
% O 0 1.6903698440984272e-09
in O 0 1.617582595647704e-10
the O 0 1.9141617180196135e-09
two O 0 2.0229137809302244e-10
populations O 0 2.421212397241135e-10
analyzed O 0 1.1312061287682695e-09
( O 0 1.3875400828311513e-10
Australian O 0 1.975458685521403e-09
Aboriginal O 0 6.430895371778433e-09
and O 0 3.999068021176555e-10
Chinese O 0 3.514603497123403e-09
) O 0 1.525677806313297e-09
. O 0 1.606855448699207e-08

In O 0 1.8769819476460725e-08
the O 0 1.5191190527730214e-08
Australian O 0 6.830978449556824e-09
Aboriginal O 0 4.485713578361583e-09
samples O 0 1.4377504742313363e-10
, O 0 3.407298748703269e-11
187 O 0 6.641614480606961e-10
C O 0 7.473926366685646e-09
- O 0 2.8994071143984e-08
- O 0 1.8494552023184951e-07
> O 0 2.1822762263923323e-08
G O 0 2.0409768808349327e-07
was O 0 1.2984514574654327e-09
found O 0 3.622618871546024e-11
to O 0 3.230891942873626e-11
be O 0 2.911050220322231e-11
associated O 0 1.967598445284935e-10
with O 0 1.1313076031527203e-09
HLA O 0 0.00024508917704224586
haplotypes O 0 1.776873759240516e-08
common O 0 4.6488321525650633e-10
in O 0 6.259694151911077e-11
Caucasians O 0 1.3884839056288456e-08
, O 0 6.006745101316824e-11
suggesting O 0 2.978958746346905e-11
that O 0 6.02425097653847e-12
it O 0 4.2492041135711034e-11
was O 0 9.928760036359563e-10
introduced O 0 6.632195903577554e-10
by O 0 2.5779964274441625e-10
recent O 0 1.2181275543809988e-08
admixture O 0 7.715942729191738e-07
. O 0 4.279769427739666e-07

In O 0 3.104694101807581e-08
the O 0 1.6440166561437763e-08
Chinese O 0 7.041045524402989e-09
samples O 0 1.4348437715749895e-10
analyzed O 0 2.673513077589007e-10
, O 0 6.028300081339921e-11
187 O 0 6.423401810451423e-10
C O 0 3.306674489778061e-09
- O 0 9.408221757212232e-09
- O 0 2.8080906488980872e-08
> O 0 5.737271102645991e-09
G O 0 8.142296081814493e-08
was O 0 1.1798433341425607e-09
present O 0 8.339730989126437e-11
in O 0 4.002057019114602e-11
association O 0 5.461531227268779e-11
with O 0 3.1346789747255244e-11
a O 0 1.8404582025066674e-10
wide O 0 1.6857150342275418e-08
variety O 0 7.538495161441006e-09
of O 0 1.6741735109349065e-08
HLA O 0 4.386329692351865e-06
haplotypes O 0 2.730730752631416e-09
, O 0 7.334170076811475e-11
showing O 0 1.408568262029064e-10
this O 0 1.0046475804048605e-11
mutation O 0 4.1631007668962994e-11
to O 0 2.1689858242801563e-11
be O 0 5.373618217063836e-11
widespread O 0 9.009632484513475e-10
and O 0 6.44260422788534e-10
likely O 0 4.3852196873750415e-10
to O 0 3.414691307490614e-10
predate O 0 3.4200134280126804e-08
the O 0 4.331123903966727e-09
more O 0 5.809117076260861e-10
genetically O 0 1.2913983660212125e-08
restricted O 0 5.713301387544334e-09
845 O 0 1.2686101058534405e-07
G O 0 5.816950761072803e-07
- O 0 6.771722382836742e-07
- O 0 2.28381668421207e-06
> O 0 2.809087789046316e-07
A O 0 5.281403900880832e-07
mutation O 0 1.4366148093358788e-07
. O 0 2.858564052132806e-08

Genotype O 0 9.083436452783644e-06
- O 0 1.4842804603176774e-06
phenotype O 0 1.6130098856592667e-07
correlations O 0 1.2056094078616297e-07
in O 0 2.743313309849782e-08
attenuated B-Disease 1 0.9695979952812195
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 4.425431143317837e-06

Germ O 0 6.047392889740877e-05
- O 0 4.368379450170323e-06
line O 0 7.661491281396593e-07
mutations O 0 1.217096468053569e-08
of O 0 1.2146196937123932e-08
the O 0 1.4428836792035327e-08
tumor B-Disease 0 0.00019345151667948812
suppressor O 0 2.7472271540318616e-05
APC O 0 6.668898890893615e-07
are O 0 1.8085927200317542e-10
implicated O 0 2.1922041959498983e-09
in O 0 2.1224078050607886e-09
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.1652202753539314e-07
AAPC B-Disease 1 1.0
) O 0 8.727407130315612e-10
, O 0 7.703286619697991e-11
a O 0 1.2344474054071242e-10
variant O 0 1.5220925320136303e-07
of O 0 4.107120275875786e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.456849870213773e-07
FAP B-Disease 1 0.644223690032959
) O 0 1.277556194168028e-08
. O 0 3.40358852213285e-08

AAPC B-Disease 1 1.0
is O 0 9.826543134749954e-08
recognized O 0 3.787689806244998e-08
by O 0 1.4759220234861203e-10
the O 0 3.313663787807286e-09
occurrence O 0 4.6965446642843744e-08
of O 0 1.1024198443010391e-07
< O 0 1.0983538913933444e-06
100 O 0 1.1340090821931881e-07
colonic B-Disease 0 0.0002687807136680931
adenomas I-Disease 0 3.375820961082354e-05
and O 0 3.783153346148538e-09
a O 0 8.174172450026163e-10
later O 0 3.637113277221715e-09
onset O 0 4.6440686674031895e-07
of O 0 5.143574162502773e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.655487272411165e-10
age O 0 6.848573930184898e-10
> O 0 4.2145223422274114e-10
40 O 0 2.2782439823565426e-10
years O 0 1.6923529244650126e-10
) O 0 1.124007664721205e-09
. O 0 1.870555976779542e-08

The O 0 1.6524742818546656e-07
aim O 0 1.2777444169387309e-07
of O 0 1.5345623438633993e-08
this O 0 1.1330864718717137e-10
study O 0 3.476571808214146e-10
was O 0 1.0094159952345194e-09
to O 0 4.995694413700846e-10
assess O 0 6.440890132353161e-08
genotype O 0 8.6032436286132e-08
- O 0 6.235155751710408e-07
phenotype O 0 1.0060647070986306e-07
correlations O 0 2.0757923380188004e-07
in O 0 2.397474929693999e-08
AAPC B-Disease 1 1.0
families O 0 2.141398347532686e-08
. O 0 5.670043279337733e-08

By O 0 1.3340547333484665e-08
protein O 0 1.9042287746628972e-08
- O 0 7.664401380225172e-08
truncation O 0 3.22058554047544e-07
test O 0 5.521216817072627e-09
( O 0 6.235388316788715e-10
PTT O 0 6.215248049556976e-06
) O 0 1.2462096632415154e-10
assay O 0 1.0396382643662605e-09
, O 0 4.279534365769777e-11
the O 0 1.3672246668150478e-10
entire O 0 1.6950836290163807e-09
coding O 0 2.5724768981660873e-09
region O 0 1.253032433368162e-08
of O 0 2.510510732633975e-08
the O 0 2.3559158179864426e-08
APC B-Disease 0 1.640312063955207e-07
gene O 0 4.954596177775272e-10
was O 0 6.057844781359734e-10
screened O 0 2.0195147776291833e-09
in O 0 5.203106695494952e-11
affected O 0 1.016832396061318e-09
individuals O 0 1.9049449517805073e-11
from O 0 4.832748090599637e-10
11 O 0 8.030508524825564e-08
AAPC B-Disease 1 1.0
kindreds O 0 2.4111329821607796e-06
, O 0 4.2647060882750054e-10
and O 0 1.7970629151431439e-10
their O 0 3.7342731684653074e-10
phenotypic O 0 2.3764486911659333e-07
differences O 0 1.6026469040753e-08
were O 0 1.058088838767901e-09
examined O 0 7.259652079483203e-08
. O 0 4.7563585070520276e-08

Five O 0 8.661477863824985e-07
novel O 0 4.3132294536007976e-07
germ O 0 6.797539526814944e-07
- O 0 4.1486256918688014e-07
line O 0 4.006172673598485e-07
APC B-Disease 0 1.7339429803087114e-07
mutations O 0 1.2091916357093169e-09
were O 0 5.7763325372883756e-11
identified O 0 1.0582256598778983e-10
in O 0 1.789794146223045e-10
seven O 0 1.5059839597597602e-08
kindreds O 0 1.1851861017930787e-05
. O 0 1.9155402242176933e-07

Mutations O 0 4.697682598475694e-08
were O 0 7.375248189944728e-10
located O 0 1.2683101235921868e-09
in O 0 3.9678996199832284e-11
three O 0 3.802131526287056e-11
different O 0 8.093074821413637e-12
regions O 0 8.8403262488157e-10
of O 0 1.7262568263731737e-08
the O 0 4.5932210923638195e-08
APC B-Disease 0 2.3497189260979212e-07
gene O 0 2.5855603769109337e-10
( O 0 1.2979698912896076e-11
1 O 0 6.795252138758201e-10
) O 0 9.242123559516369e-12
at O 0 1.235809093946827e-10
the O 0 4.6237355610934117e-10
5 O 0 2.0544614898199143e-09
end O 0 1.6792831569745204e-09
spanning O 0 2.5229516253943984e-09
exons O 0 3.988420704814644e-09
4 O 0 1.1850100900545613e-09
and O 0 7.98808866275813e-11
5 O 0 1.2463339249535466e-09
, O 0 8.041516758039435e-11
( O 0 1.9955962229922797e-11
2 O 0 1.2105763058656294e-09
) O 0 4.114347751382752e-11
within O 0 5.469933880841715e-11
exon O 0 3.3989417946855838e-09
9 O 0 1.234631619162485e-09
, O 0 4.312745299772658e-11
and O 0 5.108682574195278e-11
( O 0 1.021679876117565e-11
3 O 0 3.0583649501814136e-10
) O 0 9.874584656899277e-12
at O 0 9.433909209377589e-11
the O 0 2.361829898323009e-10
3 O 0 6.4561387347339405e-09
distal O 0 1.4680614413009607e-07
end O 0 8.206310297964592e-09
of O 0 2.9217906316603148e-08
the O 0 5.850018780506616e-08
gene O 0 4.619949578454907e-08
. O 0 7.925785183715561e-08

Variability O 0 1.3568289887189167e-06
in O 0 1.5608396797262003e-09
the O 0 1.978811114966561e-09
number O 0 1.4095580258555174e-09
of O 0 4.91469450025761e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 6.633263751609775e-07
most O 0 8.625696268360628e-10
apparent O 0 1.1286522827447243e-09
in O 0 2.4165006801135647e-11
individuals O 0 4.4090842088451154e-12
with O 0 8.2388557781643e-12
mutations O 0 2.796601283883149e-10
in O 0 3.2169822361538536e-11
region O 0 9.084700991479622e-09
1 O 0 3.406212201184644e-08
, O 0 1.5624115889956158e-10
and O 0 5.049090034958681e-10
upper O 0 4.0903566400629643e-07
- O 0 0.00011191487283213064
gastrointestinal O 1 1.0
manifestations O 0 2.7668829716276377e-05
were O 0 3.196201359134676e-10
more O 0 2.5742413409246545e-11
severe O 0 2.3751182354203593e-08
in O 0 2.2201435134761027e-10
them O 0 1.3872125670388868e-09
. O 0 1.8341067331562044e-08

In O 0 9.525789046449518e-09
individuals O 0 1.3094787754130977e-10
with O 0 3.9296840087521545e-11
mutations O 0 2.2209312167120743e-10
in O 0 4.7070930486725615e-11
either O 0 4.2903572361474573e-10
region O 0 4.124770747182538e-09
2 O 0 8.405116602716589e-09
or O 0 1.0596232918880233e-10
region O 0 1.917684455676749e-09
3 O 0 2.6761368676631037e-09
, O 0 7.685059533191207e-11
the O 0 2.1414370277028638e-10
average O 0 2.802426901649113e-10
number O 0 4.829080468837788e-10
of O 0 1.5873627745577323e-08
adenomas B-Disease 0 9.880019206320867e-06
tended O 0 1.3793982844845232e-08
to O 0 2.728584302946757e-10
be O 0 3.118410737967814e-11
lower O 0 1.5126958019529013e-10
than O 0 3.771016051506981e-12
those O 0 6.833457411037358e-12
in O 0 4.1558154487142396e-12
individuals O 0 1.0582124369482027e-12
with O 0 3.957919929298281e-12
mutations O 0 3.425472752671688e-11
in O 0 2.6027532559758093e-11
region O 0 2.768870466240969e-09
1 O 0 6.173841438084082e-09
, O 0 7.018498976441023e-11
although O 0 6.69662658658865e-11
age O 0 1.0030059005572411e-09
at O 0 8.9874924169564e-10
diagnosis O 0 1.9365710812735415e-08
was O 0 8.983863430955807e-09
similar O 0 3.1178444714896614e-08
. O 0 1.36216641521969e-07

In O 0 1.4554079541539977e-07
all O 0 3.968579846969078e-07
AAPC B-Disease 1 1.0
kindreds O 0 1.6063540897448547e-05
, O 0 2.4987765190331857e-09
a O 0 3.805688819635833e-10
predominance O 0 3.079898647229129e-08
of O 0 4.7085187304674037e-08
right O 0 2.7383632641431177e-06
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.996641993522644
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 0 2.412186404399108e-06
was O 0 5.6035581508240284e-08
observed O 0 5.747909526121475e-08
. O 0 3.5208518767149144e-08

No O 0 9.823010259424336e-06
desmoid B-Disease 1 0.9997406601905823
tumors I-Disease 1 1.0
were O 0 1.1242334174710322e-08
found O 0 7.73609620807747e-10
in O 0 2.938257137596878e-10
these O 0 4.676813603055052e-09
kindreds O 0 2.9744098810624564e-06
. O 0 6.86071359723428e-08

Our O 0 1.0697294783312827e-07
data O 0 1.1473578753751212e-09
suggest O 0 2.089246831094016e-10
that O 0 2.4235582291032287e-11
, O 0 1.7808891861204046e-10
in O 0 1.1036601632596899e-09
AAPC B-Disease 1 1.0
families O 0 2.698184453642227e-10
, O 0 4.6117547281010474e-11
the O 0 7.700715759506593e-11
location O 0 1.4519656588163343e-09
of O 0 8.417822883188819e-09
the O 0 1.1300642910327952e-07
APC B-Disease 0 5.8096371503779665e-05
mutation O 0 1.871459289759514e-07
may O 0 3.891365452091122e-09
partially O 0 1.6706923133824603e-07
predict O 0 1.8017873415487884e-08
specific O 0 1.5257048957550978e-08
phenotypic O 0 5.172547389520332e-06
expression O 0 4.9426045478639935e-08
. O 0 4.2191917515310706e-08

This O 0 1.3472176707551853e-09
should O 0 2.71151573416617e-10
help O 0 2.794589559762528e-11
in O 0 2.5602858375051163e-11
the O 0 5.270027192416649e-10
design O 0 2.602181403688064e-08
of O 0 1.5003443820660323e-08
tailored O 0 4.288005683861229e-08
clinical O 0 4.033705636175e-08
- O 0 1.7432173038400833e-08
management O 0 2.061920190143951e-09
protocols O 0 5.531631153132821e-09
in O 0 7.521310657621072e-11
this O 0 4.7204708891745994e-11
subset O 0 3.868763531755803e-09
of O 0 3.6193419372665403e-09
FAP B-Disease 0 0.0002640854800119996
patients O 0 1.9764876402206255e-09
. O 0 3.8704001115164033e-10
. O 0 1.496580281923343e-08

Wilms B-Disease 1 1.0
' I-Disease 0 5.725367373088375e-05
tumor I-Disease 1 0.6834142208099365
1 O 0 2.3204421495393035e-07
and O 0 4.389296925921826e-09
Dax O 1 0.9997987151145935
- O 0 4.31016161428488e-07
1 O 0 5.4048545194973485e-08
modulate O 0 3.39632535428791e-08
the O 0 5.863577623443916e-09
orphan O 0 4.7102254541186994e-08
nuclear O 0 3.674811921428045e-08
receptor O 0 2.3947007932179076e-08
SF O 1 0.9999998807907104
- O 0 1.7430453169708926e-07
1 O 0 8.103111959201215e-09
in O 0 5.908860900571966e-11
sex O 0 1.3559667277895926e-10
- O 0 7.126743639673805e-10
specific O 0 3.5207073367793384e-10
gene O 0 1.49896783874226e-09
expression O 0 3.385399960365021e-09
. O 0 7.911101995716763e-09

Products O 0 8.46294938128267e-07
of O 0 3.6124649227531336e-07
steroidogenic O 0 1.245567727892194e-05
factor O 0 6.795348639343501e-08
1 O 0 3.9528583073433765e-08
( O 0 5.489146359671793e-10
SF O 1 1.0
- O 0 1.552841553120743e-07
1 O 0 2.7416970027616117e-08
) O 0 3.122090364016117e-10
and O 0 1.8286948622048271e-09
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.999998927116394
1 O 0 1.8899798703841952e-07
( O 0 6.565940013913973e-10
WT1 O 0 8.636759048386011e-06
) O 0 4.895404914773138e-11
genes O 0 1.2090474454939937e-11
are O 0 6.296485143171549e-13
essential O 0 9.520293581255501e-11
for O 0 6.395269036563178e-11
mammalian O 0 1.9869775158554148e-08
gonadogenesis O 0 8.751917448535096e-07
prior O 0 1.2171196495103231e-08
to O 0 7.883265595864941e-09
sexual O 0 5.5275840793456155e-08
differentiation O 0 4.7683300863354816e-08
. O 0 4.894291905088721e-08

In O 0 2.3989752406805565e-08
males O 0 1.2449660857782874e-08
, O 0 1.2981493657804322e-09
SF O 1 1.0
- O 0 6.839911179667979e-07
1 O 0 3.665641301608957e-08
participates O 0 1.8303421001064635e-09
in O 0 4.2580557135796226e-11
sexual O 0 5.045352330368402e-11
development O 0 2.848543666569836e-12
by O 0 1.6789986284973524e-12
regulating O 0 7.629597398306487e-09
expression O 0 3.542599547046166e-10
of O 0 1.6311599848606306e-09
the O 0 8.253731920149221e-09
polypeptide O 0 6.273232884268509e-07
hormone O 0 2.4444116775157454e-07
Mullerian O 0 2.552792284404859e-05
inhibiting O 0 1.1932527286262484e-06
substance O 0 2.0461257577153447e-07
( O 0 3.6810043901880363e-09
MIS O 1 0.9999836683273315
) O 0 8.476921387057246e-09
. O 0 4.2667121391559704e-08

Here O 0 1.0456645327394654e-08
, O 0 2.5491493360618733e-09
we O 0 3.820802285670055e-10
show O 0 2.117244601862467e-09
that O 0 8.585809840866432e-10
WT1 O 0 0.008366167545318604
- O 0 6.885131733724847e-05
KTS O 1 0.9568309783935547
isoforms O 0 8.889127656175333e-09
associate O 0 1.2313657649087872e-08
and O 0 1.7173398259018313e-09
synergize O 0 3.0714270451426273e-06
with O 0 6.7719141405575556e-09
SF O 1 1.0
- O 0 4.770254690811271e-06
1 O 0 2.855769025700283e-07
to O 0 9.230686437433633e-09
promote O 0 1.6230534356509452e-06
MIS O 1 1.0
expression O 0 1.9459540112620743e-07
. O 0 2.912804397681157e-08

In O 0 3.6679629999980534e-08
contrast O 0 7.98590633621643e-08
, O 0 8.523749528421831e-08
WT1 O 1 0.9993540644645691
missense O 0 3.3199082736246055e-06
mutations O 0 1.2470241728124165e-08
, O 0 1.2072229327309003e-10
associated O 0 1.754650730267926e-10
with O 0 2.6328120239504926e-10
male B-Disease 0 2.500107854075395e-08
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.9627717229298014e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.252248331226838e-09
fail O 0 2.536269505526434e-08
to O 0 2.0215611407081724e-09
synergize O 0 1.479019283578964e-05
with O 0 2.274165211701984e-08
SF O 1 1.0
- O 1 0.5990369319915771
1 O 0 4.989642093278235e-06
. O 0 9.765854969145948e-08

Additionally O 0 1.4499467226869456e-07
, O 0 2.2630264329137617e-09
the O 0 1.7445335176446974e-09
X O 0 8.83134191553836e-07
- O 0 3.0014291496627266e-07
linked O 0 9.225796304690448e-08
, O 0 7.532713341973363e-10
candidate O 0 2.9381859167898483e-09
dosage O 0 1.6419961923475057e-07
- O 0 3.996159492203333e-08
sensitive O 0 2.4757932237662317e-07
sex O 0 1.127937854228378e-09
- O 0 3.917713709000736e-09
reversal O 0 3.1026916591514464e-09
gene O 0 2.7517163547763346e-10
, O 0 2.221795525336745e-10
Dax O 0 0.09561702609062195
- O 0 2.0080967999547283e-07
1 O 0 8.50616004299809e-08
, O 0 2.676790344935398e-09
antagonizes O 0 2.041480229308945e-06
synergy O 0 1.6167366823083285e-07
between O 0 2.908067564533212e-09
SF O 1 0.9999998807907104
- O 0 7.299375681668607e-08
1 O 0 1.3668766563057488e-08
and O 0 6.585330059039052e-10
WT1 O 0 0.00013623286213260144
, O 0 4.459904667797332e-10
most O 0 1.2908503432829121e-10
likely O 0 1.0843501790924748e-10
through O 0 2.5079702203889553e-11
a O 0 5.458448623651968e-11
direct O 0 1.5973838918270644e-10
interaction O 0 3.4650002311842343e-10
with O 0 9.616936136325194e-10
SF O 1 1.0
- O 0 2.8338090487523004e-05
1 O 0 1.3589658465207322e-06
. O 0 8.422772879157492e-08

We O 0 6.755081471965241e-08
propose O 0 2.489833583751988e-08
that O 0 1.4324108565944016e-09
WT1 O 0 0.0015497333370149136
and O 0 7.218684316967483e-08
Dax O 1 0.9999651908874512
- O 0 4.724468567474105e-07
1 O 0 3.955173610847851e-08
functionally O 0 4.090268124201657e-09
oppose O 0 4.1576989073810466e-10
each O 0 1.633331317418829e-11
other O 0 3.355548477967929e-11
in O 0 5.485888479594969e-11
testis O 0 1.0973722908147465e-07
development O 0 1.925868492458349e-10
by O 0 2.9798125078528415e-10
modulating O 0 1.2990178674954223e-06
SF O 1 1.0
- O 0 1.773487929312978e-05
1 O 0 8.967411986304796e-07
- O 0 3.865218616283528e-07
mediated O 0 8.688980557280956e-08
transactivation O 0 1.2413179319992196e-06
. O 0 2.758270278846453e-09
. O 0 1.8098056386861572e-08

A O 0 1.6994246152535197e-06
mouse O 0 4.156108701636185e-08
model O 0 1.594371301649744e-09
for O 0 2.799735554503968e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9565805792808533
- O 0 6.160335033200681e-05
centre O 0 2.3065342702466296e-06
mutations O 0 3.409495548112318e-07
. O 0 2.3296054862953497e-08

Imprinting O 0 1.0068505616800394e-05
in O 0 2.306253499284594e-08
the O 0 6.018474607571989e-08
15q11 O 0 9.11109509615926e-06
- O 0 1.4945769635232864e-06
q13 O 0 8.352893928531557e-06
region O 0 9.498831587961831e-08
involves O 0 1.3878325155758375e-08
an O 0 3.6158764871174753e-10
imprinting O 0 3.714851288805221e-07
centre O 0 1.0917189285919449e-07
( O 0 7.530184809034779e-10
IC O 0 1.309345975641918e-06
) O 0 6.28656779411152e-11
, O 0 1.5754881774188156e-11
mapping O 0 3.417465269106579e-11
in O 0 1.2632919016430932e-11
part O 0 3.453572150480255e-10
to O 0 1.6253513812625187e-10
the O 0 9.81198233773739e-10
promoter O 0 1.5194717661870527e-07
and O 0 6.19170759108556e-09
first O 0 1.37391040766488e-08
exon O 0 9.843028010436683e-07
of O 0 2.183955984946806e-06
SNRPN O 1 1.0
. O 0 9.59468025030219e-07

Deletion O 0 6.727259005856467e-06
of O 0 3.09178830093515e-07
this O 0 5.499146471521499e-09
IC O 0 3.346657831571065e-05
abolishes O 0 2.638033265611739e-06
local O 0 1.7873157176495624e-08
paternally O 0 7.082736175334503e-08
derived O 0 4.401543296506105e-10
gene O 0 8.460953465627696e-11
expression O 0 3.116603156105846e-11
and O 0 1.1694955767693749e-11
results O 0 2.9678658836074234e-11
in O 0 2.0740323347645528e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.73082450173024e-08
PWS B-Disease 1 1.0
) O 0 2.063077886305109e-08
. O 0 4.009520182535198e-08

We O 0 3.201097698024569e-08
have O 0 4.6483530913299376e-10
created O 0 2.469980442398878e-09
two O 0 8.387511796215108e-10
deletion O 0 6.443286082458144e-08
mutations O 0 4.354889782121063e-09
in O 0 2.1447070508440191e-10
mice O 0 1.0557408280931213e-08
to O 0 1.9018755459399017e-09
understand O 0 1.6788453294225292e-08
PWS B-Disease 1 1.0
and O 0 6.59999521701593e-09
the O 0 1.6058833152143848e-09
mechanism O 0 1.7357910664372866e-09
of O 0 2.473445670503338e-09
this O 0 8.537440754352588e-10
IC O 0 5.1922193961218e-05
. O 0 1.6132189273321274e-07

Mice O 0 0.0001229200279340148
harbouring O 0 1.689658165560104e-05
an O 0 1.4928854596973906e-08
intragenic O 0 6.312527148111258e-06
deletion O 0 1.817496126932383e-07
in O 0 1.7701210497378383e-09
Snrpn O 1 0.5196497440338135
are O 0 2.68852784479634e-09
phenotypically O 0 2.5830351546574093e-07
normal O 0 4.054700131206346e-09
, O 0 6.813210412515147e-11
suggesting O 0 1.7838673593839616e-10
that O 0 2.44009864397432e-11
mutations O 0 2.064364013065756e-09
of O 0 5.545596870604186e-09
SNRPN O 1 0.999958872795105
are O 0 1.375319580443346e-10
not O 0 3.546586635483351e-11
sufficient O 0 1.9107255777583987e-09
to O 0 7.067376461833419e-09
induce O 0 6.798785307182698e-06
PWS B-Disease 1 1.0
. O 0 4.344349690654781e-06

Mice O 0 1.1887209439009894e-06
with O 0 2.6004085551534217e-09
a O 0 3.2016580497895575e-09
larger O 0 1.6130245583667602e-08
deletion O 0 4.445827173071848e-08
involving O 0 2.0512742615608204e-09
both O 0 1.0913472348050846e-09
Snrpn O 0 4.840464953304036e-06
and O 0 1.6367884825285728e-09
the O 0 1.262566318160907e-08
putative O 0 4.885226189799141e-06
PWS O 1 1.0
- O 0 8.03546208771877e-06
IC O 0 4.5562508603325114e-05
lack O 0 2.4799280851084404e-08
expression O 0 1.155783468931304e-09
of O 0 2.5086521748818313e-09
the O 0 3.818851901371545e-09
imprinted O 0 1.273628669196114e-07
genes O 0 7.599127549440254e-09
Zfp127 O 0 3.006969564012252e-06
( O 0 1.0843673736715687e-09
mouse O 0 2.109860552934606e-08
homologue O 0 4.1990809052094846e-08
of O 0 1.966069795855674e-08
ZNF127 O 1 1.0
) O 0 1.7685383157939327e-09
, O 0 2.3179431707376352e-09
Ndn O 0 3.821878181042848e-06
and O 0 1.0074200140763878e-08
Ipw O 0 8.890943377082294e-07
, O 0 7.840899041156035e-10
and O 0 9.576993642568254e-10
manifest O 0 1.6242498901419822e-08
several O 0 5.349446441371697e-10
phenotypes O 0 7.539821211821618e-08
common O 0 5.889278398285569e-09
to O 0 2.3437605634057945e-08
PWS B-Disease 1 1.0
infants O 0 0.00023488888109568506
. O 0 6.600324553573955e-08

These O 0 9.644161913513472e-09
data O 0 3.9675229768221243e-10
demonstrate O 0 2.4963647815567924e-10
that O 0 4.346460257681484e-12
both O 0 1.734101751083017e-11
the O 0 1.5671870745581629e-10
position O 0 2.828395850862364e-10
of O 0 8.036797893851144e-10
the O 0 9.335535677834628e-10
IC O 0 1.4201298199623125e-06
and O 0 5.734566155268794e-10
its O 0 5.405075831355077e-10
role O 0 6.909031680102373e-10
in O 0 8.148296620769102e-11
the O 0 5.569859018450529e-10
coordinate O 0 6.451026934861659e-10
expression O 0 4.665166586370617e-10
of O 0 1.4730737740720201e-09
genes O 0 1.0652242976583182e-10
is O 0 3.025859077188109e-11
conserved O 0 1.1554969203686483e-09
between O 0 1.5690354571162857e-10
mouse O 0 4.469495440417859e-09
and O 0 5.739774766588823e-10
human O 0 2.177293206839792e-10
, O 0 3.032792766921588e-11
and O 0 4.699924477380435e-11
indicate O 0 5.024838531375586e-11
that O 0 4.70802433497064e-12
the O 0 3.537198034475608e-10
mouse O 0 8.379696936344772e-09
is O 0 8.416241314979089e-11
a O 0 3.576155344076071e-11
suitable O 0 3.624134325974637e-10
model O 0 6.085473097661165e-11
system O 0 6.979877786861266e-11
in O 0 1.2020526067579862e-11
which O 0 2.0693924004944186e-11
to O 0 7.762267911770593e-11
investigate O 0 1.815772532332005e-09
the O 0 6.178797473666009e-10
molecular O 0 2.1891204404766995e-09
mechanisms O 0 2.7153570503202218e-09
of O 0 4.304917755604265e-09
imprinting O 0 2.343036697993739e-08
in O 0 4.761960964438927e-11
this O 0 1.8719022859547962e-11
region O 0 2.24240226387451e-09
of O 0 2.5193258590405776e-09
the O 0 1.8041249605360576e-09
genome O 0 4.20965401426443e-10
. O 0 1.148187656063726e-09
. O 0 3.596620246071325e-08

Mutations O 0 4.196775194031943e-07
of O 0 3.526370164763648e-07
the O 0 1.7060646939626167e-07
ATM O 0 0.00020040212257299572
gene O 0 3.6027518746095666e-08
detected O 0 1.2728814446916203e-08
in O 0 7.676946855994515e-10
Japanese O 0 0.04470937326550484
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 7.761050824228732e-08
: O 0 4.0423619313001424e-12
possible O 0 9.013645732580677e-12
preponderance O 0 9.840306347541627e-09
of O 0 2.5771620393300054e-09
the O 0 2.5157245175932985e-09
two O 0 7.896866494050414e-10
founder O 0 1.287667572569262e-07
mutations O 0 8.56138768767778e-08
4612del165 O 0 1.067740527105343e-06
and O 0 3.495965117394917e-08
7883del5 O 0 1.578620504005812e-05
. O 0 3.06573355146611e-07

The O 0 1.858551513578277e-06
ATM O 0 0.04416469857096672
( O 0 6.445596767434836e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 5.047291917747998e-09
mutated O 0 1.0089468815976943e-08
) O 0 1.0026955654662828e-10
gene O 0 3.116985280993134e-10
on O 0 2.683860689245421e-09
human O 0 7.710703187058243e-09
chromosome O 0 1.2911254998471122e-07
11q22 O 0 4.208047357678879e-06
. O 0 1.0676137662812835e-07

3 O 0 1.5722536090834183e-06
has O 0 3.7689580345556806e-09
recently O 0 2.274858079687192e-09
been O 0 1.25353796787131e-10
identified O 0 5.207435524456905e-11
as O 0 3.134834405948972e-11
the O 0 1.6315075679340652e-10
gene O 0 1.1304140262735629e-10
responsible O 0 1.9428660069653603e-10
for O 0 4.998055788685285e-11
the O 0 6.800856766631114e-09
human O 0 5.203770001571684e-07
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.2302091906567512e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.010927672799426e-09
. O 0 1.8512439581286344e-08

In O 0 5.279034098748525e-09
order O 0 1.3192564818353958e-09
to O 0 8.546952035004551e-11
define O 0 1.3629735118314557e-09
the O 0 1.7658711992663e-10
types O 0 3.577380169872413e-09
of O 0 8.276148655284032e-09
disease O 0 4.23166602558922e-06
- O 0 3.970759644289501e-05
causing O 0 1.0324712093279231e-05
ATM O 0 1.1364334568497725e-05
mutations O 0 1.6409958947249947e-09
in O 0 5.6219952304648046e-11
Japanese O 0 1.2047668462855654e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 9.432258307739971e-10
as O 0 1.6105627248519383e-11
well O 0 1.1613021308476412e-11
as O 0 9.269168765868585e-12
to O 0 1.7914562194798478e-11
look O 0 1.1351738993248262e-10
for O 0 9.575637505143675e-11
possible O 0 4.36843361484307e-09
mutational O 0 1.4043173450772883e-06
hotspots O 0 6.534524743528891e-08
, O 0 5.417357673564993e-10
reverse O 0 2.987069480653304e-09
- O 0 8.781478655350838e-09
transcribed O 0 1.495335522072594e-09
RNA O 0 1.1164141833219787e-09
derived O 0 1.729761126001428e-11
from O 0 3.838621694812749e-12
ten O 0 5.503896782776962e-10
patients O 0 2.0877162845711617e-11
belonging O 0 2.209500984950985e-11
to O 0 8.141973900643862e-11
eight O 0 1.49639123314671e-09
unrelated O 0 7.93098386964175e-09
Japanese O 0 1.371905256064565e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 7.015768521689836e-11
was O 0 4.232648120883198e-10
analyzed O 0 4.615171300681453e-10
for O 0 1.1213475981097787e-10
mutations O 0 1.0110031561927357e-10
by O 0 2.0421803137438133e-11
the O 0 1.8884360741822093e-09
restriction O 0 6.6054357539258035e-09
endonuclease O 0 3.9219695935344134e-08
fingerprinting O 0 3.7004987518685084e-08
method O 0 1.228552903853597e-08
. O 0 1.0986179077576708e-08

As O 0 5.139241210372347e-08
has O 0 6.753774761669717e-10
been O 0 5.828092175530486e-11
reported O 0 2.2412368835822427e-11
by O 0 7.017826424149387e-12
others O 0 2.3025065187809446e-10
, O 0 3.295107520173701e-10
mutations O 0 5.690883320141893e-10
that O 0 8.900417902690805e-11
lead O 0 9.944153944729806e-09
to O 0 6.046996237074609e-09
exon O 0 2.153351488232147e-06
skipping O 0 1.117079136747634e-06
or O 0 1.555879691750306e-08
premature O 0 1.7799198559487195e-08
protein O 0 1.1745936445706207e-09
truncation O 0 8.042398746965773e-09
were O 0 7.480092933942473e-11
also O 0 1.9218540647791826e-10
predominant O 0 8.804522444449958e-09
in O 0 4.272554809947593e-10
our O 0 1.0728922639202665e-08
mutants O 0 3.0780430648746915e-08
. O 0 2.4673308729461496e-08

Six O 0 6.472070879226521e-08
different O 0 9.521110982957381e-11
mutations O 0 1.8236016863237836e-10
were O 0 2.166034018813434e-11
identified O 0 3.2975323860373607e-11
on O 0 5.428176796939965e-10
12 O 0 2.7410316238984933e-09
of O 0 3.4492293465859802e-09
the O 0 1.4152536920164493e-08
16 O 0 1.1706492841767613e-07
alleles O 0 1.4505575407497417e-08
examined O 0 2.2176575953380961e-07
. O 0 2.165633077311213e-07

Four O 0 7.38293977065041e-08
were O 0 5.362331023661682e-09
deletions O 0 7.100049259634034e-08
involving O 0 1.2690318129671141e-08
a O 0 4.7808588199416135e-09
loss O 0 2.2293542656370846e-07
of O 0 3.3009331446010037e-07
a O 0 2.17840874228159e-08
single O 0 1.1654223364132577e-08
exon O 0 1.9237069182054256e-07
exon O 0 1.5648102191789803e-07
7 O 0 7.531858159381954e-08
, O 0 2.195493120638048e-09
exon O 0 7.490255171660465e-08
16 O 0 2.3299344675820066e-08
, O 0 1.8172208182676286e-09
exon O 0 2.1531060667712154e-07
33 O 0 1.2546759364795435e-07
or O 0 4.393929220469772e-09
exon O 0 8.383423732993833e-07
35 O 0 3.738970235644956e-07
. O 0 7.102866561581322e-08

The O 0 1.42068230957193e-07
others O 0 3.8969654170273316e-09
were O 0 8.642131454905666e-10
minute O 0 1.0932984650935396e-07
deletions O 0 6.850984135553517e-08
, O 0 4.684812981992081e-09
4649delA O 0 3.432987227824924e-07
in O 0 3.1219249407854477e-09
exon O 0 4.882739972345007e-07
33 O 0 1.0867866961916661e-07
and O 0 5.312275508373432e-09
7883del5 O 0 1.6393751138821244e-06
in O 0 1.580486852503782e-08
exon O 0 8.259960850409698e-06
55 O 0 1.8173468561144546e-06
. O 0 2.8861876444352674e-07

The O 0 9.609129847376607e-07
mutations O 0 7.474356777947833e-08
4612del165 O 0 1.6359190624370967e-07
and O 0 2.26485274978927e-09
7883del5 O 0 1.1139201916421371e-07
were O 0 1.2797107817874576e-10
found O 0 1.557234029225807e-11
in O 0 5.503744595486415e-12
more O 0 3.247404515432928e-12
than O 0 4.173800194351429e-12
two O 0 4.4618913598581944e-12
unrelated O 0 1.350018291601529e-10
families O 0 3.5191576215620746e-13
; O 0 1.7343322958329743e-12
44 O 0 1.7326015622209923e-10
% O 0 1.0333841421461543e-11
( O 0 4.064706037032462e-12
7 O 0 8.651697136485836e-10
of O 0 1.4140765225434393e-09
16 O 0 2.0343291495805715e-09
) O 0 3.740615456271357e-11
of O 0 1.2141326832804111e-09
the O 0 1.4349101906674377e-09
mutant O 0 1.0680369477711338e-08
alleles O 0 1.6395051982698305e-11
had O 0 5.0987724459217176e-11
one O 0 4.813886095300646e-11
of O 0 8.963524367189279e-10
the O 0 3.724920816239319e-09
two O 0 4.612876747245309e-09
mutations O 0 1.9881230173268705e-07
. O 0 9.552265112233727e-08

The O 0 6.100567020439485e-07
4612del165 O 0 2.9482018817361677e-06
mutations O 0 8.111565863444525e-10
in O 0 4.0795120753722713e-11
three O 0 9.295796771224829e-12
different O 0 8.777391790823486e-13
families O 0 1.0242388127955707e-13
were O 0 5.2431921651607816e-12
all O 0 3.141862117694849e-11
ascribed O 0 5.332700947491276e-09
to O 0 4.81678141817099e-10
the O 0 4.011124321579018e-09
same O 0 3.4854703567788192e-09
T O 0 5.707874493054987e-07
- O 0 3.59894073653777e-07
- O 0 2.413000004253263e-07
> O 0 1.287993800502818e-08
A O 0 1.2820037476046764e-08
substitution O 0 1.4499592637662317e-09
at O 0 9.852715310287863e-10
the O 0 1.3569686485581656e-09
splice O 0 3.446389840178199e-08
donor O 0 4.495467054166369e-10
site O 0 1.4012382365535814e-08
in O 0 1.203187682818907e-08
intron O 0 1.698660707916133e-05
33 O 0 4.561883088172181e-06
. O 0 3.4925736258628604e-07

Microsatellite O 0 5.230705573922023e-05
genotyping O 0 4.19770594817237e-06
around O 0 5.386474200008706e-08
the O 0 6.630709492583264e-08
ATM O 0 0.00034753212821669877
locus O 0 9.875287787508569e-07
also O 0 5.643143285993801e-09
indicated O 0 1.6243358880174696e-09
that O 0 4.1211808271546246e-11
a O 0 1.8848475558108646e-10
common O 0 4.6412301779596987e-10
haplotype O 0 8.620404834402962e-09
was O 0 3.564738504380216e-09
shared O 0 2.0494546337790354e-10
by O 0 1.6527041887814953e-11
the O 0 1.7533735574559728e-09
mutant O 0 2.5878620135699748e-08
alleles O 0 1.375484864896137e-10
in O 0 2.017911948648532e-10
both O 0 9.417989055293674e-09
mutations O 0 2.1201134359216667e-07
. O 0 1.2044854713622044e-07

This O 0 3.4885165867137857e-09
suggests O 0 1.4287110383648383e-09
that O 0 3.881161711460912e-11
these O 0 4.2655032284066863e-10
two O 0 3.7907790795266294e-10
founder O 0 3.214834265463651e-08
mutations O 0 1.0774386716150275e-08
may O 0 1.179338710022293e-10
be O 0 7.121930128972664e-11
predominant O 0 7.1677126456393125e-09
among O 0 1.1973172453494385e-09
Japanese O 0 5.6369284351376336e-08
ATM O 0 1.5269604773493484e-05
mutant O 0 3.0040575893508503e-06
alleles O 0 4.883056092808147e-08
. O 0 3.853543262266612e-08

W474C O 0 0.00013544199464377016
amino O 0 2.707988926431426e-07
acid O 0 1.0116137261206859e-08
substitution O 0 6.682339126484749e-10
affects O 0 4.117521601454399e-10
early O 0 3.375963050777919e-11
processing O 0 8.517110350325652e-10
of O 0 1.9429040598595293e-09
the O 0 9.210702756057287e-10
alpha O 0 1.9626293923380445e-09
- O 0 2.479283445211422e-09
subunit O 0 5.111608913921373e-10
of O 0 7.959591319384174e-10
beta O 0 6.7144489968029575e-09
- O 0 1.2290497508615772e-08
hexosaminidase O 0 3.5007636256523256e-07
A O 0 6.223533244309465e-09
and O 0 1.1577354352976243e-10
is O 0 1.977205725534059e-11
associated O 0 3.083586996854848e-10
with O 0 3.6836240724369418e-09
subacute O 0 0.01443179789930582
G B-Disease 0 0.000187842728337273
( I-Disease 0 7.56815854430215e-09
M2 I-Disease 1 0.9999998807907104
) I-Disease 0 7.015403724608404e-08
gangliosidosis I-Disease 0 4.398759119794704e-05
. O 0 2.1389128335158603e-07

Mutations O 0 5.239893994257727e-07
in O 0 1.1001403343868787e-08
the O 0 9.644957543741839e-08
HEXA O 0 0.0001678289845585823
gene O 0 1.310488828565326e-09
, O 0 1.9111838500673883e-10
encoding O 0 3.9381498062596165e-10
the O 0 1.1543426214899455e-09
alpha O 0 1.4525501912387995e-09
- O 0 2.1277459794077913e-09
subunit O 0 3.7644085071342204e-10
of O 0 2.5082311783108935e-09
beta O 0 4.725414726181043e-08
- O 0 1.3994825565077917e-07
hexosaminidase O 0 2.6197915303782793e-06
A O 0 1.0667221772564517e-07
( O 0 2.996569381519265e-10
Hex O 0 1.9918895759474253e-06
A O 0 1.9449627686185522e-08
) O 0 7.462551410153395e-11
, O 0 7.328102014092508e-11
that O 0 5.741370573408844e-11
abolish O 0 5.573912744694098e-07
Hex O 0 1.044443342834711e-05
A O 0 6.359783100151617e-08
enzyme O 0 1.8383260469434504e-09
activity O 0 6.873464020173969e-10
cause O 0 1.7157306331228028e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.4082304211626706e-09
TSD B-Disease 1 0.9999442100524902
) O 0 2.8314400823958863e-10
, O 0 1.5707062039904685e-10
the O 0 3.90431598162877e-09
fatal O 0 1.6176124972844264e-06
infantile B-Disease 0 1.789992438716581e-06
form I-Disease 0 2.471280957649924e-09
of I-Disease 0 1.0648276571600945e-07
G I-Disease 0 4.136561983614229e-06
( I-Disease 0 3.434260098522657e-10
M2 I-Disease 1 0.9877814054489136
) I-Disease 0 1.8166351756221388e-09
gangliosidosis I-Disease 0 5.295409550853947e-07
, I-Disease 0 6.453106937698294e-10
Type I-Disease 0 6.888011938599448e-08
1 I-Disease 0 1.313531612368024e-07
. O 0 3.502131917798579e-08

Less O 0 1.3982501059217611e-06
severe O 1 0.6769718527793884
, O 0 5.855309836988454e-08
subacute O 1 0.5014286041259766
( O 0 2.8458109202489368e-09
juvenile O 1 0.9985023736953735
- O 0 1.3826606846123468e-05
onset O 0 1.6175978089449927e-05
) O 0 6.082447323585427e-10
and O 0 3.4634424217472315e-09
chronic O 1 1.0
( O 0 9.137768874900587e-10
adult O 0 1.1480058503821056e-07
- O 0 1.8994808215211378e-07
onset O 0 1.5741035497285338e-07
) O 0 7.871928803249162e-11
variants O 0 7.355945297327082e-10
are O 0 6.641303826326883e-12
characterized O 0 4.96152563478347e-11
by O 0 6.771245023018402e-12
a O 0 8.090578207387011e-11
broad O 0 1.917128455986017e-09
spectrum O 0 3.3647038488737735e-09
of O 0 1.5758503391083423e-09
clinical O 0 4.680276166624253e-09
manifestations O 0 2.420668776537127e-09
and O 0 1.6131389626861115e-11
are O 0 1.3650240876864062e-12
associated O 0 1.1847671281539629e-11
with O 0 1.3747288030163674e-11
residual O 0 4.776914920512354e-06
levels O 0 4.960738309023327e-08
of O 0 3.615783583654775e-08
Hex O 0 7.48398742871359e-05
A O 0 3.0280838814178423e-07
enzyme O 0 1.0696965091483435e-08
activity O 0 8.453316269196876e-09
. O 0 1.54326240675573e-08

We O 0 1.1046720516105779e-07
identified O 0 4.2773212527436044e-08
a O 0 1.3535441212297883e-08
1422 O 0 7.773881952743977e-05
G O 0 2.028917515417561e-05
- O 0 6.4808314164110925e-06
- O 0 3.0721448638360016e-06
> O 0 1.17797462451108e-07
C O 0 2.9519901545427274e-07
( O 0 2.157829193105698e-10
amino O 0 1.078196754100702e-09
acid O 0 5.565388150330364e-10
W474C O 0 3.922626223840098e-09
) O 0 1.1949472444525155e-12
substitution O 0 1.3165353356103804e-11
in O 0 3.3543692996851338e-12
the O 0 1.6414082593119161e-10
first O 0 1.6849419082198835e-10
position O 0 9.59202162142958e-10
of O 0 2.2182651271407394e-09
exon O 0 4.4438436930249736e-08
13 O 0 1.8957088343540818e-08
of O 0 2.9936131795693655e-08
HEXA O 1 0.9998185038566589
of O 0 1.0590186150238878e-07
a O 0 2.7689759374283085e-09
non O 0 5.701395267010412e-08
- O 0 2.958691247556544e-08
Jewish O 0 2.235907281544769e-08
proband O 0 1.6164898397619254e-06
who O 0 3.370504098043625e-09
manifested O 0 3.954260918703767e-08
a O 0 2.089192152610053e-09
subacute O 0 6.06200455877115e-06
variant O 0 1.1770706009883725e-07
of O 0 2.2387810076907044e-06
G B-Disease 0 0.0005852425820194185
( I-Disease 0 3.0267106598813598e-09
M2 I-Disease 1 0.9999994039535522
) I-Disease 0 2.3592297893060277e-08
gangliosidosis I-Disease 0 2.4468345145578496e-05
. O 0 2.167469830283153e-07

On O 0 2.7986592954221123e-07
the O 0 4.298126654589396e-08
second O 0 4.341812598340766e-08
maternally O 0 3.9084540048861527e-07
inherited O 0 4.7182552975755243e-07
allele O 0 5.902379029976146e-09
, O 0 2.7639093791442804e-10
we O 0 8.002942752938225e-11
identified O 0 1.0460265986722561e-10
the O 0 7.764596743342622e-10
common O 0 1.840018342136318e-07
infantile O 1 0.9999997615814209
disease O 1 1.0
- O 1 0.9999817609786987
causing O 0 0.2381742149591446
4 O 0 5.322146421349316e-07
- O 0 1.6335634711595048e-07
bp O 0 2.6125801966259132e-08
insertion O 0 1.7024849086055838e-08
, O 0 1.5118255536350489e-09
+ O 0 1.7557372444798602e-08
TATC O 0 0.00030251796124503016
1278 O 0 4.852161873714067e-05
, O 0 6.757797876844052e-09
in O 0 5.536148872664626e-09
exon O 0 1.880377112684073e-06
11 O 0 2.494835200650414e-07
. O 0 9.036729409217514e-08

Pulse O 0 7.608180021634325e-05
- O 0 2.5098295282077743e-06
chase O 0 3.9870080570381106e-08
analysis O 0 4.7593301522042e-10
using O 0 2.374890506473548e-09
proband O 0 2.428435891488334e-06
fibroblasts O 0 9.889942198526569e-09
revealed O 0 4.123362984387313e-09
that O 0 1.179262243411472e-10
the O 0 1.9064372303034816e-09
W474C O 0 3.1023148494568886e-07
- O 0 1.6029769511760605e-08
containing O 0 3.87674115032155e-09
alpha O 0 2.8386821782078187e-09
- O 0 3.642326884545355e-09
subunit O 0 1.5580824408445437e-09
precursor O 0 4.655951180154716e-09
was O 0 1.4760549449377436e-09
normally O 0 4.2189356175281745e-11
synthesized O 0 1.284344713914365e-10
, O 0 2.207003156617926e-11
but O 0 1.4308146681352163e-11
not O 0 1.7413803038435205e-11
phosphorylated O 0 1.7475609848105478e-09
or O 0 6.248791067919868e-11
secreted O 0 1.4904258383019453e-10
, O 0 1.064131768813148e-10
and O 0 4.4702605506152793e-10
the O 0 1.29527375491989e-08
mature O 0 1.760429171326905e-07
lysosomal O 0 3.955332488203567e-07
alpha O 0 2.1045511999773225e-08
- O 0 2.115328356921964e-08
subunit O 0 4.2098324826156386e-09
was O 0 7.220636977223194e-09
not O 0 8.377487592525767e-10
detected O 0 3.42545831699681e-08
. O 0 4.254116703350519e-08

When O 0 6.126301599351791e-08
the O 0 1.474212929508667e-08
W474C O 0 2.2132589094780997e-07
- O 0 1.2810796867768204e-08
containing O 0 2.673825383325834e-09
alpha O 0 1.0511631565179869e-09
- O 0 2.5300064265820765e-09
subunit O 0 1.0742288170106917e-09
was O 0 5.381501022583279e-09
transiently O 0 1.2535871007912647e-08
co O 0 1.6021508564278975e-09
- O 0 3.363407774514826e-09
expressed O 0 1.006558517091527e-10
with O 0 2.0477813889030472e-11
the O 0 3.2397670657324795e-10
beta O 0 1.4267257375522036e-09
- O 0 1.3318676161944154e-09
subunit O 0 1.2399645199501208e-10
to O 0 7.11693273758307e-11
produce O 0 5.320509366413262e-09
Hex O 0 2.332431176910177e-05
A O 0 2.0368857178709732e-07
( O 0 7.135693702586821e-10
alphabeta O 0 3.1727117288937734e-07
) O 0 2.477935079348015e-10
in O 0 2.3163465590059218e-10
COS O 0 3.947139703086577e-06
- O 0 1.7192446577496412e-08
7 O 0 5.309064743386216e-09
cells O 0 1.8465473941575716e-11
, O 0 2.534766493922369e-11
the O 0 2.681019573014254e-10
mature O 0 1.03168751319771e-09
alpha O 0 2.1045810927322606e-10
- O 0 2.4213234195435973e-10
subunit O 0 4.703915382209267e-11
was O 0 2.1798696181463129e-10
present O 0 2.7949415351558038e-11
, O 0 1.383036914159863e-11
but O 0 3.6881318311865474e-12
its O 0 2.0108798307050257e-11
level O 0 1.91116206194053e-10
was O 0 7.659834433404455e-10
much O 0 2.805154164509105e-10
lower O 0 1.380771608161524e-09
than O 0 5.6129094427870285e-11
that O 0 1.4073483697862876e-11
from O 0 2.652120745239017e-10
normal O 0 2.1240926795229598e-09
alpha O 0 2.5582771456811315e-09
- O 0 6.373162442230296e-09
subunit O 0 1.5148331478087584e-09
transfections O 0 1.6646582423618383e-07
, O 0 9.293071867588765e-11
although O 0 1.840815520848249e-11
higher O 0 7.228925097413352e-11
than O 0 3.9807996309038085e-12
in O 0 1.587275623438078e-11
those O 0 2.967278645016336e-10
cells O 0 6.659343909642956e-11
transfected O 0 2.334328286224263e-09
with O 0 3.904587764225198e-11
an O 0 1.0942189515583678e-10
alpha O 0 4.971590694680117e-09
- O 0 1.969410057256482e-08
subunit O 0 9.869233430492841e-09
associated O 0 7.421735226387227e-09
with O 0 5.5284488098550355e-08
infantile O 0 0.02570328675210476
TSD B-Disease 1 0.999990701675415
. O 0 5.291164484333422e-07

Furthermore O 0 1.5678888587444817e-07
, O 0 2.914664509745535e-09
the O 0 1.6480157238873971e-09
precursor O 0 5.8661950852467726e-09
level O 0 5.992984331015805e-09
of O 0 1.6977409700302815e-08
the O 0 3.263449244172989e-08
W474C O 0 1.1169502158736577e-06
alpha O 0 6.95888191515337e-09
- O 0 6.361357662854061e-09
subunit O 0 8.409762330963133e-10
was O 0 1.979336028412604e-09
found O 0 5.77357883724261e-11
to O 0 6.245788608527647e-11
accumulate O 0 9.615505058846452e-10
in O 0 4.691998178874002e-11
comparison O 0 6.820650710892551e-10
to O 0 6.420780018778771e-10
the O 0 6.435680433014568e-09
normal O 0 6.9890107035064375e-09
alpha O 0 8.584619237694824e-09
- O 0 2.5449143237210592e-08
subunit O 0 1.193064047555481e-08
precursor O 0 3.321968122804719e-08
levels O 0 2.8515065864098688e-08
. O 0 1.869457477710057e-08

We O 0 3.104877777104775e-08
conclude O 0 5.1009174661942325e-09
that O 0 1.444338815215218e-10
the O 0 6.257289353328588e-09
1422 O 0 8.776105096330866e-05
G O 0 1.4071690202399623e-05
- O 0 3.0825663088762667e-06
- O 0 1.034526462717622e-06
> O 0 2.9604636964108977e-08
C O 0 6.328202317718024e-08
mutation O 0 2.2507741503918766e-10
is O 0 1.0129095479038952e-11
the O 0 5.473597269878283e-11
cause O 0 9.995453353894845e-10
of O 0 1.2332460386232924e-08
Hex B-Disease 1 0.9999957084655762
A I-Disease 0 2.9165819796617143e-05
enzyme I-Disease 1 0.9999940395355225
deficiency I-Disease 1 1.0
in O 0 2.086524064637274e-09
the O 0 4.242367523943358e-08
proband O 0 2.840974229911808e-05
. O 0 1.754559519895338e-07

The O 0 6.5407715510446e-07
resulting O 0 1.3505790263934614e-07
W474C O 0 2.400990751993959e-06
substitution O 0 8.118477268226343e-08
clearly O 0 2.3075472199707292e-08
interferes O 0 1.1673577660076262e-08
with O 0 2.844409430213801e-10
alpha O 0 1.4368519707375071e-09
- O 0 1.0219382007292666e-09
subunit O 0 6.05076266868565e-11
processing O 0 2.3249870084729451e-10
, O 0 7.662165173172308e-12
but O 0 3.1936510727637035e-12
because O 0 1.6627208290764806e-11
the O 0 6.242036748593804e-11
base O 0 6.10299311087914e-10
substitution O 0 1.2070670019070917e-09
falls O 0 3.5226520367359626e-08
at O 0 6.062225166303392e-10
the O 0 1.2564853602015091e-09
first O 0 1.0794560800775344e-09
position O 0 4.564068234458318e-09
of O 0 2.5771436540367176e-08
exon O 0 3.7511745176743716e-07
13 O 0 5.1235225839718623e-08
, O 0 1.4680082704998654e-09
aberrant O 0 2.963512990561412e-09
splicing O 0 3.7257659180056635e-09
may O 0 1.170611940715105e-10
also O 0 1.4321534236305666e-10
contribute O 0 5.745536268975115e-10
to O 0 2.2293356050084867e-09
Hex B-Disease 1 0.9999972581863403
A I-Disease 0 1.9975806935690343e-05
deficiency I-Disease 0 1.9441897620708914e-06
in O 0 1.2294290030467891e-09
this O 0 1.1076586314828774e-09
proband O 0 3.377882649147068e-06
. O 0 9.217648866410855e-09
. O 0 7.638001875420741e-08

Two O 0 9.657714628019676e-08
frequent O 0 3.330438289594895e-07
missense O 0 1.6308609929183149e-06
mutations O 0 2.2279812128545018e-07
in O 0 5.892393417639141e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.4477712941006757e-06

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 8.176051125019512e-08
an O 0 3.7369920846686e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 2.610827607441024e-07
by O 0 5.006718997724313e-11
early O 0 2.6362956262460102e-09
childhood O 1 0.9999040365219116
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 0 1.5943218386382796e-05

A O 0 4.971584530721884e-07
century O 0 2.3528654580218245e-09
after O 0 1.8831010362152512e-10
its O 0 4.778474838040836e-11
recognition O 0 3.195835818203818e-10
as O 0 5.018347404295298e-10
a O 0 3.32345595488448e-09
syndrome O 0 3.0127682748570805e-07
by O 0 1.6314702366848621e-10
Vaughan O 0 5.387665282796661e-07
Pendred O 1 0.9989124536514282
, O 0 1.8262271694879928e-09
the O 0 5.128388824715557e-09
disease O 0 8.072453283602954e-07
gene O 0 9.763019725994582e-09
( O 0 1.1774468067216048e-09
PDS O 1 1.0
) O 0 8.822639840921909e-10
was O 0 8.791533723240263e-09
mapped O 0 5.72497640405345e-08
to O 0 4.673014863953995e-09
chromosome O 0 3.2035049457590503e-07
7q22 O 0 1.3187536751502194e-05
- O 0 7.167904641391942e-06
q31 O 0 4.4745080231223255e-05
. O 0 2.3323983100453916e-07

1 O 0 1.9377576165879873e-07
and O 0 4.215328530676743e-09
, O 0 8.014006125378614e-10
recently O 0 4.140535470043005e-09
, O 0 3.3485431094604223e-10
found O 0 1.1736055183231286e-10
to O 0 3.205279652807036e-10
encode O 0 7.343388119807059e-09
a O 0 1.700336582644013e-08
putative O 0 2.3178399715106934e-06
sulfate O 0 2.6388763672002824e-06
transporter O 0 3.6507001368590863e-06
. O 0 2.902038716001698e-07

We O 0 2.1499763747101497e-08
performed O 0 5.478877795894732e-09
mutation O 0 9.326526356767673e-11
analysis O 0 1.91279474898165e-11
of O 0 8.757422009786353e-10
the O 0 1.6267922120505318e-08
PDS B-Disease 1 0.9999998807907104
gene O 0 1.5807091191533118e-09
in O 0 1.125294163406565e-10
patients O 0 8.533122125564674e-11
from O 0 2.1996448065775276e-11
14 O 0 1.0520677662384514e-09
Pendred B-Disease 0 1.8736164975052816e-07
families O 0 1.1913607036659335e-12
originating O 0 4.372303300664848e-12
from O 0 4.236779330146767e-12
seven O 0 2.4738206275132235e-11
countries O 0 1.2049857639473416e-12
and O 0 9.872781758790694e-11
identified O 0 9.904360664947376e-10
all O 0 2.6860831336961155e-09
mutations O 0 4.721955093600627e-08
. O 0 7.269767365869484e-08

The O 0 5.933275133429561e-07
mutations O 0 3.920391833389658e-08
include O 0 7.0629293524859804e-09
three O 0 5.765229960097429e-10
single O 0 2.557027090066555e-10
base O 0 4.137938436343802e-09
deletions O 0 2.970962498238805e-08
, O 0 3.902291378921063e-09
one O 0 5.288245397139235e-09
splice O 0 1.38944216132586e-07
site O 0 8.742706114617249e-09
mutation O 0 3.5408851406515396e-09
and O 0 2.4088320227377835e-09
10 O 0 1.0197058486483002e-07
missense O 0 2.933461246357183e-06
mutations O 0 4.894553740086849e-07
. O 0 1.6660384005717788e-07

One O 0 3.3618048291828018e-06
missense O 0 7.3053543019341305e-06
mutation O 0 5.1481883645010384e-08
( O 0 8.395498740654261e-10
L236P O 0 3.1613492978976865e-07
) O 0 2.2909765751144562e-10
was O 0 1.2965063467262894e-09
found O 0 6.856360618145985e-11
in O 0 9.123658079035479e-11
a O 0 8.599609913062523e-10
homozygous O 0 3.906133638764686e-09
state O 0 3.270830550849979e-10
in O 0 9.506956333282801e-11
two O 0 6.421180948068539e-11
consanguineous O 0 6.458872991998987e-09
families O 0 2.62135495601723e-12
and O 0 1.0610870689042873e-11
in O 0 3.739460130436356e-11
a O 0 5.883178944010581e-10
heterozygous O 0 1.4325503006062945e-09
state O 0 3.771249978967717e-10
in O 0 1.1474973748981654e-10
five O 0 1.7755982795186753e-10
additional O 0 8.918945582081506e-10
non O 0 6.055112322655987e-08
- O 0 2.0650470844429947e-07
consanguineous O 0 1.4845566056465032e-06
families O 0 5.925375745619021e-10
. O 0 1.2533408089154818e-08

Another O 0 5.3282169574231375e-06
missense O 0 8.31206671136897e-06
mutation O 0 7.739128449202326e-08
( O 0 1.480063960279665e-09
T416P O 0 4.3625365719890397e-07
) O 0 1.44831674431245e-10
was O 0 7.298212589823549e-10
found O 0 3.972534107221648e-11
in O 0 4.610866549681347e-11
a O 0 4.562951683162453e-10
homozygous O 0 2.6151214527203592e-09
state O 0 3.202590692641394e-10
in O 0 5.063795216475597e-11
one O 0 5.660158799991599e-11
family O 0 1.0781791258407392e-11
and O 0 4.135322639875483e-11
in O 0 6.38651631579279e-11
a O 0 5.735287800234801e-10
heterozygous O 0 1.1811965849872763e-09
state O 0 2.8057856038543605e-10
in O 0 1.3221955474929104e-10
four O 0 1.176474695441243e-09
families O 0 6.719605427640829e-11
. O 0 5.866788388431132e-09

Pendred B-Disease 0 0.002060646889731288
patients O 0 1.1938487887164229e-07
in O 0 5.064754171613117e-10
three O 0 9.428732239413762e-10
non O 0 3.141327198363797e-08
- O 0 1.866454013565999e-08
consanguineous O 0 6.016431086663943e-08
families O 0 5.307507471713491e-12
were O 0 3.545989456926746e-12
shown O 0 6.9717179078387925e-12
to O 0 3.584069499518172e-11
be O 0 8.922922817289347e-11
compound O 0 2.91999513457597e-09
heterozygotes O 0 3.93651653496363e-08
for O 0 1.3995653525000762e-09
L236P O 0 3.0068893011048203e-06
and O 0 2.1092366964126086e-08
T416P O 0 2.2856749637867324e-05
. O 0 2.331402129129856e-07

In O 0 3.5299883016648437e-09
total O 0 4.992208313403523e-10
, O 0 7.710283106421301e-11
one O 0 2.4975256238124466e-11
or O 0 1.1163917880419039e-11
both O 0 1.3436775130049039e-11
of O 0 6.22762674762356e-10
these O 0 4.133193440281069e-11
mutations O 0 3.129188921868753e-11
were O 0 1.0202661632208176e-11
found O 0 1.0116314036467955e-11
in O 0 1.3126188504186675e-11
nine O 0 5.189511043113271e-10
of O 0 5.641977995907155e-10
the O 0 1.9573358489566317e-09
14 O 0 5.7127782504551305e-09
families O 0 2.6485504761586398e-11
analyzed O 0 7.190402051548972e-09
. O 0 2.6673729891513176e-08

The O 0 1.721738662752159e-08
identification O 0 1.1386858567163927e-08
of O 0 1.85739423841369e-08
two O 0 1.9729131661705424e-09
frequent O 0 8.610845014800361e-08
PDS B-Disease 1 1.0
mutations O 0 4.0314212412795314e-08
will O 0 1.1331102028888651e-10
facilitate O 0 3.5060382375107224e-10
the O 0 2.429678402915414e-10
molecular O 0 1.0719554133231668e-08
diagnosis O 0 5.333985342304004e-08
of O 0 0.005319708492606878
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.5851910575293005e-06

Insertional O 0 0.00017719532479532063
mutation O 0 3.5990083802062145e-08
by O 0 5.805949054860093e-10
transposable O 0 3.1907293873700837e-07
element O 0 8.689108987880445e-09
, O 0 1.0758096635754555e-09
L1 O 0 1.1680186617013533e-05
, O 0 7.85483456056113e-10
in O 0 4.1192965705150186e-10
the O 0 3.2804930327756665e-08
DMD B-Disease 1 1.0
gene O 0 5.90260418320554e-09
results O 0 2.50988563266219e-10
in O 0 1.9969337294867273e-10
X B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999982118606567
linked I-Disease 1 0.9999182224273682
dilated I-Disease 0 6.947902147658169e-05
cardiomyopathy I-Disease 1 1.0
. O 0 2.8791279760298494e-07

X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999997615814209
dilated I-Disease 1 0.5582106709480286
cardiomyopathy I-Disease 1 1.0
( O 0 2.3446549590744326e-08
XLDCM B-Disease 1 1.0
) O 0 3.250923308328879e-09
is O 0 4.450344814888041e-10
a O 0 6.353024217808922e-10
clinical O 0 9.681321699872569e-08
phenotype O 0 6.409661246209453e-09
of O 0 4.251510699049277e-09
dystrophinopathy B-Disease 0 4.040662133775186e-06
which O 0 1.3209276727987884e-10
is O 0 1.2651340912384068e-11
characterized O 0 4.188939473070974e-11
by O 0 1.7971785518100525e-11
preferential O 0 1.8086916497850325e-07
myocardial B-Disease 0 3.5430061871011276e-06
involvement I-Disease 0 5.3295083901616636e-09
without O 0 1.3638784546188276e-09
any O 0 1.4039581719416105e-09
overt O 0 2.7386082734892625e-08
clinical O 0 7.253326828049467e-08
signs O 0 5.783771825917938e-07
of O 0 2.4964970180008095e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 5.9627996051858645e-06

To O 0 3.8017873293938464e-09
date O 0 5.609746889234657e-09
, O 0 1.6678801395553222e-10
several O 0 8.926157035737958e-11
mutations O 0 5.85796244845227e-10
in O 0 1.8746078300768687e-10
the O 0 4.5380986080090224e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 5.448501951832441e-07
, O 0 1.4006228399310316e-09
DMD O 1 1.0
, O 0 3.5594507896696825e-10
have O 0 7.634680214418932e-12
been O 0 2.638768197005259e-11
identified O 0 2.9405824997219554e-11
in O 0 1.5638358663583318e-11
patients O 0 1.522752340887834e-10
with O 0 3.6787618090672325e-11
XLDCM B-Disease 1 1.0
, O 0 9.211194584857196e-10
but O 0 7.514915079109841e-11
a O 0 5.2415148610318596e-11
pathogenic O 0 9.189417005117662e-10
correlation O 0 2.893100758960543e-10
of O 0 1.954761463807131e-09
these O 0 1.0038977427129225e-09
cardiospecific O 0 4.277468121927086e-07
mutations O 0 2.136656629403433e-09
in O 0 5.243467882110053e-10
DMD O 1 1.0
with O 0 1.2356965450877055e-09
the O 0 2.7489072351727373e-08
XLDCM B-Disease 1 1.0
phenotype O 0 4.542679832297836e-08
has O 0 7.383368916258348e-10
remained O 0 1.1603142446858783e-08
to O 0 5.877940911780399e-10
be O 0 2.6913498096803323e-09
elucidated O 0 3.890361313096946e-06
. O 0 3.963587005273439e-07

We O 0 1.6014581660783733e-08
report O 0 5.136002179106924e-10
here O 0 1.025569126150705e-11
the O 0 2.994093861730107e-11
identification O 0 3.8126055090792477e-10
of O 0 2.7817972370058897e-09
a O 0 1.1660932219825781e-09
unique O 0 3.8164125193418386e-09
de O 0 8.198918294510804e-06
novo O 0 3.266330895712599e-05
L1 O 0 2.625418346724473e-05
insertion O 0 1.2644002289619038e-08
in O 0 2.448033997737298e-10
the O 0 3.4767326795304143e-09
muscle O 0 2.9081467900482494e-08
exon O 0 4.2730889049380494e-08
1 O 0 1.6060862861877467e-08
in O 0 8.140891294416974e-10
DMD O 1 1.0
in O 0 1.5799284103223954e-09
three O 0 2.8132678409065193e-09
XLDCM B-Disease 1 0.9998096823692322
patients O 0 8.127113981792888e-10
from O 0 5.371814451593515e-11
two O 0 1.7538209773348967e-10
unrelated O 0 5.375489386949539e-09
Japanese O 0 1.000530058803406e-08
families O 0 6.848257377845002e-11
. O 0 3.937731030134728e-09

The O 0 2.862547887616529e-07
insertion O 0 1.255604757943729e-07
was O 0 1.7263820595303514e-08
a O 0 9.35996280482243e-10
5 O 0 4.0926093625159865e-09
- O 0 2.1587286624935587e-08
truncated O 0 7.818278469073903e-09
form O 0 4.0576225712740666e-10
of O 0 1.349718381504772e-08
human O 0 2.288523370808093e-09
L1 O 0 1.2933205653098412e-06
inversely O 0 1.0238760950187498e-08
integrated O 0 2.367554596816035e-09
in O 0 3.088965888631279e-11
the O 0 4.1452907773020797e-10
5 O 0 2.7983686479160497e-09
- O 0 3.737070031206713e-08
untranslated O 0 1.487500594521407e-05
region O 0 5.1786596344527425e-08
in O 0 9.69946345463768e-10
the O 0 5.174144668274039e-09
muscle O 0 1.502489332949608e-08
exon O 0 9.718319482487914e-09
1 O 0 3.897471234637351e-09
, O 0 3.073462317981779e-11
which O 0 4.856843226208607e-12
affected O 0 2.7292073115359194e-11
the O 0 2.7069048391670236e-11
transcription O 0 5.242517531200974e-10
or O 0 1.943539600091082e-11
the O 0 1.8105150711988927e-10
stability O 0 1.837513785574174e-08
of O 0 2.390808084840046e-08
the O 0 1.0587030807585052e-08
muscle O 0 3.317308028272237e-08
form O 0 6.814929176535145e-10
of O 0 5.954711390643297e-09
dystrophin O 0 1.772412616674046e-08
transcripts O 0 2.783186459076603e-10
but O 0 1.067896812645408e-11
not O 0 1.9049987282082625e-12
that O 0 2.903834074238776e-12
of O 0 1.022172124720555e-09
the O 0 1.187578924088939e-08
brain O 0 1.4058680790185463e-05
or O 0 1.8801420864633656e-08
Purkinje O 0 2.8229902454768308e-05
cell O 0 1.6161841642770014e-08
form O 0 6.970528043659385e-10
, O 0 1.3883924565583072e-10
probably O 0 5.2700250413595384e-11
due O 0 4.656623420196127e-10
to O 0 7.170398996780847e-11
its O 0 2.1784107850919554e-10
unique O 0 2.718724134709305e-10
site O 0 1.6398632451952722e-09
of O 0 7.4194419497075614e-09
integration O 0 1.3669398413185263e-07
. O 0 1.4176940510424174e-07

We O 0 3.5112147855898e-08
speculate O 0 8.974648579851419e-09
that O 0 3.6680138093547754e-11
this O 0 3.62445039259196e-11
insertion O 0 6.613617209438871e-09
of O 0 7.133655888225121e-09
an O 0 1.4206945619932299e-09
L1 O 0 2.3619084458914585e-05
sequence O 0 2.5174573536901335e-09
in O 0 1.2337395549621988e-09
DMD O 1 1.0
is O 0 6.403987340419803e-10
responsible O 0 9.936673012189701e-11
for O 0 4.540011162151858e-12
some O 0 6.66828831735744e-12
of O 0 6.562506094098808e-11
the O 0 5.518116172331666e-11
population O 0 3.746604589072167e-12
of O 0 4.8352533782436424e-11
Japanese O 0 3.0057751843060032e-09
patients O 0 8.581156618614472e-11
with O 0 8.51626130726757e-11
XLDCM B-Disease 1 0.9999967813491821
. O 0 1.119735060228777e-08
. O 0 9.482412366423887e-08

Severe O 1 0.7721421718597412
early O 0 8.591059952323121e-08
- O 0 0.0005321298376657069
onset O 0 0.03542250394821167
obesity B-Disease 1 1.0
, O 0 3.104788959262805e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 9.512353358331893e-07
red O 0 0.11677652597427368
hair O 0 7.722272130195051e-05
pigmentation O 1 0.9854593276977539
caused O 0 3.514867614740069e-07
by O 0 8.34031155250159e-09
POMC O 1 0.9999991655349731
mutations O 0 6.348318493110128e-08
in O 0 1.4021678262921e-09
humans O 0 8.113643978902019e-09
. O 0 1.1317592196746773e-08

Sequential O 0 3.4613185562193394e-07
cleavage O 0 4.03787012714929e-08
of O 0 6.896161863778616e-08
the O 0 1.8788444577921837e-08
precursor O 0 2.562605594391698e-08
protein O 0 2.634335416473732e-09
pre O 0 2.0924160537560965e-07
- O 0 1.917614099511411e-06
pro O 0 1.247281670657685e-05
- O 0 4.923100732412422e-06
opiomelanocortin O 0 9.675277397036552e-06
( O 0 3.232892398230547e-09
POMC O 0 2.0756882804562338e-05
) O 0 4.772547357312362e-10
generates O 0 1.0078500256582856e-09
the O 0 1.3758240102745845e-09
melanocortin O 0 4.6452742026303895e-06
peptides O 0 2.084432715321327e-08
adrenocorticotrophin O 0 8.801308126749063e-07
( O 0 2.4604589476950878e-09
ACTH O 0 1.7439510884287301e-06
) O 0 6.503544924818527e-10
, O 0 1.1297464075354924e-09
melanocyte O 0 1.614488496670674e-06
- O 0 2.171625737901195e-06
stimulating O 0 4.3831141738337465e-06
hormones O 0 1.1158063273342123e-07
( O 0 4.120837004961686e-10
MSH O 0 5.8214329328620806e-05
) O 0 1.513899422489473e-10
alpha O 0 1.1505925101573666e-09
, O 0 3.1320612770002754e-11
beta O 0 1.8109511668029654e-09
and O 0 8.462373857209826e-11
gamma O 0 9.951364177140931e-09
as O 0 5.991686313766564e-11
well O 0 8.269371298830208e-11
as O 0 1.1790418641410838e-10
the O 0 3.892090816304261e-10
opioid O 0 1.846124462190346e-07
- O 0 6.500463456404759e-08
receptor O 0 1.684763439868675e-08
ligand O 0 6.58374119666405e-08
beta O 0 7.234134500322398e-07
- O 0 1.4125294001132715e-06
endorphin O 0 3.341919000376947e-05
. O 0 9.847218507275102e-08

While O 0 2.717835378973632e-08
a O 0 8.883140334425832e-10
few O 0 4.722706670179377e-10
cases O 0 8.005252016829445e-10
of O 0 2.4876312565424996e-08
isolated O 0 0.0009762894478626549
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9993820190429688
have O 0 7.518101141634759e-10
been O 0 8.957577457557875e-10
reported O 0 5.091586263716863e-09
( O 0 2.8712177080336687e-09
OMIM O 1 0.9998811483383179
201400 O 0 3.6150468076812103e-06
) O 0 7.761042919440797e-10
, O 0 6.237600991276793e-10
an O 0 2.581259872513897e-09
inherited O 1 1.0
POMC O 1 1.0
defect O 0 0.007471879944205284
has O 0 2.778461682950706e-09
not O 0 1.315561964920775e-10
been O 0 2.3633439649728416e-10
described O 0 8.498384218569299e-10
so O 0 6.470250446533043e-10
far O 0 5.044212159077688e-09
. O 0 5.2195950672739855e-08

Recent O 0 1.2686511752235674e-07
studies O 0 3.788540592353229e-09
in O 0 1.0151498391897107e-10
animal O 0 1.247763448120054e-09
models O 0 3.6985614570994585e-10
elucidated O 0 2.5127574687644483e-08
a O 0 1.2076444011466236e-10
central O 0 1.9543813234434992e-09
role O 0 2.704868773406588e-09
of O 0 1.154735151942532e-08
alpha O 0 5.651073919921146e-08
- O 0 6.127347091933188e-07
MSH O 1 0.9986520409584045
in O 0 5.452624463053724e-10
the O 0 7.053878592344631e-10
regulation O 0 2.615151428742024e-09
of O 0 7.876122531946805e-10
food O 0 5.728200899723923e-11
intake O 0 1.5936094457935646e-11
by O 0 3.570882738807013e-13
activation O 0 1.5404090225601408e-09
of O 0 2.0102307374259e-08
the O 0 2.080715546526335e-07
brain O 0 8.467195584671572e-07
melanocortin O 0 7.416271273541497e-06
- O 0 1.8129260581645212e-07
4 O 0 3.443446416895313e-08
- O 0 3.856550279124349e-08
receptor O 0 5.654197554605389e-09
( O 0 3.17111087388966e-10
MC4 O 0 0.00011852569878101349
- O 0 1.1039221448072567e-07
R O 0 8.043967625326331e-08
; O 0 5.368823788320931e-11
refs O 0 2.1835284691462675e-09
3 O 0 1.770072977080872e-10
- O 0 2.303279650339718e-10
5 O 0 1.0268771249988262e-10
) O 0 5.0989937099010785e-12
and O 0 2.608990801178379e-11
the O 0 5.009415104950676e-10
linkage O 0 2.3013585703779427e-08
of O 0 3.5903834572081905e-08
human O 0 1.7208522606892984e-08
obesity B-Disease 1 1.0
to O 0 6.808433261618063e-10
chromosome O 0 2.0526635946538363e-09
2 O 0 1.1728608084737857e-09
in O 0 8.874414397785912e-11
close O 0 1.5006555997842952e-09
proximity O 0 6.156144483071557e-09
to O 0 1.0391565385958756e-09
the O 0 1.8469375362428764e-08
POMC O 0 3.1702988053439185e-05
locus O 0 7.24514137573351e-08
, O 0 5.107593792352816e-10
led O 0 4.36922303892473e-10
to O 0 6.530689877770612e-11
the O 0 2.087032491271401e-10
proposal O 0 3.5477384918713994e-10
of O 0 1.5933011576763079e-09
an O 0 1.0936326844124267e-10
association O 0 5.75000935754133e-10
of O 0 6.700199861597866e-08
POMC O 1 1.0
with O 0 3.470003662187082e-08
human O 0 1.4498266409646021e-06
obesity B-Disease 1 1.0
. O 0 1.5936188901832793e-07

The O 0 8.367945270038035e-08
dual O 0 1.3259628417472413e-07
role O 0 1.2156904816151837e-08
of O 0 1.3486560135334003e-07
alpha O 0 1.1233587429160252e-06
- O 0 2.4606850274722092e-05
MSH O 1 1.0
in O 0 2.8759534753675098e-09
regulating O 0 4.224953897846717e-07
food O 0 9.250809562821871e-10
intake O 0 7.925702316669003e-10
and O 0 9.485837115796869e-11
influencing O 0 6.375037031602915e-08
hair O 0 2.502470124454703e-07
pigmentation O 0 4.604124569596024e-06
predicts O 0 1.1956839074400705e-08
that O 0 2.8425258674635856e-11
the O 0 4.190763569500433e-10
phenotype O 0 4.770536188303254e-10
associated O 0 1.554143064241842e-10
with O 0 2.0568992342706593e-10
a O 0 5.5002580268137535e-09
defect O 0 1.6097826005534444e-07
in O 0 4.045067836244698e-09
POMC O 1 0.9999934434890747
function O 0 9.459846239678882e-09
would O 0 3.741802145906803e-10
include O 0 1.5421353083411304e-08
obesity B-Disease 1 1.0
, O 0 1.620152567660682e-09
alteration O 0 8.432771636535108e-08
in O 0 1.234631619162485e-09
pigmentation O 1 0.8926997184753418
and O 0 1.8422499579173746e-06
ACTH B-Disease 1 1.0
deficiency I-Disease 0 0.21279296278953552
. O 0 2.617017003103683e-07

The O 0 6.70858852913625e-08
observation O 0 3.783516433486511e-08
of O 0 1.1114281051050057e-08
these O 0 3.498198175577727e-09
symptoms O 0 2.1909204406256322e-07
in O 0 3.003733650697171e-10
two O 0 1.546585526313038e-09
probands O 0 3.5105501865473343e-06
prompted O 0 7.666182355592355e-09
us O 0 1.195039761592298e-10
to O 0 8.664474693276247e-11
search O 0 3.474364129729679e-10
for O 0 1.6187461093775113e-10
mutations O 0 5.175832651360679e-09
within O 0 2.939418930480997e-09
their O 0 1.1492025997483779e-08
POMC O 0 0.00023573380894958973
genes O 0 5.5162093559602e-08
. O 0 3.3499389928692835e-08

Patient O 0 4.8014412641350646e-06
1 O 0 8.923735350663264e-08
was O 0 3.807564041835576e-09
found O 0 4.642104409202652e-11
to O 0 5.836424399330298e-11
be O 0 6.449732414814946e-11
a O 0 1.3339465643191772e-10
compound O 0 6.620505255128251e-10
heterozygote O 0 4.3562775609018445e-09
for O 0 8.980752946863291e-11
two O 0 2.473666271818331e-10
mutations O 0 3.8401926083508897e-10
in O 0 2.780883301412018e-10
exon O 0 1.0521209503622231e-07
3 O 0 3.7404859654088796e-08
( O 0 3.8594163975780305e-10
G7013T O 0 3.416773779463256e-07
, O 0 3.9649661331964126e-10
C7133delta O 0 5.804305374113028e-07
) O 0 8.458855838000545e-11
which O 0 1.6113615650126256e-11
interfere O 0 2.4774246543124434e-10
with O 0 1.4741964593500967e-11
appropriate O 0 4.428067634787425e-10
synthesis O 0 4.779452389414018e-10
of O 0 6.741757374584267e-09
ACTH O 0 1.0830307473952416e-05
and O 0 2.0656884203162917e-08
alpha O 0 3.04914146909141e-06
- O 0 7.560763333458453e-05
MSH O 1 0.9999995231628418
. O 0 4.81849610878271e-07

Patient O 0 4.5059373405820224e-06
2 O 0 1.596537941850329e-07
was O 0 3.686064786734278e-08
homozygous O 0 1.1919246034608477e-08
for O 0 7.22617188309016e-10
a O 0 1.216982181695414e-09
mutation O 0 6.367666949280704e-10
in O 0 4.39212527458821e-10
exon O 0 1.434974450376103e-07
2 O 0 9.314290139172954e-08
( O 0 1.2597560772320548e-09
C3804A O 0 7.282450269485707e-07
) O 0 1.2223768663943702e-09
which O 0 3.1990332605147387e-09
abolishes O 0 2.1333065888029523e-05
POMC O 0 0.0005067114834673703
translation O 0 1.9479631419017096e-07
. O 0 1.8182190331117454e-07

These O 0 6.169674549028059e-09
findings O 0 4.2723105608821754e-10
represent O 0 6.014862219405614e-11
the O 0 7.583684374923294e-11
first O 0 1.232903779069261e-10
examples O 0 6.553628750793905e-10
of O 0 1.1495117746562755e-08
a O 0 1.4491582156495042e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 8.938500606348043e-09
the O 0 1.04799067202066e-08
POMC O 0 3.0902472644811496e-05
gene O 0 6.643958161411945e-10
and O 0 1.8816541380584084e-10
define O 0 2.2644339736643815e-09
a O 0 1.760100953873689e-10
new O 0 3.8775773703036975e-09
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9951269626617432
resulting O 0 9.825039448685402e-09
in O 0 2.352189970578067e-11
early O 0 5.544240622157304e-10
- O 0 8.894455163499515e-07
onset O 0 0.00010422327613923699
obesity B-Disease 1 1.0
, O 0 2.45648390517772e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 5.375184173317393e-07
red O 0 2.95043719233945e-05
hair O 0 3.2405421279690927e-06
pigmentation O 0 1.8462405932950787e-05
. O 0 1.5900566197046828e-08
. O 0 8.77391528320004e-08

A O 0 2.9847046789654996e-06
European O 0 2.08628691211743e-07
multicenter O 0 1.0043379006674513e-05
study O 0 3.5527801145462945e-08
of O 0 1.105746605389868e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.3339573889936673e-09
classification O 0 2.0825559055026588e-09
of O 0 2.1080461820588425e-08
105 O 0 8.777898585776711e-08
mutations O 0 6.423830356538929e-10
and O 0 2.801892329262756e-10
a O 0 2.1712054376621381e-10
general O 0 1.0645621884020073e-10
system O 0 3.4048189267998907e-10
for O 0 4.681753248969578e-11
genotype O 0 8.411367158345229e-10
- O 0 1.9882049340225194e-09
based O 0 7.525131073826685e-10
prediction O 0 1.269942799808632e-07
of O 0 1.2824713735426485e-07
metabolic O 0 0.0002531006175559014
phenotype O 0 1.1702452695772081e-07
. O 0 2.3086476730327377e-08

Phenylketonuria B-Disease 1 0.5548079013824463
( O 0 2.215195138433046e-07
PKU B-Disease 1 0.9999997615814209
) O 0 8.390764527632655e-09
and O 0 5.994402307862856e-09
mild B-Disease 1 0.5498965978622437
hyperphenylalaninemia I-Disease 1 1.0
( O 0 2.354276773530728e-07
MHP B-Disease 1 1.0
) O 0 1.0624616741949922e-08
are O 0 1.0441673081729164e-09
allelic B-Disease 0 0.4053654968738556
disorders I-Disease 1 0.9957242012023926
caused O 0 2.3681687721932576e-09
by O 0 2.170881356622356e-11
mutations O 0 2.6129415298115077e-10
in O 0 2.8826946038562618e-11
the O 0 1.4437280260182206e-09
gene O 0 6.8833205801865915e-09
encoding O 0 4.684985199787661e-08
phenylalanine O 0 5.859600150870392e-06
hydroxylase O 0 0.0002111723879352212
( O 0 3.7734125157840026e-08
PAH O 1 1.0
) O 0 8.723088029682913e-08
. O 0 1.4133713932551473e-07

Previous O 0 2.530662470690004e-07
studies O 0 5.782522904951293e-09
have O 0 2.3317004577139144e-11
suggested O 0 1.6176505968079624e-10
that O 0 4.3550744607823155e-12
the O 0 2.071446902895957e-10
highly O 0 2.0256338828517073e-08
variable O 0 1.7637378846302454e-07
metabolic O 0 3.0362343750311993e-05
phenotypes O 0 4.506816821958637e-07
of O 0 4.3530299080885015e-06
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 1.6276292171824025e-06
with O 0 6.053645762449378e-08
PAH O 1 1.0
genotypes O 0 0.00023532645718660206
. O 0 1.5335170644448226e-07

We O 0 5.1584898130840884e-08
identified O 0 3.7328296009775386e-09
both O 0 1.0287989349322402e-09
causative O 0 3.6400928138391464e-07
mutations O 0 8.220158775884556e-09
in O 0 4.849932677686297e-10
686 O 0 1.3257404418709484e-07
patients O 0 6.980080957674772e-10
from O 0 1.6919883549793013e-10
seven O 0 1.197792420803978e-09
European O 0 3.465596698504214e-09
centers O 0 6.726267542944697e-09
. O 0 1.6049165552090017e-08

On O 0 6.694911292015604e-08
the O 0 2.931099585268271e-09
basis O 0 4.4484013694834346e-10
of O 0 3.347508659157228e-10
the O 0 5.034492267519397e-10
phenotypic O 0 4.1739599510037806e-07
characteristics O 0 1.3809408727638584e-08
of O 0 1.9624955882591166e-08
297 O 0 3.3679029343147704e-08
functionally O 0 3.1700377434162874e-08
hemizygous O 0 1.9955693630890892e-07
patients O 0 6.54855558668288e-10
, O 0 4.2336793792951966e-11
105 O 0 4.262227903950588e-09
of O 0 1.6325076845902231e-09
the O 0 2.216045125180699e-09
mutations O 0 5.174112804873232e-10
were O 0 3.4614842242541854e-11
assigned O 0 3.298597228695854e-10
to O 0 6.542060643210945e-11
one O 0 2.399393739249689e-10
of O 0 4.252021401640604e-09
four O 0 1.7575991773099986e-09
arbitrary O 0 6.330360236006527e-09
phenotype O 0 1.703316598877791e-08
categories O 0 4.487367277761223e-08
. O 0 1.576837327377234e-08

We O 0 3.6206831310892085e-08
proposed O 0 1.6061290963875763e-08
and O 0 1.8126652401306842e-09
tested O 0 3.5209439808170373e-09
a O 0 7.749116626154517e-11
simple O 0 6.520732565018506e-11
model O 0 2.515079290665856e-11
for O 0 6.560975721048301e-12
correlation O 0 3.749602017766307e-11
between O 0 3.787106045427535e-11
genotype O 0 1.0421378204839016e-09
and O 0 1.1416146916687353e-09
phenotypic O 0 2.1000596461817622e-06
outcome O 0 1.571138454892207e-07
. O 0 7.798502821287912e-08

The O 0 4.733226717235084e-07
observed O 0 4.220254012921032e-08
phenotype O 0 9.444937276725796e-09
matched O 0 5.732775587574679e-09
the O 0 2.631462825419817e-09
predicted O 0 6.246211992078088e-09
phenotype O 0 6.710911826246502e-10
in O 0 7.930567313962911e-11
79 O 0 3.15581671905818e-09
% O 0 2.480946177663146e-11
of O 0 1.276548866613325e-10
the O 0 1.3439166446360673e-10
cases O 0 7.796900625134384e-11
, O 0 1.2477217176121158e-11
and O 0 7.258214862471135e-11
in O 0 5.3549970013833104e-11
only O 0 4.443887618998943e-11
5 O 0 5.170186501146645e-10
of O 0 4.1867206923562605e-10
184 O 0 1.208304012401129e-09
patients O 0 1.4787199242860538e-10
was O 0 6.739375724151841e-10
the O 0 8.558668773694933e-10
observed O 0 1.2558024620190622e-09
phenotype O 0 1.3003394194743834e-10
more O 0 3.1731527128098236e-12
than O 0 3.087256145173356e-12
one O 0 1.2004533651854832e-11
category O 0 1.1268556227017612e-10
away O 0 4.030394906706647e-10
from O 0 2.9061241260674997e-11
that O 0 3.888126626216959e-11
expected O 0 5.493590027327855e-09
. O 0 8.028425924067051e-08

Among O 0 4.200009939836491e-08
the O 0 1.0645388570651448e-08
seven O 0 9.217416274687196e-10
contributing O 0 2.534854826041766e-10
centers O 0 1.0425747071218794e-10
, O 0 1.3060059977920702e-11
the O 0 6.462883700431021e-11
proportion O 0 3.489526445576985e-10
of O 0 5.233904976087445e-10
patients O 0 9.486271490555254e-11
for O 0 5.1044161952784606e-11
whom O 0 4.1424452756899655e-10
the O 0 1.3225871509092713e-09
observed O 0 2.283169431294141e-09
phenotype O 0 2.169893015269153e-10
did O 0 6.66473196075934e-11
not O 0 1.7958834072628882e-11
match O 0 1.2382965763890752e-09
the O 0 2.5439037543151244e-09
predicted O 0 4.6934522934805045e-09
phenotype O 0 3.521365421477185e-10
was O 0 1.3444813040663917e-09
4 O 0 2.019029388122817e-09
% O 0 7.425181997033903e-11
- O 0 5.086849164115392e-09
23 O 0 1.412858630089886e-08
% O 0 7.730284745655069e-10
( O 0 4.517833052108955e-10
P O 0 2.338871354368166e-07
< O 0 7.349861608219044e-09
. O 0 1.4302561912593603e-10
0001 O 0 8.111461724524816e-09
) O 0 8.461017997341003e-11
, O 0 5.959284454792879e-11
suggesting O 0 8.669930051663499e-11
that O 0 1.0030048840092842e-11
differences O 0 9.202238970829058e-10
in O 0 3.4826228706430484e-11
methods O 0 1.7238466210045544e-10
used O 0 1.1847134384623814e-10
for O 0 1.8752337183070011e-10
mutation O 0 6.557132614659622e-09
detection O 0 1.5210709136681544e-07
or O 0 1.8189200146068174e-09
phenotype O 0 4.745662973704157e-09
classification O 0 1.47447365428377e-09
may O 0 5.11489323118397e-11
account O 0 1.3417491076528343e-11
for O 0 7.330977838670982e-12
a O 0 6.639280097919809e-11
considerable O 0 1.5488290650012004e-09
proportion O 0 3.196325204513073e-09
of O 0 4.848168533300168e-09
genotype O 0 1.009769263760063e-07
- O 0 1.6327471712429542e-06
phenotype O 0 2.9032872816969757e-07
inconsistencies O 0 7.790874292368244e-07
. O 0 2.70248847300536e-07

Our O 0 2.0861219240941864e-07
data O 0 6.359149651302687e-09
indicate O 0 4.092505778707789e-10
that O 0 5.5229383566501866e-11
the O 0 8.546862773073371e-09
PAH O 1 1.0
- O 0 3.475021367194131e-05
mutation O 0 9.920587018541482e-09
genotype O 0 5.248700918336624e-10
is O 0 5.309674141334986e-12
the O 0 1.385619310262376e-11
main O 0 4.635526185126082e-09
determinant O 0 1.178538724389e-07
of O 0 2.6195808189299896e-08
metabolic O 0 0.00019973712915088981
phenotype O 0 4.7056074592433106e-09
in O 0 5.440031064507522e-11
most O 0 7.202476948187098e-10
patients O 0 1.3446556090812578e-09
with O 0 1.122341597437071e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.0764309738297015e-06

In O 0 9.705204639942622e-09
the O 0 3.5976068790688487e-09
present O 0 6.83066270212862e-10
study O 0 1.4309246842980627e-10
, O 0 4.919104013012543e-11
the O 0 2.1264263960762975e-10
classification O 0 6.664510276976898e-09
of O 0 2.0295050973118123e-08
105 O 0 2.7434971343609504e-06
PAH O 1 1.0
mutations O 0 1.5287056953638967e-07
may O 0 1.687968653740768e-10
allow O 0 1.5539948494680544e-10
the O 0 2.132909404650718e-10
prediction O 0 1.4810248138985571e-08
of O 0 1.2329708809488693e-08
the O 0 1.2082747247177394e-08
biochemical O 0 5.276268666420947e-08
phenotype O 0 1.0213536683068014e-09
in O 0 8.912241084013672e-11
> O 0 3.389567515554859e-09
10 O 0 5.804376979057224e-10
, O 0 8.036656062859748e-11
000 O 0 2.4326658465412265e-09
genotypes O 0 5.081089327063637e-09
, O 0 1.9952232574449447e-11
which O 0 2.4455209992474414e-12
may O 0 8.159023803799847e-12
be O 0 4.416912148530461e-12
useful O 0 1.689130432747099e-11
for O 0 7.837467654037145e-12
the O 0 2.449556668615571e-10
management O 0 2.3069652854701417e-09
of O 0 3.351472699364422e-08
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.1266144639421327e-07
newborns O 0 1.1703517657224438e-06
. O 0 4.474956938338437e-08

Somatic O 0 1.6595649867667817e-05
instability O 0 6.651723083450634e-07
of O 0 5.374604938879202e-07
the O 0 3.053603450098308e-07
CTG O 1 0.6279652714729309
repeat O 0 9.554342739193089e-08
in O 0 6.260975071725738e-10
mice O 0 5.13021802817093e-09
transgenic O 0 1.5475070114234768e-08
for O 0 3.2061298060881427e-10
the O 0 4.8839037702919086e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 6.615325219172519e-06
is O 0 7.522303890894477e-10
age O 0 6.489196402448272e-10
dependent O 0 6.36552616173347e-11
but O 0 4.174007060125939e-12
not O 0 4.0469134120202366e-12
correlated O 0 7.615170716235298e-10
to O 0 2.2290794210455545e-10
the O 0 3.878383392219575e-09
relative O 0 3.003095017106716e-08
intertissue O 0 3.3029689348040847e-06
transcription O 0 2.0016571511405346e-07
levels O 0 6.37329833352851e-08
and O 0 2.3897229084468563e-08
proliferative O 0 0.0019223564304411411
capacities O 0 2.9903863833169453e-05
. O 0 7.735718554613413e-07

A O 0 4.059561979374848e-05
( O 0 1.0540672690240172e-07
CTG O 0 0.0004405230865813792
) O 0 8.76340777722362e-09
nexpansion O 0 1.0837433137567132e-06
in O 0 3.296653783291248e-10
the O 0 1.5832708477603319e-09
3 O 0 1.0743297806925511e-08
- O 0 1.1946038114274415e-07
untranslated O 0 2.603448047011625e-05
region O 0 7.002623192420288e-08
( O 0 6.678809727489465e-10
UTR O 0 3.4046399377984926e-05
) O 0 3.4910907498186816e-10
of O 0 7.399204360325484e-09
the O 0 3.2525129256555374e-08
DM O 1 1.0
protein O 0 3.751063673007593e-07
kinase O 0 7.348280917085503e-08
gene O 0 1.0986530574186304e-09
( O 0 5.194251626039481e-11
DMPK O 1 0.9885665774345398
) O 0 8.97648899655934e-11
is O 0 2.59806603314372e-11
responsible O 0 2.779456942381131e-10
for O 0 6.067593094627455e-10
causing O 0 0.2843283712863922
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.193521585373674e-06
DM B-Disease 1 1.0
) O 0 2.28773018307038e-08
. O 0 3.401213533038572e-08

Major O 0 1.8703365640249103e-05
instability O 0 5.849092872267647e-07
, O 0 8.911990589943741e-10
with O 0 8.956257263603717e-11
very O 0 1.1228671464857953e-10
large O 0 1.8528113487903397e-09
expansions O 0 5.732100305522181e-08
between O 0 6.45421494027687e-10
generations O 0 5.15913367582499e-10
and O 0 9.032546932630225e-11
high O 0 4.1400460837337505e-09
levels O 0 2.153061284815294e-09
of O 0 6.1413674146137964e-09
somatic O 0 8.457432443265134e-08
mosaicism O 0 5.151272830516973e-07
, O 0 5.770114386294267e-10
is O 0 1.8091757258975605e-10
observed O 0 1.0523969473652528e-09
in O 0 7.969769288962425e-10
patients O 0 8.580281374293008e-09
. O 0 2.33396431070787e-08

There O 0 5.9532492713287866e-08
is O 0 2.9234614729034547e-09
a O 0 9.318849025774512e-10
good O 0 1.0555369911458001e-09
correlation O 0 3.7461581059439197e-10
between O 0 1.7146191411132605e-10
repeat O 0 1.3882820448785083e-09
size O 0 8.708682663893796e-10
( O 0 5.095292243684213e-11
at O 0 7.536621882131556e-10
least O 0 5.6222523164839444e-11
in O 0 5.785253179291239e-11
leucocytes O 0 3.7693524745918694e-07
) O 0 2.7165730775990937e-10
, O 0 8.960887587505795e-11
clinical O 0 2.533053100606253e-09
severity O 0 1.796146342769589e-08
and O 0 4.922954821573455e-10
age O 0 8.345738322645957e-09
of O 0 1.925110204581415e-08
onset O 0 1.7978915138883167e-06
. O 0 1.0236480108005708e-07

The O 0 1.865996750893828e-06
trinucleotide O 0 4.783179610967636e-05
repeat O 0 4.358897740530665e-07
instability O 0 1.0257705440608333e-07
mechanisms O 0 2.9993856287546805e-08
involved O 0 1.0405607486774215e-09
in O 0 7.20684623090051e-10
DM B-Disease 1 1.0
and O 0 1.3874017668058514e-07
other O 0 4.6687564925207425e-09
human O 0 4.6759954130948245e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.6323853380129094e-10
unknown O 0 2.1037873665363804e-09
. O 0 2.764901863017144e-09

We O 0 1.4319491015157837e-07
studied O 0 5.540207439480582e-07
somatic O 0 5.356251335797424e-07
instability O 0 2.313699809519676e-08
by O 0 1.9564093400870064e-10
measuring O 0 8.585594741816749e-07
the O 0 6.293414855917945e-08
CTG O 0 4.187506056041457e-05
repeat O 0 4.257588948064495e-09
length O 0 1.757980566674533e-10
at O 0 1.4930433278603772e-10
several O 0 1.7754558934157672e-10
ages O 0 1.6553677872899186e-10
in O 0 2.3891678566090313e-11
various O 0 8.056889044816273e-10
tissues O 0 9.414306667565597e-09
of O 0 6.067838675960502e-09
transgenic O 0 1.6300697325277724e-07
mice O 0 5.0202455526005e-09
carrying O 0 4.3769970980989115e-10
a O 0 8.549723429229772e-11
( O 0 2.3245433355967293e-10
CTG O 0 1.3391440006671473e-05
) O 0 9.813161394589542e-10
55expansion O 0 3.349837527366617e-07
surrounded O 0 1.7760131143518265e-08
by O 0 7.824088599228674e-11
45 O 0 4.770756678595944e-09
kb O 0 2.574088853180001e-07
of O 0 4.6513378038071096e-08
the O 0 5.199126462684944e-08
human O 0 8.145868690689895e-08
DM B-Disease 1 1.0
region O 0 1.8512514543544967e-07
, O 0 1.8624371489472935e-10
using O 0 1.4081008581356969e-10
small O 0 2.399981102740867e-09
- O 0 6.948857844690792e-08
pool O 0 5.561085814065336e-08
PCR O 0 2.0771190634150116e-07
. O 0 1.30555717348102e-08

These O 0 9.737582473690054e-08
mice O 0 2.5177081752758568e-08
have O 0 3.059904066238239e-11
been O 0 2.7329059154590496e-11
shown O 0 7.037100503010096e-12
to O 0 1.3339661840416905e-11
reproduce O 0 8.499324577471157e-10
the O 0 3.5176667134706463e-10
intergenerational O 0 4.428577060622274e-09
and O 0 1.5546152143386394e-09
somatic O 0 5.798186464289756e-08
instability O 0 1.9469931444859867e-08
of O 0 2.5662151514893594e-08
the O 0 3.48410296169277e-08
55 O 0 2.4063726300482813e-07
CTG O 0 9.968742961063981e-05
repeat O 0 3.2776348746210715e-08
suggesting O 0 6.104518557314975e-10
that O 0 8.235100969200548e-12
surrounding O 0 2.1367705382857594e-09
sequences O 0 8.18702536320437e-11
and O 0 8.941936774364834e-11
the O 0 1.8936686940751457e-10
chromatin O 0 2.9545053070734184e-09
environment O 0 7.656036915548725e-10
are O 0 6.021769454606085e-12
involved O 0 1.6224206006443254e-11
in O 0 7.768310994471506e-11
instability O 0 1.485947365154061e-07
mechanisms O 0 5.457405336528609e-07
. O 0 2.3742762778056203e-07

As O 0 1.1586136494656785e-08
observed O 0 1.074755506813574e-09
in O 0 4.1206617978906124e-11
some O 0 8.950126056950225e-11
of O 0 8.389416383813852e-10
the O 0 1.1742664618452636e-09
tissues O 0 4.9171415383852946e-08
of O 0 2.1483209877715126e-07
DM B-Disease 1 1.0
patients O 0 6.6875318616155255e-09
, O 0 1.3195117741504614e-11
there O 0 9.227714946324905e-12
is O 0 1.819202601061054e-11
a O 0 3.4543347349202946e-11
tendency O 0 2.9150412639289414e-10
for O 0 4.421752547445479e-11
repeat O 0 1.5025229949117147e-09
length O 0 6.018835985166504e-10
and O 0 1.7836538912519018e-09
somatic O 0 6.749118597326742e-08
mosaicism O 0 7.606932683756895e-08
to O 0 4.619008300843497e-11
increase O 0 1.7768066531975713e-11
with O 0 9.16747233681292e-12
the O 0 5.454912632707476e-10
age O 0 1.9101134007826204e-09
of O 0 1.942229710394372e-09
the O 0 1.1574011082871039e-08
mouse O 0 4.789121135218011e-07
. O 0 1.4181212293351564e-07

Furthermore O 0 1.191706857639474e-07
, O 0 3.378362700701132e-09
we O 0 2.3635285395506855e-10
observed O 0 3.6641209510968054e-10
no O 0 1.5810097675483803e-10
correlation O 0 6.91169066424635e-11
between O 0 1.0775711573041136e-10
the O 0 2.5441559969863192e-09
somatic O 0 3.874496101730074e-08
mutation O 0 1.289812256999312e-09
rate O 0 8.803728857031956e-10
and O 0 1.3706431545301712e-09
tissue O 0 1.519171917152562e-07
proliferation O 0 8.053536475927103e-06
capacity O 0 3.5641357953863917e-07
. O 0 1.1776140240726818e-07

The O 0 8.981533596852387e-07
somatic O 0 4.4290018763604166e-07
mutation O 0 1.9062917910872557e-09
rates O 0 3.4076383381709263e-10
in O 0 1.3518857040761834e-11
different O 0 1.9094338957192925e-11
tissues O 0 6.158772380970845e-10
were O 0 4.627985841776372e-11
also O 0 4.219772795077681e-11
not O 0 1.2691218735649823e-11
correlated O 0 1.2096574852904496e-09
to O 0 1.4920754909386602e-10
the O 0 1.4270876702582314e-09
relative O 0 8.033445908495196e-09
inter O 0 1.146806880569784e-06
- O 0 9.15147609248379e-07
tissue O 0 4.437279343960654e-08
difference O 0 2.568814272407849e-09
in O 0 2.751211064522252e-11
transcriptional O 0 1.097071530842264e-10
levels O 0 1.827846624058438e-10
of O 0 2.4591345626490124e-10
the O 0 5.804022262800856e-10
three O 0 2.6151400489560217e-10
genes O 0 7.890779696317907e-11
( O 0 6.676106195646625e-11
DMAHP O 1 0.9999967813491821
, O 0 2.2924377951483166e-09
DMPK O 0 0.02356155961751938
and O 0 3.896638567368882e-09
59 O 0 1.375622638022378e-08
) O 0 9.239431442154e-11
surrounding O 0 2.3731391962655835e-08
the O 0 2.729064307871454e-09
repeat O 0 1.5204902226173544e-08
. O 0 1.1338003869099111e-09
. O 0 3.521724778465796e-08

A O 0 7.640632247785106e-06
novel O 0 1.8594558923723525e-06
missense O 0 2.076254759231233e-06
mutation O 0 1.5732144476032772e-08
in O 0 1.5319931434554235e-10
patients O 0 3.495094769156992e-10
from O 0 6.368513355559102e-11
a O 0 6.827705623102531e-10
retinoblastoma B-Disease 0 2.981419129355345e-07
pedigree O 0 4.891193938760807e-08
showing O 0 6.157201415391e-09
only O 0 5.505955136264618e-10
mild O 0 4.2460104765496e-08
expression O 0 4.078276882868437e-10
of O 0 2.075976501814125e-09
the O 0 7.920130329353015e-09
tumor B-Disease 0 2.1090125301270746e-05
phenotype O 0 5.817705428512454e-08
. O 0 1.0850547127461141e-08

We O 0 3.128602799051805e-08
have O 0 2.687654820920926e-10
used O 0 3.82634479656474e-10
single O 0 5.45158418407965e-10
strand O 0 6.189814771850877e-10
conformation O 0 4.355809601896965e-10
polymorphism O 0 1.2576427399491052e-10
analysis O 0 1.014340261090707e-11
to O 0 1.5674911021945626e-11
study O 0 4.445905449346199e-11
the O 0 2.5853630347683065e-10
27 O 0 7.842801963420243e-09
exons O 0 2.0217006735379073e-08
of O 0 2.437906587715588e-08
the O 0 4.3899856194684617e-08
RB1 O 0 0.00025459975586272776
gene O 0 4.382543772329939e-10
in O 0 4.003125955720499e-11
individuals O 0 6.581355252444077e-12
from O 0 1.3825780798004672e-11
a O 0 1.2351586420322747e-10
family O 0 3.409523774422496e-10
showing O 0 1.1640493902120852e-08
mild O 0 6.077281113903155e-07
expression O 0 1.0360103885886929e-08
of O 0 1.5365481331741648e-08
the O 0 2.051189085250371e-08
retinoblastoma B-Disease 0 7.990209269337356e-06
phenotype O 0 3.166255453379563e-07
. O 0 4.373921669298397e-08

In O 0 6.378439998400154e-09
this O 0 1.387312487111103e-10
family O 0 5.148772519447675e-10
affected O 0 1.4615934018635812e-09
individuals O 0 4.202768341676766e-11
developed O 0 4.2693475421629046e-09
unilateral B-Disease 1 0.6180071830749512
tumors I-Disease 1 1.0
and O 0 1.961283224716226e-08
, O 0 2.774568075292194e-10
as O 0 8.39756042481099e-11
a O 0 7.780455446582124e-11
result O 0 3.5745817417165426e-10
of O 0 1.955507311635074e-09
linkage O 0 4.538113884677841e-09
analysis O 0 1.9923113159237005e-10
, O 0 2.251272224196299e-10
unaffected O 0 2.71325646394871e-08
mutation O 0 5.250623269503762e-10
carriers O 0 3.64818453224558e-11
were O 0 3.96921662204619e-11
also O 0 2.7220137255312693e-10
identified O 0 5.510588096946378e-10
within O 0 1.18722054409659e-09
the O 0 7.468339724425732e-09
pedigree O 0 1.3630244666273938e-06
. O 0 3.368462557773455e-07

A O 0 4.691254616773222e-06
single O 0 2.3168881924107154e-08
band O 0 3.1422263901959013e-08
shift O 0 5.0980384358467745e-09
using O 0 1.7719824496609249e-09
SSCP O 1 0.9739742279052734
was O 0 4.179623758204798e-08
identified O 0 7.427296000450667e-10
in O 0 3.4620670219531746e-10
exon O 0 1.4677688398023747e-07
21 O 0 1.2862924059220404e-08
which O 0 4.0703093673322144e-11
resulted O 0 1.657858517134514e-09
in O 0 2.9970034787218935e-10
a O 0 7.79189868183039e-09
missense O 0 1.1193751561222598e-06
mutation O 0 3.2828090468228766e-08
converting O 0 8.759501923805146e-08
a O 0 1.4046473317819164e-08
cys O 0 0.0012090206146240234
- O 0 5.7728061619855e-06
- O 0 1.7085181980291964e-06
> O 0 7.012594949173945e-08
arg O 0 7.601071843055252e-07
at O 0 6.260775009536701e-09
nucleotide O 0 3.526697156530645e-09
position O 0 1.7879046021462841e-09
28 O 0 3.137062387637002e-09
in O 0 1.8181836591857348e-10
the O 0 2.987270519838603e-08
exon O 0 4.581043413054431e-06
. O 0 5.571521342062624e-07

The O 0 9.196340329253871e-07
mutation O 0 1.4693654293296277e-07
destroyed O 0 6.917159680597251e-07
an O 0 1.2806204985338354e-08
NdeI O 0 2.0271110770408995e-05
restriction O 0 4.0132815115612175e-07
enzyme O 0 1.6938498603735752e-08
site O 0 6.813921515913535e-08
. O 0 5.520840673511884e-08

Analysis O 0 3.2760707480150586e-09
of O 0 6.904424587617086e-09
all O 0 4.945221454555337e-10
family O 0 1.19870141590539e-10
members O 0 2.5462396947839583e-12
demonstrated O 0 1.378605146706846e-10
that O 0 3.3168096741365005e-11
the O 0 6.386060569241181e-09
missense O 0 5.893033971915429e-07
mutation O 0 1.9969624176496836e-08
co O 0 7.549632030645625e-09
- O 0 3.053740016412121e-08
segregated O 0 6.0483689168222554e-09
with O 0 3.713509708069829e-11
patients O 0 3.193173225835011e-10
with O 0 1.0578422166007684e-10
tumors B-Disease 1 1.0
or O 0 5.222958066042338e-09
who O 0 1.8959023240228134e-10
, O 0 5.730834556905151e-11
as O 0 1.6971531124898576e-10
a O 0 1.6064340135901745e-10
result O 0 7.935428425476232e-10
of O 0 3.1174860470883914e-09
linkage O 0 3.1566413927208714e-09
analysis O 0 2.395689757683783e-10
had O 0 6.32867869221343e-10
been O 0 5.111472356489344e-10
predicted O 0 2.794224629454334e-09
to O 0 7.254772893539041e-10
carry O 0 5.6082494204190425e-09
the O 0 1.4440372453350392e-08
predisposing O 0 9.135839718510397e-06
mutation O 0 6.534848466799303e-07
. O 0 2.0666921329848265e-07

These O 0 2.3115514835581052e-08
observations O 0 1.4476636778226748e-08
point O 0 4.6112051954594335e-09
to O 0 1.0233382197188945e-10
another O 0 1.8736034945732172e-10
region O 0 6.920219508543823e-09
of O 0 1.4030568706857593e-08
the O 0 4.9508322774727276e-08
RB1 O 0 0.0019047472160309553
gene O 0 4.765545735807564e-09
where O 0 4.557326960252794e-09
mutations O 0 4.2862430271739527e-10
only O 0 1.553205827842241e-11
modify O 0 5.311704964761077e-10
the O 0 1.3562485856599693e-10
function O 0 6.551350434369496e-11
of O 0 5.817943904418144e-10
the O 0 9.117922528112388e-10
gene O 0 1.9464416189940437e-10
and O 0 2.0950489953985851e-10
raise O 0 2.159930456713255e-09
important O 0 8.090026981655285e-10
questions O 0 3.816257310162996e-10
for O 0 4.395039193694217e-11
genetic O 0 5.288898208277715e-10
counseling O 0 4.042826837191704e-11
in O 0 2.113936629910551e-12
families O 0 4.742052562255183e-13
with O 0 3.758048559843186e-12
these O 0 2.5863397534742205e-10
distinctive O 0 4.104587603137588e-08
phenotypes O 0 6.706299160441631e-08
. O 0 2.486747474605977e-09
. O 0 3.826961858521827e-08

Maternal B-Disease 0 7.490663119824603e-05
disomy I-Disease 0 0.00018214121519122273
and O 0 1.482513539485808e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 3.56047735294851e-06
with O 0 1.584155917555563e-09
gamete O 0 1.3966479173177504e-07
complementation O 0 1.5383845664018736e-07
in O 0 1.0241387599085883e-10
a O 0 4.704438505420683e-10
case O 0 4.10018019536551e-09
of O 0 7.180426564445952e-08
familial O 0 6.47355193450494e-07
translocation O 0 1.6387946999429914e-08
( O 0 2.2477440048129793e-11
3 O 0 3.842244022944641e-10
; O 0 1.0864488995954158e-11
15 O 0 4.956439703107662e-10
) O 0 9.987635024577557e-11
( O 0 1.3891553185541028e-10
p25 O 0 1.482840019662035e-07
; O 0 1.319321318860034e-10
q11 O 0 1.1322152460024881e-07
. O 0 1.8341748952988013e-10
2 O 0 1.9301142017980055e-08
) O 0 3.7238763184177515e-09
. O 0 6.183754663879881e-08

Maternal B-Disease 1 0.9990469813346863
uniparental I-Disease 1 1.0
disomy I-Disease 1 1.0
( I-Disease 0 4.314399575378047e-06
UPD I-Disease 1 1.0
) I-Disease 0 6.632149052165914e-09
for I-Disease 0 6.840167321442436e-10
chromosome I-Disease 0 4.573261769280634e-09
15 I-Disease 0 1.1617841133571005e-09
is O 0 2.8569842672188095e-11
responsible O 0 6.702172150596653e-11
for O 0 2.218779153462247e-11
an O 0 1.1115643128167818e-11
estimated O 0 3.29706088819659e-11
30 O 0 2.0728933847191655e-10
% O 0 4.536479698835638e-12
of O 0 3.184407251777266e-11
cases O 0 2.4556273681142216e-11
of O 0 3.2307180930502e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.8868534823468508e-07
PWS B-Disease 1 1.0
) O 0 1.2918122571647928e-08
. O 0 2.4077353444340588e-08

We O 0 1.3055596603805952e-08
report O 0 1.9903742543014857e-10
on O 0 1.07853614927933e-09
an O 0 5.7580398782342e-11
unusual O 0 3.277056404016321e-10
case O 0 6.512656525181626e-10
of O 0 1.1184693171628624e-08
maternal B-Disease 0 2.840336037479574e-07
disomy I-Disease 0 0.00011528747563716024
15 I-Disease 0 4.385357854630456e-08
in O 0 2.3893707012945242e-09
PWS B-Disease 1 1.0
that O 0 6.942849628543968e-10
is O 0 2.884015803950035e-10
most O 0 6.861095719346011e-11
consistent O 0 2.8159721776610525e-10
with O 0 1.3621793797102821e-11
adjacent O 0 7.544795010971939e-09
- O 0 1.2746403932339945e-08
1 O 0 1.6967341309737094e-08
segregation O 0 4.232103378853935e-08
of O 0 7.2479990897988955e-09
a O 0 1.0505979419761502e-09
paternal O 0 1.27172139485765e-08
t O 0 1.7002840246860274e-09
( O 0 1.7142650146628746e-11
3 O 0 6.752254866349006e-10
; O 0 1.7979808614176918e-11
15 O 0 5.027123162193448e-10
) O 0 7.035037830060986e-11
( O 0 7.461469636593776e-11
p25 O 0 6.331751478683145e-08
; O 0 3.97979184330044e-11
q11 O 0 2.6380273965287415e-08
. O 0 2.1371925063018438e-11
2 O 0 5.614304021683836e-10
) O 0 5.446655279572887e-11
with O 0 1.524920606454927e-10
simultaneous O 0 2.505936969043887e-08
maternal O 0 2.5927292313099315e-07
meiotic O 0 4.384556632430758e-06
nondisjunction O 0 7.82776260166429e-06
for O 0 1.440933772300923e-08
chromosome O 0 9.802338496456287e-08
15 O 0 3.9231892401403456e-08
. O 0 2.767372464518303e-08

The O 0 7.841023830224003e-07
patient O 0 1.467547576794459e-07
( O 0 2.3012772243369284e-10
J O 0 6.004921004887365e-08
. O 0 3.6790282625931425e-11
B O 0 3.067749387852814e-09
. O 0 5.925357860619984e-12
) O 0 6.241676446527844e-12
, O 0 2.4308544760431872e-11
a O 0 8.641105192497278e-11
17 O 0 7.981179050986498e-10
- O 0 1.4118289870523881e-09
year O 0 1.2388393089146632e-10
- O 0 9.766651487552735e-09
old O 0 2.027752366018376e-08
white O 0 7.129680734685451e-10
male O 0 3.275081872367025e-10
with O 0 5.350821175031939e-11
PWS B-Disease 1 1.0
, O 0 1.955451356394633e-09
was O 0 4.557648480840726e-09
found O 0 1.1406411232206537e-10
to O 0 1.8549567437631254e-10
have O 0 1.4396246694747816e-10
47 O 0 4.134735220873154e-09
chromosomes O 0 3.749044130696433e-11
with O 0 2.720512357057281e-11
a O 0 1.4312910856517647e-09
supernumerary O 0 2.8465623813644925e-07
, O 0 1.0694796159782527e-09
paternal O 0 8.106701443466591e-08
der O 0 0.000223752751480788
( O 0 1.2759672485262996e-10
15 O 0 3.1109209652768754e-10
) O 0 3.6090238870328806e-12
consisting O 0 1.3005224501483337e-11
of O 0 1.4220928601371696e-10
the O 0 3.3095440277186583e-10
short O 0 9.694617331135191e-10
arm O 0 3.991891261989622e-09
and O 0 1.24851573524154e-09
the O 0 1.7508414273947892e-08
proximal O 0 5.373521617002552e-06
long O 0 2.3278200700360685e-08
arm O 0 5.605429009847285e-08
of O 0 2.0992191096524948e-08
chromosome O 0 2.7732374618949507e-08
15 O 0 3.3886109473968418e-09
, O 0 3.1714977866137417e-10
and O 0 7.11727921043348e-09
distal O 0 0.0002327469555893913
chromosome O 0 3.639222995843738e-05
arm O 0 1.948775206983555e-05
3p O 0 0.00013391594984568655
. O 0 1.1910608463949757e-06

The O 0 4.865898404204927e-07
t O 0 1.46995073890821e-08
( O 0 1.2376726032936602e-10
3 O 0 6.509576766511316e-10
; O 0 1.183610674748703e-11
15 O 0 1.0531032296201559e-10
) O 0 6.248990474383431e-12
was O 0 1.6096605992554913e-10
present O 0 2.254089449815755e-11
in O 0 1.0326136647142992e-11
the O 0 2.566976353701733e-10
balanced O 0 2.856328062961211e-09
state O 0 1.3987533353798653e-10
in O 0 2.0498993127948673e-11
the O 0 4.5198672582458244e-10
patients O 0 1.265854088217111e-10
father O 0 8.739099999210964e-10
and O 0 3.814498494847385e-09
a O 0 2.5802325609447507e-08
sister O 0 7.366944601017167e-07
. O 0 3.223387921025278e-07

Fluorescent O 0 1.3600493730336893e-05
in O 0 1.9193651112914267e-08
situ O 0 5.789069632555766e-07
hybridization O 0 1.339101829422873e-09
analysis O 0 3.032723377982549e-11
demonstrated O 0 4.5841910129018615e-11
that O 0 1.1298574055518262e-11
the O 0 3.647631530157014e-09
PWS B-Disease 1 1.0
critical O 0 5.409422669799824e-07
region O 0 1.4322031915980915e-07
resided O 0 9.87869128721286e-08
on O 0 1.5554553201013732e-08
the O 0 5.429898308761949e-09
derivative O 0 2.9039343374392956e-08
chromosome O 0 9.055839411686861e-10
3 O 0 2.4000895715303727e-10
and O 0 1.8275913768461827e-11
that O 0 4.314956378315138e-12
there O 0 1.7403276736382978e-11
was O 0 6.921826445349666e-10
no O 0 6.138647368203465e-10
deletion O 0 9.584418592112343e-09
of O 0 5.021059568122155e-09
the O 0 2.8275570329583388e-08
PWS B-Disease 1 1.0
region O 0 2.0309501280735276e-07
on O 0 1.655331516303704e-08
the O 0 3.3651919029153987e-09
normal O 0 1.8813681723628406e-09
pair O 0 2.422228528864423e-10
of O 0 1.5593519808732026e-09
15s O 0 1.7911965244366002e-07
present O 0 2.296779211263811e-09
in O 0 3.787319347026141e-09
J O 0 0.00011936045484617352
. O 0 2.2478467087694298e-07

B O 0 0.0018436488462612033
. O 0 1.641452740841487e-06

Methylation O 0 2.1244487413696334e-07
analysis O 0 2.6664408458998423e-09
at O 0 4.542998421896982e-09
exon O 0 6.124665219431336e-08
alpha O 0 9.949238766182589e-09
of O 0 6.196232416044722e-09
the O 0 3.1638507369535773e-09
small O 0 2.3366579782191366e-09
nuclear O 0 5.794670698833215e-08
ribonucleoprotein O 0 2.2987576642208296e-07
- O 0 4.048373369869296e-08
associated O 0 5.875825603851581e-09
polypeptide O 0 2.3509922186804033e-07
N O 0 1.0917063519855219e-07
( O 0 3.8711975292038403e-10
SNRPN O 1 0.9955596923828125
) O 0 6.198203061913432e-10
gene O 0 4.827625521564016e-10
showed O 0 5.335455410815371e-10
a O 0 8.190242928307612e-11
pattern O 0 5.040757256047357e-10
characteristic O 0 2.2382657949293616e-09
of O 0 1.7210286529234509e-09
only O 0 9.458339667034465e-11
the O 0 3.653645719303711e-10
maternal O 0 1.5248000195811073e-08
chromosome O 0 1.3942321075433028e-08
15 O 0 9.13576947425554e-09
in O 0 2.8000985974330206e-09
J O 0 0.00012351111217867583
. O 0 2.9673984158762323e-07

B O 0 0.0021323247347027063
. O 0 1.8626078599481843e-06

Maternal B-Disease 0 0.0003154757432639599
disomy I-Disease 0 0.00038014465826563537
was O 0 2.142064801091692e-07
confirmed O 0 2.851037406159662e-09
by O 0 2.1165935670808267e-10
polymerase O 0 2.760412343150165e-09
chain O 0 2.1621975321295395e-09
reaction O 0 8.402126910889152e-11
analysis O 0 1.0971656916325401e-10
of O 0 5.6333568920763355e-09
microsatellite O 0 3.0058114930398006e-07
repeats O 0 1.1667784516333768e-09
at O 0 1.3010743593611096e-09
the O 0 4.19786161387492e-09
gamma O 0 4.3603282051662973e-07
- O 0 4.4275995492171205e-07
aminobutyric O 0 5.206656624068273e-06
acid O 0 1.669200031528817e-07
receptor O 0 5.545819359298321e-09
beta3 O 0 5.684792085958179e-07
subunit O 0 1.475892386082478e-08
( O 0 1.6962091731187456e-09
GABRB3 O 0 0.008455815725028515
) O 0 2.3943400151438254e-08
locus O 0 1.49208187849581e-06
. O 0 1.193337624272317e-07

A O 0 4.0617884224047884e-05
niece O 0 3.4578349641378736e-06
( O 0 1.151598150173072e-09
B O 0 4.059678104795239e-08
. O 0 1.7522684692128365e-11
B O 0 2.057696901758277e-09
. O 0 3.4548204141254812e-12
) O 0 2.1647857118001212e-12
with O 0 1.9623691560610723e-11
45 O 0 7.652752320730372e-10
chromosomes O 0 3.7514028342067185e-12
and O 0 1.0618604086298777e-11
the O 0 3.704687945305096e-11
derivative O 0 2.8432270426925754e-10
3 O 0 8.318506300453166e-11
but O 0 2.6790436188917077e-12
without O 0 2.425773470982051e-11
the O 0 1.2574316587965484e-10
der O 0 4.958466888638213e-06
( O 0 2.707417345870766e-10
15 O 0 2.3517572333986436e-09
) O 0 1.57983709447862e-10
demonstrated O 0 5.162500427147165e-10
a O 0 2.7123533974382497e-10
phenotype O 0 1.1876825078971365e-09
consistent O 0 6.467671398446839e-10
with O 0 6.3429929711422695e-12
that O 0 7.1642435907348645e-12
reported O 0 1.4068336773309653e-10
for O 0 1.804674604199974e-10
haploinsufficiency O 0 2.6753834845294477e-06
of O 0 1.7801276896989293e-07
distal O 0 5.0415441364748403e-05
3 O 0 4.671868737204932e-06
p O 0 5.125809821038274e-07
. O 0 5.294636906683081e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 1.5783952278525248e-07
with O 0 4.4040313618154414e-09
unbalanced O 0 4.968333087163046e-07
segregation O 0 2.954136277821817e-07
of O 0 1.7643520777710364e-07
non O 0 0.023582369089126587
- O 0 1.8885628378484398e-05
Robertsonian O 1 0.9994553923606873
translocations O 0 1.0647722774592694e-06
has O 0 6.737074786933306e-10
been O 0 9.632314390550789e-11
reported O 0 4.564568514831002e-11
previously O 0 3.755995792165123e-10
but O 0 1.724075916753609e-11
has O 0 1.4871595274690286e-11
not O 0 6.724204526520339e-12
, O 0 1.5814856368923103e-11
to O 0 4.247138057911215e-11
our O 0 1.8787743583104088e-10
knowledge O 0 1.4043725904411275e-10
, O 0 8.491250758080326e-11
been O 0 1.8009815860864364e-10
observed O 0 3.8492567466796856e-10
in O 0 2.1822242624036647e-10
a O 0 1.7504532268119988e-09
case O 0 1.1617470541125385e-08
of O 0 1.9745505142054753e-07
PWS B-Disease 1 1.0
. O 0 2.008866204050719e-06

Furthermore O 0 3.7225257187856187e-07
, O 0 3.941608373025929e-09
our O 0 1.3551579858273044e-09
findings O 0 1.4181571195148734e-10
are O 0 1.1249267142798836e-11
best O 0 9.681682122675284e-10
interpreted O 0 1.6593264540176733e-09
as O 0 7.56687046354898e-10
true O 0 6.807449715040548e-09
gamete O 0 1.6913293165998766e-07
complementation O 0 9.537843652651645e-07
resulting O 0 1.3124155984201025e-08
in O 0 1.5071670578237217e-09
maternal B-Disease 0 4.471199645195156e-06
UPD I-Disease 1 1.0
15 I-Disease 0 6.894978014315711e-06
and O 0 1.3048834262008313e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 0 0.04962320253252983
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 2.0155333402271935e-07
2 I-Disease 0 3.4559874961814785e-08
and O 0 8.266726192474039e-10
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 1.9703023934614095e-10
a O 0 9.158598879288604e-11
case O 0 1.5277969167559746e-10
for O 0 1.546531652740768e-10
" O 0 2.949314348299481e-09
lumping O 0 3.9365397697110893e-07
" O 0 6.06395360591705e-08
. O 0 5.087996868269329e-08

Recent O 0 2.1728149945943187e-08
studies O 0 9.214867757734169e-10
demonstrated O 0 1.3716160429666502e-09
the O 0 1.2014922390335414e-09
existence O 0 6.165706833982654e-10
of O 0 1.775737890064022e-09
a O 0 4.990722834996575e-10
genetically O 0 2.785901731527929e-09
distinct O 0 2.089721173881287e-10
, O 0 8.911879914585974e-12
usually O 0 2.838607170499441e-12
lethal O 0 4.8555857251608714e-11
form O 0 1.347333919779481e-12
of O 0 8.395014544637647e-11
the O 0 2.372055329935563e-10
Schwartz B-Disease 0 4.280530902178725e-06
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.502421544598349e-10
SJS B-Disease 1 1.0
) O 0 3.644849755346513e-09
of O 0 1.8913610233539657e-07
myotonia B-Disease 1 1.0
and O 0 4.538622420113825e-07
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.4352085075941545e-09
which O 0 3.2876867894771067e-10
we O 0 6.401495999952544e-10
called O 0 7.671915547291519e-09
SJS B-Disease 1 1.0
type I-Disease 0 3.540392208378762e-05
2 I-Disease 0 5.276447609503521e-06
. O 0 1.6245883216470247e-07

This O 0 9.057259831024567e-09
disorder O 0 4.74742637379677e-06
is O 0 5.213142140192417e-10
reminiscent O 0 8.39729619173113e-09
of O 0 2.3623321965260402e-08
another O 0 1.7772457949760678e-09
rare O 0 1.2726768527926424e-09
condition O 0 1.929719273263686e-09
, O 0 1.9954907171104708e-10
the O 0 1.5214699500276652e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.5156661703485952e-08
SWS B-Disease 1 0.999969482421875
) O 0 2.689070077721567e-10
, O 0 3.90489307555697e-11
which O 0 3.086050859302247e-11
comprises O 0 2.0020336499726454e-09
campomelia B-Disease 0 1.0254791504848981e-07
at O 0 1.4784443669313418e-09
birth O 0 1.0630698099589608e-08
with O 0 2.6843571809820332e-09
skeletal B-Disease 1 0.9999997615814209
dysplasia I-Disease 1 1.0
, O 0 2.121615771955021e-08
contractures B-Disease 1 0.7536956071853638
, O 0 2.089829864715398e-09
and O 0 1.2688375905511862e-09
early B-Disease 0 1.5430622113399295e-08
death I-Disease 0 2.2080176620420389e-07
. O 0 1.1351463058417721e-07

To O 0 8.153995700865835e-09
test O 0 4.0484621210978844e-10
for O 0 1.355821843684879e-10
possible O 0 1.4520875613044382e-09
nosologic O 0 1.1979320788668701e-06
identity O 0 4.473074965982704e-10
between O 0 9.627942193501937e-11
these O 0 5.427493454668308e-10
disorders O 0 9.807631329294964e-08
, O 0 6.546928277284536e-11
we O 0 3.441313900509613e-11
reviewed O 0 3.564063488781244e-10
the O 0 2.153458661391383e-10
literature O 0 6.986244222018101e-11
and O 0 3.284933436376036e-11
obtained O 0 3.9147220187718546e-11
a O 0 2.104680492387434e-11
follow O 0 1.2866610554773672e-11
- O 0 2.1116780546392988e-10
up O 0 1.948923245009837e-10
of O 0 1.521219678002339e-10
the O 0 8.671815349137191e-11
only O 0 1.7055634682350274e-11
two O 0 1.9589998026536826e-11
surviving O 0 5.857965668099041e-09
patients O 0 3.7002337305303e-10
, O 0 7.909132376804351e-11
one O 0 1.0133623801200642e-10
with O 0 1.3855459835010464e-10
SJS B-Disease 1 0.9661601185798645
type I-Disease 0 5.4486275047338495e-08
2 I-Disease 0 5.5102127305417525e-09
at O 0 2.331790593945726e-10
age O 0 2.417659128450822e-10
10 O 0 3.8947324532134786e-11
years O 0 1.5958970256413352e-11
and O 0 8.7192496278643e-11
another O 0 1.9701670850302833e-10
with O 0 2.910030549863052e-10
SWS B-Disease 0 1.8245420505991206e-05
at O 0 2.100140150673724e-08
age O 0 1.6913380918026633e-08
7 O 0 2.3023419615242346e-08
years O 0 5.578537187744814e-09
. O 0 5.44965637061523e-08

Patients O 0 5.213485678723373e-07
reported O 0 3.8306260385923e-09
as O 0 1.5880614601115894e-09
having O 0 1.2228019485860386e-08
either O 0 7.284354808234639e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 4.796278972207801e-06
SWS B-Disease 1 0.9999576807022095
presented O 0 1.4599502939915965e-08
a O 0 2.300044182890204e-10
combination O 0 6.804616314859402e-10
of O 0 1.138311889192778e-09
a O 0 4.075423332139394e-10
severe O 0 1.3331319337339664e-07
, O 0 2.0679848111715415e-10
prenatal O 0 7.524793232960292e-08
- O 0 1.5338007415266475e-06
onset O 0 0.1662389189004898
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 9.269536249689736e-09
with O 0 2.60183469436015e-07
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999998807907104
contractures I-Disease 1 1.0
, O 0 4.608433812336443e-07
respiratory O 1 1.0
and O 0 3.2379791292669324e-08
feeding O 0 4.357257694209693e-06
difficulties O 0 2.2253320821619127e-06
, O 0 6.437886890253708e-10
tendency O 0 6.1283085273089455e-09
to O 0 1.3634414708363352e-09
hyperthermia B-Disease 0 0.00021281163208186626
, O 0 3.3119434972306294e-10
and O 0 4.826198329865861e-10
frequent O 0 3.2171574293471394e-09
death O 0 7.275992253141794e-09
in O 0 3.967190187470493e-10
infancy O 0 8.25554291594699e-09
) O 0 5.3632764895894525e-11
with O 0 8.221232028482461e-11
a O 0 1.7820352971043008e-09
distinct O 0 4.486323135211023e-08
campomelic B-Disease 0 8.183086174540222e-05
- I-Disease 0 0.05094386264681816
metaphyseal I-Disease 1 0.999996542930603
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 2.613645165183698e-06

The O 0 5.217146181735188e-08
similarity O 0 2.2400437060809963e-08
of O 0 3.061630593492737e-08
the O 0 1.1288207701909414e-08
clinical O 0 6.875345093249052e-08
and O 0 1.2427543438775501e-09
radiographic O 0 2.59287789958762e-05
findings O 0 3.131801484812513e-09
is O 0 1.2514261849005948e-10
so O 0 1.820500868110475e-11
extensive O 0 1.3349806815554643e-09
that O 0 7.45936368229394e-11
these O 0 1.9211661150819737e-09
disorders O 0 4.6065665060268657e-07
appear O 0 1.850306574624483e-10
to O 0 4.218412771872515e-11
be O 0 7.732742918209468e-11
a O 0 5.008268799677751e-10
single O 0 4.2524028742718656e-09
entity O 0 1.24755516139885e-07
. O 0 1.241471352386725e-07

The O 0 1.0250156634583618e-07
follow O 0 5.8618887521788565e-09
- O 0 2.368224194526647e-08
up O 0 2.195166493024203e-09
observation O 0 3.0768321224172723e-09
of O 0 6.993540746513816e-10
an O 0 1.5049766988184388e-11
identical O 0 1.0528421190425519e-10
and O 0 4.35480262961363e-11
unique O 0 5.360947796795301e-10
pattern O 0 4.2912269293537975e-09
of O 0 3.1749390672075606e-08
progressive O 1 0.9999997615814209
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9829845428466797
in O 0 2.461358894478849e-10
the O 0 3.5753815463834826e-09
two O 0 1.189640747023546e-10
patients O 0 9.23944878938876e-11
( O 0 4.64677081535303e-12
one O 0 6.976431238259195e-11
with O 0 1.191084730844949e-10
SJS B-Disease 1 1.0
type I-Disease 0 3.365139491506852e-07
2 I-Disease 0 4.537267628279551e-08
, O 0 8.295104880762239e-11
one O 0 6.520795015063641e-11
with O 0 1.8030438253546777e-10
SWS B-Disease 0 0.0004136572824791074
) O 0 6.647155714745168e-09
surviving O 0 1.9853000310376956e-07
beyond O 0 4.159598532282871e-08
infancy O 0 5.665370395036007e-09
adds O 0 5.336297376201671e-11
to O 0 1.713153750804164e-11
the O 0 8.81962280985249e-11
evidence O 0 8.131637724284602e-11
in O 0 3.5715267548974694e-11
favor O 0 2.079483918393521e-09
of O 0 8.95717189308698e-09
identity O 0 8.103374860013446e-09
. O 0 2.6875397907133447e-08

The O 0 3.653190105978865e-07
hypothesis O 0 7.339386343119259e-08
that O 0 1.3672697418698476e-09
SWS B-Disease 1 0.9404767751693726
and O 0 1.3966733547476906e-07
SJS B-Disease 1 1.0
type I-Disease 0 1.4414306406251853e-06
2 I-Disease 0 4.2131443223070164e-08
are O 0 1.56114184080014e-11
the O 0 8.919093935633171e-11
same O 0 5.205987863021733e-10
disorder O 0 3.654740794445388e-07
should O 0 8.168966614263695e-10
be O 0 1.1868801774728155e-10
testable O 0 6.609897074127957e-09
by O 0 2.5813951670672353e-11
molecular O 0 7.746756569559921e-10
methods O 0 6.47767173234115e-10
. O 0 4.335510839226231e-10
. O 0 2.466168780301814e-08

A O 0 1.8449680965204607e-06
mouse O 0 1.1032653901565936e-07
model O 0 5.204818798176802e-09
of O 0 1.2753845091140192e-08
severe O 1 0.9999350309371948
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 6.865693649160676e-07
defects O 1 0.9999618530273438
in O 0 8.816553709323216e-09
hemostasis O 1 1.0
and O 0 6.25737527570891e-07
thrombosis B-Disease 0 5.5411037465091795e-05
. O 0 2.853264504665276e-07

von B-Disease 1 0.9997548460960388
Willebrand I-Disease 1 1.0
factor I-Disease 0 0.00045549057540483773
( I-Disease 0 2.585072991223569e-07
vWf I-Disease 1 1.0
) I-Disease 0 4.486304533202201e-05
deficiency I-Disease 1 1.0
causes O 1 0.9999221563339233
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 3.1762931484990986e-07
humans O 0 7.374664079407012e-08
. O 0 8.230387038565823e-09

We O 0 1.071596003043851e-07
generated O 0 2.6946695541596455e-08
a O 0 1.6270118585737237e-09
mouse O 0 9.590269911541327e-09
model O 0 6.127557905521996e-10
for O 0 4.9524301326542286e-11
this O 0 1.9906010867432045e-11
disease O 0 4.821018584344472e-10
by O 0 2.9452301708587925e-11
using O 0 8.689899910763188e-10
gene O 0 3.993825714587729e-09
targeting O 0 4.0471068274428035e-08
. O 0 5.0616879576637075e-08

vWf B-Disease 0 0.0060618044808506966
- I-Disease 1 0.812574028968811
deficient I-Disease 0 0.00039504648884758353
mice O 0 7.346220058934705e-07
appeared O 0 4.5598915754396785e-09
normal O 0 1.4495665778824218e-09
at O 0 1.199378374394655e-10
birth O 0 6.93694268694145e-11
; O 0 2.401424328488111e-12
they O 0 3.4111598094799245e-12
were O 0 2.7388652110160727e-11
viable O 0 6.658626983124805e-09
and O 0 1.5795276198105057e-09
fertile O 0 1.1190132909177919e-06
. O 0 1.5316022938804963e-07

Neither O 0 3.07434493151959e-05
vWf O 0 0.0009851476643234491
nor O 0 8.332177458214574e-06
vWf O 0 0.000551969395019114
propolypeptide O 0 0.0001658656692598015
( O 0 4.564314082244891e-08
von B-Disease 0 0.00021378477686084807
Willebrand I-Disease 1 0.9992840886116028
antigen O 0 7.695836075072293e-07
II O 1 1.0
) O 0 1.8622213771024576e-09
were O 0 5.130215696702578e-10
detectable O 0 6.035694610773135e-08
in O 0 9.019187480197033e-11
plasma O 0 5.709957395794163e-09
, O 0 6.582212552785904e-11
platelets O 0 9.660690025725671e-10
, O 0 6.129354662709474e-11
or O 0 2.245019101176915e-11
endothelial O 0 4.2604461625295187e-10
cells O 0 4.882294221686401e-11
of O 0 2.55324650311195e-09
the O 0 1.2881019806343375e-08
homozygous O 0 5.523083359548764e-07
mutant O 0 1.6593293139521847e-06
mice O 0 1.8436085724715667e-07
. O 0 1.5892227978042683e-08

The O 0 9.425644975635805e-07
mutant O 0 8.879573215381242e-06
mice O 0 5.3242479225446e-07
exhibited O 0 6.993813030931051e-07
defects O 0 9.79333071882138e-06
in O 0 8.066698975461861e-10
hemostasis O 0 6.975893484195694e-06
with O 0 5.199398689370582e-10
a O 0 3.6793057489603598e-09
highly O 0 2.9574624704764574e-07
prolonged O 0 4.168743907939643e-05
bleeding O 1 0.9983623623847961
time O 0 3.001822124204523e-09
and O 0 1.0466922439889004e-08
spontaneous O 0 1.2265094539998245e-07
bleeding O 0 4.450536152944551e-07
events O 0 1.9303440790263693e-10
in O 0 2.166595895747303e-11
approximately O 0 1.4967273254118396e-10
10 O 0 1.3965834044782355e-10
% O 0 1.073396718731523e-10
of O 0 2.857483138996031e-09
neonates O 0 8.501065167365596e-07
. O 0 1.198099539578834e-07

As O 0 1.8035994031606606e-08
in O 0 4.937982800434781e-10
the O 0 1.4524088598477647e-09
human O 0 4.0643227672276794e-10
disease O 0 1.7247684391819007e-09
, O 0 5.371261421749374e-11
the O 0 6.536201579976364e-10
factor O 0 8.491971570379064e-09
VIII O 0 0.0005604895995929837
level O 0 3.590643515849479e-08
in O 0 3.871374609776268e-10
these O 0 5.234823685640322e-10
mice O 0 4.90932361429941e-09
was O 0 9.62880997157356e-10
reduced O 0 1.5360492877647403e-09
strongly O 0 8.644879950781004e-11
as O 0 6.261390017581192e-11
a O 0 2.9621988889561024e-11
result O 0 6.489737913728533e-11
of O 0 4.5427184236501716e-10
the O 0 2.814055100053281e-10
lack O 0 1.159736195965877e-09
of O 0 1.718738928957464e-09
protection O 0 4.2553825352342756e-08
provided O 0 1.6315830908553153e-09
by O 0 2.593246506421565e-09
vWf O 0 0.00010961283987853676
. O 0 9.608910431779805e-07

Defective O 1 1.0
thrombosis B-Disease 0 7.60559705668129e-05
in O 0 2.8184361511307543e-08
mutant O 0 2.4922223929024767e-06
mice O 0 1.3791720654410256e-08
was O 0 1.3130407872097294e-09
also O 0 8.161440273601883e-11
evident O 0 8.148099417404353e-10
in O 0 2.2880758052123973e-11
an O 0 2.3146186356459708e-11
in O 0 1.0052308985208924e-10
vivo O 0 5.548752923800748e-08
model O 0 5.112313683497405e-09
of O 0 1.98636612935843e-07
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 1.0210112577624386e-06

In O 0 2.7628352938791068e-09
this O 0 3.7070062297583917e-11
model O 0 2.651695807376342e-10
, O 0 1.2524242753997328e-10
the O 0 1.3378559371446386e-09
exteriorized O 0 1.6866947589733172e-06
mesentery O 0 1.3268855582282413e-05
was O 0 1.1305805713845984e-07
superfused O 0 1.0598128028505016e-05
with O 0 2.1015186035810984e-08
ferric O 0 3.4140106436097994e-05
chloride O 0 8.416188990167939e-08
and O 0 1.3494764417032457e-08
the O 0 3.6630343203114535e-08
accumulation O 0 2.344669610465644e-06
of O 0 6.604266218346311e-07
fluorescently O 0 2.103109727613628e-05
labeled O 0 2.4739429704823124e-07
platelets O 0 1.0208909628772744e-07
was O 0 1.9178024501798063e-08
observed O 0 2.267364074270972e-09
by O 0 3.8643960253992304e-10
intravital O 0 2.3104068986867787e-06
microscopy O 0 1.8961030079367447e-08
. O 0 9.363398589812277e-08

We O 0 5.17382190423632e-08
conclude O 0 8.093720360591306e-09
that O 0 4.7425723070926296e-11
these O 0 4.779105999830335e-10
mice O 0 5.573591810303924e-09
very O 0 1.8277281077505592e-10
closely O 0 5.369628297557938e-09
mimic O 0 0.0017701404867693782
severe O 1 1.0
human O 0 0.00026790317497216165
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 1.8222857889327315e-08
will O 0 1.5122687824220549e-10
be O 0 1.3133400617038049e-11
very O 0 4.837926500383949e-12
useful O 0 1.5220344082300663e-11
for O 0 4.346494084789265e-12
investigating O 0 1.3627492190249058e-10
the O 0 5.002101510775958e-10
role O 0 2.3155526385210123e-09
of O 0 1.3899703610320557e-08
vWf O 0 1.9276585589977913e-06
in O 0 2.5375939127769698e-09
normal O 0 1.0178962561724347e-08
physiology O 0 9.911352849556465e-10
and O 0 9.46326628170624e-11
in O 0 1.2645992586435284e-10
disease O 0 2.825065292810791e-09
models O 0 1.0972331931924373e-09
. O 0 5.990706819503089e-10
. O 0 1.5952176468658763e-08

Oral O 0 1.8120172171620652e-05
contraceptives O 0 1.544139081488538e-06
and O 0 1.2179039998727603e-09
the O 0 3.1033426939330866e-09
risk O 0 6.893399699947622e-07
of O 0 0.0011073390487581491
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.284941049561894e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 0.03888572379946709
Study O 0 2.859283831924131e-08
Group O 0 3.413507920768666e-09
. O 0 5.0976596277507724e-09

BACKGROUND O 0 2.589447603895678e-06
Women O 0 2.398661824720705e-10
with O 0 2.8161856527320062e-11
mutations O 0 1.5727838476031764e-10
in O 0 2.6741438924338112e-11
either O 0 3.619063937421174e-10
the O 0 2.64500421565117e-09
BRCA1 O 0 6.197759461201713e-08
or O 0 6.884551262409389e-10
the O 0 9.906745646048876e-09
BRCA2 O 0 1.666445257342275e-07
gene O 0 9.214669305368517e-11
have O 0 6.015478479920455e-12
a O 0 2.1780646730640285e-11
high O 0 6.66705268770329e-09
lifetime O 0 1.6563674876124423e-08
risk O 0 1.9625898062258784e-07
of O 0 1.5145994439080823e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.483573666722805e-07

Oral O 0 0.022086946293711662
contraceptives O 1 0.999992847442627
protect O 1 0.9999178647994995
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.0664079619360223e-09
general O 0 8.109860005767189e-11
, O 0 1.3946714443047181e-11
but O 0 7.420534672841761e-12
it O 0 1.285868633793541e-11
is O 0 8.933084306994576e-12
not O 0 2.8621916035170836e-12
known O 0 3.938898859856543e-11
whether O 0 3.15288350982712e-11
they O 0 9.828736782790948e-12
also O 0 4.461519001464076e-11
protect O 0 5.507302169860395e-09
against O 0 6.05481176307876e-08
hereditary B-Disease 1 1.0
forms I-Disease 1 0.9999731779098511
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.274642980637509e-07

METHODS O 0 2.885819014863955e-07
We O 0 1.7936395702022878e-09
enrolled O 0 2.7452067286048987e-09
207 O 0 1.3148477862046093e-09
women O 0 3.085591851470504e-11
with O 0 2.0135875189453145e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.3099690221451965e-09
161 O 0 3.398304970758659e-10
of O 0 2.348645167238317e-10
their O 0 2.310530933247179e-10
sisters O 0 6.002147223682641e-09
as O 0 2.5969276729043145e-10
controls O 0 6.329988622155724e-08
in O 0 7.071148111492676e-10
a O 0 1.9690185038001573e-09
case O 0 3.4900140555294e-09
- O 0 1.6828293780690728e-07
control O 0 3.1591432048116985e-07
study O 0 1.9049769761636526e-08
. O 0 1.971285534807521e-08

All O 0 6.174538214054337e-08
the O 0 7.703500060074475e-09
patients O 0 1.2203594801363238e-09
carried O 0 4.3278683414804675e-10
a O 0 2.481131966547423e-10
pathogenic O 0 1.3154028088990799e-08
mutation O 0 1.2606117261171335e-09
in O 0 3.52741558184988e-10
either O 0 1.1423623824668994e-08
BRCA1 O 0 3.592822039877319e-08
( O 0 4.491599106537514e-11
179 O 0 9.484503182832782e-10
women O 0 3.2942680701364413e-12
) O 0 2.7306445299357662e-11
or O 0 6.351267844983965e-10
BRCA2 O 0 1.3944878674010397e-07
( O 0 1.2240000679675234e-10
28 O 0 2.2483220618596533e-08
women O 0 4.867343333936347e-11
) O 0 3.399614478816204e-10
. O 0 9.727498806455515e-09

The O 0 1.6452015927370667e-07
control O 0 1.9716978272299457e-07
women O 0 1.224308293634735e-10
were O 0 3.9300888932114475e-11
enrolled O 0 3.392114089617593e-10
regardless O 0 5.15484217811224e-11
of O 0 1.723218789884129e-10
whether O 0 7.4558643980982e-11
or O 0 4.095806679926817e-11
not O 0 1.3181861852062937e-11
they O 0 7.144133895575777e-11
had O 0 2.4493616024301446e-09
either O 0 9.41500744033874e-09
mutation O 0 1.2652064640406024e-07
. O 0 1.2473697097448166e-07

Lifetime O 0 7.813920092303306e-06
histories O 0 5.60171883989824e-07
of O 0 1.5299308131488942e-07
oral O 0 5.561021225730656e-07
- O 0 3.8161303450579e-08
contraceptive O 0 1.963644136182552e-09
use O 0 2.19224378233962e-11
were O 0 7.440262815572307e-12
obtained O 0 6.122633216393281e-12
by O 0 3.604944251098252e-12
interview O 0 2.388818032272866e-10
or O 0 1.7435771576534975e-11
by O 0 2.5039156945766416e-12
written O 0 2.4870484144345895e-11
questionnaire O 0 8.005778331932056e-12
and O 0 9.867919849304574e-12
were O 0 7.560745432511062e-12
compared O 0 2.0345600204585423e-11
between O 0 2.9997931222380814e-11
patients O 0 4.855178412088712e-11
and O 0 1.987383868584658e-11
control O 0 1.1145360190312203e-08
women O 0 6.602402652378103e-12
, O 0 1.7471682737732475e-12
after O 0 6.58268621903102e-12
adjustment O 0 2.990347303111207e-09
for O 0 3.034875822871541e-11
year O 0 8.679791607679732e-11
of O 0 3.5847773638408853e-09
birth O 0 9.863080130401158e-09
and O 0 4.395957819980367e-09
parity O 0 1.175347051685094e-06
. O 0 1.3728369196996937e-07

RESULTS O 0 4.298589715290291e-07
The O 0 1.8418612413029223e-08
adjusted O 0 5.96439804212423e-08
odds O 0 6.443052313898079e-08
ratio O 0 4.870173597737448e-08
for O 0 7.024656412113472e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.972266128191791e-09
with O 0 9.760403596459355e-11
any O 0 1.0365139857526628e-09
past O 0 9.022529945390545e-10
use O 0 2.705646540146489e-10
of O 0 2.304005874975701e-09
oral O 0 1.252612378266349e-07
contraceptives O 0 5.217549983171921e-07
was O 0 1.6800241198211552e-08
0 O 0 4.41478178458965e-08
. O 0 3.866109921091265e-08

5 O 0 4.330416345510457e-07
( O 0 3.3179012870476754e-09
95 O 0 1.2184732156583777e-07
percent O 0 1.3609740001641057e-08
confidence O 0 1.4947167947809703e-09
interval O 0 4.6147136112395515e-10
, O 0 4.149956073229433e-11
0 O 0 1.2215954636740634e-10
. O 0 1.057220370276335e-11
3 O 0 2.8448110533929594e-10
to O 0 4.4219045092219744e-11
0 O 0 3.988114560815603e-10
. O 0 6.885295805725278e-11
8 O 0 9.69691527075156e-09
) O 0 3.678161997200391e-09
. O 0 3.358050548740721e-08

The O 0 3.6565361938301066e-07
risk O 0 2.68640036438228e-07
decreased O 0 1.1679903266781366e-08
with O 0 7.758611808572624e-11
increasing O 0 1.1929155441237071e-09
duration O 0 7.122371581402831e-09
of O 0 2.47880138637413e-09
use O 0 1.2993780496017848e-09
( O 0 3.854575825190665e-10
P O 0 1.6049020246100554e-07
for O 0 6.004800545689193e-10
trend O 0 8.83493722625417e-09
, O 0 1.4095653810830555e-10
< O 0 9.494113273333937e-10
0 O 0 1.84064069541634e-10
. O 0 9.596824203372822e-12
001 O 0 4.73165118197727e-10
) O 0 8.617033952704189e-13
; O 0 6.274390729199553e-13
use O 0 5.616269168479127e-12
for O 0 2.5188909985596197e-11
six O 0 3.580215984788637e-11
or O 0 1.0783436643624356e-11
more O 0 1.4031691390400947e-12
years O 0 2.7513212194629766e-11
was O 0 2.1810839245794966e-10
associated O 0 8.002423723674212e-11
with O 0 7.817286401534673e-11
a O 0 6.28470109287349e-10
60 O 0 2.9656446187686925e-09
percent O 0 4.4072639981962425e-10
reduction O 0 1.4729284458780967e-08
in O 0 2.3645581048725717e-09
risk O 0 4.1868966604852176e-07
. O 0 7.618665165409766e-08

Oral O 0 2.8720780392177403e-05
- O 0 7.173595690801449e-07
contraceptive O 0 4.1514820026122834e-08
use O 0 2.2300501445471355e-09
protected O 1 0.9999953508377075
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.1479943384795632e-10
for O 0 1.6547008555023446e-11
carriers O 0 3.0941194051337106e-11
of O 0 5.482292952940782e-10
the O 0 6.1263922823684425e-09
BRCA1 O 0 4.942369002947089e-08
mutation O 0 3.2548178041658105e-10
( O 0 1.1253322058923931e-11
odds O 0 2.5997044517112045e-09
ratio O 0 2.4867272130357776e-10
, O 0 5.0829813448560746e-12
0 O 0 4.4614506533591225e-11
. O 0 4.6567966496824376e-12
5 O 0 1.2660568426969832e-10
; O 0 1.99341255308072e-11
95 O 0 5.798471036655428e-09
percent O 0 1.3804213327972548e-09
confidence O 0 2.5883925558467524e-10
interval O 0 4.274087195277332e-10
, O 0 3.654661295815487e-11
0 O 0 5.3856336057478416e-11
. O 0 4.516148306016321e-12
3 O 0 7.385492217792944e-11
to O 0 7.714501780442529e-12
0 O 0 5.08787283137746e-11
. O 0 5.033449785446509e-12
9 O 0 1.620683170999726e-10
) O 0 5.653779094200173e-12
and O 0 1.2862953757686313e-11
for O 0 1.8715059016405355e-11
carriers O 0 4.399344222250079e-10
of O 0 3.5027516442909246e-09
the O 0 1.0654980542312842e-07
BRCA2 O 0 2.410503157079802e-06
mutation O 0 2.3637822810229636e-09
( O 0 3.815833413134406e-11
odds O 0 6.511120087537847e-09
ratio O 0 6.278171316154157e-10
, O 0 9.739199030578405e-12
0 O 0 5.056103105638421e-11
. O 0 9.801217129568052e-12
4 O 0 2.5305263440245085e-10
; O 0 3.0337878043074085e-11
95 O 0 1.042659292238568e-08
percent O 0 2.0559394187102953e-09
confidence O 0 4.830481015183352e-10
interval O 0 9.33664034974413e-10
, O 0 7.104726529316707e-11
0 O 0 1.5012789622570466e-10
. O 0 1.2797931117636274e-11
2 O 0 2.2157692347590796e-10
to O 0 2.38608455910283e-11
1 O 0 5.567606931045077e-10
. O 0 5.621351648055217e-11
1 O 0 8.717129240665145e-09
) O 0 2.4104636064947726e-09
. O 0 3.0659023764201265e-08

CONCLUSIONS O 0 4.591982815327356e-06
Oral O 0 4.5432789193000644e-06
- O 0 2.015268307786755e-07
contraceptive O 0 7.831845394434822e-09
use O 0 6.482315378919523e-11
may O 0 6.507037964009754e-12
reduce O 0 2.5708077333597146e-10
the O 0 1.833066198830835e-10
risk O 0 4.489541538532649e-08
of O 0 0.0011707129888236523
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.671693587532388e-10
women O 0 1.532956162182686e-12
with O 0 2.4469705775520545e-13
pathogenic O 0 6.862892476533489e-10
mutations O 0 1.0167116454296021e-10
in O 0 2.7351848216894403e-11
the O 0 6.9356000942377705e-09
BRCA1 O 0 7.342171670643438e-07
or O 0 1.0526467519866856e-07
BRCA2 O 0 4.324795736465603e-05
gene O 0 2.636222461660509e-06

A O 0 1.4296488188847434e-06
Japanese O 0 1.5853423462885985e-07
family O 0 4.9970312332447975e-09
with O 0 9.913058818256104e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.268795805728587e-08
a O 0 4.0356447073008894e-08
codon O 0 7.47649551158247e-08
291 O 0 4.533804887074666e-09
deletion O 0 7.169695059872083e-09
: O 0 2.7007368563758405e-11
a O 0 5.5246876518033616e-11
clinical O 0 2.9833058245998245e-09
, O 0 6.468766494682754e-11
biochemical O 0 3.6005309844711064e-09
, O 0 1.744499544820144e-10
pathological O 0 1.132102980250238e-07
, O 0 1.2716376562860177e-10
and O 0 6.215392089892191e-10
genetic O 0 1.8098884169148732e-08
report O 0 2.369677787328328e-09
. O 0 2.8167377763566037e-08

We O 0 9.961619085174789e-09
report O 0 4.999660130344807e-10
a O 0 2.0008072976196445e-10
Japanese O 0 8.789656114061017e-09
family O 0 1.5703714995041196e-09
with O 0 8.346693114447135e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.2317108257775544e-06
ALD B-Disease 1 1.0
) O 0 9.177436033347419e-10
with O 0 9.211786888840834e-11
a O 0 4.630336947197833e-10
three O 0 1.823413919854744e-10
base O 0 8.621588776236422e-09
pair O 0 7.013033265224067e-09
deletion O 0 1.0898252078561654e-08
( O 0 2.2778527675182403e-10
delGAG O 0 4.5180357233221e-07
291 O 0 1.4312747653733027e-09
) O 0 1.9207354456929338e-11
in O 0 8.442319066048753e-11
the O 0 3.3499006235615525e-08
ALD B-Disease 1 1.0
gene O 0 3.352828912284167e-07
. O 0 8.5461977050727e-08

A O 0 5.188101113162702e-07
variety O 0 1.584123410225402e-08
of O 0 1.3374330087856379e-08
phenotypes O 0 3.348788979451456e-08
were O 0 3.3001515409303295e-10
observed O 0 7.818259373237879e-10
within O 0 1.7661473672436756e-10
this O 0 5.854586954123775e-11
family O 0 3.350020483239291e-09
. O 0 6.215018544253326e-08

While O 0 1.9343973178820306e-07
the O 0 9.605046358274194e-08
proband O 0 6.46780026727356e-05
( O 0 4.70966599053213e-09
patient O 0 1.0956862084299246e-08
1 O 0 1.0929769089784713e-08
) O 0 1.627799284253939e-10
was O 0 1.1220692153202094e-09
classified O 0 3.192608399871233e-09
as O 0 5.328082419708835e-10
having O 0 1.0462446464742925e-09
a O 0 1.5833334643389207e-10
rare O 0 6.665447083165077e-10
intermediate O 0 2.2958079881618687e-08
type O 0 4.6872976611211925e-09
of O 0 3.732076692131159e-08
adult O 0 8.12755388324149e-07
cerebral O 0 3.988650831843188e-08
and O 0 1.2940901683577977e-09
cerebello O 0 0.07811543345451355
- O 0 8.211844942707103e-06
brain O 0 3.223584883471631e-07
stem O 0 2.3722828146333086e-09
forms O 0 9.559250613300208e-11
, O 0 3.8931336453218446e-12
his O 0 2.3823887307372615e-10
younger O 0 2.2244339703547666e-09
brother O 0 3.284241323342485e-09
( O 0 5.0617961211418816e-11
patient O 0 9.224099262183927e-10
2 O 0 2.444144220348221e-09
) O 0 1.2158400675144065e-10
and O 0 1.7679616659549424e-09
nephew O 0 8.628746854810743e-07
( O 0 8.599937983966299e-10
patient O 0 4.573706302579694e-09
3 O 0 7.580467809020774e-09
) O 0 1.9254976779681243e-10
had O 0 3.2254274806575722e-09
a O 0 2.0454070437381233e-08
childhood O 0 2.6174186132266186e-05
ALD B-Disease 1 1.0
type O 0 0.00020429427968338132
. O 0 1.9825414199203806e-07

Another O 0 2.245730684080627e-06
nephew O 0 1.1423051546444185e-05
( O 0 1.1869040861256508e-08
patient O 0 5.468669428410067e-08
4 O 0 8.542984097914541e-09
) O 0 1.4715396956521687e-10
of O 0 2.7878630515232317e-09
patient O 0 3.7211569381412346e-09
1 O 0 3.496984035677997e-09
was O 0 1.0892137192186624e-09
classified O 0 1.9590165045713093e-09
as O 0 4.928384922386897e-10
having O 0 1.7865684487361477e-09
an O 0 6.680096475975006e-10
adolescent O 0 2.400147707248834e-07
form O 0 5.956994897360346e-09
. O 0 2.9260235123729217e-08

The O 0 3.1515543241766864e-07
tau O 0 6.696558330077096e-07
level O 0 1.3114647146039715e-08
in O 0 1.0833625108119804e-09
the O 0 3.211083665632941e-08
cerebrospinal O 0 7.624900604241702e-07
fluid O 0 2.407228691936325e-07
( O 0 3.6468243980181114e-09
CSF O 1 1.0
) O 0 3.277206284124645e-10
in O 0 9.722722627003577e-11
patient O 0 1.1438333613611462e-09
1 O 0 2.071376847823103e-09
was O 0 1.2355598766333742e-09
as O 0 7.751718711368483e-11
high O 0 2.187984904367113e-09
as O 0 3.1556330465365434e-11
that O 0 6.549560373214636e-12
of O 0 1.613725264526522e-09
patients O 0 1.0154486140834251e-09
with O 0 1.5788228502344737e-09
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999653100967407
( O 0 4.691015909052965e-10
AD B-Disease 0 3.49064208648997e-07
) O 0 2.463802495356049e-09
. O 0 1.8963488557233177e-08

His O 0 0.00012151326518505812
brain O 0 0.01998528093099594
magnetic O 0 2.0133484213147312e-06
resonance O 0 1.66253400379901e-07
image O 0 6.670247643114635e-08
( O 0 1.7170047328374238e-10
MRI O 0 1.5675908798584715e-05
) O 0 1.3588974390188469e-10
showed O 0 7.246875877164882e-10
abnormalities B-Disease 0 8.630180303725865e-08
in I-Disease 0 8.352307040437879e-11
the I-Disease 0 6.6696217437822725e-09
bilateral I-Disease 0 0.0029449877329170704
cerebellar I-Disease 1 1.0
hemispheres I-Disease 0 1.722375236568041e-05
and O 0 8.803900719556168e-09
brain O 0 8.001244822253284e-08
stem O 0 1.7505599192446653e-09
, O 0 5.032394206211377e-12
but O 0 1.1362190485350587e-12
not O 0 6.284690649838165e-13
in O 0 3.5701762726714215e-12
the O 0 3.554077865342009e-10
cerebral O 0 8.20753065511326e-09
white O 0 6.432707144732319e-10
matter O 0 6.961360932145055e-10
, O 0 1.6748991082948805e-11
where O 0 1.8903153348182045e-11
marked O 0 1.0458051785677824e-10
reductions O 0 7.692517733914883e-09
of O 0 5.335203834277991e-09
the O 0 1.3033925938543689e-08
cerebral O 0 3.1099753527996654e-07
blood O 0 6.226549054133557e-09
flow O 0 7.2374310988720936e-09
and O 0 8.422315067591057e-10
oxygen O 0 8.276981322552501e-10
metabolism O 0 7.008509883554837e-10
were O 0 9.474770967798918e-11
clearly O 0 5.020108773123866e-10
demonstrated O 0 5.358330446014747e-10
by O 0 4.241473283705943e-10
positron O 0 6.935152327969263e-07
emission O 0 2.453693923598621e-06
tomography O 0 5.5029055090471957e-08
( O 0 2.3763675471855095e-09
PET O 0 1.3159647096472327e-05
) O 0 2.2872752580838096e-09
. O 0 2.3658223824440938e-08

In O 0 1.453728870615123e-08
patients O 0 2.292581902096913e-09
2 O 0 1.5853709456337128e-09
and O 0 1.6677274838894363e-10
3 O 0 2.4402870835160684e-09
, O 0 7.093541726232999e-11
the O 0 2.4198643089334837e-10
autopsy O 0 1.9495050906925826e-08
findings O 0 5.316489470885699e-10
showed O 0 4.689309829331023e-09
massive O 0 2.42539931605279e-06
demyelination B-Disease 1 1.0
of I-Disease 1 0.9852980375289917
the I-Disease 0 4.6962222199908865e-07
cerebral I-Disease 0 1.1840532465612341e-07
white I-Disease 0 7.085242947901804e-10
matter I-Disease 0 6.32741137263082e-10
with O 0 1.386486411791843e-11
sparing O 0 6.095969951047664e-09
of O 0 1.5882593018545776e-08
the O 0 1.3213372618281483e-08
U O 0 1.1222473403904587e-06
- O 0 2.2471137128832197e-07
fibers O 0 8.588816058363591e-08
, O 0 2.544979782470591e-10
compatible O 0 2.2016701795024574e-09
with O 0 2.0860922364529522e-11
the O 0 5.375753731051702e-10
findings O 0 4.794105668004534e-10
of O 0 1.498345447714655e-08
childhood O 0 0.00015882222214713693
ALD B-Disease 1 1.0
. O 0 1.4718465308760642e-06

Oleic O 0 0.04022446647286415
and O 0 2.3962923023646e-06
erucic O 0 0.004216148518025875
acids O 0 5.478723323903978e-07
( O 0 1.4183553220803446e-09
Lorenzos O 0 3.730045591510134e-06
Oil O 0 2.1681206163748357e-08
) O 0 1.0202706041129161e-10
were O 0 7.70687264006753e-11
administered O 0 2.2160651091951422e-10
to O 0 4.370921333207711e-11
patients O 0 2.4980925314443958e-11
1 O 0 2.473859728180372e-10
and O 0 7.103994476009845e-11
4 O 0 1.5632410921284645e-09
, O 0 2.2930126547526797e-11
but O 0 5.1000345439866646e-12
sufficient O 0 2.878882687795681e-10
effectiveness O 0 7.846179816972665e-10
was O 0 2.464122239587141e-09
not O 0 3.4110589353097964e-10
obtained O 0 9.92933291144027e-09
. O 0 1.0152674434493747e-07

The O 0 1.5379870887954894e-07
findings O 0 4.019081512041112e-09
in O 0 1.458682480359741e-10
this O 0 9.882390739068825e-11
family O 0 2.4769664097590294e-10
suggest O 0 1.1093726631772327e-10
that O 0 8.843876152242469e-12
delGAG291 O 0 2.4695342659697417e-08
is O 0 8.999408857013336e-11
part O 0 4.813631715450128e-10
of O 0 4.2418797363552585e-09
the O 0 4.929722852153873e-09
cause O 0 1.7994656431596923e-08
of O 0 7.45738262253326e-08
Japanese O 0 4.554045972327003e-06
ALD B-Disease 1 1.0
with O 0 3.377861901299184e-08
phenotypic O 0 7.532653398811817e-05
variations O 0 2.1102200662426185e-06
. O 0 6.41981827698146e-08

Moreover O 0 1.6922230372529157e-07
, O 0 1.195354815131111e-09
although O 0 2.040670549208201e-10
the O 0 1.8435641901959343e-10
scale O 0 1.0573752540210535e-08
of O 0 4.086298854844017e-09
the O 0 6.364339610875902e-10
study O 0 8.518486610542553e-11
is O 0 1.7321116763113764e-11
limited O 0 8.427646080999551e-11
, O 0 3.565741452105087e-11
there O 0 8.504898174610531e-11
is O 0 1.4045359320036255e-10
a O 0 4.129988018242159e-10
possibility O 0 4.750073223647178e-09
that O 0 2.611033333987933e-10
PET O 0 0.00019482335483189672
can O 0 1.4467658182582e-09
detect O 0 1.111778473728009e-07
an O 0 2.513412811211424e-09
insidious B-Disease 0 4.131814876018325e-06
lesion I-Disease 0 5.556316682486795e-05
which O 0 2.420447176021412e-09
is O 0 1.2486944811485046e-09
undetectable O 0 6.577415234687578e-08
by O 0 4.826720967354703e-11
computed O 0 4.769958650285844e-08
tomogram O 0 5.8941523093380965e-06
( O 0 1.946977468136879e-09
CT O 0 6.499321170849726e-05
) O 0 2.2107962682760274e-10
or O 0 4.2670148664436525e-11
MRI O 0 3.506235657368961e-08
analysis O 0 1.3810468393882225e-11
, O 0 5.577348045210373e-12
and O 0 9.774501520676271e-12
that O 0 2.359782941968591e-12
the O 0 6.816147646304671e-11
higher O 0 1.7995736845133337e-10
level O 0 2.787691466554776e-10
of O 0 7.165931736885511e-10
tau O 0 3.077608567991774e-08
reflects O 0 2.261670156711304e-10
the O 0 2.380167729576499e-10
process O 0 3.110736945810544e-10
of O 0 1.402684901563589e-08
neuronal B-Disease 0 4.344283752288902e-06
degeneration I-Disease 1 1.0
in O 0 4.15436852563289e-06
ALD B-Disease 1 1.0
. O 0 5.994626917527057e-06

Lorenzos O 0 4.757028364110738e-05
Oil O 0 1.0097577529677437e-07
should O 0 1.8493363784788386e-10
be O 0 1.1307068129018383e-11
given O 0 7.352472797261811e-12
in O 0 5.405812950054489e-12
the O 0 9.001348971748868e-11
early O 0 8.957064534520498e-10
stage O 0 1.319800801979909e-08
. O 0 3.0785523019716265e-09
. O 0 7.257921197378892e-08

Nonsense O 0 1.614690881979186e-05
mutation O 0 3.547843618889601e-08
in O 0 1.4046974694537084e-09
exon O 0 1.4948992088648083e-07
4 O 0 7.421341052804564e-08
of O 0 1.9096116687933318e-08
human O 0 3.508990431555503e-09
complement O 0 1.5706598688325357e-08
C9 O 0 0.15299950540065765
gene O 0 1.83843829049124e-09
is O 0 6.606298147415757e-11
the O 0 1.8636098220170538e-10
major O 0 8.474432711125246e-09
cause O 0 1.0124881377748807e-08
of O 0 2.7130496960126038e-08
Japanese O 0 4.6623563321190886e-07
complement B-Disease 0 4.715021077572601e-06
C9 I-Disease 1 1.0
deficiency I-Disease 0 0.0030005432199686766
. O 0 2.3575437069212057e-07

Deficiency B-Disease 1 0.9901375770568848
of I-Disease 0 6.5547737904125825e-06
the I-Disease 0 4.793045604856161e-07
ninth I-Disease 0 2.5090130861826765e-07
component I-Disease 0 2.2963148182952864e-07
of I-Disease 0 1.6120533530283865e-07
human I-Disease 0 4.236527129108936e-09
complement I-Disease 0 1.4025591354993594e-08
( O 0 3.4355965294885493e-10
C9 O 1 1.0
) O 0 1.6536573499426055e-10
is O 0 1.2834305666842294e-11
the O 0 1.9767833203676588e-11
most O 0 4.054943186782012e-11
common O 0 4.936137054656342e-10
complement B-Disease 1 0.9999980926513672
deficiency I-Disease 1 1.0
in O 0 2.523869724324612e-10
Japan O 0 2.3111184077606595e-09
but O 0 4.341508055838439e-11
is O 0 4.863668495724838e-11
rare O 0 1.657162185253469e-10
in O 0 4.110167067805648e-11
other O 0 4.845466805569743e-10
countries O 0 1.626644652308329e-10
. O 0 3.240116441816099e-08

We O 0 5.329104624252068e-08
studied O 0 4.553358579073574e-08
the O 0 1.7613713820807675e-09
molecular O 0 1.2049806707992161e-09
basis O 0 7.672614210640916e-10
of O 0 1.4452881558213448e-08
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9976045489311218
in O 0 6.0816152114284705e-09
four O 0 4.581581780627175e-09
Japanese O 0 7.728478124136018e-08
C9 B-Disease 1 1.0
- I-Disease 0 1.0663194188964553e-05
deficient I-Disease 0 6.687727363896556e-06
patients O 0 2.3269810967008198e-08
who O 0 6.741792124564938e-10
had O 0 5.800462332672396e-09
suffered O 0 9.466309052186261e-07
from O 0 4.303310419118134e-08
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 8.130160722430446e-08

Direct O 0 3.930439902433136e-07
sequencing O 0 4.2290935198252555e-08
of O 0 7.449293804029367e-08
amplified O 0 8.789389198682329e-07
C9 O 0 9.903404861688614e-05
cDNA O 0 1.169399066469623e-08
and O 0 2.0388195576259704e-09
DNA O 0 1.5518816454118678e-08
revealed O 0 2.6633657501662356e-09
a O 0 9.352325580636034e-10
nonsense O 0 2.29429364395628e-08
substitution O 0 5.328410601634914e-09
( O 0 4.13213907535237e-10
CGA O 0 9.317821422882844e-06
- O 0 1.759352812769066e-06
- O 0 1.0208943876932608e-06
> O 0 1.1954494993915432e-07
TGA O 0 4.684280156652676e-06
) O 0 1.6057845331207687e-10
at O 0 8.124076966709026e-10
codon O 0 1.6961378968005647e-09
95 O 0 1.3155124767294524e-09
in O 0 3.690343516882244e-11
exon O 0 1.42197498220753e-08
4 O 0 4.0809013945874995e-09
in O 0 1.8155846270850873e-10
the O 0 3.822218541671418e-09
four O 0 3.0450488797129083e-09
C9 B-Disease 1 0.8856942653656006
- I-Disease 0 5.715991392207798e-06
deficient I-Disease 0 8.289404718198057e-07
individuals O 0 8.310184762549966e-10
. O 0 1.2342861843706032e-08

An O 0 8.039396703907187e-08
allele O 0 2.1885538714627728e-08
- O 0 9.917184939922663e-08
specific O 0 7.903017795740652e-09
polymerase O 0 5.979865047578414e-09
chain O 0 6.817637121514508e-09
reaction O 0 1.0099315828071553e-10
system O 0 1.9958484864801562e-10
designed O 0 2.3838673257614573e-09
to O 0 1.4255417679631677e-10
detect O 0 1.1193480586868532e-09
exclusively O 0 2.0715575088647853e-10
only O 0 8.191691248937705e-12
one O 0 1.2830634124605389e-11
of O 0 2.728428039056041e-10
the O 0 8.885817637249716e-10
normal O 0 1.3143387489478187e-09
and O 0 5.251915569104426e-10
mutant O 0 1.0361961955140941e-08
alleles O 0 2.96358909634975e-11
indicated O 0 2.238438774615492e-11
that O 0 3.0431573060096806e-12
all O 0 1.607303526385273e-11
the O 0 5.204198530450732e-11
four O 0 6.142392150465525e-11
patients O 0 1.2480692694605278e-11
were O 0 2.9222711056542394e-11
homozygous O 0 8.916479221632301e-10
for O 0 6.601121732563442e-11
the O 0 9.393658073619804e-10
mutation O 0 1.5909620842968764e-10
in O 0 8.8030353839752e-11
exon O 0 1.2861084641713205e-08
4 O 0 2.145665645159056e-09
and O 0 5.290358429110853e-11
that O 0 3.677721321926342e-12
the O 0 9.952568630344771e-11
parents O 0 3.067997939032452e-11
of O 0 5.709616668347905e-10
patient O 0 1.521446635344148e-09
2 O 0 6.435262989157309e-09
were O 0 3.7173120137623528e-09
heterozygous O 0 9.298900494059126e-08
. O 0 3.354139721523097e-08

The O 0 4.3243909431112115e-07
common O 0 3.8460459705902394e-08
mutation O 0 3.6792984214883973e-09
at O 0 6.040276279151158e-09
codon O 0 2.248708064200855e-08
95 O 0 1.930846948994258e-08
in O 0 6.94798940603647e-10
exon O 0 1.0747523049303709e-07
4 O 0 1.552595030318571e-08
might O 0 2.41271141954158e-10
be O 0 1.9617292165707845e-11
responsible O 0 5.139037112522615e-11
for O 0 3.22970886146301e-11
most O 0 3.148828697785433e-10
Japanese O 0 1.1190245885472905e-07
C9 B-Disease 1 1.0
deficiency I-Disease 0 2.8082784410798922e-05
. O 0 1.3000730270107397e-08
. O 0 7.809026669747254e-08

BRCA1 O 0 1.4763140825380106e-06
required O 0 6.012264464061445e-09
for O 0 6.251643647203764e-10
transcription O 0 1.0592570021117353e-07
- O 0 3.1231002139975317e-07
coupled O 0 7.370586274646485e-08
repair O 0 1.622586296434747e-07
of O 0 1.0557150886825184e-07
oxidative O 0 1.3480738516591373e-06
DNA O 0 8.88865429260477e-07
damage O 0 3.409289274713956e-05
. O 0 1.6428482751962292e-07

The O 0 2.9315735901036533e-06
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 0.10796456038951874
gene O 0 1.1203722038999331e-07
BRCA1 O 0 2.2518419484640617e-07
encodes O 0 3.938707582307188e-09
a O 0 4.7329690167075e-10
zinc O 0 1.806199065867986e-07
finger O 0 2.2932356102955964e-07
protein O 0 3.1308340364688547e-09
of O 0 4.192764357924261e-09
unknown O 0 7.342071395299854e-09
function O 0 4.115026985829218e-09
. O 0 7.958623982062818e-09

Association O 0 1.382361887181105e-07
of O 0 1.785793273256786e-07
the O 0 6.884964420805773e-08
BRCA1 O 0 2.1390675897237088e-08
protein O 0 4.102360673385874e-10
with O 0 1.1122748555525419e-11
the O 0 6.944438912803719e-10
DNA O 0 6.154137199843035e-09
repair O 0 1.5471970371550015e-08
protein O 0 2.158505374438846e-09
Rad51 O 0 8.330378875598399e-08
and O 0 3.550270077923301e-10
changes O 0 2.409685506687964e-10
in O 0 2.426361195295712e-11
the O 0 1.81391637821271e-10
phosphorylation O 0 6.375344002718109e-11
and O 0 1.6126321111809006e-10
cellular O 0 5.606449193784613e-10
localization O 0 6.657547402255659e-09
of O 0 1.1433214375244916e-08
the O 0 7.633222054437283e-09
protein O 0 2.155736478215431e-09
after O 0 4.84001727585337e-10
exposure O 0 2.8311243127632224e-08
to O 0 3.2029634500219117e-10
DNA O 0 2.3867347209716172e-08
- O 0 6.710277489219152e-08
damaging O 0 1.5411745835081092e-07
agents O 0 1.1708664593435003e-10
are O 0 1.886518068497378e-12
consistent O 0 5.012414094895945e-11
with O 0 3.5539995425770687e-12
a O 0 6.850765094101874e-11
role O 0 5.354795495904341e-10
for O 0 1.1819694112347179e-09
BRCA1 O 0 5.021588478371086e-08
in O 0 9.163845793302983e-10
DNA O 0 1.2321555686867214e-07
repair O 0 6.911686227795144e-07
. O 0 2.00426654828334e-07

Here O 0 5.432612582012553e-09
, O 0 7.386509737195013e-10
it O 0 9.666197009483568e-11
is O 0 7.529793455418599e-11
shown O 0 1.426259804704344e-10
that O 0 4.741498860205695e-10
mouse O 0 2.5544761683704564e-07
embryonic O 0 8.512700588880762e-08
stem O 0 3.379666324576647e-08
cells O 0 1.6500027733012956e-10
deficient B-Disease 0 1.7381466266286338e-09
in I-Disease 0 1.1117302911589633e-10
BRCA1 I-Disease 0 5.095491584228284e-09
are O 0 4.129905185196181e-12
defective O 0 9.32382726581693e-10
in O 0 1.3929647366128783e-11
the O 0 2.0869529715472623e-10
ability O 0 7.825551318063617e-11
to O 0 5.6247406038378855e-11
carry O 0 5.454122153913943e-10
out O 0 3.81078057998252e-10
transcription O 0 2.4421137112540237e-08
- O 0 8.489579528259128e-08
coupled O 0 1.9645479909513597e-08
repair O 0 7.145915503770084e-08
of O 0 2.3224894007967123e-08
oxidative O 0 3.297845552197032e-08
DNA O 0 9.219214724964786e-09
damage O 0 7.688032610531081e-08
, O 0 7.906387350375965e-11
and O 0 1.8809293012012063e-10
are O 0 9.755025259794436e-11
hypersensitive O 0 4.1014499174707453e-07
to O 0 5.562949656479077e-09
ionizing O 0 0.00019594373588915914
radiation O 0 1.9435947251622565e-05
and O 0 9.216365448594388e-09
hydrogen O 0 2.978088531335743e-08
peroxide O 0 5.895024202118293e-08
. O 0 1.394912985119845e-08

These O 0 7.281909830680888e-08
results O 0 2.1711983322347805e-09
suggest O 0 6.073335723222328e-10
that O 0 1.3158329981166617e-10
BRCA1 O 0 1.729697629571092e-08
participates O 0 1.6555675719232e-09
, O 0 2.4228016815008857e-10
directly O 0 2.844311730587634e-10
or O 0 1.5889302373839342e-10
indirectly O 0 4.985205026564188e-10
, O 0 7.452054251455564e-11
in O 0 1.6232570843044414e-10
transcription O 0 6.519597661736043e-08
- O 0 1.3367348117299116e-07
coupled O 0 1.0559483065719633e-08
repair O 0 5.27981249831555e-08
of O 0 1.7608213553899077e-08
oxidative O 0 1.1500144125875522e-07
DNA O 0 6.22020124296796e-08
damage O 0 5.306303592078621e-07
. O 0 2.981690450098995e-09
. O 0 2.2739916616387745e-08

Truncation O 0 1.187648103950778e-05
mutations O 0 6.232992433297113e-08
in O 0 1.0885594647902508e-09
the O 0 5.554404047813932e-09
transactivation O 0 2.9051197998342104e-06
region O 0 2.6326546276322915e-07
of O 0 5.551801223191433e-07
PAX6 O 1 0.9999980926513672
result O 0 1.1110530273583663e-08
in O 0 1.510660929682217e-09
dominant O 0 2.3543442750906252e-07
- O 0 4.3166693330931594e-07
negative O 0 1.0906740754990096e-07
mutants O 0 4.761695393540322e-08
. O 0 6.959545384432886e-09

PAX6 O 1 0.9999017715454102
is O 0 9.513626508805828e-08
a O 0 3.55224294423806e-09
transcription O 0 2.0652748844440794e-08
factor O 0 2.8812352503848615e-09
with O 0 4.004905088117461e-11
two O 0 4.9095432580470444e-11
DNA O 0 2.0855690507914915e-09
- O 0 8.276922258687591e-09
binding O 0 8.373322479826584e-09
domains O 0 3.0980908949373998e-09
( O 0 4.9308650912349705e-11
paired O 0 3.5173799428633856e-09
box O 0 2.4640058882141602e-08
and O 0 2.6408655262599723e-09
homeobox O 0 2.1668394367679866e-07
) O 0 2.0724506832880962e-10
and O 0 9.787570753871933e-10
a O 0 2.548303568161714e-09
proline O 0 3.2921462889135e-07
- O 0 6.943227504052629e-08
serine O 0 5.148011794631202e-08
- O 0 2.0566450587011786e-07
threonine O 0 1.4096735867497046e-07
( O 0 4.4921155684107816e-10
PST O 1 0.9999982118606567
) O 0 1.1473278327400749e-08
- O 0 5.066972335043829e-07
rich O 0 4.957749411005352e-08
transactivation O 0 2.322917316632811e-05
domain O 0 1.0186283816437935e-06
. O 0 1.1049038306509829e-07

PAX6 O 1 1.0
regulates O 0 0.00047185190487653017
eye O 1 0.9987791180610657
development O 0 3.520012370472614e-08
in O 0 3.0627564928664697e-09
animals O 0 7.471617102794426e-09
ranging O 0 8.398289175204354e-09
from O 0 2.3881713273610217e-10
jellyfish O 0 3.958626482170047e-10
to O 0 8.413768987081127e-11
Drosophila O 0 7.277088709400914e-09
to O 0 1.416770922801902e-09
humans O 0 7.420177361439073e-09
. O 0 1.9610512325130003e-08

Heterozygous O 0 2.509731302779983e-06
mutations O 0 1.8519395794669435e-08
in O 0 6.766436300154055e-10
the O 0 7.829231485345645e-09
human O 0 1.1116126685806194e-08
PAX6 O 0 0.011633239686489105
gene O 0 1.8516349564734469e-09
result O 0 3.4236913304397376e-10
in O 0 3.581882707104356e-11
various O 0 2.924413766702827e-10
phenotypes O 0 3.806358783720043e-09
, O 0 3.8723326628575805e-11
including O 0 3.2826555362852616e-10
aniridia B-Disease 1 1.0
, O 0 4.2351859796951885e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 6.327453405674532e-08
autosomal B-Disease 0 0.0006491383537650108
dominant I-Disease 0 0.036487236618995667
keratitis I-Disease 1 0.8059018850326538
, O 0 2.1288798279783805e-08
and O 0 2.1169960007227928e-07
familial B-Disease 1 0.9999998807907104
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 1.12835768959485e-05

It O 0 1.4310653106974769e-08
is O 0 3.758969802092338e-10
believed O 0 1.3165786516555755e-10
that O 0 7.480360948719511e-12
the O 0 3.534446346709075e-10
mutated O 0 1.3013878863432637e-08
allele O 0 4.5898298495217205e-09
of O 0 1.53515884449007e-07
PAX6 O 1 1.0
produces O 0 1.1691675894098807e-07
an O 0 3.4677108406988566e-10
inactive O 0 4.6494395888885265e-08
protein O 0 6.050076883923339e-09
and O 0 2.163315304670732e-09
aniridia B-Disease 1 1.0
is O 0 1.1115044884490999e-08
caused O 0 2.835669299372512e-08
due O 0 4.7662570779039015e-08
to O 0 2.4947109267259293e-08
genetic O 0 6.534324938911595e-07
haploinsufficiency O 0 5.9255369706079364e-05
. O 0 3.582851775263407e-07

However O 0 3.1469525652028096e-08
, O 0 4.607996206829057e-09
several O 0 1.762816559391922e-09
truncation O 0 1.6096875299353997e-07
mutations O 0 2.5946071957605454e-09
have O 0 2.8845316760173212e-11
been O 0 7.082631703347886e-11
found O 0 2.2508673744314756e-11
to O 0 3.317594116092337e-11
occur O 0 3.170407686381438e-11
in O 0 1.9535780979018647e-11
the O 0 4.3289252737999107e-10
C O 0 1.2132952420529364e-08
- O 0 7.908219856744836e-09
terminal O 0 3.646115187549981e-09
half O 0 1.0081921963944751e-09
of O 0 4.414408838471218e-09
PAX6 O 0 0.00012507580686360598
in O 0 3.822522576246712e-10
patients O 0 4.096988581725469e-10
with O 0 9.576003184852411e-11
Aniridia B-Disease 1 1.0
resulting O 0 2.4897813588609097e-08
in O 0 2.592256131972448e-10
mutant O 0 4.217660443117666e-09
proteins O 0 1.0405894895759715e-11
that O 0 2.507729700979011e-12
retain O 0 2.2269726063228745e-09
the O 0 3.267843495802225e-10
DNA O 0 5.93591786834935e-10
- O 0 1.2573075913735465e-09
binding O 0 9.381303511801775e-10
domains O 0 1.3419954036919535e-10
but O 0 1.465044578707886e-11
have O 0 1.0822132252841232e-11
lost O 0 2.306419721875841e-09
most O 0 1.210935934858881e-10
of O 0 2.4769486461906354e-09
the O 0 1.2887703348951618e-08
transactivation O 0 1.8673868908081204e-05
domain O 0 9.616885563445976e-07
. O 0 2.7597249641075905e-07

It O 0 6.323843226851977e-09
is O 0 1.1735898364229058e-10
not O 0 1.663336308965757e-11
clear O 0 2.80878958980324e-10
whether O 0 1.4322243391262646e-10
such O 0 8.740417278829682e-10
mutants O 0 1.5115492857376012e-08
really O 0 3.768670264747698e-09
behave O 0 1.5368983863339736e-10
as O 0 2.507727636658075e-10
loss O 0 8.793009875773805e-09
- O 0 2.701658097237214e-08
of O 0 4.54568720442694e-08
- O 0 1.1808348432396087e-07
function O 0 2.5013513482718963e-09
mutants O 0 2.8751196978760163e-09
as O 0 1.9758647495926596e-10
predicted O 0 3.746831733764111e-09
by O 0 3.033512996353238e-09
haploinsufficiency O 0 8.396097109653056e-05
. O 0 7.78647745391936e-07

Contrary O 0 2.0225692765052372e-07
to O 0 1.2879293187495477e-09
this O 0 7.387774419997939e-11
theory O 0 8.086633584980518e-10
, O 0 7.010096669812782e-11
our O 0 1.122447482182487e-10
data O 0 3.5430842287853537e-11
showed O 0 5.132914579486503e-11
that O 0 1.0588873528005749e-11
these O 0 6.154941140090742e-11
mutants O 0 2.543019406164859e-10
are O 0 1.169790046079422e-11
dominant O 0 6.376566830113006e-09
- O 0 1.498168344937767e-08
negative O 0 1.8914749766452132e-09
in O 0 7.882836744466104e-11
transient O 0 1.5880160519898823e-09
transfection O 0 4.725373980996039e-10
assays O 0 2.402269494439224e-10
when O 0 6.653326500849488e-11
they O 0 2.727781542311014e-11
are O 0 9.411025778116588e-12
coexpressed O 0 7.702239912532605e-08
with O 0 3.446563867637309e-10
wild O 0 5.794913136014657e-07
- O 0 2.2902900127519388e-06
type O 0 4.391327365738107e-06
PAX6 O 1 0.9999911785125732
. O 0 5.030715328757651e-07

We O 0 6.952328046594403e-09
found O 0 7.797331530445817e-11
that O 0 1.9560724567879717e-11
the O 0 8.03454525133418e-10
dominant O 0 2.8666448770309216e-08
- O 0 7.39875645194843e-08
negative O 0 1.2670074767129336e-08
effects O 0 8.916232019373638e-08
result O 0 1.3806024379281467e-10
from O 0 1.5454221236055332e-11
the O 0 8.442769400263117e-11
enhanced O 0 1.932924043046569e-09
DNA O 0 1.39075728711191e-09
binding O 0 2.31633023872746e-09
ability O 0 4.4918416208794554e-10
of O 0 3.1852851467562004e-09
these O 0 1.2508922786480525e-09
mutants O 0 2.8516696559677257e-08
. O 0 1.6569552840906e-08

Kinetic O 0 9.772541034180904e-07
studies O 0 3.5217837535128638e-09
of O 0 1.4909951051578219e-09
binding O 0 4.4751593542002865e-09
and O 0 8.295599762675465e-10
dissociation O 0 3.4497553702550476e-09
revealed O 0 3.835098072446641e-10
that O 0 1.7580735478528453e-11
various O 0 7.953248060132978e-10
truncation O 0 3.749721955159657e-08
mutants O 0 1.5170131817399124e-09
have O 0 2.038864216347136e-11
3 O 0 1.0402789740737717e-09
- O 0 3.4821345806790305e-09
5 O 0 3.042796237195944e-09
- O 0 4.113645424297374e-09
fold O 0 7.949805258533615e-10
higher O 0 5.1031602554818534e-11
affinity O 0 1.3777974421091965e-11
to O 0 2.069179202979221e-11
various O 0 3.845776128108547e-11
DNA O 0 2.4425958478069276e-10
- O 0 3.980180907081632e-10
binding O 0 3.9447953237292666e-10
sites O 0 1.419204337382851e-10
when O 0 1.4554552008050337e-11
compared O 0 1.9056572292397433e-11
with O 0 1.678356065237807e-11
the O 0 2.088777817377263e-09
wild O 0 2.0587390281434637e-07
- O 0 1.2959874311491149e-06
type O 0 1.7014938293868909e-06
PAX6 O 1 0.9999817609786987
. O 0 3.17155326001739e-07

These O 0 1.108136693517281e-08
results O 0 4.410451170944185e-10
provide O 0 5.684122270088743e-11
a O 0 6.423312576275819e-11
new O 0 1.6231363475505134e-10
insight O 0 1.1529249777098016e-10
into O 0 1.9087858030286675e-11
the O 0 1.2624831735585929e-10
role O 0 5.975118733125839e-10
of O 0 1.918131786737831e-08
mutant O 0 1.937563183673774e-06
PAX6 O 1 0.5909426212310791
in O 0 9.580507054351983e-09
causing O 0 9.291379683418199e-07
aniridia B-Disease 1 1.0
. O 0 5.186844376225963e-08
. O 0 1.363943482601826e-07

Reversal O 0 1.0833961141543114e-06
of O 0 2.0055258573847823e-06
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 2.3151702066570579e-07
excellent O 0 7.323166073547327e-08
neuropsychologic O 0 1.2014330650345073e-06
outcome O 0 9.277849599698129e-09
in O 0 2.2939673771649183e-10
very B-Disease 0 5.970425265289236e-10
- I-Disease 0 3.175169638325315e-07
long I-Disease 0 6.56714860269858e-08
- I-Disease 0 6.735718329764495e-07
chain I-Disease 0 1.18558432404825e-07
acyl I-Disease 0 1.102932998264805e-07
- I-Disease 0 5.903338973212158e-08
coenzyme I-Disease 0 4.720349888742703e-09
A I-Disease 0 2.563192822435667e-07
dehydrogenase I-Disease 0 2.8645324618992163e-06
deficiency I-Disease 0 2.4257591576315463e-05
. O 0 9.933806666140299e-08

Very B-Disease 0 1.9813167284610245e-07
- I-Disease 0 9.390384434482257e-07
long I-Disease 0 8.489368497066607e-08
- I-Disease 0 2.735753241722705e-07
chain I-Disease 0 3.714486140893314e-08
acyl I-Disease 0 3.685383020979316e-08
- I-Disease 0 2.7241252809062644e-08
coenzyme I-Disease 0 2.0068968709097135e-09
A I-Disease 0 2.6253079710159e-08
dehydrogenase I-Disease 0 8.884957658494841e-09
( I-Disease 0 2.539515264743386e-10
VLCAD I-Disease 1 1.0
) I-Disease 0 9.690425351038812e-09
deficiency I-Disease 0 0.00010215373185928911
is O 0 1.0236139713626358e-09
a O 0 3.898876332897316e-09
disorder O 1 0.9998816251754761
of O 0 1.5296860510716215e-05
fatty O 0 0.00011275027645751834
acid O 0 1.1288384627050618e-07
beta O 0 1.9701604792032867e-09
oxidation O 0 3.9809247565081307e-10
that O 0 1.0506830648571164e-11
reportedly O 0 1.0938689953832181e-09
has O 0 8.118774402765538e-11
high O 0 5.195396113322204e-09
rates O 0 1.3577841073697527e-09
of O 0 2.9959537073409592e-09
morbidity O 0 2.032361862802645e-06
and O 0 3.626267286449547e-08
mortality O 0 5.5486534620285966e-06
. O 0 1.296971419151305e-07

We O 0 8.869194267902003e-09
describe O 0 5.734741015395173e-10
the O 0 3.6169800488039527e-10
outcome O 0 1.2821889106007234e-09
of O 0 1.881361066935483e-09
a O 0 2.3118446046410668e-10
5 O 0 9.039514137221261e-10
- O 0 7.106952248925325e-10
year O 0 5.0215238217576896e-11
- O 0 4.614064685881658e-09
old O 0 2.6187866097870938e-08
girl O 0 2.289518796771972e-09
with O 0 2.0988806526123227e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 9.532167943859804e-09
was O 0 6.438356958682334e-09
first O 0 4.019830579515826e-10
seen O 0 3.406520898696641e-10
at O 0 2.674507559863315e-10
5 O 0 8.358812531028548e-10
months O 0 6.043796019206127e-11
of O 0 3.75704883870398e-10
age O 0 1.2016504458145505e-09
with O 0 3.0292790498265276e-10
severe O 1 0.9998785257339478
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 7.85732117947191e-06
hepatomegaly B-Disease 1 1.0
, O 1 0.9997789263725281
encephalopathy B-Disease 1 0.999998927116394
, O 0 1.0897565516643226e-08
and O 0 9.572546844083263e-08
hypotonia B-Disease 1 0.9797148108482361
. O 0 1.417034468431666e-06

Biochemical O 0 5.358772341423901e-06
studies O 0 1.2061498466664489e-07
indicated O 0 2.786429604384466e-06
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.9985873223049566e-06
by O 0 1.4382256496858759e-09
a O 0 9.244711662859117e-09
stable O 0 5.311508033400969e-08
yet O 0 1.3892574202145624e-08
inactive O 0 5.033518277741678e-07
enzyme O 0 5.6791677138789964e-08
. O 0 3.773995516098694e-08

Molecular O 0 3.29174412172506e-07
genetic O 0 6.557983489585695e-09
analysis O 0 5.818454051897959e-10
of O 0 1.641929614493165e-08
her O 0 3.1868424343883817e-08
VLCAD O 1 1.0
gene O 0 7.312195293707191e-08
revealed O 0 4.1653070326219677e-08
a O 0 1.042543917861849e-08
T1372C O 0 3.993960035586497e-06
( O 0 3.573902063180867e-09
F458L O 0 3.4537254123279126e-06
) O 0 8.839420750916815e-09
missense O 0 3.850649079595314e-07
mutation O 0 6.0798290846264536e-09
and O 0 2.3530404291705054e-09
a O 0 2.1162485097647732e-08
1668 O 0 0.00015042978338897228
ACAG O 1 0.9999961853027344
1669 O 0 0.00036486246972344816
splice O 0 2.583134119049646e-05
site O 0 1.539366394354147e-06
mutation O 0 4.286272030640248e-07
. O 0 1.3847289892510162e-07

After O 0 6.021230092301266e-08
initial O 0 1.7829915321954104e-08
treatment O 0 1.874498956055959e-08
with O 0 2.943501831165207e-10
intravenous O 0 2.645575669646405e-08
glucose O 0 6.350450121317408e-08
and O 0 1.6094097166075017e-09
carnitine O 0 3.9076192592801817e-07
, O 0 4.637956130260079e-10
the O 0 4.859704194615233e-09
patient O 0 2.4027805523019197e-08
has O 0 5.986766082877182e-10
thrived O 0 1.4456024821640767e-08
on O 0 5.714598572126306e-09
a O 0 1.1602672156385552e-09
low O 0 1.899422308326848e-08
- O 0 1.041256609823904e-07
fat O 0 1.8035827054063702e-07
diet O 0 2.2183510139939244e-08
supplemented O 0 1.0249854298649552e-09
with O 0 2.0182879673091847e-11
medium O 0 9.104478948529504e-08
- O 0 6.371633531898624e-08
chain O 0 8.167802434400073e-09
triglyceride O 0 1.7196022383814125e-08
oil O 0 2.1953048268130715e-09
and O 0 4.5402584469833585e-10
carnitine O 0 2.4537777676414407e-07
and O 0 1.6558171500591357e-09
avoidance O 0 5.330453404894797e-06
of O 0 4.012527483610029e-07
fasting O 0 6.467418529609859e-07
. O 0 6.88638266410635e-08

Her O 0 0.0004526589473243803
ventricular O 1 1.0
hypertrophy O 0 0.0006552690174430609
resolved O 0 1.1242703124025866e-07
significantly O 0 6.706664112954286e-10
over O 0 2.564509715696772e-10
1 O 0 1.4286891669712531e-09
year O 0 4.169108114293607e-11
, O 0 4.8316947665050236e-11
and O 0 3.2810340555577966e-10
cognitively O 0 5.8635471589241206e-08
, O 0 1.0947282663709146e-10
she O 0 1.3708829904590658e-10
is O 0 2.1909396172303808e-11
in O 0 1.389130824258622e-11
the O 0 2.4873819670645503e-10
superior O 0 2.4262631015403713e-08
range O 0 5.7972464162503456e-08
for O 0 1.8089764131090647e-09
age O 0 5.3568026459061e-08
. O 0 2.97983273611635e-08

Clinical O 0 2.346558540011756e-05
recognition O 0 7.55208304781263e-07
of O 1 0.9996351003646851
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 3.862202113680269e-09
important O 0 2.936845211465311e-10
because O 0 5.5064876269828034e-11
it O 0 1.1482105197191395e-11
is O 0 1.5718744014736608e-11
one O 0 1.158969968606538e-11
of O 0 2.499528362065462e-10
the O 0 6.233283889045538e-10
few O 0 2.8301132548591568e-09
directly O 0 1.0560731844577731e-08
treatable O 1 0.8527458906173706
causes O 0 6.417639042410883e-08
of O 0 4.107599522740202e-07
cardiomyopathy B-Disease 1 1.0
in O 0 7.313866401403857e-09
children O 0 2.9888533870092715e-09
. O 0 6.645010097727777e-10
. O 0 1.3914053909047652e-08

Cloning O 0 9.600595518577393e-08
of O 0 1.0441717712694754e-08
a O 0 5.444809048071875e-10
novel O 0 8.015232921820825e-09
member O 0 4.573930956208727e-10
of O 0 2.2409314404114866e-09
the O 0 6.889371850782311e-10
low O 0 9.596967665004286e-09
- O 0 3.398774950369443e-08
density O 0 9.261301059382276e-09
lipoprotein O 0 3.395423846086487e-06
receptor O 0 8.578485477528375e-08
family O 0 6.967687316006277e-09
. O 0 2.233848483967904e-08

A O 0 2.8113279313402018e-06
gene O 0 9.149703217303795e-09
encoding O 0 7.942337454380777e-09
a O 0 3.978513074542889e-09
novel O 0 5.599049401894263e-08
transmembrane O 0 8.493721281865874e-09
protein O 0 1.9052230904037515e-09
was O 0 1.0897872604331837e-09
identified O 0 2.750927784178625e-11
by O 0 6.146607962193018e-12
DNA O 0 4.174934842282596e-10
sequence O 0 1.4074664177188279e-11
analysis O 0 3.834597136348483e-12
within O 0 1.4249157409551572e-11
the O 0 1.726607329333163e-10
insulin B-Disease 0 2.6751444238470867e-05
- I-Disease 1 0.9999988079071045
dependent I-Disease 1 0.9964637160301208
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 3.810433302220417e-09
IDDM B-Disease 1 0.9999866485595703
) O 0 1.2345139355218748e-09
locus O 0 2.2720023196143302e-07
IDDM4 O 0 8.824096585158259e-05
on O 0 7.599101792266083e-08
chromosome O 0 5.914586722610693e-07
11q13 O 0 1.1273359632468782e-05
. O 0 2.391759608144639e-07

Based O 0 1.1178379999421395e-08
on O 0 5.053591323189721e-09
its O 0 2.020863254514893e-09
chromosomal O 0 2.375884662342287e-07
position O 0 1.2266960780493719e-08
, O 0 2.4965743361526904e-10
this O 0 3.5563680472749937e-11
gene O 0 3.1114966159151436e-10
is O 0 1.013095649038398e-10
a O 0 1.7592685641609762e-10
candidate O 0 6.176936184765225e-10
for O 0 2.875562288284783e-10
conferring O 0 9.341564322085105e-08
susceptibility O 0 4.226108558214037e-06
to O 0 1.1671323107975695e-07
diabetes B-Disease 1 1.0
. O 0 1.0836937462954666e-06

The O 0 6.354908350658661e-07
gene O 0 1.8719763517083265e-08
, O 0 3.3035036928197314e-09
termed O 0 4.325908520286248e-08
low O 0 7.595305362428917e-08
- O 0 1.0958161311691583e-07
density O 0 1.2639783442125463e-08
lipoprotein O 0 1.134259377977287e-06
receptor O 0 1.3595106373998078e-08
related O 0 6.336170255138995e-09
protein O 0 7.345695718363743e-10
5 O 0 6.364145876958105e-10
( O 0 2.621331277041783e-11
LRP5 O 0 0.0009796400554478168
) O 0 2.436421342455475e-10
, O 0 1.9233833969956038e-10
encodes O 0 6.194492141453622e-10
a O 0 3.0030117281754087e-10
protein O 0 5.137814618194625e-10
of O 0 2.8600841694981227e-09
1615 O 0 3.3514479014229437e-07
amino O 0 6.502829830168366e-09
acids O 0 3.881504007097192e-10
that O 0 1.4848231151554092e-12
contains O 0 1.8804774404301838e-10
conserved O 0 3.3396391208029286e-10
modules O 0 7.134928758922854e-11
which O 0 1.1356947283644447e-12
are O 0 7.006974753025197e-13
characteristic O 0 3.7348715786755804e-10
of O 0 5.176165607245764e-10
the O 0 6.908807970162911e-10
low O 0 1.82914945412449e-08
- O 0 6.722935097513982e-08
density O 0 1.507414992829581e-08
lipoprotein O 0 2.3857870473875664e-05
( O 0 4.606405923368584e-09
LDL O 1 1.0
) O 0 4.188256408355073e-09
receptor O 0 1.8128977430365012e-08
family O 0 5.42708233908229e-09
. O 0 2.3028340123687485e-08

These O 0 4.346834359125751e-08
modules O 0 3.787350166817305e-08
include O 0 9.900360531389651e-09
a O 0 5.511368694754992e-09
putative O 0 9.192317662609639e-08
signal O 0 2.6913293815766792e-09
peptide O 0 9.271689527245996e-10
for O 0 6.876057362381616e-11
protein O 0 6.125287776992394e-11
export O 0 3.0727034250332963e-09
, O 0 2.867724668842442e-10
four O 0 6.758671400319827e-10
epidermal O 0 1.7962565834750421e-07
growth O 0 5.148617976402647e-09
factor O 0 8.998542355698191e-09
( O 0 5.754617338205037e-10
EGF O 0 1.2982120097149163e-05
) O 0 5.248471102170527e-10
repeats O 0 3.3726180181936627e-10
with O 0 2.2094125140537102e-11
associated O 0 1.6600925079046647e-09
spacer O 0 4.0037274828819136e-08
domains O 0 6.951095254947859e-09
, O 0 6.019904019716193e-10
three O 0 1.0359881841282004e-09
LDL O 1 1.0
- O 0 4.1889961721608415e-06
receptor O 0 2.1865385946284732e-08
( O 0 1.4807632897628764e-10
LDLR O 1 0.999901294708252
) O 0 1.243132957684523e-10
repeats O 0 4.048832658032353e-10
, O 0 4.4585241748551496e-11
a O 0 1.5453817392430125e-10
single O 0 1.1171681357780017e-09
transmembrane O 0 5.133174330040902e-09
spanning O 0 1.1427241375372432e-08
domain O 0 1.732857768388385e-08
, O 0 7.243835531411946e-10
and O 0 1.5816379317357132e-09
a O 0 6.962320497905239e-09
cytoplasmic O 0 3.4271974413968564e-07
domain O 0 6.106818659645796e-07
. O 0 2.1796394378270634e-07

The O 0 1.7884194392081554e-07
encoded O 0 5.827897719967723e-09
protein O 0 3.745760146500743e-09
has O 0 1.0920130771863157e-10
a O 0 7.320530293064564e-11
unique O 0 7.447976263508238e-11
organization O 0 2.6101057079563894e-11
of O 0 6.4123510945535145e-09
EGF O 0 0.007145974785089493
and O 0 3.210973531508898e-08
LDLR O 1 0.9999990463256836
repeats O 0 1.6064776175994666e-09
; O 0 4.003125955720499e-11
therefore O 0 1.2924047942952654e-10
, O 0 2.0521653820715358e-10
LRP5 O 0 0.00016836400027386844
likely O 0 1.8194716844277536e-09
represents O 0 1.827180906577297e-10
a O 0 1.23026745041388e-11
new O 0 2.2606770622157768e-11
category O 0 4.99205621284915e-10
of O 0 2.1028727648086942e-09
the O 0 7.533234480661122e-09
LDLR O 1 0.9999996423721313
family O 0 9.140723733480627e-08
. O 0 2.2876304228702793e-07

Both O 0 2.8506102012215706e-07
human O 0 2.9602210460666356e-08
and O 0 1.3823850508742908e-08
mouse O 0 1.948964381881524e-06
LRP5 O 1 1.0
cDNAs O 0 2.6710376914707012e-05
have O 0 5.946287351399349e-10
been O 0 7.729488160634901e-10
isolated O 0 1.4574678131040741e-09
and O 0 2.6919852458284765e-10
the O 0 1.0685172746605076e-09
encoded O 0 1.7595572221473788e-10
mature O 0 1.1249384757050507e-09
proteins O 0 5.708108031382553e-12
are O 0 2.4867816139639842e-12
95 O 0 4.329998581908967e-10
% O 0 2.1914494524599704e-11
identical O 0 1.1035458657993047e-10
, O 0 4.433508074552783e-11
indicating O 0 8.147788554957458e-10
a O 0 3.4383171310103933e-10
high O 0 2.938243426342524e-08
degree O 0 1.0259658012046202e-08
of O 0 4.504515871417425e-09
evolutionary O 0 1.5658850882616093e-09
conservation O 0 8.26022095168355e-09
. O 0 8.378606142223077e-10
. O 0 2.086533079648234e-08

The O 0 7.106449970706308e-07
APC B-Disease 0 1.157659198725014e-06
variants O 0 3.08888772337923e-08
I1307K O 0 5.541063501368626e-07
and O 0 1.0885324863707524e-09
E1317Q O 0 1.679015610989154e-07
are O 0 1.2844248234444855e-11
associated O 0 2.589172765077308e-10
with O 0 1.0984816753989435e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.9201844558836e-09
but O 0 1.4181752994169017e-11
not O 0 3.2834911005419354e-12
always O 0 4.189450869551692e-11
with O 0 1.0816849152495145e-11
a O 0 5.228996124984064e-10
family O 0 2.4201054493744323e-09
history O 0 7.277494518120875e-08
. O 0 9.445678728070561e-08

Classical O 0 0.11313027143478394
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.683540060388623e-06
FAP B-Disease 1 1.0
) O 0 2.8219093728409916e-09
is O 0 4.68731331526584e-10
a O 0 3.433290873822159e-10
high O 0 1.20105869427789e-05
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9983667731285095
that O 0 1.382146341821766e-10
predisposes O 0 1.148941741746512e-08
to O 0 4.1205518164222354e-11
hundreds O 0 2.5293298011597187e-10
or O 0 4.9378105770880865e-11
thousands O 0 2.3226687240196497e-10
of O 0 2.1503871039385558e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 4.995413860342524e-07
that O 0 2.678872679240385e-10
results O 0 1.3750074689955483e-10
from O 0 1.282391276502537e-10
truncating O 0 1.28863320014716e-07
mutations O 0 6.685743625389762e-10
in O 0 1.473458022260843e-10
the O 0 1.0436322916973495e-08
APC B-Disease 0 1.5737628018541727e-06
gene O 0 6.086747106337498e-08
. O 0 7.432943505136791e-08

A O 0 7.67620633723709e-07
variant O 0 1.8157636816340528e-07
of O 0 1.659911816886961e-07
FAP B-Disease 1 0.999987006187439
is O 0 8.292442998936167e-08
attenuated B-Disease 1 0.9948121309280396
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 3.877998366874635e-09
which O 0 1.0704873099065537e-10
results O 0 7.366246501661067e-11
from O 0 4.6461261921093566e-11
germ O 0 1.048840569950471e-08
- O 0 1.0383724102780434e-08
line O 0 1.8002792145921376e-08
mutations O 0 9.651918847497498e-11
in O 0 7.585561519196649e-12
the O 0 7.051023653836808e-11
5 O 0 2.56454885105839e-10
and O 0 3.677288334946738e-11
3 O 0 1.0095854152680772e-09
regions O 0 1.045588282622134e-09
of O 0 7.62194662939919e-09
the O 0 3.156077355015441e-08
APC B-Disease 0 3.359439460837166e-06
gene O 0 1.0052072951793889e-07
. O 0 7.635846088760445e-08

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 1.993447403947357e-05
have O 0 1.6374870903668182e-10
" O 0 1.6933385804662748e-09
multiple O 0 1.5121989349609066e-07
" O 0 0.007788145449012518
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 3.0213982427085284e-09
typically O 0 1.3210889326931152e-10
fewer O 0 9.465721262369442e-11
than O 0 3.1865688473325937e-12
100 O 0 4.1474001316599285e-11
) O 0 8.148308416888739e-12
without O 0 5.186599066897557e-11
the O 0 3.2209870881594327e-10
florid O 0 5.976863235446217e-07
phenotype O 0 1.1858586113078218e-08
of O 0 1.0028418984120435e-08
classical O 0 3.222650377665559e-07
FAP B-Disease 0 0.00013631863112095743
. O 0 1.0738097699913851e-07

Another O 0 9.81077405981523e-08
group O 0 6.936813901070593e-10
of O 0 5.0274993057541906e-09
patients O 0 1.2492160639254735e-09
with O 0 1.8600798679102581e-10
multiple O 0 3.6202695241627225e-07
adenomas B-Disease 1 0.9999998807907104
has O 0 9.053564120620194e-09
no O 0 4.353204019480472e-09
mutations O 0 1.785317310654122e-10
in O 0 6.318688627882096e-11
the O 0 6.4030629687295004e-09
APC B-Disease 0 8.78434747164647e-08
gene O 0 2.0146045942581736e-10
, O 0 4.4325102616094014e-11
and O 0 1.2947190541900966e-10
their O 0 3.8242145561362406e-10
phenotype O 0 1.1802213650824456e-09
probably O 0 7.349882508167482e-11
results O 0 1.5402869951719467e-11
from O 0 3.463168293804664e-11
variation O 0 4.281334842204387e-09
at O 0 1.4020662408853468e-09
a O 0 4.6294715283501375e-10
locus O 0 9.570790382440464e-09
, O 0 2.2930793375230962e-10
or O 0 1.7069150259896304e-10
loci O 0 1.4085689281628788e-09
, O 0 1.2948721261896168e-10
elsewhere O 0 4.163483724450856e-10
in O 0 1.6798076818425045e-10
the O 0 9.344964801982769e-09
genome O 0 1.5825198929064754e-08
. O 0 4.01133313232549e-08

Recently O 0 1.7353460179947433e-07
, O 0 2.2118855635966383e-09
however O 0 4.928761287992245e-10
, O 0 8.47229453260212e-10
a O 0 1.925740900077244e-09
missense O 0 1.4326171537959453e-07
variant O 0 5.453836493529707e-08
of O 0 4.151421762799146e-06
APC B-Disease 0 6.629560812143609e-05
( O 0 1.5775224460057302e-09
I1307K O 0 7.189361781456682e-07
) O 0 2.5174418105677887e-10
was O 0 1.2817511496621137e-09
described O 0 2.9526056599671335e-10
that O 0 2.48595293655951e-11
confers O 0 4.4544146149405606e-09
an O 0 1.3775478154010035e-11
increased O 0 1.8488002795358227e-10
risk O 0 1.3419712452389376e-08
of O 0 1.6441412071799277e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.691217725394381e-08
including O 0 3.3315987746362907e-09
multiple O 0 3.6849048257181494e-08
adenomas B-Disease 0 1.9717084796866402e-05
, O 0 1.1618085382636423e-09
in O 0 4.079718340932459e-09
Ashkenazim O 0 1.5080041521287058e-05
. O 0 2.1555695184360957e-07

We O 0 2.95620914414485e-08
have O 0 1.4100466627642305e-10
studied O 0 8.370527382339787e-09
a O 0 2.407452570629687e-10
set O 0 5.457535534603153e-10
of O 0 4.390149077604377e-10
164 O 0 2.5030888473054347e-09
patients O 0 9.869920852834113e-11
with O 0 1.811876204627083e-10
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999822378158569
/ I-Disease 1 1.0
or I-Disease 0 8.452064321318176e-06
carcinoma I-Disease 1 1.0
and O 0 4.467266535357339e-06
analyzed O 0 1.0132572469956358e-06
codons O 0 3.142934019706445e-07
1263 O 0 1.743172788337688e-06
- O 0 1.75873438479357e-07
1377 O 0 1.6185771301024943e-06
( O 0 2.3390211989493537e-09
exon O 0 2.799582716761506e-07
15G O 0 6.745308951394691e-07
) O 0 1.677380873088552e-10
of O 0 2.766906703755012e-09
the O 0 3.6396392566473423e-09
APC B-Disease 0 2.1891389678785345e-07
gene O 0 2.335851290169444e-09
for O 0 8.235784831889248e-10
germ O 0 5.033858769820654e-07
- O 0 2.5544565573909495e-07
line O 0 3.2511920267097594e-07
variants O 0 1.406232144063324e-07
. O 0 4.226924588124348e-08

Three O 0 8.935317197256154e-08
patients O 0 2.4653818986308806e-09
with O 0 3.909401968815729e-11
the O 0 2.692561729134013e-09
I1307K O 0 5.651396577377454e-07
allele O 0 5.37676847489621e-10
were O 0 9.398276601402245e-11
detected O 0 7.105109278704447e-10
, O 0 6.691685400239678e-11
each O 0 5.0381976368640835e-11
of O 0 4.4198178450471914e-09
Ashkenazi O 0 2.987709706303576e-07
descent O 0 8.817802665816998e-08
. O 0 6.226979820667111e-08

Four O 0 7.644857760169543e-07
patients O 0 7.433553150804073e-08
had O 0 7.927898337811712e-09
a O 0 8.347632807215177e-09
germ O 0 2.7714349926100112e-06
- O 0 6.189034138515126e-06
line O 0 8.63904097059276e-06
E1317Q O 0 9.064857295015827e-06
missense O 0 3.021446275397466e-07
variant O 0 1.783392811205431e-08
of O 0 4.6038604040177233e-08
APC O 0 2.4541607857031522e-08
that O 0 1.3329920500737558e-11
was O 0 1.9216232771679387e-10
not O 0 8.400872879288368e-12
present O 0 1.8963894690693373e-11
in O 0 1.1848936762315354e-11
controls O 0 5.4729767384742445e-09
; O 0 5.809491429586977e-11
one O 0 4.705548797834247e-11
of O 0 2.647208563466563e-10
these O 0 1.1132856442275241e-10
individuals O 0 6.6136705487163105e-12
had O 0 1.3799179854334653e-10
an O 0 3.6737342334891565e-11
unusually O 0 1.4876772036487296e-09
large O 0 3.760047384560039e-09
number O 0 1.6599025487451513e-09
of O 0 2.3198374776711717e-08
metaplastic B-Disease 0 6.051880700397305e-05
polyps I-Disease 0 5.077326477476163e-06
of I-Disease 0 6.172643338686612e-07
the I-Disease 0 7.45204999930138e-07
colorectum I-Disease 0 0.0002758121700026095
. O 0 5.690058060281444e-07

There O 0 1.2011949657164678e-08
is O 0 3.135410264754057e-10
increasing O 0 7.292963455363122e-11
evidence O 0 1.4004833404079875e-10
that O 0 1.484775843940689e-11
there O 0 1.4136174175671812e-10
exist O 0 3.3934083321085495e-10
germ O 0 1.1118162390744146e-08
- O 0 6.765820348419993e-09
line O 0 1.275545091772301e-08
variants O 0 4.363179151312124e-09
of O 0 1.557194906354198e-08
the O 0 1.0382140480658109e-08
APC B-Disease 0 1.812549044188927e-07
gene O 0 4.1962822106000885e-10
that O 0 1.4248125249083365e-11
predispose O 0 2.2699258028779923e-09
to O 0 4.937735290089229e-11
the O 0 1.3688972178016456e-10
development O 0 3.307593920975904e-10
of O 0 7.513119726354489e-08
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 5.341445508122433e-09
but O 0 1.2447654018643561e-10
without O 0 1.4953632776482095e-10
the O 0 2.9591340489076856e-10
florid O 0 9.97261082602563e-08
phenotype O 0 5.318802065445993e-10
of O 0 2.722657654885552e-10
classical O 0 1.229860546736461e-09
FAP B-Disease 0 1.0499793461349327e-06
, O 0 1.5453926333064416e-11
and O 0 1.1662210259999473e-11
possibly O 0 1.5393325503154642e-11
with O 0 3.1450319779025016e-12
importance O 0 9.327673744508047e-09
for O 0 5.073092879115393e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.6099238564493135e-07
in O 0 1.5586872070816327e-11
the O 0 7.581833078029732e-11
general O 0 7.115711492255983e-11
population O 0 2.013800584621528e-11
. O 0 1.535146315623237e-10
. O 0 1.658491832756681e-08

Genomic O 0 7.105929000772448e-08
structure O 0 4.841146150624809e-09
of O 0 8.732373046882458e-09
the O 0 3.371167878185588e-08
human O 0 0.15248964726924896
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.208446889222614e-07
CLD B-Disease 1 1.0
) O 0 1.5196929936678316e-08
gene O 0 4.8245929917811736e-08
. O 0 4.376692430696494e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.842608298829873e-06
CLD B-Disease 1 1.0
) O 0 6.219997406020639e-09
is O 0 3.3338853899778087e-10
caused O 0 1.1793437337814794e-09
by O 0 1.7030939158946268e-10
mutations O 0 4.376998763433448e-09
in O 0 4.120263297213711e-10
a O 0 1.0366503211400868e-09
gene O 0 4.794151742260055e-10
which O 0 2.1180554532485019e-10
encodes O 0 5.341801667668733e-09
an O 0 2.3389277181706802e-09
intestinal O 0 7.650594488950446e-05
anion O 0 5.633313321595779e-06
transporter O 0 5.530179805646185e-06
. O 0 4.1824310414995125e-07

We O 0 1.4782843393845724e-08
report O 0 3.594065878242958e-10
here O 0 3.8361643722728545e-11
the O 0 3.9968262033340807e-10
complete O 0 3.651374480551084e-10
genomic O 0 8.18108247813143e-10
organization O 0 6.23700258106652e-11
of O 0 7.885581965183519e-09
the O 0 3.050514862934506e-08
human O 0 2.572694235425388e-08
CLD B-Disease 0 0.02384219504892826
gene O 0 3.729292430421083e-09
which O 0 1.2837347851402114e-10
spans O 0 4.231932138054617e-09
approximately O 0 1.516271969093097e-10
39kb O 0 4.1684621976401104e-08
, O 0 1.767886531611751e-10
and O 0 1.088640400048746e-09
comprises O 0 2.2557832934921862e-08
21 O 0 1.2257318360298086e-07
exons O 0 1.0834230579348514e-06
. O 0 2.0984229820442124e-07

All O 0 2.5820252176345093e-06
exon O 0 1.162206353910733e-05
/ O 0 3.3967191939154873e-06
intron O 0 2.6148891265620477e-06
boundaries O 0 3.1968387048664226e-08
conform O 0 4.8717043732438015e-09
to O 0 1.178943498381102e-09
the O 0 2.4647251350984334e-08
GT O 1 0.5502391457557678
/ O 0 0.110850490629673
AG O 1 1.0
rule O 0 3.75190461454622e-06
. O 0 4.126001158510917e-07

An O 0 5.544317449590608e-09
analysis O 0 1.372218005890602e-09
of O 0 1.201410348983245e-08
the O 0 2.6641190586929042e-08
putative O 0 7.453684247593628e-07
promoter O 0 2.4380613012908725e-06
region O 0 2.501658684650465e-07
sequence O 0 9.242314469304347e-09
shows O 0 5.251106660608684e-09
a O 0 2.576203694815149e-09
putative O 0 2.2102867092144152e-07
TATA O 0 4.1270541260018945e-06
box O 0 5.157997975402395e-07
and O 0 2.714260638470023e-08
predicts O 0 8.952375196713547e-08
multiple O 0 1.0438372832766163e-08
transcription O 0 3.6378644097112556e-08
factor O 0 7.333925911012784e-09
binding O 0 2.0314569582069453e-08
sites O 0 4.243192819330943e-08
. O 0 3.771642198557856e-08

The O 0 2.875856921491504e-07
genomic O 0 6.124081153302541e-08
structure O 0 6.881180958373534e-09
was O 0 3.1350648743710963e-09
determined O 0 2.2127789878201298e-10
using O 0 3.457037087151171e-11
DNA O 0 4.000692832573094e-10
from O 0 2.545779732854303e-11
several O 0 9.894876584759515e-11
sources O 0 1.0502668873479948e-10
including O 0 1.9712309562436303e-10
multiple O 0 1.4841827766787219e-09
large O 0 1.673502936228033e-08
- O 0 9.90604689832253e-07
insert O 0 2.96295610269226e-07
libaries O 0 1.8859660713133053e-06
and O 0 1.0445975195949586e-09
genomic O 0 1.4627710598347221e-08
DNA O 0 1.113420466936077e-08
from O 0 6.362810833770993e-10
Finnish O 0 0.00010270294296788052
CLD B-Disease 1 0.9999653100967407
patients O 0 2.7497515375785042e-08
and O 0 3.4782450253345587e-09
controls O 0 2.431444045214448e-06
. O 0 2.0515459198122699e-07

Exon O 0 1.1029557754227426e-05
- O 0 3.729597040091903e-07
specific O 0 9.539334655528364e-09
primers O 0 2.202574300724791e-08
developed O 0 4.640026418645249e-10
in O 0 2.8264260723553924e-11
this O 0 1.5502224504082562e-11
study O 0 4.179410290072738e-11
will O 0 1.371088919482899e-11
facilitate O 0 1.7897359982921301e-10
mutation O 0 7.266665047467313e-11
screening O 0 4.0179909399640223e-10
studies O 0 1.280052591701164e-10
of O 0 2.0971360759070024e-10
patients O 0 6.19240977939306e-11
with O 0 1.516982893468022e-11
the O 0 1.6050298867753554e-08
disease O 0 1.2270796787561267e-06
. O 0 5.703831718051333e-08

Genomic O 0 8.583212434132292e-07
sequencing O 0 6.803415431022586e-08
of O 0 1.4229779310426238e-07
a O 0 1.2075977906533808e-07
BAC O 1 1.0
clone O 0 6.919416591699701e-06
H O 1 1.0
_ O 0 3.967404182958489e-09
RG364P16 O 0 1.3081212557608524e-07
revealed O 0 2.9204505480606713e-10
the O 0 1.2535714133399267e-10
presence O 0 1.9326207301162412e-10
of O 0 2.018952338644908e-09
another O 0 7.100544041627188e-10
, O 0 1.812719557792164e-10
highly O 0 9.083656604680357e-10
homologous O 0 8.012152746816881e-11
gene O 0 2.0252070853654658e-10
3 O 0 2.192229286990255e-09
of O 0 6.0649343325280825e-09
the O 0 2.2568332980199557e-08
CLD B-Disease 0 0.0005582497688010335
gene O 0 2.682980060342288e-09
, O 0 1.5113460483107133e-10
with O 0 2.7337191538245875e-11
a O 0 1.4029910566648596e-10
similar O 0 4.676264583891587e-11
genomic O 0 5.158198868038255e-10
structure O 0 3.3110467145824884e-10
, O 0 3.0453244093120446e-11
recently O 0 1.5052759039235752e-10
identified O 0 2.991633676896477e-11
as O 0 6.874640440246438e-11
the O 0 1.212985178966619e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 6.647728127973096e-07
( O 0 4.17345580316919e-09
PDS B-Disease 1 0.9739614129066467
) O 0 9.93410242955406e-10
. O 0 1.2726768527926424e-09
. O 0 2.858193326460423e-08

The O 0 5.410124117588566e-07
APCI1307K O 1 1.0
allele O 0 1.0513946335777291e-07
and O 0 1.9360205882890114e-08
cancer B-Disease 0 6.479534022219013e-06
risk O 0 1.317356748131715e-07
in O 0 2.1904351943380362e-10
a O 0 3.305897222638521e-10
community O 0 6.162576698942601e-11
- O 0 5.919659762376739e-10
based O 0 1.0727888022366017e-10
study O 0 2.7167219862622716e-11
of O 0 3.0417560137330213e-10
Ashkenazi O 0 1.1248276088338116e-08
Jews O 0 1.3261900022598638e-08
. O 0 2.240907015504945e-08

Mutations O 0 7.061342444103502e-07
in O 0 2.3714594732382466e-09
APC O 0 1.8495786946459702e-07
are O 0 5.500001148961431e-11
classically O 0 1.549923211996429e-08
associated O 0 1.1354711615396695e-09
with O 0 3.8418669134898664e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.057006571159036e-07
FAP B-Disease 1 0.999964714050293
) O 0 1.671957156057502e-10
, O 0 2.3554718939222674e-11
a O 0 2.661241782497825e-10
highly O 0 0.0029605503659695387
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 2.2744477234937222e-07
by O 0 2.2890241091477748e-10
multiple O 0 7.606033136653423e-08
intestinal O 1 0.9999847412109375
polyps B-Disease 0 4.158111187280156e-05
and O 0 2.3198141185787335e-09
, O 0 1.5689156918075042e-10
without O 0 2.0988927262877155e-10
surgical O 0 2.8461661827350326e-07
intervention O 0 1.5519606710867606e-09
, O 0 4.136884237948557e-11
the O 0 2.5160401539991994e-10
development O 0 2.1122106286242115e-09
of O 0 6.077941361581907e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.9973738218936887e-08
CRC B-Disease 1 0.9575952291488647
) O 0 3.1500857478050648e-09
. O 0 1.2422478157247951e-08

APC B-Disease 0 6.798501999583095e-05
is O 0 6.613026926061139e-08
a O 0 2.7162080584730575e-08
tumour O 1 1.0
- O 0 4.31041007686872e-06
suppressor O 0 3.029877234439482e-06
gene O 0 1.4262658831754038e-09
, O 0 1.3019624267585073e-10
and O 0 1.2023679829553657e-09
somatic O 0 3.3045142799892346e-07
loss O 0 1.8781463495542994e-07
occurs O 0 1.986612874205207e-09
in O 0 4.424119293133799e-09
tumours B-Disease 1 1.0
. O 0 1.404483327860362e-06

The O 0 4.210431598039577e-06
germline O 0 2.592516693766811e-06
T O 0 9.624078529668623e-07
- O 0 2.8487342262906168e-08
to O 0 9.423375413319945e-10
- O 0 4.266533082386559e-08
A O 0 2.980935676077934e-08
transversion O 0 1.1754888618042969e-07
responsible O 0 9.412273183073694e-10
for O 0 1.5603210390402467e-10
the O 0 5.121175039590753e-09
APC O 0 7.729155413471744e-07
I1307K O 0 2.9632601581397466e-06
allele O 0 4.796074648538706e-09
converts O 0 1.0426308705291376e-09
the O 0 1.0441951747708345e-09
wild O 0 1.9224170699772003e-08
- O 0 7.882935193492813e-09
type O 0 4.91278928649308e-09
sequence O 0 3.3375757713116627e-10
to O 0 1.7341290903249984e-10
a O 0 5.450090156955412e-09
homopolymer O 1 0.9999332427978516
tract O 1 0.9999998807907104
( O 0 1.217161482713891e-08
A8 O 1 0.9999347925186157
) O 0 1.1794601406656113e-10
that O 0 2.038176051544216e-11
is O 0 3.103246271063398e-10
genetically O 0 1.957284467835052e-08
unstable O 0 1.980688679736886e-08
and O 0 8.222996505935498e-09
prone O 0 3.51103540197073e-06
to O 0 7.722083239514177e-08
somatic O 0 5.715740826417459e-06
mutation O 0 5.006411925023713e-07
. O 0 6.661665707952125e-08

The O 0 5.721477123188379e-07
I1307K O 0 7.899712727521546e-06
allele O 0 1.3588987712864764e-08
was O 0 6.222761861351955e-09
found O 0 6.096722016124545e-10
in O 0 1.4530017189429145e-09
6 O 0 5.635272373183398e-07
. O 0 1.8340548990636307e-07

1 O 0 3.634667677943071e-07
% O 0 5.023751192823056e-09
of O 0 1.1227697882532084e-08
unselected O 0 2.3445274564437568e-05
Ashkenazi O 0 6.397791452172896e-08
Jews O 0 3.924167657487487e-09
and O 0 2.1070954703272804e-10
higher O 0 5.219399912270717e-10
proportions O 0 1.6300745198094546e-09
of O 0 3.020395933361897e-09
Ashkenazim O 0 6.445916369557381e-07
with O 0 7.780340260943319e-10
family O 0 2.318159886272042e-09
or O 0 1.986370401496629e-09
personal O 0 2.8914543648284052e-08
histories O 0 3.77221809344519e-08
of O 0 6.368650792865083e-05
CRC B-Disease 1 1.0
( O 0 2.334497484213216e-09
ref O 0 9.763172670318454e-08
. O 0 3.2191876941922715e-10
2 O 0 2.1169549668798027e-08
) O 0 2.793856923588578e-09
. O 0 3.142400117894795e-08

To O 0 5.567429184338835e-09
evaluate O 0 1.8721335592886135e-08
the O 0 1.2862795273349548e-09
role O 0 2.527233311511168e-09
of O 0 3.268756998409117e-08
I1307K O 0 2.3188060822576517e-06
in O 0 1.260530013702521e-09
cancer B-Disease 0 3.843281888293859e-07
, O 0 8.97365182161991e-10
we O 0 1.4749348409281993e-09
genotyped O 0 1.8373879129285342e-06
5 O 0 7.124344847397879e-08
, O 0 4.698880839981712e-09
081 O 0 4.503599939198466e-06
Ashkenazi O 0 6.603737290333811e-08
volunteers O 0 8.574538412631227e-09
in O 0 9.217784868731371e-10
a O 0 4.552939358859476e-09
community O 0 3.498905387644413e-09
survey O 0 7.110969590939931e-09
. O 0 3.7108321748746675e-08

Risk O 0 3.6724197798321256e-06
of O 0 2.4901265760490787e-07
developing O 0 1.4345915587909985e-05
colorectal B-Disease 1 1.0
, I-Disease 0 1.7795042595025734e-06
breast I-Disease 1 0.9999998807907104
and I-Disease 0 6.916168082682361e-09
other I-Disease 0 2.3886825850638616e-09
cancers I-Disease 0 0.005868854001164436
were O 0 1.6447709860756277e-10
compared O 0 3.617683930201565e-10
between O 0 7.387158107441394e-10
genotyped O 0 2.88638261736196e-06
I1307K O 0 1.1376313580058195e-07
carriers O 0 1.0250415793944256e-10
and O 0 6.789211554059094e-11
non O 0 2.4141491028473183e-09
- O 0 8.084520275453144e-10
carriers O 0 3.6479340381756487e-11
and O 0 1.793186085730092e-11
their O 0 2.020352288245597e-11
first O 0 5.681563899906372e-11
- O 0 4.621939275750719e-09
degree O 0 8.656852124033776e-09
relatives O 0 2.136481214165542e-09
. O 0 1.3453130165430593e-08

Sperm O 0 3.1168397640612966e-08
DNA O 0 8.793429095987904e-09
analysis O 0 1.700750235089643e-10
in O 0 4.683685106421365e-10
a O 0 5.770164435148217e-08
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 0.999994158744812
carrier O 0 1.7042744104855956e-07
suggests O 0 2.21851177428789e-08
both O 0 3.147190952290657e-09
meiotic O 0 6.463238264586835e-07
and O 0 2.2387453668670787e-08
mitotic O 0 8.833357156845523e-08
expansion O 0 8.844517651596107e-08
in O 0 1.9382773164267064e-09
the O 0 6.035902089251977e-08
FRDA B-Disease 1 0.9993426203727722
gene O 0 4.1330977751385944e-07
. O 0 2.419403699605027e-07

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 7.065585577947786e-06
usually O 0 1.8542618107630915e-08
caused O 0 3.5944243137464582e-09
by O 0 3.626358588415535e-11
an O 0 1.5498034799943383e-10
expansion O 0 5.4682526950955435e-08
of O 0 9.035867520879037e-08
a O 0 9.59719059778763e-08
GAA O 0 0.0004692654183600098
trinucleotide O 0 3.018165625690017e-05
repeat O 0 1.1529343169058848e-07
in O 0 1.0257344973396698e-09
intron O 0 1.3913954433064646e-07
1 O 0 3.663823733290883e-08
of O 0 3.2316734177584294e-08
the O 0 7.121600020809637e-08
FRDA B-Disease 1 0.9997155070304871
gene O 0 2.3553683092814026e-07
. O 0 1.2937668714130268e-07

Occasionally O 0 1.027171947498573e-06
, O 0 1.6954821546733e-08
a O 0 4.58766802324817e-09
fully O 0 2.9592442274406494e-08
expanded O 0 5.592568186330027e-09
allele O 0 8.175684573785702e-10
has O 0 5.368905667268997e-11
been O 0 3.110438642761615e-11
found O 0 7.949448391220137e-12
to O 0 3.3730154086475395e-11
arise O 0 2.661069142817496e-10
from O 0 9.026863978522925e-11
a O 0 3.8577827043972945e-10
premutation O 0 2.7773012334364466e-07
of O 0 3.162235273634906e-08
100 O 0 3.073924403906858e-08
or O 0 1.773649338510097e-09
less O 0 7.8826190019754e-09
triplet O 0 3.5531777484720806e-06
repeats O 0 8.780980209621703e-08
. O 0 1.427726061820067e-07

We O 0 9.641922105174672e-08
have O 0 4.729719949025935e-10
examined O 0 6.645571204444423e-09
the O 0 6.580658795662941e-10
sperm O 0 1.1543332262275996e-10
DNA O 0 1.6239858346978053e-09
of O 0 5.1631721120770635e-09
a O 0 1.0211281598060395e-08
premutation O 0 1.8894275854108855e-05
carrier O 0 2.771292599845765e-07
. O 0 2.6858700152843085e-07

This O 0 1.561960338847257e-08
mans O 0 2.268439402541844e-06
leucocyte O 0 1.0021745993071818e-06
DNA O 0 2.8278591912567208e-08
showed O 0 9.181498894506035e-10
one O 0 1.3730130921096872e-10
normal O 0 1.3670603538074033e-10
allele O 0 2.0836903383281147e-11
and O 0 5.846997885861072e-11
one O 0 2.191475612089988e-10
allele O 0 2.9823485347968415e-10
of O 0 5.837387462293009e-09
approximately O 0 4.505581241431855e-09
100 O 0 2.2771514451846997e-08
repeats O 0 1.55255079903327e-08
. O 0 4.471535319794384e-08

His O 0 2.3633069758943748e-06
sperm O 0 1.2449210551324086e-08
showed O 0 1.0657816851278312e-09
an O 0 1.3285786359951146e-10
expanded O 0 4.6298973543912325e-09
allele O 0 1.0258205396240783e-09
in O 0 6.047881639936747e-10
a O 0 8.892111935665525e-09
tight O 0 2.38209182157334e-07
range O 0 1.617395213315831e-07
centering O 0 2.5319968344206245e-08
on O 0 3.150007588104131e-09
a O 0 6.142641395534554e-10
size O 0 6.045255407371997e-09
of O 0 3.5582122137611805e-08
approximately O 0 6.374355621119321e-08
320 O 0 2.1534509642151534e-07
trinucleotide O 0 2.3214226530399173e-05
repeats O 0 4.483825364332006e-07
. O 0 2.488113466370123e-07

His O 0 2.7946371119469404e-06
affected O 0 2.1830564946867526e-06
son O 0 2.866409886337351e-06
has O 0 1.2402259663701898e-08
repeat O 0 1.527839366133321e-08
sizes O 0 5.4873798838173116e-09
of O 0 9.591293981259241e-09
1040 O 0 1.4184513474901905e-07
and O 0 1.0439846320764445e-08
540 O 0 6.881917897771928e-07
. O 0 1.1429468571577672e-07

These O 0 1.5965966326803027e-08
data O 0 8.626782621590223e-10
suggest O 0 3.8863787188425647e-10
that O 0 1.0182870172070757e-11
expansion O 0 1.3520985442383449e-09
occurs O 0 8.809145253529937e-12
in O 0 5.399691544588636e-12
two O 0 9.268284924257575e-12
stages O 0 3.3054434189772053e-10
, O 0 3.877965309984077e-11
the O 0 2.2270650601452502e-10
first O 0 3.7267025576603885e-10
during O 0 5.483851150955843e-10
meiosis O 0 1.8572093862800898e-09
followed O 0 4.171862300061946e-10
by O 0 1.7008376651528323e-10
a O 0 4.412144427590192e-09
second O 0 2.9665796930089527e-08
mitotic O 0 2.3637166179923952e-07
expansion O 0 1.8008515780820744e-06
. O 0 6.337121476462926e-07

We O 0 1.6228069554813374e-08
also O 0 3.1953176216070744e-10
show O 0 1.1964126911401252e-10
that O 0 3.287194301482277e-12
in O 0 1.8514705393823938e-11
all O 0 1.6219016407692521e-10
informative O 0 2.7288511450507258e-09
carrier O 0 1.9513717308683454e-09
father O 0 8.892446778929752e-10
to O 0 2.6072807801647e-10
affected O 0 1.7130247220720207e-09
child O 0 1.5031822453437371e-09
transmissions O 0 2.1331249266953733e-10
, O 0 1.906551652663957e-11
with O 0 9.202352421744386e-12
the O 0 6.044882927547235e-10
notable O 0 9.207440143654821e-09
exception O 0 3.6364198319205343e-09
of O 0 9.256744704089215e-09
the O 0 1.4056174890697548e-08
premutation O 0 1.981669129236252e-06
carrier O 0 6.122759188542659e-09
, O 0 8.206619273032345e-10
the O 0 2.5182593788031227e-09
expansion O 0 1.9334965628559075e-08
size O 0 1.2088579914859565e-08
decreases O 0 1.5626874017016235e-08
. O 0 1.8923842493023812e-09
. O 0 4.347165827311983e-08

The O 0 7.750412578388932e-07
R496H O 0 9.174902515951544e-06
mutation O 0 2.2027423440817984e-08
of O 0 2.0623383889528668e-08
arylsulfatase O 0 4.702784281107597e-05
A O 0 1.028110773404478e-06
does O 0 2.7250126599653868e-09
not O 0 4.4920747122034754e-09
cause O 0 1.1068808589698165e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 5.483194399857894e-06

Deficiency B-Disease 1 0.999962329864502
of I-Disease 0 6.106141518102959e-05
arylsulfatase I-Disease 1 0.9999995231628418
A I-Disease 0 0.0007774648838676512
( O 0 6.893912996019935e-08
ARSA O 1 0.9999997615814209
) O 0 1.3248222963113676e-08
enzyme O 0 3.1151817125874004e-08
activity O 0 6.479083491939264e-09
causes O 0 1.8046597460852354e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.537189516260696e-07
MLD B-Disease 1 1.0
) O 0 7.968652226963968e-08
. O 0 8.442733445690465e-08

A O 0 6.608096896343341e-07
number O 0 1.2151688544292938e-08
of O 0 1.2182478315025946e-07
ARSA O 1 0.9999998807907104
gene O 0 2.85667084654051e-07
mutations O 0 2.35848283125506e-08
responsible O 0 7.186370609701953e-09
for O 0 5.172930528374309e-09
MLD B-Disease 1 1.0
have O 0 3.827186567662011e-09
been O 0 1.6752905729333634e-09
identified O 0 3.348672450442791e-09
. O 0 1.4228050737585818e-08

Recently O 0 4.946509193359816e-07
, O 0 9.46459266515376e-09
the O 0 1.5000267694631475e-08
R496H O 0 2.4997416403493844e-06
mutation O 0 1.5338425640720743e-08
of O 0 6.337297264735753e-08
ARSA O 1 0.9999996423721313
was O 0 3.70692703199893e-08
proposed O 0 4.8700781185573305e-09
to O 0 3.333910925107375e-10
be O 0 2.536121590512863e-10
a O 0 5.904493005637335e-10
cause O 0 2.498801698891384e-08
of O 0 3.362835911957518e-07
MLD B-Disease 1 1.0
( O 0 2.1731880295305928e-08
Draghia O 0 1.1578785233723465e-05
et O 0 2.4099730211446513e-08
al O 0 5.6691211725024004e-09
. O 0 3.215352428753704e-10
, O 0 9.077282814295984e-10
1997 O 0 2.8960025488800056e-08
) O 0 1.1176333636342406e-08
. O 0 8.592945022201093e-08

We O 0 9.189232486050969e-08
have O 0 6.913144501297097e-10
investigated O 0 9.646369925064846e-09
the O 0 3.323684216738343e-09
R496H O 0 6.514824804071395e-07
mutation O 0 5.018672699641513e-10
and O 0 1.9762037839488045e-10
found O 0 9.917947019211226e-11
this O 0 1.5185895943514716e-11
mutation O 0 2.6334601166411176e-10
at O 0 9.048829463509378e-10
a O 0 3.4360159162361015e-10
relatively O 0 1.249906567135639e-10
high O 0 7.914418009846713e-10
frequency O 0 8.233267539958788e-11
in O 0 1.4459670440170047e-11
an O 0 4.825101082572836e-11
African O 0 7.146259972667934e-11
American O 0 2.4617860527875735e-10
population O 0 2.2101627819570702e-11
( O 0 9.750388864360193e-12
f O 0 2.4793260777755677e-09
= O 0 2.522859143816447e-10
0 O 0 3.8661504553338943e-10
. O 0 9.696590752561463e-11
09 O 0 1.6465688190692163e-07
, O 0 1.563712159757813e-09
n O 0 4.663879060728959e-09
= O 0 8.863563216721104e-09
61 O 0 3.4789035652238454e-08
subjects O 0 4.8804952967884674e-08
) O 0 4.9768376086944954e-09
. O 0 4.709075440700872e-08

The O 0 4.522252766037127e-06
ARSA O 0 0.00179487734567374
enzyme O 0 1.2274707472670343e-08
activity O 0 6.38692210230829e-10
in O 0 1.0364397708129136e-11
subjects O 0 8.568893372640218e-10
with O 0 7.50285163858555e-12
and O 0 1.2844450503202154e-10
without O 0 6.359716642201363e-10
the O 0 1.900483104222417e-09
R496H O 0 3.5852377777700895e-07
mutation O 0 5.177508421994048e-10
was O 0 5.746653708449401e-10
determined O 0 5.5934190612561e-10
and O 0 1.569774865650686e-10
found O 0 6.361472459914808e-11
to O 0 1.6206522235329146e-10
be O 0 6.787946316144655e-10
normal O 0 2.4908930029710064e-08
. O 0 4.261003283545506e-08

It O 0 4.1722561405777014e-08
is O 0 1.8039048033102745e-09
therefore O 0 7.16384063181863e-10
concluded O 0 5.164705885185583e-10
that O 0 2.3673445148642003e-11
the O 0 1.6453962636830965e-09
R496H O 0 1.5109980040506343e-06
mutation O 0 7.160073867140682e-09
of O 0 8.905202264486434e-08
ARSA O 1 0.9999417066574097
does O 0 2.734300785789401e-09
not O 0 5.869076752373914e-11
negatively O 0 7.209486341253069e-10
influence O 0 1.3441838753180946e-09
the O 0 8.93164486814868e-10
activity O 0 1.249301884165277e-09
of O 0 3.0169930997914207e-09
ARSA O 0 0.0008254297426901758
and O 0 3.181812147090568e-09
is O 0 4.722805480028569e-10
not O 0 1.5229731364918564e-10
a O 0 2.0359518515533637e-09
cause O 0 7.073906260757212e-08
of O 0 3.573029061954003e-06
MLD B-Disease 1 1.0

Down O 0 2.741566959230113e-06
- O 0 2.627813557865011e-07
regulation O 0 8.425424624647349e-08
of O 0 6.488212989097519e-08
transmembrane O 0 3.963556878261443e-07
carbonic O 0 1.5739995433250442e-05
anhydrases O 0 5.573674934566952e-05
in O 0 4.435037226357963e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 2.633584244904341e-06
by O 0 1.1779477393503157e-09
wild O 0 1.0935054888250306e-06
- O 0 6.803142014177865e-07
type O 0 1.8258818954564049e-06
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 0 0.012983212247490883
Lindau I-Disease 0 0.07015091180801392
transgenes O 0 8.127761248033494e-05
. O 0 3.6291464766691206e-07

To O 0 1.1641964192676824e-07
discover O 0 6.827422627253554e-09
genes O 0 3.0242794379908844e-10
involved O 0 9.536686718103482e-11
in O 0 5.497192701042763e-10
von B-Disease 1 0.9999994039535522
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 1.8238823429328477e-07
VHL B-Disease 1 1.0
) O 0 1.4545526560993949e-08
- O 0 5.75614819808834e-07
mediated O 0 7.519083311535724e-08
carcinogenesis O 0 6.628056144108996e-05
, O 0 4.805632003446192e-10
we O 0 4.77493045103472e-11
used O 0 9.237268172590518e-10
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.5334317684173584
stably O 0 1.7052339899237268e-05
transfected O 0 4.276749976384053e-08
with O 0 4.2997699845059856e-10
wild O 0 2.2218448236799304e-07
- O 0 1.3008191217522835e-06
type O 0 3.1483295970247127e-06
VHL O 1 0.9999998807907104
- O 0 9.307536856795195e-06
expressing O 0 1.3525344400022732e-07
transgenes O 0 9.02845749806147e-06
. O 0 1.0097480895865374e-07

Large O 0 3.9132055462687276e-07
- O 0 2.1953356110770983e-07
scale O 0 2.6064091684929735e-07
RNA O 0 5.736672292755429e-08
differential O 0 7.143186930846923e-09
display O 0 2.5551609716956136e-09
technology O 0 4.228661865113281e-10
applied O 0 3.419123040249161e-10
to O 0 3.362378431237545e-11
these O 0 6.585175460482873e-11
cell O 0 1.540143845790709e-10
lines O 0 8.712172094860193e-10
identified O 0 1.522235532069871e-10
several O 0 1.9315374299999633e-10
differentially O 0 1.159595264255131e-08
expressed O 0 1.185703618622469e-10
genes O 0 1.3081506711198898e-10
, O 0 1.1299657043384315e-10
including O 0 2.2691887258119436e-10
an O 0 4.0757186514639443e-10
alpha O 0 1.6632348831535637e-07
carbonic O 0 2.840806928361417e-06
anhydrase O 0 8.417780918534845e-06
gene O 0 2.188082248721912e-08
, O 0 7.1959718184189114e-09
termed O 0 1.8690814158617286e-06
CA12 O 1 0.9999986886978149
. O 0 2.006962631639908e-06

The O 0 7.55828637011291e-07
deduced O 0 1.4701055306431954e-07
protein O 0 3.412453208895272e-09
sequence O 0 2.0034307546268337e-10
was O 0 9.293962821566026e-10
classified O 0 6.587745460251426e-09
as O 0 5.726095153590904e-10
a O 0 3.7599881541616753e-10
one O 0 3.165998019305505e-10
- O 0 1.663856750155901e-07
pass O 0 8.631084256194299e-07
transmembrane O 0 3.5307752455082664e-07
CA O 0 0.08659648150205612
possessing O 0 2.6921424023385043e-07
an O 0 1.0856421317484433e-09
apparently O 0 3.5114677832126517e-09
intact O 0 1.744061961517218e-08
catalytic O 0 3.118992353279282e-08
domain O 0 9.542027612496895e-09
in O 0 3.888499522375355e-10
the O 0 1.3173461432813838e-08
extracellular O 0 2.775730933990417e-07
CA O 0 0.0007089227437973022
module O 0 3.0171036087267566e-06
. O 0 3.5306706536175625e-07

Reintroduced O 0 7.324988109758124e-05
wild O 0 9.095242603507359e-06
- O 0 9.953587323252577e-06
type O 0 2.7218197828915436e-06
VHL B-Disease 0 0.00444011390209198
strongly O 0 1.4219233790413455e-08
inhibited O 0 9.846088389053875e-09
the O 0 9.717870952385965e-10
overexpression O 0 6.081313674854982e-09
of O 0 5.192028140754701e-09
the O 0 7.56804308110759e-09
CA12 O 1 0.9999330043792725
gene O 0 1.7807338936748351e-09
in O 0 1.3824258404682155e-10
the O 0 4.822989563280089e-09
parental O 0 1.4725999790243804e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.31518733501434326
. O 0 5.340929192243493e-07

Similar O 0 2.2824391265885424e-08
results O 0 5.712252892919878e-10
were O 0 9.890801372369751e-11
obtained O 0 1.3661088926752996e-10
with O 0 1.5520160157045382e-10
CA9 O 0 3.221094448235817e-05
, O 0 1.593975951230675e-09
encoding O 0 8.475661061879691e-09
another O 0 5.890660403906622e-09
transmembrane O 0 5.319822449223466e-08
CA O 0 6.338158527796622e-06
with O 0 1.1164418278752919e-09
an O 0 2.0724515437109403e-09
intact O 0 1.9895361447197502e-07
catalytic O 0 1.451312414246786e-06
domain O 0 5.908926254960534e-07
. O 0 1.5678440945521288e-07

Although O 0 4.86333249227755e-08
both O 0 5.980823392093271e-09
domains O 0 3.415932425809842e-08
of O 0 6.674179786614332e-08
the O 0 7.022231329756323e-08
VHL B-Disease 0 0.0005338251357898116
protein O 0 7.837941851107644e-09
contribute O 0 7.162133108806756e-10
to O 0 7.913779354051798e-11
regulation O 0 1.3711616730915921e-08
of O 0 8.897137604435557e-08
CA12 O 1 1.0
expression O 0 4.98914554114549e-09
, O 0 1.882242833817216e-10
the O 0 8.84712414439548e-10
elongin O 0 3.4965728445968125e-07
binding O 0 1.4185237873221013e-08
domain O 0 1.357608692131862e-08
alone O 0 5.25120702477011e-09
could O 0 4.330174441236068e-09
effectively O 0 3.94962597738413e-07
regulate O 0 6.219481292646378e-06
CA9 O 1 0.6932547092437744
expression O 0 1.7855527403298765e-06
. O 0 3.737383735824551e-07

We O 0 7.710014529038745e-07
mapped O 0 6.484460755018517e-06
CA12 O 1 0.9999905824661255
and O 0 1.2146889503128477e-06
CA9 O 0 0.002207099925726652
loci O 0 4.064528695835179e-07
to O 0 8.96416185725002e-09
chromosome O 0 7.733757456662715e-08
bands O 0 3.919233506621822e-07
15q22 O 0 1.1947185157623608e-05
and O 0 6.337309343962261e-08
17q21 O 0 4.220943810651079e-05
. O 0 4.5966572770339553e-07

2 O 0 3.037700935237808e-07
respectively O 0 1.1157079704560147e-08
, O 0 2.161413936718759e-09
regions O 0 2.6533378161275323e-08
prone O 0 1.042166601905592e-07
to O 0 6.87627010886871e-10
amplification O 0 4.4304798052507977e-08
in O 0 8.951906993459602e-10
some O 0 5.6674238635423535e-09
human O 0 3.643753387905235e-08
cancers B-Disease 1 0.895511269569397
. O 0 2.014718631926371e-07

Additional O 0 7.181892414109825e-08
experiments O 0 1.632822099750797e-09
are O 0 7.036161150247855e-12
needed O 0 2.0439453948806197e-11
to O 0 2.4973349777024367e-11
define O 0 5.022234850216023e-10
the O 0 2.832585277445787e-10
role O 0 7.965241244356491e-10
of O 0 1.4820166427398362e-08
CA O 0 8.97729660209734e-06
IX O 1 0.9999996423721313
and O 0 2.0758905705520192e-08
CA O 0 7.182945410022512e-06
XII O 1 0.9967151880264282
enzymes O 0 1.338499089342804e-09
in O 0 8.994758410318937e-11
the O 0 4.996799640721861e-10
regulation O 0 5.226944210789952e-09
of O 0 1.6394879898129489e-09
pH O 0 5.547355996782244e-08
in O 0 2.3064625209734402e-10
the O 0 1.8359642695031653e-09
extracellular O 0 5.237902556132212e-09
microenvironment O 0 1.0388483673295923e-07
and O 0 1.2609291388798738e-09
its O 0 1.3823764355436197e-09
potential O 0 7.54757323306876e-09
impact O 0 3.19500408352269e-08
on O 0 5.8610979181139555e-08
cancer B-Disease 0 7.603458925586892e-06
cell O 0 1.6484071352351748e-07
growth O 0 1.4176912088714744e-07
. O 0 1.0453259591258757e-07

A O 0 3.1703207241662312e-06
gene O 0 2.3132054494112708e-08
encoding O 0 3.54806672930863e-08
a O 0 7.837314797143335e-09
transmembrane O 0 3.3750023220591174e-08
protein O 0 1.4856534669149823e-08
is O 0 1.7859712320156262e-10
mutated O 0 6.660312856787698e-10
in O 0 9.678902644638665e-12
patients O 0 1.1603640270863025e-10
with O 0 1.8831981807299059e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 2.8059548640158027e-06
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 6.532292040617449e-09
. O 0 1.76548233810081e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2717653589788824e-05
WFS B-Disease 1 0.9999997615814209
; O 0 5.3462279936411505e-08
OMIM O 1 0.9995372295379639
222300 O 0 2.5757094590517227e-06
) O 0 5.250262447020759e-10
is O 0 1.1258351889642526e-10
an O 0 2.2023336487819734e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.1844490660782867e-09
by O 0 1.2277521881098874e-11
young O 0 6.758310577836824e-10
- O 0 2.5702908246216793e-08
onset O 0 3.0495341434289003e-06
non O 1 0.8425474762916565
- O 0 6.274358020164073e-05
immune O 1 0.725636899471283
insulin B-Disease 1 0.9999995231628418
- I-Disease 1 0.9794427752494812
dependent I-Disease 0 0.0004284685419406742
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.983945730898995e-05
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 9.98370410343341e-07

Linkage O 0 3.2594050480838632e-06
to O 0 2.1588975940289856e-08
markers O 0 3.535043902047619e-07
on O 0 1.0465369371104316e-07
chromosome O 0 3.339859517836885e-07
4p O 0 1.494007051405788e-06
was O 0 9.116048360624518e-09
confirmed O 0 9.46870581941539e-10
in O 0 3.8229017174096214e-10
five O 0 1.9983217303121137e-09
families O 0 1.0747917833509035e-10
. O 0 6.719522271936285e-09

On O 0 4.912398310352728e-08
the O 0 4.730425828824991e-09
basis O 0 3.4753671052101254e-09
of O 0 1.6905415733958762e-08
meiotic O 0 2.623056025186088e-05
recombinants O 1 0.999987006187439
and O 0 1.3229276873971685e-07
disease O 0 5.758307452197187e-06
- O 0 1.0806723338419033e-07
associated O 0 4.4744425942155885e-09
haplotypes O 0 1.3694418043996848e-08
, O 0 4.1218747859339544e-10
the O 0 1.1255442800006676e-08
WFS B-Disease 1 0.6330291628837585
gene O 0 2.933080800460175e-08
was O 0 2.907780860539333e-08
localized O 0 1.87242301308288e-06
to O 0 1.9268295403662705e-08
a O 0 1.770649475929531e-07
BAC O 1 1.0
/ O 0 1.852604327723384e-05
P1 O 0 0.00011788996926043183
contig O 0 5.728280939365504e-06
of O 0 2.3332610510351515e-08
less O 0 1.5045131807056578e-09
than O 0 2.1946965078623037e-10
250 O 0 1.2566657048296292e-08
kb O 0 3.624294322435162e-06
. O 0 1.3756704220213578e-07

Mutations O 0 1.9095249115252955e-07
in O 0 3.436168460879685e-09
a O 0 6.9423231607856906e-09
novel O 0 8.958404862369207e-08
gene O 0 3.2876759092914654e-09
( O 0 1.0693429475239213e-09
WFS1 O 1 0.9983850717544556
) O 0 2.0721986349059307e-09
encoding O 0 1.0237354963749112e-08
a O 0 2.9928408640245152e-09
putative O 0 6.904914329197709e-08
transmembrane O 0 1.7393141371613297e-09
protein O 0 1.7431955878777217e-10
were O 0 1.2768380970584747e-11
found O 0 2.274707115376695e-12
in O 0 1.8774686666445106e-12
all O 0 1.4367709279261565e-11
affected O 0 2.7015716053124805e-11
individuals O 0 1.005421548967711e-12
in O 0 2.1164632546533113e-11
six O 0 1.1702442348493491e-09
WFS B-Disease 0 5.566726485994877e-06
families O 0 9.734352213186526e-12
, O 0 9.505773772289228e-12
and O 0 4.040452347697787e-11
these O 0 1.3101783546964896e-10
mutations O 0 4.035094203214129e-10
were O 0 2.0148572046907454e-11
associated O 0 2.2183614667437013e-10
with O 0 2.1905227631791035e-10
the O 0 7.46466923828848e-08
disease O 0 9.733543265610933e-06
phenotype O 0 3.9084687841750565e-07
. O 0 7.969519089101595e-08

WFS1 O 1 0.9999992847442627
appears O 0 7.599217610732012e-08
to O 0 9.011832946548282e-10
function O 0 7.21867787767394e-10
in O 0 2.4417573518675795e-10
survival O 0 5.469566488613964e-08
of O 0 2.962260126082583e-08
islet O 0 7.576142252219142e-06
beta O 0 1.2657386605496868e-07
- O 0 5.3145690515066235e-08
cells O 0 1.350589917681333e-10
and O 0 1.5987798585026525e-10
neurons O 0 3.2636284785780845e-09
. O 0 6.876847424841515e-10
. O 0 2.0205558115549138e-08

Stable O 0 1.8251785149914213e-06
interaction O 0 2.094666440299875e-09
between O 0 1.2350079292566818e-10
the O 0 3.229137512938962e-10
products O 0 2.266283383178802e-09
of O 0 3.128756587145176e-09
the O 0 3.4332551024363056e-08
BRCA1 O 0 1.201218765345402e-06
and O 0 9.977062376265167e-08
BRCA2 O 0 8.174901267921086e-06
tumor B-Disease 0 1.1873446055687964e-05
suppressor O 0 9.152915936283534e-07
genes O 0 1.08828757117152e-09
in O 0 3.533118519971623e-10
mitotic O 0 2.6449853862686723e-08
and O 0 1.58148178996953e-08
meiotic O 0 6.954644959478173e-06
cells O 0 3.40816193045157e-08
. O 0 6.500215476989979e-08

BRCA1 O 0 1.6576859707129188e-05
and O 0 1.0212026069211788e-07
BRCA2 O 0 3.462969289103057e-07
account O 0 1.999985940748239e-11
for O 0 2.8804560733147744e-12
most O 0 5.157042327896821e-12
cases O 0 1.8260198908492953e-11
of O 0 3.7860464763284085e-10
familial O 0 6.598575197358514e-08
, O 0 1.4300133299727236e-10
early O 0 8.109369287190304e-10
onset O 0 2.7700582450052025e-06
breast B-Disease 1 0.9999998807907104
and I-Disease 0 1.4274118029788951e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.729602348125695e-10
encode O 0 6.366691895909327e-11
products O 0 1.782013980822228e-10
that O 0 2.926642652181788e-12
each O 0 7.361832497776444e-12
interact O 0 2.5255587551842318e-11
with O 0 1.572816876738159e-10
hRAD51 O 0 3.7036945741419913e-06
. O 0 9.468027428738424e-08

Results O 0 2.2555122214384937e-08
presented O 0 7.722123385178747e-09
here O 0 1.245187980503104e-10
show O 0 9.448337667805617e-10
that O 0 1.9172520515642333e-10
BRCA1 O 0 8.485321245643718e-08
and O 0 2.8791822259677247e-08
BRCA2 O 0 2.0202708128636004e-06
coexist O 0 6.897593163301963e-09
in O 0 1.1557299561815171e-10
a O 0 2.1188717447273575e-10
biochemical O 0 4.39366942828201e-09
complex O 0 2.756466388476042e-09
and O 0 7.648768285406504e-10
colocalize O 0 8.236293638219649e-07
in O 0 1.4269734283089974e-09
subnuclear O 0 7.1315075729216915e-06
foci O 0 4.3231250401731813e-07
in O 0 5.396844637850506e-10
somatic O 0 5.454416474037771e-09
cells O 0 1.364319421326421e-11
and O 0 1.6438041899879963e-11
on O 0 2.7312291317471704e-10
the O 0 2.1346635570296257e-10
axial O 0 8.109837246195184e-09
elements O 0 7.098445164999134e-10
of O 0 4.962590338664086e-09
developing O 0 2.8583677647020522e-08
synaptonemal O 0 7.648287464689929e-06
complexes O 0 3.872106617563986e-07
. O 0 1.0845833742223476e-07

Like O 0 1.2828925264329882e-06
BRCA1 O 0 3.0879566565999994e-06
and O 0 1.2950593486493744e-07
RAD51 O 1 0.9999998807907104
, O 0 3.486789523776679e-07
BRCA2 O 0 3.1507929634244647e-06
relocates O 0 6.542892805327938e-08
to O 0 2.5718684959485927e-09
PCNA O 0 1.7710490283207037e-05
+ O 0 3.115013580412551e-09
replication O 0 2.3156573880633857e-10
sites O 0 2.1597067190182173e-10
following O 0 7.524553202742368e-11
exposure O 0 2.893904138545622e-08
of O 0 1.3462551962106772e-08
S O 0 7.411962315018172e-07
phase O 0 2.8810003271928508e-08
cells O 0 2.792491793357499e-10
to O 0 1.933676330168055e-09
hydroxyurea O 0 4.693858954851748e-06
or O 0 3.6697127114848627e-08
UV O 1 0.9999998807907104
irradiation O 0 5.512703410204267e-06
. O 0 1.0147389417625163e-07

Thus O 0 2.773807068479073e-07
, O 0 2.4720131719391247e-08
BRCA1 O 0 1.4869750941670645e-07
and O 0 7.619562758520715e-09
BRCA2 O 0 6.095111615422866e-08
participate O 0 1.7630710780203174e-10
, O 0 4.1804070621820344e-11
together O 0 2.372701167485669e-11
, O 0 6.340806352200801e-11
in O 0 9.794493688319861e-11
a O 0 1.2947937166885026e-09
pathway O 0 2.8190312306719534e-09
( O 0 9.507318543544585e-11
s O 0 9.69128999273039e-10
) O 0 8.601602936864072e-12
associated O 0 2.155211946408553e-11
with O 0 5.653240028880013e-12
the O 0 2.3481167010785953e-10
activation O 0 9.228604547217856e-10
of O 0 3.0254350136260655e-09
double O 0 5.955912429911336e-10
- O 0 7.796670864479438e-09
strand O 0 2.5971964578985762e-09
break O 0 5.213333320597258e-09
repair O 0 2.362800977095958e-08
and O 0 7.0546892771972125e-09
/ O 0 1.0504686542844865e-07
or O 0 2.2983919212293813e-09
homologous O 0 1.2741682153816214e-09
recombination O 0 2.6423871979375235e-09
. O 0 1.62009161641663e-08

Dysfunction O 0 0.009185713715851307
of O 0 7.273309847732889e-07
this O 0 7.775859955927444e-10
pathway O 0 4.015372923049654e-09
may O 0 8.671021539674584e-11
be O 0 6.785716433199696e-11
a O 0 1.026740012455285e-10
general O 0 1.3373348262124551e-10
phenomenon O 0 3.2755129164563357e-10
in O 0 6.191248902442936e-12
the O 0 8.801088330345763e-11
majority O 0 9.181365737132019e-12
of O 0 8.50136280816649e-11
cases O 0 1.355793394219873e-10
of O 0 5.788286117081043e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.090741161950518e-09
. O 0 1.2497911150433083e-08

A O 0 4.148453172092559e-06
novel O 0 7.898302669673285e-07
Arg362Ser O 0 1.313086522714002e-05
mutation O 0 4.417322951866254e-09
in O 0 2.967929235708766e-10
the O 0 4.425976030120182e-09
sterol O 0 1.118682462220022e-06
27 O 0 1.7427991849672253e-07
- O 0 4.5373283796834585e-07
hydroxylase O 0 1.3516034414351452e-05
gene O 0 3.029444073376908e-08
( O 0 9.650229504387653e-10
CYP27 O 1 0.9999983310699463
) O 0 3.5033978496024076e-10
: O 0 2.425482037438087e-11
its O 0 7.37330335676134e-11
effects O 0 8.185737421229078e-09
on O 0 2.458366843427484e-09
pre O 0 6.353030101990953e-08
- O 0 1.1197287541619971e-08
mRNA O 0 2.0120440868964806e-09
splicing O 0 7.553143110961003e-10
and O 0 2.0647331067102925e-10
enzyme O 0 1.2757292999765468e-09
activity O 0 3.7116016926574957e-09
. O 0 1.6031053817755492e-08

A O 0 1.75538423263788e-06
novel O 0 8.3445797827153e-08
C O 0 4.5227000811109974e-08
to O 0 4.423830191058187e-10
A O 0 2.646665819838745e-08
mutation O 0 8.429965614453749e-10
in O 0 1.4383016999630627e-10
the O 0 5.060700303261001e-09
sterol O 0 7.741282956885698e-07
27 O 0 8.955261421306204e-08
- O 0 2.4513684593330254e-07
hydroxylase O 0 3.9212850424519274e-06
gene O 0 7.687984471260734e-09
( O 0 5.040439732262314e-10
CYP27 O 1 0.9992383718490601
) O 0 3.5246444651804154e-10
was O 0 1.4793808400526132e-09
identified O 0 5.904591399152892e-11
by O 0 3.2484778755836885e-11
sequencing O 0 8.899458947553285e-09
amplified O 0 3.392212022390595e-07
CYP27 O 1 0.9999874830245972
gene O 0 7.855527783817706e-09
products O 0 7.137358259967641e-09
from O 0 2.027928241998822e-10
a O 0 6.548093178793124e-10
patient O 0 1.6644932099296739e-09
with O 0 6.731025181672123e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 4.402026547722926e-07
CTX B-Disease 1 0.9999997615814209
) O 0 5.824244908581022e-08
. O 0 1.4116336899405724e-07

The O 0 5.010529093851801e-07
mutation O 0 7.544079494437028e-08
changed O 0 8.165979892282849e-09
the O 0 8.818505037311297e-09
adrenodoxin O 0 1.323618448623165e-06
cofactor O 0 4.28251079043207e-09
binding O 0 1.2009979677429783e-08
residue O 0 1.8017742320353136e-07
362Arg O 0 6.246726229619526e-07
to O 0 1.3057788628145772e-08
362Ser O 0 1.3398605915426742e-05
( O 0 5.0843492971353044e-08
CGT O 1 0.9994250535964966
362Arg O 0 9.840580787567887e-06
to O 0 5.7097423677987535e-08
AGT O 1 1.0
362Ser O 0 1.1063858664783766e-06
) O 0 2.043728242195897e-10
, O 0 4.8786547718338014e-11
and O 0 6.902390464746944e-11
was O 0 1.6549077663796652e-09
responsible O 0 8.650410388000296e-10
for O 0 5.36618527391397e-10
deficiency O 0 6.989339453866705e-07
in O 0 2.3596922194002445e-09
the O 0 1.400356950398418e-07
sterol O 0 3.3448395697632805e-06
27 O 0 9.024655156508743e-08
- O 0 7.636938192945308e-08
hydroxylase O 0 1.0116274324900587e-06
activity O 0 1.9402561779457983e-09
, O 0 3.7355535331684564e-11
as O 0 1.8506867913159475e-11
confirmed O 0 1.109281156513875e-11
by O 0 2.0168065134607005e-11
expression O 0 1.0118178517259935e-09
of O 0 9.139150769499338e-09
mutant O 0 7.727962270109856e-08
cDNA O 0 6.391605467115369e-09
into O 0 1.4787179258846095e-09
COS O 0 4.628241185855586e-06
- O 0 4.8478938197149546e-08
1 O 0 7.260496204253286e-08
cells O 0 1.2037860708247194e-09
. O 0 5.31059374253573e-09

Quantitative O 0 3.377085988631734e-07
analysis O 0 5.917277223765893e-10
showed O 0 2.1674566308416132e-10
that O 0 1.0060512319054471e-11
the O 0 5.969537641981049e-10
expression O 0 6.05240468853907e-10
of O 0 3.4907861046207245e-09
CYP27 O 0 0.00013695326924789697
gene O 0 4.734269087869336e-10
mRNA O 0 6.836527455256203e-10
in O 0 8.066418366592387e-11
the O 0 2.759422690346014e-09
patient O 0 8.983999322254022e-09
represented O 0 6.1003428974970575e-09
52 O 0 1.6534799840428605e-07
. O 0 1.1654350373646594e-07

5 O 0 1.0255241278400717e-07
% O 0 1.945162253491617e-09
of O 0 6.2335483441700035e-09
the O 0 9.321378335869213e-09
normal O 0 1.1075412231775772e-07
level O 0 8.071261703435084e-08
. O 0 1.079108997714684e-07

As O 0 7.803607360301612e-08
the O 0 1.3445640156817262e-08
mutation O 0 2.429364487355201e-09
occurred O 0 1.0898183466778733e-09
at O 0 1.1315579584447732e-09
the O 0 1.5787053886384683e-09
penultimate O 0 2.087703343534031e-08
nucleotide O 0 2.063954562814274e-09
of O 0 2.6000629205213954e-08
exon O 0 1.210158302455966e-07
6 O 0 4.006202658501934e-08
( O 0 6.16205905745737e-11
- O 0 4.996306479654322e-09
2 O 0 5.5263162934693355e-09
position O 0 5.2222608459828734e-09
of O 0 6.443836131353464e-09
exon O 0 2.0288825908210129e-07
6 O 0 1.312693882482563e-07
- O 0 2.440102946366096e-07
intron O 0 3.041794514047069e-07
6 O 0 2.0180062065833226e-08
splice O 0 4.725881019851386e-09
site O 0 3.316963093080716e-10
) O 0 1.6642154668233822e-11
of O 0 4.577404566497023e-10
the O 0 9.202905659755345e-10
gene O 0 4.260137520528673e-10
, O 0 2.399970777666738e-10
we O 0 2.1657706184008418e-10
hypothesized O 0 9.196483574669401e-10
that O 0 1.91216001366179e-11
the O 0 1.3909616791707435e-09
mutation O 0 3.0645095350223528e-09
may O 0 4.572735801122718e-10
partially O 0 4.11467588889991e-08
affect O 0 1.2611938160489444e-09
the O 0 9.688960744824726e-10
normal O 0 3.1173300052422803e-10
splicing O 0 1.177792030571112e-10
efficiency O 0 8.871118839515191e-10
in O 0 2.369572593696745e-10
exon O 0 2.810694965660332e-08
6 O 0 2.193058534771808e-08
and O 0 1.5024025357135429e-09
cause O 0 1.6180711215341148e-09
alternative O 0 3.1409946865679217e-10
splicing O 0 1.6810929037713862e-10
elsewhere O 0 1.1306684755130192e-10
, O 0 4.0465141654122405e-11
which O 0 1.6071564218345102e-11
resulted O 0 9.652291188544382e-10
in O 0 7.692715214835388e-11
decreased O 0 3.295561379346168e-09
transcript O 0 1.9005848006514725e-09
in O 0 7.252793920997647e-10
the O 0 5.7210687742781374e-08
patient O 0 1.2201300592096231e-07
. O 0 7.905071441882683e-08

Transfection O 0 1.2621734413187369e-06
of O 0 1.0505166869734239e-07
constructed O 0 6.58425562960474e-08
minigenes O 0 8.148283541231649e-07
, O 0 2.1595830679288497e-10
with O 0 2.0467270239743485e-11
or O 0 1.565352708565726e-10
without O 0 2.5339555453918194e-10
the O 0 9.92573023772536e-10
mutation O 0 8.441163878991631e-10
, O 0 2.8541047303320966e-10
into O 0 1.5421729449016652e-09
COS O 0 1.73872358573135e-05
- O 0 2.4484753780029678e-08
1 O 0 6.112339523411947e-09
cells O 0 1.0979166360780557e-11
confirmed O 0 1.1893587677225259e-11
that O 0 3.089005396958444e-12
the O 0 7.719646588633111e-10
mutant O 0 7.292361914323919e-08
minigene O 0 9.642902796258568e-07
was O 0 7.941519442056233e-09
responsible O 0 1.7103279903452062e-09
for O 0 3.229907730162296e-10
a O 0 1.0126286476008772e-09
mRNA O 0 1.0381031145811903e-08
species O 0 3.8225517196011083e-10
alternatively O 0 3.951725613404733e-09
spliced O 0 1.919017300622272e-08
at O 0 3.7485334836162565e-09
an O 0 1.7282129061158003e-09
activated O 0 5.659994144480152e-07
cryptic O 0 6.299432016021456e-07
5 O 0 8.31839130910339e-08
splice O 0 3.801724517416005e-07
site O 0 1.1292465273982089e-07
88 O 0 2.412919570815575e-07
bp O 0 2.4204577897535273e-08
upstream O 0 1.0780162540413585e-08
from O 0 1.1229229351927827e-10
the O 0 9.469554029806204e-10
3 O 0 6.2678848777864005e-09
end O 0 3.5224152483692706e-09
of O 0 1.8167018112080768e-08
exon O 0 1.257401436305372e-06
6 O 0 1.1924608998015174e-06
. O 0 2.0386384846915462e-07

Our O 0 1.6799479851670185e-07
data O 0 2.5630100264351086e-09
suggest O 0 1.7957781095478964e-10
that O 0 8.179856965384591e-12
the O 0 2.918167651966286e-10
C O 0 1.0308933262592745e-08
to O 0 3.7081748782696877e-10
A O 0 3.0035764098101936e-08
mutation O 0 1.9584178723164314e-10
at O 0 3.9810768570625044e-10
the O 0 4.866575475936941e-10
penultimate O 0 8.15709011448007e-09
nucleotide O 0 2.9077279473099793e-10
of O 0 2.0711397041850432e-09
exon O 0 1.463491106079573e-08
6 O 0 9.04238195431617e-09
of O 0 4.499620676057248e-09
the O 0 5.809552394708817e-09
CYP27 O 1 0.9999407529830933
gene O 0 6.091224746818114e-10
not O 0 3.2899936247554606e-11
only O 0 3.184771890651916e-11
causes O 0 4.0183359417689246e-10
the O 0 1.1293457280459052e-09
deficiency B-Disease 0 8.110583138432048e-08
in I-Disease 0 1.1536844812809477e-09
the I-Disease 0 2.378931185376132e-08
sterol I-Disease 0 8.166542215803929e-07
27 I-Disease 0 5.575752837216896e-08
- I-Disease 0 6.279793751673424e-08
hydroxylase I-Disease 0 7.989514756445715e-07
activity I-Disease 0 2.0079726770205752e-09
, O 0 5.92476276373155e-11
but O 0 5.914341238977272e-11
also O 0 7.645749033891036e-10
partially O 0 1.0306577991059385e-07
leads O 0 5.279363612942234e-10
to O 0 9.031375647339246e-11
alternative O 0 5.071907338560777e-10
pre O 0 1.0465724287200828e-08
- O 0 4.05107458689713e-09
mRNA O 0 1.3782457397581993e-09
splicing O 0 1.4973505768622886e-09
of O 0 2.0380965803923345e-09
the O 0 8.651635852174877e-09
gene O 0 1.854760611763595e-08
. O 0 5.795820001708307e-08

To O 0 2.5009043724821822e-08
our O 0 4.790616348060439e-09
knowledge O 0 2.0864275585008585e-10
, O 0 2.6990992774145184e-11
this O 0 4.242294016076897e-12
is O 0 3.17208932731905e-11
the O 0 1.5672946274136734e-10
first O 0 3.4832622897162935e-10
report O 0 2.5477189802280975e-10
regarding O 0 2.9660349731841507e-09
effects O 0 4.830909716702081e-08
on O 0 7.0084196224229345e-09
pre O 0 4.596130764866757e-08
- O 0 6.091645854411354e-09
mRNA O 0 4.5532319581376157e-10
splicing O 0 2.474270233143727e-10
of O 0 5.853740825401132e-10
a O 0 9.819522278631254e-11
mutation O 0 3.6817097981423075e-11
at O 0 8.239865734172014e-11
the O 0 1.8328144557600012e-10
- O 0 5.515059520178056e-09
2 O 0 5.076749243215772e-09
position O 0 2.8465165780033885e-09
of O 0 4.009839127405712e-09
a O 0 3.773597434530984e-09
5 O 0 4.638606654339128e-08
splice O 0 4.783442477673816e-07
site O 0 1.889857230708003e-07
. O 0 1.2698750140316406e-07

ATM O 0 0.0014462301041930914
germline O 0 1.0216024747933261e-05
mutations O 0 8.99574885693255e-08
in O 0 2.907446505773237e-09
classical O 1 0.6534894108772278
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 2.287359990305049e-07
in O 0 5.011438833357751e-11
the O 0 3.9445394173220905e-10
Dutch O 0 2.6735111191555916e-07
population O 0 4.111941342976877e-10
. O 0 3.920501701060175e-09

Germline O 0 1.3219457287050318e-05
mutations O 0 3.2476464184583165e-08
in O 0 9.475317197527033e-10
the O 0 5.063229835400307e-09
ATM O 0 8.771971238275e-07
gene O 0 3.1068472794437696e-10
are O 0 1.7231973226811137e-12
responsible O 0 1.7182978997998255e-11
for O 0 1.1848845689332865e-11
the O 0 1.3297872669681965e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.277299060438054e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 9.430751291006345e-09
. O 0 2.5557083560556748e-08

In O 0 2.089663375670625e-08
our O 0 2.7665265633913805e-09
study O 0 8.979913340700918e-11
, O 0 3.18387261000197e-11
we O 0 1.4771293563309307e-11
have O 0 2.5372271558049553e-12
determined O 0 1.0161824159915511e-10
the O 0 4.757823024448271e-10
ATM O 0 5.260051239019958e-07
mutation O 0 2.322306569269017e-09
spectrum O 0 4.048263502198779e-09
in O 0 3.314123420139481e-10
19 O 0 1.140109429087488e-08
classical O 0 3.8353359599341275e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.3795516668201344e-09
, O 0 1.0563334928992418e-11
including O 0 1.4436604689471721e-11
some O 0 9.900289789366301e-12
immigrant O 0 1.923683261295661e-11
populations O 0 1.013222665491309e-11
, O 0 4.7004782878501405e-12
as O 0 1.1290151105680657e-11
well O 0 4.6471895776001304e-11
as O 0 8.382054772493319e-11
12 O 0 6.191586132686666e-10
of O 0 8.138345553021509e-10
Dutch O 0 4.4917734953742183e-07
ethnic O 0 1.1796908339078982e-08
origin O 0 2.7673552338569607e-09
. O 0 9.373777309917841e-09

Both O 0 6.587873713215231e-08
the O 0 3.3721970993383366e-08
protein O 0 4.494328909032674e-09
truncation O 0 6.201637603453491e-08
test O 0 6.268338736958867e-09
( O 0 1.5154515420334747e-09
PTT O 0 7.671225466765463e-05
) O 0 7.741409735473326e-10
and O 0 7.994098161212548e-10
the O 0 1.6914728506733923e-09
restriction O 0 1.011000261286199e-08
endonuclease O 0 7.73778552343174e-08
fingerprinting O 0 2.8080156866394645e-08
( O 0 3.5912289808592845e-10
REF O 0 3.839757596324489e-07
) O 0 8.42531166361793e-12
method O 0 5.259899720638783e-12
were O 0 7.128282881498083e-13
used O 0 3.0428090602718783e-12
and O 0 1.208973546273917e-11
compared O 0 1.7243916364262368e-11
for O 0 1.16511600714575e-11
their O 0 7.856534867123344e-12
detection O 0 2.2673543598195067e-10
efficiency O 0 3.745372068042485e-10
, O 0 1.7994114878683298e-11
identifying O 0 1.2647728697690042e-10
76 O 0 1.1373613162390939e-09
% O 0 3.758536017139935e-12
and O 0 9.526373613566452e-12
60 O 0 1.7497378546060816e-10
% O 0 1.626336738891343e-11
of O 0 2.042827851322926e-10
the O 0 2.297042112076042e-09
mutations O 0 1.444350528068128e-09
, O 0 7.44549422115881e-10
respectively O 0 8.650843597024505e-09
. O 0 8.235164727921074e-08

Most O 0 4.776686424179388e-08
patients O 0 4.8139279229530985e-09
were O 0 1.2503287294407528e-10
found O 0 7.813172331339047e-11
to O 0 1.9767014414195927e-10
be O 0 8.743185064830072e-10
compound O 0 4.078273008190081e-08
heterozygote O 0 9.918582009049715e-07
. O 0 8.593026734615705e-08

Seventeen O 0 6.591331839445047e-06
mutations O 0 6.472772096088875e-09
were O 0 1.746163907911935e-10
distinct O 0 1.751901818058954e-10
, O 0 1.2132980384271796e-11
of O 0 9.696869002207009e-11
which O 0 6.942432306117352e-12
10 O 0 1.3421644351474527e-10
were O 0 2.8586140399244897e-11
not O 0 4.9391105788609835e-11
reported O 0 8.853082711368643e-10
previously O 0 2.3176134789082425e-07
. O 0 2.8398918061611766e-07

Mutations O 0 7.014894549683959e-07
are O 0 1.2956707928779565e-09
small O 0 6.835840338226262e-09
deletions O 0 1.693706934702277e-07
or O 0 1.7235262106396476e-08
point O 0 9.429744523004047e-07
mutations O 0 9.010723545088695e-08
frequently O 0 2.090229500595342e-08
affecting O 0 2.824520493049931e-07
splice O 0 1.4946597275411477e-06
sites O 0 2.2134487664970948e-07
. O 0 1.327918113247506e-07

Moreover O 0 3.997189139681723e-07
, O 0 1.6324616325391617e-08
a O 0 1.1492332419038576e-08
16 O 0 1.1719115633468391e-07
. O 0 1.0138064965303784e-07

7 O 0 2.1207554254942806e-06
- O 0 1.2245066045579733e-06
kb O 0 2.331131781829754e-06
genomic O 0 2.983028579706115e-08
deletion O 0 3.6625016353042383e-09
of O 0 1.955447803680954e-09
the O 0 6.581311606801421e-10
3 O 0 8.084134472952087e-10
end O 0 2.2782525865849834e-10
of O 0 3.542403315126563e-10
the O 0 2.852542646536449e-10
gene O 0 7.253786460381662e-11
, O 0 3.2567785274162375e-11
most O 0 6.094487414731731e-11
likely O 0 1.1437760460975e-10
a O 0 4.0940962425795036e-11
result O 0 1.173943581234127e-10
of O 0 5.498745347942702e-10
recombination O 0 2.4711326734871975e-11
between O 0 5.440799200062685e-11
two O 0 7.475600694029083e-11
LINE O 0 2.212967586956438e-07
elements O 0 1.45199341439195e-09
, O 0 1.476651301235421e-10
was O 0 6.258101148404194e-09
identified O 0 7.094604015378536e-09
. O 0 8.388175842810597e-08

The O 0 1.060866381408232e-07
most O 0 1.1116438880520718e-09
frequently O 0 3.3776523244988255e-10
found O 0 3.5523344682486524e-11
mutation O 0 6.074073882755826e-11
, O 0 3.582408675262272e-11
identified O 0 3.810756918354308e-11
in O 0 5.059228730397436e-11
three O 0 2.0274797118968735e-10
unrelated O 0 4.3947840921987336e-09
Turkish O 0 3.200065989972245e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 1.5102914752151975e-10
, O 0 4.2970543789877524e-11
was O 0 1.0000641426088919e-09
previously O 0 1.2640788416007354e-09
described O 0 7.699672843752836e-11
to O 0 8.484370150885212e-11
be O 0 8.659567507507404e-11
a O 0 2.543135979582445e-10
Turkish O 0 2.458462518006854e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 3.372532228240743e-05
mutation O 0 5.211219331613393e-07
. O 0 4.1032571118648775e-08

The O 0 6.721870704495814e-08
presence O 0 2.667016829605018e-08
of O 0 3.0665316330669157e-07
a O 0 3.413249061168244e-08
founder O 0 1.7942842589491192e-07
mutation O 0 2.365410312066274e-09
among O 0 5.883737247414089e-11
relatively O 0 4.3057012816261064e-11
small O 0 5.4096831181293936e-11
ethnic O 0 4.731919717171351e-11
population O 0 4.0539731402562673e-13
groups O 0 1.3886128033026301e-13
in O 0 3.763284822655422e-12
Western O 0 4.138356324290271e-09
Europe O 0 2.158970779930769e-09
could O 0 5.633805644222889e-10
indicate O 0 2.197142606741309e-10
a O 0 2.2975053803886425e-10
high O 0 6.331459356800906e-09
carrier O 0 3.9097244886043825e-10
frequency O 0 5.818920345568301e-10
in O 0 2.0854566684658238e-10
such O 0 6.986504708095254e-09
communities O 0 2.944347166078387e-08
. O 0 7.160021908703129e-08

In O 0 6.276199115973213e-09
patients O 0 6.090062898422843e-10
of O 0 4.4311176949918263e-10
Dutch O 0 1.027915175200178e-07
ethnic O 0 2.6836596833668125e-10
origin O 0 9.438798700966977e-12
, O 0 1.7290674100833847e-12
however O 0 7.539547978996364e-12
, O 0 1.0423798629810577e-10
no O 0 9.378298138074115e-10
significant O 0 8.926948957821423e-09
founder O 0 3.347933130726233e-08
effect O 0 3.155631844720119e-08
could O 0 2.0973891512454657e-09
be O 0 7.485506658966301e-10
identified O 0 7.284837622023588e-09
. O 0 5.305999906113357e-08

The O 0 1.6347510722880543e-07
observed O 0 1.9835393771927556e-08
genetic O 0 4.5043870855465684e-09
heterogeneity O 0 1.4536539971743423e-08
including O 0 6.970355403979056e-10
the O 0 1.8228029086131414e-09
relative O 0 1.9229879910653835e-09
high O 0 6.866970636565384e-08
percentage O 0 1.1615122197383698e-08
of O 0 1.8088739395238917e-08
splice O 0 4.27238830980059e-07
- O 0 2.94165914738187e-07
site O 0 3.3907397778421e-08
mutations O 0 8.336002110809204e-09
had O 0 1.2060774601252433e-09
no O 0 6.102318095280168e-10
reflection O 0 2.2993740245169647e-09
on O 0 3.448051844046063e-09
the O 0 1.4105081547199916e-08
phenotype O 0 1.460148695286989e-07
. O 0 8.494583880747086e-08

All O 0 1.322828069305615e-07
patients O 0 7.596272055820918e-09
manifested O 0 5.773122424557187e-09
classical O 0 2.2162954138593705e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
and O 0 1.7471551316816658e-08
increased O 0 2.267183774051773e-08
cellular O 0 2.4840513646040563e-08
radioresistant O 0 1.63334516400937e-06
DNA O 0 6.954532238978572e-08
synthesis O 0 3.4096050427478986e-08
. O 0 1.966418672338932e-08

Determination O 0 2.062914518319303e-06
of O 0 1.55685100367009e-07
the O 0 6.834458332605209e-09
genomic O 0 1.1063900906549406e-08
structure O 0 2.665266229939789e-09
of O 0 5.653431500718398e-09
the O 0 5.663695734625662e-09
COL4A4 O 1 0.9999220371246338
gene O 0 8.566017895006439e-10
and O 0 1.4170700723958873e-10
of O 0 6.820368270155086e-09
novel O 0 2.9233847271825653e-06
mutations O 0 4.00681710743811e-06
causing O 0 2.6442130547366105e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.300023652423988e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 3.2766917001936235e-07
a O 0 4.7121123003535104e-08
progressive O 1 0.9953141212463379
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 2.1279070097079966e-06
by O 0 2.0663257771502686e-09
glomerular B-Disease 1 0.9999982118606567
basement I-Disease 1 0.999699592590332
membrane I-Disease 0 3.9002869016258046e-05
abnormalities I-Disease 1 0.9999967813491821
and O 0 6.85272949496607e-10
associated O 0 6.550966435980854e-10
with O 0 1.9653405292086035e-10
mutations O 0 7.75033315303375e-10
in O 0 5.76327006951427e-11
either O 0 5.709420713984059e-10
the O 0 2.4804753806506596e-09
COL4A3 O 1 1.0
or O 0 1.685116268745901e-09
the O 0 5.0440678300844866e-09
COL4A4 O 1 0.9447343349456787
gene O 0 4.97516472464099e-10
, O 0 5.886027082402379e-11
which O 0 1.8956227212929555e-11
encode O 0 1.6270698677267603e-10
the O 0 1.2574610241955497e-09
alpha3 O 0 1.5257651284628082e-06
and O 0 1.2178766439774336e-08
alpha4 O 0 3.1518167816102505e-05
type O 0 1.381159745506011e-05
IV O 1 1.0
collagen O 1 1.0
chains O 0 5.132412115926854e-05
, O 0 8.03707855823177e-09
respectively O 0 3.522349700801897e-08
. O 0 6.29845828825637e-08

To O 0 1.0136804284854861e-08
date O 0 9.177790971648392e-09
, O 0 2.802822418601636e-10
mutation O 0 3.5141507759295365e-11
screening O 0 2.435942558776105e-10
in O 0 6.146025355313611e-11
the O 0 1.1173173497525113e-09
two O 0 2.492530071229737e-10
genes O 0 2.577514590651475e-10
has O 0 9.559323471686199e-11
been O 0 1.2338731425476368e-10
hampered O 0 2.8508756244605138e-08
by O 0 8.640544529869842e-11
the O 0 1.590319653743677e-09
lack O 0 3.6976250950004896e-09
of O 0 6.4346004080562125e-09
genomic O 0 5.257523127966124e-08
structure O 0 2.234304474768578e-08
information O 0 2.7908424460321157e-09
. O 0 3.418917771114138e-08

We O 0 9.772372244754024e-09
report O 0 3.513341562122463e-10
here O 0 1.6150662404679217e-11
the O 0 1.831542417729537e-10
complete O 0 1.8748652630407037e-10
characterization O 0 1.2972979357428471e-09
of O 0 4.67471794607377e-09
the O 0 1.094194956863248e-08
48 O 0 3.313741459010089e-08
exons O 0 1.391044524012841e-08
of O 0 8.648339644423686e-08
the O 0 2.335006854536914e-07
COL4A4 O 1 1.0
gene O 0 4.341943249386304e-09
, O 0 2.3628571321765435e-10
a O 0 1.3574363855184401e-10
comprehensive O 0 2.1591024523814895e-09
gene O 0 8.810292079219906e-11
screen O 0 2.43906805863503e-09
, O 0 5.562243721168869e-11
and O 0 4.787168578213041e-11
the O 0 8.051262434527473e-11
subsequent O 0 1.5689397003804118e-10
detection O 0 7.241128252566398e-10
of O 0 9.429415026573906e-10
10 O 0 1.3923179276176256e-09
novel O 0 7.778504063082892e-09
mutations O 0 6.817945652493052e-10
in O 0 1.5196007646656184e-11
eight O 0 6.820599085521906e-10
patients O 0 5.851753526187053e-10
diagnosed O 0 1.5382665807806006e-08
with O 0 1.4657483227153989e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 7.277604368027824e-07

Furthermore O 0 4.1356685187565745e-07
, O 0 1.0460795785149912e-08
we O 0 1.6463631569152426e-09
identified O 0 1.9002004414403473e-09
a O 0 1.2563798890141697e-09
glycine O 0 4.669611364249704e-09
to O 0 6.737974622694765e-10
alanine O 0 2.432889800729754e-08
substitution O 0 3.136117365798441e-09
in O 0 5.939644331931504e-10
the O 0 1.1400333121969197e-08
collagenous O 0 2.1632893094647443e-06
domain O 0 2.9764852804703423e-09
that O 0 3.312264004740051e-11
is O 0 1.3620476968512207e-10
apparently O 0 7.19539150484394e-10
silent O 0 1.4949199211855557e-08
in O 0 1.493613011049888e-10
the O 0 2.117688913116922e-09
heterozygous O 0 9.33838562033884e-10
carriers O 0 1.7537941932044276e-10
, O 0 1.0880295969739606e-10
in O 0 2.925758524341404e-10
11 O 0 4.1035622899698865e-08
. O 0 6.698717669451071e-08

5 O 0 2.0576587544951508e-08
% O 0 3.760863287460836e-10
of O 0 3.196945486116931e-10
all O 0 5.48601407357463e-11
control O 0 1.0789042992342956e-09
individuals O 0 8.790983566098198e-12
, O 0 1.6790764958973803e-11
and O 0 8.47552306115773e-11
in O 0 1.0442324782644619e-10
one O 0 5.095109889552418e-10
control O 0 1.691054407615411e-08
individual O 0 8.764841630259923e-10
homozygous O 0 5.070730058065465e-09
for O 0 1.6975190697543496e-10
this O 0 1.7322249190598882e-10
glycine O 0 2.3110446889518244e-08
substitution O 0 6.237439720280236e-08
. O 0 5.3818734357946596e-08

There O 0 2.0863657468339625e-08
has O 0 6.167847343974131e-10
been O 0 3.267557058261872e-10
no O 0 1.8845132399025744e-10
previous O 0 7.799611512204763e-10
finding O 0 8.227086789602822e-10
of O 0 1.5238513784154861e-09
a O 0 4.768953010270138e-10
glycine O 0 6.340277192151689e-10
substitution O 0 3.8648970135390925e-10
that O 0 1.6233306365798228e-11
is O 0 2.1707571504214762e-11
not O 0 2.1372810205672055e-12
associated O 0 1.320957232486819e-11
with O 0 3.148965116439584e-11
any O 0 2.6561721711004793e-09
obvious O 0 1.3953653343889982e-08
phenotype O 0 2.8554674180725215e-09
in O 0 1.1606212657611081e-09
homozygous O 0 3.0201729828149837e-07
individuals O 0 3.8565484139496675e-09
. O 0 4.732008207497529e-08

Founder O 0 0.00024958018912002444
BRCA1 O 0 7.333882876991993e-06
and O 0 1.6212899822676263e-07
BRCA2 O 0 5.062444870418403e-06
mutations O 0 2.7103999045152705e-09
in O 0 1.1274017136519987e-10
French O 0 3.277154121406056e-07
Canadian O 0 2.3710570076218573e-06
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.452728268906526e-10
. O 0 2.5278406035056378e-09

We O 0 1.0021764751400042e-08
have O 0 6.332563640132349e-11
identified O 0 9.930894301346527e-11
four O 0 4.329600220009944e-11
mutations O 0 3.038154103296442e-11
in O 0 1.129749679223968e-11
each O 0 5.865719021613813e-11
of O 0 7.566671733627572e-09
the O 0 1.668713025537727e-07
breast B-Disease 1 1.0
cancer I-Disease 0 4.603984507411951e-06
- O 0 1.8077982133490877e-07
susceptibility O 0 9.861297201041452e-08
genes O 0 2.647051744464335e-10
, O 0 4.5432879680618043e-11
BRCA1 O 0 3.4678118154829463e-09
and O 0 3.220508026924307e-10
BRCA2 O 0 7.22700548294597e-08
, O 0 2.3090583264884224e-11
in O 0 1.715802500079633e-11
French O 0 6.188852097466224e-08
Canadian O 0 2.9829379855073057e-07
breast B-Disease 1 0.9999970197677612
cancer I-Disease 0 0.0014887757133692503
and O 0 1.179541726514799e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.2583804538143255e-11
from O 0 7.067746388145224e-11
Quebec O 0 1.2704069831670495e-06
. O 0 3.218141131355878e-08

To O 0 9.961166824723477e-08
identify O 0 1.629909576195132e-07
founder O 0 2.151320330767703e-07
effects O 0 0.0001489813148509711
, O 0 6.903108307199091e-09
we O 0 6.891369697115124e-10
examined O 0 3.927912217704943e-09
independently O 0 4.2995160209891026e-10
ascertained O 0 2.4860469238774385e-08
French O 0 1.4562903771775382e-08
Canadian O 0 4.368008621469244e-09
cancer B-Disease 0 2.15057016639264e-09
families O 0 7.928850718347258e-13
for O 0 1.0854706890273125e-12
the O 0 1.0775541917085185e-11
distribution O 0 4.134218314910676e-11
of O 0 7.482965913574446e-10
these O 0 9.54140433329087e-10
eight O 0 1.0114709070307981e-08
mutations O 0 4.5582243757280594e-08
. O 0 5.710744233056175e-08

Mutations O 0 1.699630587381762e-07
were O 0 1.207117739099317e-09
found O 0 2.598290471667042e-10
in O 0 1.385213194149415e-10
41 O 0 8.516464866659135e-09
of O 0 7.548134561830011e-09
97 O 0 1.1793819965078001e-07
families O 0 1.8593102057984368e-10
. O 0 2.0993393690105222e-08

Six O 0 9.630765873680502e-08
of O 0 4.174588852379202e-08
eight O 0 8.652592420332894e-09
mutations O 0 1.1278733502706473e-09
were O 0 1.1213776435203826e-10
observed O 0 5.122168800220095e-10
at O 0 2.205145843703349e-09
least O 0 6.61221410958035e-10
twice O 0 1.1031261237803847e-08
. O 0 7.400760893006009e-08

The O 0 6.5109757088066544e-06
BRCA1 O 0 2.3675031115999445e-05
C4446T O 0 1.4204591025190894e-05
mutation O 0 2.4120515362824335e-08
was O 0 3.531779535492774e-09
the O 0 9.494602881687797e-10
most O 0 2.4809712617646085e-10
common O 0 2.2231690099960844e-10
mutation O 0 1.9933452111153827e-10
found O 0 7.540356533608517e-11
, O 0 7.637480925470896e-11
followed O 0 3.6101013844991314e-10
by O 0 2.779759200599585e-10
the O 0 1.6571124206166132e-07
BRCA2 O 0 1.5008822629170027e-05
8765delAG O 0 5.854265964444494e-06
mutation O 0 2.1863202448457741e-07
. O 0 6.814376263264421e-08

Together O 0 1.7817743724890533e-08
, O 0 1.1957653756056175e-09
these O 0 1.4976810069899926e-10
mutations O 0 1.2093202828022953e-10
were O 0 1.78124841265781e-11
found O 0 1.427900419431749e-11
in O 0 2.136597322677236e-11
28 O 0 2.715916380680028e-09
of O 0 1.3714538393827524e-09
41 O 0 3.2761331425490425e-09
families O 0 2.2971921673914375e-12
identified O 0 4.1443085074810426e-11
to O 0 1.2097331469895778e-10
have O 0 2.719372504955686e-10
a O 0 1.0529435989781177e-08
mutation O 0 1.0534542838058769e-07
. O 0 9.152516611266037e-08

The O 0 9.40137283578224e-08
odds O 0 1.0919166726353069e-07
of O 0 2.1879265066360176e-09
detection O 0 4.363728489664709e-09
of O 0 3.884587318481181e-09
any O 0 1.1429850399480301e-09
of O 0 3.791620351023539e-09
the O 0 5.5998259362866065e-09
four O 0 4.436490286252592e-09
BRCA1 O 0 4.195614522473079e-08
mutations O 0 1.9403560980180146e-09
was O 0 1.1532648613865604e-08
18 O 0 6.16914661577539e-08
. O 0 5.55784076539112e-08

7x O 0 0.00029724204796366394
greater O 0 2.742780509379372e-07
if O 0 2.1991226617501525e-09
one O 0 1.5311313328325582e-10
or O 0 1.3172838687902644e-11
more O 0 1.2949228278200109e-12
cases O 0 9.542527878991791e-11
of O 0 7.639501404810289e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.8185061789743884e-10
also O 0 8.917575879119344e-12
present O 0 1.3973395357469443e-11
in O 0 2.8252993694577455e-11
the O 0 2.2593777959656336e-09
family O 0 7.527187761979803e-09
. O 0 5.4934460536060215e-08

The O 0 1.512364775635433e-07
odds O 0 1.394139417243423e-07
of O 0 2.401304266541615e-09
detection O 0 6.776359029458945e-09
of O 0 2.477506200193602e-09
any O 0 7.340275609557523e-10
of O 0 5.984508888445816e-09
the O 0 1.4280959526047354e-08
four O 0 2.3411246274918085e-08
BRCA2 O 0 9.210918960889103e-07
mutations O 0 2.4996058556325806e-09
was O 0 6.536953200964035e-09
5 O 0 7.61692149353621e-08
. O 0 4.895524341463897e-08

3x O 0 3.131416815449484e-05
greater O 0 1.1084499362823408e-07
if O 0 1.250272108066497e-09
there O 0 7.264683299368357e-11
were O 0 4.394192995582635e-11
at O 0 1.5400734854065234e-10
least O 0 2.1381545839416205e-11
five O 0 1.236699805062802e-11
cases O 0 4.600579639468805e-11
of O 0 3.3773188690133793e-09
breast B-Disease 1 0.9931594133377075
cancer I-Disease 0 2.788253539165453e-07
in O 0 4.457251234768478e-10
the O 0 2.0770826836269407e-08
family O 0 1.913206304493542e-08
. O 0 4.5928008063356174e-08

Interestingly O 0 9.908034570571544e-08
, O 0 1.7377389527339915e-09
the O 0 1.5674599396220401e-09
presence O 0 3.4905600632129108e-09
of O 0 6.429106491623315e-08
a O 0 3.7233100158573507e-08
breast B-Disease 0 0.07392420619726181
cancer I-Disease 0 7.536758062087756e-07
case O 0 2.7759774479108046e-09
< O 0 4.042260304260026e-09
36 O 0 6.686712294978747e-10
years O 0 3.3514292036018745e-11
of O 0 5.626374921519073e-10
age O 0 6.890896742106634e-10
was O 0 2.0514531740012387e-10
strongly O 0 1.956971737437918e-11
predictive O 0 1.1947486333596657e-09
of O 0 3.0098240566545087e-10
the O 0 6.043957695434088e-11
presence O 0 5.3432636787364984e-11
of O 0 3.1152258550548595e-10
any O 0 2.596164949686397e-10
of O 0 1.386070036524245e-09
the O 0 2.4803430420661243e-09
eight O 0 8.694182263013772e-09
mutations O 0 1.1338227245971666e-08
screened O 0 2.405959378393163e-07
. O 0 1.0542401440716276e-07

Carriers O 0 3.149047955730566e-08
of O 0 1.4971057282764377e-08
the O 0 1.0707962294631557e-09
same O 0 9.526015393168663e-11
mutation O 0 9.457834515558261e-11
, O 0 1.2662204618152373e-11
from O 0 6.974511246315984e-12
different O 0 7.04833110279357e-12
families O 0 1.0525318680856821e-12
, O 0 2.0558939967108003e-11
shared O 0 1.5802620323412953e-10
similar O 0 4.14005191240463e-10
haplotypes O 0 1.9835422193636987e-09
, O 0 1.8383322641923883e-10
indicating O 0 7.43392902791129e-10
that O 0 4.117778687473539e-11
the O 0 1.9479802215727204e-09
mutant O 0 1.9824728525463797e-08
alleles O 0 6.126339713308226e-11
were O 0 2.6979824624406845e-11
likely O 0 2.6734505234604633e-11
to O 0 1.4984633325831886e-11
be O 0 1.7232408208722738e-11
identical O 0 4.897898406297507e-11
by O 0 1.275603928041491e-11
descent O 0 6.287434461960117e-10
for O 0 2.335155402377609e-10
a O 0 7.924251255175818e-10
mutation O 0 6.007126462925783e-10
in O 0 3.004283766205873e-10
the O 0 1.4013184390648803e-08
founder O 0 1.6460727181311086e-07
population O 0 1.6053351981071273e-09
. O 0 2.234014573332388e-08

The O 0 5.2261466265690615e-09
identification O 0 2.955542699467628e-09
of O 0 1.0271093309199841e-08
common O 0 8.05798805458835e-08
BRCA1 O 0 1.4764705156267155e-06
and O 0 1.9410127549690515e-07
BRCA2 O 0 1.4474047020485159e-05
mutations O 0 2.469655369097268e-09
will O 0 5.258438129374099e-11
facilitate O 0 9.043579773937438e-11
carrier O 0 9.187554883549609e-11
detection O 0 1.7352151937544136e-09
in O 0 1.9193154010554991e-10
French O 0 7.096040803844517e-07
Canadian O 0 5.762365731243335e-07
breast B-Disease 1 0.999996542930603
cancer I-Disease 0 0.024947119876742363
and O 0 6.452614798035938e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.54886203757232e-10
. O 0 1.2417875616677065e-09

Are O 0 1.0414294138172409e-07
Dp71 O 0 9.099673479795456e-05
and O 0 2.2713392411333189e-07
Dp140 O 0 0.00038382908678613603
brain O 0 1.1740055015252437e-05
dystrophin O 0 1.860564452726976e-06
isoforms O 0 1.0387963378377663e-08
related O 0 1.3090006412141975e-08
to O 0 1.5351880877645385e-09
cognitive B-Disease 0 0.03747854381799698
impairment I-Disease 1 0.9999886751174927
in O 0 3.3659193832136225e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 0 2.8067150196875446e-05

Molecular O 0 2.9561539349742816e-07
study O 0 1.2565644080808624e-09
and O 0 2.484555894355367e-10
neuropsychological O 0 1.3709635027225886e-07
analysis O 0 9.864500188916381e-11
were O 0 2.7153749734831756e-11
performed O 0 1.7901456705882168e-10
concurrently O 0 8.373362420099895e-11
on O 0 1.8769155674114302e-10
49 O 0 1.170349683832228e-08
patients O 0 3.5633632156084616e-10
with O 0 7.220278597230845e-09
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.0620102841585322e-07
DMD B-Disease 1 1.0
) O 0 3.415288885033618e-11
in O 0 6.935841224270378e-12
order O 0 7.376679128645591e-11
to O 0 5.056932650404633e-11
find O 0 8.070327045528458e-11
a O 0 2.5742706577513985e-11
molecular O 0 3.7565187072097217e-10
explanation O 0 8.69971386596724e-11
for O 0 5.23937594698598e-11
the O 0 3.921691416053363e-09
cognitive B-Disease 0 2.815459765770356e-06
impairment I-Disease 0 1.3924827726441436e-06
observed O 0 2.971267010209999e-09
in O 0 2.939081200636906e-10
most O 0 2.597356640876569e-08
DMD B-Disease 1 1.0
patients O 0 1.6317059703396808e-07
. O 0 3.107934887225383e-08

Complete O 0 5.7420471932800865e-08
analysis O 0 1.6911115841011792e-09
of O 0 1.1057424309512953e-08
the O 0 1.627034329487742e-08
dystrophin O 0 1.073285147867864e-06
gene O 0 2.3993311781822513e-09
was O 0 5.596569430110776e-09
performed O 0 2.5101647427305807e-09
to O 0 2.845169100318401e-10
define O 0 3.190721242773975e-09
the O 0 1.0265878147563967e-09
localization O 0 1.7277820063554827e-08
of O 0 2.700689449852689e-08
deletions O 0 4.5151324457037845e-08
and O 0 6.487715253911119e-09
duplications O 0 7.423380310456196e-08
in O 0 4.0615405483279687e-10
relation O 0 1.7802108676079342e-09
to O 0 3.5026359590517586e-10
the O 0 5.538134395521865e-09
different O 0 9.77587788497658e-09
DMD B-Disease 1 1.0
promoters O 0 1.4403848581423517e-05
. O 0 6.577515136996226e-07

Qualitative O 0 7.898498211034166e-07
analysis O 0 5.005301506599835e-09
of O 0 1.4100749901047038e-08
the O 0 9.952768387222477e-09
Dp71 O 0 2.9838479349564295e-06
transcript O 0 3.4102149992776276e-09
and O 0 4.5239895163362576e-10
testing O 0 3.1521876775464364e-10
for O 0 1.453929077827043e-11
the O 0 1.001823832225135e-10
specific O 0 1.5666969110927909e-10
first O 0 1.727882281699067e-10
exon O 0 1.9564708964026067e-08
of O 0 4.121784513699822e-08
Dp140 O 0 1.7886035266201361e-06
were O 0 1.004106464641552e-09
also O 0 4.653551710642745e-10
carried O 0 3.350665744861203e-09
out O 0 5.503091760061807e-09
. O 0 2.3406157012573203e-08

Neuropsychological O 0 4.235007145325653e-05
analysis O 0 1.1954124801150101e-08
assessed O 0 1.5766261185490293e-07
verbal O 0 5.645708611723421e-08
and O 0 6.463630075614901e-09
visuospatial O 0 6.383846198332321e-07
intelligence O 0 1.1170574465424465e-09
, O 0 2.1706765274132067e-09
verbal O 0 1.2359734569145076e-07
memory O 0 2.893416240112856e-05
, O 0 3.857239860849404e-09
and O 0 7.630673870551163e-09
reading O 0 1.99647297449701e-06
skills O 0 3.4856657293858007e-07
. O 0 1.1124615184598952e-07

Comparison O 0 3.852871088838583e-07
of O 0 1.6564771954108437e-07
molecular O 0 1.688382589293269e-08
and O 0 2.017708888857328e-09
psychometric O 0 1.767916018025062e-07
findings O 0 1.0920844228934357e-09
demonstrated O 0 5.599855579241364e-10
that O 0 1.8288048159176284e-11
deletions O 0 1.6607258901402133e-09
and O 0 2.8240079719132893e-10
duplications O 0 1.230128621187987e-08
that O 0 3.9459973483202404e-11
were O 0 9.234833037163881e-11
localized O 0 1.9947885121496256e-08
in O 0 1.5046444645783197e-10
the O 0 2.791502584642558e-09
distal O 0 6.993733450144646e-07
part O 0 2.241060848007237e-08
of O 0 1.010494429465325e-06
the O 0 2.475269127444335e-07
gene O 0 3.8760461507081345e-09
seemed O 0 1.4104077905585655e-09
to O 0 1.4298059958228748e-10
be O 0 6.848740324860714e-11
preferentially O 0 1.836524710085996e-09
associated O 0 1.916580227856457e-09
with O 0 1.2320869657855837e-08
cognitive B-Disease 0 0.020200315862894058
impairment I-Disease 1 0.9892405867576599
. O 0 2.915673462666746e-07

Two O 0 1.389244772553866e-07
altered O 0 2.4590721636741364e-07
Dp71 O 0 6.384969765349524e-06
transcripts O 0 3.128054260059798e-08
and O 0 5.565422789288732e-09
two O 0 1.123201864849932e-09
deleted O 0 2.4981488877529046e-08
Dp140 O 0 1.0618320800404035e-07
DNA O 0 8.162845954728937e-10
sequences O 0 4.6723420271677085e-11
were O 0 6.894807207807885e-12
found O 0 6.165159528725983e-12
in O 0 1.0562771143862726e-11
four O 0 1.8791219968949946e-10
patients O 0 1.4534501380225606e-10
with O 0 5.46330536366213e-10
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9999972581863403
. O 0 2.4554725541747757e-07

These O 0 7.153933978543137e-08
findings O 0 3.6539540282376493e-09
suggest O 0 1.0350337253939301e-10
that O 0 2.6001518646512345e-12
some O 0 5.828644858429932e-12
sequences O 0 1.0302902628267496e-11
located O 0 2.990254432955197e-10
in O 0 2.7240067840272886e-11
the O 0 1.26980348458261e-09
distal O 0 1.7537465168970812e-07
part O 0 1.5385365870201895e-08
of O 0 1.0173531705959249e-07
the O 0 6.13626260914657e-09
gene O 0 3.168092524430399e-11
and O 0 1.013924985637793e-10
, O 0 3.773104398363536e-11
in O 0 1.4556272853738506e-11
particular O 0 1.1533209109959586e-10
, O 0 7.390311279609207e-11
some O 0 3.336442788715033e-10
DMD B-Disease 1 1.0
isoforms O 0 1.2012013606010896e-09
expressed O 0 1.8852358563137273e-10
in O 0 1.8282406144543017e-10
the O 0 6.690798137753973e-09
brain O 0 2.5337610054521065e-07
may O 0 6.796532087127716e-11
be O 0 7.536383843376182e-12
related O 0 1.824088796675838e-10
to O 0 6.638242039391784e-11
the O 0 3.493577205304632e-09
cognitive B-Disease 0 1.5562347471131943e-05
impairment I-Disease 0 2.7967700589215383e-05
associated O 0 5.4530642223937775e-09
with O 0 1.59988591263982e-08
DMD B-Disease 1 1.0
. O 0 9.386909916031527e-09
. O 0 2.3239250523943156e-08

I1307K O 0 8.374202298000455e-05
APC O 0 2.948320116047398e-06
and O 0 2.636317297799451e-08
hMLH1 O 0 2.4482196749886498e-06
mutations O 0 7.629859410940298e-09
in O 0 1.345311778644387e-10
a O 0 4.847731660539978e-10
non O 0 2.306363455772953e-08
- O 0 9.990960059269582e-09
Jewish O 0 1.2062109089328032e-09
family O 0 3.945952245509865e-11
with O 0 6.216409331738504e-11
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1447111774032237e-06

We O 0 2.982806890372558e-08
describe O 0 7.163516446695439e-09
a O 0 1.1695681090273524e-09
French O 0 7.609210683767742e-08
Canadian O 0 1.8827839198820584e-07
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.158106546332419e-07
HNPCC B-Disease 1 1.0
) O 0 2.0386834442831514e-09
kindred O 0 1.5175587009252922e-07
which O 0 1.0434102193368489e-10
carries O 0 4.624399085884079e-09
a O 0 2.0905065178933313e-10
novel O 0 3.316466390401729e-08
truncating O 0 4.5077754862177244e-07
mutation O 0 9.20036491436349e-09
in O 0 1.0892967639009044e-09
hMLH1 O 0 5.232760486251209e-06
. O 0 1.762579415753862e-07

Interestingly O 0 3.8985439232419594e-07
, O 0 6.148892506274706e-09
the O 0 6.365022731102954e-09
I1307K O 0 1.8061696209770162e-06
APC O 0 8.763996817151565e-08
polymorphism O 0 7.396180889962523e-10
, O 0 9.963889435748996e-11
associated O 0 7.227298620682276e-11
with O 0 5.583651943585899e-11
an O 0 3.94398055880707e-11
increased O 0 1.2047624009525748e-09
risk O 0 7.732164419849141e-08
of O 0 2.1998630472808145e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 8.694426290034585e-10
is O 0 2.0315740409393435e-11
also O 0 9.83259914461021e-12
present O 0 2.0526538802023708e-11
in O 0 3.087222491537922e-11
this O 0 1.6918817735689373e-10
family O 0 3.569548878701312e-09
. O 0 5.34071453728302e-08

The O 0 7.885101354077051e-07
I1307K O 0 4.666587301471736e-06
polymorphism O 0 9.756131902349807e-09
has O 0 1.3800659504070723e-09
previously O 0 1.7050969525200799e-09
only O 0 5.641308600812245e-11
been O 0 2.477862706684597e-11
identified O 0 2.950470423535023e-11
in O 0 1.1307455839715264e-11
individuals O 0 2.075828051117945e-11
of O 0 4.446452539497159e-09
self O 0 4.467545977604459e-07
- O 0 2.2134064181500435e-07
reported O 0 5.7509770279295935e-09
Ashkenazi O 0 4.140284914910808e-08
Jewish O 0 3.909415013936268e-08
origins O 0 2.129062437461471e-08
. O 0 1.5211981008178554e-08

In O 0 5.281934889467266e-09
addition O 0 1.3563759004853182e-09
, O 0 1.087417517142697e-10
in O 0 1.5093346711347877e-11
this O 0 1.086900708324734e-11
family O 0 1.0434302033512921e-10
, O 0 6.065564717161465e-11
there O 0 5.544258802059332e-11
appears O 0 8.625972158782247e-11
to O 0 3.723332753224895e-11
be O 0 8.818160091017546e-11
no O 0 4.5337161802549986e-10
relationship O 0 5.0950587499043465e-11
between O 0 6.738382768434192e-11
the O 0 8.423552966263514e-10
I1307K O 0 1.8489254571818492e-08
polymorphism O 0 1.0699381658429985e-10
and O 0 1.232024621211636e-10
the O 0 4.497019423510551e-10
presence O 0 1.4881993415372108e-09
or O 0 8.517564986654236e-10
absence O 0 2.1088343515884844e-08
of O 0 5.4088765466531186e-08
cancer B-Disease 0 3.3080709727073554e-07
. O 0 3.5678673349082146e-09
. O 0 3.8155334891598613e-08

Identification O 0 6.07681727160525e-08
of O 0 6.611034564230067e-08
a O 0 1.9308312726451504e-09
novel O 0 7.752968933516513e-09
mutation O 0 5.807721525918907e-10
of O 0 2.8365712001487964e-09
the O 0 8.28080626291694e-09
CPO O 1 0.8691728711128235
gene O 0 1.0042769948981345e-09
in O 0 2.6183544221680677e-10
a O 0 2.9039881610515295e-09
Japanese O 0 3.234383996186807e-07
hereditary B-Disease 1 0.9998373985290527
coproporphyria I-Disease 1 0.7108111381530762
family O 0 2.0436276315649593e-07
. O 0 3.2205426236942003e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 8.421036454819841e-07
HCP B-Disease 1 1.0
) O 0 2.4148318900074628e-08
is O 0 1.8302233062428286e-09
an O 0 3.1725280180694426e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
characterized O 0 2.6944111386484337e-09
by O 0 5.138056646813993e-11
a O 0 1.8551700176061559e-09
deficiency B-Disease 0 4.5183383917901665e-05
of I-Disease 0 8.34691381896846e-05
coproporphyrinogen I-Disease 1 0.9999996423721313
oxidase I-Disease 0 1.3964495337859262e-07
( O 0 3.3764929741053606e-10
CPO O 1 0.9040135145187378
) O 0 3.089827560476266e-10
caused O 0 5.241837519598391e-10
by O 0 4.0795818112560056e-11
a O 0 5.035509786921466e-10
mutation O 0 7.336552476644442e-10
in O 0 2.873040694240103e-10
the O 0 3.4291712580625244e-08
CPO O 1 0.7578601837158203
gene O 0 1.6895785392989637e-07
. O 0 1.8675494573017204e-07

Only O 0 2.4692893063615884e-08
11 O 0 1.1531064991743278e-08
mutations O 0 3.13176573563112e-09
of O 0 5.28938537414092e-09
the O 0 7.032442628229774e-09
gene O 0 1.5110587225919403e-09
have O 0 1.01611462299811e-10
been O 0 2.7470647978589113e-10
reported O 0 8.681385610387338e-10
in O 0 3.732822495550181e-09
HCP B-Disease 1 1.0
patients O 0 3.460031052782142e-07
. O 0 6.454121859178485e-08

We O 0 3.743133447642322e-08
report O 0 2.3192125997439916e-09
another O 0 1.508285718543334e-09
mutation O 0 1.6849555084519352e-09
in O 0 4.3138581595769665e-10
a O 0 4.299608225011298e-09
Japanese O 0 8.76565167118315e-08
family O 0 1.583528508319887e-08
. O 0 8.825071518003824e-08

Polymerase O 0 1.273727320949547e-06
chain O 0 5.196845975774522e-08
reaction O 0 1.4930754410613645e-09
- O 0 1.7429512055855412e-08
single O 0 7.369285737190978e-10
strand O 0 1.274318872646063e-09
conformational O 0 2.372254614968483e-10
polymorphism O 0 2.30429911263208e-10
and O 0 3.456465114126672e-10
direct O 0 1.1623493278989372e-09
sequence O 0 9.817911067466767e-11
analyses O 0 1.4281225091394845e-09
demonstrated O 0 2.181879787954699e-09
a O 0 1.0159484364891114e-09
C O 0 1.754532164000011e-08
to O 0 5.394179547479894e-10
T O 0 8.744106771985116e-09
substitution O 0 1.800844195987139e-10
in O 0 6.293430360182484e-11
exon O 0 7.474581842359385e-09
1 O 0 5.704862360289553e-09
of O 0 5.69563152197361e-09
the O 0 7.501017584843339e-09
CPO O 0 4.0713828639127314e-05
gene O 0 3.4163721851498963e-10
at O 0 9.152211766227936e-10
nucleotide O 0 6.375298622351977e-10
position O 0 1.2240590763212822e-09
85 O 0 4.903352834872976e-09
, O 0 5.93447721519702e-11
which O 0 3.1454356480553614e-11
lies O 0 7.567465765134784e-09
in O 0 1.0508840325718083e-10
the O 0 5.57040369386641e-09
putative O 0 1.595028322753933e-07
presequence O 0 5.915443921367114e-07
for O 0 2.1197215094304056e-09
targeting O 0 1.609373612154741e-08
to O 0 5.416223913812246e-09
mitochondria O 0 4.8611902059292333e-08
. O 0 2.1117853066243697e-07

This O 0 1.680975891815706e-08
mutation O 0 9.211093221495048e-09
changes O 0 1.932828341821846e-09
the O 0 2.8087319137171107e-09
codon O 0 9.23445497846842e-09
for O 0 2.537069998531649e-10
glutamine O 0 1.4667831393921915e-08
to O 0 2.107265251183321e-09
a O 0 1.042822361796425e-08
termination O 0 1.949977956883231e-07
codon O 0 7.789717670902974e-08
at O 0 1.4044009510882915e-08
amino O 0 5.04913373333693e-08
acid O 0 3.517032709510204e-08
position O 0 2.1099811675640012e-08
29 O 0 2.2295840551578294e-07
. O 0 1.3615029104130372e-07

MaeI O 0 5.193279139348306e-05
restriction O 0 3.1542477074708586e-08
analysis O 0 1.4697557060294741e-10
showed O 0 1.330470456029076e-10
two O 0 1.510985087049832e-11
other O 0 2.5089175528791863e-11
carriers O 0 4.90048696066836e-11
in O 0 3.9536516421856405e-11
the O 0 5.222499765977773e-09
family O 0 1.8976225035771677e-08
. O 0 1.184446247748383e-07

The O 0 3.6677192838396877e-07
C O 0 1.0132212992175482e-05
- O 0 0.00013134478649590164
T O 0 2.125072933267802e-05
mutation O 0 4.1801877515013075e-09
is O 0 1.256271475735815e-10
located O 0 1.2242481473023759e-09
within O 0 4.3686732009717844e-10
a O 0 2.7690380544065363e-10
recently O 0 1.8620118780177108e-09
proposed O 0 1.2986008712800867e-08
putative O 0 1.551959201151476e-07
alternative O 0 3.3084979200737052e-09
translation O 0 3.146578553270274e-09
initiation O 0 1.0553383056333132e-08
codon O 0 1.3439435342377237e-08
( O 0 5.561989063762596e-11
TIC O 0 5.394349855691871e-08
- O 0 5.717389672810214e-09
1 O 0 2.744850791103204e-09
) O 0 3.153280761503119e-11
, O 0 2.3507413030032787e-11
supporting O 0 1.6340986896956622e-10
that O 0 1.5804723849099922e-11
TIC O 0 6.887827908030886e-08
- O 0 9.056051020195355e-09
1 O 0 8.115066840730378e-09
is O 0 1.1000490102164306e-10
the O 0 4.6368414663433555e-10
real O 0 1.2821509187688207e-07
TIC O 0 1.4274838804340106e-06
rather O 0 7.922361655587906e-10
than O 0 1.3390397124446451e-10
TIC O 0 2.026229708462779e-07
- O 0 5.4899686574572115e-08
2 O 0 2.8327500345426415e-08
. O 0 2.151361977453803e-09
. O 0 2.1908592273689464e-08

Human B-Disease 0 3.3677487465411104e-08
complement I-Disease 0 3.4258505365869496e-08
factor I-Disease 0 1.0508298373679281e-06
H I-Disease 1 1.0
deficiency I-Disease 0 0.01778257265686989
associated O 0 3.231698428862728e-07
with O 1 0.5302786231040955
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.158368033633451e-06

This O 0 2.2379500475011582e-09
study O 0 2.0325906235907354e-10
reports O 0 7.13978806632376e-11
on O 0 2.6525759366791135e-10
six O 0 7.308587068877159e-11
cases O 0 6.79387518465191e-11
of O 0 1.9287036412407588e-09
deficiency B-Disease 0 1.1775729262808454e-06
in I-Disease 0 2.122205522425702e-09
the I-Disease 0 4.199313252684078e-08
human I-Disease 0 1.2689295170176251e-09
complement I-Disease 0 2.434095369707734e-09
regulatory I-Disease 0 5.201583608283045e-09
protein I-Disease 0 7.188921014034122e-09
Factor I-Disease 0 4.0952663482585194e-08
H I-Disease 1 1.0
( O 0 2.8118660178044763e-10
FH O 0 0.00011723081115633249
) O 0 9.090371684561394e-12
in O 0 2.2276193476639117e-12
the O 0 2.1600929378529088e-11
context O 0 4.92083075676053e-11
of O 0 1.1554345674680278e-10
an O 0 2.8582014532929634e-10
acute B-Disease 0 0.21798279881477356
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 8.950153755904466e-07

Five O 0 2.3108725599740865e-08
of O 0 1.867866972204979e-09
the O 0 1.2277692751361258e-10
cases O 0 2.3829329134916755e-11
were O 0 4.213875342412576e-12
observed O 0 1.2351486153305835e-11
in O 0 2.642534194935431e-12
children O 0 1.5694955751710538e-11
presenting O 0 1.5035865885693056e-09
with O 0 1.6117020606998267e-08
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.377000444335863e-06
HUS B-Disease 1 1.0
) O 0 1.1298777735646581e-07
. O 0 1.62761537580991e-07

Two O 0 1.9366512837848404e-09
of O 0 4.2249230780555536e-09
the O 0 1.6856498419315358e-09
children O 0 5.652760481922314e-10
exhibited O 0 5.8516146594911334e-08
a O 0 1.4392143476982255e-08
homozygous O 0 5.198935923544923e-06
deficiency O 0 4.475077275856165e-06
characterized O 0 2.3342390242930833e-09
by O 0 5.297901353729095e-11
the O 0 4.285526156166952e-09
absence O 0 2.0078703144577048e-08
of O 0 1.9663961126070717e-08
the O 0 3.150061766987733e-09
150 O 0 5.219599197303637e-10
- O 0 2.986938474336398e-09
kD O 0 5.163008154340787e-07
form O 0 7.804235729880205e-11
of O 0 7.966243775747728e-10
Factor O 0 9.443171578027432e-09
H O 0 0.33794450759887695
and O 0 6.059817925230249e-11
the O 0 9.868639933019452e-11
presence O 0 9.64591878593879e-11
, O 0 2.314746658238498e-11
upon O 0 1.6283520365423243e-10
immunoblotting O 0 1.0396036032034317e-07
, O 0 2.1706340891380904e-10
of O 0 2.28589702722104e-09
the O 0 3.106908064154368e-09
42 O 0 1.566770180261301e-08
- O 0 2.5235786793587067e-08
kD O 0 7.030592769297073e-06
Factor O 0 1.3416683941613883e-07
H O 0 0.1585237979888916
- O 0 2.3977905883043604e-08
like O 0 6.079049486018562e-10
protein O 0 6.037312871853828e-10
1 O 0 1.96040694788735e-09
( O 0 4.358965619011279e-11
FHL O 0 3.511032218739274e-06
- O 0 4.369674844184601e-09
1 O 0 1.3669099185875666e-09
) O 0 1.3671484083710439e-11
and O 0 4.034984499301508e-11
other O 0 1.8802441548171345e-10
FH O 0 4.2883515561698005e-05
- O 0 1.3217783312313713e-08
related O 0 6.954728348773642e-09
protein O 0 2.7566451343830067e-09
( O 0 4.8161731547313735e-11
FHR O 0 0.1661159098148346
) O 0 1.3108287788554662e-09
bands O 0 3.6217267052052193e-07
. O 0 5.384420020959624e-08

Southern O 0 5.714825420000125e-06
blot O 0 1.0075948921439704e-05
and O 0 1.428841822637139e-09
PCR O 0 9.409006906935247e-10
analysis O 0 5.485875208960378e-12
of O 0 4.7143705605989794e-11
DNA O 0 4.499138284153048e-10
of O 0 7.11099346073496e-10
one O 0 1.4378216672827904e-10
patient O 0 7.076733643529565e-10
with O 0 4.090032201808924e-10
homozygous O 0 4.0683321458345745e-06
deficiency O 0 3.9202154766826425e-06
ruled O 0 2.1884746459477356e-08
out O 0 4.4380196739801647e-10
the O 0 2.2214564909806e-10
presence O 0 1.1999023996622782e-10
of O 0 9.380444199180715e-10
a O 0 1.2515717628946987e-10
large O 0 2.0546770951312965e-09
deletion O 0 5.598480790069971e-09
of O 0 3.886618138437825e-09
the O 0 1.227936774483851e-08
FH O 1 0.9999947547912598
gene O 0 5.262554281237897e-10
as O 0 5.67320426747564e-11
the O 0 4.028050670790151e-10
underlying O 0 4.309775292199447e-08
defect O 0 1.0816453510642532e-08
for O 0 5.932443425393785e-10
the O 0 3.4906554446934024e-07
deficiency O 1 0.9997566342353821
. O 0 9.245804903912358e-07

The O 0 1.8267018120354805e-08
other O 0 4.643656570380017e-10
four O 0 6.61559140802126e-11
children O 0 1.679563432777087e-11
presented O 0 2.605878846040355e-10
with O 0 3.1712679704476443e-10
heterozygous O 0 3.0805807682554587e-07
deficiency O 0 1.2821456948586274e-05
and O 0 7.497169995929198e-09
exhibited O 0 7.012486662461015e-07
a O 0 3.007644799879472e-09
normal O 0 6.427731236158252e-09
immunoblotting O 0 1.0272585626580621e-07
pattern O 0 1.3357498440669247e-09
of O 0 5.771721434122412e-10
proteins O 0 3.4187236375160523e-11
of O 0 1.2286085482315912e-09
the O 0 1.4679192972266719e-08
FH O 1 0.9999992847442627
family O 0 2.5673168480011554e-08
. O 0 6.59914221046165e-08

Factor B-Disease 1 0.9999827146530151
H I-Disease 1 1.0
deficiency I-Disease 1 0.9996675252914429
is O 0 1.4702723483139835e-09
the O 0 1.364409252246901e-09
only O 0 2.1976884756469417e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 2.6390742036142e-08
with O 0 5.9044765521321096e-08
HUS B-Disease 1 1.0
. O 0 1.6938132603172562e-06

These O 0 5.7515396889584736e-08
observations O 0 3.4748513400018055e-08
suggest O 0 1.8022058290156906e-09
a O 0 3.395648207060731e-10
role O 0 1.9936541306719846e-09
for O 0 2.5309332407630336e-09
FH O 1 1.0
and O 0 1.433138496764741e-08
/ O 0 7.842489821996423e-07
or O 0 1.70278049438366e-08
FH O 0 0.0016729921335354447
receptors O 0 1.528380644266747e-09
in O 0 1.4439752171746534e-10
the O 0 3.4766396428409507e-09
pathogenesis O 0 7.525324008383905e-07
of O 0 2.1470879119078745e-07
idiopathic O 1 0.9998001456260681
HUS B-Disease 1 1.0
. O 0 1.080523901464403e-07
. O 0 1.85207809977328e-07

Further O 0 1.2446948005617742e-07
evidence O 0 6.403306773705708e-09
for O 0 7.773428012392003e-10
a O 0 9.215675444984583e-10
major O 0 2.5796765612540185e-08
ancient O 0 1.5267636399585172e-07
mutation O 0 2.6194516067334916e-06
underlying O 0 0.009614500217139721
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.0488629698102159e-07
linkage O 0 1.6180554496258992e-07
disequilibrium O 0 2.276665078682072e-08
studies O 0 2.1895035784424977e-10
in O 0 1.720196554644282e-11
the O 0 1.6061306451486956e-10
Japanese O 0 3.6474785414242206e-09
population O 0 6.300985427865058e-11
. O 0 3.632052436586264e-09

The O 0 0.0005086978781037033
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.4078073799610138
DM B-Disease 1 1.0
) O 0 1.7905913196614165e-08
mutation O 0 1.2837753082806103e-08
is O 0 1.9107901372272806e-10
an O 0 2.183327546534386e-10
unstable O 0 3.421762428956754e-08
( O 0 2.541289845225947e-09
CTG O 0 3.312853004899807e-05
) O 0 4.797334751671656e-10
n O 0 3.4968286599657006e-10
repeat O 0 7.431802395707621e-10
, O 0 3.97189781065066e-11
present O 0 2.0408483930589583e-11
at O 0 2.1515372816693912e-10
a O 0 5.7329665320571266e-11
copy O 0 7.932553502953965e-10
number O 0 7.171041538356349e-11
of O 0 8.455312006105942e-10
5 O 0 3.015433902575637e-09
- O 0 2.6460096336222705e-08
37 O 0 1.3711302315755347e-08
repeats O 0 3.369043377610126e-10
on O 0 1.023469531347132e-09
normal O 0 9.054751393122729e-10
chromosomes O 0 4.069905870651702e-11
but O 0 1.5452453552833312e-11
amplified O 0 3.6433760453036257e-09
to O 0 3.496108402778475e-10
50 O 0 4.224093519411554e-09
- O 0 6.767549631803149e-09
3000 O 0 1.6159059645914908e-09
copies O 0 1.1179674963557318e-09
on O 0 6.919865569443573e-08
DM B-Disease 1 1.0
chromosomes O 0 1.1864077009704488e-07
. O 0 3.524123570741722e-08

Previous O 0 1.7894925008477003e-07
findings O 0 2.7517912393193456e-09
in O 0 2.2429830215386914e-10
Caucasian O 0 4.164059674849341e-08
populations O 0 2.2358379592191113e-09
of O 0 2.4049951363736e-08
a O 0 2.0371187758883025e-07
DM B-Disease 1 1.0
founder O 0 6.944736014702357e-06
chromosome O 0 4.910280893000163e-08
raise O 0 4.4272256971567e-09
a O 0 3.4563663042774806e-10
question O 0 5.696932925403075e-10
about O 0 2.888275209278479e-11
the O 0 1.7398107954313957e-10
molecular O 0 3.9037481580628253e-10
events O 0 9.898878244873899e-11
involved O 0 3.589994274078023e-11
in O 0 1.0076765116773245e-10
the O 0 2.9965192549497033e-09
expansion O 0 5.174384796191589e-07
mutation O 0 1.0070226608149824e-07
. O 0 6.893558435194791e-08

To O 0 8.970254583573478e-08
investigate O 0 7.834597681721789e-08
whether O 0 2.6894626969919955e-08
a O 0 1.2346370148463848e-08
founder O 0 1.3452866198804259e-07
chromosome O 0 1.1569706970249172e-08
for O 0 9.269460754524061e-10
the O 0 5.559844851177331e-08
DM B-Disease 1 1.0
mutation O 0 9.700096725850926e-09
exists O 0 5.3428764884566604e-11
in O 0 5.575475844898925e-12
the O 0 4.509325204904435e-11
Japanese O 0 5.617731835272366e-10
population O 0 4.713522974708617e-12
, O 0 1.992272145867613e-11
we O 0 1.1493022505915107e-10
genotyped O 0 1.8325057737911266e-07
families O 0 1.3656836946041029e-11
using O 0 1.1268577737588714e-10
polymorphic O 0 4.1970551478698326e-08
markers O 0 1.624916734499493e-07
near O 0 1.2701256935088168e-07
the O 0 2.1600508048891243e-08
( O 0 3.545210569555479e-09
CTG O 0 3.285170896560885e-05
) O 0 9.940508416406146e-10
n O 0 1.5507385375812532e-09
repeat O 0 5.1628372688128366e-09
region O 0 1.8577512861384093e-09
and O 0 2.002209287255141e-09
constructed O 0 2.2788378828408895e-07
haplotypes O 0 6.053138008610404e-07
. O 0 8.822983943446161e-08

Six O 0 7.098207532862943e-08
different O 0 2.017934985776293e-10
haplotypes O 0 1.3726367820154906e-09
were O 0 7.569551235819816e-11
found O 0 9.36081490099383e-11
and O 0 3.179324581381593e-09
DM B-Disease 1 1.0
alleles O 0 3.820891603112386e-09
were O 0 4.870652214883364e-10
always O 0 8.190984779332666e-09
haplotype O 0 2.1796270743834611e-07
A O 0 1.259172563550237e-06
. O 0 3.151496912323637e-07

To O 0 6.43916786557952e-09
find O 0 2.629775841533899e-10
an O 0 1.419300961480463e-11
origin O 0 3.091111394626367e-11
of O 0 9.50014622524975e-10
the O 0 3.3991622849782743e-09
( O 0 2.2324759818559414e-09
CTG O 0 6.482669414253905e-05
) O 0 1.5202458181207135e-09
n O 0 2.1213959477961453e-09
repeat O 0 3.6400558123261817e-09
mutation O 0 2.8333740909047833e-10
and O 0 7.008987140677547e-11
to O 0 7.46101444515368e-11
investigate O 0 5.319025220273943e-10
the O 0 2.0875698392153197e-10
mechanism O 0 1.3873264759212134e-09
of O 0 2.5446609264179187e-09
the O 0 2.548050881401309e-09
expansion O 0 2.425689338281245e-08
mutation O 0 1.628516627105725e-10
in O 0 2.4358392039514065e-11
the O 0 2.535406051773492e-10
Japanese O 0 9.712681769968867e-10
population O 0 4.4739238355684385e-12
we O 0 6.948963540004405e-12
have O 0 6.3583157836055726e-12
studied O 0 6.684267361833918e-09
90 O 0 1.0868339117564574e-08
Japanese O 0 3.959423366950432e-08
DM B-Disease 1 1.0
families O 0 9.973927933559779e-11
comprising O 0 2.27227237026284e-10
190 O 0 6.499948912441766e-10
affected O 0 4.585076485152939e-10
and O 0 6.666973084712424e-10
130 O 0 3.6447541873485534e-08
unaffected O 0 1.5004252418293618e-07
members O 0 4.1966585762054365e-10
. O 0 2.3077232569335138e-08

The O 0 1.5732751990071847e-07
results O 0 5.594701590894147e-09
suggest O 0 6.184645573448222e-10
that O 0 2.438200509546906e-11
a O 0 1.5759517302260662e-10
few O 0 8.195637501984265e-10
common O 0 6.916046069171955e-10
ancestral O 0 8.886330782331697e-09
mutations O 0 1.761744305994739e-09
in O 0 9.349002821901209e-11
both O 0 5.608823405722774e-10
Caucasian O 0 4.015505083998505e-08
and O 0 6.138413111145269e-10
Japanese O 0 1.0794627414156821e-08
populations O 0 1.321207310223116e-10
have O 0 1.0992633669645868e-12
originated O 0 3.0811676994535464e-12
by O 0 4.201243519741382e-12
expansion O 0 8.152844621633903e-09
of O 0 6.799067531204628e-09
an O 0 5.128396041165217e-10
ancestral O 0 1.576031571914882e-08
n O 0 2.1376755920954338e-09
= O 0 1.421003537060983e-09
5 O 0 4.437454848016387e-09
repeat O 0 4.319665070084966e-09
to O 0 8.985469590605533e-10
n O 0 2.413071964468827e-09
= O 0 2.449744851418245e-09
19 O 0 7.217194841757646e-09
- O 0 1.7436395438608088e-08
37 O 0 1.0661766580710719e-08
copies O 0 7.501689935907052e-09
. O 0 2.3038356999904863e-08

These O 0 1.3744005933347125e-08
data O 0 1.137183458510549e-09
support O 0 1.647091074641338e-10
multistep O 0 1.6991533513532886e-08
models O 0 7.80483944140542e-09
of O 0 1.1926788090477203e-07
triplet O 0 3.5267037219455233e-06
repeat O 0 3.347728849689702e-08
expansion O 0 6.1202256596004645e-09
that O 0 1.1369153882223593e-11
have O 0 2.2069852455980365e-12
been O 0 6.295083811863611e-12
proposed O 0 1.2612701161263118e-10
for O 0 6.451466444401532e-11
both O 0 2.322191550163666e-09
DM B-Disease 1 1.0
and O 0 3.2951709272310836e-07
Friedreichs B-Disease 1 0.9999988079071045
ataxia I-Disease 1 0.9999954700469971
. O 0 7.437382265607084e-08
. O 0 2.804617622587102e-07

The O 0 9.300656245159189e-08
molecular O 0 2.134547649745855e-08
basis O 0 1.3085663219669641e-08
of O 0 1.7967105350180645e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 9.453979821216763e-10
the O 0 1.3198152570836896e-09
western O 0 3.3625098261325093e-09
Cape O 0 1.887132299316363e-07
, O 0 5.029981431370345e-10
South O 0 1.2221910594689689e-08
Africa O 0 2.9887792241112265e-09
. O 0 3.0021730879070674e-08

Deficiency B-Disease 1 0.8219025731086731
of I-Disease 0 6.4328078224207275e-06
the I-Disease 0 3.482788031305972e-07
sixth I-Disease 0 2.8178078537166584e-07
component I-Disease 0 6.907772842623672e-08
of I-Disease 0 7.0894401460464e-08
human I-Disease 0 3.418225036355693e-09
complement I-Disease 0 4.650592799748665e-08
( O 0 1.6711161343607728e-09
C6 O 1 1.0
) O 0 2.0374658904476206e-10
has O 0 6.814925707088193e-11
been O 0 3.842491255734437e-11
reported O 0 1.9279293439478096e-11
in O 0 9.885345146620761e-12
a O 0 2.4309517940301895e-11
number O 0 6.504358249920239e-12
of O 0 3.312687277268189e-11
families O 0 2.0637141897716232e-13
from O 0 8.797319968854855e-13
the O 0 2.5293959635130925e-11
western O 0 5.288979254558512e-10
Cape O 0 1.4941765869025403e-07
, O 0 6.727033374787084e-10
South O 0 1.6703268101991853e-08
Africa O 0 5.117952728284081e-09
. O 0 2.8808079477471438e-08

Meningococcal B-Disease 1 0.533024787902832
disease I-Disease 0 8.220871677622199e-05
is O 0 1.3245992080967994e-09
endemic O 0 2.360511563992418e-09
in O 0 3.557521291441823e-11
the O 0 3.889522870448303e-10
Cape O 0 9.331039763083027e-08
and O 0 2.150359751373898e-10
almost O 0 2.881529043152753e-11
all O 0 6.54707494815443e-12
pedigrees O 0 8.346211499699052e-10
of O 0 3.4539560100910194e-09
total O 0 5.547415184992133e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 5.141463699231963e-09
C6Q0 O 1 1.0
) O 0 2.922790898196581e-10
have O 0 1.478470991467251e-11
been O 0 4.337171247148497e-11
ascertained O 0 6.5468479526487044e-09
because O 0 6.126295581942998e-10
of O 0 2.096982143484638e-08
recurrent O 1 0.9999957084655762
disease O 0 0.2724338173866272
. O 0 3.465053737272683e-07

We O 0 2.153325162623787e-08
have O 0 1.315908354504458e-10
sequenced O 0 1.5997141389334502e-09
the O 0 4.158452193703255e-10
expressed O 0 2.1504090175206159e-10
exons O 0 1.6026927340817565e-08
of O 0 7.135400892366306e-08
the O 0 1.2239726743246138e-07
C6 O 0 0.13270774483680725
gene O 0 2.215540945149641e-10
from O 0 1.4392394394324715e-11
selected O 0 5.0345855956424046e-11
cases O 0 8.15315870372757e-12
and O 0 1.576714800388679e-11
have O 0 5.483720248722346e-12
found O 0 5.378868531136227e-11
three O 0 1.470016469662383e-10
molecular O 0 4.0729648276283115e-07
defects O 1 0.9969310760498047
leading O 0 1.4445735985191277e-07
to O 0 6.313755740450233e-09
total O 0 3.4586028618832643e-07
deficiency O 1 0.9999974966049194
879delG O 0 0.00020119744294788688
, O 0 4.5184878061377276e-10
which O 0 7.369423127290275e-11
is O 0 6.549826653268198e-11
the O 0 4.110208284835437e-10
common O 0 1.457957199413329e-09
defect O 0 5.2394213412298996e-09
in O 0 6.040039302046551e-11
the O 0 2.7151809689485162e-09
Cape O 0 1.8081481130138854e-06
and O 0 8.553565855606848e-09
hitherto O 0 1.1554979550965072e-07
unreported O 0 4.4779024932495304e-08
, O 0 9.755043300918587e-11
and O 0 1.617749129101398e-10
1195delC O 0 3.3202262272880034e-08
and O 0 6.979601896439647e-10
1936delG O 0 7.582654149018708e-08
, O 0 1.580792580169188e-10
which O 0 3.513460355986098e-11
have O 0 2.3802028056851832e-11
been O 0 9.824786123546758e-11
previously O 0 1.1717606884786846e-09
reported O 0 1.8684680191949354e-10
in O 0 7.867455992238703e-11
African O 0 6.851343936631338e-10
- O 0 6.388889772779294e-08
Americans O 0 7.4751055345601e-10
. O 0 6.770429106239817e-09

We O 0 1.2426031759105172e-08
also O 0 3.8682820835411746e-10
show O 0 4.5432296813530115e-10
that O 0 1.1777780140054261e-11
the O 0 4.3565159812963827e-10
879delG O 0 1.6902473021218611e-07
and O 0 3.612314447565268e-09
1195delC O 0 5.070837232779013e-06
defects O 0 1.5657476524211233e-06
are O 0 1.349083171564569e-11
associated O 0 1.9958637520467448e-10
with O 0 1.2369698598746481e-09
characteristic O 1 1.0
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
region O 0 4.979370942237438e-07
DNA O 0 1.0702417796437658e-07
marker O 0 5.821079795964579e-08
haplotypes O 0 1.0209426637430852e-09
, O 0 1.2836973671548346e-11
although O 0 3.161724007605393e-11
small O 0 5.977239259102873e-10
variations O 0 2.5624098398679962e-08
were O 0 9.563595471107078e-10
observed O 0 1.8108208266198744e-08
. O 0 3.105618162635437e-08

The O 0 1.1670994126689038e-06
1936delG O 0 1.3807369214191567e-05
defect O 0 1.1365723366907332e-06
was O 0 1.9707929510559552e-08
observed O 0 2.2233439533891897e-09
only O 0 1.4951921645245392e-10
once O 0 3.6904154732120276e-10
in O 0 2.3831010081964976e-11
the O 0 2.6674973341300756e-10
Cape O 0 1.780372258508578e-07
, O 0 1.4392868841195394e-10
but O 0 3.2013860312707365e-11
its O 0 1.2122207404541285e-10
associated O 0 5.97174643068854e-10
haplotype O 0 2.906483231868151e-08
could O 0 5.010249104486775e-09
be O 0 3.928878555825577e-09
deduced O 0 1.5754297066905565e-07
. O 0 8.756110503327363e-08

The O 0 1.4033517459210998e-07
data O 0 8.632679460163217e-09
from O 0 8.093206660397811e-10
the O 0 4.897576566520456e-09
haplotypes O 0 1.1610160832731253e-08
indicate O 0 4.2974168668052926e-10
that O 0 3.209995116937314e-11
these O 0 3.259931213861478e-10
three O 0 2.2579892122731593e-10
molecular O 0 1.704720631323653e-08
defects O 0 1.3771669671314157e-07
account O 0 4.252739133070449e-11
for O 0 9.138078488346579e-11
the O 0 1.0034082897902863e-08
defects O 0 3.2382374683948e-06
in O 0 5.910070211001539e-10
all O 0 2.666486587088457e-09
the O 0 1.163170537665792e-08
38 O 0 5.039463957245971e-08
unrelated O 0 1.1742631045308372e-07
C6Q0 O 1 0.999998927116394
individuals O 0 3.7362821170283667e-10
we O 0 1.4148419935633427e-10
have O 0 1.2036747466803721e-11
studied O 0 1.882854316903604e-09
from O 0 2.6248045403853837e-10
the O 0 3.5198630676802622e-09
Cape O 0 1.4839365576335695e-06
. O 0 1.0582795795244238e-07

We O 0 2.521774256081244e-08
have O 0 2.537563770221851e-10
also O 0 1.954156558792164e-10
observed O 0 6.756841197663732e-10
the O 0 1.0555530893796572e-09
879delG O 0 3.279330087480048e-07
defect O 0 3.043355079057619e-08
in O 0 4.598195435523422e-10
two O 0 4.738589964858875e-09
Dutch O 1 1.0
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 1.1897634067281615e-05
, O 0 3.4743311005946964e-10
but O 0 7.425663556270834e-11
the O 0 1.2052887576885496e-09
879delG O 0 2.1143929984646093e-07
defect O 0 1.465206089790172e-08
in O 0 1.354289180799384e-10
the O 0 4.236462292084298e-09
Cape O 0 2.3811408027540892e-06
probably O 0 1.592055598464981e-09
did O 0 2.350563077513357e-10
not O 0 3.525476438559494e-11
come O 0 3.0296591624345837e-11
from O 0 1.801241794607833e-11
The O 0 1.2025446194385836e-09
Netherlands O 0 1.5989378709946322e-07
. O 0 8.063580914097201e-09
. O 0 7.545748559323329e-08

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.6922735918997205e-08
seven O 0 5.299806815628472e-09
further O 0 8.5710070152345e-09
molecular O 0 1.2720130371235427e-07
defects O 0 2.9962697567498253e-07
and O 0 7.217989539398673e-10
their O 0 9.328986472212364e-10
associated O 0 8.449270616495141e-09
marker O 0 8.647910362924449e-06
haplotypes O 0 1.6073604456323665e-06
. O 0 1.4998843766989012e-07

Seven O 0 1.57451040649903e-07
further O 0 4.500350758718241e-09
molecular O 0 9.380197951713853e-09
bases O 0 3.2720254949936134e-08
of O 0 9.90651187748881e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 9.590014116156453e-09
described O 0 1.0899977809231132e-08
. O 0 3.221113331619563e-08

All O 0 1.4679978121989734e-08
these O 0 5.495243149411522e-10
new O 0 6.700373034185247e-10
molecular O 0 4.568190092868463e-08
defects O 0 2.2877613048422063e-07
involve O 0 1.210897160319746e-09
single O 0 2.396284004557714e-10
- O 0 3.6185687779521913e-09
nucleotide O 0 1.764155266315015e-09
events O 0 1.5488696436527505e-10
, O 0 5.51946335858311e-11
deletions O 0 1.4744567788937957e-09
and O 0 2.0394097521858612e-10
substitutions O 0 4.641445006114964e-09
, O 0 6.768136745494147e-11
some O 0 3.2901317087441484e-11
of O 0 5.897154986556075e-10
which O 0 1.22312729389229e-10
alter O 0 1.780001390727648e-08
splice O 0 2.285292310943987e-08
sites O 0 1.912585201324646e-09
, O 0 3.487942434876601e-10
and O 0 3.00417046794621e-09
others O 0 1.7867430202045398e-08
codons O 0 1.2393696806611842e-06
. O 0 1.2210543332003e-07

They O 0 2.2644424113593686e-09
are O 0 2.1914411257872857e-11
distributed O 0 4.7678683917640186e-11
along O 0 1.9188186595187062e-09
the O 0 1.9420713925910604e-08
C7 O 0 0.00025368068600073457
gene O 0 4.964084143743719e-10
, O 0 4.7930701074783144e-11
but O 0 1.5044828230448282e-11
predominantly O 0 9.743291590202929e-11
towards O 0 1.7416269815218044e-10
the O 0 4.5987219587928507e-10
3 O 0 1.9193100442294053e-08
end O 0 4.565759681440795e-08
. O 0 1.0998952859608835e-07

All O 0 2.49597693624537e-08
were O 0 4.853430435325379e-10
found O 0 8.025596853755701e-11
in O 0 1.2152649719876507e-10
compound O 0 1.7263227292119154e-08
heterozygous O 0 4.600182634817429e-08
individuals O 0 6.562409504695665e-10
. O 0 1.7016603237607342e-08

The O 0 2.9207682018750347e-05
C6 O 1 1.0
/ O 1 0.9999845027923584
C7 O 1 1.0
marker O 0 1.1622606507444289e-05
haplotypes O 0 6.566371979488395e-08
associated O 0 2.6632234195744786e-09
with O 0 3.4034441931396486e-09
most O 0 3.347790311636345e-07
C7 B-Disease 1 1.0
defects I-Disease 0 0.07122449576854706
are O 0 8.054584221817152e-10
tabulated O 0 2.142150279382804e-08
. O 0 1.622128320555305e-09
. O 0 3.318947250363635e-08

A O 0 3.449179985182127e-06
genome O 0 1.722014530969318e-08
- O 0 4.8508354666410014e-08
wide O 0 5.197559715952593e-08
search O 0 5.284884752043695e-10
for O 0 2.2087982831653363e-10
chromosomal O 0 2.866973090931424e-06
loci O 0 2.781040677746205e-07
linked O 0 1.525299637705757e-07
to O 0 3.4091225398213965e-09
mental O 0 0.08077236264944077
health O 0 2.6492978122405475e-07
wellness O 0 3.1340326245299366e-07
in O 0 4.286707100398246e-11
relatives O 0 6.17516662804185e-11
at O 0 5.218372262083548e-11
high O 0 3.4646596702714305e-08
risk O 0 6.966573806721499e-08
for O 0 5.367191135974281e-09
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 1.3942792476129284e-09
the O 0 1.1939718103093355e-09
Old O 0 1.4301913608960604e-07
Order O 0 2.810276811260337e-08
Amish O 0 7.20578086088608e-08
. O 0 2.0213036577843013e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 7.156048695833306e-07
BPAD B-Disease 1 1.0
; O 0 1.8489696458345861e-06
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.967801199764807e-10
is O 0 1.4915908785884113e-11
characterized O 0 3.5811451026823704e-11
by O 0 6.32823784693648e-12
episodes O 0 1.419297745997028e-08
of O 0 1.321110971730377e-07
mania B-Disease 0 0.005396330263465643
and O 0 1.6777152112013027e-08
/ O 0 4.092138624400832e-06
or O 0 1.1456200432746755e-08
hypomania B-Disease 0 9.230131581716705e-06
interspersed O 0 3.01467615315687e-08
with O 0 2.5077803722517444e-10
periods O 0 2.1122723126154597e-08
of O 0 5.570427674683742e-08
depression B-Disease 0 6.3811712607275695e-06
. O 0 8.700074971557115e-08

Compelling O 0 7.729051958449418e-07
evidence O 0 1.5944024767122755e-08
supports O 0 3.854947294712474e-08
a O 0 2.081190109137765e-09
significant O 0 4.209431025969934e-09
genetic O 0 8.134186102459751e-10
component O 0 3.626113631582939e-09
in O 0 4.957666221994117e-11
the O 0 1.3607344140353916e-09
susceptibility O 0 1.4713677387589996e-07
to O 0 2.596702763923986e-08
develop O 0 6.848735938547179e-05
BPAD B-Disease 1 1.0
. O 0 5.0830194595619105e-06

To O 0 6.050238532395724e-09
date O 0 9.166507553004521e-09
, O 0 6.661672324881351e-10
however O 0 8.681517726927268e-10
, O 0 7.723151562721853e-10
linkage O 0 1.1635011176736043e-08
studies O 0 7.877850594084634e-10
have O 0 3.915349294780768e-11
attempted O 0 4.957633414903739e-09
only O 0 5.5651944858015057e-11
to O 0 2.887494687797698e-10
identify O 0 7.324419737386734e-09
chromosomal O 0 1.1997201454505557e-06
loci O 0 5.6755506960826096e-08
that O 0 6.017711329242559e-10
cause O 0 5.735028452136248e-09
or O 0 3.1256875560048414e-11
increase O 0 3.029295217449324e-11
the O 0 3.4470568066602425e-10
risk O 0 8.217493352447036e-09
of O 0 2.013423561209038e-08
developing O 0 1.5240271977745579e-06
BPAD B-Disease 1 1.0
. O 0 1.7523533415442216e-06

To O 0 9.991341975990053e-09
determine O 0 1.7578607458546003e-09
whether O 0 1.7496912252390473e-10
there O 0 5.0765308623468286e-11
could O 0 8.891662406362855e-11
be O 0 8.223976361021457e-11
protective O 0 4.989110280462228e-08
alleles O 0 1.3083528704882497e-10
that O 0 4.016676748153092e-12
prevent O 0 7.661616896470491e-10
or O 0 3.101907619651456e-11
reduce O 0 8.294713249590302e-10
the O 0 2.8515417804797494e-10
risk O 0 2.382671615563936e-09
of O 0 3.1025852997856873e-09
developing O 0 7.089737863452683e-08
BPAD B-Disease 1 1.0
, O 0 3.939532033925275e-10
similar O 0 4.193688105114113e-11
to O 0 2.1361490701310437e-11
what O 0 1.545970643168637e-11
is O 0 1.3820323357949249e-11
observed O 0 6.376025402099472e-11
in O 0 2.0240243508995448e-11
other O 0 3.253689984106245e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 4.3788173087477844e-10
we O 0 1.3374469587379423e-10
used O 0 1.2039766961180476e-09
mental O 0 1.5089939552126452e-05
health O 0 1.0790534332727475e-07
wellness O 0 1.1756787898775656e-06
( O 0 1.6953664166985405e-11
absence O 0 5.850827600184516e-10
of O 0 1.3801080278597055e-09
any O 0 2.853670633129468e-09
psychiatric B-Disease 0 0.19686807692050934
disorder I-Disease 0 1.093725472856022e-06
) O 0 1.919658702831395e-11
as O 0 3.168014114929285e-11
the O 0 3.2068206423652157e-10
phenotype O 0 9.475498163880047e-10
in O 0 1.8916292143789093e-10
our O 0 1.9787056437792216e-09
genome O 0 9.366946107647323e-10
- O 0 5.2017053775443856e-08
wide O 0 4.5417181127049844e-07
linkage O 0 3.740493070836237e-08
scan O 0 4.995423452669456e-08
of O 0 8.871952061895172e-09
several O 0 8.601545586905956e-10
large O 0 1.0149301843398462e-08
multigeneration O 0 1.0189276054006768e-06
Old O 0 1.220199976614822e-07
Order O 0 6.051807943663334e-09
Amish O 0 6.788765549714526e-09
pedigrees O 0 4.0846392934668074e-09
exhibiting O 0 4.827314992184029e-09
an O 0 1.0524145444001931e-10
extremely O 0 2.124696196759146e-09
high O 0 7.688267089633882e-08
incidence O 0 1.4447226703850902e-06
of O 0 1.1728294339263812e-05
BPAD B-Disease 1 1.0
. O 0 9.649733328842558e-06

We O 0 5.69053106858064e-08
have O 0 1.7835474763749914e-10
found O 0 6.941681257588428e-11
strong O 0 1.88783016996652e-10
evidence O 0 4.369923034541756e-10
for O 0 4.414617282844091e-10
a O 0 1.5985703871734813e-09
locus O 0 8.815885621515918e-08
on O 0 8.323502243001712e-08
chromosome O 0 3.052587373986171e-07
4p O 0 1.326900587628188e-06
at O 0 3.286800165369641e-08
D4S2949 O 0 2.219800080638379e-06
( O 0 1.9041985765966274e-09
maximum O 0 1.1567460234118698e-07
GENEHUNTER O 0 0.0001889244158519432
- O 0 6.302087740550633e-07
PLUS O 0 5.766631829828839e-07
nonparametric O 0 1.119453685305416e-07
linkage O 0 3.998459785492514e-09
score O 0 2.6934914298948343e-09
= O 0 1.3978573853989928e-10
4 O 0 3.1007613143785306e-10
. O 0 4.545576415271313e-11
05 O 0 4.879760240328324e-07
, O 0 1.6144210412960547e-09
P O 0 4.3242255998166e-08
= O 0 1.9397482231564567e-10
5 O 0 2.1061954957879436e-10
. O 0 3.0655002841717405e-11
22 O 0 9.930957167725296e-10
x O 0 5.914524425776335e-10
10 O 0 8.01036847963843e-10
( O 0 4.0426568342910585e-11
- O 0 7.41301953155471e-09
4 O 0 4.267149744663357e-09
) O 0 1.2610705535376354e-10
; O 0 2.525241959983049e-10
SIBPAL O 0 8.488628373015672e-05
Pempirical O 0 1.2191779887871235e-06
value O 0 6.880839453771159e-09
< O 0 1.279748085281085e-09
3 O 0 5.633719601938481e-10
x O 0 4.837562017634411e-10
10 O 0 4.356092153656732e-10
( O 0 1.4399589159941328e-11
- O 0 2.7396411805824528e-09
5 O 0 9.025731828593564e-10
) O 0 2.298863183147759e-11
) O 0 2.2306946220740365e-11
and O 0 9.983407156521906e-11
suggestive O 0 5.987923046291144e-09
evidence O 0 9.6969057783447e-11
for O 0 7.927709183563891e-11
a O 0 6.323284673648288e-10
locus O 0 9.33237487288352e-08
on O 0 6.25043341528908e-08
chromosome O 0 9.596565178071614e-07
4q O 0 5.1619281293824315e-06
at O 0 2.3610258637063453e-08
D4S397 O 0 1.2084576610504882e-06
( O 0 1.6028721683269964e-09
maximum O 0 6.25285352384708e-08
GENEHUNTER O 0 0.0002413581678410992
- O 0 9.388683110955753e-07
PLUS O 0 1.1307482736810925e-06
nonparametric O 0 2.727325920659496e-07
linkage O 0 4.948639276136646e-09
score O 0 1.8617560826328372e-09
= O 0 7.307667665434892e-11
3 O 0 1.7509732552767332e-10
. O 0 3.5702055894981655e-11
29 O 0 5.29661381420965e-09
, O 0 5.108119482954976e-10
P O 0 2.982078584068404e-08
= O 0 2.3184064390502357e-10
2 O 0 4.5613940402589037e-10
. O 0 5.2791798710316584e-11
57 O 0 1.7360228810048284e-09
x O 0 5.332983499251043e-10
10 O 0 6.4207678063255e-10
( O 0 1.992325575350673e-11
- O 0 5.991967366725248e-09
3 O 0 3.7480183401328304e-09
) O 0 1.0571725439501023e-10
; O 0 2.888089489783141e-10
SIBPAL O 0 6.708405271638185e-05
Pempirical O 0 1.344680299553147e-06
value O 0 3.944090387619781e-09
< O 0 8.960345243558265e-10
1 O 0 7.422665260214956e-10
x O 0 5.43220579629633e-10
10 O 0 4.4723924563783157e-10
( O 0 1.637520674613313e-11
- O 0 2.8250759509518275e-09
3 O 0 5.785277812364598e-10
) O 0 1.0856906519640663e-11
) O 0 5.68542045040199e-12
that O 0 3.488750954794284e-12
are O 0 1.4361353252445586e-11
linked O 0 4.995916125238864e-09
to O 0 3.7023111243428275e-09
mental O 0 0.0015122209442779422
health O 0 2.622008423713851e-06
wellness O 0 1.2844146112911403e-05
. O 0 4.032228773098723e-08

These O 0 2.148435029880602e-08
findings O 0 1.1943931399471808e-09
are O 0 2.5366915165636605e-11
consistent O 0 3.9754086134102806e-10
with O 0 1.693556579696054e-11
the O 0 3.720438124243941e-10
hypothesis O 0 3.487623245757021e-10
that O 0 8.67622813871538e-12
certain O 0 7.892559383826381e-10
alleles O 0 1.5654244567286923e-10
could O 0 1.934380017276638e-10
prevent O 0 6.585923806312621e-09
or O 0 3.5521868779753163e-10
modify O 0 4.4607917359940075e-09
the O 0 8.05779554191588e-10
clinical O 0 1.5688454979567723e-08
manifestations O 0 3.2685573359003683e-08
of O 0 4.1769382619349926e-08
BPAD B-Disease 1 1.0
and O 0 7.275631208614186e-09
perhaps O 0 5.925409607421273e-10
other O 0 9.955725133181659e-10
related O 0 5.732472345698625e-06
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 2.0122203636674385e-07

Segregation O 0 0.00013007820234633982
distortion O 0 0.05528083071112633
in O 0 2.647504743436002e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 4.375577191240154e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 1.0553849705274843e-07
is O 0 3.2216154188802193e-09
an O 0 2.145452926427538e-09
autosomal B-Disease 1 0.9999966621398926
dominant I-Disease 1 0.9999953508377075
disease I-Disease 1 0.9837243556976318
which O 0 9.364922032295553e-11
, O 0 1.3951291510938546e-11
in O 0 7.576567845335447e-12
the O 0 1.619935297014763e-10
typical O 0 9.706606629578118e-10
pedigree O 0 2.623864903128492e-09
, O 0 6.445206174321427e-11
shows O 0 2.545494370842505e-10
a O 0 6.082377934646388e-10
three O 0 9.85807213638168e-10
generation O 0 1.440516061990138e-08
anticipation O 0 5.105953277961817e-07
cascade O 0 3.0142620744300075e-05
. O 0 3.373156118868792e-07

This O 0 8.370523718603806e-10
results O 0 7.526623768683294e-10
in O 0 8.954980645903277e-10
infertility B-Disease 0 0.0016089717391878366
and O 1 0.8781954646110535
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.1466627465069905e-08
CDM B-Disease 0 0.000649986497592181
) O 0 2.946679705795319e-11
with O 0 1.378544067093257e-11
the O 0 1.1489981188717024e-09
disappearance O 0 2.1901490399045542e-08
of O 0 9.607501283426245e-08
DM B-Disease 1 1.0
in O 0 6.355463710860931e-09
that O 0 2.52311038728692e-09
pedigree O 0 6.836377224317403e-07
. O 0 6.376447458933399e-08

The O 0 8.661000805432195e-08
concept O 0 8.957719010993515e-09
of O 0 1.3050368785627597e-08
segregation O 0 2.0099496111924964e-07
distortion O 0 6.11298389685544e-07
, O 0 1.17188536652435e-10
where O 0 1.3235580686998816e-10
there O 0 1.2354171505246647e-11
is O 0 7.53621210575206e-12
preferential O 0 1.9559922570522303e-09
transmission O 0 5.588811635703905e-10
of O 0 8.038223975326275e-10
the O 0 1.1389416076923453e-09
larger O 0 2.0958974555895793e-09
allele O 0 1.161615179046116e-10
at O 0 9.814133949959114e-10
the O 0 2.614244998255799e-08
DM B-Disease 1 1.0
locus O 0 2.430949166409846e-07
, O 0 7.116094935533113e-10
has O 0 1.2843862084999103e-10
been O 0 9.795390887301636e-11
put O 0 1.9934298656210103e-09
forward O 0 1.586351050519852e-09
to O 0 1.1965656243617673e-10
explain O 0 3.508493218173925e-10
partially O 0 1.196831611594007e-08
the O 0 4.400964037643007e-10
maintenance O 0 6.645294803320212e-08
of O 0 2.3179715924470656e-07
DM B-Disease 1 1.0
in O 0 9.099146325297625e-09
the O 0 1.9689370134301498e-08
population O 0 8.621913183404217e-10
. O 0 7.889613407030538e-09

In O 0 3.8568742866118555e-08
a O 0 2.997405434967959e-09
survey O 0 5.772525235592241e-10
of O 0 5.790060875199288e-09
DM B-Disease 1 1.0
in O 0 2.4183151037249218e-09
Northern O 0 5.10165989453526e-07
Ireland O 0 8.617548985512258e-08
, O 0 3.5039811052683945e-09
59 O 0 2.4100739182131292e-08
pedigrees O 0 2.31564225572356e-08
were O 0 2.9028917047924097e-09
ascertained O 0 7.494912779293372e-07
. O 0 8.044028732001607e-08

Sibships O 0 1.3431228580884635e-05
where O 0 4.100735306877823e-09
the O 0 5.096966182449592e-10
status O 0 1.0950671480713936e-09
of O 0 1.3167927859214501e-09
all O 0 9.744480916618059e-11
the O 0 1.6707521477421494e-10
members O 0 7.0698464443852416e-12
had O 0 1.9975431031493684e-10
been O 0 8.247350719026159e-11
identified O 0 3.795349798330072e-11
were O 0 6.494468157702826e-11
examined O 0 6.747362113479483e-10
to O 0 3.789100283535518e-11
determine O 0 1.264953836122018e-10
the O 0 2.600471782354674e-10
transmission O 0 4.305213074928815e-09
of O 0 1.687939032990471e-07
the O 0 9.980666618503164e-06
DM B-Disease 1 1.0
expansion O 0 4.647724836104317e-06
from O 0 1.1751559725325933e-09
affected O 0 2.3084354427993503e-09
parents O 0 5.191349780608867e-11
to O 0 6.366352583997426e-11
their O 0 7.226778619973118e-10
offspring O 0 3.278947957596756e-08
. O 0 2.241821661641552e-08

Where O 0 3.876181509099297e-08
the O 0 2.37579769191143e-08
transmitting O 0 6.737042212989763e-07
parent O 0 3.1465084759929596e-08
was O 0 4.525047359038581e-08
male O 0 1.844480301826934e-08
, O 0 2.7551416703630593e-09
58 O 0 2.463132489083364e-07
. O 0 1.3824595157529984e-07

3 O 0 2.568188683937933e-08
% O 0 3.023356842657421e-10
of O 0 6.765945581577171e-10
the O 0 3.850901542090668e-10
offspring O 0 4.608802506300691e-10
were O 0 1.101140012504942e-11
affected O 0 6.584623124528122e-11
, O 0 9.737638646811764e-12
and O 0 1.4744721069104294e-11
in O 0 1.6353076878750095e-11
the O 0 2.1629635582609552e-10
case O 0 1.2109867275622577e-10
of O 0 9.64807567171988e-10
a O 0 9.327615346776952e-10
female O 0 1.4689941485457325e-09
transmitting O 0 2.5226160715874357e-08
parent O 0 8.592858868894382e-09
, O 0 4.605904990739873e-09
68 O 0 1.0853816547751194e-06
. O 0 1.9786429561463592e-07

7 O 0 5.222278787186951e-07
% O 0 4.695968947032725e-09
were O 0 1.1502151453512965e-09
affected O 0 2.7499876154024605e-08
. O 0 9.690374014326153e-08

Studies O 0 1.3334357618077775e-07
on O 0 5.9185364165159626e-08
meiotic O 0 1.8525314544604043e-06
drive O 0 2.982955038532964e-07
in O 0 8.62132587542419e-09
DM B-Disease 1 1.0
have O 0 3.1911942532936166e-10
shown O 0 1.5368390587910952e-11
increased O 0 5.2088257318505526e-11
transmission O 0 1.0224602414732331e-10
of O 0 1.0048493981340556e-10
the O 0 1.77242429066915e-10
larger O 0 9.270167966590748e-10
allele O 0 8.279329305471705e-11
at O 0 6.231535842893265e-10
the O 0 1.2638143864762696e-08
DM B-Disease 1 1.0
locus O 0 3.9895189729577396e-07
in O 0 3.927567604478099e-09
non O 0 1.648579927859828e-05
- O 0 0.00010771933011710644
DM O 1 1.0
heterozygotes O 0 5.182224867894547e-06
for O 0 2.527268527785509e-08
CTGn O 0 9.084396879188716e-05
. O 0 1.8481433983197348e-07

This O 0 8.821314345652809e-09
study O 0 9.924330246491309e-10
provides O 0 1.118199491334515e-10
further O 0 6.009404085460801e-11
evidence O 0 1.1121035342620544e-10
that O 0 2.4067262072158258e-11
the O 0 1.5266129693713992e-08
DM B-Disease 1 1.0
expansion O 0 1.6890513734324486e-06
tends O 0 4.695944255672657e-08
to O 0 1.2387689762860532e-09
be O 0 2.0593891036924106e-09
transmitted O 0 1.5929069618891845e-08
preferentially O 0 1.0689707607980381e-07
. O 0 5.9483120651293575e-08

Diagnosis O 1 0.8396880626678467
of O 0 0.0013814881676808
hemochromatosis B-Disease 1 1.0
. O 0 3.848046253551729e-05

If O 0 1.3223781252236222e-06
untreated O 1 1.0
, O 0 5.085959031703169e-08
hemochromatosis B-Disease 1 1.0
can O 0 1.917466647682886e-07
cause O 0 1.523905393696623e-05
serious O 1 0.9999970197677612
illness O 0 0.0001114797851187177
and O 0 2.0024604197033113e-10
early B-Disease 0 1.8433531090433775e-10
death I-Disease 0 1.4407021131646047e-09
, O 0 2.1014674375652298e-11
but O 0 2.59554010229035e-11
the O 0 4.4451781144871916e-10
disease O 0 7.914304944733885e-08
is O 0 4.084715066188238e-10
still O 0 4.690711707944217e-10
substantially O 0 2.6277113818196085e-09
under O 0 2.0675647860457502e-08
- O 0 0.006269465666264296
diagnosed O 0 2.4907443730626255e-05
. O 0 2.640885270466242e-07

The O 0 1.6864925100890105e-07
cornerstone O 0 2.767930027403054e-06
of O 0 2.3601751664159565e-08
screening O 0 8.227781123082423e-09
and O 0 4.714211243594946e-10
case O 0 1.2475796784539028e-10
detection O 0 5.820854465099501e-09
is O 0 7.442764460297013e-11
the O 0 1.8463582052152816e-10
measurement O 0 7.632682930136525e-09
of O 0 2.5955340987593445e-08
serum O 0 2.3236504276269443e-08
transferrin O 0 6.801404595080385e-08
saturation O 0 4.270424724950317e-08
and O 0 2.4745543392157288e-09
the O 0 1.3284052080564379e-08
serum O 0 5.2424926622052226e-08
ferritin O 0 8.795560688668047e-07
level O 0 1.813029655295395e-07
. O 0 8.516630600752251e-08

Once O 0 2.6810127451426524e-07
the O 0 8.295129028113024e-09
diagnosis O 0 6.607353242316094e-08
is O 0 8.392552763858419e-10
suspected O 0 4.695278832400618e-09
, O 0 8.439457466202782e-10
physicians O 0 1.8009206348423845e-09
must O 0 3.0184188481996443e-10
use O 0 6.477733349719017e-10
serum O 0 5.123695689945862e-09
ferritin O 0 1.5654266860565258e-07
levels O 0 9.928712074724899e-08
and O 0 4.980287116040927e-08
hepatic O 1 0.9999992847442627
iron O 1 0.9999915361404419
stores O 0 8.460482092687016e-08
on O 0 3.2809371219855166e-08
liver O 0 1.7709073745209025e-06
biopsy O 0 1.9746993018543435e-07
specimens O 0 2.568387946766393e-09
to O 0 3.8195471091517774e-11
assess O 0 2.2237764962795836e-09
patients O 0 2.9377236754335456e-11
for O 0 4.588308899489135e-12
the O 0 2.1067418642939373e-10
presence O 0 1.625783396796976e-09
of O 0 9.274810253145915e-08
iron B-Disease 1 0.53121018409729
overload I-Disease 0 1.0462495993124321e-05
. O 0 1.7379063876887813e-07

Liver O 1 1.0
biopsy O 0 0.0009732924518175423
is O 0 3.7018732523819153e-09
also O 0 1.0111285420055793e-10
used O 0 3.2035363944915574e-11
to O 0 2.464439242955141e-11
establish O 0 1.396959076194193e-10
the O 0 1.9421546315623317e-10
presence O 0 4.0877859430743513e-10
or O 0 7.392598755373569e-10
absence O 0 1.3119800357230815e-08
of O 0 1.0994883581361137e-07
cirrhosis B-Disease 1 1.0
, O 0 6.812355679564064e-10
which O 0 1.0265070043979918e-10
can O 0 1.1444875602784066e-10
affect O 0 3.048023833329694e-09
prognosis O 0 2.763114252957166e-07
and O 0 8.853982436107799e-09
management O 0 1.545335237551626e-07
. O 0 1.4790042257573077e-07

A O 0 5.426856546364434e-07
DNA O 0 8.28717450218619e-09
- O 0 2.2033461721804315e-09
based O 0 1.4900052025534904e-10
test O 0 6.115143114104882e-11
for O 0 1.1277523359609631e-10
the O 0 6.639059080271181e-09
HFE O 0 0.0011567898327484727
gene O 0 1.9536434692213334e-09
is O 0 4.019897609230938e-11
commercially O 0 2.297032147824396e-10
available O 0 9.703728272303369e-12
, O 0 5.907134156823979e-12
but O 0 2.0530990102463065e-12
its O 0 8.863211380105707e-12
place O 0 4.654117022329096e-11
in O 0 4.7398300562218054e-12
the O 0 1.2141969374379613e-10
diagnosis O 0 1.1155760759606892e-08
of O 0 6.64575097175657e-08
hemochromatosis B-Disease 1 1.0
is O 0 4.562860667078894e-08
still O 0 5.973367134259888e-09
being O 0 3.125404601789228e-09
evaluated O 0 4.884574522634466e-08
. O 0 2.4457030178837158e-08

Currently O 0 1.3315867875007825e-07
, O 0 8.090814129779744e-10
the O 0 4.139980858131054e-10
most O 0 7.211903296777677e-11
useful O 0 8.676017543285397e-11
role O 0 7.843483501579485e-11
for O 0 1.711442272622765e-11
this O 0 4.562720860856739e-12
test O 0 2.675822584341514e-11
is O 0 1.022054142707507e-11
in O 0 4.6476746062840135e-12
the O 0 9.771207454267739e-11
detection O 0 2.039551993959776e-08
of O 0 6.08026127224548e-08
hemochromatosis B-Disease 1 1.0
in O 0 2.866457515793286e-09
the O 0 8.371597637335526e-09
family O 0 2.7290630866261267e-10
members O 0 6.6784464243518915e-12
of O 0 2.7864582863301735e-10
patients O 0 7.750580038878851e-11
with O 0 1.703249000173379e-11
a O 0 4.2964989899196837e-10
proven O 0 4.889269877850211e-09
case O 0 6.24933105264347e-10
of O 0 1.0813730355607731e-08
the O 0 6.694630627634979e-08
disease O 0 2.0925285753037315e-06
. O 0 1.1711227188015982e-07

It O 0 7.559891379571582e-09
is O 0 7.7066120152125e-10
crucial O 0 9.62696056205914e-09
to O 0 3.646254187472664e-09
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999998807907104
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.0034553816076368093
because O 0 1.953443096169849e-08
phlebotomy O 0 0.4490964412689209
therapy O 0 8.811313279011301e-08
can O 0 1.6678165792871624e-10
avert O 0 2.909473835188692e-07
serious O 1 1.0
chronic O 1 1.0
disease O 1 0.9996970891952515
and O 0 4.0069933482378417e-10
can O 0 5.2808316747254835e-11
even O 0 1.7988736888963075e-10
lead O 0 2.293067513647884e-09
to O 0 5.95687832394276e-10
normal O 0 1.5551291809856593e-08
life O 0 1.3814565047454153e-09
expectancy O 0 1.685399042550273e-09
. O 0 1.6660010870861441e-10
. O 0 1.0979078091111205e-08

Prevalence O 0 1.1546861060196534e-05
of O 0 1.3219595302871312e-06
the O 0 3.3319759040750796e-07
I1307K O 0 2.6195535610895604e-05
APC B-Disease 0 1.5765539274070761e-06
gene O 0 2.1998274313261845e-09
variant O 0 1.3065853954330464e-09
in O 0 3.028393855131206e-11
Israeli O 0 7.836727378141006e-10
Jews O 0 5.066065622560956e-11
of O 0 2.8386629852272804e-11
differing O 0 2.162533346838913e-11
ethnic O 0 1.2871322931096163e-11
origin O 0 2.656279276397333e-12
and O 0 2.4421891592352196e-11
risk O 0 1.2306753838231543e-08
for O 0 4.5975863116609617e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.397580831508094e-06

BACKGROUND O 0 3.7750003230030416e-06
& O 0 5.247024432719627e-07
AIMS O 0 3.99240803972134e-07
Israeli O 0 2.9533673284731776e-09
Jews O 0 6.740878966127184e-10
of O 0 1.1382857989516992e-09
European O 0 1.5874830339157597e-09
birth O 0 3.930122449702367e-09
, O 0 1.3039805346615196e-10
i O 0 1.9596509137631557e-10
. O 0 2.428453792224783e-11
e O 0 1.514277730985114e-10
. O 0 4.059896516195316e-11
, O 0 1.9834466014057028e-10
Ashkenazim O 0 1.3864982406630588e-07
, O 0 1.709208607980628e-10
have O 0 2.6500865737966173e-11
the O 0 5.364773070226647e-10
highest O 0 4.485875251702964e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.00015393916692119092
of O 0 5.276087478023328e-08
any O 0 4.698863076413318e-09
Israeli O 0 1.4056551478347501e-08
ethnic O 0 7.972115412258063e-09
group O 0 9.419636182173008e-10
. O 0 1.072843147653657e-08

The O 0 5.190677256905474e-06
I1307K O 0 0.00022358258138410747
APC B-Disease 0 6.8714780354639515e-06
gene O 0 2.1962522467333656e-08
variant O 0 1.8149078684359665e-08
was O 0 7.409542313041584e-09
found O 0 4.5927087133357247e-10
in O 0 6.953849718271954e-10
6 O 0 2.4771867401796044e-07
. O 0 6.719780998309943e-08

1 O 0 1.5582735102270817e-08
% O 0 1.2465900534053276e-10
of O 0 1.7614644465258067e-10
American O 0 7.072035318467229e-11
Jews O 0 6.288498194395586e-11
, O 0 7.857854124326824e-12
28 O 0 4.167456379988721e-10
% O 0 2.8487840558755195e-11
of O 0 5.973774253043018e-10
their O 0 1.9741149159813176e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 4.590024715867003e-08
, O 0 4.108589770485116e-12
but O 0 9.780558524533078e-13
not O 0 1.3266325971789117e-12
in O 0 1.5216454832267523e-11
non O 0 2.7342448305489597e-08
- O 0 5.402545966148864e-08
Jews O 0 1.686116846144614e-08
. O 0 1.566713514478124e-08

We O 0 1.0806702732679696e-07
assessed O 0 1.2106897884223145e-06
the O 0 2.2052057957466786e-08
I1307K O 0 1.574432417328353e-06
prevalence O 0 1.6450643514076546e-08
in O 0 6.46433809259328e-11
Israeli O 0 1.0811538331267911e-09
Jews O 0 1.0355767632308499e-10
of O 0 6.340685615446873e-11
differing O 0 2.0940334535812788e-11
ethnic O 0 1.986906472684069e-11
origin O 0 4.800954772621324e-12
and O 0 2.816282276829618e-11
risk O 0 6.693185117256917e-09
for O 0 2.5043840778948834e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1807419468823355e-06

METHODS O 0 6.302063866314711e-07
DNA O 0 6.633944948930548e-09
samples O 0 1.503084046117209e-10
from O 0 1.613391364951866e-11
500 O 0 1.7897223980600785e-10
unrelated O 0 4.73074857065825e-10
Jews O 0 1.2006830252264677e-10
of O 0 8.151332386852062e-10
European O 0 9.321302618658933e-10
or O 0 8.896412079240079e-11
non O 0 1.6075075714994114e-09
- O 0 3.1866387306678234e-10
European O 0 7.152068520754895e-11
origin O 0 4.542609777918871e-12
, O 0 4.768591120932197e-13
with O 0 6.61908082597723e-13
or O 0 2.334833541783876e-11
without O 0 1.1200992910964658e-10
a O 0 7.648151556516325e-11
personal O 0 8.206994528414668e-10
and O 0 3.7082883985739556e-10
/ O 0 2.531726295273984e-08
or O 0 9.311848514492738e-10
family O 0 5.437295613752724e-10
history O 0 2.0873280881517076e-09
of O 0 1.1901638785616342e-08
neoplasia B-Disease 0 4.427820840646746e-06
, O 0 1.4168539952397197e-10
were O 0 8.523281386230153e-11
examined O 0 1.6342990294404558e-09
for O 0 1.7460506651634233e-10
the O 0 2.6207740422279358e-09
I1307K O 0 2.95617098799994e-07
variant O 0 1.2162650886438087e-09
by O 0 2.751788380495057e-11
the O 0 1.8023776915399026e-09
allele O 0 9.156542191135486e-10
- O 0 2.35712036555924e-08
specific O 0 1.632203172619029e-08
oligonucleotide O 0 2.7714671091416676e-07
( O 0 2.8146955877161872e-09
ASO O 0 9.212090662913397e-05
) O 0 4.208034365404956e-09
method O 0 3.443354401611032e-08
. O 0 2.5695946703763184e-08

RESULTS O 0 1.4156066185933014e-07
In O 0 1.880255950936771e-09
persons O 0 4.349497845224093e-11
at O 0 3.1193089777836747e-11
average O 0 1.2326779874616278e-10
risk O 0 2.214342265105529e-09
for O 0 7.91244492148735e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 4.683830212570683e-09
I1307K O 0 3.2381956316385185e-07
was O 0 1.706033869730561e-09
found O 0 1.290141327103811e-10
in O 0 3.0282043539386905e-10
5 O 0 9.046093651932097e-08
. O 0 5.248426049320187e-08

0 O 0 7.659257050818269e-08
% O 0 8.60591042872727e-10
of O 0 8.535128714903806e-10
120 O 0 3.635920453604058e-09
European O 0 1.3092347206367094e-09
and O 0 3.4006992777335654e-09
1 O 0 2.767141040749266e-07
. O 0 6.313963041293391e-08

6 O 0 2.650718045060785e-07
% O 0 1.434923957432943e-09
of O 0 1.9894186298330396e-09
188 O 0 3.6645630974163623e-09
non O 0 1.6117327916731483e-08
- O 0 2.6886217696642234e-08
European O 0 6.779332206718891e-09
Jews O 0 5.65277380459861e-09
( O 0 3.501066658806451e-10
P O 0 9.013215418463005e-08
= O 0 5.493199783934699e-10
0 O 0 5.25641474791172e-10
. O 0 1.4620696320299942e-10
08 O 0 2.4263562181658926e-07
) O 0 4.1463841249367306e-09
. O 0 5.5412439081692355e-08

It O 0 2.7652619749574114e-08
occurred O 0 9.813128087898804e-09
in O 0 2.5581794460549645e-09
15 O 0 1.1136886257645529e-07
. O 0 1.210944446938811e-07

4 O 0 1.2836484586387087e-07
% O 0 1.1706526859001087e-09
of O 0 2.2398032317738625e-09
52 O 0 9.495295216765953e-09
Ashkenazi O 0 4.1406323703085945e-08
Israelis O 0 2.064309967408917e-08
with O 0 1.2302929341956315e-08
familial O 1 0.999906063079834
cancer B-Disease 1 0.9999998807907104
( O 0 2.795136122557551e-09
P O 0 1.1174014957759937e-07
= O 0 9.579985416063863e-11
0 O 0 4.867992814405753e-11
. O 0 1.0332322671058325e-11
02 O 0 8.665474560132225e-09
) O 0 1.023212677780938e-11
and O 0 5.8187399343268e-11
was O 0 1.4969221417970857e-09
not O 0 3.800703501921632e-11
detected O 0 4.882315662868564e-10
in O 0 1.317623787855382e-10
51 O 0 1.281522088447673e-08
non O 0 5.1406501277995176e-09
- O 0 2.8121092121580205e-09
European O 0 5.86193038554228e-10
Jews O 0 3.9386982564337814e-10
at O 0 2.1646970327360293e-10
increased O 0 3.897515643558336e-09
cancer B-Disease 0 2.352310843889427e-07
risk O 0 6.581819889106555e-08
. O 0 2.8176781796673822e-08

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9944889545440674
occurred O 0 2.7408822234065155e-07
personally O 0 8.907053938855825e-08
or O 0 3.2451352716122983e-10
in O 0 3.016535285449429e-11
the O 0 1.7703566390636638e-10
families O 0 1.837958604755663e-12
of O 0 2.4320429004021094e-10
13 O 0 1.1350835826817729e-09
of O 0 2.8646045535651865e-09
20 O 0 4.973430556276526e-09
Ashkenazi O 0 2.9939426493541532e-09
I1307K O 0 5.7233279449064867e-08
carriers O 0 6.784447309504671e-11
, O 0 2.229074043402779e-11
8 O 0 4.541773901411972e-10
of O 0 7.826689296663858e-10
whom O 0 1.2523245773721214e-09
also O 0 7.935216372878529e-10
had O 0 3.4293787809502874e-09
a O 0 1.041243757882171e-09
personal O 0 7.698564452596202e-09
or O 0 6.54540865951958e-10
family O 0 4.749345916543746e-10
history O 0 1.735381438550121e-08
of O 0 2.6174987510785286e-07
noncolonic O 0 0.023401549085974693
neoplasia B-Disease 0 0.037726081907749176
. O 0 4.552047130346182e-07

CONCLUSIONS O 0 2.524614728827146e-06
The O 0 1.6259181734312733e-07
I1307K O 0 1.4673569239675999e-05
APC O 0 1.0727202379712253e-06
variant O 0 1.6357692800283985e-07
may O 0 3.783492630304863e-09
represent O 0 1.0586844734206124e-09
a O 0 3.1512498166463843e-10
susceptibility O 0 3.0352506286135394e-08
gene O 0 3.3404415344939764e-10
for O 0 5.319004681147987e-10
colorectal B-Disease 1 1.0
, I-Disease 0 1.7214498271300727e-08
or I-Disease 0 4.4469253279721954e-10
other I-Disease 0 2.072936960972882e-10
, I-Disease 0 1.306096342190699e-10
cancers I-Disease 0 8.117826411080387e-08
in O 0 7.254560840941338e-11
Ashkenazi O 0 3.5924778707396854e-09
Jews O 0 7.952853375847724e-10
, O 0 9.238462078675624e-11
and O 0 6.832108767618195e-10
partially O 0 2.608167051221244e-07
explains O 0 1.5104679729205372e-09
the O 0 1.2861219034210336e-10
higher O 0 5.125589397358965e-10
incidence O 0 1.0397205585377378e-07
of O 0 1.1809912393800914e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.105569548888525e-09
European O 0 1.644832181568745e-08
Israelis O 0 8.287901920311924e-09
. O 0 8.605521628624047e-09

Systematic O 0 1.461767737964692e-07
analysis O 0 3.10716874452055e-09
of O 0 2.6349598059027812e-08
coproporphyrinogen O 0 0.00011309947876725346
oxidase O 0 4.649120910471538e-06
gene O 0 7.151136287575355e-07
defects O 0 0.0001914541207952425
in O 0 1.1418177514599392e-08
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 1.1001833399859606e-06
mutation O 0 4.7132991198850505e-07
update O 0 1.7159203480332508e-07
. O 0 1.3138824783709424e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 7.748373604954395e-07
HC B-Disease 1 1.0
) O 0 6.547587361183105e-08
is O 0 1.5167614941802299e-09
an O 0 1.12749476421925e-09
acute O 1 0.9999983310699463
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9111262559890747
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 0 0.006651028990745544
caused O 0 3.4633384160542846e-08
by O 0 6.642307537330083e-11
deficient B-Disease 0 2.4613283855501322e-08
activity I-Disease 0 2.952252220467244e-09
of I-Disease 0 1.451454245682271e-08
coproporphyrinogen I-Disease 0 2.7213862267672084e-05
III I-Disease 1 1.0
oxidase I-Disease 0 5.698486233995936e-07
( O 0 3.3957021638997276e-09
CPO O 0 0.0651560127735138
) O 0 1.5361877103714505e-08
. O 0 6.637922211893965e-08

Clinical O 0 0.0001133363475673832
manifestations O 0 1.934067222464364e-05
of O 0 8.608529356024519e-08
the O 0 9.032572911849002e-09
disease O 0 5.372129407987813e-07
are O 0 1.0601038276381036e-11
characterized O 0 1.1827311352519132e-10
by O 0 1.3972089110692032e-11
acute O 0 1.6020928228499542e-07
attacks O 0 4.377867401927915e-09
of O 1 0.8491123914718628
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 4.269443132365325e-10
precipitated O 0 5.245978651480243e-10
by O 0 4.5356318527367545e-12
drugs O 0 4.723896274150263e-10
, O 0 8.871334222781968e-11
fasting O 0 8.63628635272562e-09
, O 0 2.0153589908034064e-09
cyclical O 1 0.9909384250640869
hormonal O 0 1.0369343726779334e-05
changes O 0 4.516921947583796e-09
, O 0 9.044550663972473e-10
or O 0 8.708122223310966e-09
infectious B-Disease 0 7.995422492967919e-06
diseases I-Disease 0 2.0884037439827807e-05
. O 0 1.0471239875187166e-07

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 5.398528912792244e-08
also O 0 2.4062880576991574e-09
be O 0 3.8709760397104276e-10
present O 0 2.0704762349055272e-09
. O 0 2.991295744436684e-08

The O 0 4.80145047276892e-07
seven O 0 3.9112947547437216e-08
exons O 0 7.777068589120972e-08
, O 0 2.7280133707563436e-09
the O 0 2.5436138528789343e-08
exon O 0 6.994600312282273e-07
/ O 0 3.340585692512832e-07
intron O 0 4.5212900090518815e-07
boundaries O 0 9.795980027149653e-09
and O 0 2.2990485903928715e-10
part O 0 1.0660419214048034e-09
of O 0 5.1443969084630226e-09
3 O 0 8.68112515206576e-09
noncoding O 0 1.378949008312702e-07
sequence O 0 7.121688794242687e-10
of O 0 2.3792021686119824e-09
the O 0 8.849491806017795e-09
CPO O 0 0.0005290707922540605
gene O 0 2.1962638374617427e-09
were O 0 2.1752014078835202e-10
systematically O 0 6.231274940482479e-10
analyzed O 0 1.0950478718241285e-10
by O 0 1.0525163206265287e-11
an O 0 1.406747912602313e-10
exon O 0 4.25765591671734e-08
- O 0 3.789337199577858e-08
by O 0 2.0296162528410377e-09
- O 0 3.440608452365268e-06
exon O 0 9.433789273316506e-06
denaturing O 0 4.519019421422854e-05
gradient O 0 2.3339826782375894e-07
gel O 0 3.2822146067701397e-07
electrophoresis O 0 6.275482888895567e-08
( O 0 5.998184726685452e-10
DGGE O 0 9.0280213044025e-05
) O 0 1.4459484998230465e-10
strategy O 0 2.7144753111940645e-10
followed O 0 3.3422372508473686e-11
by O 0 8.285597034862757e-12
direct O 0 3.5455333113887377e-10
sequencing O 0 2.7061214380452725e-10
in O 0 1.349629435987154e-10
seven O 0 4.951046683743243e-09
unrelated O 0 1.35585082716716e-07
heterozygous O 0 1.3635701634484576e-07
HC B-Disease 1 1.0
patients O 0 3.0003568518566226e-09
from O 0 4.238406153822538e-11
France O 0 5.874567499120076e-10
, O 0 3.3122955767073137e-11
Holland O 0 9.00998031738709e-09
, O 0 1.0731449062717502e-10
and O 0 5.120175949890893e-10
Czech O 0 0.00011670013918774202
Republic O 0 9.991542356146965e-06
. O 0 5.512553684638988e-07

Seven O 0 2.404789540833008e-07
novel O 0 7.449691707961392e-08
mutations O 0 1.354806489217708e-09
and O 0 3.4892866374036657e-10
two O 0 1.511922809172006e-10
new O 0 4.685070109644585e-10
polymorphisms O 0 1.0531564953453199e-08
were O 0 3.269142068162978e-09
detected O 0 1.28145288158521e-07
. O 0 8.040623811211844e-08

Among O 0 2.0710853476657576e-08
these O 0 1.1843344083217744e-09
mutations O 0 1.2975949204019344e-09
two O 0 1.9598564438005894e-10
are O 0 7.699232917879328e-11
missense O 0 2.8905006388413312e-08
( O 0 3.0521646321446383e-10
G197W O 0 3.928191461000097e-07
, O 0 3.472330478704322e-10
W427R O 0 1.0762006041886707e-07
) O 0 5.705846906067791e-11
, O 0 4.7406824993379004e-11
two O 0 2.3474526142375218e-11
are O 0 1.306987851279473e-11
nonsense O 0 4.71286476511068e-09
( O 0 6.345500513926794e-11
Q306X O 0 1.0509977244055335e-07
, O 0 2.77520312286228e-10
Q385X O 0 1.0198245092851721e-07
) O 0 8.23366028135375e-11
, O 0 6.526020696062673e-11
two O 0 2.413612538998411e-11
are O 0 1.1394706359024731e-11
small O 0 7.770982191068754e-10
deletions O 0 2.2192395476849924e-08
( O 0 6.006885544529439e-10
662de14bp O 0 2.623371528898133e-07
; O 0 5.859325802326509e-10
1168del3bp O 0 1.2167990917077987e-06
removing O 0 1.6540381864160736e-07
a O 0 1.9909143222918146e-09
glycine O 0 1.631900614640358e-09
at O 0 1.283167461174628e-09
position O 0 2.892986517011309e-09
390 O 0 1.2989618269898529e-09
) O 0 2.0091775465580497e-11
, O 0 3.666460884899081e-11
and O 0 2.0044244042338732e-10
one O 0 4.4095088691520345e-10
is O 0 2.065371346171574e-10
a O 0 1.152353990008237e-09
splicing O 0 9.904066189392324e-08
mutation O 0 1.524433557165139e-08
( O 0 1.93817739635449e-09
IVS1 O 1 0.9717888832092285
- O 0 1.719260012578161e-06
15c O 0 2.4784208108030725e-06
- O 0 1.1337269256728177e-07
- O 0 7.618228892170009e-08
> O 0 1.0017903839809605e-08
g O 0 2.1510253578327365e-09
) O 0 3.339178586414526e-11
which O 0 4.9821514969128344e-11
creates O 0 4.9918775779644875e-09
a O 0 2.3298965534657157e-10
new O 0 9.82241177283072e-10
acceptor O 0 4.363826244802027e-10
splice O 0 2.2121488996162952e-07
site O 0 9.522576505105462e-08
. O 0 8.439739218601972e-08

The O 0 2.7957409542977985e-07
pathological O 0 7.662397933927423e-07
significance O 0 1.1426580215356807e-07
of O 0 4.680546084046e-08
the O 0 1.555841144806891e-08
point O 0 1.9027061171073e-07
mutations O 0 2.2582142822358264e-09
G197W O 0 1.2727070952678332e-07
, O 0 5.587468820955621e-10
W427R O 0 2.6494492999518116e-07
, O 0 2.7636454236201757e-10
and O 0 3.093047207247679e-10
the O 0 1.3914021046446123e-09
in O 0 3.2450733766786755e-10
- O 0 1.0064984934388121e-07
frame O 0 6.34446877256778e-08
deletion O 0 1.7523181128353826e-08
390delGly O 0 1.6081463272143992e-08
were O 0 2.2232186577819668e-11
assessed O 0 2.4701265477489187e-09
by O 0 1.6649773573740312e-11
their O 0 1.1330540672371825e-10
respective O 0 2.635461182620702e-09
expression O 0 4.1566600161857536e-10
in O 0 8.05995895025724e-11
a O 0 7.906074683816655e-10
prokaryotic O 0 5.214096931993595e-10
system O 0 6.140193353765255e-10
using O 0 1.2840138674530266e-10
site O 0 3.3044427194539594e-09
- O 0 1.6921577028483625e-08
directed O 0 2.751005290235753e-08
mutagenesis O 0 7.33770320948679e-06
. O 0 1.2489408618421294e-07

These O 0 3.129014913838546e-08
mutations O 0 3.0363609404560066e-09
resulted O 0 3.450038477126327e-09
in O 0 5.247196427360379e-11
the O 0 1.7688250864011934e-09
absence O 0 9.964355562885885e-09
or O 0 6.188964896125526e-10
a O 0 7.224849052356319e-10
dramatic O 0 3.971539896951981e-08
decrease O 0 6.195194401925619e-08
of O 0 2.9762949793621374e-07
CPO O 1 0.9999092817306519
activity O 0 3.543032960351411e-07
. O 0 1.290379429974564e-07

The O 0 8.180714416994306e-08
two O 0 7.895239462207826e-10
polymorphisms O 0 3.557301120338252e-09
were O 0 5.433770655649539e-10
localized O 0 4.343071680068533e-08
in O 0 5.132084757164534e-10
noncoding O 0 2.8087796977160906e-07
part O 0 8.599253753516223e-09
of O 0 2.743784399683591e-08
the O 0 4.3143706385251335e-09
gene O 0 3.100915080267441e-10
1 O 0 3.2876696920425275e-09
) O 0 1.292668611041492e-10
a O 0 5.782453960101464e-10
C O 0 3.487952682235118e-08
/ O 0 1.8342220187150815e-08
G O 0 2.353849737346536e-08
polymorphism O 0 2.1218807266798478e-10
in O 0 9.021389885122133e-11
the O 0 2.2947694855446343e-09
promotor O 0 1.2108514965802897e-05
region O 0 1.783638623464867e-07
, O 0 7.166345739051394e-09
142 O 0 3.7508879557890396e-08
bp O 0 9.02458285878538e-09
upstream O 0 1.781087988206309e-08
from O 0 1.3351690864027432e-09
the O 0 4.888822235926682e-09
transcriptional O 0 1.846085240231332e-08
initiation O 0 1.0748790302272937e-08
site O 0 8.657973893377857e-09
( O 0 3.079413946061038e-10
- O 0 7.029078830100843e-08
142C O 0 1.2213962463647476e-06
/ O 0 2.1215672774133054e-08
G O 0 3.4218142985764644e-08
) O 0 3.6197111280555916e-11
, O 0 2.320679239053991e-11
and O 0 8.648871202554531e-11
2 O 0 2.7325126605859396e-09
) O 0 2.618613936800074e-10
a O 0 7.555995829022777e-10
6 O 0 7.516814726216126e-09
bp O 0 4.263309261176573e-09
deletion O 0 9.89901605130683e-10
polymorphism O 0 4.994939184488345e-11
in O 0 1.9068789949838738e-11
the O 0 1.676766642200178e-10
3 O 0 1.5917246409813401e-09
noncoding O 0 9.313064452953768e-08
part O 0 3.3490175077588447e-09
of O 0 1.990771103521638e-08
the O 0 3.146244154095257e-08
CPO O 0 0.20621532201766968
gene O 0 4.46090231420726e-09
, O 0 1.7152412823406848e-09
574 O 0 5.406648284633775e-08
bp O 0 3.458557440438881e-09
downstream O 0 7.95476928772132e-09
of O 0 1.4662425718015015e-09
the O 0 7.018101100264573e-10
last O 0 1.8965061465703315e-10
base O 0 3.247031754582963e-09
of O 0 6.400815877327659e-09
the O 0 1.3610311100364925e-08
normal O 0 4.391995744867927e-08
termination O 0 4.4092612228041617e-08
codon O 0 6.3817765294516e-08
( O 0 2.7489950316095246e-09
+ O 0 1.7112229855342775e-08
574 O 0 8.640655835279176e-08
delATTCTT O 0 1.1847213272631052e-06
) O 0 8.732239820119503e-09
. O 0 5.357528110039311e-08

Five O 0 7.503588221879909e-07
intragenic O 0 6.497514732473064e-06
dimorphisms O 0 6.437416686821962e-06
are O 0 8.162596154548396e-10
now O 0 3.2569663632742163e-10
well O 0 1.1930446908170467e-10
characterized O 0 4.1072306666833924e-10
and O 0 7.81239725688998e-11
the O 0 6.390626361429952e-10
high O 0 4.185822888302937e-08
degree O 0 1.2978382812889322e-08
of O 0 1.4666152736708682e-08
allelic O 0 1.5296988067348138e-06
heterogeneity O 0 2.20982940390968e-07
in O 0 2.3063229104280936e-09
HC B-Disease 1 1.0
is O 0 2.8909235005869505e-09
demonstrated O 0 1.459458942587588e-10
with O 0 1.9125102543315897e-11
seven O 0 1.9255774058590802e-11
new O 0 4.6470010998944655e-12
different O 0 1.4119884731919607e-12
mutations O 0 3.313964033746508e-11
making O 0 4.815392182222489e-11
a O 0 5.2166607839021495e-11
total O 0 1.3204641546860074e-10
of O 0 3.2431570762270212e-09
nineteen O 0 1.161159843832138e-06
CPO O 1 1.0
gene B-Disease 0 1.4839818049949827e-06
defects I-Disease 0 1.8368400560575537e-05
reported O 0 1.337513988453054e-09
so O 0 2.4764515438313595e-10
far O 0 7.832677839658686e-10
. O 0 1.0949585682595853e-09
. O 0 3.7892942117423445e-08

Coincidence O 0 6.561908207913802e-07
of O 0 7.264652168714747e-08
two O 0 2.5423125826762316e-09
novel O 0 3.5169389178690835e-08
arylsulfatase O 0 2.869292757168296e-06
A O 0 1.6525341095530166e-07
alleles O 0 1.8332768636497576e-09
and O 0 5.181561402167745e-09
mutation O 0 5.7373288342432716e-08
459 O 0 8.801553974535636e-08
+ O 0 1.8821836533788883e-08
1G O 0 2.8778355044778436e-05
> O 0 6.814792641307577e-08
A O 0 1.2150348993600346e-07
within O 0 1.319284126388709e-09
a O 0 5.164509375710225e-10
family O 0 5.97304483651584e-10
with O 0 5.53717338647175e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.628697732236617e-09
molecular O 0 1.1235489205674298e-09
basis O 0 1.6241955003160058e-10
of O 0 8.647226268365671e-10
phenotypic O 0 9.695911103335675e-06
heterogeneity O 0 4.271738816896686e-06
. O 0 1.749203306644631e-07

In O 0 1.0777490011548707e-08
a O 0 7.373250343611915e-10
family O 0 9.425203673085747e-11
with O 0 3.141412477369876e-11
three O 0 2.872048987523357e-10
siblings O 0 1.7148193975913273e-09
, O 0 1.0172082620663048e-10
one O 0 8.273599166885859e-11
developed O 0 6.701344479331794e-10
classical O 0 3.053268216035576e-08
late O 0 1.7256913054097822e-07
infantile O 1 0.9999997615814209
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.040197699670898e-08
MLD B-Disease 1 1.0
) O 0 1.9614094792785863e-09
, O 0 4.702186973126743e-10
fatal O 0 5.217322573969341e-09
at O 0 4.366706995995173e-10
age O 0 5.910983369439293e-10
5 O 0 5.281317605465574e-10
years O 0 7.756510711498521e-11
, O 0 3.8647550437698186e-11
with O 0 8.020990122092897e-11
deficient O 0 4.1929186522793316e-07
arylsulfatase O 0 7.132454629754648e-05
A O 0 2.9706054647249402e-06
( O 0 6.139306396590882e-09
ARSA O 0 0.0678834468126297
) O 0 4.637159822795667e-10
activity O 0 2.702583157265792e-10
and O 0 1.085330991745792e-10
increased O 0 2.7004924962881205e-09
galactosylsulfatide O 0 4.767457539855968e-06
( O 0 2.179264768642497e-08
GS O 1 1.0
) O 0 1.450906061961632e-08
excretion O 0 1.315325448558724e-07
. O 0 1.1997411064612606e-08

The O 0 4.944179465837806e-08
two O 0 4.40539826840336e-10
other O 0 2.18194948220507e-10
siblings O 0 3.2565710128551473e-09
, O 0 5.054312524066518e-10
apparently O 0 2.8094284676427606e-09
healthy O 0 2.330804660388708e-09
at O 0 8.629580383612279e-10
12 O 0 1.8707762006187068e-09
( O 0 1.9040295382022343e-11
1 O 0 1.320132447801825e-09
/ O 0 3.988517571773542e-10
2 O 0 4.197314995568746e-10
) O 0 2.535887081919763e-12
and O 0 1.5766665750760467e-11
15 O 0 7.376228794431228e-11
years O 0 9.676023003668544e-12
, O 0 6.684664974332399e-12
respectively O 0 3.130842807230749e-11
, O 0 1.1306161736002185e-11
and O 0 1.593980503145076e-11
their O 0 2.670280663252811e-11
father O 0 8.389224315230592e-10
, O 0 4.79193962288349e-10
apparently O 0 1.6364699595428078e-09
healthy O 0 9.583974724947097e-10
as O 0 3.67444165372266e-11
well O 0 1.0438680475566287e-10
, O 0 1.3704805346126392e-10
presented O 0 3.17526591686601e-08
ARSA O 1 0.9999693632125854
and O 0 9.084894969646484e-08
GS O 1 0.9999998807907104
values O 0 1.6626021670518298e-09
within O 0 8.001446727412542e-11
the O 0 1.6084605869437496e-10
range O 0 4.3235164781663116e-08
of O 0 3.8835370474998854e-08
MLD B-Disease 1 1.0
patients O 0 2.6087067794833274e-07
. O 0 3.746633581158676e-08

Mutation O 0 2.1384765602761036e-07
screening O 0 1.4959582017581852e-08
and O 0 5.310226147692276e-10
sequence O 0 4.7683228893147245e-11
analysis O 0 1.1747672279405208e-11
disclosed O 0 2.5074550769055293e-10
the O 0 2.891479278233078e-10
involvement O 0 9.549451229773354e-10
of O 0 1.3525789377411002e-08
three O 0 9.501631703656699e-10
different O 0 1.2741729893406273e-09
ARSA O 1 0.9999384880065918
mutations O 0 1.714254693752082e-08
being O 0 5.295155980356014e-10
the O 0 4.201471948128699e-10
molecular O 0 1.4099855727423005e-09
basis O 0 5.138843794938452e-10
of O 0 5.75226088983527e-09
intrafamilial O 0 1.2611443708010484e-05
phenotypic O 0 1.434709247405408e-05
heterogeneity O 0 4.296325187169714e-06
. O 0 2.721448879583477e-07

The O 0 1.6341601849489962e-07
late O 0 1.1899828677996993e-07
infantile O 0 3.457541242823936e-05
patient O 0 1.3680796939752327e-07
inherited O 0 3.5834054301631113e-07
from O 0 2.9035784887554428e-09
his O 0 1.5539689002253e-07
mother O 0 3.4492703804289704e-08
the O 0 8.603388224059927e-09
frequent O 0 3.391172853639546e-08
0 O 0 4.192302682781701e-08
- O 0 4.931164312438341e-07
type O 0 1.4184096244207467e-06
mutation O 0 2.1336566646823485e-07
459 O 0 1.1514630671172199e-07
+ O 0 3.418394456389251e-09
1G O 0 1.5642104926882894e-06
> O 0 3.634699874410785e-09
A O 0 6.148658027171905e-09
, O 0 2.383364686164846e-11
and O 0 1.8467232951180357e-11
from O 0 3.366151107853099e-11
his O 0 1.1908695141116254e-09
father O 0 2.89686297172409e-09
a O 0 5.112486545222339e-10
novel O 0 5.549787296388331e-09
, O 0 4.479384640987405e-10
single O 0 2.598375958839938e-09
basepair O 0 1.6481916418342735e-06
microdeletion O 0 3.1723652682558168e-06
of O 0 1.5733290581465553e-07
guanine O 0 4.234138017977784e-08
at O 0 6.7181127327842205e-09
nucleotide O 0 4.913267126482879e-09
7 O 0 3.566187123382747e-09
in O 0 3.5353228677870163e-10
exon O 0 1.7303038646332425e-07
1 O 0 1.1880823080900882e-07
( O 0 3.0133353590144907e-09
7delG O 0 1.6842258219185169e-06
) O 0 1.2746720123857358e-08
. O 0 5.543633108118229e-08

The O 0 2.248717265729283e-07
two O 0 2.5920215307451144e-08
clinically O 0 1.5723136357337353e-06
unaffected O 0 1.1570173796826566e-07
siblings O 0 2.341490734636409e-08
carried O 0 5.171905126388765e-09
the O 0 1.614458966514576e-08
maternal O 0 1.9862784483848372e-06
mutation O 0 5.910882237003534e-07
459 O 0 3.894723761277419e-07
+ O 0 3.775651435944383e-08
1G O 0 2.5585730327293277e-05
> O 0 2.465256443429098e-08
A O 0 1.6298296046102223e-08
and O 0 2.6039659317689257e-10
, O 0 4.356156407814282e-11
on O 0 5.259704338733684e-10
their O 0 1.7616526293284807e-10
paternal O 0 1.2524303372174472e-08
allele O 0 1.3729823944430564e-09
, O 0 3.804440096288886e-10
a O 0 1.2942037441732168e-09
novel O 0 3.630669098697581e-08
cytosine O 0 5.442841910507923e-08
to O 0 2.5596780250936035e-09
thymidine O 0 2.415532662780606e-07
transition O 0 4.266703967914509e-08
at O 0 2.102079754706665e-08
nucleotide O 0 4.404797593338117e-08
2435 O 0 2.4782648324617185e-06
in O 0 1.9185368849150564e-09
exon O 0 1.0071398293121092e-07
8 O 0 1.597647525386492e-08
, O 0 2.076027127984048e-10
resulting O 0 4.562325239820808e-10
in O 0 4.491247998505976e-11
substitution O 0 2.2971120561265934e-09
of O 0 1.145049832729228e-08
alanine O 0 5.071874511486385e-07
464 O 0 9.557805213944448e-08
by O 0 1.3135418308607427e-09
valine O 0 7.552453098469414e-06
( O 0 7.289521875009086e-09
A464V O 0 7.557856861239998e-06
) O 0 1.649192427066737e-08
. O 0 8.38516882595286e-08

The O 0 3.255535716562008e-07
fathers O 0 1.1848111824974694e-07
genotype O 0 1.8201772533643634e-08
thus O 0 6.1565206266323e-09
was O 0 5.966810334712136e-08
7delG O 0 1.7682594261714257e-05
/ O 0 3.0195504223229364e-05
A464V O 0 0.00019623222760856152
. O 0 1.1961934660575935e-06

Mutation O 0 1.3652816051035188e-06
A464V O 0 3.845239461952588e-06
was O 0 1.735881483000412e-08
not O 0 1.1004393229985254e-10
found O 0 7.60422350087886e-11
in O 0 1.035049476683092e-10
18 O 0 1.4029498451861855e-08
unrelated O 0 5.218614091972995e-07
MLD B-Disease 1 1.0
patients O 0 2.084746952846217e-08
and O 0 2.624765960135278e-09
50 O 0 3.5692714561719185e-08
controls O 0 3.114372930212994e-06
. O 0 2.442419315684674e-07

A464V O 0 2.499691618140787e-05
, O 0 1.091037837852582e-08
although O 0 3.822874461434367e-09
clearly O 0 4.1799268046815996e-08
modifying O 0 1.6178763644347782e-06
ARSA O 1 1.0
and O 0 8.418875836468942e-07
GS O 1 1.0
levels O 0 3.458585595694785e-08
, O 0 1.797405835279875e-10
apparently O 0 6.107860883730609e-10
bears O 0 1.042962125552549e-07
little O 0 1.5301775402321027e-09
significance O 0 1.712450625745987e-08
for O 0 2.1386695192582295e-10
clinical O 0 4.426552280278884e-08
manifestation O 0 1.0607935507778166e-07
of O 0 6.63234089870457e-08
MLD B-Disease 1 1.0
, O 0 6.835044974451421e-09
mimicking O 0 1.6265711622054368e-07
the O 0 2.9997977435414214e-08
frequent O 0 5.37781943421578e-07
ARSA O 1 0.9971522092819214
pseudodeficiency O 0 0.0003485199995338917
allele O 0 1.2265156783541897e-06
. O 0 3.732283460067265e-07

Our O 0 1.0033549813215359e-07
results O 0 1.0973504327438377e-09
demonstrate O 0 4.241764439694151e-10
that O 0 6.951402561211628e-12
in O 0 3.061807404836081e-11
certain O 0 9.745749762757328e-10
genetic O 0 5.035281969156813e-09
conditions O 0 7.889493502943878e-09
MLD B-Disease 1 1.0
- O 0 0.009161156602203846
like O 0 9.797833655511567e-08
ARSA O 1 1.0
and O 0 5.536426428420782e-08
GS O 1 1.0
values O 0 9.557504787593984e-10
need O 0 3.966083711448576e-11
not O 0 5.852238832426693e-12
be O 0 1.0844738301818424e-11
paralleled O 0 2.2856168346852002e-10
by O 0 2.4548313035110958e-11
clinical O 0 4.761459493352049e-08
disease O 0 2.7120044876483007e-08
, O 0 8.94773699577911e-11
a O 0 1.1664796906174502e-10
finding O 0 1.0294971819480025e-10
with O 0 5.785164708393964e-11
serious O 0 1.2238126601005206e-07
diagnostic O 0 1.7465042674302822e-06
and O 0 2.8870898560739988e-08
prognostic O 1 1.0
implications O 0 6.393658168235561e-06
. O 0 9.252688926153496e-08

Moreover O 0 1.0059800388262374e-06
, O 0 2.6789724216769173e-08
further O 0 1.7322803103070328e-07
ARSA O 0 0.02698139101266861
alleles O 0 1.8056439898828103e-08
functionally O 0 2.0004582879096233e-08
similar O 0 2.5755880761479943e-10
to O 0 2.5150420635000614e-10
A464V O 0 3.4475610277695523e-07
might O 0 3.198726561404186e-10
exist O 0 2.6090603635897658e-11
which O 0 5.953044480977443e-12
, O 0 1.5584405294033488e-11
together O 0 2.342093749843621e-12
with O 0 4.513315502580051e-12
0 O 0 1.3521449515607742e-09
- O 0 2.5877534781670875e-08
type O 0 3.527768654976171e-08
mutations O 0 7.827006598404296e-09
, O 0 1.0576162168263181e-10
may O 0 5.038219286213064e-10
cause O 0 1.7608078550779283e-08
pathological O 0 3.884585021296516e-05
ARSA O 1 1.0
and O 0 5.494305455044923e-08
GS O 1 1.0
levels O 0 3.729619724168742e-09
, O 0 2.1292337684664098e-11
but O 0 1.2620154921094695e-11
not O 0 8.392224415398886e-12
clinical O 0 1.8425454495485383e-09
outbreak O 0 5.75757053145054e-10
of O 0 1.8083623487541445e-09
the O 0 6.175361111360189e-09
disease O 0 3.095871647929016e-08
. O 0 1.8412036340009763e-09
. O 0 3.393748215785308e-08

Human O 1 0.5425623059272766
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.00024035919341258705
to O 0 4.103445689906948e-07
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 3.060028745949239e-07
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.40915611386299133
1 I-Disease 0 2.623356158437673e-05
. O 0 1.0068652755990115e-07

Heterozygous O 0 1.2913540558656678e-05
germ O 0 2.214801043010084e-06
- O 0 5.851139803780825e-07
line O 0 1.439829873106646e-07
mutations O 0 8.205178758657894e-10
in O 0 2.681079490363114e-11
the O 0 2.954064493021491e-10
DNA O 0 1.0058590405037648e-08
mismatch O 0 6.365207809722051e-07
repair O 0 2.486820562808134e-07
genes O 0 2.3039410379510628e-08
lead O 0 2.1046956177883658e-08
to O 0 8.653038285899584e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.8611059406102868e-06

The O 0 1.6531110702544538e-07
disease O 0 1.8658847977803816e-07
susceptibility O 0 6.548710729248342e-08
of O 0 2.4645893859087664e-07
individuals O 0 3.471324061532499e-10
who O 0 1.8967458714769236e-09
constitutionally O 0 1.6417894244113995e-07
lack O 0 5.722266216423577e-09
both O 0 1.0495625479833848e-09
wild O 0 1.1526638132863809e-07
- O 0 6.882272884922713e-08
type O 0 2.7419217119017958e-08
alleles O 0 1.043685471380229e-09
is O 0 1.2947883043512576e-10
unknown O 0 2.599620074761333e-09
. O 0 4.656039997996686e-09

We O 0 1.061698018389734e-08
have O 0 4.296062811048884e-11
identified O 0 8.317522365297592e-11
three O 0 3.862713621183289e-11
offspring O 0 4.762744088004922e-10
in O 0 4.807628600778102e-11
a O 0 4.67406691129213e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.2953527402714826e-05
who O 0 4.45281767014194e-09
developed O 0 3.12643173572269e-08
hematological B-Disease 1 0.999996542930603
malignancy I-Disease 0 6.513441621791571e-05
at O 0 1.7999659540635093e-09
a O 0 8.138790336120749e-11
very O 0 7.38655837884128e-12
early O 0 6.070680763636815e-11
age O 0 2.5444266138485716e-10
, O 0 1.0682798395889037e-11
and O 0 1.3457524157545198e-11
at O 0 1.637099761309102e-10
least O 0 1.648259306819e-11
two O 0 6.887367846181158e-12
of O 0 1.4130431547076938e-10
them O 0 9.366869085924989e-11
displayed O 0 1.2645908320507715e-08
signs O 0 1.7643688465796004e-07
of O 0 8.597157830081414e-08
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 0 4.5379356379271485e-06
1 I-Disease 0 6.667042384833621e-07
( O 0 2.137944710156603e-09
NF1 B-Disease 0 0.0008260899339802563
) O 0 6.9026997451260286e-09
. O 0 2.773671425870816e-08

DNA O 0 7.18031785140738e-08
sequence O 0 1.3199001613894978e-10
analysis O 0 1.524855762491395e-11
and O 0 1.837209551158736e-11
allele O 0 6.0392559009248e-11
- O 0 5.787065826545756e-10
specific O 0 1.5202798742119938e-10
amplification O 0 2.7814843761575503e-09
in O 0 8.366912024326822e-11
two O 0 2.670230980772459e-10
siblings O 0 1.2423947204354135e-08
revealed O 0 6.99741375953522e-09
a O 0 2.2398557675273878e-08
homozygous O 0 4.447016635822365e-06
MLH1 O 1 0.9999932050704956
mutation O 0 9.242299370271212e-08
( O 0 6.738873903344711e-10
C676T O 0 9.958087048289599e-07
- O 0 8.595811209488602e-07
- O 0 1.1727527180482866e-06
> O 0 1.3463480286191043e-07
Arg226Stop O 0 1.4889724297972862e-05
) O 0 7.734446860752087e-09
. O 0 3.775658896643108e-08

Thus O 0 4.0401550904789474e-07
, O 0 1.662647441946774e-08
a O 0 2.4618401539555634e-08
homozygous O 0 1.142431869993743e-06
germ O 0 3.134431835860596e-06
- O 0 7.555493539257441e-06
line O 0 6.158476480777608e-06
MLH1 O 1 0.999963641166687
mutation O 0 7.010133629137272e-08
and O 0 2.5965181116305303e-09
consequent O 0 5.617347596853506e-06
mismatch O 1 0.9997774958610535
repair O 1 0.9933949112892151
deficiency O 1 0.9999436140060425
results O 0 8.329755551983453e-09
in O 0 7.726688178166796e-10
a O 0 8.810536300529748e-09
mutator O 0 1.670637539064046e-05
phenotype O 0 4.267222575293772e-09
characterized O 0 2.407306021190436e-10
by O 0 5.499319402635372e-11
leukemia B-Disease 1 0.9964961409568787
and O 0 8.674044238432543e-08
/ O 1 1.0
or O 0 0.017627133056521416
lymphoma B-Disease 1 1.0
associated O 0 9.471510225012025e-07
with O 0 5.026377536410109e-09
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 4.788838054992084e-07
1 I-Disease 0 5.740153241617918e-08
. O 0 7.93700272172515e-10
. O 0 8.484168922961999e-09

Missense O 0 3.954713974962942e-05
mutations O 0 4.390546948229712e-08
in O 0 5.259062074713938e-10
the O 0 8.13968059620862e-10
most O 0 1.4032212891645912e-10
ancient O 0 1.095184165578189e-09
residues O 0 4.009948639804861e-08
of O 0 1.2700052565151054e-08
the O 0 3.121587255350278e-08
PAX6 O 1 0.9922657608985901
paired O 0 3.2012448514251446e-07
domain O 0 8.984911659126738e-08
underlie O 0 5.714567805625848e-07
a O 0 1.560696794022931e-09
spectrum O 0 8.189301325955967e-08
of O 0 4.6919157625779917e-07
human O 1 0.999998927116394
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 3.373147592355963e-06

Mutations O 0 3.021691270532756e-07
of O 0 7.940659685345963e-08
the O 0 1.028081442200346e-08
human O 0 1.4401012826681381e-08
PAX6 O 1 0.9999971389770508
gene O 0 4.808305220649345e-07
underlie O 1 0.9999995231628418
aniridia B-Disease 1 1.0
( O 1 0.9999948740005493
congenital B-Disease 1 1.0
absence I-Disease 0 3.117341520919581e-06
of I-Disease 0 1.1405768418626394e-06
the I-Disease 0 1.652870729174083e-08
iris I-Disease 0 3.98037514059979e-07
) O 0 1.7499081350624834e-10
, O 0 1.1895159857111537e-10
a O 0 6.649358841315234e-10
rare O 0 4.836460121282471e-08
dominant O 1 0.565692663192749
malformation B-Disease 1 1.0
of I-Disease 0 0.0005443216650746763
the I-Disease 0 4.327288934291573e-06
eye I-Disease 1 0.9998127818107605
. O 0 5.19412139965425e-07

The O 0 1.957817374886872e-07
spectrum O 0 7.788593734403548e-07
of O 0 1.164195737146656e-06
PAX6 O 1 1.0
mutations O 0 1.905744255736863e-07
in O 0 2.7857689488541837e-09
aniridia B-Disease 1 1.0
patients O 0 8.977849574876018e-09
is O 0 2.5928977714917423e-11
highly O 0 1.3889381311749105e-10
biased O 0 3.798045489222801e-10
, O 0 1.1511840959654851e-11
with O 0 8.673861975894148e-12
92 O 0 6.11105743786311e-09
% O 0 2.7507808531002098e-11
of O 0 5.818731607654115e-10
all O 0 3.7082245607500397e-10
reported O 0 1.906379054616991e-09
mutations O 0 8.692191855175224e-09
leading O 0 1.2737848997801393e-08
to O 0 2.2458950255099808e-09
premature O 0 3.693278216587714e-08
truncation O 0 7.794755418899513e-08
of O 0 4.835555955651216e-08
the O 0 2.1761911384032828e-08
protein O 0 1.4578820373145618e-09
( O 0 4.696384947600052e-11
nonsense O 0 3.867494768883262e-09
, O 0 3.631944744952875e-11
splicing O 0 8.549466690155327e-10
, O 0 9.743105627846305e-11
insertions O 0 1.6496133348198327e-09
and O 0 2.2434107349589283e-10
deletions O 0 1.3941569010356147e-09
) O 0 1.907271736378835e-11
and O 0 4.272112871794853e-11
just O 0 1.0080532936163067e-10
2 O 0 6.562784760077989e-10
% O 0 2.7759110982072954e-11
leading O 0 6.122530954444372e-11
to O 0 1.0669174745070453e-11
substitution O 0 5.355694221442775e-10
of O 0 3.9376257809919935e-09
one O 0 5.563455807156004e-10
amino O 0 5.172612893566964e-10
acid O 0 2.5505195178077145e-10
by O 0 8.849646709885306e-12
another O 0 8.068268830818681e-10
( O 0 1.4371095424792202e-09
missense O 0 4.460862044197711e-07
) O 0 1.0295964081308284e-08
. O 0 7.441525440299301e-08

The O 0 1.1962637813667243e-07
extraordinary O 0 5.732141428183013e-09
conservation O 0 2.6682789311394117e-08
of O 0 8.152875707878593e-09
the O 0 1.3287726474686679e-08
PAX6 O 0 0.00010117951751453802
protein O 0 4.652169316443633e-09
at O 0 9.932471511930885e-10
the O 0 1.293076090647105e-09
amino O 0 8.594989608923242e-09
acid O 0 1.0033910591289441e-08
level O 0 6.835918497927196e-09
amongst O 0 2.4603945547596595e-08
vertebrates O 0 3.014716867255629e-07
predicts O 0 4.828984501159539e-08
that O 0 2.5099349265644832e-09
pathological O 0 1.939402864081785e-05
missense O 0 3.059237769775791e-07
mutations O 0 3.740726839396302e-09
should O 0 1.1059100163413049e-10
in O 0 1.1512718729733695e-11
fact O 0 5.20179697927059e-11
be O 0 2.223116829513927e-11
common O 0 4.695166824775221e-11
even O 0 2.0726630481360253e-11
though O 0 2.0562510028021563e-11
they O 0 2.30848586774135e-11
are O 0 1.306930518668592e-11
hardly O 0 2.8280520147916377e-09
ever O 0 2.4626656269788327e-09
seen O 0 6.2863105831922894e-09
in O 0 4.1023002772533346e-09
aniridia B-Disease 1 1.0
patients O 0 2.418999827114021e-07
. O 0 7.049782624335421e-08

This O 0 3.2268983041205956e-09
indicates O 0 1.1223967311124738e-09
that O 0 3.357276956439392e-11
there O 0 1.0991681176353296e-10
is O 0 1.3202122728372956e-10
a O 0 2.583637748188039e-10
heavy O 0 3.617329014105053e-07
ascertainment O 0 1.5790139968885342e-06
bias O 0 1.64263767032935e-08
in O 0 8.585740451927393e-11
the O 0 5.172967609823331e-10
selection O 0 7.85495446464779e-10
of O 0 1.749385081240007e-09
patients O 0 5.170837091839076e-10
for O 0 3.286721173001439e-10
PAX6 O 1 0.5662559270858765
mutation O 0 3.5323571845324864e-10
analysis O 0 7.424867144723013e-12
and O 0 1.811042461830059e-11
that O 0 1.0925667488781432e-11
the O 0 2.839673163279599e-09
missing O 0 8.591109690314624e-08
PAX6 O 1 0.9998462200164795
missense O 0 2.1396330339484848e-05
mutations O 0 2.174915607611183e-07
frequently O 0 1.2699373996838403e-08
may O 0 4.591940161446928e-09
underlie O 0 1.6728157561374246e-06
phenotypes O 0 3.2673176519892877e-07
distinct O 0 1.3107794849531729e-08
from O 0 3.208676213617423e-09
textbook O 0 1.9761999283218756e-05
aniridia B-Disease 1 1.0
. O 0 1.8440250642015599e-06

Here O 0 4.3107513114648555e-09
we O 0 5.068793718088216e-10
present O 0 3.466599785006963e-10
four O 0 1.0164447061811188e-09
novel O 0 1.0156218621659718e-07
PAX6 O 0 0.0007921269279904664
missense O 0 2.7032461957787746e-07
mutations O 0 6.688578135793932e-09
, O 0 3.413668792084934e-10
two O 0 6.556250681244435e-11
in O 0 6.120370876772085e-11
association O 0 5.020587834358992e-10
with O 0 8.751778191040671e-10
atypical O 0 1.544318820378976e-06
phenotypes O 0 2.4923863293224713e-06
ectopia B-Disease 0 1.4314607142296154e-05
pupillae I-Disease 0 1.9350738966750214e-06
( O 0 6.154471376973447e-11
displaced B-Disease 0 3.4782812047273737e-11
pupils I-Disease 0 2.2431327628691378e-10
) O 0 4.4243700370039107e-10
and O 0 1.0046167062682798e-06
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9994877576828003
( O 0 4.222504290662954e-10
searching B-Disease 0 1.1498509921992195e-09
gaze I-Disease 0 2.014779454384552e-08
) O 0 1.90189530790974e-11
, O 0 3.350675292779215e-11
and O 0 1.3004833321339504e-10
two O 0 4.085819529930923e-11
in O 0 3.858943026235906e-11
association O 0 9.528704214556427e-11
with O 0 9.091069563815779e-11
more O 0 7.798391932212212e-10
recognizable O 0 3.9199148886837065e-05
aniridia B-Disease 1 1.0
phenotypes O 0 6.957603545743041e-06
. O 0 1.669940417059479e-07

Strikingly O 0 1.688360669049871e-07
, O 0 1.5641836714763713e-09
all O 0 3.657892044817146e-10
four O 0 4.151824717357755e-11
mutations O 0 1.2494513756955428e-10
are O 0 4.233418737092931e-12
located O 0 1.2522983761087403e-09
within O 0 1.0664180649655464e-09
the O 0 1.302512764311814e-08
PAX6 O 1 0.9969484210014343
paired O 0 2.2856438874896412e-07
domain O 0 3.494045586194261e-08
and O 0 2.3905695201165145e-09
affect O 0 1.2041403429918773e-08
amino O 0 1.1471696925724473e-09
acids O 0 1.1324469834095297e-10
which O 0 2.161113952722782e-12
are O 0 5.873773689657469e-13
highly O 0 9.036200260270633e-11
conserved O 0 1.3498876461071063e-09
in O 0 7.635383297843745e-11
all O 0 2.1777502023923034e-10
known O 0 1.5675346576315974e-09
paired O 0 2.7336295005397915e-08
domain O 0 3.409221349670588e-08
proteins O 0 3.733406028771924e-09
. O 0 1.6620829157432127e-08

Our O 0 1.552349999656144e-07
results O 0 2.774103835534447e-09
support O 0 5.550271353627068e-10
the O 0 8.860447930914006e-10
hypothesis O 0 1.8851603611480527e-10
that O 0 2.2779417241380884e-12
the O 0 3.237665344157925e-11
under O 0 1.773411695271676e-10
- O 0 5.920961054783902e-09
representation O 0 5.517740153671014e-10
of O 0 1.1132039290373541e-08
missense O 0 1.8825445522452355e-06
mutations O 0 1.4422485605791735e-07
is O 0 5.407076453245452e-10
caused O 0 1.5922561047432282e-09
by O 0 1.8921271494054537e-10
ascertainment O 0 2.977679059767979e-06
bias O 0 2.222306250132533e-08
and O 0 4.0618117203017334e-10
suggest O 0 1.700636576007497e-10
that O 0 6.705019785918642e-12
a O 0 7.000931084855111e-11
substantial O 0 8.627544012540511e-09
burden O 0 6.659035420852888e-07
of O 0 6.419610940611165e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999649524688721
related I-Disease 1 0.9955769777297974
disease I-Disease 1 0.9998134970664978
remains O 0 1.4848771989761644e-08
to O 0 6.624682746814159e-11
be O 0 5.933153968129545e-11
uncovered O 0 4.1787928672931685e-09
. O 0 1.1951816203392696e-09
. O 0 2.7886249753805714e-08

The O 0 1.2020446149563213e-07
chromosomal O 0 1.5767102468089433e-07
order O 0 3.0129159167557873e-09
of O 0 1.9190867561746927e-08
genes O 0 3.6591012442244164e-09
controlling O 0 4.613526471075602e-06
the O 0 5.4548767280948596e-08
major O 0 4.9037012104236055e-06
histocompatibility O 0 0.04759020358324051
complex O 0 1.204411091748625e-06
, O 0 5.947387582416752e-10
properdin O 0 9.317683691278944e-08
factor O 0 4.739800996134136e-09
B O 0 1.4388717772817472e-07
, O 0 2.764920063735854e-11
and O 0 2.224246203885727e-10
deficiency B-Disease 0 2.3702854434759502e-07
of I-Disease 0 1.2968810381153162e-07
the I-Disease 0 4.263490538392034e-08
second I-Disease 0 1.808597893671049e-08
component I-Disease 0 6.388255968658996e-08
of I-Disease 0 3.8439342375795604e-08
complement I-Disease 0 2.1586077991742059e-07
. O 0 7.779279798114658e-08

The O 0 9.010482671101272e-08
relationship O 0 8.048809951866076e-10
of O 0 6.453479972634568e-09
the O 0 1.0723434362702733e-09
genes O 0 1.580503228293395e-10
coding O 0 1.2611888200453336e-09
for O 0 7.507440225040796e-10
HLA O 0 2.6664429242373444e-07
to O 0 4.735723480031595e-10
those O 0 2.0025979485804868e-10
coding O 0 9.598024597323729e-10
for O 0 1.767812285446979e-10
properdin O 0 2.101972000900787e-07
Factor O 0 9.399612643790078e-09
B O 0 3.951953431169386e-08
allotypes O 0 8.158024478177595e-09
and O 0 1.664262998246624e-11
for O 0 6.633976701309052e-11
deficiency B-Disease 0 6.819382036837851e-08
of I-Disease 0 7.066827123480834e-08
the I-Disease 0 1.3448000046878406e-08
second I-Disease 0 4.1289895946761135e-09
component I-Disease 0 1.4019493121963933e-08
of I-Disease 0 8.553842967273795e-09
complement I-Disease 0 1.8112627842015172e-08
( O 0 5.439079187041784e-10
C2 O 0 2.257614141853992e-06
) O 0 4.060051253529373e-11
was O 0 1.9258281080958284e-10
studied O 0 5.955866910767327e-10
in O 0 8.94957545571895e-12
families O 0 2.14568705685092e-12
of O 0 1.0767903929620459e-10
patients O 0 2.833303869298476e-10
with O 0 1.0644164438744497e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 1.9927225025639927e-07

Patients O 0 1.9557215580334741e-07
were O 0 5.814970172046685e-10
selected O 0 9.444769411004472e-10
because O 0 2.3692686701437538e-11
they O 0 1.3357127903734778e-11
were O 0 1.1994835680262383e-10
heterozygous O 0 4.671936615352479e-09
or O 0 2.0805153155833978e-09
homozygous O 0 6.872696758364327e-07
for O 0 4.897831331618363e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 5.03937769735785e-07

12 O 0 2.7797523216577247e-07
families O 0 2.7873514607534844e-10
with O 0 1.2689434225610086e-10
15 O 0 1.1527678367428962e-08
matings O 0 2.9845912763448723e-07
informative O 0 1.6464008467664826e-07
for O 0 1.056599501225719e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 8.38615665799125e-09
found O 0 3.4415403860066363e-09
. O 0 1.1101697339199745e-08

Of O 0 3.146021754218964e-06
57 O 0 3.712227112373512e-07
informative O 0 4.3933532367645967e-08
meioses O 0 6.254701929719886e-07
, O 0 3.3104782803938804e-10
two O 0 1.8197856416213298e-11
crossovers O 0 2.791426534365371e-10
were O 0 2.7678642364192818e-11
noted O 0 3.2305358388384775e-10
between O 0 5.614881892768153e-10
the O 0 2.6888173465522414e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.9710742754929242e-09
and O 0 8.330736656070314e-10
the O 0 3.907221657328819e-09
HLA O 0 1.8416877765048412e-06
- O 0 4.5626782707586244e-07
B O 0 2.114932613039855e-06
gene O 0 1.0349744672399908e-10
, O 0 7.744016365662798e-12
with O 0 4.421395975034992e-12
a O 0 5.395740798608273e-11
recombinant O 0 9.762451264050398e-11
fraction O 0 6.029027277421051e-10
of O 0 2.262417808651662e-09
0 O 0 2.900778994785469e-08
. O 0 2.2427498080901387e-08

035 O 0 0.018529152497649193
. O 0 1.717138547974173e-05

A O 0 8.92959008069738e-07
lod O 0 4.279469521861756e-06
score O 0 4.443385748231776e-08
of O 0 7.959990000472317e-09
13 O 0 1.796913062790395e-09
was O 0 4.281953125406801e-10
calculated O 0 2.8534513640821046e-10
for O 0 8.126009587439142e-11
linkage O 0 1.945161898220249e-07
between O 0 1.861446548900858e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.0489466184537832e-08
HLA O 0 1.1198781066923402e-06
- O 0 6.061999613393709e-08
B O 0 1.8199712314981298e-07
at O 0 3.5061253900181555e-10
a O 0 3.3588399422912474e-11
maximum O 0 1.9435257569977438e-10
likelihood O 0 7.422944897639283e-11
value O 0 1.6062869090394116e-10
of O 0 3.143494076152109e-10
the O 0 3.6782163426174463e-10
recombinant O 0 4.1996453536974343e-10
fraction O 0 1.6230506938441636e-09
of O 0 3.3263158893959144e-09
0 O 0 5.065435360052106e-08
. O 0 3.460815989342336e-08

04 O 0 0.0041100094094872475
. O 0 1.0509017556614708e-05

18 O 0 1.2154058026681014e-07
families O 0 1.178443731486567e-10
with O 0 1.0586777982046769e-10
21 O 0 1.483572198424099e-08
informative O 0 2.1657935889152213e-08
matings O 0 3.290538330702475e-08
for O 0 3.6600067421233007e-10
both O 0 1.100410540466612e-09
properdin O 0 1.0498451956664212e-06
Factor O 0 1.5199718461644807e-07
B O 0 1.0820227771546342e-06
allotype O 0 2.7204472985431494e-07
and O 0 1.578940311830479e-09
HLA O 0 1.7428270666641765e-06
- O 0 2.632325788454182e-07
B O 0 1.9222172795707593e-06
were O 0 3.9496136916561397e-10
found O 0 5.016940196611586e-10
. O 0 8.738104462224783e-09

Of O 0 9.872728696791455e-06
72 O 0 1.8546492128734826e-06
informative O 0 1.6932190760599042e-07
meioses O 0 4.355475539341569e-06
, O 0 2.2226358531440837e-09
three O 0 4.965561295477983e-10
recombinants O 0 6.90003076897483e-08
were O 0 1.561994561471991e-10
found O 0 5.1834741360279324e-11
, O 0 7.304936516794314e-11
giving O 0 2.2393366327921882e-10
a O 0 1.2413418903900464e-10
recombinant O 0 5.803004188287275e-10
fraction O 0 1.2882338529252024e-09
of O 0 1.8476811192158493e-08
0 O 0 1.2230846380134608e-07
. O 0 5.0007805896257196e-08

042 O 0 0.0060730562545359135
. O 0 2.2836573407403193e-05

A O 0 6.762589919162565e-07
lod O 0 4.0246022763312794e-06
score O 0 3.452515073831819e-08
of O 0 1.7159031528990454e-08
16 O 0 4.533286190877561e-09
between O 0 1.220149398184489e-10
HLA O 0 8.734009782074281e-08
- O 0 1.9906723380813673e-08
B O 0 1.1044065217902244e-07
and O 0 9.284071428306007e-11
Factor O 0 9.026097202990968e-09
B O 0 1.6882029285625322e-07
allotypes O 0 8.45203018684515e-08
was O 0 1.3814512866971995e-09
calculated O 0 2.626387163306987e-10
at O 0 1.6897340471278e-10
a O 0 1.2236080204619526e-10
maximum O 0 1.0468333977442512e-09
likelihood O 0 1.6948241421399501e-10
value O 0 2.1058740862223146e-10
of O 0 2.8589153266977974e-10
the O 0 2.585728020587652e-10
recombinant O 0 1.2565302964784308e-10
fraction O 0 4.688118226958693e-10
of O 0 4.543171172599614e-09
0 O 0 4.2444153081078184e-08
. O 0 3.480874610772844e-08

04 O 0 0.004189527127891779
. O 0 1.0784402547869831e-05

A O 0 1.1829341701741214e-06
crossover O 0 1.1196330262919219e-07
was O 0 6.636451388430942e-09
shown O 0 2.776547880500857e-10
to O 0 1.537238530913143e-10
have O 0 1.0213720494367529e-11
occurred O 0 5.721965609661872e-11
between O 0 7.422572972926034e-12
genes O 0 5.151458686708521e-12
for O 0 5.15963010164211e-12
Factor O 0 1.654989811861185e-09
B O 0 1.970319551958255e-08
and O 0 1.502794555463538e-10
HLA O 0 1.391855874999237e-07
- O 0 1.3691159495010652e-07
D O 0 6.283846687438199e-06
, O 0 2.1273270645050246e-10
in O 0 4.4298731349812215e-11
which O 0 1.518680042833509e-10
HLA O 0 6.759623829566408e-07
- O 0 3.4052774822157517e-07
D O 0 6.503081749542616e-06
segregared O 0 1.5280425031960476e-06
with O 0 4.490051108696491e-10
HLA O 0 1.926291361087351e-06
- O 0 1.6198279695345263e-07
A O 0 6.14289277223179e-08
and O 0 3.459335928823748e-09
B O 0 2.4468658921250608e-06
. O 0 1.693817530679098e-08

These O 0 1.7008783714800302e-08
studies O 0 6.999011925579168e-10
suggest O 0 4.3027623131131065e-11
that O 0 1.6244231437409495e-12
the O 0 2.8489363645967103e-11
genes O 0 5.264356225248568e-12
for O 0 1.3136156225279638e-11
Factor O 0 1.118915733400172e-07
B O 1 0.9999998807907104
and O 0 4.1628376834523806e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.4799380471108847e-11
located O 0 9.795390887301636e-11
outside O 0 6.002542213279227e-11
those O 0 1.464533182227168e-11
for O 0 1.4479209498041712e-11
HLA O 0 3.776681367639867e-08
, O 0 4.002972953109918e-11
that O 0 2.7659736480389885e-12
the O 0 1.0608406514345248e-10
order O 0 2.2060364646137032e-10
of O 0 2.605969662283769e-09
genese O 0 1.3360763659875374e-06
is O 0 1.257485116035184e-09
HLA O 0 1.380646494908433e-07
- O 0 3.985396190842039e-08
A O 0 3.402426784759882e-08
, O 0 2.6262055030645826e-11
- O 0 8.799061479436432e-10
B O 0 1.740990995813263e-08
, O 0 9.258002350853722e-12
- O 0 1.198381949230054e-09
D O 0 4.723108304460766e-08
, O 0 7.503542925890727e-11
Factor O 0 1.516013270475014e-08
B O 0 1.2135103133914527e-05
allotype O 0 0.03551390767097473
, O 0 1.7201753621520766e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 2.6174556966296336e-10
that O 0 7.236978377678227e-12
the O 0 2.891175909791599e-10
genes O 0 8.179054100665439e-10
coding O 0 9.039125359322497e-08
for O 0 3.9230852166838304e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.0345309881264484e-09
Factor O 0 3.247553337359932e-08
B O 0 8.010773910882563e-08
allotypes O 0 3.708171902871982e-08
are O 0 4.10310761062016e-12
approximately O 0 1.5572846831513054e-11
3 O 0 3.9751261310394526e-11
- O 0 1.9906096215827063e-10
- O 0 1.719270170674747e-09
5 O 0 6.120467466175228e-10
centimorgans O 0 1.0469458189277248e-08
from O 0 1.6546724060373386e-11
the O 0 1.9127664729889915e-10
HLA O 0 1.0997651855859658e-07
- O 0 4.683921872583596e-08
A O 0 3.933004322220768e-08
and O 0 4.897817151849893e-10
HLA O 0 2.5284262505920196e-07
- O 0 2.476505756021652e-08
B O 0 1.1080800277341041e-07
loci O 0 2.1829152374586158e-10
, O 0 3.3453667353661176e-12
and O 0 2.6996644936910785e-12
that O 0 7.064935659065186e-13
the O 0 7.721659422976757e-11
apparent O 0 1.2163903218009864e-09
lack O 0 1.1073881811540787e-09
of O 0 5.651911827442291e-09
recombinants O 0 1.3800553233522805e-07
between O 0 1.1693690460390371e-10
the O 0 9.74112235319069e-10
Factor O 0 1.7559490572693903e-07
B O 1 0.9999703168869019
gene O 0 4.781535949405225e-07
and O 0 0.007334010675549507
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 5.602561081730073e-09
suggests O 0 9.804700107363118e-11
that O 0 1.2082999531481953e-12
these O 0 1.0070074114854055e-11
two O 0 7.515426649062906e-12
genes O 0 1.054035678182963e-10
lie O 0 1.3438096191364934e-09
in O 0 8.815906338277557e-11
close O 0 2.099230123064899e-09
proximity O 0 1.3182258840060967e-08
to O 0 3.0510021176155533e-09
one O 0 7.632188214756752e-09
another O 0 2.8264141249678687e-08
. O 0 1.3727060377277667e-07

Distribution O 0 6.381801398447351e-08
of O 0 7.154424963573547e-08
emerin O 0 4.891650405625114e-06
and O 0 1.0334329836325651e-08
lamins O 0 8.817380034997768e-07
in O 0 1.0070775324777514e-09
the O 0 1.1563176194329117e-08
heart O 0 2.0459268057493318e-07
and O 0 2.9762925457532674e-09
implications O 0 3.688856864414447e-08
for O 0 6.785486617033598e-10
Emery B-Disease 1 0.9994581341743469
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.1765021099563455e-06

Emerin O 1 0.9795761108398438
is O 0 1.3028959244820726e-07
a O 0 6.935203522573374e-09
nuclear O 0 2.0330888972353023e-08
membrane O 0 3.5069431802980944e-09
protein O 0 5.145630588287986e-10
which O 0 4.174717863070221e-11
is O 0 8.044938326623452e-11
missing O 0 5.98625204961678e-10
or O 0 1.4019772842654987e-10
defective O 0 1.3651518138146912e-08
in O 0 4.69002336966895e-10
Emery B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.0766522251515198e-07
EDMD B-Disease 1 1.0
) O 0 3.034162432413723e-08
. O 0 3.166460160741735e-08

It O 0 4.123512198361823e-09
is O 0 2.5863891583988163e-10
one O 0 1.1107213065963961e-10
member O 0 5.276763748174318e-11
of O 0 4.668382569406049e-09
a O 0 3.0007918372376707e-09
family O 0 3.1820241996882714e-09
of O 0 7.524448619733448e-08
lamina O 1 0.9995840191841125
- O 0 3.9120192241171026e-07
associated O 0 2.123023312705641e-09
proteins O 0 5.1403110934433727e-11
which O 0 8.771689104236646e-12
includes O 0 3.460112751874078e-10
LAP1 O 1 0.9809448719024658
, O 0 2.5970181560808214e-09
LAP2 O 0 0.0017118238611146808
and O 0 3.157727235247876e-08
lamin O 0 1.0074574674945325e-05
B O 0 0.00010562781244516373
receptor O 0 4.121054075767461e-07
( O 0 1.1816771561257156e-08
LBR O 1 0.999997615814209
) O 0 2.0400070965820305e-08
. O 0 5.9491743087392024e-08

A O 0 2.421659701212775e-06
panel O 0 3.095918899020944e-08
of O 0 3.522040614711841e-08
16 O 0 9.491167851649607e-09
monoclonal O 0 1.263599891387912e-08
antibodies O 0 2.599545689818683e-09
( O 0 1.7471434021754106e-10
mAbs O 0 1.237525566466502e-07
) O 0 2.2481312644817564e-10
has O 0 7.577669741687387e-11
been O 0 8.732980311121352e-11
mapped O 0 3.830078032507345e-09
to O 0 1.9262616501869445e-10
six O 0 2.2307170000068766e-10
specific O 0 3.02371433447135e-10
sites O 0 1.4133700876328703e-09
throughout O 0 6.520934903164743e-10
the O 0 1.2966704154848685e-08
emerin O 0 1.8176501725974958e-06
molecule O 0 5.158621863010637e-10
using O 0 2.9604832474383613e-10
phage O 0 9.748022833377945e-09
- O 0 4.123567265423844e-09
displayed O 0 2.62902477565774e-09
peptide O 0 6.911325400871249e-10
libraries O 0 1.0834984298657702e-10
and O 0 1.1453937798222569e-10
has O 0 2.8492133999358238e-11
been O 0 1.747469183244199e-11
used O 0 7.324803957819981e-11
to O 0 4.859804225709752e-10
localize O 0 8.481702593599039e-07
emerin O 0 4.594221081788419e-06
in O 0 2.7719353479227493e-09
human O 0 4.143426934888339e-09
and O 0 1.1849316194911808e-08
rabbit O 0 7.590650511701824e-06
heart O 0 1.4277834452514071e-05
. O 0 1.914528411361971e-07

Several O 0 2.584730509624933e-07
mAbs O 0 1.3721579534831108e-06
against O 0 9.06632067199098e-08
different O 0 4.80722972540093e-09
emerin O 0 2.997515366587322e-06
epitopes O 0 2.3245752345246729e-07
did O 0 2.3943020899253042e-09
not O 0 4.5937864623368796e-10
recognize O 0 7.1083934294335904e-09
intercalated O 0 2.414210769074998e-07
discs O 0 1.7778644689769862e-07
in O 0 4.364225925090892e-10
the O 0 3.5797897979250592e-09
heart O 0 3.264925041435163e-08
, O 0 9.658806393586516e-11
though O 0 8.1458416401059e-11
they O 0 7.2334492562387e-11
recognized O 0 5.219353393925985e-09
cardiomyocyte O 0 2.9715866389778967e-07
nuclei O 0 5.496335830912358e-09
strongly O 0 1.662271431612794e-10
, O 0 9.786650656540274e-11
both O 0 1.0097967600986024e-10
at O 0 2.059180825852991e-09
the O 0 1.398786864115209e-08
rim O 0 1.4655479390057735e-06
and O 0 6.244341488326199e-09
in O 0 4.609191694981973e-09
intranuclear O 0 1.4095088772592135e-05
spots O 0 2.807095427215245e-07
or O 0 1.3546909372053051e-08
channels O 0 5.5022756129119443e-08
. O 0 8.460965972290069e-08

A O 0 2.5945151719497517e-05
polyclonal O 0 2.7759908334701322e-05
rabbit O 0 6.100113409956975e-07
antiserum O 0 1.4686581835121615e-06
against O 0 1.554723496610677e-07
emerin O 0 1.5021768376755062e-05
did O 0 9.122484101453665e-09
recognize O 0 1.5148801324471606e-08
both O 0 1.2602368038017175e-09
nuclear O 0 3.0541944084916395e-08
membrane O 0 3.867863362927437e-09
and O 0 1.1831648993876343e-09
intercalated O 0 1.2096724333332531e-07
discs O 0 2.248716590713684e-08
but O 0 1.2153091033528796e-10
, O 0 6.326503210196677e-11
after O 0 6.00675689743646e-11
affinity O 0 1.6459163199034066e-10
purification O 0 8.120857764026823e-09
against O 0 1.1104640762482632e-08
a O 0 2.819509736795567e-09
pure O 0 3.213761701204021e-08
- O 0 2.4577115453894294e-08
emerin O 0 1.0169588904318516e-06
band O 0 1.1909859765069086e-08
on O 0 1.996626197708906e-09
a O 0 5.211352460676721e-10
western O 0 5.5835509549240214e-09
blot O 0 3.416015260881977e-06
, O 0 3.950578197908783e-10
it O 0 6.393756357692126e-11
stained O 0 2.0743277673318516e-07
only O 0 5.998790908456897e-10
the O 0 2.3017876493725e-09
nuclear O 0 7.701814297433884e-08
membrane O 0 9.017583124659723e-08
. O 0 8.525439909590204e-08

These O 0 1.0620767376678941e-08
results O 0 1.9372932424932543e-10
would O 0 2.3283363084769526e-11
not O 0 9.504794520887039e-12
be O 0 1.1841300509574104e-11
expected O 0 3.0888375190940565e-10
if O 0 5.356102783515837e-10
immunostaining O 0 3.838747204554238e-07
at O 0 3.873895426664831e-09
intercalated O 0 1.196366383737768e-07
discs O 0 9.298970837789966e-08
were O 0 6.124414864139283e-10
due O 0 3.1300815273027638e-09
to O 0 3.8300979054994855e-10
a O 0 1.6556014892366022e-10
product O 0 7.605996388271308e-10
of O 0 3.959043759493852e-09
the O 0 4.7895842847367476e-09
emerin O 0 1.2218062011015718e-06
gene O 0 2.9865609985080255e-10
and O 0 2.433462875650605e-10
, O 0 7.974190058268604e-11
therefore O 0 4.356447494413551e-11
, O 0 1.6685824597018062e-11
cast O 0 2.6986787804439416e-10
some O 0 2.1559027132966868e-11
doubt O 0 7.250387512591772e-10
upon O 0 1.1930127719050887e-10
the O 0 1.7839489607762715e-10
hypothesis O 0 5.112155143649488e-10
that O 0 7.390071887769523e-11
cardiac B-Disease 0 0.0022940889466553926
defects I-Disease 0 0.0001228542678290978
in O 0 5.861698681997041e-09
EDMD B-Disease 1 1.0
are O 0 1.3913092899997537e-09
caused O 0 1.462206911106989e-09
by O 0 1.0287472956838073e-10
absence O 0 4.849771073622833e-08
of O 0 1.426313502861376e-07
emerin O 0 0.00022285257000476122
from O 0 4.4472351135027566e-08
intercalated O 0 3.266212297603488e-05
discs O 0 3.950711106881499e-05
. O 0 6.516229404951446e-07

Although O 0 1.2609712030098308e-07
emerin O 0 7.522019132011337e-06
was O 0 2.5285027405175242e-08
abundant O 0 8.448351351830752e-09
in O 0 3.413499760629435e-10
the O 0 5.371041389423681e-09
membranes O 0 1.7807618490905952e-08
of O 0 9.169273340603468e-08
cardiomyocyte O 0 4.527915280050365e-06
nuclei O 0 1.939380211979369e-08
, O 0 6.87057702397631e-11
it O 0 2.4040651414036773e-11
was O 0 8.438330589832788e-10
absent O 0 2.6195596802836008e-09
from O 0 7.959678055557973e-11
many O 0 3.15843434739449e-10
non O 0 3.308878149255179e-08
- O 0 3.103391676972933e-08
myocyte O 0 6.563817009919148e-07
cells O 0 9.526869571008234e-11
in O 0 7.673869178992376e-11
the O 0 1.0930999216895998e-08
heart O 0 8.564422842027852e-07
. O 0 1.3042857460732193e-07

This O 0 3.749269783526188e-09
distribution O 0 1.0786538773288612e-08
of O 0 1.6588588280797012e-08
emerin O 0 5.669308848155197e-06
was O 0 9.321484029101157e-09
similar O 0 1.7633536297800845e-10
to O 0 8.180141980451694e-11
that O 0 4.1779038562062e-11
of O 0 8.629847947361213e-09
lamin O 0 1.0352755452913698e-06
A O 0 1.2543281400212436e-06
, O 0 1.4585858076898717e-09
a O 0 7.912078769933828e-10
candidate O 0 1.9831603026432276e-09
gene O 0 1.2205404742449133e-10
for O 0 6.161753746125598e-11
an O 0 2.0401645650647282e-10
autosomal O 0 8.015373964553874e-08
form O 0 1.6907833355617186e-08
of O 0 1.7532462152303196e-05
EDMD B-Disease 1 1.0
. O 0 1.845348151618964e-06

In O 0 1.9300884446238342e-08
contrast O 0 4.379706908252956e-08
, O 0 1.1686811518529794e-08
lamin O 0 1.563694058859255e-05
B1 O 0 0.2692221999168396
was O 0 2.6023556642940093e-07
absent O 0 2.2580481129352847e-07
from O 0 6.199293522968219e-09
cardiomyocyte O 0 3.688449851324549e-06
nuclei O 0 1.064973886855114e-07
, O 0 8.37077906989947e-10
showing O 0 4.678044618344757e-09
that O 0 7.796472911714147e-10
lamin O 0 5.030777174397372e-06
B1 O 0 2.026964102697093e-05
is O 0 2.3380877789414e-10
not O 0 1.0717452099406888e-11
essential O 0 2.2619375816823606e-10
for O 0 3.7958566845297526e-11
localization O 0 1.925477377540119e-08
of O 0 3.3154989864669915e-08
emerin O 0 8.616168997832574e-06
to O 0 1.3544738663995304e-08
the O 0 1.0071398293121092e-07
nuclear O 0 3.3406283819203964e-06
lamina O 1 0.999687910079956
. O 0 1.6341989521606592e-06

Lamin O 0 0.04892202466726303
B1 O 1 0.9998946189880371
is O 0 1.456598752724858e-08
also O 0 1.327110421556199e-09
almost O 0 1.1718098713586755e-09
completely O 0 9.975841486209447e-09
absent O 0 1.4674546910953268e-08
from O 0 1.719181574877382e-09
skeletal O 0 2.4789860617602244e-05
muscle O 0 1.877712202258408e-05
nuclei O 0 2.6764196263684426e-06
. O 0 6.889798953579884e-08

In O 0 7.037315441493774e-08
EDMD B-Disease 1 1.0
, O 0 4.795269958890458e-09
the O 0 9.942745515800766e-10
additional O 0 2.3062436405041353e-09
absence O 0 9.407432166597118e-09
of O 0 4.014394505702512e-08
lamin O 0 2.4485221729264595e-05
B1 O 1 0.9999810457229614
from O 0 2.581738911544562e-08
heart O 1 1.0
and O 0 2.517610937502468e-06
skeletal O 1 1.0
muscle O 1 0.9997269511222839
nuclei O 0 9.87395992524398e-07
which O 0 1.3389835074040235e-10
already O 0 4.4914902352921615e-10
lack O 0 2.0701285130542146e-09
emerin O 0 6.790593261030153e-07
may O 0 1.0790437987573398e-10
offer O 0 2.5158805594394096e-11
an O 0 3.705470392328936e-12
alternative O 0 1.4835450923289528e-10
explanation O 0 6.833617005597148e-11
of O 0 7.992603801021403e-10
why O 0 6.887243553244105e-10
these O 0 2.35007902027462e-10
tissues O 0 9.310148207930524e-09
are O 0 3.222669353597496e-11
particularly O 0 2.1297386076923885e-10
affected O 0 1.3973995294236374e-09
. O 0 1.5888824700382997e-09
. O 0 3.1846187908968204e-08

Genetic O 0 2.8849493105553847e-07
mapping O 0 1.7621719194949037e-08
of O 0 1.3127302622706338e-07
the O 0 3.673319781682949e-07
copper B-Disease 0 4.3149582779733464e-05
toxicosis I-Disease 0 0.006826390977948904
locus O 0 5.656169832946034e-06
in O 0 6.067505609053114e-08
Bedlington O 0 4.316176273277961e-05
terriers O 0 1.1333099791954737e-05
to O 0 1.0094280078476459e-08
dog O 0 4.294783195746277e-08
chromosome O 0 4.396728758848667e-09
10 O 0 4.781823270683105e-10
, O 0 3.789794172925909e-11
in O 0 5.7529682406798344e-11
a O 0 1.115554204567104e-09
region O 0 2.516685704279098e-08
syntenic O 0 2.305014959347318e-06
to O 0 5.32780086714979e-09
human O 0 1.4923786650911097e-08
chromosome O 0 7.229790810470149e-08
region O 0 1.7915381533839536e-07
2p13 O 0 7.059347990434617e-05
- O 0 1.782088838808704e-05
p16 O 0 1.2039876310154796e-05
. O 0 2.2802987587056123e-07

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 0 4.4924734538653865e-05
accumulation I-Disease 0 4.680654001276707e-06
is O 0 2.028045287261193e-09
recognized O 0 3.889220945296756e-09
as O 0 2.8213267833088196e-10
an O 0 9.215904706039169e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 3.409663662523599e-08
man O 0 1.3678703503217093e-08
, O 0 6.123164753013555e-10
mouse O 0 8.822900099403341e-08
, O 0 5.689073656611754e-09
rat O 0 9.062964636541437e-06
and O 0 1.5396233266073978e-07
dog O 0 4.681100563175278e-06
. O 0 4.2513875087024644e-07

The O 0 2.6908233508038393e-07
major O 0 3.4549179872556124e-06
cause O 0 1.960069675988052e-05
of O 1 0.9689124822616577
hepatic B-Disease 1 1.0
copper I-Disease 0 0.04690328240394592
accumulation I-Disease 0 4.234213065501535e-06
in O 0 3.9799021855913e-09
man O 0 1.1654266884875142e-08
is O 0 5.859303597866017e-10
a O 0 1.5586769652742305e-09
dysfunctional O 0 1.2413435968028352e-07
ATP7B O 1 1.0
gene O 0 1.6436155547694398e-08
, O 0 7.606156260386854e-10
causing O 0 7.670836055240216e-08
Wilson B-Disease 0 2.7652520202536834e-06
disease I-Disease 0 3.353242618686636e-06
( O 0 1.247466752118953e-08
WD B-Disease 1 1.0
) O 0 3.443768292754612e-08
. O 0 6.305454292032664e-08

Mutations O 0 2.6401573904877296e-07
in O 0 2.759949158104291e-09
the O 0 1.2795291937095499e-08
ATP7B O 1 0.9998766183853149
genes O 0 9.43981670609162e-10
have O 0 1.3890725375498292e-11
also O 0 4.062654032632729e-11
been O 0 1.0871915173682467e-10
demonstrated O 0 7.181570893521894e-10
in O 0 6.142629738192795e-10
mouse O 0 3.0409242413043103e-07
and O 0 5.6969060580058795e-08
rat O 0 4.5285705709829926e-05
. O 0 3.5114064189656347e-07

The O 0 1.9941969640058232e-06
ATP7B O 1 1.0
gene O 0 1.0801774585900148e-08
has O 0 5.332495001120208e-10
been O 0 2.2152113476892055e-10
excluded O 0 2.5981876650149616e-09
in O 0 2.7628534876589228e-11
the O 0 8.107358673292708e-10
much O 0 4.6795793906539984e-09
rarer O 0 9.232694537786301e-07
human O 0 2.657623383583996e-07
copper B-Disease 0 0.49790358543395996
overload I-Disease 0 0.0003908722719643265
disease O 0 0.00032075418857857585
non B-Disease 0 0.0001328317739535123
- I-Disease 0 1.3555046507462976e-06
Indian I-Disease 0 8.55815063260934e-09
childhood I-Disease 0 2.059769258266897e-06
cirrhosis I-Disease 1 0.9999988079071045
, O 0 2.1386299398074016e-09
indicating O 0 1.3999986947510479e-08
genetic O 0 8.151199892836303e-08
heterogeneity O 0 1.1311980188111193e-06
. O 0 6.839781718781524e-08

By O 0 2.035633439589901e-09
investigating O 0 7.3757160379273046e-09
the O 0 3.423446415240505e-08
common O 0 2.069137053695158e-06
autosomal O 1 0.9999996423721313
recessive O 1 1.0
copper B-Disease 1 0.9999997615814209
toxicosis I-Disease 1 0.9999998807907104
( O 0 1.8061296458427023e-08
CT B-Disease 1 0.9902517795562744
) O 0 2.381072672363871e-09
in O 0 2.153233813473321e-09
Bedlington O 0 1.1564350643311627e-05
terriers O 0 2.1606397240248043e-06
, O 0 7.917150823821828e-10
we O 0 5.5384984792850034e-11
have O 0 3.8380214804900614e-12
identified O 0 2.5665638017646764e-11
a O 0 1.0009408232813932e-11
new O 0 4.866155048355303e-11
locus O 0 1.4514375479279806e-08
involved O 0 4.526579111541196e-10
in O 0 1.0205317702016714e-09
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.732513332328381e-07

We O 0 3.2855840714773876e-08
examined O 0 2.775978913405197e-08
whether O 0 2.23114771102928e-09
the O 0 9.078672924545117e-09
WD B-Disease 1 0.999995231628418
gene O 0 1.898010424383756e-07
ATP7B O 1 1.0
was O 0 1.2173035202067695e-07
also O 0 2.3071589083656363e-09
causative O 0 7.552976910574216e-08
for O 0 4.468768688425939e-10
CT B-Disease 0 1.4326406017062254e-06
by O 0 1.1331513505297153e-10
investigating O 0 1.958650353017788e-09
the O 0 9.591404115383284e-09
chromosomal O 0 9.4494964741898e-07
co O 0 1.939827853902898e-08
- O 0 3.373934021055902e-08
localization O 0 8.372639115350466e-08
of O 0 7.217334996312275e-08
ATP7B O 1 0.9999998807907104
and O 0 4.5030037476578855e-09
C04107 O 0 3.975853246629413e-07
, O 0 2.07177885958032e-10
using O 0 2.2684269740391727e-10
fluorescence O 0 7.730185380694365e-09
in O 0 2.133394572112479e-09
situ O 0 9.61981186264893e-07
hybridization O 0 1.1927636656139384e-08
( O 0 8.13598632909418e-10
FISH O 0 1.025715278046846e-06
) O 0 2.6805506703198034e-09
. O 0 1.4653624980098812e-08

C04107 O 0 0.0001645682059461251
is O 0 5.712356454523615e-08
an O 0 2.1513864023603446e-09
anonymous O 0 1.0220912116665204e-07
microsatellite O 0 2.8502831810328644e-06
marker O 0 2.375155645495397e-06
closely O 0 4.852871171578954e-08
linked O 0 5.018151796321035e-07
to O 0 7.322160655576226e-08
CT B-Disease 1 1.0
. O 0 6.716269922435458e-07

However O 0 3.6804939895773714e-07
, O 0 9.983058646412246e-08
BAC O 1 1.0
clones O 0 4.5143160605221055e-06
containing O 0 3.1280694656743435e-07
ATP7B O 1 0.9999990463256836
and O 0 5.018467064132892e-08
C04107 O 0 4.6651725824631285e-06
mapped O 0 9.026496883279833e-08
to O 0 3.635822976022496e-09
the O 0 2.322347647520928e-08
canine O 0 3.373301979081589e-06
chromosome O 0 1.368588584682584e-07
regions O 0 4.709039558292716e-08
CFA22q11 O 0 2.209646481787786e-05
and O 0 5.078899523169866e-09
CFA10q26 O 0 1.255451570614241e-05
, O 0 5.284884752043695e-10
respectively O 0 1.7082080194796845e-10
, O 0 7.420962455650937e-11
demonstrating O 0 5.939848057856523e-10
that O 0 1.2323066178598907e-10
WD B-Disease 0 0.0009340379037894309
cannot O 0 3.988359864592894e-09
be O 0 2.701109336200602e-10
homologous O 0 1.2084238054654861e-09
to O 0 2.734545923033238e-09
CT B-Disease 0 0.20839600265026093
. O 0 3.3401843779756746e-07

The O 0 2.24315976993239e-06
copper O 0 8.673248430568492e-07
transport O 0 3.16514388032374e-08
genes O 0 1.2737872978618725e-08
CTR1 O 1 0.9819943308830261
and O 0 1.8143332169984205e-08
CTR2 O 1 1.0
were O 0 2.4837611967143403e-09
also O 0 1.2013181560632802e-09
excluded O 0 1.3290971878632263e-08
as O 0 2.8102203897262257e-10
candidate O 0 1.946624639259653e-09
genes O 0 1.4569223605320758e-10
for O 0 9.32321789215429e-11
CT B-Disease 0 0.26849907636642456
since O 0 1.35429756298322e-09
they O 0 4.212296345063038e-10
both O 0 4.903462635930111e-10
mapped O 0 8.421874042596755e-08
to O 0 6.120669304721105e-09
canine O 0 9.049111213244032e-06
chromosome O 0 1.4609944400945096e-06
region O 0 5.698274776477774e-07
CFA11q22 O 0 0.015779072418808937
. O 0 1.096729533855978e-06

2 O 0 6.378019406838575e-06
- O 0 6.4157206907111686e-06
22 O 0 7.282769729499705e-07
. O 0 1.5835803424124606e-07

5 O 0 1.7535337974550202e-05
. O 0 1.67133600825764e-06

A O 0 2.2105512016423745e-06
transcribed O 0 5.930956348265681e-08
sequence O 0 1.377864489171543e-09
identified O 0 6.034722166425865e-10
from O 0 1.3653769781463154e-10
the O 0 3.188379116281226e-09
C04107 O 0 7.382889180007624e-07
- O 0 2.2446634773132246e-07
containing O 0 9.201789907820057e-08
BAC O 1 1.0
was O 0 4.219004257066672e-09
found O 0 3.40183090030699e-11
to O 0 2.6163262528688946e-11
be O 0 1.7660792966944783e-11
homologous O 0 1.525478354746923e-11
to O 0 1.208637634420029e-10
a O 0 1.7784800299125436e-09
gene O 0 2.936365151029463e-09
expressed O 0 8.587972000206889e-10
from O 0 7.091786602408945e-10
human O 0 4.464741021337204e-09
chromosome O 0 1.329533194649457e-08
2p13 O 0 2.5400851200174657e-07
- O 0 4.908052630980819e-08
p16 O 0 2.9587138072884045e-08
, O 0 1.2811664229506192e-10
a O 0 9.260726213655701e-11
region O 0 2.685217381781513e-09
devoid O 0 1.0042817422117878e-07
of O 0 8.843957566284644e-09
any O 0 9.140353363079612e-09
positional O 0 9.189878937831963e-07
candidate O 0 1.7236320104530023e-07
genes O 0 5.523452983879906e-08
. O 0 5.5365319440170424e-08

Molecular O 0 4.7751747445090587e-08
analysis O 0 1.015014849947704e-09
of O 0 1.2516469638512717e-08
the O 0 1.9499736936268164e-08
APC B-Disease 0 5.858432245986478e-07
gene O 0 1.0446413734044313e-09
in O 0 2.2303212054985977e-10
205 O 0 2.6157849219998752e-09
families O 0 1.7152756645599787e-11
: O 0 3.355548477967929e-11
extended O 0 4.3955719064570076e-09
genotype O 0 1.094695978309801e-08
- O 0 7.549606806378506e-08
phenotype O 0 9.362752351194104e-09
correlations O 0 2.315177383138689e-09
in O 0 5.68948048396134e-11
FAP B-Disease 0 3.63146625659283e-07
and O 0 1.9207208740157355e-11
evidence O 0 1.653883627272812e-11
for O 0 6.445522934828141e-12
the O 0 1.2734362175859104e-10
role O 0 8.955902686125228e-10
of O 0 5.759034138463903e-09
APC B-Disease 0 5.620523211291584e-07
amino O 0 1.876563082703342e-08
acid O 0 6.331942081772013e-09
changes O 0 1.445739639116539e-09
in O 0 1.3721034974878421e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 2.723632519519015e-07

BACKGROUND O 0 2.217156725237146e-05
/ O 0 2.084762627418968e-06
AIMS O 0 5.025449354434386e-06
The O 0 1.5688446097783526e-09
development O 0 9.441869508464151e-10
of O 0 3.5878713333659107e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.7480984154948374e-09
a O 0 1.0157231999929905e-10
variable O 0 2.0821340485088768e-10
range O 0 1.4915584323205167e-09
of O 0 1.3548090427306647e-09
extracolonic O 0 1.1057308029194246e-06
manifestations O 0 2.0833306280110264e-07
in O 0 3.0313167087570037e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.2315870868160346e-08
FAP B-Disease 0 0.007379267364740372
) O 0 9.982149828946518e-11
is O 0 8.175302448898414e-12
the O 0 1.0990292009793734e-11
result O 0 2.327683358560595e-11
of O 0 3.5524105879147783e-10
the O 0 1.3840569801359948e-09
dominant O 0 2.0981909187867132e-07
inheritance O 0 3.458517539911554e-06
of O 0 3.960722824558616e-05
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.632387025551907e-08
APC B-Disease 0 5.955259325673978e-07
) O 0 3.1282312296099235e-09
gene O 0 3.476429455417929e-08
mutations O 0 5.52211503190847e-08
. O 0 3.356142741495205e-08

In O 0 1.329021070972658e-08
this O 0 1.43671977093085e-10
study O 0 1.1825687651345618e-10
, O 0 6.675061892114087e-11
direct O 0 1.2729213516582405e-10
mutation O 0 2.4549249785787985e-11
analysis O 0 1.531162696633004e-11
of O 0 1.058522824948227e-09
the O 0 1.0784934723062634e-08
APC B-Disease 0 8.772205433160707e-07
gene O 0 3.8030205651296e-09
was O 0 7.756577602435755e-09
performed O 0 3.203563636589024e-09
to O 0 3.802989312351457e-10
determine O 0 2.3272239690896868e-09
genotype O 0 2.6583109047351172e-09
- O 0 3.77000262119509e-08
phenotype O 0 7.208665220304056e-09
correlations O 0 4.117821639226804e-09
for O 0 4.926561936180462e-10
nine O 0 2.8508524430037596e-09
extracolonic O 0 6.216951646820235e-07
manifestations O 0 2.3067375565233306e-08
and O 0 1.8566133352937442e-10
to O 0 1.1892187234963103e-10
investigate O 0 2.0210098039541435e-09
the O 0 6.333001345559808e-10
incidence O 0 1.3792093511710846e-07
of O 0 1.328931489297247e-07
APC B-Disease 0 8.933218850870617e-06
mutations O 0 6.678404940174687e-09
in O 0 5.5716115054949e-10
non O 0 0.05895787850022316
- O 1 0.9999996423721313
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.94607923226431e-07

METHODS O 0 3.1720508104626788e-06
The O 0 1.741651090014784e-07
APC B-Disease 0 1.0918631687673042e-06
gene O 0 4.054143243337194e-09
was O 0 4.093920757952674e-09
analysed O 0 9.00986041330043e-09
in O 0 2.8606828017530006e-10
190 O 0 7.887235753401e-09
unrelated O 0 1.555793716079279e-08
FAP B-Disease 0 2.6738714950624853e-05
and O 0 1.5949613851873323e-09
15 O 0 1.740552768580983e-08
non O 0 1.2324462659307756e-05
- O 1 0.9999799728393555
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 5.0498080383931665e-08
using O 0 6.551603703996989e-10
denaturing O 0 1.2338928172539454e-06
gradient O 0 1.789375936311899e-08
gel O 0 2.510199337280028e-08
electrophoresis O 0 3.0164808428878587e-09
, O 0 7.553916520075532e-11
the O 0 4.719122870255887e-10
protein O 0 1.4020173910722633e-10
truncation O 0 2.059503012574737e-09
test O 0 2.3059873455189006e-10
, O 0 4.765250000149379e-11
and O 0 3.22444182465631e-10
direct O 0 5.75560799020991e-09
sequencing O 0 2.2185201231650353e-08
. O 0 2.0423312818707018e-08

RESULTS O 0 1.0309237040928565e-05
Chain O 0 2.452271132824535e-07
terminating O 0 1.5168982514524032e-08
signals O 0 7.231356069503647e-10
were O 0 5.991800805515979e-11
only O 0 4.2127360627697286e-11
identified O 0 2.159837586557245e-11
in O 0 2.371692252312041e-11
patients O 0 3.4716285401970026e-10
belonging O 0 4.127922656471661e-11
to O 0 3.081188082454389e-10
the O 0 3.7020093657247344e-08
FAP B-Disease 1 0.9999997615814209
group O 0 2.2090356210924256e-09
( O 0 2.5691218596968213e-10
105 O 0 6.654655493321116e-08
patients O 0 1.4668998238320796e-09
) O 0 7.935852530671639e-10
. O 0 2.7148043812985634e-08

Amino O 0 3.398347985239525e-07
acid O 0 6.9380878819913505e-09
changes O 0 1.6397873336959634e-10
were O 0 2.9602275491980024e-11
identified O 0 1.9089094888125047e-11
in O 0 1.0404406503017327e-11
four O 0 2.681069255494606e-11
patients O 0 9.335312904645843e-12
, O 0 5.1949529747408185e-12
three O 0 2.133559301453758e-11
of O 0 4.940047926282887e-09
whom O 0 2.2924200315799226e-09
belonged O 0 4.308819523402008e-09
to O 0 1.2852029440679757e-09
the O 0 2.9764530395937072e-08
non O 0 0.0001828937092795968
- O 0 2.407258580205962e-05
FAP O 1 1.0
group O 0 5.31592458941077e-09
of O 0 4.554432507575257e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.9101837551716017e-06
. O 0 5.076178144491905e-09

Genotype O 0 3.0075863833189942e-05
- O 0 2.6548063942755107e-06
phenotype O 0 6.828962284544104e-08
correlations O 0 1.2566536256031213e-08
identified O 0 5.510041867218263e-10
significant O 0 1.0080499768250206e-09
differences O 0 1.4374358370261575e-09
in O 0 7.121427753054022e-11
the O 0 1.0763823166115571e-09
nature O 0 1.0316210996563768e-08
of O 0 1.3114346941733857e-08
certain O 0 3.6852984663937605e-08
extracolonic O 0 5.407945081969956e-06
manifestations O 0 3.768673195736483e-07
in O 0 1.3107213092666825e-09
FAP B-Disease 0 0.2664061188697815
patients O 0 1.892633383349107e-09
belonging O 0 1.6484046072573477e-10
to O 0 4.1360187497119227e-10
three O 0 5.77939163193264e-09
mutation O 0 1.1309569458717306e-07
subgroups O 0 3.701205173456401e-07
. O 0 2.1185101672926976e-08

CONCLUSIONS O 0 1.0796132301038597e-05
Extended O 0 1.008758431453316e-06
genotype O 0 1.3177789526253036e-07
- O 0 1.707301748865575e-07
phenotype O 0 9.43118294571832e-09
correlations O 0 6.234035954122419e-09
made O 0 5.197950958546471e-10
in O 0 3.3690803619146337e-11
this O 0 7.135414221287606e-12
study O 0 1.3637860805937319e-11
may O 0 1.109998638143539e-11
have O 0 2.306548181618684e-12
the O 0 3.1813111173173425e-11
potential O 0 1.0580278320126979e-10
to O 0 8.734291935541538e-12
determine O 0 7.68462030120709e-11
the O 0 2.1176636832986873e-10
most O 0 1.1081059680950744e-10
appropriate O 0 4.956222099394836e-10
surveillance O 0 1.070376054457256e-08
and O 0 7.254845169057944e-09
prophylactic O 0 1.6385905610150076e-06
treatment O 0 9.179156101879471e-09
regimens O 0 2.876962890141499e-09
for O 0 5.898791437947137e-12
those O 0 1.694771580018628e-11
patients O 0 7.195220114164513e-12
with O 0 4.360784736784362e-12
mutations O 0 7.023069348299771e-10
associated O 0 3.293285366634535e-10
with O 0 8.559843944766499e-10
life O 0 4.071620196555159e-08
threatening O 0 4.756204248224094e-07
conditions O 0 1.1711149028315049e-07
. O 0 8.802594919643525e-08

This O 0 1.934499005429302e-09
study O 0 3.3187097514542074e-10
also O 0 3.800014816701669e-11
provided O 0 1.2226321517705419e-11
evidence O 0 2.7128228483053185e-11
for O 0 9.662583233538413e-11
the O 0 2.8567856968919614e-09
pathological O 0 4.965102675669186e-07
nature O 0 4.796825159303353e-09
of O 0 4.7690917881482164e-09
amino O 0 1.9420407504355808e-09
acid O 0 7.308549321294322e-10
changes O 0 5.397799915374257e-11
in O 0 2.5740153064557347e-11
APC O 0 2.2537832933267055e-08
associated O 0 2.1854563991841047e-10
with O 0 7.572829169300022e-11
both O 0 5.930316238078603e-10
FAP B-Disease 1 0.9998507499694824
and O 0 3.902052903015374e-09
non O 1 0.9355260729789734
- O 1 0.9999990463256836
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 9.274081058663342e-09
. O 0 5.3145401274212745e-11
. O 0 1.9803327866441123e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.014604630880057812
cancer B-Disease 1 0.9999723434448242
risk O 0 7.74869818087609e-07
of O 0 4.305116618752436e-08
the O 0 5.8505211342207986e-08
APC O 0 4.436202289070934e-06
I1307K O 0 5.461478849611012e-06
polymorphism O 0 1.4726116148722213e-07
. O 0 6.632986782051375e-08

Germ O 0 3.548697350197472e-05
- O 0 1.7736489326125593e-06
line O 0 4.576335470574122e-07
and O 0 8.511852556125632e-09
somatic O 0 1.5247572093812778e-07
truncating O 0 3.482635406726331e-07
mutations O 0 4.896642202822932e-09
of O 0 6.317923517684676e-09
the O 0 1.1230931740158212e-08
APC B-Disease 0 4.274617708688311e-07
gene O 0 2.0730526184564724e-09
are O 0 3.421182434570902e-11
thought O 0 3.211441945705218e-10
to O 0 2.4069016224537165e-10
initiate O 0 2.6916649176200735e-07
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 0 2.0621514522645157e-06
in O 0 4.908586248575375e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.4686588062650117e-07
sporadic O 1 0.6242722272872925
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 5.7346813520098294e-08
respectively O 0 5.114832646313516e-08
. O 0 9.723068927769418e-08

Recently O 0 2.0801671780645847e-06
, O 0 2.83399295142317e-08
an O 0 1.8116498523568225e-08
isoleucine O 0 6.156776362331584e-05
- O 0 8.909582902560942e-06
- O 0 2.901382003983599e-06
> O 0 1.6581793715886306e-07
lysine O 0 1.5133646513731946e-07
polymorphism O 0 4.362870953400488e-09
at O 0 7.1608119434074524e-09
codon O 0 2.332495796508738e-08
1307 O 0 2.969447905343259e-07
( O 0 4.563543709590334e-10
I1307K O 0 3.215472759166005e-07
) O 0 2.094617396197762e-10
of O 0 4.002107090173013e-09
the O 0 1.660257886726413e-08
APC B-Disease 0 2.950909276933089e-07
gene O 0 9.952839663540658e-10
has O 0 2.059093590078831e-10
been O 0 4.2880810013912196e-11
identified O 0 2.0052494387190478e-11
in O 0 1.320634747392635e-11
6 O 0 1.6271700653547327e-09
% O 0 2.7039634420411574e-11
- O 0 8.319557820435364e-10
7 O 0 1.3391682207597455e-09
% O 0 3.219277969201961e-11
of O 0 1.7868026502831924e-10
the O 0 6.041597777617369e-10
Ashkenazi O 0 8.150682795360353e-09
Jewish O 0 7.505296828469454e-09
population O 0 1.7725459988682246e-10
. O 0 5.9220228720846535e-09

To O 0 8.369776871575141e-09
assess O 0 7.177879979280988e-08
the O 0 4.514070894856559e-09
risk O 0 8.400756534854281e-09
of O 0 9.346867724246977e-10
this O 0 9.104222931100026e-11
common O 0 4.005497711290218e-09
APC B-Disease 0 7.672605875086447e-07
allelic O 0 2.1968739929434378e-06
variant O 0 1.2272317917449982e-06
in O 0 2.77515308511056e-08
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 6.829688814491419e-09
we O 0 3.754240807118947e-10
have O 0 1.8671595519714757e-11
analyzed O 0 3.8017416992275344e-10
a O 0 2.9865311612642387e-11
large O 0 3.974324480626734e-10
cohort O 0 6.603545710248682e-09
of O 0 5.345043074811429e-09
unselected O 0 1.0929394193226472e-05
Ashkenazi O 0 2.821674094377613e-08
Jewish O 0 2.7896943421978904e-08
subjects O 0 7.10834200390309e-08
with O 0 1.310663799714007e-09
adenomatous B-Disease 0 0.0010490628192201257
polyps I-Disease 0 3.455603291513398e-05
and O 0 2.058623493894629e-09
. O 0 1.631688895109562e-09
or O 0 1.442539087292971e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.144830896748772e-09
for O 0 2.2165808077900806e-10
the O 0 1.0468658828699517e-08
APC O 0 1.6184598052859656e-06
I1307K O 0 3.872756678902078e-06
polymorphism O 0 5.799934044148358e-08
. O 0 4.585667312539954e-08

The O 0 1.6438621059933212e-06
APC O 0 6.711392416036688e-06
I1307K O 0 3.345665845699841e-06
allele O 0 4.9895643172703785e-09
was O 0 3.691501548885867e-09
identified O 0 2.2109902797495806e-10
in O 0 1.850024300420472e-10
48 O 0 9.018783941883157e-09
( O 0 4.411693926842375e-11
10 O 0 2.5281432503021506e-10
. O 0 1.498934830423959e-11
1 O 0 1.3997950576438711e-09
% O 0 4.821899476925573e-11
) O 0 4.138565531941474e-11
of O 0 3.2354707801829363e-09
476 O 0 1.7642308591803157e-07
patients O 0 6.022272902583836e-09
. O 0 1.2980982511123784e-08

Compared O 0 5.748169940034131e-09
with O 0 3.073638218942243e-11
the O 0 2.5468541164919145e-10
frequency O 0 1.492155149440677e-10
in O 0 3.725904307305683e-11
two O 0 9.48400941114258e-11
separate O 0 6.167009264368417e-11
population O 0 2.722374626076829e-12
control O 0 2.3080598543501196e-10
groups O 0 5.072869641714606e-12
, O 0 6.031704302689178e-11
the O 0 2.7246229716837433e-09
APC O 0 9.633261015551398e-07
I1307K O 0 3.073196694458602e-06
allele O 0 2.5709365747417223e-09
is O 0 4.001293740785172e-11
associated O 0 2.4781463339729193e-11
with O 0 1.6395801383239927e-11
an O 0 2.6138521902474565e-11
estimated O 0 1.9130219630625334e-10
relative O 0 7.886359898456874e-10
risk O 0 3.642583790153253e-09
of O 0 1.1328995519477303e-08
1 O 0 6.333556825666165e-07
. O 0 9.025739444723513e-08

5 O 0 3.0539140425389633e-06
- O 0 2.8993354135309346e-06
1 O 0 1.11498661681253e-06
. O 0 1.7386955164511164e-07

7 O 0 1.0977581723636831e-06
for O 0 9.197999872867513e-08
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 1.9925565197809192e-08
both O 0 1.528358062330426e-08
P O 0 2.496401975804474e-06
= O 0 3.338315845979878e-09
. O 0 7.108240662745402e-10
01 O 0 5.314589088811772e-07
) O 0 4.219744997868702e-09
. O 0 4.512205364903821e-08

Furthermore O 0 1.0258820992703477e-07
, O 0 1.3789924757645622e-09
compared O 0 2.567989987323216e-10
with O 0 5.268500080646277e-10
noncarriers O 0 2.160366057069041e-05
, O 0 2.2960183088116537e-08
APC O 0 2.424959802738158e-06
I1307K O 0 2.037287003986421e-06
carriers O 0 2.129784126836398e-09
had O 0 1.4159137751157402e-10
increased O 0 6.114466571949251e-11
numbers O 0 2.8824196501853194e-11
of O 0 1.909486790907522e-09
adenomas B-Disease 1 0.9999970197677612
and O 0 0.4056181311607361
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 6.067019597821854e-08
patient O 0 3.1718585091766727e-08
( O 0 9.552506702315e-11
P O 0 4.0793313615949955e-08
= O 0 7.036526916692765e-11
. O 0 9.946547925576699e-12
03 O 0 2.0272032941193174e-08
) O 0 2.862531565950288e-11
, O 0 3.6591254332085654e-11
as O 0 4.8524195078725185e-11
well O 0 7.007463359576249e-11
as O 0 1.1239043029576123e-10
a O 0 2.2788175513266395e-10
younger O 0 1.7305977761949976e-09
age O 0 2.9319271455108264e-09
at O 0 5.036809191949487e-09
diagnosis O 0 3.0887207458363264e-07
. O 0 1.136506782017932e-07

We O 0 5.497806654375381e-08
conclude O 0 1.4168418438487151e-08
that O 0 1.5357320970466048e-10
the O 0 7.452488404169344e-09
APC O 0 4.951340997649822e-06
I1307K O 0 2.2601716409553774e-05
variant O 0 1.2638814723686664e-06
leads O 0 3.3497343565613846e-08
to O 0 1.1947804967604725e-09
increased O 0 6.135655894468073e-08
adenoma B-Disease 1 1.0
formation O 0 2.56127259490313e-06
and O 0 2.3051981656863063e-08
directly O 0 6.657750351024561e-09
contributes O 0 2.7843769512259087e-09
to O 0 6.603589897125062e-11
3 O 0 6.471916336181494e-10
% O 0 1.2724667673713608e-11
- O 0 1.3971802881318496e-10
4 O 0 1.8935494838778766e-10
% O 0 4.7131187841387145e-12
of O 0 2.426990726445144e-11
all O 0 4.9903206567059044e-11
Ashkenazi O 0 3.466589859613123e-08
Jewish O 0 1.9100652934866957e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.9790620576241054e-07

The O 0 7.221755993214174e-08
estimated O 0 5.111903789156713e-09
relative O 0 5.9663527451903065e-09
risk O 0 1.0343538470181102e-08
for O 0 3.1354818741391455e-10
carriers O 0 1.1798387822281597e-09
may O 0 9.469314915522276e-11
justify O 0 3.051956687372126e-09
specific O 0 3.029764494844045e-10
clinical O 0 2.98342961446707e-10
screening O 0 3.2152419615627537e-10
for O 0 4.965927669076109e-11
the O 0 4.3890771572741016e-10
360 O 0 1.8822976510790568e-09
, O 0 2.3106972932285252e-11
000 O 0 3.1922414711615943e-10
Americans O 0 2.228074062055052e-12
expected O 0 2.407460862607902e-11
to O 0 3.133830001056381e-11
harbor O 0 2.158745360247849e-08
this O 0 7.823085061697821e-12
allele O 0 5.7651172030714903e-11
, O 0 5.409518319399176e-11
and O 0 4.586893365132738e-11
genetic O 0 6.587311252026495e-11
testing O 0 2.5582747725794164e-11
in O 0 5.426038958422641e-12
the O 0 1.5917300810741608e-10
setting O 0 1.648377212504215e-09
of O 0 1.8322841022211378e-09
long O 0 1.1814781375463212e-09
- O 0 1.826060902487825e-08
term O 0 4.1141716700110464e-09
- O 0 5.601834551782758e-09
outcome O 0 1.4458444441700635e-09
studies O 0 1.9991250321815812e-10
may O 0 2.7903073948620793e-11
impact O 0 1.286083239904201e-09
significantly O 0 9.164929370975017e-10
on O 0 1.588517477557616e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 2.5266378997912398e-06
in O 0 8.177146459953377e-11
this O 0 2.6967220123630398e-11
population O 0 1.1146348427581998e-10
. O 0 3.812258064783691e-09

Localization O 0 8.783079579188779e-07
of O 0 2.708745796553558e-07
human O 0 3.413027727106055e-08
BRCA1 O 0 4.780569540230317e-08
and O 0 3.794388969691198e-10
its O 0 1.0997893706843342e-09
loss O 0 6.058344936832327e-09
in O 0 3.3164932605744823e-11
high O 0 3.2982168107764664e-08
- O 0 2.942674015571356e-08
grade O 0 9.9883152415714e-08
, O 0 5.275246905966924e-10
non B-Disease 0 2.6288239496352617e-06
- I-Disease 0 7.5981741247233e-05
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 4.089868070877856e-06

Although O 0 2.3663277559649032e-08
the O 0 4.615957394094039e-09
link O 0 5.528509205987575e-09
between O 0 1.5990552215683351e-09
the O 0 4.9490196829538036e-08
BRCA1 O 0 7.3687265285116155e-06
tumour B-Disease 1 1.0
- O 0 2.3856639018049464e-05
suppressor O 0 0.0006672954186797142
gene O 0 2.125868903135597e-08
and O 0 1.1247503373112977e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 5.5557124872818164e-11
established O 0 2.4168925541467878e-11
, O 0 2.046507277878029e-12
the O 0 8.554938875360296e-12
role O 0 6.602053626014737e-11
, O 0 1.2859396707198822e-11
if O 0 1.4328630296156497e-11
any O 0 1.2430524665152376e-10
, O 0 7.64435945099784e-11
of O 0 3.4589138220297855e-09
BRCA1 O 0 1.1918079678707727e-07
in O 0 1.934155946514693e-09
non B-Disease 1 0.9999593496322632
- I-Disease 1 0.9975932240486145
familial I-Disease 1 0.9999558925628662
cancers I-Disease 1 1.0
is O 0 6.5697012274767985e-09
unclear O 0 6.60503252092326e-09
. O 0 1.489341805438471e-08

BRCA1 O 0 1.1372009794285987e-05
mutations O 0 1.737090293829624e-08
are O 0 2.224475464940312e-10
rare O 0 1.4557673955195582e-09
in O 0 3.009640314743933e-10
sporadic B-Disease 0 1.4528578731187736e-06
cancers I-Disease 1 0.9999997615814209
, O 0 9.838949655005536e-10
but O 0 4.3394901561022436e-10
loss O 0 8.779070981290715e-08
of O 0 4.7178096451716556e-07
BRCA1 O 0 2.1498865976354864e-07
resulting O 0 1.7968925236644395e-09
from O 0 1.180130715372485e-10
reduced O 0 8.30126989370683e-09
expression O 0 4.749463600184356e-10
or O 0 7.731489753970422e-11
incorrect O 0 7.666177692655651e-10
subcellular O 0 2.348074268354594e-08
localization O 0 1.7354542691805364e-08
is O 0 2.7633925703263174e-10
postulated O 0 7.639232579847999e-10
to O 0 3.816081131646776e-11
be O 0 2.5510338633183416e-11
important O 0 2.4269086740247303e-10
in O 0 1.6888801468439851e-10
non B-Disease 0 5.011923349229619e-06
- I-Disease 0 0.00010106881381943822
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 4.031702474094345e-07

Epigenetic O 0 0.00029382153297774494
loss O 0 2.9205453756731004e-05
, O 0 2.824073863649801e-09
however O 0 6.859320333951757e-10
, O 0 1.9393708861059622e-10
has O 0 4.263231781487242e-11
not O 0 1.4018509443547433e-11
received O 0 1.4649138846412058e-10
general O 0 1.7602956592366326e-10
acceptance O 0 1.1146651379689843e-09
due O 0 2.715978553169407e-09
to O 0 9.011935642178059e-10
controversy O 0 2.5483872789777706e-08
regarding O 0 7.321011796790344e-09
the O 0 7.2479160451166535e-09
subcellular O 0 9.487297347732238e-08
localization O 0 7.616441877189573e-08
of O 0 1.7947171215837443e-07
BRCA1 O 0 2.1970736341359043e-08
proteins O 0 3.338535350949634e-11
, O 0 8.145387142555194e-12
reports O 0 2.0292427460599782e-11
of O 0 3.0997207578487007e-10
which O 0 2.320944825218163e-11
have O 0 9.211747684090277e-12
ranged O 0 3.9356864989237295e-10
from O 0 1.119690711676169e-11
exclusively O 0 1.4064313602624168e-10
nuclear O 0 1.8730255124665973e-09
, O 0 6.865939761180329e-11
to O 0 2.5446789120309177e-10
conditionally O 0 5.70279823364217e-08
nuclear O 0 1.050235809429978e-08
, O 0 2.4336577197914266e-10
to O 0 3.742658682970301e-10
the O 0 1.2203274835087541e-08
ER O 0 0.3595149517059326
/ O 0 3.627215789947513e-07
golgi O 0 2.8773658300451643e-07
, O 0 1.4189722730151288e-09
to O 0 2.212248384481086e-09
cytoplasmic O 0 1.41372453299482e-07
invaginations O 0 2.0153308923909208e-06
into O 0 1.250816605846694e-08
the O 0 2.3370647639353592e-08
nucleus O 0 2.0883132378912705e-07
. O 0 4.438015821506269e-08

In O 0 2.5633779543454693e-08
an O 0 1.9765817871331137e-09
attempt O 0 3.771114975847922e-09
to O 0 2.1215568191124135e-10
resolve O 0 1.9827970376695703e-09
this O 0 4.394377223215784e-11
issue O 0 4.167672873478523e-09
, O 0 3.469986797899338e-10
we O 0 4.5846740293065125e-10
have O 0 5.916126477600869e-10
comprehensively O 0 1.7130898868344957e-06
characterized O 0 5.5995620584781136e-08
19 O 0 8.628173020497343e-08
anti O 0 7.323241675294412e-07
- O 0 6.386565473803785e-06
BRCA1 O 0 6.204004421306308e-07
antibodies O 0 2.9222031017184236e-08
. O 0 1.2577903163446535e-08

These O 0 1.6418835002696142e-07
reagents O 0 5.634057629322342e-07
detect O 0 2.0536757006084372e-07
a O 0 4.18453538486574e-09
220 O 0 9.071575490793293e-09
- O 0 6.168523469796128e-08
kD O 0 1.7366222891723737e-05
protein O 0 2.6577140488370787e-08
localized O 0 1.0213272361170311e-07
in O 0 2.7909474731302453e-10
discrete O 0 3.296076966918804e-09
nuclear O 0 1.3209693783267085e-08
foci O 0 3.081349930766919e-08
in O 0 1.2246913205782306e-10
all O 0 6.445357580986411e-10
epithelial O 0 6.219403658747069e-09
cell O 0 9.888184715478587e-10
lines O 0 1.0115823734224705e-09
, O 0 2.7658325282842178e-11
including O 0 2.761167856857316e-11
those O 0 6.800279089835826e-11
derived O 0 2.597061454778782e-10
from O 0 6.084594494915052e-10
breast B-Disease 0 5.3487299737753347e-05
malignancies I-Disease 0 1.8612281564855948e-05
. O 0 1.223532706262631e-07

Immunohistochemical O 0 3.468207796686329e-05
staining O 0 2.296221282449551e-06
of O 0 8.533832556167908e-07
human O 0 2.4713626700645364e-08
breast O 0 1.6192285556826391e-06
specimens O 0 3.397323311560285e-08
also O 0 1.0414383799783877e-09
revealed O 0 3.228475975447509e-08
BRCA1 O 0 6.169501034491987e-07
nuclear O 0 8.045885380170148e-08
foci O 0 6.011694040353177e-07
in O 0 3.6588847507346145e-09
benign O 1 1.0
breast O 1 1.0
, O 0 3.6360162880555436e-07
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 3.9938890949997585e-07
low B-Disease 1 0.9999953508377075
- I-Disease 1 0.9999721050262451
grade I-Disease 1 0.9845773577690125
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 2.0589581254171208e-05

Conversely O 0 1.5490329587919405e-06
, O 0 9.646981169453284e-08
BRCA1 O 0 2.3372838597879309e-07
expression O 0 2.4594641878650236e-09
was O 0 1.7935164464688569e-09
reduced O 0 2.9403275370043502e-09
or O 0 9.969516184815674e-11
undetectable O 0 2.3220096956322323e-09
in O 0 5.0126790739069005e-12
the O 0 7.527452966504811e-11
majority O 0 9.642897591533028e-12
of O 0 3.7630518145981284e-10
high O 0 1.0437918973593696e-07
- O 0 5.218703904574795e-07
grade O 0 4.25814141635783e-06
, O 0 2.9045144067652018e-09
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 1.6861136487023032e-08
suggesting O 0 8.763336722950044e-10
that O 0 4.794560581888874e-11
absence O 0 9.975365422576488e-09
of O 0 4.412003562492828e-08
BRCA1 O 0 1.0044904996675541e-07
may O 0 6.760086240786833e-11
contribute O 0 1.7270916641276557e-10
to O 0 2.1977114572635514e-11
the O 0 3.069603182748182e-10
pathogenesis O 0 4.7828311977582416e-08
of O 0 7.874249696726565e-09
a O 0 8.980808874348156e-10
significant O 0 7.812106517235406e-09
percentage O 0 2.7182188944152585e-08
of O 0 2.9403736334643327e-08
sporadic B-Disease 0 0.0005718441097997129
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 8.873678680743069e-09
. O 0 4.851455059906584e-08

